ID   ITB2L_MOUSE             Reviewed;         738 AA.
AC   Q3UV74; O88424; Q2KHL5;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   22-NOV-2017, entry version 106.
DE   RecName: Full=Integrin beta-2-like protein;
DE   AltName: Full=Protein pactolus;
DE   Flags: Precursor;
GN   Name=Itgb2l {ECO:0000312|MGI:MGI:1277979};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC25502.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND SUBCELLULAR
RP   LOCATION.
RC   STRAIN=Swiss Webster / NIH {ECO:0000312|EMBL:AAC25502.1};
RC   TISSUE=Bone marrow {ECO:0000312|EMBL:AAC25502.1};
RX   PubMed=9535848; DOI=10.1074/jbc.273.15.8711;
RA   Chen Y., Garrison S., Weis J.J., Weis J.H.;
RT   "Identification of pactolus, an integrin beta subunit-like cell-
RT   surface protein preferentially expressed by cells of the bone
RT   marrow.";
RL   J. Biol. Chem. 273:8711-8718(1998).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=129/Sv {ECO:0000269|PubMed:10556426};
RX   PubMed=10556426; DOI=10.1007/s003359901164;
RA   Margraf R.L., Chen Y., Garrison S., Weis J.J., Weis J.H.;
RT   "Genomic organization, chromosomal localization, and transcriptional
RT   variants of the murine Pactolus gene.";
RL   Mamm. Genome 10:1075-1081(1999).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAE23399.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAE23399.1};
RC   TISSUE=Bone {ECO:0000312|EMBL:BAE23399.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAI13143.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305}
RP   SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, GLYCOSYLATION,
RP   POLYMORPHISM, AND VARIANT SER-539.
RX   PubMed=11461913; DOI=10.1074/jbc.M104369200;
RA   Garrison S., Hojgaard A., Patillo D., Weis J.J., Weis J.H.;
RT   "Functional characterization of pactolus, a beta-integrin-like protein
RT   preferentially expressed by neutrophils.";
RL   J. Biol. Chem. 276:35500-35511(2001).
RN   [6] {ECO:0000305}
RP   SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=14662885; DOI=10.4049/jimmunol.171.12.6795;
RA   Garrison S., Hojgaard A., Margraf R., Weis J.J., Weis J.H.;
RT   "Surface translocation of pactolus is induced by cell activation and
RT   death, but is not required for neutrophil migration and function.";
RL   J. Immunol. 171:6795-6806(2003).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16836649; DOI=10.1111/j.1365-2567.2006.02426.x;
RA   Hojgaard A., Close R., Dunn D.M., Weiss R.B., Weis J.J., Weis J.H.;
RT   "Altered localization of CXCL13 expressing cells in mice deficient in
RT   pactolus following an inflammatory stimulus.";
RL   Immunology 119:212-223(2006).
RN   [8]
RP   STRUCTURE BY NMR OF 124-335, AND SUBUNIT.
RX   PubMed=17523188; DOI=10.1002/prot.21458;
RA   Sen M., Legge G.B.;
RT   "Pactolus I-domain: functional switching of the Rossmann fold.";
RL   Proteins 68:626-635(2007).
CC   -!- FUNCTION: During inflammatory stimulation, plays a role in
CC       retaining Cxcl13-expressing cells at the site of the inflammatory
CC       response. {ECO:0000269|PubMed:16836649}.
CC   -!- SUBUNIT: Monomer and homodimer (Probable). Unlike integrin beta
CC       chains, no alpha chain partner has yet been found.
CC       {ECO:0000269|PubMed:11461913, ECO:0000269|PubMed:17523188,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11461913,
CC       ECO:0000269|PubMed:14662885, ECO:0000269|PubMed:9535848}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:11461913,
CC       ECO:0000269|PubMed:14662885, ECO:0000269|PubMed:9535848}. Note=In
CC       unactivated neutrophils, the majority of the protein is contained
CC       in intracellular granules and is released to the cell surface
CC       following inflammatory activation or induction of necrotic or
CC       apoptotic cell death. {ECO:0000269|PubMed:11461913,
CC       ECO:0000269|PubMed:14662885, ECO:0000269|PubMed:9535848}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:9535848}; Synonyms=A
CC       {ECO:0000269|PubMed:10556426}, Membrane-bound
CC       {ECO:0000269|PubMed:9535848};
CC         IsoId=Q3UV74-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9535848}; Synonyms=B
CC       {ECO:0000269|PubMed:10556426}, Truncated
CC       {ECO:0000269|PubMed:9535848};
CC         IsoId=Q3UV74-2; Sequence=VSP_052321, VSP_052322;
CC       Name=3 {ECO:0000269|PubMed:10556426}; Synonyms=C
CC       {ECO:0000269|PubMed:10556426};
CC         IsoId=Q3UV74-3; Sequence=VSP_052319, VSP_052320;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in maturing and mature
CC       neutrophils. {ECO:0000269|PubMed:11461913}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11461913}.
CC   -!- POLYMORPHISM: Strain C57BL/6 preferentially expresses isoform 1
CC       while strains BALB/c and C3H/HeJ preferentially express isoform 2.
CC       This is due to a single nucleotide difference at the second splice
CC       acceptor site in exon 13 which results in production of isoform 2
CC       when this splice site is used in strains BALB/c and C3H/HeJ.
CC       {ECO:0000269|PubMed:11461913}.
CC   -!- DISRUPTION PHENOTYPE: Mice display normal neutrophil maturation
CC       and function including appropriate migration into sites of
CC       inflammation and response to bacterial infection. Following
CC       inflammatory stimulus in the peritoneal cavity, they display
CC       decreased levels of Cxcl13 due to the migration of resident
CC       Cxcl13-expressing macrophages from the peritoneal cavity during
CC       the inflammatory response. {ECO:0000269|PubMed:14662885,
CC       ECO:0000269|PubMed:16836649}.
CC   -!- MISCELLANEOUS: The human orthologous protein seems not to exist.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF051367; AAC25502.1; -; mRNA.
DR   EMBL; AK137534; BAE23399.1; -; mRNA.
DR   EMBL; BC113142; AAI13143.1; -; mRNA.
DR   CCDS; CCDS28358.1; -. [Q3UV74-1]
DR   RefSeq; NP_032431.2; NM_008405.3. [Q3UV74-1]
DR   UniGene; Mm.12872; -.
DR   PDB; 2IUE; NMR; -; A=124-335.
DR   PDBsum; 2IUE; -.
DR   ProteinModelPortal; Q3UV74; -.
DR   SMR; Q3UV74; -.
DR   STRING; 10090.ENSMUSP00000000161; -.
DR   iPTMnet; Q3UV74; -.
DR   PhosphoSitePlus; Q3UV74; -.
DR   PaxDb; Q3UV74; -.
DR   PRIDE; Q3UV74; -.
DR   Ensembl; ENSMUST00000000161; ENSMUSP00000000161; ENSMUSG00000000157. [Q3UV74-1]
DR   Ensembl; ENSMUST00000131567; ENSMUSP00000114497; ENSMUSG00000000157. [Q3UV74-2]
DR   GeneID; 16415; -.
DR   KEGG; mmu:16415; -.
DR   UCSC; uc008adb.1; mouse. [Q3UV74-1]
DR   CTD; 16415; -.
DR   MGI; MGI:1277979; Itgb2l.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; Q3UV74; -.
DR   KO; K06464; -.
DR   PhylomeDB; Q3UV74; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-MMU-166016; Toll Like Receptor 4 (TLR4) Cascade.
DR   Reactome; R-MMU-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-MMU-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   EvolutionaryTrace; Q3UV74; -.
DR   PRO; PR:Q3UV74; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   Bgee; ENSMUSG00000000157; -.
DR   CleanEx; MM_ITGB2L; -.
DR   ExpressionAtlas; Q3UV74; baseline and differential.
DR   Genevisible; Q3UV74; MM.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0030141; C:secretory granule; IDA:MGI.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015439; Integrin_bsu-2.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 2.
DR   PANTHER; PTHR10082:SF15; PTHR10082:SF15; 2.
DR   Pfam; PF00362; Integrin_beta; 2.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Inflammatory response; Integrin;
KW   Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    738       Integrin beta-2-like protein.
FT                                /FTId=PRO_0000278124.
FT   TOPO_DOM     23    671       Extracellular. {ECO:0000255}.
FT   TRANSMEM    672    692       Helical. {ECO:0000255}.
FT   TOPO_DOM    693    738       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       24     74       PSI. {ECO:0000255}.
FT   DOMAIN      126    329       VWFA. {ECO:0000255}.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    173    173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    226    226       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    252    252       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    360    360       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    386    386       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    473    473       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    627    627       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    669    669       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     25    419       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID     33     43       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID     36     73       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID     46     62       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    218    258       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    358    372       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    417    421       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    439    478       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    444    453       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    455    469       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    484    489       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    486    521       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    491    506       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    508    513       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    529    534       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    531    562       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    536    545       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    547    554       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    568    573       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    575    584       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    594    603       {ECO:0000250|UniProtKB:P05106}.
FT   DISULFID    600    664       {ECO:0000250|UniProtKB:P05106}.
FT   VAR_SEQ     432    490       GGKGAMECGICRCNSGYAGKNCECQTQGPSSQDLEGSCRKD
FT                                NSSIMCSGLGDCICGQCE -> LQEDESWQPRLFSRKRPLL
FT                                LWPMLLSLQLRGLSLPVPDVHFRLSEQQDGGVQWPWSMLL
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:10556426}.
FT                                /FTId=VSP_052319.
FT   VAR_SEQ     491    738       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10556426}.
FT                                /FTId=VSP_052320.
FT   VAR_SEQ     525    540       ERGHCSCGRCFCRYGF -> ASWAQPASAGCPLQAV (in
FT                                isoform 2). {ECO:0000303|PubMed:9535848}.
FT                                /FTId=VSP_052321.
FT   VAR_SEQ     541    738       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9535848}.
FT                                /FTId=VSP_052322.
FT   VARIANT     539    539       G -> S (in strain: BALB/c and C3H/HeJ).
FT                                {ECO:0000269|PubMed:11461913}.
FT   CONFLICT    509    509       N -> D (in Ref. 1; AAC25502 and 4;
FT                                AAI13143). {ECO:0000305}.
FT   CONFLICT    710    710       A -> V (in Ref. 1; AAC25502).
FT                                {ECO:0000305}.
FT   STRAND      127    134       {ECO:0000244|PDB:2IUE}.
FT   HELIX       137    139       {ECO:0000244|PDB:2IUE}.
FT   TURN        140    142       {ECO:0000244|PDB:2IUE}.
FT   HELIX       143    160       {ECO:0000244|PDB:2IUE}.
FT   STRAND      164    174       {ECO:0000244|PDB:2IUE}.
FT   STRAND      176    184       {ECO:0000244|PDB:2IUE}.
FT   HELIX       186    194       {ECO:0000244|PDB:2IUE}.
FT   STRAND      202    206       {ECO:0000244|PDB:2IUE}.
FT   HELIX       208    217       {ECO:0000244|PDB:2IUE}.
FT   HELIX       219    222       {ECO:0000244|PDB:2IUE}.
FT   STRAND      226    234       {ECO:0000244|PDB:2IUE}.
FT   HELIX       244    248       {ECO:0000244|PDB:2IUE}.
FT   STRAND      260    265       {ECO:0000244|PDB:2IUE}.
FT   HELIX       266    269       {ECO:0000244|PDB:2IUE}.
FT   HELIX       276    286       {ECO:0000244|PDB:2IUE}.
FT   STRAND      289    295       {ECO:0000244|PDB:2IUE}.
FT   HELIX       296    308       {ECO:0000244|PDB:2IUE}.
FT   STRAND      313    319       {ECO:0000244|PDB:2IUE}.
FT   HELIX       322    333       {ECO:0000244|PDB:2IUE}.
SQ   SEQUENCE   738 AA;  81547 MW;  CCAA3138FEFF0D5A CRC64;
     MLGQCTLLPV LAGLLSLESA LSQLCTKDNV STCQDCIRSG PSCAWCQKLN FTGRGEPDSV
     RCDTPEQLLL KGCTSEYLVD PKSLAESQED KERDQRQLSP RNVTVFLRPG QAATFKVDFQ
     RTQDNSVDLY FLMGLSGSAQ GHLSNVQTLG SDLLKALNEI SRSGRIGFGS IVNMTFQHIL
     KLTADSSQFQ RELRKQLVSG KLATPKGQLD AVVQVAICLG EIGWRNGTRF LVLVTDNDFH
     LAKDKTLGTR QNTSDGRCHL DDGMYRSRGE PDYQSVVQLA SKLAENNIQP IFVVPSRMVK
     TYEKLTTFIP KLTIGELSDD SSNVAQLIRN AYSKLSSIVV LNHSTIPSIL KVTYDSYCSN
     GTSNPGKPSG DCSGVQINDQ VTFQVNITAS ECFREQFFFI QALGFMDSVT VRVLPLCECQ
     CQEQSQHHSL CGGKGAMECG ICRCNSGYAG KNCECQTQGP SSQDLEGSCR KDNSSIMCSG
     LGDCICGQCE CHTSDIPNKE IYGQYCECNN VNCERYDGQV CGGPERGHCS CGRCFCRYGF
     VGSACQCRMS TSGCLNNRMV ECSGHGRCYC NRCLCDPGYQ PPLCEKRPGY FHRCSEYYSC
     ARCLKDNSAI KCRECWNLLF SNTPFSNKTC MTERDSEGCW TTYTLYQPDQ SDINSIYIKE
     SLVCAEISNT TILLGVIVGV LLAVIFLLVY CMVYLKGTQK AAKLPRKGGA QSTLAQQPHF
     QEPHHVEPVW NQERQGTQ
//
ID   ITB8_RABIT              Reviewed;         768 AA.
AC   P26013;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   22-NOV-2017, entry version 122.
DE   RecName: Full=Integrin beta-8;
DE   Flags: Precursor;
GN   Name=ITGB8;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=New Zealand white; TISSUE=Placenta;
RX   PubMed=1918072;
RA   Moyle M., Napier M.A., McLean J.W.;
RT   "Cloning and expression of a divergent integrin subunit beta 8.";
RL   J. Biol. Chem. 266:19650-19658(1991).
CC   -!- FUNCTION: Integrin alpha-V/beta-8 is a receptor for fibronectin.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-8
CC       associates with alpha-V.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Placenta, kidney, brain, ovary, uterus and in
CC       several transformed cells.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M73781; AAA31280.1; -; mRNA.
DR   PIR; B41029; B41029.
DR   RefSeq; NP_001075773.1; NM_001082304.1.
DR   UniGene; Ocu.1889; -.
DR   ProteinModelPortal; P26013; -.
DR   SMR; P26013; -.
DR   STRING; 9986.ENSOCUP00000001898; -.
DR   Ensembl; ENSOCUT00000002200; ENSOCUP00000001898; ENSOCUG00000002197.
DR   GeneID; 100009141; -.
DR   KEGG; ocu:100009141; -.
DR   CTD; 3696; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P26013; -.
DR   KO; K06591; -.
DR   OMA; DDFSCPY; -.
DR   OrthoDB; EOG091G029W; -.
DR   Proteomes; UP000001811; Chromosome 10.
DR   Bgee; ENSOCUG00000002197; -.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0034686; C:integrin alphav-beta8 complex; IEA:Ensembl.
DR   GO; GO:1990430; F:extracellular matrix protein binding; IEA:Ensembl.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0001573; P:ganglioside metabolic process; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015442; Integrin_bsu-8.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF9; PTHR10082:SF9; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 2.
PE   2: Evidence at transcript level;
KW   Cell adhesion; Complete proteome; Disulfide bond; Glycoprotein;
KW   Integrin; Membrane; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     42       {ECO:0000255}.
FT   CHAIN        43    768       Integrin beta-8.
FT                                /FTId=PRO_0000016355.
FT   TOPO_DOM     43    683       Extracellular. {ECO:0000255}.
FT   TRANSMEM    684    703       Helical. {ECO:0000255}.
FT   TOPO_DOM    704    768       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      146    384       VWFA.
FT   REPEAT      471    510       I.
FT   REPEAT      511    552       II.
FT   REPEAT      553    592       III.
FT   REPEAT      593    629       IV.
FT   REGION      471    629       Cysteine-rich tandem repeats.
FT   CARBOHYD    233    233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    402    402       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    421    421       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    431    431       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    456    456       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    648    648       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     47    469       {ECO:0000250}.
FT   DISULFID     55     65       {ECO:0000250}.
FT   DISULFID     58     94       {ECO:0000250}.
FT   DISULFID     68     83       {ECO:0000250}.
FT   DISULFID    211    218       {ECO:0000250}.
FT   DISULFID    266    307       {ECO:0000250}.
FT   DISULFID    407    419       {ECO:0000250}.
FT   DISULFID    467    471       {ECO:0000250}.
FT   DISULFID    481    491       {ECO:0000250}.
FT   DISULFID    494    499       {ECO:0000250}.
FT   DISULFID    526    531       {ECO:0000250}.
FT   DISULFID    528    561       {ECO:0000250}.
FT   DISULFID    533    546       {ECO:0000250}.
FT   DISULFID    567    572       {ECO:0000250}.
FT   DISULFID    574    583       {ECO:0000250}.
FT   DISULFID    585    593       {ECO:0000250}.
FT   DISULFID    607    612       {ECO:0000250}.
FT   DISULFID    609    657       {ECO:0000250}.
FT   DISULFID    614    624       {ECO:0000250}.
FT   DISULFID    627    630       {ECO:0000250}.
FT   DISULFID    634    643       {ECO:0000250}.
SQ   SEQUENCE   768 AA;  84406 MW;  C3F6DF0322FFB544 CRC64;
     MCGSALGLPP AAFVRLRSCR PGPAAFLRAA WVLSLVLGLG RSENSRCASS HAVSCSECLA
     LGPDCGWCVH EDFISGGPRS ERCDIVSNLI SKGCPVDSIE YPSVHVTIPS ENEVNTQVTP
     GEVSIQLRPG AAANFMLKIH PLKKYPVDLY YLVDVSASMH NNIEKLNSVG NDLSRKMAFF
     SRDFRLGFGS YVDKTVSPYI SIHPERIHNQ CSDYNLDCMP PHGYIHVLSL TENITEFERA
     VHRQKISGNI DTPEGGFDAM LQAAVCESHI GWRKEAKRLL LVMTDQTSHL ALDSKLAGIV
     VPNDGNCHLR NNVYVKSTTM EHPSLGQLSE KLIDNNINVI FAVQGKQFHW YKDLLPLLPG
     TIAGEIESKA ANLNNLVVEA YQKLISEVKV QVESKVPGVY FNVTAICPDG ARKLGMEGCS
     NVTSSDEVLF NVTVTMEKCS VTGGKNYAII KPIGFNETSK IHIHQNCGCE CEASRGGAAK
     CAEEAPLDST CPQCQESQCH QEEAQSPSQG CKAHEDQPVC SGRGVCVCGK CLCHKMKLGK
     VYGKYCEKDD FSCPYHHGSL CAGHGECEAG RCQCFSGWEG DRCQCPSAAA QHCVNSKGQV
     CSGRGTCVCG RCECSDPRSI GRFCEHCPTC PTACSENWNC VQCLHPHNLS QAILDQCRTS
     CASMEQPYVE QASECFSSPS YLRIFFIIFI VTFLIGLLKI LIIRQVILQW NSSKIKSSSD
     YRVSASKKDK LILQSVCTRA VTYRREKPEE IKLDISKLNA HETFRCNF
//
ID   ITB2_MOUSE              Reviewed;         771 AA.
AC   P11835; Q64482;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   20-DEC-2017, entry version 178.
DE   RecName: Full=Integrin beta-2;
DE   AltName: Full=Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta;
DE   AltName: Full=Complement receptor C3 subunit beta;
DE   AltName: CD_antigen=CD18;
DE   Flags: Precursor;
GN   Name=Itgb2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6 X CBA; TISSUE=Thymus;
RX   PubMed=2569711; DOI=10.1093/nar/17.13.5397;
RA   Wilson R.W., O'Brien W.E., Beaudet A.L.;
RT   "Nucleotide sequence of the cDNA from the mouse leukocyte adhesion
RT   protein CD18.";
RL   Nucleic Acids Res. 17:5397-5397(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1969385; DOI=10.1007/BF00211555;
RA   Zeger D.L., Osman N., Hennings M., McKenzie I.F., Sears D.W.,
RA   Hogarth P.M.;
RT   "Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement
RT   receptor/Mac-1 antigen.";
RL   Immunogenetics 31:191-197(1990).
RN   [3]
RP   SEQUENCE REVISION TO N-TERMINUS.
RX   PubMed=1671669; DOI=10.1007/BF00211699;
RA   Kofler R.;
RT   "Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement
RT   receptor/Mac-1 antigen.";
RL   Immunogenetics 33:77-77(1991).
RN   [4]
RP   FUNCTION DURING LUNG INJURY.
RX   PubMed=18587400; DOI=10.1038/ni.1628;
RA   Xu J., Gao X.-P., Ramchandran R., Zhao Y.-Y., Vogel S.M., Malik A.B.;
RT   "Nonmuscle myosin light-chain kinase mediates neutrophil
RT   transmigration in sepsis-induced lung inflammation by activating beta2
RT   integrins.";
RL   Nat. Immunol. 9:880-886(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Liver, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH FGR.
RX   PubMed=19903482; DOI=10.1016/j.febslet.2009.11.009;
RA   Baruzzi A., Iacobucci I., Soverini S., Lowell C.A., Martinelli G.,
RA   Berton G.;
RT   "c-Abl and Src-family kinases cross-talk in regulation of myeloid cell
RT   migration.";
RL   FEBS Lett. 584:15-21(2010).
CC   -!- FUNCTION: Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2,
CC       ICAM3 and ICAM4. Integrins ITGAM/ITGB2 and ITGAX/ITGB2 are
CC       receptors for the iC3b fragment of the third complement component
CC       and for fibrinogen. Integrin ITGAX/ITGB2 recognizes the sequence
CC       G-P-R in fibrinogen alpha-chain. Integrin ITGAM/ITGB2 recognizes
CC       P1 and P2 peptides of fibrinogen gamma chain. Integrin ITGAM/ITGB2
CC       is also a receptor for factor X. Integrin ITGAD/ITGB2 is a
CC       receptor for ICAM3 and VCAM1. Contributes to natural killer cell
CC       cytotoxicity (By similarity). Involved in leukocyte adhesion and
CC       transmigration of leukocytes including T-cells and neutrophils (By
CC       similarity). Triggers neutrophil transmigration during lung injury
CC       through PTK2B/PYK2-mediated activation (PubMed:18587400). Integrin
CC       ITGAL/ITGB2 in association with ICAM3, contributes to apoptotic
CC       neutrophil phagocytosis by macrophages (By similarity). In
CC       association with alpha subunit ITGAM/CD11b, required for CD177-
CC       PRTN3-mediated activation of TNF primed neutrophils (By
CC       similarity). Alpha-M/beta-2 play a critical role in mast cell
CC       development and in immune complex-mediated glomerulonephritis.
CC       Mice expressing a null mutation of the alpha-M subunit gene
CC       demonstrate increase in neutrophil accumulation, in response to a
CC       impaired degranulation and phagocytosis, events that apparently
CC       accelerate apoptosis in neutrophils. These mice develop obesity.
CC       {ECO:0000250|UniProtKB:P05107, ECO:0000269|PubMed:18587400,
CC       ECO:0000269|PubMed:19903482}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. ITGB2
CC       associates with either ITGAL, ITGAM, ITGAX or ITGAD. Found in a
CC       complex with CD177 and ITGAM/CD11b (By similarity). Interacts with
CC       FGR (PubMed:19903482). Interacts with COPS5 and RANBP9 (By
CC       similarity). Interacts with FLNA (via filamin repeats 4, 9, 12,
CC       17, 19, 21, and 23) (By similarity).
CC       {ECO:0000250|UniProtKB:P05107, ECO:0000269|PubMed:19903482}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P05107}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P05107}. Membrane raft
CC       {ECO:0000250|UniProtKB:P05107}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P05107}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14951; CAA33077.1; -; mRNA.
DR   EMBL; M31039; AAA39325.1; -; mRNA.
DR   PIR; A45839; A45839.
DR   PIR; S04847; S04847.
DR   RefSeq; NP_032430.2; NM_008404.4.
DR   UniGene; Mm.1137; -.
DR   ProteinModelPortal; P11835; -.
DR   SMR; P11835; -.
DR   BioGrid; 200828; 2.
DR   CORUM; P11835; -.
DR   DIP; DIP-37428N; -.
DR   IntAct; P11835; 9.
DR   MINT; MINT-1662243; -.
DR   STRING; 10090.ENSMUSP00000000299; -.
DR   iPTMnet; P11835; -.
DR   PhosphoSitePlus; P11835; -.
DR   SwissPalm; P11835; -.
DR   EPD; P11835; -.
DR   MaxQB; P11835; -.
DR   PaxDb; P11835; -.
DR   PeptideAtlas; P11835; -.
DR   PRIDE; P11835; -.
DR   GeneID; 16414; -.
DR   KEGG; mmu:16414; -.
DR   CTD; 3689; -.
DR   MGI; MGI:96611; Itgb2.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P11835; -.
DR   KO; K06464; -.
DR   PRO; PR:P11835; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_ITGB2; -.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:1903561; C:extracellular vesicle; ISO:MGI.
DR   GO; GO:0034687; C:integrin alphaL-beta2 complex; ISO:MGI.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:MGI.
DR   GO; GO:0044853; C:plasma membrane raft; ISO:MGI.
DR   GO; GO:0043235; C:receptor complex; ISO:MGI.
DR   GO; GO:0001540; F:amyloid-beta binding; IMP:ARUK-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISO:MGI.
DR   GO; GO:0001851; F:complement component C3b binding; IGI:ARUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:MGI.
DR   GO; GO:0030369; F:ICAM-3 receptor activity; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0050798; P:activated T cell proliferation; IMP:MGI.
DR   GO; GO:0097242; P:amyloid-beta clearance; IMP:ARUK-UCL.
DR   GO; GO:0007155; P:cell adhesion; IMP:MGI.
DR   GO; GO:0098609; P:cell-cell adhesion; IGI:MGI.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:MGI.
DR   GO; GO:0045123; P:cellular extravasation; IMP:MGI.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IDA:UniProtKB.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; ISO:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; ISO:MGI.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IMP:MGI.
DR   GO; GO:1990266; P:neutrophil migration; ISO:MGI.
DR   GO; GO:0006911; P:phagocytosis, engulfment; IMP:ARUK-UCL.
DR   GO; GO:0043315; P:positive regulation of neutrophil degranulation; ISO:MGI.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; ISO:MGI.
DR   GO; GO:0043113; P:receptor clustering; ISO:MGI.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISO:MGI.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015439; Integrin_bsu-2.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF15; PTHR10082:SF15; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Membrane; Metal-binding;
KW   Phagocytosis; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23
FT   CHAIN        24    771       Integrin beta-2.
FT                                /FTId=PRO_0000016342.
FT   TOPO_DOM     24    702       Extracellular. {ECO:0000255}.
FT   TRANSMEM    703    725       Helical. {ECO:0000255}.
FT   TOPO_DOM    726    771       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      125    364       VWFA.
FT   REPEAT      450    497       I.
FT   REPEAT      498    541       II.
FT   REPEAT      542    582       III.
FT   REPEAT      583    618       IV.
FT   REGION      450    618       Cysteine-rich tandem repeats.
FT   METAL       139    139       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       142    142       Calcium. {ECO:0000250}.
FT   METAL       143    143       Calcium. {ECO:0000250}.
FT   METAL       348    348       Calcium. {ECO:0000250}.
FT   MOD_RES     747    747       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   MOD_RES     758    758       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   MOD_RES     760    760       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   MOD_RES     762    762       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   CARBOHYD     51     51       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    117    117       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    255    255       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    502    502       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    626    626       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    644    644       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     26     44       {ECO:0000250}.
FT   DISULFID     34    448       {ECO:0000250}.
FT   DISULFID     37     63       {ECO:0000250}.
FT   DISULFID     47     74       {ECO:0000250}.
FT   DISULFID    192    199       {ECO:0000250}.
FT   DISULFID    247    287       {ECO:0000250}.
FT   DISULFID    387    401       {ECO:0000250}.
FT   DISULFID    421    446       {ECO:0000250}.
FT   DISULFID    450    468       {ECO:0000250}.
FT   DISULFID    460    471       {ECO:0000250}.
FT   DISULFID    473    482       {ECO:0000250}.
FT   DISULFID    484    515       {ECO:0000250}.
FT   DISULFID    498    513       {ECO:0000250}.
FT   DISULFID    507    518       {ECO:0000250}.
FT   DISULFID    520    535       {ECO:0000250}.
FT   DISULFID    537    560       {ECO:0000250}.
FT   DISULFID    542    558       {ECO:0000250}.
FT   DISULFID    550    563       {ECO:0000250}.
FT   DISULFID    565    574       {ECO:0000250}.
FT   DISULFID    576    599       {ECO:0000250}.
FT   DISULFID    583    597       {ECO:0000250}.
FT   DISULFID    591    602       {ECO:0000250}.
FT   DISULFID    604    613       {ECO:0000250}.
FT   DISULFID    616    619       {ECO:0000250}.
FT   DISULFID    623    664       {ECO:0000250}.
FT   DISULFID    630    649       {ECO:0000250}.
FT   DISULFID    633    645       {ECO:0000250}.
FT   DISULFID    672    697       {ECO:0000250}.
FT   CONFLICT      4      6       LRP -> PH (in Ref. 1; CAA33077).
FT                                {ECO:0000305}.
FT   CONFLICT    449    449       Q -> H (in Ref. 2; AAA39325).
FT                                {ECO:0000305}.
FT   CONFLICT    667    667       R -> K (in Ref. 2; AAA39325).
FT                                {ECO:0000305}.
SQ   SEQUENCE   771 AA;  85026 MW;  6FA51DA93AB40D8A CRC64;
     MLGLRPSLLL ALAGLFFLGS AVSQECTKYK VSSCRDCIQS GPGCSWCQKL NFTGPGEPDS
     LRCDTRAQLL LKGCPADDIM DPRSIANPEF DQRGQRKQLS PQKVTLYLRP GQAAAFNVTF
     RRAKGYPIDL YYLMDLSYSM LDDLNNVKKL GGDLLQALNE ITESGRIGFG SFVDKTVLPF
     VNTHPEKLRN PCPNKEKACQ PPFAFRHVLK LTDNSNQFQT EVGKQLISGN LDAPEGGLDA
     IMQVAACPEE IGWRNVTRLL VFATDDGFHF AGDGKLGAIL TPNDGRCHLE DNMYKRSNEF
     DYPSVGQLAH KLSESNIQPI FAVTKKMVKT YEKLTEIIPK SAVGELSDDS SNVVQLIKNA
     YYKLSSRVFL DHSTLPDTLK VTYDSFCSNG ASSIGKSRGD CDGVQINNPV TFQVKVMASE
     CIQEQSFVIR ALGFTDTVTV QVRPQCECQC RDQSREQSLC GGKGVMECGI CRCESGYIGK
     NCECQTQGRS SQELERNCRK DNSSIVCSGL GDCICGQCVC HTSDVPNKEI FGQYCECDNV
     NCERYNSQVC GGSDRGSCNC GKCSCKPGYE GSACQCQRST TGCLNARLVE CSGRGHCQCN
     RCICDEGYQP PMCEDCPSCG SHCRDNHTSC AECLKFDKGP FEKNCSVQCA GMTLQTIPLK
     KKPCKERDSE GCWITYTLQQ KDGRNIYNIH VEDSLECVKG PNVAAIVGGT VVGVVLIGVL
     LLVIWKALTH LTDLREYRRF EKEKLKSQWN NDNPLFKSAT TTVMNPKFAE S
//
ID   ITA2B_PAPCY             Reviewed;         604 AA.
AC   P53711;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-NOV-2017, entry version 91.
DE   RecName: Full=Integrin alpha-IIb;
DE   AltName: Full=GPalpha IIb;
DE            Short=GPIIb;
DE   AltName: Full=Platelet membrane glycoprotein IIb;
DE   AltName: CD_antigen=CD41;
DE   Contains:
DE     RecName: Full=Integrin alpha-IIb heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-IIb light chain;
DE   Flags: Fragment;
GN   Name=ITGA2B;
OS   Papio cynocephalus (Yellow baboon).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Cercopithecidae; Cercopithecinae; Papio.
OX   NCBI_TaxID=9556;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7828888; DOI=10.1016/0378-1119(94)90669-6;
RA   Hayzer D.J., Shoji M., Kim T.M., Runge M.S., Hanson S.R.;
RT   "Alternative splicing of the mRNA encoding baboon glycoprotein
RT   receptor GPIIb.";
RL   Gene 151:267-271(1994).
CC   -!- FUNCTION: Integrin alpha-IIb/beta-3 is a receptor for fibronectin,
CC       fibrinogen, plasminogen, prothrombin, thrombospondin and
CC       vitronectin. It recognizes the sequence R-G-D in a wide array of
CC       ligands. It recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in
CC       fibrinogen gamma chain. Following activation integrin alpha-
CC       IIb/beta-3 brings about platelet/platelet interaction through
CC       binding of soluble fibrinogen. This step leads to rapid platelet
CC       aggregation which physically plugs ruptured endothelial cell
CC       surface.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-IIb associates with beta-3. Directly
CC       interacts with RNF181. Interacts (via C-terminus cytoplasmic tail
CC       region) with CIB1; the interaction is direct and calcium-
CC       dependent. Interacts (via C-terminus cytoplasmic tail region) with
CC       CIB2, CIB3 and CIB4; the interactions are stabilized/increased in
CC       a calcium and magnesium-dependent manner (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12233; AAA65936.1; -; mRNA.
DR   PIR; I36917; I36917.
DR   ProteinModelPortal; P53711; -.
DR   SMR; P53711; -.
DR   HOVERGEN; HBG006186; -.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031092; C:platelet alpha granule membrane; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 1.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell adhesion; Disulfide bond; Glycoprotein; Integrin;
KW   Membrane; Metal-binding; Receptor; Transmembrane; Transmembrane helix.
FT   CHAIN        <1    467       Integrin alpha-IIb heavy chain.
FT                                /FTId=PRO_0000016281.
FT   CHAIN       468    604       Integrin alpha-IIb light chain.
FT                                /FTId=PRO_0000016282.
FT   TOPO_DOM     <1    558       Extracellular. {ECO:0000255}.
FT   TRANSMEM    559    584       Helical. {ECO:0000255}.
FT   TOPO_DOM    585    604       Cytoplasmic. {ECO:0000255}.
FT   REPEAT        1     61       FG-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND      22     30       {ECO:0000255}.
FT   MOTIF       587    591       GFFKR motif.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    276    276       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    527    527       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     69     80       {ECO:0000250}.
FT   DISULFID     86    141       {ECO:0000250}.
FT   DISULFID    198    204       {ECO:0000250}.
FT   DISULFID    270    283       {ECO:0000250}.
FT   DISULFID    422    476       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    481    486       {ECO:0000250}.
FT   NON_TER       1      1
SQ   SEQUENCE   604 AA;  66066 MW;  0B13BD1BD9E37F88 CRC64;
     QVLDSPFPTG SAFGFSLRGA VDIDDNGYPD LIVGAYGANQ VAVYRAQPVV KASVQLLVQD
     SLNPAVKSCV LPQTKTPVSC FKIQMCVGAT GHNIPQKLSL NAELQLDRQK PRQGRRVLLL
     GSQQAGTTLN LDLGGKHSPI CHTTMAFLRD EADIRDKLSP IVLSLNVSLP PTEAGMAPAV
     VLHGDTHVQE QTRIVLDCGE DDVCVPQLQL TASVTGSPLL VGADNVLELQ MDTANEGEGA
     YEAELAVHLP QGAHYMRARS NVEGFERLIC NQKKENETRV VLCELGNPMK KNTQIGIAML
     VSVGNLEEAG ESVSFQLQIR SKNSQNPNSK IVLLDVPVRA EAQVELRGNS FPASLVVAAE
     EGDREQNSLD SWGPKVEHTY ELHNNGPGTV NGLHLSIHLP GQSQHSDLLY ILDIQPQGGL
     QCFPQPPVNP LKVDWGLPTP SPSPVHPAHH KRDRRQIFLP EPEQPSRLQD PVLVSCDSAP
     CTVVQCDLQE MARGQRAMVT VLAFLWLPSL HQRPLDQFVL QSQAWFNVSS LPYAVPPLSL
     PRGEAQVRTQ LLRALEERAI PIWWVLVGVL GGLLLLTILV LAMWKVGFFK RNRPPLEEDD
     EEGE
//
ID   ITB6_CAVPO              Reviewed;         577 AA.
AC   P18563;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   22-NOV-2017, entry version 111.
DE   RecName: Full=Integrin beta-6;
DE   Flags: Fragment;
GN   Name=ITGB6;
OS   Cavia porcellus (Guinea pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
OC   Hystricomorpha; Caviidae; Cavia.
OX   NCBI_TaxID=10141;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Hartley;
RX   PubMed=2365683;
RA   Sheppard D., Rozzo C., Starr L., Quaranta V., Erle D.J., Pytela R.;
RT   "Complete amino acid sequence of a novel integrin beta subunit (beta
RT   6) identified in epithelial cells using the polymerase chain
RT   reaction.";
RL   J. Biol. Chem. 265:11502-11507(1990).
CC   -!- FUNCTION: Integrin alpha-V/beta-6 is a receptor for fibronectin
CC       and cytotactin. It recognizes the sequence R-G-D in its ligands.
CC       ITGAV:ITGB6 acts as a receptor for fibrillin-1 (FBN1) and mediates
CC       R-G-D-dependent cell adhesion to FBN1.
CC       {ECO:0000250|UniProtKB:P18564}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-6
CC       associates with alpha-V. Interacts with FLNB. Interacts with HAX1.
CC       ITGAV:ITGB6 interacts with FBN1. {ECO:0000250|UniProtKB:P18564}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:P18564}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M35197; AAA37043.1; -; mRNA.
DR   PIR; B37057; B37057.
DR   ProteinModelPortal; P18563; -.
DR   SMR; P18563; -.
DR   STRING; 10141.ENSCPOP00000011065; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P18563; -.
DR   Proteomes; UP000005447; Unassembled WGS sequence.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015436; Integrin_bsu-6.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF11; PTHR10082:SF11; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 2.
PE   2: Evidence at transcript level;
KW   Cell adhesion; Cell junction; Complete proteome; Disulfide bond;
KW   Glycoprotein; Integrin; Membrane; Receptor; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix.
FT   CHAIN        <1   >577       Integrin beta-6.
FT                                /FTId=PRO_0000174223.
FT   TOPO_DOM     <1    566       Extracellular. {ECO:0000255}.
FT   TRANSMEM    567   >577       Helical. {ECO:0000255}.
FT   DOMAIN       <1    230       VWFA.
FT   REPEAT      315    360       I.
FT   REPEAT      361    402       II.
FT   REPEAT      403    441       III.
FT   REPEAT      442    478       IV.
FT   REGION      315    478       Cysteine-rich tandem repeats.
FT   CARBOHYD    119    119       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    246    246       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    255    255       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    277    277       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    330    330       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    400    400       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    434    434       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    555    555       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     56     63       {ECO:0000250}.
FT   DISULFID    111    152       {ECO:0000250}.
FT   DISULFID    253    265       {ECO:0000250}.
FT   DISULFID    285    529       {ECO:0000250}.
FT   DISULFID    311    315       {ECO:0000250}.
FT   DISULFID    326    338       {ECO:0000250}.
FT   DISULFID    335    370       {ECO:0000250}.
FT   DISULFID    340    349       {ECO:0000250}.
FT   DISULFID    351    361       {ECO:0000250}.
FT   DISULFID    376    381       {ECO:0000250}.
FT   DISULFID    378    411       {ECO:0000250}.
FT   DISULFID    383    396       {ECO:0000250}.
FT   DISULFID    398    403       {ECO:0000250}.
FT   DISULFID    417    422       {ECO:0000250}.
FT   DISULFID    419    450       {ECO:0000250}.
FT   DISULFID    424    433       {ECO:0000250}.
FT   DISULFID    435    442       {ECO:0000250}.
FT   DISULFID    456    461       {ECO:0000250}.
FT   DISULFID    458    504       {ECO:0000250}.
FT   DISULFID    463    473       {ECO:0000250}.
FT   DISULFID    476    479       {ECO:0000250}.
FT   DISULFID    483    492       {ECO:0000250}.
FT   DISULFID    489    561       {ECO:0000250}.
FT   DISULFID    508    537       {ECO:0000250}.
FT   NON_TER       1      1
FT   NON_TER     577    577
SQ   SEQUENCE   577 AA;  62299 MW;  B83B468C83EDCCF9 CRC64;
     SASMDDDLNT IKELGSLLSK EMSKLTSNFR LGFGSFVEKP VSPFMKTTPE EIANPCSSIP
     YICLPTFGFK HILPLTNDAE RFNEIVKKQK ISANIDNPEG GFDAIMQAAV CKEKIGWRND
     SLHLLVFVSD ADSHFGMDSK LAGIVIPNDG LCHLDSKNEY SMSTVMEYPT IGQLIDKVVQ
     NNVLLIFAVT QEQVPLYENY AKLIPGATVG LLHKDSGNIL QLIISAYEEL RSEVELEVLG
     DTEGLNLSFS AVCNNGTLFP HQKKCLHMKV GETASFNVTV SIPNCERKSR HVIIKPVGLG
     DTLEILVSPE CSCDCQKEVE VNSSKCHNGN GSYQCGVCAC NPGHMGPHCE CGEDTLSTDS
     CKETPDHPSC SGRGDCYCGQ CICHLSPYGN IYGPYCQCDN FSCVRHKGLL CGDNGDCECG
     ECVCRSGWTG EYCNCTTSTD TCISEDGTLC SGRGDCVCGK CVCTNPGASG PTCERCPTCS
     DPCNSKRSCI ECHLSADGQP GEECVDKCKL AGVTISKEAD FSKDSSVSCS LQGENECLIT
     FLISTDNEGK TIIHNISEKD CPKPPNIPMI MLGVSLA
//
ID   ITAX_HUMAN              Reviewed;        1163 AA.
AC   P20702; Q8IVA6;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 3.
DT   22-NOV-2017, entry version 175.
DE   RecName: Full=Integrin alpha-X;
DE   AltName: Full=CD11 antigen-like family member C;
DE   AltName: Full=Leu M5;
DE   AltName: Full=Leukocyte adhesion glycoprotein p150,95 alpha chain;
DE   AltName: Full=Leukocyte adhesion receptor p150,95;
DE   AltName: CD_antigen=CD11c;
DE   Flags: Precursor;
GN   Name=ITGAX; Synonyms=CD11C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-251.
RX   PubMed=3327687;
RA   Corbi A.L., Miller L.J., O'Connor K., Larson R.S., Springer T.A.;
RT   "cDNA cloning and complete primary structure of the alpha subunit of a
RT   leukocyte adhesion glycoprotein, p150,95.";
RL   EMBO J. 6:4023-4028(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-201 AND THR-251.
RX   PubMed=2303426;
RA   Corbi A.L., Garcia-Aguilar J., Springer T.A.;
RT   "Genomic structure of an integrin alpha subunit, the leukocyte p150,95
RT   molecule.";
RL   J. Biol. Chem. 265:2782-2788(1990).
RN   [3]
RP   ERRATUM.
RA   Corbi A.L., Garcia-Aguilar J., Springer T.A.;
RL   J. Biol. Chem. 265:12750-12751(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LYS-547.
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 20-43.
RX   PubMed=3549901;
RA   Miller L.J., Wiebe M., Springer T.A.;
RT   "Purification and alpha subunit N-terminal sequences of human Mac-1
RT   and p150,95 leukocyte adhesion proteins.";
RL   J. Immunol. 138:2381-2383(1987).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-899.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 20-1103 IN COMPLEX WITH
RP   ITGB2, GLYCOSYLATION AT ASN-61; ASN-392; ASN-697; ASN-735 AND ASN-899,
RP   DISULFIDE BONDS, METAL-BINDING SITES, AND SUBUNIT.
RX   PubMed=20033057; DOI=10.1038/emboj.2009.367;
RA   Xie C., Zhu J., Chen X., Mi L., Nishida N., Springer T.A.;
RT   "Structure of an integrin with an alphaI domain, complement receptor
RT   type 4.";
RL   EMBO J. 29:666-679(2010).
RN   [8]
RP   STRUCTURE BY NMR OF 1129-1163.
RX   PubMed=22844534; DOI=10.1371/journal.pone.0041924;
RA   Chua G.L., Tang X.Y., Patra A.T., Tan S.M., Bhattacharjya S.;
RT   "Structure and binding interface of the cytosolic tails of alphaXbeta2
RT   integrin.";
RL   PLoS ONE 7:E41924-E41924(2012).
RN   [9]
RP   VARIANT VAL-1012.
RX   PubMed=21763482; DOI=10.1016/j.ajhg.2011.06.001;
RA   Vilarino-Guell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M.,
RA   Lincoln S.J., Soto-Ortolaza A.I., Cobb S.A., Wilhoite G.J.,
RA   Bacon J.A., Behrouz B., Melrose H.L., Hentati E., Puschmann A.,
RA   Evans D.M., Conibear E., Wasserman W.W., Aasly J.O., Burkhard P.R.,
RA   Djaldetti R., Ghika J., Hentati F., Krygowska-Wajs A., Lynch T.,
RA   Melamed E., Rajput A., Rajput A.H., Solida A., Wu R.M., Uitti R.J.,
RA   Wszolek Z.K., Vingerhoets F., Farrer M.J.;
RT   "VPS35 mutations in Parkinson disease.";
RL   Am. J. Hum. Genet. 89:162-167(2011).
CC   -!- FUNCTION: Integrin alpha-X/beta-2 is a receptor for fibrinogen. It
CC       recognizes the sequence G-P-R in fibrinogen. It mediates cell-cell
CC       interaction during inflammatory responses. It is especially
CC       important in monocyte adhesion and chemotaxis.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-X
CC       associates with beta-2. {ECO:0000269|PubMed:20033057}.
CC   -!- INTERACTION:
CC       P05107:ITGB2; NbExp=3; IntAct=EBI-2568308, EBI-300173;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in monocytes and
CC       granulocytes.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M81695; AAA59180.1; -; mRNA.
DR   EMBL; M29165; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M29487; AAA51620.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M29482; AAA51620.1; JOINED; Genomic_DNA.
DR   EMBL; M29483; AAA51620.1; JOINED; Genomic_DNA.
DR   EMBL; M29484; AAA51620.1; JOINED; Genomic_DNA.
DR   EMBL; M29485; AAA51620.1; JOINED; Genomic_DNA.
DR   EMBL; M29486; AAA51620.1; JOINED; Genomic_DNA.
DR   EMBL; BC038237; AAH38237.1; -; mRNA.
DR   CCDS; CCDS10711.1; -.
DR   PIR; A36584; RWHU1C.
DR   RefSeq; NP_000878.2; NM_000887.4.
DR   RefSeq; NP_001273304.1; NM_001286375.1.
DR   UniGene; Hs.248472; -.
DR   PDB; 1N3Y; X-ray; 1.65 A; A=147-338.
DR   PDB; 2LUV; NMR; -; A=1129-1163.
DR   PDB; 3K6S; X-ray; 3.50 A; A/C/E/G=20-1103.
DR   PDB; 3K71; X-ray; 3.95 A; A/C/E/G=20-1103.
DR   PDB; 3K72; X-ray; 3.70 A; A/C=20-1103.
DR   PDB; 4NEH; X-ray; 2.75 A; A=20-1101.
DR   PDB; 4NEN; X-ray; 2.90 A; A=20-1101.
DR   PDB; 5ES4; X-ray; 3.30 A; A/C/E/G=20-1103.
DR   PDBsum; 1N3Y; -.
DR   PDBsum; 2LUV; -.
DR   PDBsum; 3K6S; -.
DR   PDBsum; 3K71; -.
DR   PDBsum; 3K72; -.
DR   PDBsum; 4NEH; -.
DR   PDBsum; 4NEN; -.
DR   PDBsum; 5ES4; -.
DR   ProteinModelPortal; P20702; -.
DR   SMR; P20702; -.
DR   BioGrid; 109893; 1.
DR   DIP; DIP-59369N; -.
DR   IntAct; P20702; 2.
DR   STRING; 9606.ENSP00000268296; -.
DR   iPTMnet; P20702; -.
DR   PhosphoSitePlus; P20702; -.
DR   BioMuta; ITGAX; -.
DR   DMDM; 146345441; -.
DR   EPD; P20702; -.
DR   PaxDb; P20702; -.
DR   PeptideAtlas; P20702; -.
DR   PRIDE; P20702; -.
DR   DNASU; 3687; -.
DR   Ensembl; ENST00000268296; ENSP00000268296; ENSG00000140678.
DR   GeneID; 3687; -.
DR   KEGG; hsa:3687; -.
DR   UCSC; uc002ebu.2; human.
DR   CTD; 3687; -.
DR   DisGeNET; 3687; -.
DR   EuPathDB; HostDB:ENSG00000140678.16; -.
DR   GeneCards; ITGAX; -.
DR   H-InvDB; HIX0012988; -.
DR   HGNC; HGNC:6152; ITGAX.
DR   HPA; CAB004458; -.
DR   HPA; CAB072871; -.
DR   HPA; HPA004723; -.
DR   MIM; 151510; gene.
DR   neXtProt; NX_P20702; -.
DR   OpenTargets; ENSG00000140678; -.
DR   PharmGKB; PA29952; -.
DR   eggNOG; ENOG410IPBA; Eukaryota.
DR   eggNOG; ENOG410ZFBE; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000113114; -.
DR   HOVERGEN; HBG100530; -.
DR   InParanoid; P20702; -.
DR   KO; K06462; -.
DR   PhylomeDB; P20702; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P20702; -.
DR   SIGNOR; P20702; -.
DR   ChiTaRS; ITGAX; human.
DR   EvolutionaryTrace; P20702; -.
DR   GeneWiki; CD11c; -.
DR   GenomeRNAi; 3687; -.
DR   PRO; PR:P20702; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000140678; -.
DR   CleanEx; HS_ITGAX; -.
DR   ExpressionAtlas; P20702; baseline and differential.
DR   Genevisible; P20702; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Integrin;
KW   Magnesium; Membrane; Metal-binding; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:3549901}.
FT   CHAIN        20   1163       Integrin alpha-X.
FT                                /FTId=PRO_0000016294.
FT   TOPO_DOM     20   1107       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1108   1128       Helical. {ECO:0000255}.
FT   TOPO_DOM   1129   1163       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       23     78       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       79    138       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      165    339       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      340    391       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      392    443       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      444    504       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      507    565       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      570    630       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     466    474
FT   CA_BIND     530    538
FT   CA_BIND     593    601
FT   MOTIF      1131   1135       GFFKR motif.
FT   METAL       157    157       Magnesium.
FT   METAL       159    159       Magnesium.
FT   METAL       161    161       Magnesium.
FT   METAL       259    259       Magnesium.
FT   METAL       466    466       Calcium 2.
FT   METAL       468    468       Calcium 2.
FT   METAL       470    470       Calcium 2.
FT   METAL       472    472       Calcium 2; via carbonyl oxygen.
FT   METAL       532    532       Calcium 3.
FT   METAL       534    534       Calcium 3.
FT   METAL       536    536       Calcium 3; via carbonyl oxygen.
FT   METAL       593    593       Calcium 1.
FT   METAL       595    595       Calcium 1.
FT   METAL       597    597       Calcium 1.
FT   METAL       599    599       Calcium 1; via carbonyl oxygen.
FT   METAL       601    601       Calcium 1.
FT   CARBOHYD     61     61       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20033057}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    392    392       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20033057}.
FT   CARBOHYD    697    697       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20033057}.
FT   CARBOHYD    735    735       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20033057}.
FT   CARBOHYD    899    899       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:20033057}.
FT   CARBOHYD    939    939       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1050   1050       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     69     76       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    108    126       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    116    145       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    495    506       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    639    722       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    655    712       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    771    777       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    848    863       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    998   1022       {ECO:0000269|PubMed:20033057}.
FT   DISULFID   1027   1032       {ECO:0000269|PubMed:20033057}.
FT   VARIANT      48     48       W -> R (in dbSNP:rs2230424).
FT                                /FTId=VAR_018672.
FT   VARIANT     201    201       F -> L (in dbSNP:rs1574566).
FT                                {ECO:0000269|PubMed:2303426}.
FT                                /FTId=VAR_049632.
FT   VARIANT     251    251       A -> T (in dbSNP:rs2230428).
FT                                {ECO:0000269|PubMed:2303426,
FT                                ECO:0000269|PubMed:3327687}.
FT                                /FTId=VAR_031925.
FT   VARIANT     517    517       P -> R (in dbSNP:rs2230429).
FT                                /FTId=VAR_031926.
FT   VARIANT     547    547       E -> K (in dbSNP:rs17853815).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031927.
FT   VARIANT     564    564       I -> V (in dbSNP:rs189592567).
FT                                /FTId=VAR_059363.
FT   VARIANT     971    971       F -> L (in dbSNP:rs2230427).
FT                                /FTId=VAR_031928.
FT   VARIANT    1012   1012       A -> V (in dbSNP:rs181404376).
FT                                {ECO:0000269|PubMed:21763482}.
FT                                /FTId=VAR_066662.
FT   CONFLICT    209    209       S -> T (in Ref. 1; AAA59180 and 2;
FT                                AAA51620). {ECO:0000305}.
FT   CONFLICT    266    266       S -> T (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT    327    327       N -> T (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       K -> R (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT    335    335       A -> P (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT    460    460       A -> P (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT    469    469       S -> T (in Ref. 1; AAA59180).
FT                                {ECO:0000305}.
FT   CONFLICT    480    480       A -> P (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT    490    490       G -> A (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT    756    756       D -> L (in Ref. 1; AAA59180).
FT                                {ECO:0000305}.
FT   CONFLICT    819    819       I -> V (in Ref. 4; AAH38237).
FT                                {ECO:0000305}.
FT   CONFLICT    990    990       H -> L (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT   1005   1005       P -> G (in Ref. 2; AAA51620).
FT                                {ECO:0000305}.
FT   CONFLICT   1161   1163       SEK -> TPHYPQDNV (in Ref. 4; AAH38237).
FT                                {ECO:0000305}.
FT   STRAND       24     26       {ECO:0000244|PDB:4NEH}.
FT   STRAND       28     31       {ECO:0000244|PDB:4NEH}.
FT   TURN         35     38       {ECO:0000244|PDB:4NEH}.
FT   STRAND       39     44       {ECO:0000244|PDB:4NEH}.
FT   TURN         45     47       {ECO:0000244|PDB:4NEH}.
FT   STRAND       48     59       {ECO:0000244|PDB:4NEH}.
FT   STRAND       62     69       {ECO:0000244|PDB:4NEH}.
FT   TURN         71     73       {ECO:0000244|PDB:4NEH}.
FT   STRAND       75     78       {ECO:0000244|PDB:4NEH}.
FT   STRAND       87     89       {ECO:0000244|PDB:5ES4}.
FT   STRAND       94     99       {ECO:0000244|PDB:4NEH}.
FT   TURN        100    103       {ECO:0000244|PDB:4NEH}.
FT   STRAND      104    116       {ECO:0000244|PDB:4NEH}.
FT   STRAND      119    129       {ECO:0000244|PDB:4NEH}.
FT   STRAND      131    133       {ECO:0000244|PDB:4NEN}.
FT   STRAND      136    141       {ECO:0000244|PDB:4NEH}.
FT   STRAND      150    157       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       164    178       {ECO:0000244|PDB:1N3Y}.
FT   TURN        183    185       {ECO:0000244|PDB:1N3Y}.
FT   STRAND      186    201       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       203    208       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       212    216       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       228    236       {ECO:0000244|PDB:1N3Y}.
FT   TURN        237    240       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       242    244       {ECO:0000244|PDB:1N3Y}.
FT   STRAND      250    260       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       269    278       {ECO:0000244|PDB:1N3Y}.
FT   STRAND      282    289       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       290    293       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       298    304       {ECO:0000244|PDB:1N3Y}.
FT   STRAND      307    309       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       310    312       {ECO:0000244|PDB:1N3Y}.
FT   STRAND      313    318       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       319    325       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       326    334       {ECO:0000244|PDB:1N3Y}.
FT   HELIX       336    338       {ECO:0000244|PDB:4NEH}.
FT   TURN        341    343       {ECO:0000244|PDB:4NEH}.
FT   STRAND      348    351       {ECO:0000244|PDB:3K6S}.
FT   STRAND      354    361       {ECO:0000244|PDB:4NEH}.
FT   STRAND      364    369       {ECO:0000244|PDB:4NEH}.
FT   HELIX       372    375       {ECO:0000244|PDB:4NEH}.
FT   STRAND      379    381       {ECO:0000244|PDB:4NEH}.
FT   STRAND      384    386       {ECO:0000244|PDB:3K6S}.
FT   STRAND      389    391       {ECO:0000244|PDB:4NEH}.
FT   HELIX       398    400       {ECO:0000244|PDB:4NEH}.
FT   STRAND      407    424       {ECO:0000244|PDB:4NEH}.
FT   HELIX       427    429       {ECO:0000244|PDB:4NEH}.
FT   STRAND      432    439       {ECO:0000244|PDB:4NEH}.
FT   STRAND      442    450       {ECO:0000244|PDB:4NEH}.
FT   STRAND      460    465       {ECO:0000244|PDB:4NEH}.
FT   STRAND      470    472       {ECO:0000244|PDB:4NEH}.
FT   STRAND      475    484       {ECO:0000244|PDB:4NEH}.
FT   STRAND      489    496       {ECO:0000244|PDB:4NEH}.
FT   STRAND      508    510       {ECO:0000244|PDB:4NEH}.
FT   STRAND      514    521       {ECO:0000244|PDB:4NEN}.
FT   STRAND      523    529       {ECO:0000244|PDB:4NEH}.
FT   STRAND      531    535       {ECO:0000244|PDB:4NEH}.
FT   STRAND      538    543       {ECO:0000244|PDB:4NEH}.
FT   HELIX       546    549       {ECO:0000244|PDB:4NEH}.
FT   STRAND      551    556       {ECO:0000244|PDB:4NEH}.
FT   TURN        560    562       {ECO:0000244|PDB:4NEH}.
FT   STRAND      569    573       {ECO:0000244|PDB:4NEH}.
FT   HELIX       574    577       {ECO:0000244|PDB:4NEH}.
FT   STRAND      586    592       {ECO:0000244|PDB:4NEH}.
FT   STRAND      595    599       {ECO:0000244|PDB:4NEH}.
FT   STRAND      601    606       {ECO:0000244|PDB:4NEH}.
FT   STRAND      609    615       {ECO:0000244|PDB:4NEH}.
FT   STRAND      618    632       {ECO:0000244|PDB:4NEH}.
FT   TURN        634    636       {ECO:0000244|PDB:4NEH}.
FT   STRAND      641    643       {ECO:0000244|PDB:3K6S}.
FT   STRAND      648    661       {ECO:0000244|PDB:4NEH}.
FT   TURN        662    664       {ECO:0000244|PDB:3K6S}.
FT   TURN        668    670       {ECO:0000244|PDB:5ES4}.
FT   STRAND      673    682       {ECO:0000244|PDB:4NEH}.
FT   STRAND      685    687       {ECO:0000244|PDB:3K6S}.
FT   TURN        693    695       {ECO:0000244|PDB:4NEH}.
FT   STRAND      696    706       {ECO:0000244|PDB:4NEH}.
FT   STRAND      708    719       {ECO:0000244|PDB:4NEH}.
FT   STRAND      726    728       {ECO:0000244|PDB:5ES4}.
FT   STRAND      730    740       {ECO:0000244|PDB:4NEH}.
FT   TURN        744    747       {ECO:0000244|PDB:4NEH}.
FT   STRAND      760    765       {ECO:0000244|PDB:4NEH}.
FT   STRAND      772    774       {ECO:0000244|PDB:4NEH}.
FT   STRAND      782    786       {ECO:0000244|PDB:4NEH}.
FT   STRAND      791    795       {ECO:0000244|PDB:4NEH}.
FT   STRAND      800    808       {ECO:0000244|PDB:4NEH}.
FT   STRAND      814    824       {ECO:0000244|PDB:4NEH}.
FT   STRAND      827    829       {ECO:0000244|PDB:4NEH}.
FT   STRAND      838    841       {ECO:0000244|PDB:4NEH}.
FT   STRAND      847    853       {ECO:0000244|PDB:4NEH}.
FT   TURN        854    857       {ECO:0000244|PDB:4NEH}.
FT   STRAND      858    870       {ECO:0000244|PDB:4NEH}.
FT   STRAND      875    884       {ECO:0000244|PDB:4NEH}.
FT   STRAND      892    901       {ECO:0000244|PDB:4NEH}.
FT   STRAND      908    910       {ECO:0000244|PDB:5ES4}.
FT   STRAND      914    924       {ECO:0000244|PDB:4NEH}.
FT   STRAND      926    930       {ECO:0000244|PDB:4NEH}.
FT   STRAND      932    934       {ECO:0000244|PDB:4NEN}.
FT   STRAND      937    941       {ECO:0000244|PDB:4NEH}.
FT   STRAND      948    959       {ECO:0000244|PDB:4NEH}.
FT   STRAND      961    963       {ECO:0000244|PDB:4NEH}.
FT   STRAND      965    977       {ECO:0000244|PDB:4NEH}.
FT   STRAND      980    989       {ECO:0000244|PDB:4NEH}.
FT   STRAND      991    993       {ECO:0000244|PDB:4NEN}.
FT   STRAND      999   1003       {ECO:0000244|PDB:4NEH}.
FT   HELIX      1010   1016       {ECO:0000244|PDB:4NEH}.
FT   STRAND     1019   1021       {ECO:0000244|PDB:4NEN}.
FT   TURN       1022   1024       {ECO:0000244|PDB:4NEH}.
FT   STRAND     1025   1037       {ECO:0000244|PDB:4NEH}.
FT   STRAND     1042   1053       {ECO:0000244|PDB:4NEH}.
FT   HELIX      1054   1058       {ECO:0000244|PDB:4NEH}.
FT   STRAND     1062   1073       {ECO:0000244|PDB:4NEH}.
FT   TURN       1076   1078       {ECO:0000244|PDB:4NEH}.
FT   STRAND     1079   1081       {ECO:0000244|PDB:4NEH}.
FT   HELIX      1086   1089       {ECO:0000244|PDB:4NEH}.
FT   STRAND     1090   1100       {ECO:0000244|PDB:4NEH}.
FT   HELIX      1133   1144       {ECO:0000244|PDB:2LUV}.
FT   STRAND     1147   1149       {ECO:0000244|PDB:2LUV}.
FT   TURN       1150   1154       {ECO:0000244|PDB:2LUV}.
FT   TURN       1160   1162       {ECO:0000244|PDB:2LUV}.
SQ   SEQUENCE   1163 AA;  127829 MW;  8947288C43E76BE2 CRC64;
     MTRTRAALLL FTALATSLGF NLDTEELTAF RVDSAGFGDS VVQYANSWVV VGAPQKITAA
     NQTGGLYQCG YSTGACEPIG LQVPPEAVNM SLGLSLASTT SPSQLLACGP TVHHECGRNM
     YLTGLCFLLG PTQLTQRLPV SRQECPRQEQ DIVFLIDGSG SISSRNFATM MNFVRAVISQ
     FQRPSTQFSL MQFSNKFQTH FTFEEFRRSS NPLSLLASVH QLQGFTYTAT AIQNVVHRLF
     HASYGARRDA AKILIVITDG KKEGDSLDYK DVIPMADAAG IIRYAIGVGL AFQNRNSWKE
     LNDIASKPSQ EHIFKVEDFD ALKDIQNQLK EKIFAIEGTE TTSSSSFELE MAQEGFSAVF
     TPDGPVLGAV GSFTWSGGAF LYPPNMSPTF INMSQENVDM RDSYLGYSTE LALWKGVQSL
     VLGAPRYQHT GKAVIFTQVS RQWRMKAEVT GTQIGSYFGA SLCSVDVDSD GSTDLVLIGA
     PHYYEQTRGG QVSVCPLPRG WRRWWCDAVL YGEQGHPWGR FGAALTVLGD VNGDKLTDVV
     IGAPGEEENR GAVYLFHGVL GPSISPSHSQ RIAGSQLSSR LQYFGQALSG GQDLTQDGLV
     DLAVGARGQV LLLRTRPVLW VGVSMQFIPA EIPRSAFECR EQVVSEQTLV QSNICLYIDK
     RSKNLLGSRD LQSSVTLDLA LDPGRLSPRA TFQETKNRSL SRVRVLGLKA HCENFNLLLP
     SCVEDSVTPI TLRLNFTLVG KPLLAFRNLR PMLAADAQRY FTASLPFEKN CGADHICQDN
     LGISFSFPGL KSLLVGSNLE LNAEVMVWND GEDSYGTTIT FSHPAGLSYR YVAEGQKQGQ
     LRSLHLTCDS APVGSQGTWS TSCRINHLIF RGGAQITFLA TFDVSPKAVL GDRLLLTANV
     SSENNTPRTS KTTFQLELPV KYAVYTVVSS HEQFTKYLNF SESEEKESHV AMHRYQVNNL
     GQRDLPVSIN FWVPVELNQE AVWMDVEVSH PQNPSLRCSS EKIAPPASDF LAHIQKNPVL
     DCSIAGCLRF RCDVPSFSVQ EELDFTLKGN LSFGWVRQIL QKKVSVVSVA EITFDTSVYS
     QLPGQEAFMR AQTTTVLEKY KVHNPTPLIV GSSIGGLLLL ALITAVLYKV GFFKRQYKEM
     MEEANGQIAP ENGTQTPSPP SEK
//
ID   ITA8_CHICK              Reviewed;        1044 AA.
AC   P26009;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   22-NOV-2017, entry version 117.
DE   RecName: Full=Integrin alpha-8;
DE   Contains:
DE     RecName: Full=Integrin alpha-8 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-8 light chain;
DE   Flags: Precursor;
GN   Name=ITGA8;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=1714374;
RA   Bossy B., Bossy-Wetzel E., Reichardt L.F.;
RT   "Characterization of the integrin alpha 8 subunit: a new integrin beta
RT   1-associated subunit, which is prominently expressed on axons and on
RT   cells in contact with basal laminae in chick embryos.";
RL   EMBO J. 10:2375-2385(1991).
RN   [2]
RP   FUNCTION.
RX   PubMed=7541634; DOI=10.1016/0896-6273(95)90268-6;
RA   Varnum-Finney B., Venstrom K., Mueller U., Kypta R., Backus C.,
RA   Chiquet M., Reichardt L.F.;
RT   "The integrin receptor alpha 8 beta 1 mediates interactions of
RT   embryonic chick motor and sensory neurons with tenascin-C.";
RL   Neuron 14:1213-1222(1995).
RN   [3]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=9712662;
RA   Zhang Z., Galileo D.S.;
RT   "Retroviral transfer of antisense integrin alpha6 or alpha8 sequences
RT   results in laminar redistribution or clonal cell death in developing
RT   brain.";
RL   J. Neurosci. 18:6928-6938(1998).
CC   -!- FUNCTION: Integrin alpha-8/beta-1 functions in the genesis of
CC       kidney and probably of other organs by regulating the recruitment
CC       of mesenchymal cells into epithelial structures. It recognizes the
CC       sequence R-G-D in a wide array of ligands including TNC, FN1,
CC       SPP1, TGFB1, TGFB3 and VTN. NPNT is probably its functional ligand
CC       in kidney genesis (By similarity). Neuronal receptor for TNC it
CC       mediates cell-cell interactions and regulates neurite outgrowth of
CC       sensory and motor neurons. {ECO:0000250,
CC       ECO:0000269|PubMed:1714374, ECO:0000269|PubMed:7541634,
CC       ECO:0000269|PubMed:9712662}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-8 associates with beta-1.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell membrane {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Prominently expressed on axons and on cells in
CC       contact with basal laminae in embryos.
CC   -!- DEVELOPMENTAL STAGE: Expressed in developing tectum (at protein
CC       level). {ECO:0000269|PubMed:9712662}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X58519; CAA41409.1; -; mRNA.
DR   PIR; S16516; S16516.
DR   RefSeq; NP_990619.1; NM_205288.2.
DR   UniGene; Gga.1784; -.
DR   ProteinModelPortal; P26009; -.
DR   SMR; P26009; -.
DR   STRING; 9031.ENSGALP00000014220; -.
DR   PaxDb; P26009; -.
DR   GeneID; 396225; -.
DR   KEGG; gga:396225; -.
DR   CTD; 8516; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; P26009; -.
DR   KO; K06584; -.
DR   PhylomeDB; P26009; -.
DR   PRO; PR:P26009; -.
DR   Proteomes; UP000000539; Unplaced.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 6.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond; Glycoprotein;
KW   Integrin; Membrane; Metal-binding; Neurogenesis; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   1044       Integrin alpha-8.
FT                                /FTId=PRO_0000016313.
FT   CHAIN        24    887       Integrin alpha-8 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016314.
FT   CHAIN       888   1044       Integrin alpha-8 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016315.
FT   TOPO_DOM     24    991       Extracellular. {ECO:0000255}.
FT   TRANSMEM    992   1015       Helical. {ECO:0000255}.
FT   TOPO_DOM   1016   1044       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       28     90       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      104    165       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      170    222       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      236    288       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      289    354       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      355    413       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      417    480       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     311    319       {ECO:0000255}.
FT   CA_BIND     377    385       {ECO:0000255}.
FT   CA_BIND     441    449       {ECO:0000255}.
FT   MOTIF       437    439       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    104    104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    159    159       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    221    221       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    284    284       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    293    293       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    486    486       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    587    587       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    701    701       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    719    719       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    751    751       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    762    762       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    818    818       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    877    877       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    904    904       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    952    952       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    986    986       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     81     88       {ECO:0000250}.
FT   DISULFID    132    153       {ECO:0000250}.
FT   DISULFID    169    182       {ECO:0000250}.
FT   DISULFID    489    500       {ECO:0000250}.
FT   DISULFID    506    562       {ECO:0000250}.
FT   DISULFID    623    629       {ECO:0000250}.
FT   DISULFID    695    708       {ECO:0000250}.
FT   DISULFID    849    905       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    910    915       {ECO:0000250}.
SQ   SEQUENCE   1044 AA;  116142 MW;  3D59A318B51320CE CRC64;
     MPRRQPPRPL LLLSALLCAP ASAFNLDEEK LTVYSGPPGS YFGYSVDFYI PDPSTVSVLV
     GAPRANTTQP DIVEGGAVYH CGWPAARCRQ IPFDNTNNRK IKVNGTREPI EFKTNQWFGA
     TVKAHKEKVV ACAPLYHWRT LKDSPEKDPV GTCYVAIQNF SAYAEYSPCR NSNADPEGQG
     FCQAGFSLDF YKNGDLIVGG PGSFYWQGQV ITASIADIIT NYSFKDILRK LAHEKQTGVA
     PPTYDDNYMG YSVAAGEFTG DSEEELVAGV PRGAQNFGYV SIINSSDLTF IQNFTGEQMA
     SYFGYTVAVS DVNNDGLDDI LVGAPLFMER EFESKPKEVG QVYLYLQESA FLFRDPQILT
     GTEVFGRFGS AITHLGDLNQ DGYNDIAVGA PFAGEDRRGK VLIYNGYSNG LKTDPSQVLN
     GAWASQSMPS GFGFTLRGDS DVDKNDYPDL IVGAFGAGKA VVYRARPVVT VNALLILNPM
     IVNPDNKTCQ PPGSPLFVAC FTVRVCAAFE GQSISDEIVL KGELQLDSLK QKGAVKRTLF
     FDYHQSHHYF SIVMERQKKL YCQDFLVYLR DETEFRDKLS PININLNYSL DESHFKDSLL
     VKPILNYYQR PSVTEQAYIL VDCGEDNLCI PDLHLSAVPD KDQLIIGEEN CVMLIINPRN
     DGEGAYEAEL HIKIPPEADY TGVERNNKAL RVLSCDYKME NETRMVVCDL GNPMVAGANF
     STGIRFSVQH FENSDFSINF ELQIKSSNKI NSTSNLVNLH INITAAAQVQ VRGVSHPPQI
     ILPLHNWEPK DEPTKEEEIG PLVEHIYELH NIGPSAINNT VLHVGWPVSS GEEFLLYILH
     IQTHGPLHCQ TSSPINIMQI NFAIPQDTPE LAAFLYNSTI SHYIRRREVA VAEPYRRNSA
     KILNCTNVKC ILISCNVGQL ERGKSAALKI RSRLWAETFL QRKNDPYTLS SNVSFKVKNM
     PYKVQPAKLP EGSIAIRTSV IWSTPNVSFV IPLWVIILAI MLGLLVLAVL TLALWKCGFF
     DRARPPQDDM ADREQLTNNK TTDA
//
ID   ITA5_HUMAN              Reviewed;        1049 AA.
AC   P08648; Q96HA5;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 2.
DT   22-NOV-2017, entry version 201.
DE   RecName: Full=Integrin alpha-5;
DE   AltName: Full=CD49 antigen-like family member E;
DE   AltName: Full=Fibronectin receptor subunit alpha;
DE   AltName: Full=Integrin alpha-F;
DE   AltName: Full=VLA-5;
DE   AltName: CD_antigen=CD49e;
DE   Contains:
DE     RecName: Full=Integrin alpha-5 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-5 light chain;
DE   Flags: Precursor;
GN   Name=ITGA5; Synonyms=FNRA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2958481; DOI=10.1083/jcb.105.3.1183;
RA   Argraves W.S., Suzuki S., Arai H., Thompson K., Pierschbacher M.D.,
RA   Ruoslahti E.;
RT   "Amino acid sequence of the human fibronectin receptor.";
RL   J. Cell Biol. 105:1183-1190(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-73.
RX   PubMed=1834647;
RA   Birkenmeier T.M., McQuillan J.J., Boedeker E.D., Argraves W.S.,
RA   Ruoslahti E., Dean D.C.;
RT   "The alpha 5 beta 1 fibronectin receptor. Characterization of the
RT   alpha 5 gene promoter.";
RL   J. Biol. Chem. 266:20544-20549(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 16-1049.
RX   PubMed=2450560; DOI=10.1021/bi00399a021;
RA   Fitzgerald L.A., Poncz M., Steiner B., Rall S.C., Bennett J.S.,
RA   Phillips D.R.;
RT   "Comparison of cDNA-derived protein sequences of the human fibronectin
RT   and vitronectin receptor alpha-subunits and platelet glycoprotein
RT   IIb.";
RL   Biochemistry 26:8158-8165(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 821-1049.
RX   PubMed=2944883;
RA   Argraves W.S., Pytela R., Suzuki S., Millan J.L., Pierschbacher M.D.,
RA   Ruoslahti E.;
RT   "cDNA sequences from the alpha subunit of the fibronectin receptor
RT   predict a transmembrane domain and a short cytoplasmic peptide.";
RL   J. Biol. Chem. 261:12922-12924(1986).
RN   [6]
RP   PROTEIN SEQUENCE OF 42-55.
RX   PubMed=3033641; DOI=10.1073/pnas.84.10.3239;
RA   Takada Y., Strominger J.L., Hemler M.E.;
RT   "The very late antigen family of heterodimers is part of a superfamily
RT   of molecules involved in adhesion and embryogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:3239-3243(1987).
RN   [7]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=10397733;
RA   Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S.,
RA   Manzari V., Modesti A., Nair B.C., Cafaro A., Stuerzl M., Ensoli B.;
RT   "The Tat protein of human immunodeficiency virus type-1 promotes
RT   vascular cell growth and locomotion by engaging the alpha5beta1 and
RT   alphavbeta3 integrins and by mobilizing sequestered basic fibroblast
RT   growth factor.";
RL   Blood 94:663-672(1999).
RN   [8]
RP   INTERACTION WITH NISCH.
RX   PubMed=11912194; DOI=10.1074/jbc.M111838200;
RA   Sano H., Liu S.C.H., Lane W.S., Piletz J.E., Lienhard G.E.;
RT   "Insulin receptor substrate 4 associates with the protein IRAS.";
RL   J. Biol. Chem. 277:19439-19447(2002).
RN   [9]
RP   DISULFIDE BONDS.
RX   PubMed=14596610; DOI=10.1021/bi034726u;
RA   Krokhin O.V., Cheng K., Sousa S.L., Ens W., Standing K.G.,
RA   Wilkins J.A.;
RT   "Mass spectrometric based mapping of the disulfide bonding patterns of
RT   integrin alpha chains.";
RL   Biochemistry 42:12950-12959(2003).
RN   [10]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN PARVOVIRUS
RP   B19 CAPSID PROTEIN.
RX   PubMed=12907437; DOI=10.1182/blood-2003-05-1522;
RA   Weigel-Kelley K.A., Yoder M.C., Srivastava A.;
RT   "Alpha5beta1 integrin as a cellular coreceptor for human parvovirus
RT   B19: requirement of functional activation of beta1 integrin for viral
RT   entry.";
RL   Blood 102:3927-3933(2003).
RN   [11]
RP   INTERACTION WITH NOV.
RX   PubMed=12695522; DOI=10.1074/jbc.M302028200;
RA   Lin C.G., Leu S.J., Chen N., Tebeau C.M., Lin S.X., Yeung C.Y.,
RA   Lau L.F.;
RT   "CCN3 (NOV) is a novel angiogenic regulator of the CCN protein
RT   family.";
RL   J. Biol. Chem. 278:24200-24208(2003).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH FBN1.
RX   PubMed=12807887; DOI=10.1074/jbc.M303159200;
RA   Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J.,
RA   Shuttleworth C.A., Humphries M.J., Kielty C.M.;
RT   "Cell adhesion to fibrillin-1 molecules and microfibrils is mediated
RT   by alpha 5 beta 1 and alpha v beta 3 integrins.";
RL   J. Biol. Chem. 278:34605-34616(2003).
RN   [13]
RP   INTERACTION WITH COMP.
RX   PubMed=16051604; DOI=10.1074/jbc.M504778200;
RA   Chen F.-H., Thomas A.O., Hecht J.T., Goldring M.B., Lawler J.;
RT   "Cartilage oligomeric matrix protein/thrombospondin 5 supports
RT   chondrocyte attachment through interaction with integrins.";
RL   J. Biol. Chem. 280:32655-32661(2005).
RN   [14]
RP   INTERACTION WITH RAB21.
RX   PubMed=16754960; DOI=10.1083/jcb.200509019;
RA   Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M.,
RA   Ivaska J.;
RT   "Small GTPase Rab21 regulates cell adhesion and controls endosomal
RT   traffic of beta1-integrins.";
RL   J. Cell Biol. 173:767-780(2006).
RN   [15]
RP   FUNCTION, INTERACTION WITH FBN1, AND SUBCELLULAR LOCATION.
RX   PubMed=17158881; DOI=10.1074/jbc.M607008200;
RA   Jovanovic J., Takagi J., Choulier L., Abrescia N.G., Stuart D.I.,
RA   van der Merwe P.A., Mardon H.J., Handford P.A.;
RT   "alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative
RT   studies of molecular determinants underlying integrin-rgd affinity and
RT   specificity.";
RL   J. Biol. Chem. 282:6743-6751(2007).
RN   [16]
RP   FUNCTION.
RX   PubMed=18635536; DOI=10.1074/jbc.M804835200;
RA   Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S.,
RA   Liu F.T., Takada Y.K., Takada Y.;
RT   "Pro-inflammatory secretory phospholipase A2 type IIA binds to
RT   integrins alphavbeta3 and alpha4beta1 and induces proliferation of
RT   monocytic cells in an integrin-dependent manner.";
RL   J. Biol. Chem. 283:26107-26115(2008).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297; ASN-307; ASN-675 AND
RP   ASN-773.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297; ASN-307; ASN-771 AND
RP   ASN-773.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PROTEOLYTIC CLEAVAGE BY PCSK5.
RX   PubMed=22740495; DOI=10.1093/humrep/des203;
RA   Paule S., Aljofan M., Simon C., Rombauts L.J., Nie G.;
RT   "Cleavage of endometrial alpha-integrins into their functional forms
RT   is mediated by proprotein convertase 5/6.";
RL   Hum. Reprod. 27:2766-2774(2012).
RN   [21]
RP   INTERACTION WITH CIB1.
RX   PubMed=24011356; DOI=10.1021/bi400678y;
RA   Freeman T.C. Jr., Black J.L., Bray H.G., Dagliyan O., Wu Y.I.,
RA   Tripathy A., Dokholyan N.V., Leisner T.M., Parise L.V.;
RT   "Identification of novel integrin binding partners for calcium and
RT   integrin binding protein 1 (CIB1): structural and thermodynamic basis
RT   of CIB1 promiscuity.";
RL   Biochemistry 52:7082-7090(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN
RP   METAPNEUMOVIRUS FUSION PROTEIN.
RX   PubMed=24478423; DOI=10.1128/JVI.03491-13;
RA   Wei Y., Zhang Y., Cai H., Mirza A.M., Iorio R.M., Peeples M.E.,
RA   Niewiesk S., Li J.;
RT   "Roles of the putative integrin-binding motif of the human
RT   metapneumovirus fusion (f) protein in cell-cell fusion, viral
RT   infectivity, and pathogenesis.";
RL   J. Virol. 88:4338-4352(2014).
RN   [25]
RP   FUNCTION.
RX   PubMed=25398877; DOI=10.1074/jbc.M114.579946;
RA   Fujita M., Zhu K., Fujita C.K., Zhao M., Lam K.S., Kurth M.J.,
RA   Takada Y.K., Takada Y.;
RT   "Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces
RT   integrin activation through direct binding to a newly identified
RT   binding site (site 2) in integrins alphavbeta3, alpha4beta1, and
RT   alpha5beta1.";
RL   J. Biol. Chem. 290:259-271(2015).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 42-664 IN COMPLEX WITH
RP   ANTIBODY; ITGB1 AND RGD PEPTIDE, DISULFIDE BONDS, GLYCOSYLATION AT
RP   ASN-84; ASN-182; ASN-297; ASN-307; ASN-316 AND ASN-609,
RP   SUBSTRATE-BINDING SITES, CALCIUM-BINDING SITES, AND SUBUNIT.
RX   PubMed=22451694; DOI=10.1083/jcb.201111077;
RA   Nagae M., Re S., Mihara E., Nogi T., Sugita Y., Takagi J.;
RT   "Crystal structure of alpha5beta1 integrin ectodomain: atomic details
RT   of the fibronectin receptor.";
RL   J. Cell Biol. 197:131-140(2012).
CC   -!- FUNCTION: Integrin alpha-5/beta-1 is a receptor for fibronectin
CC       and fibrinogen. It recognizes the sequence R-G-D in its ligands.
CC       ITGA5:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct
CC       from the classical ligand-binding site (site 1) and this induces
CC       integrin conformational changes and enhanced ligand binding to
CC       site 1 (PubMed:18635536, PubMed:25398877). ITGA5:ITGB1 acts as a
CC       receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell
CC       adhesion to FBN1 (PubMed:12807887, PubMed:17158881).
CC       {ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:17158881,
CC       ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:25398877}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGA5:ITGB1 acts as a
CC       receptor for human metapneumovirus (PubMed:12907437). Integrin
CC       ITGA2:ITGB1 acts as a receptor for human parvovirus B19
CC       (PubMed:24478423). In case of HIV-1 infection, the interaction
CC       with extracellular viral Tat protein seems to enhance angiogenesis
CC       in Kaposi's sarcoma lesions (PubMed:10397733).
CC       {ECO:0000269|PubMed:10397733, ECO:0000269|PubMed:12907437,
CC       ECO:0000269|PubMed:24478423}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-5 associates with beta-1. Interacts with
CC       HPS5 and NISCH. Interacts with RAB21 and COMP. Interacts with
CC       CIB1. ITGA5:ITGB1 interacts with NOV. ITGA5:ITGB1 interacts with
CC       FBN1 (PubMed:12807887, PubMed:17158881).
CC       {ECO:0000269|PubMed:11912194, ECO:0000269|PubMed:12695522,
CC       ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:16051604,
CC       ECO:0000269|PubMed:16754960, ECO:0000269|PubMed:17158881,
CC       ECO:0000269|PubMed:22451694, ECO:0000269|PubMed:24011356}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA5:ITGB1 interacts with
CC       human metapneumovirus fusion protein.
CC       {ECO:0000269|PubMed:12907437}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA2:ITGB1 interacts with
CC       human parvovirus B19 capsid proteins.
CC       {ECO:0000269|PubMed:24478423}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat.
CC       {ECO:0000269|PubMed:10397733}.
CC   -!- INTERACTION:
CC       P17813:ENG; NbExp=4; IntAct=EBI-1382311, EBI-2834630;
CC       P05556:ITGB1; NbExp=5; IntAct=EBI-1382311, EBI-703066;
CC       O14786:NRP1; NbExp=2; IntAct=EBI-1382311, EBI-1187100;
CC       P97333:Nrp1 (xeno); NbExp=3; IntAct=EBI-1382311, EBI-1555129;
CC       Q9H0F6:SHARPIN; NbExp=4; IntAct=EBI-1382311, EBI-3942966;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:17158881}. Cell surface
CC       {ECO:0000269|PubMed:17158881}.
CC   -!- PTM: Proteolytic cleavage by PCSK5 mediates activation of the
CC       precursor. {ECO:0000269|PubMed:22740495}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06256; CAA29601.1; -; mRNA.
DR   EMBL; BC008786; AAH08786.1; -; mRNA.
DR   EMBL; M13918; AAA52467.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS8880.1; -.
DR   PIR; A27079; A27079.
DR   RefSeq; NP_002196.4; NM_002205.4.
DR   UniGene; Hs.505654; -.
DR   PDB; 3VI3; X-ray; 2.90 A; A/C=42-664.
DR   PDB; 3VI4; X-ray; 2.90 A; A/C=42-664.
DR   PDB; 4WJK; X-ray; 1.85 A; A=42-491.
DR   PDB; 4WK0; X-ray; 1.78 A; A=42-491.
DR   PDB; 4WK2; X-ray; 2.50 A; A=42-491.
DR   PDB; 4WK4; X-ray; 2.50 A; A=42-491.
DR   PDBsum; 3VI3; -.
DR   PDBsum; 3VI4; -.
DR   PDBsum; 4WJK; -.
DR   PDBsum; 4WK0; -.
DR   PDBsum; 4WK2; -.
DR   PDBsum; 4WK4; -.
DR   ProteinModelPortal; P08648; -.
DR   SMR; P08648; -.
DR   BioGrid; 109884; 35.
DR   CORUM; P08648; -.
DR   DIP; DIP-40037N; -.
DR   ELM; P08648; -.
DR   IntAct; P08648; 20.
DR   MINT; MINT-5005934; -.
DR   STRING; 9606.ENSP00000293379; -.
DR   BindingDB; P08648; -.
DR   ChEMBL; CHEMBL3955; -.
DR   iPTMnet; P08648; -.
DR   PhosphoSitePlus; P08648; -.
DR   SwissPalm; P08648; -.
DR   UniCarbKB; P08648; -.
DR   BioMuta; ITGA5; -.
DR   DMDM; 23831237; -.
DR   EPD; P08648; -.
DR   MaxQB; P08648; -.
DR   PaxDb; P08648; -.
DR   PeptideAtlas; P08648; -.
DR   PRIDE; P08648; -.
DR   TopDownProteomics; P08648; -.
DR   DNASU; 3678; -.
DR   Ensembl; ENST00000293379; ENSP00000293379; ENSG00000161638.
DR   GeneID; 3678; -.
DR   KEGG; hsa:3678; -.
DR   UCSC; uc001sga.4; human.
DR   CTD; 3678; -.
DR   DisGeNET; 3678; -.
DR   EuPathDB; HostDB:ENSG00000161638.10; -.
DR   GeneCards; ITGA5; -.
DR   HGNC; HGNC:6141; ITGA5.
DR   HPA; CAB009008; -.
DR   HPA; HPA002642; -.
DR   MIM; 135620; gene.
DR   neXtProt; NX_P08648; -.
DR   OpenTargets; ENSG00000161638; -.
DR   PharmGKB; PA29941; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; P08648; -.
DR   KO; K06484; -.
DR   OMA; PAMFNPE; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   PhylomeDB; P08648; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-1566977; Fibronectin matrix formation.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-8941332; RUNX2 regulates genes involved in cell migration.
DR   SignaLink; P08648; -.
DR   SIGNOR; P08648; -.
DR   ChiTaRS; ITGA5; human.
DR   GeneWiki; ITGA5; -.
DR   GenomeRNAi; 3678; -.
DR   PRO; PR:P08648; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000161638; -.
DR   CleanEx; HS_ITGA5; -.
DR   ExpressionAtlas; P08648; baseline and differential.
DR   Genevisible; P08648; HS.
DR   GO; GO:0071062; C:alphav-beta3 integrin-vitronectin complex; TAS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0001726; C:ruffle; TAS:HGNC.
DR   GO; GO:0045202; C:synapse; IEA:Ensembl.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005161; F:platelet-derived growth factor receptor binding; TAS:BHF-UCL.
DR   GO; GO:0043184; F:vascular endothelial growth factor receptor 2 binding; TAS:BHF-UCL.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0001525; P:angiogenesis; TAS:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:UniProtKB.
DR   GO; GO:0033631; P:cell-cell adhesion mediated by integrin; IEA:Ensembl.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0007044; P:cell-substrate junction assembly; IEA:Ensembl.
DR   GO; GO:0035987; P:endodermal cell differentiation; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IEA:Ensembl.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0035313; P:wound healing, spreading of epidermal cells; IEP:BHF-UCL.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Cell junction;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Integrin;
KW   Membrane; Metal-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     41       {ECO:0000269|PubMed:3033641}.
FT   CHAIN        42   1049       Integrin alpha-5.
FT                                /FTId=PRO_0000016249.
FT   CHAIN        42    894       Integrin alpha-5 heavy chain.
FT                                /FTId=PRO_0000016250.
FT   CHAIN       895   1049       Integrin alpha-5 light chain.
FT                                /FTId=PRO_0000016251.
FT   TOPO_DOM     42    995       Extracellular. {ECO:0000255}.
FT   TRANSMEM    996   1021       Helical. {ECO:0000255}.
FT   TOPO_DOM   1022   1049       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       43    108       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      128    188       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      192    245       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      259    311       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      312    377       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      378    437       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      441    504       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     280    288
FT   CA_BIND     334    342
FT   CA_BIND     401    409
FT   CA_BIND     465    473
FT   REGION     1021   1028       Interaction with HPS5.
FT   MOTIF      1024   1028       GFFKR motif.
FT   METAL       280    280       Calcium 1.
FT   METAL       282    282       Calcium 1.
FT   METAL       284    284       Calcium 1.
FT   METAL       286    286       Calcium 1; via carbonyl oxygen.
FT   METAL       288    288       Calcium 1.
FT   METAL       334    334       Calcium 2.
FT   METAL       336    336       Calcium 2.
FT   METAL       338    338       Calcium 2.
FT   METAL       340    340       Calcium 2; via carbonyl oxygen.
FT   METAL       342    342       Calcium 2.
FT   METAL       401    401       Calcium 3.
FT   METAL       403    403       Calcium 3.
FT   METAL       405    405       Calcium 3.
FT   METAL       407    407       Calcium 3; via carbonyl oxygen.
FT   METAL       409    409       Calcium 3.
FT   METAL       465    465       Calcium 4.
FT   METAL       467    467       Calcium 4.
FT   METAL       469    469       Calcium 4.
FT   METAL       471    471       Calcium 4; via carbonyl oxygen.
FT   METAL       473    473       Calcium 4.
FT   BINDING     262    262       Arg of R-G-D substrate.
FT   BINDING     269    269       Arg of R-G-D substrate.
FT   MOD_RES     127    127       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD     84     84       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    182    182       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    307    307       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    316    316       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    524    524       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    530    530       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    593    593       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    609    609       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    675    675       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    712    712       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    724    724       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    771    771       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    773    773       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    868    868       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     99    108
FT   DISULFID    156    176
FT   DISULFID    192    205
FT   DISULFID    513    522
FT   DISULFID    528    584
FT   DISULFID    645    651
FT   DISULFID    718    731
FT   DISULFID    869    921       Interchain (between heavy and light
FT                                chains).
FT   DISULFID    911    916
FT   VARIANT     585    585       R -> I (in dbSNP:rs12318746).
FT                                /FTId=VAR_049631.
FT   CONFLICT     26     26       L -> V (in Ref. 1 and 3). {ECO:0000305}.
FT   CONFLICT     33     33       L -> V (in Ref. 1 and 3). {ECO:0000305}.
FT   STRAND       50     53       {ECO:0000244|PDB:4WK0}.
FT   TURN         56     61       {ECO:0000244|PDB:4WK0}.
FT   STRAND       62     67       {ECO:0000244|PDB:4WK0}.
FT   STRAND       69     71       {ECO:0000244|PDB:4WK0}.
FT   STRAND       75     80       {ECO:0000244|PDB:4WK0}.
FT   STRAND       95    101       {ECO:0000244|PDB:4WK0}.
FT   STRAND      102    104       {ECO:0000244|PDB:4WJK}.
FT   STRAND      109    111       {ECO:0000244|PDB:4WK2}.
FT   HELIX       122    124       {ECO:0000244|PDB:4WK0}.
FT   STRAND      125    130       {ECO:0000244|PDB:4WK0}.
FT   STRAND      133    136       {ECO:0000244|PDB:4WK0}.
FT   STRAND      144    149       {ECO:0000244|PDB:4WK0}.
FT   STRAND      152    157       {ECO:0000244|PDB:4WK0}.
FT   STRAND      165    167       {ECO:0000244|PDB:4WK0}.
FT   STRAND      175    180       {ECO:0000244|PDB:4WK0}.
FT   TURN        181    184       {ECO:0000244|PDB:4WK0}.
FT   STRAND      185    189       {ECO:0000244|PDB:4WK0}.
FT   STRAND      193    196       {ECO:0000244|PDB:4WK0}.
FT   TURN        198    204       {ECO:0000244|PDB:4WK0}.
FT   STRAND      209    213       {ECO:0000244|PDB:4WK0}.
FT   STRAND      219    223       {ECO:0000244|PDB:4WK0}.
FT   HELIX       226    229       {ECO:0000244|PDB:4WK0}.
FT   STRAND      231    236       {ECO:0000244|PDB:4WK0}.
FT   HELIX       238    243       {ECO:0000244|PDB:4WK0}.
FT   STRAND      249    251       {ECO:0000244|PDB:4WK4}.
FT   HELIX       265    267       {ECO:0000244|PDB:4WK0}.
FT   STRAND      274    279       {ECO:0000244|PDB:4WK0}.
FT   STRAND      282    286       {ECO:0000244|PDB:4WK0}.
FT   STRAND      288    293       {ECO:0000244|PDB:4WK0}.
FT   TURN        294    300       {ECO:0000244|PDB:4WK0}.
FT   STRAND      302    306       {ECO:0000244|PDB:4WK0}.
FT   TURN        308    310       {ECO:0000244|PDB:4WK0}.
FT   STRAND      313    318       {ECO:0000244|PDB:4WK0}.
FT   STRAND      328    333       {ECO:0000244|PDB:4WK0}.
FT   STRAND      335    339       {ECO:0000244|PDB:4WK0}.
FT   STRAND      342    347       {ECO:0000244|PDB:4WK0}.
FT   STRAND      351    353       {ECO:0000244|PDB:4WK0}.
FT   STRAND      359    361       {ECO:0000244|PDB:4WK0}.
FT   STRAND      364    368       {ECO:0000244|PDB:4WK0}.
FT   STRAND      380    384       {ECO:0000244|PDB:4WK0}.
FT   HELIX       392    394       {ECO:0000244|PDB:3VI3}.
FT   STRAND      396    400       {ECO:0000244|PDB:4WK0}.
FT   STRAND      405    407       {ECO:0000244|PDB:4WK0}.
FT   STRAND      409    414       {ECO:0000244|PDB:4WK0}.
FT   STRAND      424    428       {ECO:0000244|PDB:4WK0}.
FT   STRAND      440    443       {ECO:0000244|PDB:4WK0}.
FT   STRAND      458    464       {ECO:0000244|PDB:4WK0}.
FT   STRAND      466    471       {ECO:0000244|PDB:4WK0}.
FT   STRAND      473    478       {ECO:0000244|PDB:4WK0}.
FT   HELIX       479    481       {ECO:0000244|PDB:4WK0}.
FT   STRAND      483    487       {ECO:0000244|PDB:4WK0}.
FT   STRAND      492    503       {ECO:0000244|PDB:3VI3}.
FT   STRAND      513    520       {ECO:0000244|PDB:3VI3}.
FT   STRAND      522    532       {ECO:0000244|PDB:3VI3}.
FT   STRAND      534    536       {ECO:0000244|PDB:3VI3}.
FT   STRAND      538    548       {ECO:0000244|PDB:3VI3}.
FT   TURN        549    555       {ECO:0000244|PDB:3VI3}.
FT   STRAND      560    562       {ECO:0000244|PDB:3VI3}.
FT   TURN        563    565       {ECO:0000244|PDB:3VI3}.
FT   STRAND      566    577       {ECO:0000244|PDB:3VI3}.
FT   STRAND      583    591       {ECO:0000244|PDB:3VI3}.
FT   STRAND      604    612       {ECO:0000244|PDB:3VI3}.
FT   STRAND      614    616       {ECO:0000244|PDB:3VI3}.
FT   STRAND      620    622       {ECO:0000244|PDB:3VI3}.
FT   STRAND      634    641       {ECO:0000244|PDB:3VI3}.
SQ   SEQUENCE   1049 AA;  114536 MW;  6B4D558D4F739CBA CRC64;
     MGSRTPESPL HAVQLRWGPR RRPPLLPLLL LLLPPPPRVG GFNLDAEAPA VLSGPPGSFF
     GFSVEFYRPG TDGVSVLVGA PKANTSQPGV LQGGAVYLCP WGASPTQCTP IEFDSKGSRL
     LESSLSSSEG EEPVEYKSLQ WFGATVRAHG SSILACAPLY SWRTEKEPLS DPVGTCYLST
     DNFTRILEYA PCRSDFSWAA GQGYCQGGFS AEFTKTGRVV LGGPGSYFWQ GQILSATQEQ
     IAESYYPEYL INLVQGQLQT RQASSIYDDS YLGYSVAVGE FSGDDTEDFV AGVPKGNLTY
     GYVTILNGSD IRSLYNFSGE QMASYFGYAV AATDVNGDGL DDLLVGAPLL MDRTPDGRPQ
     EVGRVYVYLQ HPAGIEPTPT LTLTGHDEFG RFGSSLTPLG DLDQDGYNDV AIGAPFGGET
     QQGVVFVFPG GPGGLGSKPS QVLQPLWAAS HTPDFFGSAL RGGRDLDGNG YPDLIVGSFG
     VDKAVVYRGR PIVSASASLT IFPAMFNPEE RSCSLEGNPV ACINLSFCLN ASGKHVADSI
     GFTVELQLDW QKQKGGVRRA LFLASRQATL TQTLLIQNGA REDCREMKIY LRNESEFRDK
     LSPIHIALNF SLDPQAPVDS HGLRPALHYQ SKSRIEDKAQ ILLDCGEDNI CVPDLQLEVF
     GEQNHVYLGD KNALNLTFHA QNVGEGGAYE AELRVTAPPE AEYSGLVRHP GNFSSLSCDY
     FAVNQSRLLV CDLGNPMKAG ASLWGGLRFT VPHLRDTKKT IQFDFQILSK NLNNSQSDVV
     SFRLSVEAQA QVTLNGVSKP EAVLFPVSDW HPRDQPQKEE DLGPAVHHVY ELINQGPSSI
     SQGVLELSCP QALEGQQLLY VTRVTGLNCT TNHPINPKGL ELDPEGSLHH QQKREAPSRS
     SASSGPQILK CPEAECFRLR CELGPLHQQE SQSLQLHFRV WAKTFLQREH QPFSLQCEAV
     YKALKMPYRI LPRQLPQKER QVATAVQWTK AEGSYGVPLW IIILAILFGL LLLGLLIYIL
     YKLGFFKRSL PYGTAMEKAQ LKPPATSDA
//
ID   ITA4_HUMAN              Reviewed;        1032 AA.
AC   P13612; D3DPG4; Q7Z4L6;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   20-DEC-2017, entry version 188.
DE   RecName: Full=Integrin alpha-4;
DE   AltName: Full=CD49 antigen-like family member D;
DE   AltName: Full=Integrin alpha-IV;
DE   AltName: Full=VLA-4 subunit alpha;
DE   AltName: CD_antigen=CD49d;
DE   Flags: Precursor;
GN   Name=ITGA4; Synonyms=CD49D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2788572;
RA   Takada Y., Elices M.J., Crouse C., Hemler M.E.;
RT   "The primary structure of the alpha 4 subunit of VLA-4: homology to
RT   other integrins and a possible cell-cell adhesion function.";
RL   EMBO J. 8:1361-1368(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1551405; DOI=10.1002/eji.1830220434;
RA   Rubio M., Nueda A., Vara A., Corbi-Lopez A.L.;
RT   "A single mRNA encodes the alpha 150 and alpha 80/70 forms of the
RT   alpha subunit of VLA4.";
RL   Eur. J. Immunol. 22:1099-1102(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-878.
RX   PubMed=8643114; DOI=10.1016/0161-5890(96)00001-6;
RA   Szabo M.C., McIntyre B.W.;
RT   "Identification of two variants of the human integrin alpha 4
RT   subunit.";
RL   Mol. Immunol. 32:1453-1454(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-878.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-87 (ISOFORM 1).
RX   PubMed=2034655; DOI=10.1073/pnas.88.10.4094;
RA   Rosen G.D., Birkenmeier T.M., Dean D.C.;
RT   "Characterization of the alpha 4 integrin gene promoter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:4094-4098(1991).
RN   [8]
RP   PROTEIN SEQUENCE OF 34-47.
RX   PubMed=3033641; DOI=10.1073/pnas.84.10.3239;
RA   Takada Y., Strominger J.L., Hemler M.E.;
RT   "The very late antigen family of heterodimers is part of a superfamily
RT   of molecules involved in adhesion and embryogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:3239-3243(1987).
RN   [9]
RP   PROTEIN SEQUENCE OF 592-601, PROTEOLYTIC PROCESSING, AND MUTAGENESIS
RP   OF LYS-590 AND ARG-591.
RX   PubMed=1730718;
RA   Teixido J., Parker C.M., Kassner P.D., Hemler M.E.;
RT   "Functional and structural analysis of VLA-4 integrin alpha 4 subunit
RT   cleavage.";
RL   J. Biol. Chem. 267:1786-1791(1992).
RN   [10]
RP   DOMAIN, AND INTERACTION WITH CSPG4.
RX   PubMed=9488735; DOI=10.1074/jbc.273.10.5955;
RA   Iida J., Meijne A.M.L., Oegema T.R. Jr., Yednock T.A., Kovach N.L.,
RA   Furcht L.T., McCarthy J.B.;
RT   "A role of chondroitin sulfate glycosaminoglycan binding site in
RT   alpha4beta1 integrin-mediated melanoma cell adhesion.";
RL   J. Biol. Chem. 273:5955-5962(1998).
RN   [11]
RP   INTERACTION WITH PXN; LPXN AND TGFB1I1, AND MUTAGENESIS OF TYR-1024.
RX   PubMed=10604475; DOI=10.1038/45264;
RA   Liu S., Thomas S.M., Woodside D.G., Rose D.M., Kiosses W.B., Pfaff M.,
RA   Ginsberg M.H.;
RT   "Binding of paxillin to alpha4 integrins modifies integrin-dependent
RT   biological responses.";
RL   Nature 402:676-681(1999).
RN   [12]
RP   PHOSPHORYLATION AT SER-1021, AND MUTAGENESIS OF SER-1021.
RX   PubMed=11533025; DOI=10.1074/jbc.M102665200;
RA   Han J., Liu S., Rose D.M., Schlaepfer D.D., McDonald H.,
RA   Ginsberg M.H.;
RT   "Phosphorylation of the integrin alpha 4 cytoplasmic domain regulates
RT   paxillin binding.";
RL   J. Biol. Chem. 276:40903-40909(2001).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF THR-222 AND GLY-223.
RX   PubMed=18635536; DOI=10.1074/jbc.M804835200;
RA   Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S.,
RA   Liu F.T., Takada Y.K., Takada Y.;
RT   "Pro-inflammatory secretory phospholipase A2 type IIA binds to
RT   integrins alphavbeta3 and alpha4beta1 and induces proliferation of
RT   monocytic cells in an integrin-dependent manner.";
RL   J. Biol. Chem. 283:26107-26115(2008).
RN   [14]
RP   FUNCTION IN LEUKOCYTE TO ENDOTHELIAL CELLS ADHESION, AND INTERACTION
RP   WITH JAML.
RX   PubMed=19064666; DOI=10.1083/jcb.200805061;
RA   Luissint A.C., Lutz P.G., Calderwood D.A., Couraud P.O.,
RA   Bourdoulous S.;
RT   "JAM-L-mediated leukocyte adhesion to endothelial cells is regulated
RT   in cis by alpha4beta1 integrin activation.";
RL   J. Cell Biol. 183:1159-1173(2008).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-480; ASN-518; ASN-538 AND
RP   ASN-645.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1021, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   FUNCTION, BINDING TO CX3CL1, AND IDENTIFICATION IN A COMPLEX WITH
RP   CX3CR1 AND CX3CL1.
RX   PubMed=23125415; DOI=10.4049/jimmunol.1200889;
RA   Fujita M., Takada Y.K., Takada Y.;
RT   "Integrins alphavbeta3 and alpha4beta1 act as coreceptors for
RT   fractalkine, and the integrin-binding defective mutant of fractalkine
RT   is an antagonist of CX3CR1.";
RL   J. Immunol. 189:5809-5819(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1021, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   FUNCTION.
RX   PubMed=25398877; DOI=10.1074/jbc.M114.579946;
RA   Fujita M., Zhu K., Fujita C.K., Zhao M., Lam K.S., Kurth M.J.,
RA   Takada Y.K., Takada Y.;
RT   "Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces
RT   integrin activation through direct binding to a newly identified
RT   binding site (site 2) in integrins alphavbeta3, alpha4beta1, and
RT   alpha5beta1.";
RL   J. Biol. Chem. 290:259-271(2015).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are
CC       receptors for fibronectin. They recognize one or more domains
CC       within the alternatively spliced CS-1 and CS-5 regions of
CC       fibronectin. They are also receptors for VCAM1. Integrin alpha-
CC       4/beta-1 recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-
CC       4/beta-7 is also a receptor for MADCAM1. It recognizes the
CC       sequence L-D-T in MADCAM1. On activated endothelial cells integrin
CC       VLA-4 triggers homotypic aggregation for most VLA-4-positive
CC       leukocyte cell lines. It may also participate in cytolytic T-cell
CC       interactions with target cells. ITGA4:ITGB1 binds to fractalkine
CC       (CX3CL1) and may act as its coreceptor in CX3CR1-dependent
CC       fractalkine signaling (PubMed:23125415). ITGA4:ITGB1 binds to
CC       PLA2G2A via a site (site 2) which is distinct from the classical
CC       ligand-binding site (site 1) and this induces integrin
CC       conformational changes and enhanced ligand binding to site 1
CC       (PubMed:18635536, PubMed:25398877). {ECO:0000269|PubMed:18635536,
CC       ECO:0000269|PubMed:19064666, ECO:0000269|PubMed:23125415,
CC       ECO:0000269|PubMed:25398877}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit can sometimes be cleaved into two non-covalently
CC       associated fragments. Alpha-4 associates with either beta-1 or
CC       beta-7. Alpha-4 interacts with PXN, LPXN, and TGFB1I1/HIC5.
CC       Interacts with CSPG4 through CSPG4 chondroitin sulfate
CC       glycosaminoglycan. Interacts with JAML; integrin alpha-4/beta-1
CC       may regulate leukocyte to endothelial cells adhesion by
CC       controlling JAML homodimerization. ITGA4:ITGB1 is found in a
CC       ternary complex with CX3CR1 and CX3CL1 (PubMed:23125415).
CC       {ECO:0000269|PubMed:10604475, ECO:0000269|PubMed:19064666,
CC       ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:9488735}.
CC   -!- INTERACTION:
CC       Q8IZP0-2:ABI1; NbExp=2; IntAct=EBI-703044, EBI-7358775;
CC       P84092:Ap2m1 (xeno); NbExp=2; IntAct=EBI-703044, EBI-297693;
CC       P05556:ITGB1; NbExp=4; IntAct=EBI-703044, EBI-703066;
CC       P26010:ITGB7; NbExp=6; IntAct=EBI-703044, EBI-702932;
CC       P49023:PXN; NbExp=4; IntAct=EBI-703044, EBI-702209;
CC       O43294:TGFB1I1; NbExp=2; IntAct=EBI-703044, EBI-1051449;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13612-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13612-2; Sequence=VSP_056612, VSP_056613;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The SG1 motif is involved in binding to chondroitin
CC       sulfate glycosaminoglycan and cell adhesion.
CC       {ECO:0000269|PubMed:9488735}.
CC   -!- PTM: Phosphorylation on Ser-1027 inhibits PXN binding.
CC       {ECO:0000269|PubMed:11533025}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB59613.1; Type=Frameshift; Positions=13; Evidence={ECO:0000305};
CC       Sequence=CAA34852.1; Type=Frameshift; Positions=13; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16983; CAA34852.1; ALT_FRAME; mRNA.
DR   EMBL; L12002; AAB59613.1; ALT_FRAME; mRNA.
DR   EMBL; AC020595; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX10985.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10987.1; -; Genomic_DNA.
DR   EMBL; BC055419; AAH55419.1; -; mRNA.
DR   CCDS; CCDS42788.1; -. [P13612-1]
DR   CCDS; CCDS82540.1; -. [P13612-2]
DR   PIR; S06046; S06046.
DR   RefSeq; NP_000876.3; NM_000885.5. [P13612-1]
DR   RefSeq; NP_001303241.1; NM_001316312.1. [P13612-2]
DR   UniGene; Hs.440955; -.
DR   UniGene; Hs.72981; -.
DR   PDB; 3V4P; X-ray; 3.15 A; A/C=34-620.
DR   PDB; 3V4V; X-ray; 3.10 A; A/C=34-620.
DR   PDB; 4HKC; X-ray; 2.20 A; B=1003-1032.
DR   PDB; 5C7Z; X-ray; 2.77 A; B=1008-1015.
DR   PDB; 5FPI; X-ray; 2.77 A; B=1008-1015.
DR   PDBsum; 3V4P; -.
DR   PDBsum; 3V4V; -.
DR   PDBsum; 4HKC; -.
DR   PDBsum; 5C7Z; -.
DR   PDBsum; 5FPI; -.
DR   ProteinModelPortal; P13612; -.
DR   SMR; P13612; -.
DR   BioGrid; 109883; 517.
DR   CORUM; P13612; -.
DR   DIP; DIP-34971N; -.
DR   IntAct; P13612; 15.
DR   MINT; MINT-4098849; -.
DR   STRING; 9606.ENSP00000380227; -.
DR   BindingDB; P13612; -.
DR   ChEMBL; CHEMBL278; -.
DR   DrugBank; DB04997; ATL1102.
DR   DrugBank; DB05092; CDP323.
DR   DrugBank; DB05802; MLN-02.
DR   DrugBank; DB00108; Natalizumab.
DR   DrugBank; DB05122; R1295.
DR   DrugBank; DB05468; R411.
DR   DrugBank; DB06822; Tinzaparin.
DR   DrugBank; DB09033; Vedolizumab.
DR   GuidetoPHARMACOLOGY; 2443; -.
DR   iPTMnet; P13612; -.
DR   PhosphoSitePlus; P13612; -.
DR   BioMuta; ITGA4; -.
DR   DMDM; 311033436; -.
DR   EPD; P13612; -.
DR   MaxQB; P13612; -.
DR   PaxDb; P13612; -.
DR   PeptideAtlas; P13612; -.
DR   PRIDE; P13612; -.
DR   DNASU; 3676; -.
DR   Ensembl; ENST00000339307; ENSP00000340149; ENSG00000115232. [P13612-2]
DR   Ensembl; ENST00000397033; ENSP00000380227; ENSG00000115232. [P13612-1]
DR   GeneID; 3676; -.
DR   KEGG; hsa:3676; -.
DR   UCSC; uc002unu.4; human. [P13612-1]
DR   CTD; 3676; -.
DR   DisGeNET; 3676; -.
DR   EuPathDB; HostDB:ENSG00000115232.13; -.
DR   GeneCards; ITGA4; -.
DR   HGNC; HGNC:6140; ITGA4.
DR   HPA; HPA064041; -.
DR   MIM; 192975; gene.
DR   neXtProt; NX_P13612; -.
DR   OpenTargets; ENSG00000115232; -.
DR   PharmGKB; PA29940; -.
DR   eggNOG; ENOG410IPB2; Eukaryota.
DR   eggNOG; ENOG410XTAR; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000088626; -.
DR   HOVERGEN; HBG004538; -.
DR   InParanoid; P13612; -.
DR   KO; K06483; -.
DR   OMA; NRRDSWS; -.
DR   OrthoDB; EOG091G011V; -.
DR   PhylomeDB; P13612; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-8949275; RUNX3 Regulates Immune Response and Cell Migration.
DR   SignaLink; P13612; -.
DR   SIGNOR; P13612; -.
DR   ChiTaRS; ITGA4; human.
DR   GeneWiki; CD49d; -.
DR   GenomeRNAi; 3676; -.
DR   PRO; PR:P13612; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115232; -.
DR   CleanEx; HS_ITGA4; -.
DR   ExpressionAtlas; P13612; baseline and differential.
DR   Genevisible; P13612; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034669; C:integrin alpha4-beta7 complex; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IMP:UniProtKB.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1990405; F:protein antigen binding; IEA:Ensembl.
DR   GO; GO:0030183; P:B cell differentiation; IC:BHF-UCL.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0003366; P:cell-matrix adhesion involved in ameboidal cell migration; IMP:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl.
DR   GO; GO:1990771; P:clathrin-dependent extracellular exosome endocytosis; IEA:Ensembl.
DR   GO; GO:0050904; P:diapedesis; IEA:Ensembl.
DR   GO; GO:0035987; P:endodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0050901; P:leukocyte tethering or rolling; IMP:UniProtKB.
DR   GO; GO:0090074; P:negative regulation of protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:1903238; P:positive regulation of leukocyte tethering or rolling; IEA:Ensembl.
DR   GO; GO:2000406; P:positive regulation of T cell migration; IEA:Ensembl.
DR   GO; GO:0043113; P:receptor clustering; IMP:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Integrin; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     33       {ECO:0000269|PubMed:3033641}.
FT   CHAIN        34   1032       Integrin alpha-4.
FT                                /FTId=PRO_0000016244.
FT   TOPO_DOM     35    977       Extracellular. {ECO:0000255}.
FT   TRANSMEM    978   1001       Helical. {ECO:0000255}.
FT   TOPO_DOM   1002   1032       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       35    100       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      110    177       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      185    237       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      238    291       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      292    351       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      355    412       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      416    478       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     314    322       {ECO:0000255}.
FT   CA_BIND     377    385       {ECO:0000255}.
FT   CA_BIND     439    447       {ECO:0000255}.
FT   MOTIF       606    616       SG1.
FT   MOTIF      1003   1007       GFFKR motif.
FT   SITE        591    592       Cleavage.
FT   MOD_RES    1021   1021       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:11533025}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    480    480       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    518    518       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    538    538       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    626    626       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    645    645       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    660    660       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    806    806       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    821    821       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     91    101       {ECO:0000250}.
FT   DISULFID    144    165       {ECO:0000250}.
FT   DISULFID    183    198       {ECO:0000250}.
FT   DISULFID    486    495       {ECO:0000250}.
FT   DISULFID    501    557       {ECO:0000250}.
FT   DISULFID    622    627       {ECO:0000250}.
FT   DISULFID    698    711       {ECO:0000250}.
FT   DISULFID    852    890       {ECO:0000250}.
FT   DISULFID    897    902       {ECO:0000250}.
FT   VAR_SEQ     186    195       DYVKKFGENF -> GSISKYRART (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056612.
FT   VAR_SEQ     196   1032       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056613.
FT   VARIANT     634    634       S -> T (in dbSNP:rs35322532).
FT                                /FTId=VAR_047423.
FT   VARIANT     824    824       V -> A (in dbSNP:rs1143675).
FT                                /FTId=VAR_047424.
FT   VARIANT     878    878       R -> Q (in dbSNP:rs1143676).
FT                                {ECO:0000269|PubMed:8643114,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_003978.
FT   MUTAGEN     222    222       T->A: Blocks binding to PLA2G2A.
FT                                {ECO:0000269|PubMed:18635536}.
FT   MUTAGEN     223    223       G->A: Blocks binding to PLA2G2A.
FT                                {ECO:0000269|PubMed:18635536}.
FT   MUTAGEN     590    590       K->Q: Abolishes almost completely
FT                                cleavage. {ECO:0000269|PubMed:1730718}.
FT   MUTAGEN     591    591       R->L: Abolishes completely cleavage.
FT                                {ECO:0000269|PubMed:1730718}.
FT   MUTAGEN    1021   1021       S->A: Abolishes phosphorylation.
FT                                {ECO:0000269|PubMed:11533025}.
FT   MUTAGEN    1021   1021       S->D: Reduces PXN binding.
FT                                {ECO:0000269|PubMed:11533025}.
FT   MUTAGEN    1024   1024       Y->A: Disrupts PXN binding.
FT                                {ECO:0000269|PubMed:10604475}.
FT   STRAND       42     45       {ECO:0000244|PDB:3V4V}.
FT   STRAND       54     61       {ECO:0000244|PDB:3V4V}.
FT   STRAND       64     71       {ECO:0000244|PDB:3V4V}.
FT   STRAND       87     95       {ECO:0000244|PDB:3V4V}.
FT   STRAND      102    104       {ECO:0000244|PDB:3V4V}.
FT   STRAND      127    133       {ECO:0000244|PDB:3V4V}.
FT   STRAND      141    145       {ECO:0000244|PDB:3V4V}.
FT   TURN        152    156       {ECO:0000244|PDB:3V4V}.
FT   STRAND      165    168       {ECO:0000244|PDB:3V4V}.
FT   HELIX       174    176       {ECO:0000244|PDB:3V4V}.
FT   STRAND      178    180       {ECO:0000244|PDB:3V4V}.
FT   TURN        193    197       {ECO:0000244|PDB:3V4V}.
FT   STRAND      202    206       {ECO:0000244|PDB:3V4V}.
FT   STRAND      208    215       {ECO:0000244|PDB:3V4V}.
FT   HELIX       218    221       {ECO:0000244|PDB:3V4V}.
FT   STRAND      223    229       {ECO:0000244|PDB:3V4V}.
FT   TURN        230    233       {ECO:0000244|PDB:3V4V}.
FT   STRAND      234    237       {ECO:0000244|PDB:3V4P}.
FT   STRAND      253    258       {ECO:0000244|PDB:3V4V}.
FT   STRAND      267    272       {ECO:0000244|PDB:3V4V}.
FT   HELIX       275    277       {ECO:0000244|PDB:3V4V}.
FT   STRAND      280    286       {ECO:0000244|PDB:3V4V}.
FT   STRAND      288    298       {ECO:0000244|PDB:3V4V}.
FT   STRAND      308    313       {ECO:0000244|PDB:3V4V}.
FT   STRAND      318    320       {ECO:0000244|PDB:3V4V}.
FT   STRAND      322    327       {ECO:0000244|PDB:3V4V}.
FT   STRAND      332    334       {ECO:0000244|PDB:3V4V}.
FT   STRAND      338    344       {ECO:0000244|PDB:3V4V}.
FT   STRAND      346    349       {ECO:0000244|PDB:3V4V}.
FT   STRAND      351    353       {ECO:0000244|PDB:3V4P}.
FT   STRAND      381    383       {ECO:0000244|PDB:3V4V}.
FT   STRAND      386    390       {ECO:0000244|PDB:3V4V}.
FT   HELIX       393    396       {ECO:0000244|PDB:3V4V}.
FT   STRAND      398    403       {ECO:0000244|PDB:3V4V}.
FT   STRAND      415    419       {ECO:0000244|PDB:3V4V}.
FT   HELIX       420    422       {ECO:0000244|PDB:3V4V}.
FT   STRAND      429    438       {ECO:0000244|PDB:3V4V}.
FT   STRAND      440    445       {ECO:0000244|PDB:3V4V}.
FT   STRAND      447    452       {ECO:0000244|PDB:3V4V}.
FT   HELIX       453    455       {ECO:0000244|PDB:3V4V}.
FT   STRAND      457    461       {ECO:0000244|PDB:3V4V}.
FT   STRAND      466    474       {ECO:0000244|PDB:3V4V}.
FT   STRAND      495    505       {ECO:0000244|PDB:3V4V}.
FT   STRAND      511    522       {ECO:0000244|PDB:3V4V}.
FT   STRAND      532    534       {ECO:0000244|PDB:3V4V}.
FT   STRAND      536    538       {ECO:0000244|PDB:3V4V}.
FT   STRAND      542    554       {ECO:0000244|PDB:3V4V}.
FT   STRAND      556    564       {ECO:0000244|PDB:3V4V}.
FT   STRAND      575    583       {ECO:0000244|PDB:3V4V}.
FT   STRAND      610    617       {ECO:0000244|PDB:3V4V}.
SQ   SEQUENCE   1032 AA;  114900 MW;  73EC1204DE78CD35 CRC64;
     MAWEARREPG PRRAAVRETV MLLLCLGVPT GRPYNVDTES ALLYQGPHNT LFGYSVVLHS
     HGANRWLLVG APTANWLANA SVINPGAIYR CRIGKNPGQT CEQLQLGSPN GEPCGKTCLE
     ERDNQWLGVT LSRQPGENGS IVTCGHRWKN IFYIKNENKL PTGGCYGVPP DLRTELSKRI
     APCYQDYVKK FGENFASCQA GISSFYTKDL IVMGAPGSSY WTGSLFVYNI TTNKYKAFLD
     KQNQVKFGSY LGYSVGAGHF RSQHTTEVVG GAPQHEQIGK AYIFSIDEKE LNILHEMKGK
     KLGSYFGASV CAVDLNADGF SDLLVGAPMQ STIREEGRVF VYINSGSGAV MNAMETNLVG
     SDKYAARFGE SIVNLGDIDN DGFEDVAIGA PQEDDLQGAI YIYNGRADGI SSTFSQRIEG
     LQISKSLSMF GQSISGQIDA DNNGYVDVAV GAFRSDSAVL LRTRPVVIVD ASLSHPESVN
     RTKFDCVENG WPSVCIDLTL CFSYKGKEVP GYIVLFYNMS LDVNRKAESP PRFYFSSNGT
     SDVITGSIQV SSREANCRTH QAFMRKDVRD ILTPIQIEAA YHLGPHVISK RSTEEFPPLQ
     PILQQKKEKD IMKKTINFAR FCAHENCSAD LQVSAKIGFL KPHENKTYLA VGSMKTLMLN
     VSLFNAGDDA YETTLHVKLP VGLYFIKILE LEEKQINCEV TDNSGVVQLD CSIGYIYVDH
     LSRIDISFLL DVSSLSRAEE DLSITVHATC ENEEEMDNLK HSRVTVAIPL KYEVKLTVHG
     FVNPTSFVYG SNDENEPETC MVEKMNLTFH VINTGNSMAP NVSVEIMVPN SFSPQTDKLF
     NILDVQTTTG ECHFENYQRV CALEQQKSAM QTLKGIVRFL SKTDKRLLYC IKADPHCLNF
     LCNFGKMESG KEASVHIQLE GRPSILEMDE TSALKFEIRA TGFPEPNPRV IELNKDENVA
     HVLLEGLHHQ RPKRYFTIVI ISSSLLLGLI VLLLISYVMW KAGFFKRQYK SILQEENRRD
     SWSYINSKSN DD
//
ID   ITA9_HUMAN              Reviewed;        1035 AA.
AC   Q13797; Q14638;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   22-NOV-2017, entry version 150.
DE   RecName: Full=Integrin alpha-9;
DE   AltName: Full=Integrin alpha-RLC;
DE   Flags: Precursor;
GN   Name=ITGA9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLU-507, TISSUE SPECIFICITY, AND
RP   INDUCTION.
RC   TISSUE=Lung;
RX   PubMed=8290272;
RA   Hibi K., Yamakawa K., Ueda R., Horio Y., Murata Y., Tamari M.,
RA   Uchida K., Takahashi T., Nakamura Y., Takahashi T.;
RT   "Aberrant upregulation of a novel integrin alpha subunit gene at
RT   3p21.3 in small cell lung cancer.";
RL   Oncogene 9:611-619(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-1035, PROTEIN SEQUENCE OF 30-35,
RP   VARIANT GLU-507, AND TISSUE SPECIFICITY.
RC   TISSUE=Intestine, and Lung;
RX   PubMed=8245132; DOI=10.1083/jcb.123.5.1289;
RA   Palmer E.L., Rueegg C., Ferrando R., Pytela R., Sheppard D.;
RT   "Sequence and tissue distribution of the integrin alpha 9 subunit, a
RT   novel partner of beta 1 that is widely distributed in epithelia and
RT   muscle.";
RL   J. Cell Biol. 123:1289-1297(1993).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-225.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [5]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-750.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Integrin alpha-9/beta-1 (ITGA9:ITGB1) is a receptor for
CC       VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E-
CC       I-D-G-I-E-L in cytotactin. {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-9
CC       (ITGA9) associates with beta-1 (ITGB1). Integrin ITGA9:ITGB1
CC       interacts with FBLN5 (via N-terminus). {ECO:0000250,
CC       ECO:0000250|UniProtKB:B8JK39}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass type I
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: In airway epithelium, in the basal layer of
CC       squamous epithelium, and in smooth muscle, skeletal muscle, and
CC       hepatocytes. Abundantly expressed in fetal lung and lung cancers.
CC       {ECO:0000269|PubMed:8245132, ECO:0000269|PubMed:8290272}.
CC   -!- INDUCTION: Up-regulated in small cell lung cancers (SCLC).
CC       {ECO:0000269|PubMed:8290272}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D25303; BAA04984.1; -; mRNA.
DR   EMBL; AC092055; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093415; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP006240; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L24158; AAA16099.1; -; mRNA.
DR   CCDS; CCDS2669.1; -.
DR   PIR; I58409; I58409.
DR   RefSeq; NP_002198.2; NM_002207.2.
DR   UniGene; Hs.113157; -.
DR   ProteinModelPortal; Q13797; -.
DR   BioGrid; 109886; 22.
DR   CORUM; Q13797; -.
DR   IntAct; Q13797; 1.
DR   MINT; MINT-1534610; -.
DR   STRING; 9606.ENSP00000264741; -.
DR   ChEMBL; CHEMBL3170; -.
DR   iPTMnet; Q13797; -.
DR   PhosphoSitePlus; Q13797; -.
DR   BioMuta; ITGA9; -.
DR   DMDM; 229462922; -.
DR   PaxDb; Q13797; -.
DR   PeptideAtlas; Q13797; -.
DR   PRIDE; Q13797; -.
DR   Ensembl; ENST00000264741; ENSP00000264741; ENSG00000144668.
DR   GeneID; 3680; -.
DR   KEGG; hsa:3680; -.
DR   UCSC; uc003chd.4; human.
DR   CTD; 3680; -.
DR   DisGeNET; 3680; -.
DR   EuPathDB; HostDB:ENSG00000144668.11; -.
DR   GeneCards; ITGA9; -.
DR   H-InvDB; HIX0003172; -.
DR   HGNC; HGNC:6145; ITGA9.
DR   HPA; HPA030609; -.
DR   MIM; 603963; gene.
DR   neXtProt; NX_Q13797; -.
DR   OpenTargets; ENSG00000144668; -.
DR   Orphanet; 371007; Congenital muscular dystrophy with hyperlaxity.
DR   PharmGKB; PA29945; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000088626; -.
DR   HOVERGEN; HBG004538; -.
DR   InParanoid; Q13797; -.
DR   KO; K06585; -.
DR   OMA; IMSPTSF; -.
DR   OrthoDB; EOG091G011V; -.
DR   PhylomeDB; Q13797; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   SignaLink; Q13797; -.
DR   SIGNOR; Q13797; -.
DR   ChiTaRS; ITGA9; human.
DR   GeneWiki; ITGA9; -.
DR   GenomeRNAi; 3680; -.
DR   PRO; PR:Q13797; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000144668; -.
DR   CleanEx; HS_ITGA9; -.
DR   ExpressionAtlas; Q13797; baseline and differential.
DR   Genevisible; Q13797; HS.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:Ensembl.
DR   GO; GO:0034679; C:integrin alpha9-beta1 complex; IEA:Ensembl.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005518; F:collagen binding; IEA:Ensembl.
DR   GO; GO:0043236; F:laminin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IGI:MGI.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Integrin; Membrane; Metal-binding;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30   1035       Integrin alpha-9.
FT                                /FTId=PRO_0000016316.
FT   TOPO_DOM     30    981       Extracellular. {ECO:0000255}.
FT   TRANSMEM    982   1002       Helical. {ECO:0000255}.
FT   TOPO_DOM   1003   1035       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       35     96       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      111    174       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      182    232       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      233    289       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      290    349       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      351    408       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      411    474       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     312    320       {ECO:0000255}.
FT   CA_BIND     373    381       {ECO:0000255}.
FT   CA_BIND     435    443       {ECO:0000255}.
FT   MOTIF      1005   1009       GFFKR motif.
FT   SITE        565    566       Cleavage. {ECO:0000255}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    476    476       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    493    493       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    612    612       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    654    654       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    658    658       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    672    672       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    676    676       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    807    807       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    854    854       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    904    904       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     87     97       {ECO:0000250}.
FT   DISULFID    142    162       {ECO:0000250}.
FT   DISULFID    179    194       {ECO:0000250}.
FT   DISULFID    482    491       {ECO:0000250}.
FT   DISULFID    497    555       {ECO:0000250}.
FT   DISULFID    620    625       {ECO:0000250}.
FT   DISULFID    696    706       {ECO:0000250}.
FT   DISULFID    855    891       {ECO:0000250}.
FT   DISULFID    898    903       {ECO:0000250}.
FT   VARIANT     507    507       G -> E (in dbSNP:rs267561).
FT                                {ECO:0000269|PubMed:8245132,
FT                                ECO:0000269|PubMed:8290272}.
FT                                /FTId=VAR_055091.
FT   VARIANT     750    750       R -> C (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs781472543).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036073.
SQ   SEQUENCE   1035 AA;  114489 MW;  B812EDA867A3E836 CRC64;
     MGGPAAPRGA GRLRALLLAL VVAGIPAGAY NLDPQRPVHF QGPADSFFGY AVLEHFHDNT
     RWVLVGAPKA DSKYSPSVKS PGAVFKCRVH TNPDRRCTEL DMARGKNRGT SCGKTCREDR
     DDEWMGVSLA RQPKADGRVL ACAHRWKNIY YEADHILPHG FCYIIPSNLQ AKGRTLIPCY
     EEYKKKYGEE HGSCQAGIAG FFTEELVVMG APGSFYWAGT IKVLNLTDNT YLKLNDEVIM
     NRRYTYLGYA VTAGHFSHPS TIDVVGGAPQ DKGIGKVYIF RADRRSGTLI KIFQASGKKM
     GSYFGSSLCA VDLNGDGLSD LLVGAPMFSE IRDEGQVTVY INRGNGALEE QLALTGDGAY
     NAHFGESIAS LDDLDNDGFP DVAIGAPKED DFAGAVYIYH GDAGGIVPQY SMKLSGQKIN
     PVLRMFGQSI SGGIDMDGNG YPDVTVGAFM SDSVVLLRAR PVITVDVSIF LPGSINITAP
     QCHDGQQPVN CLNVTTCFSF HGKHVPGEIG LNYVLMADVA KKEKGQMPRV YFVLLGETMG
     QVTEKLQLTY MEETCRHYVA HVKRRVQDVI SPIVFEAAYS LSEHVTGEEE RELPPLTPVL
     RWKKGQKIAQ KNQTVFERNC RSEDCAADLQ LQGKLLLSSM DEKTLYLALG AVKNISLNIS
     ISNLGDDAYD ANVSFNVSRE LFFINMWQKE EMGISCELLE SDFLKCSVGF PFMRSKSKYE
     FSVIFDTSHL SGEEEVLSFI VTAQSGNTER SESLHDNTLV LMVPLMHEVD TSITGIMSPT
     SFVYGESVDA ANFIQLDDLE CHFQPINITL QVYNTGPSTL PGSSVSISFP NRLSSGGAEM
     FHVQEMVVGQ EKGNCSFQKN PTPCIIPQEQ ENIFHTIFAF FTKSGRKVLD CEKPGISCLT
     AHCNFSALAK EESRTIDIYM LLNTEILKKD SSSVIQFMSR AKVKVDPALR VVEIAHGNPE
     EVTVVFEALH NLEPRGYVVG WIIAISLLVG ILIFLLLAVL LWKMGFFRRR YKEIIEAEKN
     RKENEDSWDW VQKNQ
//
ID   ITA2_DROME              Reviewed;        1396 AA.
AC   P12080; E1JJN2; Q8IR07; Q8MSG3; Q9VXB6;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   22-NOV-2017, entry version 187.
DE   RecName: Full=Integrin alpha-PS2;
DE   AltName: Full=Position-specific antigen subunit alpha-2;
DE   AltName: Full=Protein inflated;
DE   Contains:
DE     RecName: Full=Integrin alpha-PS2 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-PS2 light chain;
DE   Flags: Precursor;
GN   Name=if; ORFNames=CG9623;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PS2C), IDENTIFICATION BY MASS
RP   SPECTROMETRY, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=2961459; DOI=10.1016/0092-8674(87)90580-0;
RA   Bogaert T., Brown N.H., Wilcox M.;
RT   "The Drosophila PS2 antigen is an invertebrate integrin that, like the
RT   fibronectin receptor, becomes localized to muscle attachments.";
RL   Cell 51:929-940(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 213-757 (ISOFORM PS2M8).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5]
RP   ALTERNATIVE SPLICING, AND DEVELOPMENTAL STAGE.
RX   PubMed=2507168; DOI=10.1016/0092-8674(89)90880-5;
RA   Brown N.H., King D.L., Wilcox M., Kafatos F.C.;
RT   "Developmentally regulated alternative splicing of Drosophila integrin
RT   PS2 alpha transcripts.";
RL   Cell 59:185-195(1989).
RN   [6]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Oregon-R; TISSUE=Embryo, and Larva;
RX   PubMed=8240969; DOI=10.1016/0925-4773(93)90020-X;
RA   Wehrli M., Diantonio A., Fearnley I.M., Smith R.J., Wilcox M.;
RT   "Cloning and characterization of alpha PS1, a novel Drosophila
RT   melanogaster integrin.";
RL   Mech. Dev. 43:21-36(1993).
RN   [7]
RP   FUNCTION.
RX   PubMed=7924982;
RA   Fogerty F.J., Fessler L.I., Bunch T.A., Yaron Y., Parker C.G.,
RA   Nelson R.E., Brower D.L., Gullberg D., Fessler J.H.;
RT   "Tiggrin, a novel Drosophila extracellular matrix protein that
RT   functions as a ligand for Drosophila alpha PS2 beta PS integrins.";
RL   Development 120:1747-1758(1994).
RN   [8]
RP   FUNCTION.
RX   PubMed=7972082; DOI=10.1073/pnas.91.24.11447;
RA   Gotwals P.J., Fessler L.I., Wehrli M., Hynes R.O.;
RT   "Drosophila PS1 integrin is a laminin receptor and differs in ligand
RT   specificity from PS2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:11447-11451(1994).
RN   [9]
RP   FUNCTION.
RX   PubMed=9660786; DOI=10.1074/jbc.273.29.18235;
RA   Graner M.W., Bunch T.A., Baumgartner S., Kerschen A., Brower D.L.;
RT   "Splice variants of the Drosophila PS2 integrins differentially
RT   interact with RGD-containing fragments of the extracellular proteins
RT   tiggrin, ten-m, and D-laminin 2.";
RL   J. Biol. Chem. 273:18235-18241(1998).
RN   [10]
RP   FUNCTION.
RX   PubMed=10821184; DOI=10.1007/s004380051194;
RA   Ayyub C., Rodrigues V., Hasan G., Siddiqi O.;
RT   "Genetic analysis of olfC demonstrates a role for the position-
RT   specific integrins in the olfactory system of Drosophila
RT   melanogaster.";
RL   Mol. Gen. Genet. 263:498-504(2000).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=15469969; DOI=10.1242/dev.01427;
RA   Devenport D., Brown N.H.;
RT   "Morphogenesis in the absence of integrins: mutation of both
RT   Drosophila beta subunits prevents midgut migration.";
RL   Development 131:5405-5415(2004).
RN   [12]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19035354; DOI=10.1002/dvdy.21802;
RA   Dinkins M.B., Fratto V.M., Lemosy E.K.;
RT   "Integrin alpha chains exhibit distinct temporal and spatial
RT   localization patterns in epithelial cells of the Drosophila ovary.";
RL   Dev. Dyn. 237:3927-3939(2008).
CC   -!- FUNCTION: Alpha-PS2/beta-PS is a receptor for Tig, wb and Ten-m.
CC       Involved in the function and/or development of the olfactory
CC       system. {ECO:0000269|PubMed:10821184, ECO:0000269|PubMed:7924982,
CC       ECO:0000269|PubMed:7972082, ECO:0000269|PubMed:9660786}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-PS2 associates with beta-PS.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Lateral cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Basal cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Note=During mid-oogenesis,
CC       localizes to the apical, to the lateral and to the basal membranes
CC       of follicle cells. Apical membrane localization peaks at oogenesis
CC       stages 9 and 10A in columnar follicle cells overlying the oocyte
CC       while decreases in the most posterior follicle cells. During
CC       embryogenesis, at the end of germband extension concentrates at
CC       the basal membrane of mesodermal cells, where they adhere to the
CC       ectoderm. Then, in visceral mesoderm localizes basally, whereas in
CC       somatic mesoderm is homogenously distributed.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=PS2C; Synonyms=D, F;
CC         IsoId=P12080-1; Sequence=Displayed;
CC       Name=PS2M8; Synonyms=C;
CC         IsoId=P12080-2; Sequence=VSP_002739;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: In ovaries, highly expressed in follicle
CC       cells. At syncytial blastoderm stage, expressed in the embryonic
CC       mesodermal precursors but not in the ectoderm. At embryonic stages
CC       7 and 10, expression is restricted to the mesoderm. At stage 12,
CC       expressed in the gonadal sheath and the interstitial cells of the
CC       gonad. In stage 16 embryos, expressed in the somatic and visceral
CC       muscles where localizes to sites of attachment between adjacent
CC       muscles. In third larval instar wing imaginal disk, expressed in
CC       the ventral compartment and in a subset of adepithelial and
CC       peripodial cells (at protein level). {ECO:0000269|PubMed:15469969,
CC       ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:2961459,
CC       ECO:0000269|PubMed:8240969}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout embryonic and larval
CC       development with peaks of expression during mid-embryogenesis and
CC       at third larval instar (at protein level). The relative ratio of
CC       isoform 1/PS2C and isoform 2/PS2M8 varies widely during
CC       development. {ECO:0000269|PubMed:2507168,
CC       ECO:0000269|PubMed:2961459, ECO:0000269|PubMed:8240969}.
CC   -!- PTM: The heavy-light chain cleavage site is either in 1230-1231,
CC       or 1233-1234, or 1243-1244.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAM50700.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAM50700.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M19059; AAC12788.1; -; mRNA.
DR   EMBL; AE014298; AAF48661.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09423.2; -; Genomic_DNA.
DR   EMBL; AE014298; ACZ95312.1; -; Genomic_DNA.
DR   EMBL; AE014298; ACZ95313.1; -; Genomic_DNA.
DR   EMBL; AY118840; AAM50700.1; ALT_SEQ; mRNA.
DR   PIR; A29637; A29637.
DR   RefSeq; NP_001162777.1; NM_001169306.2. [P12080-1]
DR   RefSeq; NP_001162778.1; NM_001169307.1. [P12080-1]
DR   RefSeq; NP_523378.2; NM_078654.2. [P12080-1]
DR   RefSeq; NP_728021.2; NM_167544.2. [P12080-2]
DR   UniGene; Dm.7766; -.
DR   ProteinModelPortal; P12080; -.
DR   SMR; P12080; -.
DR   BioGrid; 58994; 29.
DR   DIP; DIP-23111N; -.
DR   IntAct; P12080; 2.
DR   MINT; MINT-836239; -.
DR   STRING; 7227.FBpp0074131; -.
DR   PaxDb; P12080; -.
DR   PRIDE; P12080; -.
DR   EnsemblMetazoa; FBtr0074357; FBpp0074131; FBgn0001250. [P12080-1]
DR   EnsemblMetazoa; FBtr0301352; FBpp0290566; FBgn0001250. [P12080-2]
DR   EnsemblMetazoa; FBtr0301353; FBpp0290567; FBgn0001250. [P12080-1]
DR   EnsemblMetazoa; FBtr0301354; FBpp0290568; FBgn0001250. [P12080-1]
DR   GeneID; 32661; -.
DR   KEGG; dme:Dmel_CG9623; -.
DR   UCSC; CG9623-RA; d. melanogaster.
DR   CTD; 32661; -.
DR   FlyBase; FBgn0001250; if.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   InParanoid; P12080; -.
DR   OMA; CRQIPFD; -.
DR   OrthoDB; EOG091G02JI; -.
DR   PhylomeDB; P12080; -.
DR   Reactome; R-DME-114608; Platelet degranulation.
DR   Reactome; R-DME-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-DME-1566948; Elastic fibre formation.
DR   Reactome; R-DME-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-DME-216083; Integrin cell surface interactions.
DR   Reactome; R-DME-3000170; Syndecan interactions.
DR   Reactome; R-DME-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-DME-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-DME-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-DME-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-DME-445144; Signal transduction by L1.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   GenomeRNAi; 32661; -.
DR   PRO; PR:P12080; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0001250; -.
DR   ExpressionAtlas; P12080; differential.
DR   Genevisible; P12080; DM.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:FlyBase.
DR   GO; GO:0005925; C:focal adhesion; IDA:FlyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0008305; C:integrin complex; IDA:FlyBase.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0042383; C:sarcolemma; IDA:FlyBase.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISS:FlyBase.
DR   GO; GO:0050840; F:extracellular matrix binding; IDA:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:FlyBase.
DR   GO; GO:0004872; F:receptor activity; ISS:FlyBase.
DR   GO; GO:0007475; P:apposition of dorsal and ventral imaginal disc-derived wing surfaces; NAS:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IMP:FlyBase.
DR   GO; GO:0007414; P:axonal defasciculation; IMP:FlyBase.
DR   GO; GO:0007298; P:border follicle cell migration; IMP:FlyBase.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:FlyBase.
DR   GO; GO:0016477; P:cell migration; TAS:FlyBase.
DR   GO; GO:0098609; P:cell-cell adhesion; TAS:FlyBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISS:FlyBase.
DR   GO; GO:0021551; P:central nervous system morphogenesis; IMP:FlyBase.
DR   GO; GO:0007427; P:epithelial cell migration, open tracheal system; TAS:FlyBase.
DR   GO; GO:0035099; P:hemocyte migration; IMP:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0007476; P:imaginal disc-derived wing morphogenesis; IMP:FlyBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0035160; P:maintenance of epithelial integrity, open tracheal system; IGI:FlyBase.
DR   GO; GO:0045185; P:maintenance of protein location; IMP:FlyBase.
DR   GO; GO:0007494; P:midgut development; TAS:FlyBase.
DR   GO; GO:0016203; P:muscle attachment; IMP:FlyBase.
DR   GO; GO:0030239; P:myofibril assembly; IMP:FlyBase.
DR   GO; GO:0051492; P:regulation of stress fiber assembly; IMP:FlyBase.
DR   GO; GO:0007431; P:salivary gland development; TAS:FlyBase.
DR   GO; GO:0007435; P:salivary gland morphogenesis; IGI:FlyBase.
DR   GO; GO:0045214; P:sarcomere organization; IMP:FlyBase.
DR   GO; GO:0007608; P:sensory perception of smell; IGI:FlyBase.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:FlyBase.
DR   GO; GO:0007426; P:tracheal outgrowth, open tracheal system; TAS:FlyBase.
DR   GO; GO:0007419; P:ventral cord development; IMP:FlyBase.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 4.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Membrane; Olfaction; Receptor;
KW   Reference proteome; Repeat; Sensory transduction; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32   1396       Integrin alpha-PS2.
FT                                /FTId=PRO_0000016323.
FT   CHAIN        32  ?1243       Integrin alpha-PS2 heavy chain.
FT                                /FTId=PRO_0000016324.
FT   CHAIN     ?1244   1396       Integrin alpha-PS2 light chain.
FT                                /FTId=PRO_0000016325.
FT   TOPO_DOM     32   1341       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1342   1366       Helical. {ECO:0000255}.
FT   TOPO_DOM   1367   1396       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       36    106       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      117    174       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      186    239       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      266    317       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      318    383       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      386    445       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      452    514       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   COMPBIAS    932    938       Ser-rich.
FT   COMPBIAS   1015   1023       Ser-rich.
FT   COMPBIAS   1049   1054       Ser-rich.
FT   COMPBIAS   1217   1226       Ser-rich.
FT   CARBOHYD     69     69       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    209    209       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    584    584       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    598    598       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    741    741       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    783    783       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    833    833       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    959    959       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1005   1005       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1299   1299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1307   1307       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     225    249       Missing (in isoform PS2M8).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_002739.
FT   CONFLICT     29     29       A -> G (in Ref. 1; AAC12788).
FT                                {ECO:0000305}.
FT   CONFLICT    968    976       SPKQVEQRR -> RSQASGATA (in Ref. 1;
FT                                AAC12788). {ECO:0000305}.
FT   CONFLICT   1063   1064       Missing (in Ref. 1). {ECO:0000305}.
FT   CONFLICT   1235   1235       N -> D (in Ref. 1; AAC12788).
FT                                {ECO:0000305}.
FT   CONFLICT   1242   1242       E -> K (in Ref. 1; AAC12788).
FT                                {ECO:0000305}.
FT   CONFLICT   1245   1245       L -> Q (in Ref. 1; AAC12788).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1396 AA;  154322 MW;  2384B07DDBA28372 CRC64;
     MSGDSIHRRR MALHCPITSL ILLLIAMSAH GYNIDLPSYV RFRQSSNSMF GFSIAMHKGR
     SGFYGNQNNV SLIVGAPKFD TSRYQQGVTE AGGVFKCSLN DDDCKLVPFD SKGNNRNVDK
     EVVDRKSYQW LGATVATGRD SDLVVACAPR YVFHTMTPSR AFRIDPVGTC FTSHNFEEFY
     EVSPCRTNNW GYHRQGSCQA GFSAAINGNG SRLFIGAPGS WYWQGQTYSI PPDAKFPFKP
     PLYQPFGTGG MASSHDVTRP ENQVFSTSES ASVNDDSYLG YSMVTGDFDG DRSEDVAIGM
     PRGGNLVGRI VVNRWNMANI FNITGRQIGE YFGYSLATSD VDGDGLDDLL IGAPMYTDPD
     NVEGKYDVGR VYILLQGGPT EEKRWTTEHI RDGYHSKGRF GLALTTLGDV NGDGYGDFAV
     GAPYDGPEGR GVVYIFHGSP MGPLAKPSQI IKSEQLVEGA PYPRTFGFAL SGGLDMDGNT
     YPDLAVGAYS SDQVFIFKSR PVAAVNAETS FASNSKLISL DDRSCQLVRD HKKVPCMLLT
     TCWSYTGRYL PEQLDFDVSW LLDAKKLLNP RMFFLRDEGK NIRNQTIRLN YGQKYCLNET
     VYLLDKVQDK LTPLEVEARY NLRSSRPLDP MVRHRRSILE PVIDQNREIV LRDAINIQKN
     CGPDNICEPD LKLKVSTVDK YLFGSPEPLV IEVFISNTNE DAFEAAFYMV TPPDLQFRKL
     QQLGEKKDTP ITCSPPTPEN NHTLKCDIGN PLESGKIAHF KISLVPEEKY GSSSSYDFYW
     EANSTNLEKP GSEYDNKIRQ SVGIWVDTDL DIKGTSLPDY QLYKADDYKE LENATKEDDI
     GPQVVHIYEI RNNRPSIIEE AEVFIHLPYE TIVGDPLMYL LNQPETGGKI QCDDVAFNEY
     NLLLDEKLVK KSYLQAQGAI WNSAQVSGQS SSSSSSGGAS VHIEKARGEG FVRGVLVSNS
     TDAGDKLSPK QVEQRRQEDT LEALGDASFV HRDRASQAVQ EPQVNQTSFT TYSTSSSSSG
     SGAPSAQLRG HSTQGHIQMA GPVQHTSSSS SSNYRSWPAQ QQQQHQQLLL AGSGGSGLGS
     PVTFNDKSQF GGRNNNFHTG TLDLGTLNRG NVDNELYRSQ GQYQNPSQSL GQSQGQFQAN
     ANQGHYQGQN QAQFQARNPG FQGQTSYQGQ TQYSGQPGGY QTHHVTYSSG SKPYYGRENE
     DFYDEDNLQQ ATPGHWSSSS SSSSSSGTRR LRRSNDKDGA TEKPLQIDLN SPCQSARCKS
     IRCVVTNLGT EDGDAAFVAI RARMVAKTME KLASNVPLNV STLAVANVTL LPFIGAPKDA
     IVKTHEIFYK AEPEPLQVPD VVPLWVVVLA ACAGALIFLL LVWLLYKCGF FNRNRPTDHS
     QERQPLRNGY HGDEHL
//
ID   ITA3_DROME              Reviewed;        1115 AA.
AC   O44386; O44387; O46186; Q58CK3; Q6AWK3; Q9V7A3;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   22-NOV-2017, entry version 170.
DE   RecName: Full=Integrin alpha-PS3;
DE   AltName: Full=Position-specific antigen subunit alpha-3;
DE            Short=Protein scab;
DE   AltName: Full=Protein volado;
DE   Contains:
DE     RecName: Full=Integrin alpha-PS3 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-PS3 light chain;
DE   Flags: Precursor;
GN   Name=scb; Synonyms=alphaPS3, Vol; ORFNames=CG8095;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), FUNCTION, INTERACTION WITH
RP   MYS, AND TISSUE SPECIFICITY.
RX   PubMed=9409675;
RA   Stark K.A., Yee G.H., Roote C.E., Williams E.L., Zusman S.,
RA   Hynes R.O.;
RT   "A novel alpha integrin subunit associates with betaPS and functions
RT   in tissue morphogenesis and movement during Drosophila development.";
RL   Development 124:4583-4594(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), FUNCTION, TISSUE
RP   SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=9461212; DOI=10.1038/35079;
RA   Grotewiel M.S., Beck C.D.O., Wu K.H., Zhu X.R., Davis R.L.;
RT   "Integrin-mediated short-term memory in Drosophila.";
RL   Nature 391:455-460(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B).
RC   STRAIN=Berkeley; TISSUE=Larva, and Pupae;
RA   Stapleton M., Carlson J.W., Chavez C., Frise E., George R.A.,
RA   Pacleb J.M., Park S., Wan K.H., Yu C., Rubin G.M., Celniker S.E.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH ITGBN, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15469969; DOI=10.1242/dev.01427;
RA   Devenport D., Brown N.H.;
RT   "Morphogenesis in the absence of integrins: mutation of both
RT   Drosophila beta subunits prevents midgut migration.";
RL   Development 131:5405-5415(2004).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-82, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Oregon-R; TISSUE=Head;
RX   PubMed=17893096; DOI=10.1093/glycob/cwm097;
RA   Koles K., Lim J.-M., Aoki K., Porterfield M., Tiemeyer M., Wells L.,
RA   Panin V.;
RT   "Identification of N-glycosylated proteins from the central nervous
RT   system of Drosophila melanogaster.";
RL   Glycobiology 17:1388-1403(2007).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=19035354; DOI=10.1002/dvdy.21802;
RA   Dinkins M.B., Fratto V.M., Lemosy E.K.;
RT   "Integrin alpha chains exhibit distinct temporal and spatial
RT   localization patterns in epithelial cells of the Drosophila ovary.";
RL   Dev. Dyn. 237:3927-3939(2008).
RN   [9]
RP   FUNCTION.
RX   PubMed=18925939; DOI=10.1186/1749-8104-3-26;
RA   Tsai P.I., Kao H.H., Grabbe C., Lee Y.T., Ghose A., Lai T.T.,
RA   Peng K.P., Van Vactor D., Palmer R.H., Chen R.H., Yeh S.R.,
RA   Chien C.T.;
RT   "Fak56 functions downstream of integrin alphaPS3betanu and suppresses
RT   MAPK activation in neuromuscular junction growth.";
RL   Neural Dev. 3:26-26(2008).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-82, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [11]
RP   FUNCTION, INTERACTION WITH ITGBN, TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=23426364; DOI=10.1074/jbc.M113.451427;
RA   Nonaka S., Nagaosa K., Mori T., Shiratsuchi A., Nakanishi Y.;
RT   "Integrin alphaPS3/betanu-mediated phagocytosis of apoptotic cells and
RT   bacteria in Drosophila.";
RL   J. Biol. Chem. 288:10374-10380(2013).
CC   -!- FUNCTION: Integrin alpha-PS3/beta-PS is a receptor for laminin.
CC       Also binds to wb. Important during embryogenesis for the
CC       development of the trachea, dorsal vessel and salivary gland, as
CC       well as for dorsal closure. Required for short-term memory
CC       processes. Minor involvement in the establishment of the oocyte
CC       anterior-posterior length. Plays a role in timely border cell
CC       migration during oogenesis, probably mediated by JNK signaling.
CC       Integrin alpha-PS3/Itgbn is required for effective phagocytosis of
CC       apoptotic cells during embryonic development and for the
CC       phagocytic elimination of S.aureus by mediating the binding of
CC       S.aureus peptidoglycan to larval hemocytes, which probably
CC       activates a signaling pathway involving Rac1 and Rac2. Integrin
CC       alpha-PS3/Itgbn also regulates Fak activity during neuromuscular
CC       junction (NMJ) growth and is required for its activation in
CC       presynapsis of NMJs. Seems to be dispensable for major
CC       morphogenetic processes. {ECO:0000269|PubMed:18925939,
CC       ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:23426364,
CC       ECO:0000269|PubMed:9409675, ECO:0000269|PubMed:9461212}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Interacts with mys/beta-PS and Itgbn.
CC       {ECO:0000269|PubMed:15469969, ECO:0000269|PubMed:23426364,
CC       ECO:0000269|PubMed:9409675}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane; Single-pass type I
CC       membrane protein. Lateral cell membrane; Single-pass type I
CC       membrane protein. Cytoplasm. Note=Apical membrane localization in
CC       primordial dorsal-appendage cells at oogenesis stages 10B and 11.
CC       Later, weakly expressed in lateral membrane of cells surrounding
CC       the outgrowing dorsal appendages.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=B; Synonyms=Vol-L;
CC         IsoId=O44386-1; Sequence=Displayed;
CC       Name=A; Synonyms=Vol-S;
CC         IsoId=O44386-2; Sequence=VSP_002740;
CC   -!- TISSUE SPECIFICITY: Expressed in embryonic and larval hemocytes
CC       (at protein level). Expressed in tissues undergoing invagination,
CC       tissue movement and morphogenesis such as salivary gland, trachea,
CC       midgut endoderm, dorsal vessel, midline of the ventral nerve cord,
CC       amnioserosa and the amnioproctodeal invagination. Expressed in the
CC       mushroom body neuropil, brain areas that contain mushroom body
CC       processes in synaptic contact with other neurons. In egg chambers,
CC       expressed in border cells, in stretch cells and in dorsal
CC       appendage primordia. {ECO:0000269|PubMed:15469969,
CC       ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:23426364,
CC       ECO:0000269|PubMed:9409675, ECO:0000269|PubMed:9461212}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development. Highest
CC       expression is observed in pupae (at protein level). During
CC       oogenesis, expressed from stage 10B onwards.
CC       {ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:23426364}.
CC   -!- DISRUPTION PHENOTYPE: Flies display impaired olfactory memories
CC       within 3 min of training. Mutant embryos show reduced level of
CC       phagocytosis. {ECO:0000269|PubMed:23426364,
CC       ECO:0000269|PubMed:9461212}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U76605; AAC04505.1; -; mRNA.
DR   EMBL; AF034199; AAC38853.1; -; mRNA.
DR   EMBL; AF034200; AAC38854.1; -; mRNA.
DR   EMBL; AE013599; AAF58155.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAF58156.1; -; Genomic_DNA.
DR   EMBL; BT015245; AAT94474.1; -; mRNA.
DR   EMBL; BT021944; AAX51649.1; -; mRNA.
DR   PIR; T09403; T09403.
DR   PIR; T09433; T09433.
DR   RefSeq; NP_523750.2; NM_079026.3. [O44386-1]
DR   RefSeq; NP_725445.1; NM_166083.2. [O44386-2]
DR   UniGene; Dm.636; -.
DR   ProteinModelPortal; O44386; -.
DR   BioGrid; 62429; 11.
DR   IntAct; O44386; 1.
DR   MINT; MINT-1552140; -.
DR   STRING; 7227.FBpp0086501; -.
DR   iPTMnet; O44386; -.
DR   PaxDb; O44386; -.
DR   PRIDE; O44386; -.
DR   EnsemblMetazoa; FBtr0087369; FBpp0086501; FBgn0003328. [O44386-1]
DR   EnsemblMetazoa; FBtr0087370; FBpp0086502; FBgn0003328. [O44386-2]
DR   GeneID; 36692; -.
DR   KEGG; dme:Dmel_CG8095; -.
DR   CTD; 20242; -.
DR   FlyBase; FBgn0003328; scb.
DR   eggNOG; ENOG410IPB1; Eukaryota.
DR   eggNOG; ENOG4111GN2; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   InParanoid; O44386; -.
DR   OMA; HGICYWV; -.
DR   OrthoDB; EOG091G0B2Y; -.
DR   PhylomeDB; O44386; -.
DR   Reactome; R-DME-445355; Smooth Muscle Contraction.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   ChiTaRS; scrib; fly.
DR   GenomeRNAi; 36692; -.
DR   PRO; PR:O44386; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0003328; -.
DR   Genevisible; O44386; DM.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; ISS:FlyBase.
DR   GO; GO:0016021; C:integral component of membrane; IDA:FlyBase.
DR   GO; GO:0008305; C:integrin complex; IDA:FlyBase.
DR   GO; GO:0016328; C:lateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:FlyBase.
DR   GO; GO:0050839; F:cell adhesion molecule binding; TAS:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:FlyBase.
DR   GO; GO:0004872; F:receptor activity; TAS:FlyBase.
DR   GO; GO:0043277; P:apoptotic cell clearance; IMP:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IMP:FlyBase.
DR   GO; GO:0048149; P:behavioral response to ethanol; IMP:FlyBase.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:FlyBase.
DR   GO; GO:0016340; P:calcium-dependent cell-matrix adhesion; ISS:FlyBase.
DR   GO; GO:0007155; P:cell adhesion; TAS:FlyBase.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:FlyBase.
DR   GO; GO:0016477; P:cell migration; TAS:FlyBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:FlyBase.
DR   GO; GO:0007391; P:dorsal closure; IMP:FlyBase.
DR   GO; GO:0035001; P:dorsal trunk growth, open tracheal system; IMP:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007508; P:larval heart development; IMP:FlyBase.
DR   GO; GO:0007611; P:learning or memory; NAS:FlyBase.
DR   GO; GO:0040011; P:locomotion; NAS:FlyBase.
DR   GO; GO:0007613; P:memory; TAS:FlyBase.
DR   GO; GO:0007494; P:midgut development; TAS:FlyBase.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0045886; P:negative regulation of synaptic growth at neuromuscular junction; IGI:FlyBase.
DR   GO; GO:0008355; P:olfactory learning; NAS:FlyBase.
DR   GO; GO:0001555; P:oocyte growth; IMP:UniProtKB.
DR   GO; GO:0003344; P:pericardium morphogenesis; IMP:FlyBase.
DR   GO; GO:0006909; P:phagocytosis; IMP:FlyBase.
DR   GO; GO:0007431; P:salivary gland development; IMP:FlyBase.
DR   GO; GO:0007614; P:short-term memory; TAS:FlyBase.
DR   GO; GO:0042060; P:wound healing; IMP:FlyBase.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 7.
DR   SUPFAM; SSF69179; SSF69179; 2.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Behavior; Cell adhesion; Cell membrane;
KW   Cleavage on pair of basic residues; Complete proteome; Cytoplasm;
KW   Differentiation; Disulfide bond; Glycoprotein; Integrin; Membrane;
KW   Oogenesis; Phagocytosis; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25   1115       Integrin alpha-PS3.
FT                                /FTId=PRO_0000016326.
FT   CHAIN        25   ?929       Integrin alpha-PS3 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016327.
FT   CHAIN      ?930   1115       Integrin alpha-PS3 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016328.
FT   TOPO_DOM     25   1054       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1055   1075       Helical. {ECO:0000255}.
FT   TOPO_DOM   1076   1115       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       39     99       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      113    174       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      193    246       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      278    335       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      336    397       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      398    453       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      460    522       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     82     82       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    438    438       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    696    696       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    845    845       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    868    868       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    964    964       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     63       MNAESTMFPHIFLALLALISHIEAFNFMPRPSRVINSPKHL
FT                                KFHINQTRSSYFGYTLVIRQTS -> MVGQDRDFWALLVLG
FT                                LWCLSSHCNAFNLSPLPNRQILDPQFATNVPKVRASYFGFT
FT                                MSLRPNG (in isoform A).
FT                                {ECO:0000303|PubMed:9461212,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_002740.
FT   CONFLICT    630    630       I -> V (in Ref. 2; AAC38853/AAC38854).
FT                                {ECO:0000305}.
FT   CONFLICT    664    664       D -> N (in Ref. 2; AAC38853/AAC38854).
FT                                {ECO:0000305}.
FT   CONFLICT    753    753       I -> S (in Ref. 2; AAC38853/AAC38854).
FT                                {ECO:0000305}.
FT   CONFLICT    792    792       S -> R (in Ref. 2; AAC38853/AAC38854).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1115 AA;  124545 MW;  B3DFB52212E84185 CRC64;
     MNAESTMFPH IFLALLALIS HIEAFNFMPR PSRVINSPKH LKFHINQTRS SYFGYTLVIR
     QTSIIVGAPR AQSTLESQRT INETGAIYRC SLTNGVCSPY VLDSRGNVDA PYSEYTFDSE
     RKDFQWLGGS MDGGTKDTDK LLVCAPRFYA PSSRDNHLHG VCYWVNNTVA STPQHVTRIS
     PLRLKSEQVK EEDNGNKASF FYIMGELGLS AHVADDNTKF LIGAPGINTW RGSVILYRQV
     DPVDNPTASR RDTSKALRRT YRDVDSNDYT PEHYAPEIPT PGLWGQEEDS YFGYAVSSGF
     FDSSNPTKLL YVATAPQANK QSGEAYIFDV RGKSIHKYHV FRGEQFGEYF GYSVLAEDLN
     GDGKTDVIVS APQHALEDSH DNGAIYVFIN KGFFNFERQI LRSPVETMAR FGTALSRLGD
     INHDGYNDVA VGAPFAGNGT VFIYLGSENG LRDQPSQRLD APSQQPSKYG SHMFGHGLSR
     GSDIDGNGFN DFAIGAPNAE AVYLYRAYPV VKVHATVKSE SREIKPEQEK VKITACYRLS
     TTSTDKLVQE QELAIRIAMD KQLKRVKFTQ TQTNEISFKV NANFGEQCRD FETQVRYSEK
     DIFTPIDLEM HYELTKKVPD SEEFCETCAI VDPTEPKVST QNIIFSTGCA TDVCTADLQL
     RSKDVSPTYI LGSADTLRLN YEITNIGETA YLPQFNVTST SRLAFAQVPG NCKVVDAVMV
     CDLNRGRPLA KGDTDSVTIS FDVSQLSGQS LIIHAEVFST GYEQNPTDNR QTNVIGLKEF
     TEIDASGGQT NSQIDLEHYS NSAEIVNNYE IKSNGPSVIE QLTVSFYIPI AYKVAGSTAI
     IPIINVTSLK MQASYDSQLL SIDLYDQNNT MLVVDPVEVT TTLSGGLERT VITQNRQSYD
     IHTSGHVHQT MEVLDTSMVA TASMSRKRRD LKALTANREQ YARISNVKAH DLLSDDFKGK
     LPVNRTIVFN CRDPEMTICV RAEMRVHFRP EKSINLNMRY SVDLNEVNAI LVDPWEYFVI
     LTDLKLQKKG DPTSTSFSIN RRIEPNIISK HQETGLPIWI IIVSVIGGLL LLSAISYLLY
     KFGFFNRTKK DELDRLVQQN PVEPEAENLN SGGNN
//
ID   ITA2B_MOUSE             Reviewed;        1033 AA.
AC   Q9QUM0; Q3U3R7; Q64229; Q9Z2M0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   22-NOV-2017, entry version 148.
DE   RecName: Full=Integrin alpha-IIb;
DE   AltName: Full=GPalpha IIb;
DE            Short=GPIIb;
DE   AltName: Full=Platelet membrane glycoprotein IIb;
DE   AltName: CD_antigen=CD41;
DE   Contains:
DE     RecName: Full=Integrin alpha-IIb heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-IIb light chain;
DE   Flags: Precursor;
GN   Name=Itga2b;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=10572112;
RA   Thornton M.A., Poncz M.;
RT   "Characterization of the murine platelet alphaIIb gene and encoded
RT   cDNA.";
RL   Blood 94:3947-3950(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Heart;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 805-865.
RX   PubMed=1512266;
RA   Chen Y.Q., Gao X., Timar J., Tang D., Grossi I.M., Chelladurai M.,
RA   Kunicki T.J., Fligiel S.E., Taylor J.D., Honn K.V.;
RT   "Identification of the alpha IIb beta 3 integrin in murine tumor
RT   cells.";
RL   J. Biol. Chem. 267:17314-17320(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 790-1022.
RA   Rout U.K., Armant D.R.;
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-484.
RX   PubMed=10713093; DOI=10.1074/jbc.275.11.7795;
RA   Puzon-McLaughlin W., Kamata T., Takada Y.;
RT   "Multiple discontinuous ligand-mimetic antibody binding sites define a
RT   ligand binding pocket in integrin alphaIIbbeta3.";
RL   J. Biol. Chem. 275:7795-7802(2000).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Liver, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Integrin alpha-IIb/beta-3 is a receptor for fibronectin,
CC       fibrinogen, plasminogen, prothrombin, thrombospondin and
CC       vitronectin. It recognizes the sequence R-G-D in a wide array of
CC       ligands. It recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in
CC       fibrinogen gamma chain. Following activation integrin alpha-
CC       IIb/beta-3 brings about platelet/platelet interaction through
CC       binding of soluble fibrinogen. This step leads to rapid platelet
CC       aggregation which physically plugs ruptured endothelial cell
CC       surface.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-IIb associates with beta-3. Directly
CC       interacts with RNF181. Interacts (via C-terminus cytoplasmic tail
CC       region) with CIB1; the interaction is direct and calcium-
CC       dependent. Interacts (via C-terminus cytoplasmic tail region) with
CC       CIB2, CIB3 and CIB4; the interactions are stabilized/increased in
CC       a calcium and magnesium-dependent manner (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169829; AAF06996.1; -; Genomic_DNA.
DR   EMBL; AF170316; AAD56216.1; -; mRNA.
DR   EMBL; AK142289; BAE25013.1; -; mRNA.
DR   EMBL; AK154619; BAE32718.1; -; mRNA.
DR   EMBL; AL596258; CAM18010.1; -; Genomic_DNA.
DR   EMBL; BC120493; AAI20494.1; -; mRNA.
DR   EMBL; S43388; AAB23054.2; -; mRNA.
DR   EMBL; AF045019; AAD02339.1; -; mRNA.
DR   EMBL; AF166384; AAF43997.1; -; mRNA.
DR   CCDS; CCDS25500.1; -.
DR   PIR; A43430; A43430.
DR   RefSeq; NP_034705.2; NM_010575.2.
DR   UniGene; Mm.26646; -.
DR   ProteinModelPortal; Q9QUM0; -.
DR   SMR; Q9QUM0; -.
DR   IntAct; Q9QUM0; 1.
DR   MINT; MINT-4098793; -.
DR   STRING; 10090.ENSMUSP00000099375; -.
DR   iPTMnet; Q9QUM0; -.
DR   PhosphoSitePlus; Q9QUM0; -.
DR   SwissPalm; Q9QUM0; -.
DR   MaxQB; Q9QUM0; -.
DR   PaxDb; Q9QUM0; -.
DR   PRIDE; Q9QUM0; -.
DR   Ensembl; ENSMUST00000103086; ENSMUSP00000099375; ENSMUSG00000034664.
DR   GeneID; 16399; -.
DR   KEGG; mmu:16399; -.
DR   UCSC; uc007lrx.2; mouse.
DR   CTD; 3674; -.
DR   MGI; MGI:96601; Itga2b.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; Q9QUM0; -.
DR   KO; K06476; -.
DR   OMA; LWLLEWV; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-MMU-114608; Platelet degranulation.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   Reactome; R-MMU-3000178; ECM proteoglycans.
DR   Reactome; R-MMU-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-MMU-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-MMU-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-MMU-445144; Signal transduction by L1.
DR   PRO; PR:Q9QUM0; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   Bgee; ENSMUSG00000034664; -.
DR   CleanEx; MM_ITGA2B; -.
DR   Genevisible; Q9QUM0; MM.
DR   GO; GO:0072562; C:blood microparticle; ISO:MGI.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005925; C:focal adhesion; IDA:MGI.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0050840; F:extracellular matrix binding; IMP:MGI.
DR   GO; GO:0070051; F:fibrinogen binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:MGI.
DR   GO; GO:0070527; P:platelet aggregation; IEA:Ensembl.
DR   GO; GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Complete proteome; Disulfide bond;
KW   Glycoprotein; Integrin; Membrane; Metal-binding; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     31       {ECO:0000250}.
FT   CHAIN        32   1033       Integrin alpha-IIb.
FT                                /FTId=PRO_0000016278.
FT   CHAIN        32      ?       Integrin alpha-IIb heavy chain.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000016279.
FT   CHAIN         ?   1033       Integrin alpha-IIb light chain.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000016280.
FT   TOPO_DOM     32    988       Extracellular. {ECO:0000255}.
FT   TRANSMEM    989   1014       Helical. {ECO:0000255}.
FT   TOPO_DOM   1015   1033       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       35     96       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      109    173       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      184    237       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      252    304       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      305    370       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      372    431       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      434    495       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     273    281       {ECO:0000255}.
FT   CA_BIND     327    335       {ECO:0000255}.
FT   CA_BIND     395    403       {ECO:0000255}.
FT   CA_BIND     456    464       {ECO:0000255}.
FT   MOTIF      1017   1021       GFFKR motif.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     75     75       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    600    600       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    710    710       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    957    957       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     87     96       {ECO:0000250}.
FT   DISULFID    138    161       {ECO:0000250}.
FT   DISULFID    177    197       {ECO:0000250}.
FT   DISULFID    503    514       {ECO:0000250}.
FT   DISULFID    520    575       {ECO:0000250}.
FT   DISULFID    632    638       {ECO:0000250}.
FT   DISULFID    704    717       {ECO:0000250}.
FT   DISULFID    856    905       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    911    916       {ECO:0000250}.
FT   CONFLICT    236    236       S -> T (in Ref. 1; AAF06996/AAD56216).
FT                                {ECO:0000305}.
FT   CONFLICT    270    270       A -> S (in Ref. 1; AAF06996/AAD56216).
FT                                {ECO:0000305}.
FT   CONFLICT    464    464       D -> G (in Ref. 7; AAF43997).
FT                                {ECO:0000305}.
FT   CONFLICT    471    471       G -> W (in Ref. 1; AAF06996/AAD56216).
FT                                {ECO:0000305}.
FT   CONFLICT    483    483       V -> G (in Ref. 1; AAF06996/AAD56216).
FT                                {ECO:0000305}.
FT   CONFLICT    805    805       R -> S (in Ref. 1; AAF06996/AAD56216).
FT                                {ECO:0000305}.
FT   CONFLICT    834    834       P -> H (in Ref. 6; AAD02339).
FT                                {ECO:0000305}.
FT   CONFLICT    848    849       VQ -> LR (in Ref. 6; AAD02339).
FT                                {ECO:0000305}.
FT   CONFLICT    865    865       D -> E (in Ref. 5; AAB23054).
FT                                {ECO:0000305}.
FT   CONFLICT    933    933       V -> A (in Ref. 1; AAF06996/AAD56216).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1033 AA;  112678 MW;  7B4826E32B9130B1 CRC64;
     MARASCAWHS LWLLQWTPLF LGPSAVPPVW ALNLDSEKFS VYAGPNGSHF GFSVDFHKDK
     HGSVSIVVGA PRALNASQEE TGAVFLCPWK ANGGKCNPLL FDLRDETRNL GFQIFQTFKT
     GQGLGASVVS WNDVIVACAP WQHWNVLEKR DEAEKTPVGG CFLAQLQSGG RAEYSPCRAN
     TMSSVYAESF RGDKRYCEAG FSLAVTQAGE LVLGAPGGYF FLGLLARVPI ENIISSYRPG
     TLLWHVSNQR FTYDNSNPVF FDGYRGYSVA VGEFDGDPST TEYVSGAPTW SWTLGAVEIL
     DSYYQPLHRL HGEQMASYFG HSVAVTDVNG DGRHDLLVGA PLYMESRADR KLAEVGRVYL
     FLQPKGPQAL STPTLLLTGT QLYGRFGSAI APLGDLNRDG YNDIAVAAPY GGPSGQGQVL
     IFLGQSEGLS PRPSQVLDSP FPTGSGFGFS LRGAVDIDDN GYPDLIVGAY GASKVAVYRA
     QPVVMATVQL MVQDSLNPTL KNCVLDQTKT PVSCFNIQMC VGATGHNIPQ KLHLKAELQL
     DLQKPRQGRR VLLLASQQAS LTLSLDLGGR DKPICHTTGA FLRDEADFRD KLSPIVLSLN
     VSLPPEETGG APAVVLHGET HVQEQTRIIL DCGEDDLCVP QLRLTATAGD SPLLIGADNV
     LELKIEAAND GEGAYEAELA VHLPPGAHYM RALSNIEGFE RLVCTQKKEN ESRVALCELG
     NPMKKDTRIG ITMLVSVENL EEAGESVSFQ LQVRSKNSQN PNSKVVMLPV AIQAEATVEL
     RGNSFPASLV VAAEEGDREQ EDLDRWVSRL EHTYELHNIG PGTVNGLRLL IHIPGQSQPS
     DLLYILDVQP QGGLLCSTQP SPKVDWKLST PSPSSIRPVH HQRERRQAFL QGPKPGQQDP
     VLVSCDGSAS CTVVECELRE MVRGQRAMVT VQVMLGLSSL RQRPQEQFVL QSHAWFNVSS
     LPYSVPVVSL PSGQARVQTQ LLRALEERAI PVWWVLVGVL GGLLLLTLLV LAMWKAGFFK
     RNRPPLEEDE EEE
//
ID   ITA4_DROME              Reviewed;        1069 AA.
AC   Q9V7A4; G2J626; Q4V4A2;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   22-NOV-2017, entry version 141.
DE   RecName: Full=Integrin alpha-PS4;
DE   AltName: Full=Position-specific antigen subunit alpha-4;
DE   Flags: Precursor;
GN   Name=ItgaPS4 {ECO:0000312|FlyBase:FBgn0034005};
GN   Synonyms=alphaPS4, ItgalphaPS4;
GN   ORFNames=CG16827 {ECO:0000312|FlyBase:FBgn0034005};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 371-1069.
RC   STRAIN=Berkeley;
RA   Stapleton M., Booth B., Carlson J.W., Chavez C., Frise E.,
RA   George R.A., Pacleb J.M., Park S., Wan K.H., Yu C., Celniker S.E.;
RL   Submitted (SEP-2011) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=19035354; DOI=10.1002/dvdy.21802;
RA   Dinkins M.B., Fratto V.M., Lemosy E.K.;
RT   "Integrin alpha chains exhibit distinct temporal and spatial
RT   localization patterns in epithelial cells of the Drosophila ovary.";
RL   Dev. Dyn. 237:3927-3939(2008).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=20689801; DOI=10.1371/journal.pbio.1000441;
RA   Makki R., Meister M., Pennetier D., Ubeda J.M., Braun A., Daburon V.,
RA   Krzemien J., Bourbon H.M., Zhou R., Vincent A., Crozatier M.;
RT   "A short receptor downregulates JAK/STAT signalling to control the
RT   Drosophila cellular immune response.";
RL   PLoS Biol. 8:E1000441-E1000441(2010).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=21124962; DOI=10.1371/journal.pone.0014051;
RA   Stofanko M., Kwon S.Y., Badenhorst P.;
RT   "Lineage tracing of lamellocytes demonstrates Drosophila macrophage
RT   plasticity.";
RL   PLoS ONE 5:E14051-E14051(2010).
RN   [7]
RP   FUNCTION.
RX   PubMed=22438831; DOI=10.1371/journal.pgen.1002582;
RA   Zhai Z., Ha N., Papagiannouli F., Hamacher-Brady A., Brady N.,
RA   Sorge S., Bezdan D., Lohmann I.;
RT   "Antagonistic regulation of apoptosis and differentiation by the Cut
RT   transcription factor represents a tumor-suppressing mechanism in
RT   Drosophila.";
RL   PLoS Genet. 8:E1002582-E1002582(2012).
CC   -!- FUNCTION: Possible role in cell adhesion. Minor involvement in the
CC       establishment of the oocyte anterior-posterior length.
CC       {ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:22438831}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-PS4
CC       associates with beta-PS (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Expressed in lamellocytes (at protein level).
CC       At the anterior end of the oocyte, expressed in the follicle cells
CC       that will form the operculum and the micropyle.
CC       {ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:20689801,
CC       ECO:0000269|PubMed:21124962}.
CC   -!- DEVELOPMENTAL STAGE: Weakly expressed during late-oogenesis.
CC       {ECO:0000269|PubMed:19035354}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY55520.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=AEO17898.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE013599; AAF58154.2; -; Genomic_DNA.
DR   EMBL; BT023104; AAY55520.1; ALT_SEQ; mRNA.
DR   EMBL; BT128883; AEO17898.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_611025.2; NM_137181.3.
DR   ProteinModelPortal; Q9V7A4; -.
DR   STRING; 7227.FBpp0086503; -.
DR   PaxDb; Q9V7A4; -.
DR   PRIDE; Q9V7A4; -.
DR   EnsemblMetazoa; FBtr0087371; FBpp0086503; FBgn0034005.
DR   GeneID; 36693; -.
DR   KEGG; dme:Dmel_CG16827; -.
DR   CTD; 36693; -.
DR   FlyBase; FBgn0034005; ItgaPS4.
DR   eggNOG; ENOG410IPB1; Eukaryota.
DR   eggNOG; ENOG4111GN2; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   InParanoid; Q9V7A4; -.
DR   OMA; NNGEFAY; -.
DR   OrthoDB; EOG091G0B2Y; -.
DR   PhylomeDB; Q9V7A4; -.
DR   Reactome; R-DME-445355; Smooth Muscle Contraction.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   ChiTaRS; alphaPS4; fly.
DR   GenomeRNAi; 36693; -.
DR   PRO; PR:Q9V7A4; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0034005; -.
DR   Genevisible; Q9V7A4; DM.
DR   GO; GO:0016021; C:integral component of membrane; ISS:FlyBase.
DR   GO; GO:0008305; C:integrin complex; ISS:FlyBase.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISS:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:FlyBase.
DR   GO; GO:0004872; F:receptor activity; ISS:FlyBase.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:FlyBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0001555; P:oocyte growth; IMP:UniProtKB.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 2.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Complete proteome; Glycoprotein; Integrin; Membrane;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19   1069       Integrin alpha-PS4.
FT                                /FTId=PRO_0000016329.
FT   TOPO_DOM     19    985       Extracellular. {ECO:0000255}.
FT   TRANSMEM    986   1006       Helical. {ECO:0000255}.
FT   TOPO_DOM   1007   1069       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       29     89       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      104    165       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      184    237       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      255    310       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      312    374       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      375    430       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      437    499       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CARBOHYD     62     62       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     70     70       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    282    282       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    415    415       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    509    509       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    643    643       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    661    661       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    800    800       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    875    875       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    896    896       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    907    907       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    931    931       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    545    545       K -> E (in Ref. 3; AAY55520).
FT                                {ECO:0000305}.
FT   CONFLICT    694    694       N -> T (in Ref. 3; AAY55520).
FT                                {ECO:0000305}.
FT   CONFLICT    737    737       L -> F (in Ref. 3; AAY55520).
FT                                {ECO:0000305}.
FT   CONFLICT    820    820       K -> I (in Ref. 3; AAY55520).
FT                                {ECO:0000305}.
FT   CONFLICT    932    932       M -> L (in Ref. 3; AAY55520).
FT                                {ECO:0000305}.
FT   CONFLICT   1004   1004       A -> V (in Ref. 3; AAY55520).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1069 AA;  118911 MW;  B2AD69CF6EDA6FCC CRC64;
     MFCLLVIVLL ALQSEINAYN ISPYPNSVLN FPELEGNRRS SYFGFSLVIR EKSIMVAAPR
     ANSSLEAQRN ISEPGVIFRC YFESGNNCSP YNIDTKGNYK GMPNDGLLTA KNKDFRWLGG
     AMDGGTRDSD KFLVCAPRFY SINNENDYNN GMCYWLSDTP KNIDSTEVME KWPLRIEKKQ
     VLKLADTNLI PYYSMGELGL SAHVSDDNSK LLMGAPGIDQ WKGSVHLKQE VPSIKTSSGR
     QRRGMNTNRK CNECNPEPKN FGQEEFSYFG YAVSSGYFDS SNLSTVLYVA TAPRGNNQFG
     EAYIFDIYED SIYKYHEFRG NHFGEYFGYS VLAEDLNGDG KTDVIISAPL YALRNSYDDG
     AIYVFINKGS FTFEERIIRS PAGSGGRFGT TLSRIGDINK DGYNDVAVGA PFAGNGSVFI
     YLGSENGLRD PPSQCLDAPS QQPSKYGSYM FGHGLSRGSD IDGNGFNDFA IGAPNAEAVY
     LYRAYPVVKI HAIIKPKLQN VNPEEERVNI TVCYRLSSKS DSKAKALMEQ ELVIRIDIDT
     KSKIKLAVFD EEHGSQMSFK AKAFHEEICS EFQIEMDKRA KFTPIALEMQ YELSKKIPNS
     GDFCEDCAVV DPAEPKFVTE YITFNTGCAT DVCVADLKIS CINASSTLVL GTTAVLRLTY
     NITNNGEFAY HPKFSVTNSA GLSLAQVPGN CKVNEAVMVC DLNHGQRMAK GDTDSLTISF
     DVRQLRGRSL EIQAEVLSAR DESNPENNKL TNVLSLREKA DIYVSGVQTN DHVVLKESPY
     TAEVVNYYEI KSHGPSTLEN LTVSLYIPVA YKTPDSTNVK HIVTSSPKIQ SKYAHKIMPI
     NFIDQNNALA NNFAIDHDQS TLLFSATPQH ENVGNLSGIV EQNPSISLLN EDLPVNNTLV
     LNCQDTNVTL CVPVEIRLEN GLQLKPEELM NMTVSFTVNL KDADDIWEYF VIQTDLKVHK
     IGDPTLSSFT IEKKIESNVI CKHAEIAIWK IIVSVIVGIL VFSAATYALY KRGFFKRAIK
     DDLKQLIRDS FEDGIIRTEM EENAQSQGDA DLDEKLDAYA DTTGKCTHV
//
ID   ITA5_DROME              Reviewed;        1000 AA.
AC   Q9W1M8;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 145.
DE   RecName: Full=Integrin alpha-PS5;
DE   AltName: Full=Position-specific antigen subunit alpha-5;
DE   Flags: Precursor;
GN   Name=ItgaPS5 {ECO:0000312|FlyBase:FBgn0034880};
GN   Synonyms=alphaPS5, ItgalphaPS5;
GN   ORFNames=CG5372 {ECO:0000312|FlyBase:FBgn0034880};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [3]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=19035354; DOI=10.1002/dvdy.21802;
RA   Dinkins M.B., Fratto V.M., Lemosy E.K.;
RT   "Integrin alpha chains exhibit distinct temporal and spatial
RT   localization patterns in epithelial cells of the Drosophila ovary.";
RL   Dev. Dyn. 237:3927-3939(2008).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=21124962; DOI=10.1371/journal.pone.0014051;
RA   Stofanko M., Kwon S.Y., Badenhorst P.;
RT   "Lineage tracing of lamellocytes demonstrates Drosophila macrophage
RT   plasticity.";
RL   PLoS ONE 5:E14051-E14051(2010).
CC   -!- FUNCTION: Possible role in cell-cell interactions. Minor
CC       involvement in the establishment of the oocyte anterior-posterior
CC       length.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-PS5
CC       associates with beta-PS (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Expressed in all follicle cells overlying the
CC       oocyte during mid-oogenesis, the strongest expression is observed
CC       in the cells covering the anterior end of the oocyte and in the
CC       cells forming the dorsal appendages. After completion of oocyte
CC       enlargement, expression in main body follicle cells is down-
CC       regulated but persists strongly in the dorsal appendage forming
CC       cells. Expressed in lamellocytes. {ECO:0000269|PubMed:19035354,
CC       ECO:0000269|PubMed:21124962}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during mid- and late-oogenesis.
CC       {ECO:0000269|PubMed:19035354}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE013599; AAF47029.1; -; Genomic_DNA.
DR   RefSeq; NP_611808.1; NM_137964.2.
DR   ProteinModelPortal; Q9W1M8; -.
DR   BioGrid; 63332; 3.
DR   DIP; DIP-20602N; -.
DR   IntAct; Q9W1M8; 2.
DR   MINT; MINT-297258; -.
DR   STRING; 7227.FBpp0071972; -.
DR   PaxDb; Q9W1M8; -.
DR   PRIDE; Q9W1M8; -.
DR   EnsemblMetazoa; FBtr0072063; FBpp0071972; FBgn0034880.
DR   GeneID; 37732; -.
DR   KEGG; dme:Dmel_CG5372; -.
DR   CTD; 37732; -.
DR   FlyBase; FBgn0034880; ItgaPS5.
DR   eggNOG; ENOG410IPB1; Eukaryota.
DR   eggNOG; ENOG4111GN2; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   InParanoid; Q9W1M8; -.
DR   OMA; PGNCRVR; -.
DR   OrthoDB; EOG091G0B2Y; -.
DR   PhylomeDB; Q9W1M8; -.
DR   Reactome; R-DME-445355; Smooth Muscle Contraction.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   GenomeRNAi; 37732; -.
DR   PRO; PR:Q9W1M8; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0034880; -.
DR   Genevisible; Q9W1M8; DM.
DR   GO; GO:0016021; C:integral component of membrane; ISS:FlyBase.
DR   GO; GO:0008305; C:integrin complex; ISS:FlyBase.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISS:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:FlyBase.
DR   GO; GO:0004872; F:receptor activity; ISS:FlyBase.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:FlyBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0001555; P:oocyte growth; IMP:UniProtKB.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 2.
DR   PROSITE; PS51470; FG_GAP; 6.
PE   2: Evidence at transcript level;
KW   Cell adhesion; Complete proteome; Glycoprotein; Integrin; Membrane;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1      ?       {ECO:0000255}.
FT   CHAIN         ?   1000       Integrin alpha-PS5.
FT                                /FTId=PRO_0000016330.
FT   TOPO_DOM      ?    929       Extracellular. {ECO:0000255}.
FT   TRANSMEM    930    950       Helical. {ECO:0000255}.
FT   TOPO_DOM    951   1000       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       15     74       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       75    137       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      145    198       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      199    261       FG-GAP 4.
FT   REPEAT      262    323       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      324    379       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      386    448       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    231    231       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    516    516       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    592    592       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    622    622       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    732    732       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    771    771       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    829    829       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    842    842       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    853    853       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    922    922       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   1000 AA;  110544 MW;  BD1D95C924D0B71E CRC64;
     MNFSPLPNRV IDAPKHLKTR MIQVRSSYFG YSLVIRPTSI FVGAPRAQST LESQGSINET
     GAVYRCPLAS GSCSHYVLND KLNKQFQWLG GSMDGGTKDT DKLLVCAPRF FVPKNKNYGQ
     MRGICYWVRD TVADTPPLSD VRTISLIPSQ AEEHFMLELG LSAHVTDDNS GFLIGAPGVR
     SWKGSVLVHR GEDLAAQGSY AVKMLDSWDW VKNHFTYVGY ALSSGYFSSN NRTSLLYVTT
     APSSVLNTGK AYIFDVVGEI VRKLHVFHGE QLGEYFGYSV VAEDLNGDGL TDVVVSAPLN
     ALGDSYDVGA IYVFINKGLF KFEKKIIRLP LSSGARFGSS LSKVGDINHD GYNDLAVGAP
     FAGNGAVFIF LGSEHGLRDE PSQRLDAPSR EPGPYGAHMF GQGLSRGSDI DGNGFNDLAI
     GAPGAEAVYL YRAYPVVKIH ATVRSESRAI RPEQETITVT ACYRLETTSK ARQMQQQELT
     FRMTIDELLQ RVSFAPMRTN EVSFQAQAGL SGSCRNFSVG VHYTGGIFTP IDLELHYELA
     KKIPHSHEAF CESCAVVDPL EPKYATGTLS FMTGCAAHVC VSDLQLSSKD VNSSFIFGSL
     EVLSFSYEIT NSGEPAYVAQ FNVTSSARLP FAKVPGNCRV RHEVMLCDLN GGRALARGDS
     ESLTIIFDVT QLSGQSLTIE AAVSSAGMDQ NPKDNTMSTT ISLREYAEID ASGGPIDGHI
     ALKEYPYSAE VNNSYEFKSH GPSIIDELTV YVDVPIAYTV TGSAGIKSIF NISSLQMQAT
     HGSELVPIKL YDQTNTLAKE YPLEDSSRRA NRKRRELQQD QYAIMPDVNI SDILTKENLP
     ANRTLVLDCL RGNWTICVRS QMRVQLKPEQ PIDLRISFKV DLNDFVNTFD YLVIFTNVEM
     FKEGDSTSIA LKRNLKPNVI FNYSETPLPI WYIILSLIAG HLLLGAMTYI LYKLRFFKRG
     KKEELKRLLE EHRSETKEPA TDCEGNQEEI NVEMHSDLEN
//
ID   ITB8_HUMAN              Reviewed;         769 AA.
AC   P26012; A4D133; B4DHD4;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   22-NOV-2017, entry version 170.
DE   RecName: Full=Integrin beta-8;
DE   Flags: Precursor;
GN   Name=ITGB8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=1918072;
RA   Moyle M., Napier M.A., McLean J.W.;
RT   "Cloning and expression of a divergent integrin subunit beta 8.";
RL   J. Biol. Chem. 266:19650-19658(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Integrin alpha-V/beta-8 is a receptor for fibronectin.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-8
CC       associates with alpha-V.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P26012-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P26012-2; Sequence=VSP_056531;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Placenta, kidney, brain, ovary, uterus and in
CC       several transformed cells. Transiently expressed in 293 human
CC       embryonic kidney cells.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M73780; AAA36034.1; -; mRNA.
DR   EMBL; AK295044; BAG58095.1; -; mRNA.
DR   EMBL; AC004130; AAQ96845.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24275.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93725.1; -; Genomic_DNA.
DR   CCDS; CCDS5370.1; -. [P26012-1]
DR   PIR; A41029; A41029.
DR   RefSeq; NP_002205.1; NM_002214.2. [P26012-1]
DR   RefSeq; XP_011513698.1; XM_011515396.1. [P26012-2]
DR   RefSeq; XP_016867667.1; XM_017012178.1. [P26012-1]
DR   RefSeq; XP_016867668.1; XM_017012179.1. [P26012-1]
DR   RefSeq; XP_016867669.1; XM_017012180.1. [P26012-2]
DR   RefSeq; XP_016867670.1; XM_017012181.1. [P26012-2]
DR   RefSeq; XP_016867671.1; XM_017012182.1. [P26012-2]
DR   RefSeq; XP_016867672.1; XM_017012183.1. [P26012-2]
DR   UniGene; Hs.592171; -.
DR   UniGene; Hs.686110; -.
DR   ProteinModelPortal; P26012; -.
DR   SMR; P26012; -.
DR   BioGrid; 109902; 14.
DR   CORUM; P26012; -.
DR   IntAct; P26012; 1.
DR   STRING; 9606.ENSP00000222573; -.
DR   iPTMnet; P26012; -.
DR   PhosphoSitePlus; P26012; -.
DR   BioMuta; ITGB8; -.
DR   DMDM; 124975; -.
DR   EPD; P26012; -.
DR   MaxQB; P26012; -.
DR   PaxDb; P26012; -.
DR   PeptideAtlas; P26012; -.
DR   PRIDE; P26012; -.
DR   DNASU; 3696; -.
DR   Ensembl; ENST00000222573; ENSP00000222573; ENSG00000105855. [P26012-1]
DR   Ensembl; ENST00000537992; ENSP00000441561; ENSG00000105855. [P26012-2]
DR   GeneID; 3696; -.
DR   KEGG; hsa:3696; -.
DR   UCSC; uc003suu.4; human. [P26012-1]
DR   CTD; 3696; -.
DR   DisGeNET; 3696; -.
DR   EuPathDB; HostDB:ENSG00000105855.9; -.
DR   GeneCards; ITGB8; -.
DR   HGNC; HGNC:6163; ITGB8.
DR   HPA; HPA027796; -.
DR   HPA; HPA027797; -.
DR   MIM; 604160; gene.
DR   neXtProt; NX_P26012; -.
DR   OpenTargets; ENSG00000105855; -.
DR   PharmGKB; PA29962; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P26012; -.
DR   KO; K06591; -.
DR   OMA; DDFSCPY; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P26012; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   SignaLink; P26012; -.
DR   SIGNOR; P26012; -.
DR   ChiTaRS; ITGB8; human.
DR   GeneWiki; ITGB8; -.
DR   GenomeRNAi; 3696; -.
DR   PRO; PR:P26012; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000105855; -.
DR   CleanEx; HS_ITGB8; -.
DR   Genevisible; P26012; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0034686; C:integrin alphav-beta8 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:1990430; F:extracellular matrix protein binding; IDA:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0005102; F:receptor binding; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IMP:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0001573; P:ganglioside metabolic process; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0060674; P:placenta blood vessel development; TAS:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015442; Integrin_bsu-8.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF9; PTHR10082:SF9; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 2.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell adhesion; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     42       {ECO:0000255}.
FT   CHAIN        43    769       Integrin beta-8.
FT                                /FTId=PRO_0000016354.
FT   TOPO_DOM     43    684       Extracellular. {ECO:0000255}.
FT   TRANSMEM    685    704       Helical. {ECO:0000255}.
FT   TOPO_DOM    705    769       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      146    384       VWFA.
FT   REPEAT      471    510       I.
FT   REPEAT      511    552       II.
FT   REPEAT      553    592       III.
FT   REPEAT      593    629       IV.
FT   REGION      471    629       Cysteine-rich tandem repeats.
FT   CARBOHYD    233    233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    402    402       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    421    421       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    431    431       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    456    456       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    466    466       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    648    648       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     47    469       {ECO:0000250}.
FT   DISULFID     55     65       {ECO:0000250}.
FT   DISULFID     58     94       {ECO:0000250}.
FT   DISULFID     68     83       {ECO:0000250}.
FT   DISULFID    211    218       {ECO:0000250}.
FT   DISULFID    266    307       {ECO:0000250}.
FT   DISULFID    407    419       {ECO:0000250}.
FT   DISULFID    467    471       {ECO:0000250}.
FT   DISULFID    494    499       {ECO:0000250}.
FT   DISULFID    526    531       {ECO:0000250}.
FT   DISULFID    528    561       {ECO:0000250}.
FT   DISULFID    533    546       {ECO:0000250}.
FT   DISULFID    567    572       {ECO:0000250}.
FT   DISULFID    574    583       {ECO:0000250}.
FT   DISULFID    585    593       {ECO:0000250}.
FT   DISULFID    607    612       {ECO:0000250}.
FT   DISULFID    609    657       {ECO:0000250}.
FT   DISULFID    614    624       {ECO:0000250}.
FT   DISULFID    627    630       {ECO:0000250}.
FT   DISULFID    634    643       {ECO:0000250}.
FT   VAR_SEQ       1    135       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056531.
FT   VARIANT     552    552       S -> F (in dbSNP:rs5002476).
FT                                /FTId=VAR_034028.
SQ   SEQUENCE   769 AA;  85632 MW;  F7E3994F92B12A65 CRC64;
     MCGSALAFFT AAFVCLQNDR RGPASFLWAA WVFSLVLGLG QGEDNRCASS NAASCARCLA
     LGPECGWCVQ EDFISGGSRS ERCDIVSNLI SKGCSVDSIE YPSVHVIIPT ENEINTQVTP
     GEVSIQLRPG AEANFMLKVH PLKKYPVDLY YLVDVSASMH NNIEKLNSVG NDLSRKMAFF
     SRDFRLGFGS YVDKTVSPYI SIHPERIHNQ CSDYNLDCMP PHGYIHVLSL TENITEFEKA
     VHRQKISGNI DTPEGGFDAM LQAAVCESHI GWRKEAKRLL LVMTDQTSHL ALDSKLAGIV
     VPNDGNCHLK NNVYVKSTTM EHPSLGQLSE KLIDNNINVI FAVQGKQFHW YKDLLPLLPG
     TIAGEIESKA ANLNNLVVEA YQKLISEVKV QVENQVQGIY FNITAICPDG SRKPGMEGCR
     NVTSNDEVLF NVTVTMKKCD VTGGKNYAII KPIGFNETAK IHIHRNCSCQ CEDNRGPKGK
     CVDETFLDSK CFQCDENKCH FDEDQFSSES CKSHKDQPVC SGRGVCVCGK CSCHKIKLGK
     VYGKYCEKDD FSCPYHHGNL CAGHGECEAG RCQCFSGWEG DRCQCPSAAA QHCVNSKGQV
     CSGRGTCVCG RCECTDPRSI GRFCEHCPTC YTACKENWNC MQCLHPHNLS QAILDQCKTS
     CALMEQQHYV DQTSECFSSP SYLRIFFIIF IVTFLIGLLK VLIIRQVILQ WNSNKIKSSS
     DYRVSASKKD KLILQSVCTR AVTYRREKPE EIKMDISKLN AHETFRCNF
//
ID   ITBN_DROME              Reviewed;         799 AA.
AC   Q27591; A9UN88; Q9VIG7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   22-NOV-2017, entry version 154.
DE   RecName: Full=Integrin beta-nu;
DE   Flags: Precursor;
GN   Name=Itgbn {ECO:0000312|FlyBase:FBgn0010395};
GN   Synonyms=beta-nu, betaInt-nu,
GN   Itgbetanu {ECO:0000312|FlyBase:FBgn0010395};
GN   ORFNames=CG1762 {ECO:0000312|FlyBase:FBgn0010395};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Midgut endoderm;
RX   PubMed=8076521;
RA   Yee G.H., Hynes R.O.;
RT   "A novel, tissue-specific integrin subunit, beta nu, expressed in the
RT   midgut of Drosophila melanogaster.";
RL   Development 118:845-858(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Carlson J.W., Frise E., Kapadia B., Park S., Wan K.H.,
RA   Yu C., Celniker S.E.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, INTERACTION WITH SCB, AND TISSUE SPECIFICITY.
RX   PubMed=15469969; DOI=10.1242/dev.01427;
RA   Devenport D., Brown N.H.;
RT   "Morphogenesis in the absence of integrins: mutation of both
RT   Drosophila beta subunits prevents midgut migration.";
RL   Development 131:5405-5415(2004).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18925939; DOI=10.1186/1749-8104-3-26;
RA   Tsai P.I., Kao H.H., Grabbe C., Lee Y.T., Ghose A., Lai T.T.,
RA   Peng K.P., Van Vactor D., Palmer R.H., Chen R.H., Yeh S.R.,
RA   Chien C.T.;
RT   "Fak56 functions downstream of integrin alphaPS3betanu and suppresses
RT   MAPK activation in neuromuscular junction growth.";
RL   Neural Dev. 3:26-26(2008).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=21592968; DOI=10.1074/jbc.M110.204503;
RA   Nagaosa K., Okada R., Nonaka S., Takeuchi K., Fujita Y., Miyasaka T.,
RA   Manaka J., Ando I., Nakanishi Y.;
RT   "Integrin betanu-mediated phagocytosis of apoptotic cells in
RT   Drosophila embryos.";
RL   J. Biol. Chem. 286:25770-25777(2011).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=22547074; DOI=10.1074/jbc.M111.333807;
RA   Shiratsuchi A., Mori T., Sakurai K., Nagaosa K., Sekimizu K.,
RA   Lee B.L., Nakanishi Y.;
RT   "Independent recognition of Staphylococcus aureus by two receptors for
RT   phagocytosis in Drosophila.";
RL   J. Biol. Chem. 287:21663-21672(2012).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23054837; DOI=10.1073/pnas.1206416109;
RA   Tsai P.I., Wang M., Kao H.H., Cheng Y.J., Lin Y.J., Chen R.H.,
RA   Chien C.T.;
RT   "Activity-dependent retrograde laminin A signaling regulates synapse
RT   growth at Drosophila neuromuscular junctions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:17699-17704(2012).
RN   [10]
RP   FUNCTION, INTERACTION WITH SCB, DEVELOPMENTAL STAGE, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=23426364; DOI=10.1074/jbc.M113.451427;
RA   Nonaka S., Nagaosa K., Mori T., Shiratsuchi A., Nakanishi Y.;
RT   "Integrin alphaPS3/betanu-mediated phagocytosis of apoptotic cells and
RT   bacteria in Drosophila.";
RL   J. Biol. Chem. 288:10374-10380(2013).
CC   -!- FUNCTION: Contributes to endodermal integrity and adhesion between
CC       the midgut epithelium and the surrounding visceral muscle.
CC       Essential for migration of the primordial midgut cells and for
CC       maintaining, but not establishing, cell polarity in the midgut
CC       epithelium. Can only partially compensate for the loss of beta-PS
CC       integrin during primordial midgut cell migration. The two beta
CC       subunits mediate midgut migration by distinct mechanisms: beta-PS
CC       requires rhea/Talin and beta-nu does not. Integrin alpha-PS3/beta-
CC       nu is required for effective phagocytosis of apoptotic cells
CC       during embryonic development and for the phagocytic elimination of
CC       S.aureus by mediating the binding of S.aureus peptidoglycan to
CC       larval hemocytes, which probably activates a signaling pathway
CC       involving Rac1 and Rac2. Not required for the production of
CC       antimicrobial peptides during S.aureus. Upon activation by LanA,
CC       integrin alpha-PS3/beta-nu activates Fak in presynapsis to
CC       suppress neuromuscular junction (NMJ) growth during larval
CC       development and during low crawling activity, but not during
CC       higher-crawling conditions. Mediates, together with LanA,
CC       glutamate receptor-modulated NMJ growth.
CC       {ECO:0000269|PubMed:15469969, ECO:0000269|PubMed:18925939,
CC       ECO:0000269|PubMed:21592968, ECO:0000269|PubMed:22547074,
CC       ECO:0000269|PubMed:23054837, ECO:0000269|PubMed:23426364}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Interacts
CC       with scb/alpha-PS3. {ECO:0000269|PubMed:15469969,
CC       ECO:0000269|PubMed:23426364}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Expression is confined to the developing
CC       midgut endoderm and its precursors during embryogenesis. In the
CC       larvae, expression is concentrated in the midgut imaginal disks.
CC       Expressed in embryonic and larval hemocytes (at protein level).
CC       {ECO:0000269|PubMed:15469969, ECO:0000269|PubMed:21592968,
CC       ECO:0000269|PubMed:22547074, ECO:0000269|PubMed:8076521}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development. Highest
CC       expression occurs during 12-15 hours of embryonic development (at
CC       protein level). {ECO:0000269|PubMed:21592968,
CC       ECO:0000269|PubMed:23426364, ECO:0000269|PubMed:8076521}.
CC   -!- DISRUPTION PHENOTYPE: Homozygous mutant flies are viable and
CC       fertile. Mutant embryos show reduced level of phagocytosis, but
CC       normal level of hemocytes or apoptosis. At NMJ, mutant larvae show
CC       normal patterns of synaptic proteins but increased branch length,
CC       bouton number and quantal content in basal synaptic transmission
CC       recording. {ECO:0000269|PubMed:18925939,
CC       ECO:0000269|PubMed:21592968, ECO:0000269|PubMed:23054837,
CC       ECO:0000269|PubMed:23426364}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13305; AAC37169.1; -; mRNA.
DR   EMBL; AE014134; AAF53952.1; -; Genomic_DNA.
DR   EMBL; BT031252; ABY20493.1; -; mRNA.
DR   RefSeq; NP_001303333.1; NM_001316404.1.
DR   RefSeq; NP_523608.2; NM_078884.3.
DR   UniGene; Dm.19859; -.
DR   ProteinModelPortal; Q27591; -.
DR   SMR; Q27591; -.
DR   BioGrid; 61326; 4.
DR   IntAct; Q27591; 2.
DR   STRING; 7227.FBpp0080990; -.
DR   PaxDb; Q27591; -.
DR   PRIDE; Q27591; -.
DR   EnsemblMetazoa; FBtr0081461; FBpp0080990; FBgn0010395.
DR   EnsemblMetazoa; FBtr0346711; FBpp0312322; FBgn0010395.
DR   GeneID; 35368; -.
DR   KEGG; dme:Dmel_CG1762; -.
DR   CTD; 35368; -.
DR   FlyBase; FBgn0010395; Itgbn.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   InParanoid; Q27591; -.
DR   KO; K05719; -.
DR   OMA; MDLTWTM; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; Q27591; -.
DR   Reactome; R-DME-114608; Platelet degranulation.
DR   Reactome; R-DME-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-DME-1566948; Elastic fibre formation.
DR   Reactome; R-DME-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-DME-216083; Integrin cell surface interactions.
DR   Reactome; R-DME-3000157; Laminin interactions.
DR   Reactome; R-DME-3000170; Syndecan interactions.
DR   Reactome; R-DME-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-DME-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-DME-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-DME-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-DME-445144; Signal transduction by L1.
DR   Reactome; R-DME-445355; Smooth Muscle Contraction.
DR   Reactome; R-DME-446107; Type I hemidesmosome assembly.
DR   GenomeRNAi; 35368; -.
DR   PRO; PR:Q27591; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0010395; -.
DR   ExpressionAtlas; Q27591; differential.
DR   Genevisible; Q27591; DM.
DR   GO; GO:0016021; C:integral component of membrane; IDA:FlyBase.
DR   GO; GO:0008305; C:integrin complex; IDA:FlyBase.
DR   GO; GO:0050839; F:cell adhesion molecule binding; TAS:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:FlyBase.
DR   GO; GO:0004872; F:receptor activity; TAS:FlyBase.
DR   GO; GO:0043277; P:apoptotic cell clearance; IMP:FlyBase.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:FlyBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0035011; P:melanotic encapsulation of foreign target; IMP:FlyBase.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; IGI:FlyBase.
DR   GO; GO:0045886; P:negative regulation of synaptic growth at neuromuscular junction; IMP:FlyBase.
DR   GO; GO:0042048; P:olfactory behavior; IMP:FlyBase.
DR   GO; GO:0006909; P:phagocytosis; IMP:FlyBase.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   PROSITE; PS00022; EGF_1; 4.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS00243; INTEGRIN_BETA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Complete proteome; Glycoprotein; Integrin; Membrane;
KW   Phagocytosis; Receptor; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    799       Integrin beta-nu.
FT                                /FTId=PRO_0000016357.
FT   TOPO_DOM     27    725       Extracellular. {ECO:0000255}.
FT   TRANSMEM    726    746       Helical. {ECO:0000255}.
FT   TOPO_DOM    747    799       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      136    372       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    167    167       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    409    409       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    505    505       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    655    655       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    680    680       E -> G (in Ref. 1; AAC37169).
FT                                {ECO:0000305}.
FT   CONFLICT    701    701       V -> A (in Ref. 1; AAC37169).
FT                                {ECO:0000305}.
SQ   SEQUENCE   799 AA;  90842 MW;  351869D523F07DEB CRC64;
     MTSLGGRAFL WIYLVFLIAE ISHSDADSID DQCRHADSCE RCLSAHLECA WCTDKEYQVG
     YRCLSRRQLL NYNCSETDIY ENQPVLDVLQ DKPLKDYETS DQAVQVTPQR AYLKLVKGNT
     QRMKLSYRTA RNNPLDLYVL MDLTWTMRDD KKTLEELGAQ LSQTLKNLTG NYRLGFGSFA
     DKPTLPMILP QHRENPCAAE RATCEPTYGY RHQLSLTDDI PAFTSAVANS KITGNLDNLE
     GGLDALMQVI VCTKEIGWKE QARKVVILVT DGFMHLAGDG LLAGIIQRND KQCHLNKAGE
     YTGSLNYDYP SLEEIYRELL RRKINVIFAV TEEVVSSYWE LSALMKEISY VDILSADSSN
     ILELIKKSYE SLIKRTQFAD NSPDFIDMAY YTDCGGQFPS LQKRNYCNNV TLGKQIDFYV
     DVTLKKYPDN QVYTHKIRVE ETSLSEFMDL DVELQRPCPC QETPDPENEE GRFLCDYKGY
     LYCGMCECDE GWTGTYCNCP TDATNVTSNE ALLQKCRQPF SDKSTSELVC SNHGDCDCGT
     CLCDPGYTGP FCECRECLDC DEKLADCFCG QCVCKYGWSG SKCNCDGDTD ACVGPTGEIC
     SERGTCQCEE CQCEEPYLGK FCEIDPEKDN KLCLFYEPCV TCLIEQKQGM GVCENLTEIC
     SSLDRQETYP YNFVHELDPE QDQCLVRLVN KHGIQCDSFF VYQVIDHSNF LTIQAVDCEP
     PDYVALVGYI SAFTLLIGLL IIFIILWYIR AKDAREYAKF EEDQKNSVRQ ENPIYRDPVG
     RYEVPKALSV KYDENPFAS
//
ID   ITB2_BOVIN              Reviewed;         769 AA.
AC   P32592;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   22-NOV-2017, entry version 150.
DE   RecName: Full=Integrin beta-2;
DE   AltName: Full=Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta;
DE   AltName: Full=Complement receptor C3 subunit beta;
DE   AltName: CD_antigen=CD18;
DE   Flags: Precursor;
GN   Name=ITGB2; Synonyms=CD18;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1351021; DOI=10.1016/0378-1119(92)90586-E;
RA   Shuster D.E., Bosworth B.T., Kehrli M.E. Jr.;
RT   "Sequence of the bovine CD18-encoding cDNA: comparison with the human
RT   and murine glycoproteins.";
RL   Gene 114:267-271(1992).
RN   [2]
RP   VARIANT LAD GLY-128, AND DISEASE.
RX   PubMed=1384046; DOI=10.1073/pnas.89.19.9225;
RA   Shuster D.E., Kehrli M.E. Jr., Ackermann M.R., Gilbert R.O.;
RT   "Identification and prevalence of a genetic defect that causes
RT   leukocyte adhesion deficiency in Holstein cattle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:9225-9229(1992).
CC   -!- FUNCTION: Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2,
CC       ICAM3 and ICAM4. Integrins alpha-M/beta-2 and alpha-X/beta-2 are
CC       receptors for the iC3b fragment of the third complement component
CC       and for fibrinogen. Integrin alpha-X/beta-2 recognizes the
CC       sequence G-P-R in fibrinogen alpha-chain. Integrin alpha-M/beta-2
CC       recognizes P1 and P2 peptides of fibrinogen gamma chain. Integrin
CC       alpha-M/beta-2 is also a receptor for factor X. Integrin alpha-
CC       D/beta-2 is a receptor for ICAM3 and VCAM1. Contributes to natural
CC       killer cell cytotoxicity. Involved in leukocyte adhesion and
CC       transmigration of leukocytes including T-cells and neutrophils.
CC       Triggers neutrophil transmigration during lung injury through
CC       PTK2B/PYK2-mediated activation. Integrin alpha-L/beta-2 in
CC       association with ICAM3, contributes to apoptotic neutrophil
CC       phagocytosis by macrophages. {ECO:0000250|UniProtKB:P05107}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-2
CC       associates with either alpha-L, alpha-M, alpha-X or alpha-D.
CC       Interacts with COPS5 and RANBP9. Interacts with FGR. Interacts
CC       with FLNA (via filamin repeats 4, 9, 12, 17, 19, 21, and 23).
CC       Interacts with THBD. {ECO:0000250|UniProtKB:P05107}.
CC   -!- INTERACTION:
CC       Q7BHI8:lktA (xeno); NbExp=3; IntAct=EBI-11509482, EBI-11580242;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DISEASE: Note=Defects in ITGB2 are the cause of leukocyte adhesion
CC       deficiency (LAD). The mutation causing LAD (Gly-128) is prevalent
CC       among Holstein cattle throughout the world, placing this disorder
CC       among the most common genetic diseases known in animal
CC       agriculture. All cattle with the mutant allele are related to one
CC       bull, who through the use of artificial insemination sired many
CC       calves in the 1950s and 1960s. {ECO:0000269|PubMed:1384046}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M81233; AAA30438.1; -; mRNA.
DR   PIR; JC1121; JC1121.
DR   RefSeq; NP_786975.1; NM_175781.1.
DR   RefSeq; XP_015329203.1; XM_015473717.1.
DR   UniGene; Bt.63143; -.
DR   ProteinModelPortal; P32592; -.
DR   SMR; P32592; -.
DR   IntAct; P32592; 1.
DR   STRING; 9913.ENSBTAP00000022687; -.
DR   PaxDb; P32592; -.
DR   PeptideAtlas; P32592; -.
DR   PRIDE; P32592; -.
DR   Ensembl; ENSBTAT00000022687; ENSBTAP00000022687; ENSBTAG00000017060.
DR   GeneID; 281877; -.
DR   KEGG; bta:281877; -.
DR   CTD; 3689; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P32592; -.
DR   KO; K06464; -.
DR   OMA; RGRCRCN; -.
DR   OrthoDB; EOG091G029W; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-BTA-166016; Toll Like Receptor 4 (TLR4) Cascade.
DR   Reactome; R-BTA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-BTA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-BTA-216083; Integrin cell surface interactions.
DR   Reactome; R-BTA-6798695; Neutrophil degranulation.
DR   Proteomes; UP000009136; Chromosome 1.
DR   Bgee; ENSBTAG00000017060; -.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0099568; C:cytoplasmic region; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0034687; C:integrin alphaL-beta2 complex; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; IEA:Ensembl.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IEA:Ensembl.
DR   GO; GO:0030369; F:ICAM-3 receptor activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; ISS:UniProtKB.
DR   GO; GO:0035987; P:endodermal cell differentiation; IEA:Ensembl.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0006909; P:phagocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0043315; P:positive regulation of neutrophil degranulation; IEA:Ensembl.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IEA:Ensembl.
DR   GO; GO:0043113; P:receptor clustering; IEA:Ensembl.
DR   GO; GO:0031623; P:receptor internalization; ISS:UniProtKB.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015439; Integrin_bsu-2.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF15; PTHR10082:SF15; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Integrin; Membrane; Metal-binding;
KW   Phagocytosis; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000250}.
FT   CHAIN        23    769       Integrin beta-2.
FT                                /FTId=PRO_0000016340.
FT   TOPO_DOM     23    700       Extracellular. {ECO:0000255}.
FT   TRANSMEM    701    723       Helical. {ECO:0000255}.
FT   TOPO_DOM    724    769       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      124    363       VWFA.
FT   REPEAT      449    496       I.
FT   REPEAT      497    540       II.
FT   REPEAT      541    581       III.
FT   REPEAT      582    617       IV.
FT   REGION      449    617       Cysteine-rich tandem repeats.
FT   MOTIF       397    399       Cell attachment site. {ECO:0000255}.
FT   METAL       138    138       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       141    141       Calcium. {ECO:0000250}.
FT   METAL       142    142       Calcium. {ECO:0000250}.
FT   METAL       347    347       Calcium. {ECO:0000250}.
FT   MOD_RES     745    745       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   MOD_RES     756    756       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   MOD_RES     758    758       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   MOD_RES     760    760       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P05107}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    254    254       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    501    501       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    642    642       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     25     43       {ECO:0000250}.
FT   DISULFID     33    447       {ECO:0000250}.
FT   DISULFID     36     62       {ECO:0000250}.
FT   DISULFID     46     73       {ECO:0000250}.
FT   DISULFID    191    198       {ECO:0000250}.
FT   DISULFID    246    286       {ECO:0000250}.
FT   DISULFID    386    400       {ECO:0000250}.
FT   DISULFID    420    445       {ECO:0000250}.
FT   DISULFID    449    467       {ECO:0000250}.
FT   DISULFID    459    470       {ECO:0000250}.
FT   DISULFID    472    481       {ECO:0000250}.
FT   DISULFID    483    514       {ECO:0000250}.
FT   DISULFID    497    512       {ECO:0000250}.
FT   DISULFID    506    517       {ECO:0000250}.
FT   DISULFID    519    534       {ECO:0000250}.
FT   DISULFID    536    559       {ECO:0000250}.
FT   DISULFID    541    557       {ECO:0000250}.
FT   DISULFID    549    562       {ECO:0000250}.
FT   DISULFID    564    573       {ECO:0000250}.
FT   DISULFID    575    598       {ECO:0000250}.
FT   DISULFID    582    596       {ECO:0000250}.
FT   DISULFID    590    601       {ECO:0000250}.
FT   DISULFID    603    612       {ECO:0000250}.
FT   DISULFID    615    618       {ECO:0000250}.
FT   DISULFID    622    662       {ECO:0000250}.
FT   DISULFID    628    647       {ECO:0000250}.
FT   DISULFID    631    643       {ECO:0000250}.
FT   DISULFID    670    695       {ECO:0000250}.
FT   VARIANT     128    128       D -> G (in LAD).
FT                                {ECO:0000269|PubMed:1384046}.
SQ   SEQUENCE   769 AA;  84400 MW;  5903ADF4E8998CEA CRC64;
     MLRQRPQLLL LAGLLALQSV LSQECTNYKV STCRDCIESG PGCAWCQKLN FTGQGEPDSI
     RCDTRAELLS KGCPADDIME PKSLAETRDS QAGSRKQLSP QEVTLYLRPG QAVAFNVTFR
     RAKGYPIDLY YLMDLSYSMV DDLVNVKKLG GDLLRALNGI TESGRIGFGS FVDKTVLPFV
     NTHPEKLRNP CPNKEKECQP PFAFRHVLKL TDNSKQFETE VGKQLISGNL DAPEGGLDAM
     MQVAACPEEI GWRNVTRLLV FATDDGFHFA GDGKLGAILT PNDGRCHLED NLYKSSNEFD
     YPSVGQLAHK LAESNIQPIF AVTKKMVKTY EKLTEIIPKS AVGELSEDSR NVVELIKNAY
     NKLSSRVFLD HSTLPDTLKV TYDSFCSNGK SQVDQPRGDC DGVQINVPIT FQVKVTATEC
     IQQQSFTIRA LGFTDTVTVR VLPQCECQCR DASRDGSICG GRGSMECGVC RCDAGYIGKN
     CECQTQGRSS QELEGSCRKD NSSIICSGLG DCICGQCVCH TSDVPNKKIY GQFCECDNVN
     CERYDGQVCG GEKRGLCFCG TCRCDEQYEG SACQCLKSTQ GCLNLDGVEC SGRGRCRCNV
     CQCDPGYQPP LCSECPGCPV PCAGFAPCTE CLKFDKGPFA KNCSAACGQT KLLSSPVPGR
     KCKERDSEGC WMTYTLVQRD GRDRYDVHVD DMLECVKGPN IAAIVGGTVG GVVLVGILLL
     VIWKALTHLS DLREYHRFEK EKLKSQWNND NPLFKSATTT VMNPKFAES
//
ID   PAT2_CAEEL              Reviewed;        1226 AA.
AC   P34446;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   22-NOV-2017, entry version 142.
DE   RecName: Full=Integrin alpha pat-2;
DE   AltName: Full=Paralyzed arrest at two-fold protein 2;
DE   Flags: Precursor;
GN   Name=pat-2; ORFNames=F54F2.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLY-441.
RX   PubMed=8106547; DOI=10.1083/jcb.124.4.475;
RA   Williams B.D., Waterston R.H.;
RT   "Genes critical for muscle development and function in Caenorhabditis
RT   elegans identified through lethal mutations.";
RL   J. Cell Biol. 124:475-490(1994).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=12915588; DOI=10.1242/jcs.00705;
RA   Cram E.J., Clark S.G., Schwarzbauer J.E.;
RT   "Talin loss-of-function uncovers roles in cell contractility and
RT   migration in C. elegans.";
RL   J. Cell Sci. 116:3871-3878(2003).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-108; ASN-228; ASN-290;
RP   ASN-608 AND ASN-819, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15888633; DOI=10.1093/glycob/cwi075;
RA   Fan X., She Y.-M., Bagshaw R.D., Callahan J.W., Schachter H.,
RA   Mahuran D.J.;
RT   "Identification of the hydrophobic glycoproteins of Caenorhabditis
RT   elegans.";
RL   Glycobiology 15:952-964(2005).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16495308; DOI=10.1242/dev.02300;
RA   Dixon S.J., Alexander M., Fernandes R., Ricker N., Roy P.J.;
RT   "FGF negatively regulates muscle membrane extension in Caenorhabditis
RT   elegans.";
RL   Development 133:1263-1275(2006).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=17606640; DOI=10.1101/gad.1534807;
RA   Meighan C.M., Schwarzbauer J.E.;
RT   "Control of C. elegans hermaphrodite gonad size and shape by vab-
RT   3/Pax6-mediated regulation of integrin receptors.";
RL   Genes Dev. 21:1615-1620(2007).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-108; ASN-228; ASN-608;
RP   ASN-679 AND ASN-819, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
RN   [9]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH DEP-1,
RP   AND DISRUPTION PHENOTYPE.
RX   PubMed=28135265; DOI=10.1371/journal.pgen.1006592;
RA   Walser M., Umbricht C.A., Froehli E., Nanni P., Hajnal A.;
RT   "beta-Integrin de-phosphorylation by the density-enhanced phosphatase
RT   DEP-1 attenuates EGFR signaling in C. elegans.";
RL   PLoS Genet. 13:E1006592-E1006592(2017).
CC   -!- FUNCTION: Required for muscle development probably through the
CC       regulation of the actin-myosin cytoskeleton (PubMed:8106547,
CC       PubMed:12915588). During the formation of neuromuscular junctions
CC       at the larval stage, negatively regulates membrane protrusion from
CC       body wall muscles, probably through lamins such as epi-1, lam-2
CC       and unc-52 (PubMed:16495308). Required for distal tip cell
CC       migration and dorsal pathfinding (PubMed:17606640). Required for
CC       egg-laying (PubMed:12915588). May play a role in cell motility and
CC       cell-cell interactions (By similarity). Plays a role in vulval
CC       development (PubMed:28135265). Probably within the alpha pat-
CC       2/beta pat-3 integrin receptor complex, plays a role in the
CC       negative regulation of let-23 signaling and vulval induction. This
CC       is probably partly by restricting the mobility of the let-23
CC       receptor on the plasma membrane of vulval cells which thereby
CC       attenuates let-23 signaling (PubMed:28135265).
CC       {ECO:0000250|UniProtKB:P53708, ECO:0000269|PubMed:12915588,
CC       ECO:0000269|PubMed:16495308, ECO:0000269|PubMed:17606640,
CC       ECO:0000269|PubMed:28135265, ECO:0000269|PubMed:8106547}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit (Probable).
CC       Interacts with beta subunit pat-3 (Probable). Interacts with dep-1
CC       (PubMed:28135265). {ECO:0000269|PubMed:28135265, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in body-wall muscle cells, distal
CC       tip cells, and vulval tissue. {ECO:0000269|PubMed:17606640}.
CC   -!- DEVELOPMENTAL STAGE: Up-regulated during L3 developmental stage in
CC       distal tip cells. {ECO:0000269|PubMed:17606640}.
CC   -!- DISRUPTION PHENOTYPE: Severe paralysis at the 1-fold stage of
CC       embryonic development followed by an arrest in elongation at 2-
CC       fold stage (PubMed:8106547). Loss of myosin and actin organization
CC       in embryonic body wall muscles and loss of muscle cell
CC       polarization (PubMed:8106547). RNAi-mediated knockdown in post-
CC       hatching animals causes paralysis associated with severe
CC       disorganization of body wall muscle actin filaments and defects in
CC       egg-laying associated with embryonic hatching within the mother
CC       (the bag of worms phenotype) (PubMed:12915588). Few surviving
CC       adults, are uncoordinated with abnormal body size and shape and
CC       have defects in distal tip cells (DTC) migration resulting in
CC       abnormal gonad formation (PubMed:17606640). RNAi-mediated
CC       knockdown in L4 larval stage, causes ectopic membrane extensions
CC       from body wall muscles (PubMed:16495308). RNAi-mediated knockdown
CC       in vulval precursor cells in a let-60 gain of function mutant
CC       background results in increased vulval induction and an adjacent
CC       primary fate (Apf) phenotype whereby secondary vulval precursor
CC       cells transform into primary-like vulval cells (PubMed:28135265).
CC       {ECO:0000269|PubMed:12915588, ECO:0000269|PubMed:16495308,
CC       ECO:0000269|PubMed:17606640, ECO:0000269|PubMed:28135265,
CC       ECO:0000269|PubMed:8106547}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO081385; CCD71234.1; -; Genomic_DNA.
DR   PIR; S44824; S44824.
DR   RefSeq; NP_498948.1; NM_066547.3.
DR   UniGene; Cel.10427; -.
DR   ProteinModelPortal; P34446; -.
DR   BioGrid; 41442; 2.
DR   STRING; 6239.F54F2.1; -.
DR   iPTMnet; P34446; -.
DR   EPD; P34446; -.
DR   PaxDb; P34446; -.
DR   PeptideAtlas; P34446; -.
DR   PRIDE; P34446; -.
DR   EnsemblMetazoa; F54F2.1; F54F2.1; WBGene00003929.
DR   GeneID; 176240; -.
DR   KEGG; cel:CELE_F54F2.1; -.
DR   UCSC; F54F2.1; c. elegans.
DR   CTD; 176240; -.
DR   WormBase; F54F2.1; CE00194; WBGene00003929; pat-2.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000115457; -.
DR   InParanoid; P34446; -.
DR   OMA; CRQIPFD; -.
DR   OrthoDB; EOG091G02JI; -.
DR   PhylomeDB; P34446; -.
DR   Reactome; R-CEL-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-CEL-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   SignaLink; P34446; -.
DR   PRO; PR:P34446; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00003929; -.
DR   GO; GO:0009986; C:cell surface; IDA:WormBase.
DR   GO; GO:0008305; C:integrin complex; ISS:WormBase.
DR   GO; GO:0031430; C:M band; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:WormBase.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:WormBase.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:1901076; P:positive regulation of engulfment of apoptotic cell; IMP:WormBase.
DR   GO; GO:0040017; P:positive regulation of locomotion; IMP:WormBase.
DR   GO; GO:0040028; P:regulation of vulval development; IGI:UniProtKB.
DR   GO; GO:0072327; P:vulval cell fate specification; IGI:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 4.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Complete proteome; Glycoprotein; Integrin; Membrane;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   1226       Integrin alpha pat-2.
FT                                /FTId=PRO_0000016332.
FT   TOPO_DOM     26   1154       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1155   1177       Helical. {ECO:0000255}.
FT   TOPO_DOM   1178   1226       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       27     94       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      108    171       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      178    233       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      234    290       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      291    345       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      362    421       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      425    488       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   MOTIF       620    622       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    228    228       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    290    290       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633}.
FT   CARBOHYD    608    608       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    679    679       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    775    775       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    819    819       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   MUTAGEN     441    441       G->D: In st567; severe paralysis at
FT                                embryonic 1-fold stage followed by an
FT                                arrest in elongation at 2-fold stage.
FT                                Loss of myosin and actin organization in
FT                                embryonic muscles.
FT                                {ECO:0000269|PubMed:8106547}.
SQ   SEQUENCE   1226 AA;  135940 MW;  B9169AD75B88901D CRC64;
     MREGSFPRRI GLLLGLLGLL AGVATFNIDT KNVVVHHMAG NYFGYSLDFY HEQKGMPVLV
     VGAPEAESNN PNLAGIRRPG AVYACSVNRA TCREVHVDKM KGNLKKLNGS HLVPIEEKSH
     QFFGATVRSN DKHDKIVVCA PKYTYFYSKF EVIEPVGTCF YAENGFDNAE EFSSCKQEPA
     RHGRHRLGYG QCGFSAAVPG KKNQNRVFIG APGVWYWQGA MFSQNIKNQT DRPNTEYGSK
     EYDHDMMGYS TATGDFDGDG IDDIVAGVPR GNDLHGKLVL YTSKLKMMIN LTDEVSTQHG
     QYCGGSVAVA DVNKDGRDDI IMGCPFYTDY GSVKDAKTQE RKPQYDVGKV IVMLQTAPGV
     FGKQIAVVGD DQWGRFGHAV AAAGDLNLDG YNDVIVGAPY AGKNKQGAVY VIHGSKDGVR
     ELPTQKIEGA NIGHGNIKSF GFSLTGNEDV DGNGMPDIAV GAWKSGNAAV LLTKPVVTVT
     GQTEPESALI SVEDKNCDVD GKLGKQACKH INTCFKYEGK GDTPNDLEFD LRFNLDDHSP
     EPRAYFLQKD VKSDRSIKVA QGSKTRDHPS SIEQRVRLEK GRQKCFRHRF FASSTMKDKL
     SPIHWSVNYT YVESKTGKLR GDKLEPAIDT TVPLSFQNKI NIANNCGKDD LCVPDLKVTA
     VADREKFLLG TQDNTMLINV TVQNGGEDSY ETKLYFDVPQ GFEYGGIESV GGDGSKSAPA
     CSPTSDEPDS DGKWTFACDL GNPLPANKVV SSVVRVTASS DKPPLAPISI NAHVNSSNDE
     EAHTVADNKV TFTIPVDFKN QLSLNGRSNP EQVDFSMTNK TRVDAFDDNE IGPVVSHLYQ
     ISNRGPSEVD SATLDIFWPS FSTEGGHLLY IITEPVVNPP NKGRCRVKQL QNVNPLNLRI
     TNEHVPTEPP VAKTPNEYSR EEDDESYEDE TTTQSQSTRH QSTQHQTHHQ SGPVHVYEKD
     EEKIRQNTGN WQYVEDKKKK GDYEYIPDDQ EYDGDDFEEE DDEDFDRAGS KRVKRNPTPK
     KKKKGGEHRG EPRSDKARFS DLREAVKLSK EAGGVVDYKG PLSRASVDCN SLRCTHIECD
     IYDLKEDEFV LVEIFSRLYT NTLVDEKNPG GDISSLALAR VTSTKYNLPH KPTLITAVST
     NMNAIASEEG RDLPWWLYLL AILIGLAILI LLILLLWRCG FFKRNRPPTE HAELRADRQP
     NAQYADSQSR YTSQDQYNQG RHGQML
//
ID   ITA1_RAT                Reviewed;        1180 AA.
AC   P18614;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   22-NOV-2017, entry version 157.
DE   RecName: Full=Integrin alpha-1;
DE   AltName: Full=CD49 antigen-like family member A;
DE   AltName: Full=Laminin and collagen receptor;
DE   AltName: Full=VLA-1;
DE   AltName: CD_antigen=CD49a;
DE   Flags: Precursor;
GN   Name=Itga1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2380249; DOI=10.1083/jcb.111.2.709;
RA   Ignatius M.J., Large T.H., Houde M., Tawil J.W., Barton A., Esch F.,
RA   Carbonetto S., Reichardt L.F.;
RT   "Molecular cloning of the rat integrin alpha 1-subunit: a receptor for
RT   laminin and collagen.";
RL   J. Cell Biol. 111:709-720(1990).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 151-364.
RX   PubMed=10386626; DOI=10.1016/S0014-5793(99)00666-3;
RA   Nolte M., Pepinsky R.B., Venyaminov S.Y., Koteliansky V.,
RA   Gotwals P.J., Karpusas M.;
RT   "Crystal structure of the alpha1beta1 integrin I-domain: insights into
RT   integrin I-domain function.";
RL   FEBS Lett. 452:379-385(1999).
CC   -!- FUNCTION: Integrin alpha-1/beta-1 is a receptor for laminin and
CC       collagen. It recognizes the proline-hydroxylated sequence G-F-P-G-
CC       E-R in collagen. Involved in anchorage-dependent, negative
CC       regulation of EGF-stimulated cell growth (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-1
CC       associates with beta-1 (By similarity). Interacts with RAB21 (By
CC       similarity). Interacts (via cytoplasmic domain) with PTPN2;
CC       activates PTPN2 phosphatase activity towards EGFR and negatively
CC       regulates EGF signaling (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52140; CAA36384.1; -; mRNA.
DR   PIR; A35854; A35854.
DR   RefSeq; NP_112256.1; NM_030994.2.
DR   UniGene; Rn.91044; -.
DR   PDB; 1CK4; X-ray; 2.20 A; A/B=167-364.
DR   PDB; 1MHP; X-ray; 2.80 A; A/B=169-360.
DR   PDB; 2B2X; X-ray; 2.20 A; A/B=151-364.
DR   PDBsum; 1CK4; -.
DR   PDBsum; 1MHP; -.
DR   PDBsum; 2B2X; -.
DR   ProteinModelPortal; P18614; -.
DR   SMR; P18614; -.
DR   CORUM; P18614; -.
DR   IntAct; P18614; 1.
DR   MINT; MINT-1889950; -.
DR   STRING; 10116.ENSRNOP00000016353; -.
DR   iPTMnet; P18614; -.
DR   PhosphoSitePlus; P18614; -.
DR   UniCarbKB; P18614; -.
DR   PaxDb; P18614; -.
DR   PRIDE; P18614; -.
DR   Ensembl; ENSRNOT00000086114; ENSRNOP00000074337; ENSRNOG00000053550.
DR   GeneID; 25118; -.
DR   KEGG; rno:25118; -.
DR   CTD; 3672; -.
DR   RGD; 2923; Itga1.
DR   eggNOG; ENOG410IPB7; Eukaryota.
DR   eggNOG; ENOG410YEM8; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000059610; -.
DR   HOVERGEN; HBG006185; -.
DR   InParanoid; P18614; -.
DR   KO; K06480; -.
DR   OMA; QRFSIAI; -.
DR   OrthoDB; EOG091G00TK; -.
DR   PhylomeDB; P18614; -.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-445355; Smooth Muscle Contraction.
DR   EvolutionaryTrace; P18614; -.
DR   PRO; PR:P18614; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000053550; -.
DR   Genevisible; P18614; RN.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:RGD.
DR   GO; GO:0045178; C:basal part of cell; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; ISO:RGD.
DR   GO; GO:0034665; C:integrin alpha1-beta1 complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005518; F:collagen binding; IMP:RGD.
DR   GO; GO:0098639; F:collagen binding involved in cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0005102; F:receptor binding; IPI:RGD.
DR   GO; GO:0000187; P:activation of MAPK activity; IMP:RGD.
DR   GO; GO:0007155; P:cell adhesion; ISO:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; IMP:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0045123; P:cellular extravasation; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IMP:RGD.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0042311; P:vasodilation; IMP:RGD.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Magnesium; Membrane;
KW   Metal-binding; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     28
FT   CHAIN        29   1180       Integrin alpha-1.
FT                                /FTId=PRO_0000016231.
FT   TOPO_DOM     29   1142       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1143   1165       Helical. {ECO:0000255}.
FT   TOPO_DOM   1166   1180       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       30     91       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      101    160       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      175    364       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      365    417       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      422    474       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      475    537       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      556    614       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      618    678       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     497    505       {ECO:0000255}.
FT   CA_BIND     579    587       {ECO:0000255}.
FT   CA_BIND     641    649       {ECO:0000255}.
FT   MOTIF      1168   1172       GFFKR motif.
FT   CARBOHYD    100    100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    112    112       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    217    217       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    317    317       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    402    402       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    418    418       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    459    459       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    531    531       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    698    698       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    747    747       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    779    779       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    820    820       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    839    839       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    882    882       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    907    907       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    938    938       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    965    965       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    973    973       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1007   1007       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1084   1084       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1103   1103       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1114   1114       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     82     92       {ECO:0000250}.
FT   DISULFID    687    696       {ECO:0000250}.
FT   DISULFID    702    755       {ECO:0000250}.
FT   DISULFID    807    813       {ECO:0000250}.
FT   DISULFID    877    885       {ECO:0000250}.
FT   DISULFID   1029   1062       {ECO:0000250}.
FT   DISULFID   1066   1073       {ECO:0000250}.
FT   STRAND      171    178       {ECO:0000244|PDB:1CK4}.
FT   HELIX       186    197       {ECO:0000244|PDB:1CK4}.
FT   STRAND      208    222       {ECO:0000244|PDB:1CK4}.
FT   TURN        224    226       {ECO:0000244|PDB:1CK4}.
FT   HELIX       230    238       {ECO:0000244|PDB:1CK4}.
FT   HELIX       250    259       {ECO:0000244|PDB:1CK4}.
FT   TURN        260    262       {ECO:0000244|PDB:1MHP}.
FT   HELIX       264    266       {ECO:0000244|PDB:1CK4}.
FT   STRAND      273    282       {ECO:0000244|PDB:1CK4}.
FT   HELIX       287    289       {ECO:0000244|PDB:1CK4}.
FT   HELIX       290    299       {ECO:0000244|PDB:1CK4}.
FT   STRAND      302    309       {ECO:0000244|PDB:1CK4}.
FT   HELIX       311    315       {ECO:0000244|PDB:1CK4}.
FT   HELIX       321    328       {ECO:0000244|PDB:1CK4}.
FT   HELIX       335    338       {ECO:0000244|PDB:1CK4}.
FT   STRAND      339    345       {ECO:0000244|PDB:1CK4}.
FT   HELIX       346    350       {ECO:0000244|PDB:1CK4}.
FT   HELIX       352    359       {ECO:0000244|PDB:1CK4}.
SQ   SEQUENCE   1180 AA;  130809 MW;  8E5DA2BE02362EE4 CRC64;
     MVPRRPASLE VTVACIWLLT VILGFCVSFN VDVKNSMSFS GPVEDMFGYT VQQYENEEGK
     WVLIGSPLVG QPKARTGDVY KCPVGRERAM PCVKLDLPVN TSIPNVTEIK ENMTFGSTLV
     TNPNGGFLAC GPLYAYRCGH LHYTTGICSD VSPTFQVVNS FAPVQECSTQ LDIVIVLDGS
     NSIYPWESVI AFLNDLLKRM DIGPKQTQVG IVQYGENVTH EFNLNKYSST EEVLVAANKI
     GRQGGLQTMT ALGIDTARKE AFTEARGARR GVKKVMVIVT DGESHDNYRL KQVIQDCEDE
     NIQRFSIAIL GHYNRGNLST EKFVEEIKSI ASEPTEKHFF NVSDELALVT IVKALGERIF
     ALEATADQSA ASFEMEMSQT GFSAHYSQDW VMLGAVGAYD WNGTVVMQKA NQMVIPHNTT
     FQTEPAKMNE PLASYLGYTV NSATIPGDVL YIAGQPRYNH TGQVVIYKME DGNINILQTL
     GGEQIGSYFG SVLTTIDIDK DSYTDLLLVG APMYMGTEKE EQGKVYVYAV NQTRFEYQMS
     LEPIRQTCCS SLKDNSCTKE NKNEPCGARF GTAIAAVKDL NVDGFNDVVI GAPLEDDHAG
     AVYIYHGSGK TIREAYAQRI PSGGDGKTLK FFGQSIHGEM DLNGDGLTDV TIGGLGGAAL
     FWARDVAVVK VTMNFEPNKV NIQKKNCRVE GKETVCINAT MCFHVKLKSK EDSIYEADLQ
     YRVTLDSLRQ ISRSFFSGTQ ERKIQRNITV RESECIRHSF YMLDKHDFQD SVRVTLDFNL
     TDPENGPVLD DALPNSVHEH IPFAKDCGNK ERCISDLTLN VSTTEKSLLI VKSQHDKFNV
     SLTVKNKGDS AYNTRTVVQH SPNLIFSGIE EIQKDSCESN QNITCRVGYP FLRAGETVTF
     KIIFQFNTSH LSENAIIHLS ATSDSEEPLE SLNDNEVNIS IPVKYEVGLQ FYSSASEHHI
     SVAANETIPE FINSTEDIGN EINVFYTIRK RGHFPMPELQ LSISFPNLTA DGYPVLYPIG
     WSSSDNVNCR PRSLEDPFGI NSGKKMTISK SEVLKRGTIQ DCSSTCGVAT ITCSLLPSDL
     SQVNVSLLLW KPTFIRAHFS SLNLTLRGEL KSENSSLTLS SSNRKRELAI QISKDGLPGR
     VPLWVILLSA FAGLLLLMLL ILALWKIGFF KRPLKKKMEK
//
ID   INA1_CAEEL              Reviewed;        1139 AA.
AC   Q03600;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   22-NOV-2017, entry version 136.
DE   RecName: Full=Integrin alpha ina-1;
DE   Flags: Precursor;
GN   Name=ina-1; ORFNames=F54G8.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND INTERACTION WITH
RP   PAT-3.
RX   PubMed=9247263; DOI=10.1016/S0896-6273(00)80347-5;
RA   Baum P.D., Garriga G.;
RT   "Neuronal migrations and axon fasciculation are disrupted in ina-1
RT   integrin mutants.";
RL   Neuron 19:51-62(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7906398; DOI=10.1038/368032a0;
RA   Wilson R., Ainscough R., Anderson K., Baynes C., Berks M.,
RA   Bonfield J., Burton J., Connell M., Copsey T., Cooper J., Coulson A.,
RA   Craxton M., Dear S., Du Z., Durbin R., Favello A., Fraser A.,
RA   Fulton L., Gardner A., Green P., Hawkins T., Hillier L., Jier M.,
RA   Johnston L., Jones M., Kershaw J., Kirsten J., Laisster N.,
RA   Latreille P., Lightning J., Lloyd C., Mortimore B., O'Callaghan M.,
RA   Parsons J., Percy C., Rifken L., Roopra A., Saunders D., Shownkeen R.,
RA   Sims M., Smaldon N., Smith A., Smith M., Sonnhammer E., Staden R.,
RA   Sulston J., Thierry-Mieg J., Thomas K., Vaudin M., Vaughan K.,
RA   Waterston R., Watson A., Weinstock L., Wilkinson-Sproat J.,
RA   Wohldman P.;
RT   "2.2 Mb of contiguous nucleotide sequence from chromosome III of C.
RT   elegans.";
RL   Nature 368:32-38(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-788, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=15888633; DOI=10.1093/glycob/cwi075;
RA   Fan X., She Y.-M., Bagshaw R.D., Callahan J.W., Schachter H.,
RA   Mahuran D.J.;
RT   "Identification of the hydrophobic glycoproteins of Caenorhabditis
RT   elegans.";
RL   Glycobiology 15:952-964(2005).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-108; ASN-580; ASN-788;
RP   ASN-851 AND ASN-1026, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19023419; DOI=10.1371/journal.pgen.1000269;
RA   Lucanic M., Cheng H.J.;
RT   "A RAC/CDC-42-independent GIT/PIX/PAK signaling pathway mediates cell
RT   migration in C. elegans.";
RL   PLoS Genet. 4:E1000269-E1000269(2008).
RN   [7]
RP   FUNCTION, INTERACTION WITH SRC-1, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=20226672; DOI=10.1016/j.cub.2010.01.062;
RA   Hsu T.Y., Wu Y.C.;
RT   "Engulfment of apoptotic cells in C. elegans is mediated by integrin
RT   alpha/SRC signaling.";
RL   Curr. Biol. 20:477-486(2010).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22732572; DOI=10.1016/j.ydbio.2012.06.011;
RA   Martynovsky M., Wong M.C., Byrd D.T., Kimble J., Schwarzbauer J.E.;
RT   "mig-38, a novel gene that regulates distal tip cell turning during
RT   gonadogenesis in C. elegans hermaphrodites.";
RL   Dev. Biol. 368:404-414(2012).
RN   [9]
RP   FUNCTION.
RX   PubMed=25373777; DOI=10.1016/j.devcel.2014.08.008;
RA   Mentink R.A., Middelkoop T.C., Rella L., Ji N., Tang C.Y.,
RA   Betist M.C., van Oudenaarden A., Korswagen H.C.;
RT   "Cell intrinsic modulation of Wnt signaling controls neuroblast
RT   migration in C. elegans.";
RL   Dev. Cell 31:188-201(2014).
CC   -!- FUNCTION: Plays a role in cell migration, axon fasciculation, and
CC       morphogenesis (PubMed:9247263). During gonad morphogenesis,
CC       involved in distal tip cells (DTC)-mediated guidance of gonad
CC       elongation, in maintaining their sharp tapering morphology and in
CC       their migration (PubMed:19023419, PubMed:22732572). Involved in
CC       the anterior-posterior positioning of QR neuroblast descendants by
CC       regulating the migratory speed of QR.p (PubMed:25373777). Probably
CC       by acting as a receptor for apoptotic cells, plays a role in the
CC       clearance of apoptotic cells during mid-embryogenesis
CC       (PubMed:20226672). {ECO:0000269|PubMed:19023419,
CC       ECO:0000269|PubMed:20226672, ECO:0000269|PubMed:22732572,
CC       ECO:0000269|PubMed:25373777, ECO:0000269|PubMed:9247263}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha ina-1
CC       associates with beta pat-3 (PubMed:9247263). Interacts (via
CC       cytoplasmic domain) with src-1 (when phosphorylated at 'Tyr-416')
CC       (PubMed:20226672). {ECO:0000269|PubMed:20226672,
CC       ECO:0000269|PubMed:9247263}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:20226672};
CC       Single-pass type I membrane protein {ECO:0000250}. Cell
CC       projection, phagocytic cup {ECO:0000269|PubMed:20226672}.
CC       Cytoplasmic vesicle, phagosome membrane
CC       {ECO:0000269|PubMed:20226672}. Note=Enriched at the cell contact
CC       with apototic cells and in phagocytic pseudopods during apoptotic
CC       cell engulfment. Co-localizes with src-1 during phagosome cup
CC       formation. {ECO:0000269|PubMed:20226672}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown in distal tip cell
CC       (DTC) causes DTC morphological and guidance defects such as
CC       precocious dorsal turns, a failure to reach the vulva and a
CC       bloated distal gonad (PubMed:19023419). Embryos at the comma, 1.5-
CC       fold and 2-fold stages have increased number of cell corpses due
CC       to a defect in cell engulfment (PubMed:20226672). RNAi-mediated
CC       knockdown with mig-38 results in enhanced gonad DTC migration
CC       (PubMed:22732572). {ECO:0000269|PubMed:19023419,
CC       ECO:0000269|PubMed:20226672, ECO:0000269|PubMed:22732572}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z19155; CAA79561.1; -; Genomic_DNA.
DR   PIR; S28277; S28277.
DR   RefSeq; NP_499032.1; NM_066631.4.
DR   UniGene; Cel.17710; -.
DR   ProteinModelPortal; Q03600; -.
DR   STRING; 6239.F54G8.3.1; -.
DR   iPTMnet; Q03600; -.
DR   EPD; Q03600; -.
DR   PaxDb; Q03600; -.
DR   PeptideAtlas; Q03600; -.
DR   PRIDE; Q03600; -.
DR   EnsemblMetazoa; F54G8.3; F54G8.3; WBGene00002081.
DR   GeneID; 176296; -.
DR   KEGG; cel:CELE_F54G8.3; -.
DR   UCSC; F54G8.3; c. elegans.
DR   CTD; 176296; -.
DR   WormBase; F54G8.3; CE00205; WBGene00002081; ina-1.
DR   eggNOG; ENOG410IPBB; Eukaryota.
DR   eggNOG; ENOG410XVGZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000018098; -.
DR   InParanoid; Q03600; -.
DR   OMA; YVYINQQ; -.
DR   OrthoDB; EOG091G02JI; -.
DR   PhylomeDB; Q03600; -.
DR   Reactome; R-CEL-3000157; Laminin interactions.
DR   Reactome; R-CEL-446107; Type I hemidesmosome assembly.
DR   SignaLink; Q03600; -.
DR   PRO; PR:Q03600; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00002081; -.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0008305; C:integrin complex; IPI:WormBase.
DR   GO; GO:0016020; C:membrane; IDA:WormBase.
DR   GO; GO:0001891; C:phagocytic cup; IDA:WormBase.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0043236; F:laminin binding; ISS:WormBase.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:WormBase.
DR   GO; GO:0009887; P:animal organ morphogenesis; IMP:WormBase.
DR   GO; GO:0007413; P:axonal fasciculation; IMP:WormBase.
DR   GO; GO:0010171; P:body morphogenesis; IMP:WormBase.
DR   GO; GO:0033631; P:cell-cell adhesion mediated by integrin; IMP:WormBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0008078; P:mesodermal cell migration; IMP:WormBase.
DR   GO; GO:0002119; P:nematode larval development; IMP:WormBase.
DR   GO; GO:0045138; P:nematode male tail tip morphogenesis; IMP:WormBase.
DR   GO; GO:0001764; P:neuron migration; IMP:WormBase.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 4.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell projection; Complete proteome;
KW   Cytoplasmic vesicle; Glycoprotein; Integrin; Membrane; Neurogenesis;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   1139       Integrin alpha ina-1.
FT                                /FTId=PRO_0000016331.
FT   TOPO_DOM     20   1084       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1085   1106       Helical. {ECO:0000255}.
FT   TOPO_DOM   1107   1139       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       21     85       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      111    171       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      180    231       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      242    302       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      307    370       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      378    438       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      448    510       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    136    136       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    313    313       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    580    580       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    788    788       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    851    851       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD   1026   1026       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
SQ   SEQUENCE   1139 AA;  127767 MW;  C9AE2C6B97493B8E CRC64;
     MRECIISWTL LLCLSCVKSF NLDVNAPIYR YGPSGTNFGY SVAEHFKGDK PVMLIGAPRG
     ESGQTGTERA GAMYACDINT FYNGGSNHWC EQVRFEYENV EDYAKRPNET RGRTVHPLGK
     NDQLLASTIV SKGTKNGSAL VCAPLIRYHQ TAAYPQGACY ELESNLRLQS TYATCAQKNL
     PTTDRHNEYG GCMEGFSAAI TQDTIVTGLI GAVKWTGGVF AKKSSANIFD SVVEKYTMNQ
     PNGDMIRTRL VAHDYLGYSV DIGRFGFWYE DGKPITVVSG ATRYGEHGAV IFLPFIQDSS
     SKLTLNEDKF IINGTAMGSA FGYSIEVVDL NGDGFDDLIV GAPFEHRSGI DGNFGGIVYV
     YFSQGVQRKQ HESHLVFHPP KILKNPDFYS QFGLSITKLG NVDGDKSKLN DFAVGAPFAF
     DGAGAVYIYL GTKNIEKFRK KPAQVIKGND LPNLPPGGMR SFGFSLSGGS DMDENGYPDL
     LIGSPSKNFV ALLRSRPVIS IETKHKMEKR MVDIDKGVNC PRGAKTCFPL DMVIYVDEET
     KRGAELVDFS SDVFMCNLEA IPFRADTTAR GFIEGSHSHN YSWPCGSNSH VQKRTYRQLI
     YLPVQESKDW ITPLKFRFTV SIRNEKKPVQ PPQGSQLVDL KHYPVLNKYG ASYEFDVPFN
     TLCGEDHTCQ TDLSLKAAFK DIPLTSNGYV SNVGEKDYLD LTFTVENKKE KAYQANFYLE
     YNEEELELPQ VQGSKRMIAE TIGKNIVHLP LGNPMNGASK HQFTIQFKLT RGRTEGIGKA
     LKFMAHVNST SQETEEELKD NKWEAEVQII KKAELEIYGI SDPDRVFFGG KARAESELEL
     EEDIGTMVRH NYTIINHGPW TVRNVEAHIS WPYQLRSRFG RGKNALYLLD VPTITTEFTD
     GTSEVRKCFI KQQYEYVNPA EIKLNTKYST QETAPHRVEH RMKREIDEDE EEQSDDLGAV
     EENIPWFSTA NFWNLFAIKG GDGRPREVKH LSCQDNTANC FTVICHFDFI DANSAVVIDL
     RARLWNATFI EDYSDVESVK IRSFGKLQLD ESQGIDDDPN NNAAFVETSA DPDRPTIGDS
     RPIPWWIYVI AAVIGVLILS LIIICLSKCG FFKRNRLDQP SLYTAQLKHE REEWADTGL
//
ID   ITAD_MOUSE              Reviewed;        1168 AA.
AC   Q3V0T4;
DT   07-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   22-NOV-2017, entry version 84.
DE   RecName: Full=Integrin alpha-D;
DE   AltName: CD_antigen=CD11d;
DE   Flags: Precursor;
GN   Name=Itgad;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Integrin alpha-D/beta-2 is a receptor for ICAM3 and
CC       VCAM1. May play a role in the atherosclerotic process such as
CC       clearing lipoproteins from plaques and in phagocytosis of blood-
CC       borne pathogens, particulate matter, and senescent erythrocytes
CC       from the blood (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-D
CC       associates with beta-2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK132915; BAE21419.1; -; mRNA.
DR   UniGene; Mm.334257; -.
DR   ProteinModelPortal; Q3V0T4; -.
DR   SMR; Q3V0T4; -.
DR   STRING; 10090.ENSMUSP00000033051; -.
DR   iPTMnet; Q3V0T4; -.
DR   PhosphoSitePlus; Q3V0T4; -.
DR   MaxQB; Q3V0T4; -.
DR   PaxDb; Q3V0T4; -.
DR   PRIDE; Q3V0T4; -.
DR   Ensembl; ENSMUST00000106237; ENSMUSP00000101844; ENSMUSG00000070369.
DR   UCSC; uc009jyd.2; mouse.
DR   MGI; MGI:3578624; Itgad.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000113114; -.
DR   HOVERGEN; HBG100530; -.
DR   InParanoid; Q3V0T4; -.
DR   PhylomeDB; Q3V0T4; -.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   PRO; PR:Q3V0T4; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000070369; -.
DR   CleanEx; MM_ITGAD; -.
DR   ExpressionAtlas; Q3V0T4; baseline and differential.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050798; P:activated T cell proliferation; IMP:MGI.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; ISO:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Complete proteome; Disulfide bond;
KW   Glycoprotein; Integrin; Magnesium; Membrane; Metal-binding; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27   1168       Integrin alpha-D.
FT                                /FTId=PRO_0000045902.
FT   TOPO_DOM     27   1107       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1108   1128       Helical. {ECO:0000255}.
FT   TOPO_DOM   1129   1168       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       28     85       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       86    145       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      159    341       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      348    399       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      400    451       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      452    512       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      515    573       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      578    638       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     474    482       {ECO:0000255}.
FT   CA_BIND     538    546       {ECO:0000255}.
FT   CA_BIND     601    609       {ECO:0000255}.
FT   MOTIF      1133   1137       GFFKR motif.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     96     96       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    400    400       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    703    703       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    741    741       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    791    791       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    943    943       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1052   1052       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1077   1077       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     76     83       {ECO:0000250}.
FT   DISULFID    115    133       {ECO:0000250}.
FT   DISULFID    663    718       {ECO:0000250}.
FT   DISULFID    776    782       {ECO:0000250}.
FT   DISULFID    852    867       {ECO:0000250}.
FT   DISULFID   1000   1024       {ECO:0000250}.
FT   DISULFID   1029   1034       {ECO:0000250}.
SQ   SEQUENCE   1168 AA;  127829 MW;  15FCDF2618AD05C3 CRC64;
     MVFKTIWIER YRKLINLFRA LASCHGSNLD VEKPVVFKED AASFGQTVVQ FGGSRLVVGA
     PLEAVAVNQT GQLYDCAPAT GVCQPILLHI PLEAVNMSLG LSLVADTNNS QLLACGPTAQ
     RACAKNMYAK GSCLLLGSSL QFIQAIPATM PECPGQEMDI AFLIDGSGSI DQSDFTQMKD
     FVKALMGQLA STSTSFSLMQ YSNILKTHFT FTEFKSSLSP QSLVDAIVQL QGLTYTASGI
     QKVVKELFHS KNGARKSAKK ILIVITDGQK FRDPLEYRHV IPEAEKAGII RYAIGVGDAF
     REPTALQELN TIGSAPSQDH VFKVGNFVAL RSIQRQIQEK IFAIEGTESR SSSSFQHEMS
     QEGFSSALSM DGPVLGAVGS FSWSGGAFLY PSNMRSTFIN MSQENEDMRD AYLGYSTALA
     FWKGVHSLIL GAPRHQHTGK VVIFTQESRH WRPKSEVRGT QIGSYFGASL CSVDMDRDGS
     TDLVLIGVPH YYEHTRGGQV SVCPMPGVRS RWHCGTTLHG EQGHPWGRFG AALTVLGDVN
     GDSLADVAIG APGEEENRGA VYIFHGASRQ DIAPSPSQRV TGSQLFLRLQ YFGQSLSGGQ
     DLTQDGLVDL AVGAQGHVLL LRSLPLLKVG ISIRFAPSEV AKTVYQCWGR TPTVLEAGEA
     TVCLTVRKGS PDLLGDVQSS VRYDLALDPG RLISRAIFDE TKNCTLTRRK TLGLGDHCET
     MKLLLPDCVE DAVTPIILRL NLSLAGDSAP SRNLRPVLAV GSQDHVTASF PFEKNCKQEL
     LCEGNLGVSF NFSGLQVLEV GSSPELTVTV TVWNEGEDSY GTLIKFYYPA ELSYRRVTRA
     QQPHPYPLRL ACEAEPTGQE SLRSSSCSIN HPIFREGAKA TFMITFDVSY KAFLGDRLLL
     RASASSENNK PETSKTAFQL ELPVKYTVYT VISRQEDSTK HFNFSSSHGE RQKEAEHRYR
     VNNLSPLTLA ISVNFWVPIL LNGVAVWDVT LRSPAQGVSC VSQREPPQHS DLLTQIQGRS
     VLDCAIADCL HLRCDIPSLG TLDELDFILK GNLSFGWISQ TLQKKVLLLS EAEITFNTSV
     YSQLPGQEAF LRAQVSTMLE EYVVYEPVFL MVFSSVGGLL LLALITVALY KLGFFKRQYK
     EMLDLPSADP DPAGQADSNH ETPPHLTS
//
ID   ITAM_HUMAN              Reviewed;        1152 AA.
AC   P11215; Q4VAK0; Q4VAK1; Q4VAK2;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   20-DEC-2017, entry version 200.
DE   RecName: Full=Integrin alpha-M;
DE   AltName: Full=CD11 antigen-like family member B;
DE   AltName: Full=CR-3 alpha chain;
DE   AltName: Full=Cell surface glycoprotein MAC-1 subunit alpha;
DE   AltName: Full=Leukocyte adhesion receptor MO1;
DE   AltName: Full=Neutrophil adherence receptor;
DE   AltName: CD_antigen=CD11b;
DE   Flags: Precursor;
GN   Name=ITGAM; Synonyms=CD11B, CR3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=2457584;
RA   Corbi A.L., Kishimoto T.K., Miller L.J., Springer T.A.;
RT   "The human leukocyte adhesion glycoprotein Mac-1 (complement receptor
RT   type 3, CD11b) alpha subunit. Cloning, primary structure, and relation
RT   to the integrins, von Willebrand factor and factor B.";
RL   J. Biol. Chem. 263:12403-12411(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2833753; DOI=10.1073/pnas.85.8.2776;
RA   Arnaout M.A., Remold-O'Donnell E., Pierce M.W., Harris P., Tenen D.G.;
RT   "Molecular cloning of the alpha subunit of human and guinea pig
RT   leukocyte adhesion glycoprotein Mo1: chromosomal localization and
RT   homology to the alpha subunits of integrins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2776-2780(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2454931; DOI=10.1083/jcb.106.6.2153;
RA   Arnaout M.A., Gupta S.K., Pierce M.W., Tenen D.G.;
RT   "Amino acid sequence of the alpha subunit of human leukocyte adhesion
RT   receptor Mo1 (complement receptor type 3).";
RL   J. Cell Biol. 106:2153-2158(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=8419480;
RA   Fleming J.C., Pahl H.L., Gonzalez D.A., Smith T.F., Tenen D.G.;
RT   "Structural analysis of the CD11b gene and phylogenetic analysis of
RT   the alpha-integrin gene family demonstrate remarkable conservation of
RT   genomic organization and suggest early diversification during
RT   evolution.";
RL   J. Immunol. 150:480-490(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   HIS-77; THR-441; VAL-858 AND SER-1146.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-1152 (ISOFORM 2).
RX   PubMed=2563162; DOI=10.1073/pnas.86.1.257;
RA   Hickstein D.D., Hickey M.J., Ozols J., Baker D.M., Back A.L.,
RA   Roth G.J.;
RT   "cDNA sequence for the alpha M subunit of the human neutrophil
RT   adherence receptor indicates homology to integrin alpha subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:257-261(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9, AND TISSUE SPECIFICITY.
RX   PubMed=1683702; DOI=10.1073/pnas.88.23.10525;
RA   Shelley C.S., Arnaout M.A.;
RT   "The promoter of the CD11b gene directs myeloid-specific and
RT   developmentally regulated expression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10525-10529(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RC   TISSUE=Blood;
RX   PubMed=1346576;
RA   Pahl H.L., Rosmarin A.G., Tenen D.G.;
RT   "Characterization of the myeloid-specific CD11b promoter.";
RL   Blood 79:865-870(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 17-31.
RX   PubMed=3539202; DOI=10.1016/0167-4838(86)90037-3;
RA   Pierce M.W., Remold-O'Donnell E., Todd R.F. III, Arnaout M.A.;
RT   "N-terminal sequence of human leukocyte glycoprotein Mo1: conservation
RT   across species and homology to platelet IIb/IIIa.";
RL   Biochim. Biophys. Acta 874:368-371(1986).
RN   [10]
RP   INTERACTION WITH JAM3.
RX   PubMed=12208882; DOI=10.1084/jem.20020267;
RA   Santoso S., Sachs U.J.H., Kroll H., Linder M., Ruf A., Preissner K.T.,
RA   Chavakis T.;
RT   "The junctional adhesion molecule 3 (JAM-3) on human platelets is a
RT   counterreceptor for the leukocyte integrin Mac-1.";
RL   J. Exp. Med. 196:679-691(2002).
RN   [11]
RP   INTERACTION WITH JAM3.
RX   PubMed=15194813; DOI=10.1091/mbc.E04-04-0317;
RA   Zen K., Babbin B.A., Liu Y., Whelan J.B., Nusrat A., Parkos C.A.;
RT   "JAM-C is a component of desmosomes and a ligand for CD11b/CD18-
RT   mediated neutrophil transepithelial migration.";
RL   Mol. Biol. Cell 15:3926-3937(2004).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-900; ASN-940 AND ASN-946.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH CD177 AND ITGB2,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=21193407; DOI=10.1074/jbc.M110.171256;
RA   Jerke U., Rolle S., Dittmar G., Bayat B., Santoso S., Sporbert A.,
RA   Luft F., Kettritz R.;
RT   "Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-
RT   ANCA neutrophil activation.";
RL   J. Biol. Chem. 286:7070-7081(2011).
RN   [14]
RP   INTERACTION WITH THBD.
RX   PubMed=27055590; DOI=10.1016/j.bbrc.2016.04.007;
RA   Kawamoto E., Okamoto T., Takagi Y., Honda G., Suzuki K., Imai H.,
RA   Shimaoka M.;
RT   "LFA-1 and Mac-1 integrins bind to the serine/threonine-rich domain of
RT   thrombomodulin.";
RL   Biochem. Biophys. Res. Commun. 473:1005-1012(2016).
RN   [15]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH CD177 AND ITGB2,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=28807980; DOI=10.1182/blood-2017-03-768507;
RA   Bai M., Grieshaber-Bouyer R., Wang J., Schmider A.B., Wilson Z.S.,
RA   Zeng L., Halyabar O., Godin M.D., Nguyen H.N., Levescot A., Cunin P.,
RA   Lefort C.T., Soberman R.J., Nigrovic P.A.;
RT   "CD177 modulates human neutrophil migration through activation-
RT   mediated integrin and chemoreceptor regulation.";
RL   Blood 0:0-0(2017).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 148-331.
RX   PubMed=7867070; DOI=10.1016/0092-8674(95)90517-0;
RA   Lee J.O., Rieu P., Arnaout M.A., Liddington R.;
RT   "Crystal structure of the A domain from the alpha subunit of integrin
RT   CR3 (CD11b/CD18).";
RL   Cell 80:631-638(1995).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 148-334.
RX   PubMed=8747460; DOI=10.1016/S0969-2126(01)00271-4;
RA   Lee J.O., Bankston L.A., Arnaout M.A., Liddington R.C.;
RT   "Two conformations of the integrin A-domain (I-domain): a pathway for
RT   activation?";
RL   Structure 3:1333-1340(1995).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 148-337.
RX   PubMed=9687375; DOI=10.1016/S0969-2126(98)00093-8;
RA   Baldwin E.T., Sarver R.W., Bryant G.L. Jr., Curry K.A.,
RA   Fairbanks M.B., Finzel B.C., Garlick R.L., Heinrikson R.L.,
RA   Horton N.C., Kelley L.L., Mildner A.M., Moon J.B., Mott J.E.,
RA   Mutchler V.T., Tomich C.S., Watenpaugh K.D., Wiley V.H.;
RT   "Cation binding to the integrin CD11b I domain and activation model
RT   assessment.";
RL   Structure 6:923-935(1998).
RN   [19]
RP   3D-STRUCTURE MODELING OF 17-616.
RX   PubMed=9560195; DOI=10.1073/pnas.95.9.4870;
RA   Oxvig C., Springer T.A.;
RT   "Experimental support for a beta-propeller domain in integrin alpha-
RT   subunits and a calcium binding site on its lower surface.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:4870-4875(1998).
RN   [20]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO SLEB6, AND VARIANT HIS-77.
RX   PubMed=18204448; DOI=10.1038/ng.71;
RA   Nath S.K., Han S., Kim-Howard X., Kelly J.A., Viswanathan P.,
RA   Gilkeson G.S., Chen W., Zhu C., McEver R.P., Kimberly R.P.,
RA   Alarcon-Riquelme M.E., Vyse T.J., Li Q.-Z., Wakeland E.K.,
RA   Merrill J.T., James J.A., Kaufman K.M., Guthridge J.M., Harley J.B.;
RT   "A nonsynonymous functional variant in integrin-alpha(M) (encoded by
RT   ITGAM) is associated with systemic lupus erythematosus.";
RL   Nat. Genet. 40:152-154(2008).
RN   [21]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO SLEB6.
RX   PubMed=18204446; DOI=10.1038/ng.81;
RA   Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O.,
RA   Kimberly R.P., Moser K.L., Tsao B.P., Vyse T.J., Langefeld C.D.,
RA   Nath S.K., Guthridge J.M., Cobb B.L., Mirel D.B., Marion M.C.,
RA   Williams A.H., Divers J., Wang W., Frank S.G., Namjou B.,
RA   Gabriel S.B., Lee A.T., Gregersen P.K., Behrens T.W., Taylor K.E.,
RA   Fernando M., Zidovetzki R., Gaffney P.M., Edberg J.C., Rioux J.D.,
RA   Ojwang J.O., James J.A., Merrill J.T., Gilkeson G.S., Seldin M.F.,
RA   Yin H., Baechler E.C., Li Q.-Z., Wakeland E.K., Bruner G.R.,
RA   Kaufman K.M., Kelly J.A.;
RT   "Genome-wide association scan in women with systemic lupus
RT   erythematosus identifies susceptibility variants in ITGAM, PXK,
RT   KIAA1542 and other loci.";
RL   Nat. Genet. 40:204-210(2008).
CC   -!- FUNCTION: Integrin ITGAM/ITGB2 is implicated in various adhesive
CC       interactions of monocytes, macrophages and granulocytes as well as
CC       in mediating the uptake of complement-coated particles. It is
CC       identical with CR-3, the receptor for the iC3b fragment of the
CC       third complement component. It probably recognizes the R-G-D
CC       peptide in C3b. Integrin ITGAM/ITGB2 is also a receptor for
CC       fibrinogen, factor X and ICAM1. It recognizes P1 and P2 peptides
CC       of fibrinogen gamma chain. Regulates neutrophil migration
CC       (PubMed:28807980). In association with beta subunit ITGB2/CD18,
CC       required for CD177-PRTN3-mediated activation of TNF primed
CC       neutrophils (PubMed:21193407). May regulate phagocytosis-induced
CC       apoptosis in extravasated neutrophils (By similarity). May play a
CC       role in mast cell development (By similarity).
CC       {ECO:0000250|UniProtKB:P05555, ECO:0000269|PubMed:21193407,
CC       ECO:0000269|PubMed:28807980, ECO:0000305}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. ITGAM
CC       associates with ITGB2. Found in a complex with CD177 and
CC       ITGB2/CD18 (PubMed:21193407). Interacts with JAM3
CC       (PubMed:15194813, PubMed:12208882). Interacts with THBD
CC       (PubMed:27055590). {ECO:0000269|PubMed:12208882,
CC       ECO:0000269|PubMed:15194813, ECO:0000269|PubMed:21193407,
CC       ECO:0000269|PubMed:27055590}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21193407};
CC       Single-pass type I membrane protein {ECO:0000305}. Membrane raft
CC       {ECO:0000269|PubMed:21193407}; Single-pass type I membrane protein
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11215-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11215-2; Sequence=VSP_047365;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in monocytes and
CC       granulocytes (PubMed:1346576). Expressed in neutrophils (at
CC       protein level) (PubMed:21193407). {ECO:0000269|PubMed:1346576,
CC       ECO:0000269|PubMed:21193407}.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- DISEASE: Systemic lupus erythematosus 6 (SLEB6) [MIM:609939]: A
CC       chronic, relapsing, inflammatory, and often febrile multisystemic
CC       disorder of connective tissue, characterized principally by
CC       involvement of the skin, joints, kidneys and serosal membranes. It
CC       is of unknown etiology, but is thought to represent a failure of
CC       the regulatory mechanisms of the autoimmune system. The disease is
CC       marked by a wide range of system dysfunctions, an elevated
CC       erythrocyte sedimentation rate, and the formation of LE cells in
CC       the blood or bone marrow. {ECO:0000269|PubMed:18204446,
CC       ECO:0000269|PubMed:18204448}. Note=Disease susceptibility may be
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03925; AAA59544.1; -; mRNA.
DR   EMBL; M18044; AAA59491.1; -; mRNA.
DR   EMBL; S52227; AAB24821.1; -; Genomic_DNA.
DR   EMBL; S52152; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52153; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52154; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52155; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52157; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52159; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52161; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52164; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52165; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52167; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52169; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52170; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52173; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52174; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52180; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52181; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52184; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52189; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52191; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52192; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52203; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52212; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52213; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52216; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52219; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52220; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52221; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52222; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; S52226; AAB24821.1; JOINED; Genomic_DNA.
DR   EMBL; BC096346; AAH96346.1; -; mRNA.
DR   EMBL; BC096347; AAH96347.1; -; mRNA.
DR   EMBL; BC096348; AAH96348.1; -; mRNA.
DR   EMBL; BC099660; AAH99660.1; -; mRNA.
DR   EMBL; J04145; AAA59903.1; -; mRNA.
DR   EMBL; M76724; AAA58410.1; -; Genomic_DNA.
DR   EMBL; M84477; AAA51960.1; -; Genomic_DNA.
DR   CCDS; CCDS45470.1; -. [P11215-1]
DR   CCDS; CCDS54004.1; -. [P11215-2]
DR   PIR; A31108; RWHU1B.
DR   RefSeq; NP_000623.2; NM_000632.3. [P11215-1]
DR   RefSeq; NP_001139280.1; NM_001145808.1. [P11215-2]
DR   UniGene; Hs.172631; -.
DR   PDB; 1A8X; Model; -; A=17-1152.
DR   PDB; 1BHO; X-ray; 2.70 A; 1/2=149-337.
DR   PDB; 1BHQ; X-ray; 2.70 A; 1/2=149-337.
DR   PDB; 1IDN; X-ray; 2.70 A; 1/2=149-337.
DR   PDB; 1IDO; X-ray; 1.70 A; A=143-331.
DR   PDB; 1JLM; X-ray; 2.00 A; A=143-334.
DR   PDB; 1M1U; X-ray; 2.30 A; A=139-331.
DR   PDB; 1MF7; X-ray; 1.25 A; A=144-333.
DR   PDB; 1N9Z; X-ray; 2.50 A; A=144-335.
DR   PDB; 1NA5; X-ray; 1.50 A; A=144-335.
DR   PDB; 2LKE; NMR; -; A=1129-1152.
DR   PDB; 2LKJ; NMR; -; A=1129-1152.
DR   PDB; 3Q3G; X-ray; 2.70 A; E/G/I/L=148-337.
DR   PDB; 3QA3; X-ray; 3.00 A; E/G/I/L=148-337.
DR   PDB; 4M76; X-ray; 2.80 A; B=143-337.
DR   PDB; 4XW2; X-ray; 2.00 A; A=145-337.
DR   PDBsum; 1A8X; -.
DR   PDBsum; 1BHO; -.
DR   PDBsum; 1BHQ; -.
DR   PDBsum; 1IDN; -.
DR   PDBsum; 1IDO; -.
DR   PDBsum; 1JLM; -.
DR   PDBsum; 1M1U; -.
DR   PDBsum; 1MF7; -.
DR   PDBsum; 1N9Z; -.
DR   PDBsum; 1NA5; -.
DR   PDBsum; 2LKE; -.
DR   PDBsum; 2LKJ; -.
DR   PDBsum; 3Q3G; -.
DR   PDBsum; 3QA3; -.
DR   PDBsum; 4M76; -.
DR   PDBsum; 4XW2; -.
DR   ProteinModelPortal; P11215; -.
DR   SMR; P11215; -.
DR   BioGrid; 109890; 9.
DR   CORUM; P11215; -.
DR   IntAct; P11215; 3.
DR   MINT; MINT-1489258; -.
DR   STRING; 9606.ENSP00000441691; -.
DR   BindingDB; P11215; -.
DR   ChEMBL; CHEMBL3826; -.
DR   iPTMnet; P11215; -.
DR   PhosphoSitePlus; P11215; -.
DR   BioMuta; ITGAM; -.
DR   DMDM; 1708572; -.
DR   EPD; P11215; -.
DR   MaxQB; P11215; -.
DR   PaxDb; P11215; -.
DR   PeptideAtlas; P11215; -.
DR   PRIDE; P11215; -.
DR   Ensembl; ENST00000287497; ENSP00000287497; ENSG00000169896. [P11215-1]
DR   Ensembl; ENST00000544665; ENSP00000441691; ENSG00000169896. [P11215-2]
DR   GeneID; 3684; -.
DR   KEGG; hsa:3684; -.
DR   UCSC; uc002ebq.4; human. [P11215-1]
DR   CTD; 3684; -.
DR   DisGeNET; 3684; -.
DR   EuPathDB; HostDB:ENSG00000169896.16; -.
DR   GeneCards; ITGAM; -.
DR   HGNC; HGNC:6149; ITGAM.
DR   HPA; CAB025091; -.
DR   HPA; CAB072870; -.
DR   HPA; HPA002274; -.
DR   MalaCards; ITGAM; -.
DR   MIM; 120980; gene.
DR   MIM; 609939; phenotype.
DR   neXtProt; NX_P11215; -.
DR   OpenTargets; ENSG00000169896; -.
DR   Orphanet; 536; Systemic lupus erythematosus.
DR   PharmGKB; PA29949; -.
DR   eggNOG; ENOG410IPBA; Eukaryota.
DR   eggNOG; ENOG410ZFBE; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000113114; -.
DR   HOVERGEN; HBG100530; -.
DR   InParanoid; P11215; -.
DR   KO; K06461; -.
DR   OMA; VTSENNM; -.
DR   OrthoDB; EOG091G01BZ; -.
DR   PhylomeDB; P11215; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-166016; Toll Like Receptor 4 (TLR4) Cascade.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P11215; -.
DR   SIGNOR; P11215; -.
DR   ChiTaRS; ITGAM; human.
DR   EvolutionaryTrace; P11215; -.
DR   GeneWiki; Integrin_alpha_M; -.
DR   GenomeRNAi; 3684; -.
DR   PRO; PR:P11215; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000169896; -.
DR   CleanEx; HS_ITGAM; -.
DR   ExpressionAtlas; P11215; baseline and differential.
DR   Genevisible; P11215; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; NAS:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0034688; C:integrin alphaM-beta2 complex; NAS:ARUK-UCL.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0001851; F:complement component C3b binding; ISS:ARUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:CAFA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; NAS:ARUK-UCL.
DR   GO; GO:0097242; P:amyloid-beta clearance; ISS:ARUK-UCL.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0098742; P:cell-cell adhesion via plasma-membrane adhesion molecules; NAS:ARUK-UCL.
DR   GO; GO:0010668; P:ectodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0001774; P:microglial cell activation; ISS:ARUK-UCL.
DR   GO; GO:0045963; P:negative regulation of dopamine metabolic process; ISS:ARUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006911; P:phagocytosis, engulfment; ISS:ARUK-UCL.
DR   GO; GO:1903980; P:positive regulation of microglial cell activation; ISS:ARUK-UCL.
DR   GO; GO:1901216; P:positive regulation of neuron death; ISS:ARUK-UCL.
DR   GO; GO:0043315; P:positive regulation of neutrophil degranulation; IGI:UniProtKB.
DR   GO; GO:2000363; P:positive regulation of prostaglandin-E synthase activity; ISS:ARUK-UCL.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; ISS:ARUK-UCL.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IGI:UniProtKB.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunity; Innate immunity; Integrin;
KW   Magnesium; Membrane; Metal-binding; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Systemic lupus erythematosus;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     16       {ECO:0000269|PubMed:3539202}.
FT   CHAIN        17   1152       Integrin alpha-M.
FT                                /FTId=PRO_0000016289.
FT   TOPO_DOM     17   1104       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1105   1128       Helical. {ECO:0000255}.
FT   TOPO_DOM   1129   1152       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       18     75       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       76    135       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      150    328       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      339    390       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      391    442       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      443    503       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      506    564       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      569    629       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     465    473       {ECO:0000255}.
FT   CA_BIND     529    537       {ECO:0000255}.
FT   CA_BIND     592    600       {ECO:0000255}.
FT   MOTIF      1131   1135       GFFKR motif.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    240    240       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    391    391       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    469    469       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    692    692       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    696    696       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    734    734       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    801    801       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    880    880       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    900    900       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    911    911       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    940    940       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    946    946       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    978    978       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    993    993       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1021   1021       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1044   1044       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1050   1050       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1075   1075       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     66     73       {ECO:0000250}.
FT   DISULFID    105    123       {ECO:0000250}.
FT   DISULFID    654    711       {ECO:0000250}.
FT   DISULFID    770    776       {ECO:0000250}.
FT   DISULFID    847    864       {ECO:0000250}.
FT   DISULFID    998   1022       {ECO:0000250}.
FT   DISULFID   1027   1032       {ECO:0000250}.
FT   VAR_SEQ     499    499       G -> GQ (in isoform 2).
FT                                {ECO:0000303|PubMed:2457584,
FT                                ECO:0000303|PubMed:2563162}.
FT                                /FTId=VSP_047365.
FT   VARIANT      77     77       R -> H (influences susceptibility to SLE;
FT                                dbSNP:rs1143679).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18204448}.
FT                                /FTId=VAR_043870.
FT   VARIANT     441    441       M -> T (in dbSNP:rs1143680).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_043871.
FT   VARIANT     858    858       A -> V (in dbSNP:rs1143683).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_043872.
FT   VARIANT    1146   1146       P -> S (in dbSNP:rs1143678).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_043873.
FT   CONFLICT    965    965       L -> P (in Ref. 2; AAA59491).
FT                                {ECO:0000305}.
FT   STRAND      149    156       {ECO:0000244|PDB:1MF7}.
FT   HELIX       163    180       {ECO:0000244|PDB:1MF7}.
FT   STRAND      185    200       {ECO:0000244|PDB:1MF7}.
FT   HELIX       202    207       {ECO:0000244|PDB:1MF7}.
FT   HELIX       211    215       {ECO:0000244|PDB:1MF7}.
FT   HELIX       227    236       {ECO:0000244|PDB:1MF7}.
FT   TURN        237    239       {ECO:0000244|PDB:1MF7}.
FT   HELIX       241    243       {ECO:0000244|PDB:1MF7}.
FT   STRAND      249    259       {ECO:0000244|PDB:1MF7}.
FT   HELIX       268    270       {ECO:0000244|PDB:1MF7}.
FT   HELIX       272    277       {ECO:0000244|PDB:1MF7}.
FT   STRAND      280    288       {ECO:0000244|PDB:1MF7}.
FT   HELIX       289    291       {ECO:0000244|PDB:1MF7}.
FT   HELIX       294    303       {ECO:0000244|PDB:1MF7}.
FT   HELIX       308    311       {ECO:0000244|PDB:1MF7}.
FT   STRAND      312    317       {ECO:0000244|PDB:1MF7}.
FT   HELIX       318    324       {ECO:0000244|PDB:1MF7}.
FT   HELIX       325    333       {ECO:0000244|PDB:1MF7}.
FT   HELIX      1130   1132       {ECO:0000244|PDB:2LKE}.
FT   HELIX      1133   1143       {ECO:0000244|PDB:2LKE}.
FT   STRAND     1147   1149       {ECO:0000244|PDB:2LKE}.
SQ   SEQUENCE   1152 AA;  127179 MW;  DF77408ED5EE25F9 CRC64;
     MALRVLLLTA LTLCHGFNLD TENAMTFQEN ARGFGQSVVQ LQGSRVVVGA PQEIVAANQR
     GSLYQCDYST GSCEPIRLQV PVEAVNMSLG LSLAATTSPP QLLACGPTVH QTCSENTYVK
     GLCFLFGSNL RQQPQKFPEA LRGCPQEDSD IAFLIDGSGS IIPHDFRRMK EFVSTVMEQL
     KKSKTLFSLM QYSEEFRIHF TFKEFQNNPN PRSLVKPITQ LLGRTHTATG IRKVVRELFN
     ITNGARKNAF KILVVITDGE KFGDPLGYED VIPEADREGV IRYVIGVGDA FRSEKSRQEL
     NTIASKPPRD HVFQVNNFEA LKTIQNQLRE KIFAIEGTQT GSSSSFEHEM SQEGFSAAIT
     SNGPLLSTVG SYDWAGGVFL YTSKEKSTFI NMTRVDSDMN DAYLGYAAAI ILRNRVQSLV
     LGAPRYQHIG LVAMFRQNTG MWESNANVKG TQIGAYFGAS LCSVDVDSNG STDLVLIGAP
     HYYEQTRGGQ VSVCPLPRGR ARWQCDAVLY GEQGQPWGRF GAALTVLGDV NGDKLTDVAI
     GAPGEEDNRG AVYLFHGTSG SGISPSHSQR IAGSKLSPRL QYFGQSLSGG QDLTMDGLVD
     LTVGAQGHVL LLRSQPVLRV KAIMEFNPRE VARNVFECND QVVKGKEAGE VRVCLHVQKS
     TRDRLREGQI QSVVTYDLAL DSGRPHSRAV FNETKNSTRR QTQVLGLTQT CETLKLQLPN
     CIEDPVSPIV LRLNFSLVGT PLSAFGNLRP VLAEDAQRLF TALFPFEKNC GNDNICQDDL
     SITFSFMSLD CLVVGGPREF NVTVTVRNDG EDSYRTQVTF FFPLDLSYRK VSTLQNQRSQ
     RSWRLACESA SSTEVSGALK STSCSINHPI FPENSEVTFN ITFDVDSKAS LGNKLLLKAN
     VTSENNMPRT NKTEFQLELP VKYAVYMVVT SHGVSTKYLN FTASENTSRV MQHQYQVSNL
     GQRSLPISLV FLVPVRLNQT VIWDRPQVTF SENLSSTCHT KERLPSHSDF LAELRKAPVV
     NCSIAVCQRI QCDIPFFGIQ EEFNATLKGN LSFDWYIKTS HNHLLIVSTA EILFNDSVFT
     LLPGQGAFVR SQTETKVEPF EVPNPLPLIV GSSVGGLLLL ALITAALYKL GFFKRQYKDM
     MSEGGPPGAE PQ
//
ID   ITA2B_HUMAN             Reviewed;        1039 AA.
AC   P08514; B2RCY8; O95366; Q14443; Q17R67;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 3.
DT   20-DEC-2017, entry version 223.
DE   RecName: Full=Integrin alpha-IIb;
DE   AltName: Full=GPalpha IIb;
DE            Short=GPIIb;
DE   AltName: Full=Platelet membrane glycoprotein IIb;
DE   AltName: CD_antigen=CD41;
DE   Contains:
DE     RecName: Full=Integrin alpha-IIb heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-IIb light chain, form 1;
DE   Contains:
DE     RecName: Full=Integrin alpha-IIb light chain, form 2;
DE   Flags: Precursor;
GN   Name=ITGA2B; Synonyms=GP2B, ITGAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-313.
RX   PubMed=2439501;
RA   Poncz M., Eisman R., Heidenreich R., Silver S.M., Vilaire G.,
RA   Surrey S., Schwartz E., Bennett J.S.;
RT   "Structure of the platelet membrane glycoprotein IIb. Homology to the
RT   alpha subunits of the vitronectin and fibronectin membrane
RT   receptors.";
RL   J. Biol. Chem. 262:8476-8482(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-313.
RX   PubMed=2345548; DOI=10.1007/BF00422712;
RA   Frachet P., Uzan G., Thevenon D., Denarier E., Prandini M.H.,
RA   Marguerie G.;
RT   "GPIIb and GPIIIa amino acid sequences deduced from human
RT   megakaryocyte cDNAs.";
RL   Mol. Biol. Rep. 14:27-33(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2322558; DOI=10.1021/bi00457a020;
RA   Heidenreich R., Eisman R., Surrey S., Delgrosso K., Bennett J.S.,
RA   Schwartz E., Poncz M.;
RT   "Organization of the gene for platelet glycoprotein IIb.";
RL   Biochemistry 29:1232-1244(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-62 AND 1021-1039.
RX   PubMed=2845986; DOI=10.1016/S0006-291X(88)80884-2;
RA   Prandini M.H., Denarier E., Frachet P., Uzan G., Marguerie G.;
RT   "Isolation of the human platelet glycoprotein IIb gene and
RT   characterization of the 5' flanking region.";
RL   Biochem. Biophys. Res. Commun. 156:595-601(1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 32-56 AND 903-917.
RX   PubMed=3534886; DOI=10.1073/pnas.83.21.8351;
RA   Charo I.F., Fitzgerald L.A., Steiner B., Rall S.C., Bekeart L.S.,
RA   Phillips D.R.;
RT   "Platelet glycoproteins IIb and IIIa: evidence for a family of
RT   immunologically and structurally related glycoproteins in mammalian
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:8351-8355(1986).
RN   [9]
RP   PROTEIN SEQUENCE OF 32-42.
RX   PubMed=1953640; DOI=10.1042/bj2790419;
RA   Catimel B., Parmentier S., Leung L.L., McGregor J.L.;
RT   "Separation of important new platelet glycoproteins (GPIa, GPIc,
RT   GPIc*, GPIIa and GMP-140) by F.P.L.C. Characterization by monoclonal
RT   antibodies and gas-phase sequencing.";
RL   Biochem. J. 279:419-425(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 32 AND 872.
RX   PubMed=8620874; DOI=10.1111/j.1432-1033.1996.0205n.x;
RA   Makogonenko E.M., Yakubenko V.P., Ingham K.C., Medved L.V.;
RT   "Thermal stability of individual domains in platelet glycoprotein
RT   IIbIIIa.";
RL   Eur. J. Biochem. 237:205-211(1996).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 392-1039 (ISOFORM 1).
RX   PubMed=3422188; DOI=10.1111/j.1432-1033.1988.tb13762.x;
RA   Uzan G., Frachet P., Lajmanovich A., Prandini M.-H., Denarier E.,
RA   Duperray A., Loftus J., Ginsberg M., Plow E., Marguerie G.;
RT   "cDNA clones for human platelet GPIIb corresponding to mRNA from
RT   megakaryocytes and HEL cells. Evidence for an extensive homology to
RT   other Arg-Gly-Asp adhesion receptors.";
RL   Eur. J. Biochem. 171:87-93(1988).
RN   [12]
RP   PROTEIN SEQUENCE OF 487-501 AND 1026-1038.
RX   PubMed=3801670;
RA   Hiraiwa A., Matsukage A., Shiku H., Takahashi T., Naito K., Yamada K.;
RT   "Purification and partial amino acid sequence of human platelet
RT   membrane glycoproteins IIb and IIIa.";
RL   Blood 69:560-564(1987).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 753-1039 (ISOFORM 3), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9809974;
RA   Trikha M., Cai Y., Grignon D., Honn K.V.;
RT   "Identification of a novel truncated alphaIIb integrin.";
RL   Cancer Res. 58:4771-4775(1998).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 868-1039 (ISOFORM 1).
RX   PubMed=3479442; DOI=10.1172/JCI113277;
RA   Bray P.F., Rosa J.P., Johnston G.I., Shiu D.T., Cook R.G., Lau C.,
RA   Kan Y.W., McEver R.P., Shuman M.A.;
RT   "Platelet glycoprotein IIb. Chromosomal localization and tissue
RT   expression.";
RL   J. Clin. Invest. 80:1812-1817(1987).
RN   [15]
RP   PROTEIN SEQUENCE OF 903-922 AND 934-939.
RX   PubMed=2476117; DOI=10.1042/bj2610551;
RA   Calvete J.J., Alvarez M.V., Rivas G., Hew C.L., Henschen A.,
RA   Gonzalez-Rodriguez J.;
RT   "Interchain and intrachain disulphide bonds in human platelet
RT   glycoprotein IIb. Localization of the epitopes for several monoclonal
RT   antibodies.";
RL   Biochem. J. 261:551-560(1989).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 938-997 (ISOFORMS 1 AND 2), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Erythroleukemia;
RX   PubMed=2351656;
RA   Bray P.F., Leung C.S.-I., Shuman M.A.;
RT   "Human platelets and megakaryocytes contain alternately spliced
RT   glycoprotein IIb mRNAs.";
RL   J. Biol. Chem. 265:9587-9590(1990).
RN   [17]
RP   PARTIAL PROTEIN SEQUENCE, DISULFIDE BONDS, AND GLYCOSYLATION AT
RP   ASN-46; ASN-280; ASN-601 AND ASN-711.
RX   PubMed=2775232; DOI=10.1042/bj2610561;
RA   Calvete J.J., Henschen A., Gonzalez-Rodriguez J.;
RT   "Complete localization of the intrachain disulphide bonds and the N-
RT   glycosylation points in the alpha-subunit of human platelet
RT   glycoprotein IIb.";
RL   Biochem. J. 261:561-568(1989).
RN   [18]
RP   PARTIAL PROTEIN SEQUENCE, AND GLYCOSYLATION AT SER-878.
RX   PubMed=7688323; DOI=10.1016/0014-5793(93)80959-X;
RA   Calvete J.J., Muniz-Diaz E.;
RT   "Localization of an O-glycosylation site in the alpha-subunit of the
RT   human platelet integrin GPIIb/IIIa involved in Baka (HPA-3a)
RT   alloantigen expression.";
RL   FEBS Lett. 328:30-34(1993).
RN   [19]
RP   PROTEOLYTIC CLEAVAGE, AND PYROGLUTAMATE FORMATION AT GLN-891.
RX   PubMed=2226834; DOI=10.1016/0014-5793(90)80443-M;
RA   Calvete J.J., Schafer W., Henschen A., Gonzalez-Rodriguez J.;
RT   "Characterization of the beta-chain N-terminus heterogeneity and the
RT   alpha-chain C-terminus of human platelet GPIIb. Posttranslational
RT   cleavage sites.";
RL   FEBS Lett. 272:37-40(1990).
RN   [20]
RP   INTERACTION WITH CIB1.
RC   TISSUE=Fetal liver;
RX   PubMed=9030514; DOI=10.1074/jbc.272.8.4651;
RA   Naik U.P., Patel P.M., Parise L.V.;
RT   "Identification of a novel calcium-binding protein that interacts with
RT   the integrin alphaIIb cytoplasmic domain.";
RL   J. Biol. Chem. 272:4651-4654(1997).
RN   [21]
RP   INTERACTION WITH CIB1.
RX   PubMed=10477286; DOI=10.1042/bj3420729;
RA   Shock D.D., Naik U.P., Brittain J.E., Alahari S.K., Sondek J.,
RA   Parise L.V.;
RT   "Calcium-dependent properties of CIB binding to the integrin alphaIIb
RT   cytoplasmic domain and translocation to the platelet cytoskeleton.";
RL   Biochem. J. 342:729-735(1999).
RN   [22]
RP   MUTAGENESIS OF 1029-PRO-PRO-1030.
RX   PubMed=10212286; DOI=10.1074/jbc.274.18.12945;
RA   Leisner T.M., Wencel-Drake J.D., Wang W., Lam S.C.;
RT   "Bidirectional transmembrane modulation of integrin alphaIIbbeta3
RT   conformations.";
RL   J. Biol. Chem. 274:12945-12949(1999).
RN   [23]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-601.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [24]
RP   INTERACTION WITH RNF181.
RX   PubMed=18331836; DOI=10.1016/j.bbrc.2008.02.142;
RA   Brophy T.M., Raab M., Daxecker H., Culligan K.G., Lehmann I.,
RA   Chubb A.J., Treumann A., Moran N.;
RT   "RN181, a novel ubiquitin E3 ligase that interacts with the KVGFFKR
RT   motif of platelet integrin alpha(IIb)beta3.";
RL   Biochem. Biophys. Res. Commun. 369:1088-1093(2008).
RN   [25]
RP   INTERACTION WITH CIB1.
RX   PubMed=21388953; DOI=10.1074/jbc.M110.179028;
RA   Huang H., Ishida H., Yamniuk A.P., Vogel H.J.;
RT   "Solution structures of Ca2+-CIB1 and Mg2+-CIB1 and their interactions
RT   with the platelet integrin alphaIIb cytoplasmic domain.";
RL   J. Biol. Chem. 286:17181-17192(2011).
RN   [26]
RP   INTERACTION WITH CIB1; CIB2; CIB3 AND CIB4.
RX   PubMed=22779914; DOI=10.1139/o2012-021;
RA   Huang H., Bogstie J.N., Vogel H.J.;
RT   "Biophysical and structural studies of the human calcium- and
RT   integrin-binding protein family: understanding their functional
RT   similarities and differences.";
RL   Biochem. Cell Biol. 90:646-656(2012).
RN   [27]
RP   INTERACTION WITH CIB1.
RX   PubMed=22283712; DOI=10.1021/ja2111306;
RA   Huang H., Vogel H.J.;
RT   "Structural basis for the activation of platelet integrin
RT   alphaIIbbeta3 by calcium- and integrin-binding protein 1.";
RL   J. Am. Chem. Soc. 134:3864-3872(2012).
RN   [28]
RP   REVIEW ON GT VARIANTS.
RX   PubMed=7878622;
RA   Bray P.F.;
RT   "Inherited diseases of platelet glycoproteins: considerations for
RT   rapid molecular characterization.";
RL   Thromb. Haemost. 72:492-502(1994).
RN   [29]
RP   VARIANT HPA-3 (BAK).
RX   PubMed=2350579;
RA   Lyman S., Aster R.H., Visentin G.P., Newman P.J.;
RT   "Polymorphism of human platelet membrane glycoprotein IIb associated
RT   with the Baka/Bakb alloantigen system.";
RL   Blood 75:2343-2348(1990).
RN   [30]
RP   VARIANT GT ASP-273.
RX   PubMed=8282784; DOI=10.1172/JCI116942;
RA   Poncz M., Rifat S., Coller B.S., Newman P.J., Shattil S.J.,
RA   Parrella T., Fortina P., Bennett J.S.;
RT   "Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation
RT   adjacent to the first calcium-binding domain of platelet glycoprotein
RT   IIb.";
RL   J. Clin. Invest. 93:172-179(1994).
RN   [31]
RP   VARIANT GT ASP-449.
RX   PubMed=7508443;
RA   Wilcox D.A., Wautier J.-L., Pidard D., Newman P.J.;
RT   "A single amino acid substitution flanking the fourth calcium binding
RT   domain of alpha IIb prevents maturation of the alpha IIb beta 3
RT   integrin complex.";
RL   J. Biol. Chem. 269:4450-4457(1994).
RN   [32]
RP   VARIANT GT HIS-358.
RX   PubMed=7706461; DOI=10.1172/JCI117828;
RA   Wilcox D.A., Paddock C.M., Lyman S., Gill J.C., Newman P.J.;
RT   "Glanzmann thrombasthenia resulting from a single amino acid
RT   substitution between the second and third calcium-binding domains of
RT   GPIIb. Role of the GPIIb amino terminus in integrin subunit
RT   association.";
RL   J. Clin. Invest. 95:1553-1560(1995).
RN   [33]
RP   VARIANT GT VAL-456-457-ASP DEL, AND CHARACTERIZATION OF VARIANT GT
RP   VAL-456-457-ASP DEL.
RX   PubMed=8704171;
RA   Basani R.B., Vilaire G., Shattil S.J., Kolodziej M.A., Bennett J.S.,
RA   Poncz M.;
RT   "Glanzmann thrombasthenia due to a two amino acid deletion in the
RT   fourth calcium-binding domain of alpha IIb: demonstration of the
RT   importance of calcium-binding domains in the conformation of alpha IIb
RT   beta 3.";
RL   Blood 88:167-173(1996).
RN   [34]
RP   VARIANTS GT ILE-207; THR-596 AND GLN-1026.
RX   PubMed=9215749; DOI=10.1006/bcmd.1997.0117;
RA   French D.L., Coller B.S.;
RT   "Hematologically important mutations: Glanzmann thrombasthenia.";
RL   Blood Cells Mol. Dis. 23:39-51(1997).
RN   [35]
RP   VARIANT GT PRO-214, AND CHARACTERIZATION OF VARIANT GT PRO-214.
RX   PubMed=9473221;
RA   Grimaldi C.M., Chen F., Wu C., Weiss H.J., Coller B.S., French D.L.;
RT   "Glycoprotein IIb Leu214Pro mutation produces Glanzmann thrombasthenia
RT   with both quantitative and qualitative abnormalities in GPIIb/IIIa.";
RL   Blood 91:1562-1571(1998).
RN   [36]
RP   VARIANT GT PRO-778.
RX   PubMed=9763559;
RA   Tadokoro S., Tomiyama Y., Honda S., Arai M., Yamamoto N., Shiraga M.,
RA   Kosugi S., Kanakura Y., Kurata Y., Matsuzawa Y.;
RT   "A Gln747-->Pro substitution in the IIb subunit is responsible for a
RT   moderate IIbbeta3 deficiency in Glanzmann thrombasthenia.";
RL   Blood 92:2750-2758(1998).
RN   [37]
RP   VARIANT BDPLT16 GLN-1026, AND CHARACTERIZATION OF VARIANT BDPLT16
RP   GLN-1026.
RX   PubMed=9834222;
RA   Peyruchaud O., Nurden A.T., Milet S., Macchi L., Pannochia A.,
RA   Bray P.F., Kieffer N., Bourre F.;
RT   "R to Q amino acid substitution in the GFFKR sequence of the
RT   cytoplasmic domain of the integrin IIb subunit in a patient with a
RT   Glanzmann's thrombasthenia-like syndrome.";
RL   Blood 92:4178-4187(1998).
RN   [38]
RP   VARIANTS GT SER-320; LYS-355 AND PRO-778.
RX   PubMed=9722314; DOI=10.1046/j.1365-2141.1998.00824.x;
RA   Ambo H., Kamata T., Handa M., Kawai Y., Oda A., Murata M., Takada Y.,
RA   Ikeda Y.;
RT   "Novel point mutations in the alphaIIb subunit (Phe289-->Ser,
RT   Glu324-->Lys and Gln747-->Pro) causing thrombasthenic phenotypes in
RT   four Japanese patients.";
RL   Br. J. Haematol. 102:829-840(1998).
RN   [39]
RP   VARIANTS GT LYS-355 AND THR-596.
RX   PubMed=9734640; DOI=10.1046/j.1365-2141.1998.00852.x;
RA   Ruan J., Peyruchaud O., Alberio L., Valles G., Clemetson K.,
RA   Bourre F., Nurden A.T.;
RT   "Double heterozygosity of the GPIIb gene in a Swiss patient with
RT   Glanzmann's thrombasthenia.";
RL   Br. J. Haematol. 102:918-925(1998).
RN   [40]
RP   VARIANTS ILE-40; SER-874 AND ASN-968, AND POLYMORPHISM.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [41]
RP   VARIANT GT ARG-705, AND CHARACTERIZATION OF VARIANT GT ARG-705.
RX   PubMed=9920835;
RA   Gonzalez-Manchon C., Fernandez-Pinel M., Arias-Salgado E.G.,
RA   Ferrer M., Alvarez M.-V., Garcia-Munoz S., Ayuso M.S., Parrilla R.;
RT   "Molecular genetic analysis of a compound heterozygote for the
RT   glycoprotein (GP) IIb gene associated with Glanzmann's thrombasthenia:
RT   disruption of the 674-687 disulfide bridge in GPIIb prevents surface
RT   exposure of GPIIb-IIIa complexes.";
RL   Blood 93:866-875(1999).
RN   [42]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [43]
RP   VARIANTS GT ALA-176 AND LEU-176.
RX   PubMed=10607701;
RA   Basani R.B., French D.L., Vilaire G., Brown D.L., Chen F.,
RA   Coller B.S., Derrick J.M., Gartner T.K., Bennett J.S., Poncz M.;
RT   "A naturally occurring mutation near the amino terminus of alphaIIb
RT   defines a new region involved in ligand binding to alphaIIbbeta3.";
RL   Blood 95:180-188(2000).
RN   [44]
RP   VARIANTS GT TRP-161; LEU-222; ARG-412 AND PRO-847.
RX   PubMed=11798398; DOI=10.1080/095371001317126383;
RA   Vinciguerra C., Bordet J.C., Beaune G., Grenier C., Dechavanne M.,
RA   Negrier C.;
RT   "Description of 10 new mutations in platelet glycoprotein IIb
RT   (alphaIIb) and glycoprotein IIIa (beta3) genes.";
RL   Platelets 12:486-495(2001).
RN   [45]
RP   VARIANT GT PRO-86, AND CHARACTERIZATION OF VARIANT GT PRO-86.
RX   PubMed=12181054; DOI=10.1046/j.1365-2141.2002.03678.x;
RA   Tanaka S., Hayashi T., Hori Y., Terada C., Han K.S., Ahn H.S.,
RA   Bourre F., Tani Y.;
RT   "A Leu55 to Pro substitution in the integrin alphaIIb is responsible
RT   for a case of Glanzmann's thrombasthenia.";
RL   Br. J. Haematol. 118:833-835(2002).
RN   [46]
RP   VARIANTS GT VAL-139; ALA-176; GLU-267; ASP-380; THR-405; ASP-581;
RP   ARG-705; VAL-752 AND PRO-755.
RX   PubMed=12083483;
RA   D'Andrea G., Colaizzo D., Vecchione G., Grandone E., Di Minno G.,
RA   Margaglione M.;
RT   "Glanzmann's thrombasthenia: identification of 19 new mutations in 30
RT   patients.";
RL   Thromb. Haemost. 87:1034-1042(2002).
RN   [47]
RP   VARIANTS GT PHE-329 AND THR-405, AND CHARACTERIZATION OF VARIANTS GT
RP   PHE-329 AND THR-405.
RX   PubMed=12424194; DOI=10.1182/blood-2002-07-2266;
RA   Mitchell W.B., Li J.H., Singh F., Michelson A.D., Bussel J.,
RA   Coller B.S., French D.L.;
RT   "Two novel mutations in the alpha IIb calcium-binding domains identify
RT   hydrophobic regions essential for alpha IIbbeta 3 biogenesis.";
RL   Blood 101:2268-2276(2003).
RN   [48]
RP   VARIANT GT HIS-174, AND CHARACTERIZATION OF VARIANT GT HIS-174.
RX   PubMed=12506038; DOI=10.1182/blood-2002-07-2144;
RA   Kiyoi T., Tomiyama Y., Honda S., Tadokoro S., Arai M., Kashiwagi H.,
RA   Kosugi S., Kato H., Kurata Y., Matsuzawa Y.;
RT   "A naturally occurring Tyr143His alpha IIb mutation abolishes alpha
RT   IIb beta 3 function for soluble ligands but retains its ability for
RT   mediating cell adhesion and clot retraction: comparison with other
RT   mutations causing ligand-binding defects.";
RL   Blood 101:3485-3491(2003).
RN   [49]
RP   VARIANT GT MET-982, CHARACTERIZATION OF VARIANT GT MET-982, AND
RP   VARIANT THR-989.
RX   PubMed=15099289; DOI=10.1046/j.1538-7836.2004.00711.x;
RA   Nurden A.T., Breillat C., Jacquelin B., Combrie R., Freedman J.,
RA   Blanchette V.S., Schmugge M., Rand M.L.;
RT   "Triple heterozygosity in the integrin alphaIIb subunit in a patient
RT   with Glanzmann's thrombasthenia.";
RL   J. Thromb. Haemost. 2:813-819(2004).
RN   [50]
RP   VARIANT GT CYS-202, AND CHARACTERIZATION OF VARIANT GT CYS-202.
RX   PubMed=15219201; DOI=10.1111/j.1538-7836.2004.00758.x;
RA   Rosenberg N., Landau M., Luboshitz J., Rechavi G., Seligsohn U.;
RT   "A novel Phe171Cys mutation in integrin alpha causes Glanzmann
RT   thrombasthenia by abrogating alphaIIbbeta3 complex formation.";
RL   J. Thromb. Haemost. 2:1167-1175(2004).
RN   [51]
RP   VARIANT GT LEU-943, AND CHARACTERIZATION OF VARIANT GT LEU-943.
RX   PubMed=17018384;
RA   Jayo A., Pabon D., Lastres P., Jimenez-Yuste V., Gonzalez-Manchon C.;
RT   "Type II Glanzmann thrombasthenia in a compound heterozygote for the
RT   alpha IIb gene. A novel missense mutation in exon 27.";
RL   Haematologica 91:1352-1359(2006).
RN   [52]
RP   VARIANTS GT THR-405; THR-596; ARG-705; PRO-778; PHE-934; LEU-957;
RP   MET-982 AND THR-989, AND CHARACTERIZATION OF VARIANTS GT PHE-934 AND
RP   LEU-957.
RX   PubMed=20020534; DOI=10.1002/humu.21179;
RA   Jallu V., Dusseaux M., Panzer S., Torchet M.F., Hezard N.,
RA   Goudemand J., de Brevern A.G., Kaplan C.;
RT   "AlphaIIbbeta3 integrin: new allelic variants in Glanzmann
RT   thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression,
RT   and structure-function.";
RL   Hum. Mutat. 31:237-246(2010).
RN   [53]
RP   VARIANT BDPLT16 TRP-1026, AND CHARACTERIZATION OF VARIANT BDPLT16
RP   TRP-1026.
RX   PubMed=21454453; DOI=10.1182/blood-2010-12-323691;
RA   Kunishima S., Kashiwagi H., Otsu M., Takayama N., Eto K., Onodera M.,
RA   Miyajima Y., Takamatsu Y., Suzumiya J., Matsubara K., Tomiyama Y.,
RA   Saito H.;
RT   "Heterozygous ITGA2B R995W mutation inducing constitutive activation
RT   of the alphaIIbbeta3 receptor affects proplatelet formation and causes
RT   congenital macrothrombocytopenia.";
RL   Blood 117:5479-5484(2011).
CC   -!- FUNCTION: Integrin alpha-IIb/beta-3 is a receptor for fibronectin,
CC       fibrinogen, plasminogen, prothrombin, thrombospondin and
CC       vitronectin. It recognizes the sequence R-G-D in a wide array of
CC       ligands. It recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in
CC       fibrinogen gamma chain. Following activation integrin alpha-
CC       IIb/beta-3 brings about platelet/platelet interaction through
CC       binding of soluble fibrinogen. This step leads to rapid platelet
CC       aggregation which physically plugs ruptured endothelial cell
CC       surface.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-IIb associates with beta-3. Directly
CC       interacts with RNF181. Interacts (via C-terminus cytoplasmic tail
CC       region) with CIB1; the interaction is direct and calcium-
CC       dependent. Interacts (via C-terminus cytoplasmic tail region) with
CC       CIB2, CIB3 and CIB4; the interactions are stabilized/increased in
CC       a calcium and magnesium-dependent manner.
CC       {ECO:0000269|PubMed:10477286, ECO:0000269|PubMed:18331836,
CC       ECO:0000269|PubMed:21388953, ECO:0000269|PubMed:22283712,
CC       ECO:0000269|PubMed:22779914, ECO:0000269|PubMed:9030514}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-702693, EBI-702693;
CC       P21333:FLNA; NbExp=3; IntAct=EBI-15805658, EBI-350432;
CC       P05106:ITGB3; NbExp=11; IntAct=EBI-702693, EBI-702847;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P08514-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P08514-2; Sequence=VSP_002737;
CC       Name=3; Synonyms=tr-alpha-IIb {ECO:0000303|PubMed:9809974};
CC         IsoId=P08514-3; Sequence=VSP_002736;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in
CC       platelets and megakaryocytes, but not in reticulocytes. Not
CC       detected in Jurkat, nor in U937 cell lines (PubMed:2351656).
CC       Isoform 3 is expressed in prostate adenocarcinoma, as well as in
CC       several erythroleukemia, prostate adenocarcinoma and melanoma cell
CC       lines, including PC-3, DU-145, HEL, WM983A, WM983B and WM35. Not
CC       detected in platelets, nor in normal prostate (at protein level)
CC       (PubMed:9809974). {ECO:0000269|PubMed:2351656,
CC       ECO:0000269|PubMed:9809974}.
CC   -!- POLYMORPHISM: Position 874 is associated with platelet-specific
CC       alloantigen HPA-3/BAK/LEK. HPA-3A/BAK(A)/LEK(A) has Ile-874 and
CC       HPA-3B/BAK(B)/LEK(B) has Ser-874. HPA-3B is involved in neonatal
CC       alloimmune thrombocytopenia (NAIT or NATP).
CC       {ECO:0000269|PubMed:10391209}.
CC   -!- DISEASE: Glanzmann thrombasthenia (GT) [MIM:273800]: A common
CC       inherited disease of platelet aggregation. It is characterized by
CC       mucocutaneous bleeding of mild-to-moderate severity. GT has been
CC       classified clinically into types I and II. In type I, platelets
CC       show absence of the glycoprotein IIb-IIIa complexes at their
CC       surface and lack fibrinogen and clot retraction capability. In
CC       type II, the platelets express the GPIIb-IIIa complex at reduced
CC       levels, have detectable amounts of fibrinogen, and have low or
CC       moderate clot retraction capability. {ECO:0000269|PubMed:10607701,
CC       ECO:0000269|PubMed:11798398, ECO:0000269|PubMed:12083483,
CC       ECO:0000269|PubMed:12181054, ECO:0000269|PubMed:12424194,
CC       ECO:0000269|PubMed:12506038, ECO:0000269|PubMed:15099289,
CC       ECO:0000269|PubMed:15219201, ECO:0000269|PubMed:17018384,
CC       ECO:0000269|PubMed:20020534, ECO:0000269|PubMed:7508443,
CC       ECO:0000269|PubMed:7706461, ECO:0000269|PubMed:8282784,
CC       ECO:0000269|PubMed:8704171, ECO:0000269|PubMed:9215749,
CC       ECO:0000269|PubMed:9473221, ECO:0000269|PubMed:9722314,
CC       ECO:0000269|PubMed:9734640, ECO:0000269|PubMed:9763559,
CC       ECO:0000269|PubMed:9920835}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Bleeding disorder, platelet-type 16 (BDPLT16)
CC       [MIM:187800]: An autosomal dominant form of congenital
CC       macrothrombocytopenia associated with platelet anisocytosis. It is
CC       a disorder of platelet production. Affected individuals may have
CC       no or only mildly increased bleeding tendency. In vitro studies
CC       show mild platelet functional abnormalities.
CC       {ECO:0000269|PubMed:21454453, ECO:0000269|PubMed:9834222}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02764; AAA60114.1; -; mRNA.
DR   EMBL; M34480; AAA35926.1; -; mRNA.
DR   EMBL; M34344; AAA53150.1; -; Genomic_DNA.
DR   EMBL; M33319; AAA53150.1; JOINED; Genomic_DNA.
DR   EMBL; M33320; AAA53150.1; JOINED; Genomic_DNA.
DR   EMBL; AK315335; BAG37735.1; -; mRNA.
DR   EMBL; AC003043; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC117443; AAI17444.1; -; mRNA.
DR   EMBL; BC126442; AAI26443.1; -; mRNA.
DR   EMBL; M22568; AAA52587.1; -; Genomic_DNA.
DR   EMBL; M22569; AAA52588.1; -; Genomic_DNA.
DR   EMBL; X06831; CAA29987.1; -; mRNA.
DR   EMBL; AF098114; AAC98507.1; -; mRNA.
DR   EMBL; M18085; AAA52597.1; -; mRNA.
DR   EMBL; M54799; AAA52599.1; -; Genomic_DNA.
DR   CCDS; CCDS32665.1; -. [P08514-1]
DR   PIR; A34269; A34269.
DR   RefSeq; NP_000410.2; NM_000419.4. [P08514-1]
DR   RefSeq; XP_011523051.1; XM_011524749.1. [P08514-2]
DR   UniGene; Hs.411312; -.
DR   PDB; 1DPK; NMR; -; A=1020-1039.
DR   PDB; 1DPQ; NMR; -; A=1020-1039.
DR   PDB; 1JX5; Model; -; A=32-483.
DR   PDB; 1KUP; NMR; -; A=1018-1028.
DR   PDB; 1KUZ; NMR; -; A=1018-1028.
DR   PDB; 1M8O; NMR; -; A=1020-1039.
DR   PDB; 1RN0; Model; -; A=32-482.
DR   PDB; 1S4W; NMR; -; A=1020-1039.
DR   PDB; 1TYE; X-ray; 2.90 A; A/C/E=32-483.
DR   PDB; 1UV9; Model; -; A=32-973.
DR   PDB; 2K1A; NMR; -; A=989-1029.
DR   PDB; 2K9J; NMR; -; A=989-1029.
DR   PDB; 2KNC; NMR; -; A=991-1039.
DR   PDB; 2MTP; NMR; -; B=1019-1039.
DR   PDB; 2N9Y; NMR; -; A=989-1029.
DR   PDB; 2VC2; X-ray; 3.10 A; A=32-483.
DR   PDB; 2VDK; X-ray; 2.80 A; A=32-483.
DR   PDB; 2VDL; X-ray; 2.75 A; A=32-483.
DR   PDB; 2VDM; X-ray; 2.90 A; A=32-483.
DR   PDB; 2VDN; X-ray; 2.90 A; A=32-483.
DR   PDB; 2VDO; X-ray; 2.51 A; A=32-483.
DR   PDB; 2VDP; X-ray; 2.80 A; A=32-483.
DR   PDB; 2VDQ; X-ray; 2.59 A; A=32-483.
DR   PDB; 2VDR; X-ray; 2.40 A; A=32-483.
DR   PDB; 3FCS; X-ray; 2.55 A; A/C=32-989.
DR   PDB; 3FCU; X-ray; 2.90 A; A/C/E=32-488.
DR   PDB; 3NID; X-ray; 2.30 A; A/C=32-488.
DR   PDB; 3NIF; X-ray; 2.40 A; A/C=32-488.
DR   PDB; 3NIG; X-ray; 2.25 A; A/C=32-488.
DR   PDB; 3T3M; X-ray; 2.60 A; A/C=32-488.
DR   PDB; 3T3P; X-ray; 2.20 A; A/C=32-488.
DR   PDB; 3ZDX; X-ray; 2.45 A; A/C=32-488.
DR   PDB; 3ZDY; X-ray; 2.45 A; A/C=32-488.
DR   PDB; 3ZDZ; X-ray; 2.75 A; A/C=32-488.
DR   PDB; 3ZE0; X-ray; 2.95 A; A/C=32-488.
DR   PDB; 3ZE1; X-ray; 3.00 A; A/C=32-488.
DR   PDB; 3ZE2; X-ray; 2.35 A; A/C=32-488.
DR   PDB; 4CAK; EM; 20.50 A; A=32-989.
DR   PDB; 4Z7N; X-ray; 2.60 A; A/C=32-486.
DR   PDB; 4Z7O; X-ray; 2.85 A; A/C=32-486.
DR   PDB; 4Z7Q; X-ray; 2.70 A; A/C=32-485.
DR   PDB; 5HDB; X-ray; 2.70 A; A/C=32-485.
DR   PDBsum; 1DPK; -.
DR   PDBsum; 1DPQ; -.
DR   PDBsum; 1JX5; -.
DR   PDBsum; 1KUP; -.
DR   PDBsum; 1KUZ; -.
DR   PDBsum; 1M8O; -.
DR   PDBsum; 1RN0; -.
DR   PDBsum; 1S4W; -.
DR   PDBsum; 1TYE; -.
DR   PDBsum; 1UV9; -.
DR   PDBsum; 2K1A; -.
DR   PDBsum; 2K9J; -.
DR   PDBsum; 2KNC; -.
DR   PDBsum; 2MTP; -.
DR   PDBsum; 2N9Y; -.
DR   PDBsum; 2VC2; -.
DR   PDBsum; 2VDK; -.
DR   PDBsum; 2VDL; -.
DR   PDBsum; 2VDM; -.
DR   PDBsum; 2VDN; -.
DR   PDBsum; 2VDO; -.
DR   PDBsum; 2VDP; -.
DR   PDBsum; 2VDQ; -.
DR   PDBsum; 2VDR; -.
DR   PDBsum; 3FCS; -.
DR   PDBsum; 3FCU; -.
DR   PDBsum; 3NID; -.
DR   PDBsum; 3NIF; -.
DR   PDBsum; 3NIG; -.
DR   PDBsum; 3T3M; -.
DR   PDBsum; 3T3P; -.
DR   PDBsum; 3ZDX; -.
DR   PDBsum; 3ZDY; -.
DR   PDBsum; 3ZDZ; -.
DR   PDBsum; 3ZE0; -.
DR   PDBsum; 3ZE1; -.
DR   PDBsum; 3ZE2; -.
DR   PDBsum; 4CAK; -.
DR   PDBsum; 4Z7N; -.
DR   PDBsum; 4Z7O; -.
DR   PDBsum; 4Z7Q; -.
DR   PDBsum; 5HDB; -.
DR   ProteinModelPortal; P08514; -.
DR   SMR; P08514; -.
DR   BioGrid; 109881; 13.
DR   CORUM; P08514; -.
DR   DIP; DIP-68N; -.
DR   IntAct; P08514; 3.
DR   STRING; 9606.ENSP00000262407; -.
DR   BindingDB; P08514; -.
DR   ChEMBL; CHEMBL212; -.
DR   DrugBank; DB00054; Abciximab.
DR   DrugBank; DB04863; Lefradafiban.
DR   DrugBank; DB00775; Tirofiban.
DR   GuidetoPHARMACOLOGY; 2440; -.
DR   iPTMnet; P08514; -.
DR   PhosphoSitePlus; P08514; -.
DR   BioMuta; ITGA2B; -.
DR   DMDM; 226694183; -.
DR   OGP; P08514; -.
DR   EPD; P08514; -.
DR   PaxDb; P08514; -.
DR   PeptideAtlas; P08514; -.
DR   PRIDE; P08514; -.
DR   TopDownProteomics; P08514-1; -. [P08514-1]
DR   Ensembl; ENST00000262407; ENSP00000262407; ENSG00000005961. [P08514-1]
DR   GeneID; 3674; -.
DR   KEGG; hsa:3674; -.
DR   UCSC; uc002igt.2; human. [P08514-1]
DR   CTD; 3674; -.
DR   DisGeNET; 3674; -.
DR   EuPathDB; HostDB:ENSG00000005961.17; -.
DR   GeneCards; ITGA2B; -.
DR   HGNC; HGNC:6138; ITGA2B.
DR   HPA; CAB018611; -.
DR   HPA; HPA031168; -.
DR   HPA; HPA031169; -.
DR   HPA; HPA031170; -.
DR   HPA; HPA031171; -.
DR   MalaCards; ITGA2B; -.
DR   MIM; 187800; phenotype.
DR   MIM; 273800; phenotype.
DR   MIM; 607759; gene.
DR   neXtProt; NX_P08514; -.
DR   OpenTargets; ENSG00000005961; -.
DR   Orphanet; 140957; Autosomal dominant macrothrombocytopenia.
DR   Orphanet; 853; Fetal and neonatal alloimmune thrombocytopenia.
DR   Orphanet; 849; Glanzmann thrombasthenia.
DR   PharmGKB; PA29938; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; P08514; -.
DR   KO; K06476; -.
DR   OMA; LWLLEWV; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   PhylomeDB; P08514; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-HSA-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-HSA-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   SignaLink; P08514; -.
DR   SIGNOR; P08514; -.
DR   ChiTaRS; ITGA2B; human.
DR   EvolutionaryTrace; P08514; -.
DR   GeneWiki; ITGA2B; -.
DR   GenomeRNAi; 3674; -.
DR   PMAP-CutDB; Q17R67; -.
DR   PRO; PR:P08514; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000005961; -.
DR   CleanEx; HS_ITGA2B; -.
DR   ExpressionAtlas; P08514; baseline and differential.
DR   Genevisible; P08514; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031092; C:platelet alpha granule membrane; TAS:Reactome.
DR   GO; GO:0050840; F:extracellular matrix binding; IEA:Ensembl.
DR   GO; GO:0070051; F:fibrinogen binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0070527; P:platelet aggregation; IEA:Ensembl.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Integrin; Membrane; Metal-binding; Polymorphism;
KW   Pyrrolidone carboxylic acid; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     31       {ECO:0000269|PubMed:1953640,
FT                                ECO:0000269|PubMed:3534886,
FT                                ECO:0000269|PubMed:8620874}.
FT   CHAIN        32   1039       Integrin alpha-IIb.
FT                                /FTId=PRO_0000016275.
FT   CHAIN        32    887       Integrin alpha-IIb heavy chain.
FT                                /FTId=PRO_0000016276.
FT   CHAIN       891   1039       Integrin alpha-IIb light chain, form 1.
FT                                /FTId=PRO_0000292348.
FT   CHAIN       903   1039       Integrin alpha-IIb light chain, form 2.
FT                                /FTId=PRO_0000016277.
FT   TOPO_DOM     32    993       Extracellular. {ECO:0000255}.
FT   TRANSMEM    994   1019       Helical. {ECO:0000255}.
FT   TOPO_DOM   1020   1039       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       35     96       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      110    173       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      187    238       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      251    305       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      306    371       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      373    432       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      435    496       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     274    282       {ECO:0000255}.
FT   CA_BIND     328    336       {ECO:0000255}.
FT   CA_BIND     396    404       {ECO:0000255}.
FT   CA_BIND     457    465       {ECO:0000255}.
FT   MOTIF      1022   1026       GFFKR motif.
FT   MOD_RES     891    891       Pyrrolidone carboxylic acid; in light
FT                                chain form 1.
FT                                {ECO:0000269|PubMed:2226834}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:2775232}.
FT   CARBOHYD    280    280       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:2775232}.
FT   CARBOHYD    601    601       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:2775232}.
FT   CARBOHYD    711    711       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:2775232}.
FT   CARBOHYD    874    874       O-linked (GalNAc...) serine; in variant
FT                                S-874.
FT   CARBOHYD    878    878       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:7688323}.
FT   CARBOHYD    962    962       N-linked (GlcNAc...) asparagine.
FT   DISULFID     87     96       {ECO:0000269|PubMed:2775232}.
FT   DISULFID    138    161       {ECO:0000269|PubMed:2775232}.
FT   DISULFID    177    198       {ECO:0000269|PubMed:2775232}.
FT   DISULFID    504    515       {ECO:0000269|PubMed:2775232}.
FT   DISULFID    521    576       {ECO:0000269|PubMed:2775232}.
FT   DISULFID    633    639       {ECO:0000269|PubMed:2775232}.
FT   DISULFID    705    718       {ECO:0000269|PubMed:2775232}.
FT   DISULFID    857    911       Interchain (between heavy and light
FT                                chains). {ECO:0000269|PubMed:2775232}.
FT   DISULFID    916    921       {ECO:0000269|PubMed:2775232}.
FT   VAR_SEQ     910   1039       SCDSAPCTVVQCDLQEMARGQRAMVTVLAFLWLPSLYQRPL
FT                                DQFVLQSHAWFNVSSLPYAVPPLSLPRGEAQVWTQLLRALE
FT                                ERAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNRPPLE
FT                                EDDEEGE -> VSRLSGLWPGLPGTHGAEGMGGGRGVRVCC
FT                                GPLWATLGPWEHFK (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002736.
FT   VAR_SEQ     948    981       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002737.
FT   VARIANT      40     40       T -> I (in dbSNP:rs5915).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014176.
FT   VARIANT      86     86       L -> P (in GT; cells co-transfected with
FT                                mutated alpha-IIb and wild-type beta-3
FT                                scarcely expressed the alpha-IIb/beta-3
FT                                complex; dbSNP:rs1052533574).
FT                                {ECO:0000269|PubMed:12181054}.
FT                                /FTId=VAR_030445.
FT   VARIANT     139    139       A -> V (in GT).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030446.
FT   VARIANT     161    161       C -> W (in GT).
FT                                {ECO:0000269|PubMed:11798398}.
FT                                /FTId=VAR_030447.
FT   VARIANT     174    174       Y -> H (in GT; abolishes the binding
FT                                function of alpha-IIb/beta-3 for soluble
FT                                ligands without disturbing alpha-IIb/
FT                                beta-3 expression; functional defect is
FT                                likely caused by its allosteric effect
FT                                rather than by a defect in the ligand-
FT                                binding site itself).
FT                                {ECO:0000269|PubMed:12506038}.
FT                                /FTId=VAR_030448.
FT   VARIANT     176    176       P -> A (in GT; impairs surface expression
FT                                of alpha-IIb/beta-3 and abrogates ligand
FT                                binding to the activated integrin).
FT                                {ECO:0000269|PubMed:10607701,
FT                                ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_009885.
FT   VARIANT     176    176       P -> L (in GT; impairs surface expression
FT                                of alpha-IIb/beta-3).
FT                                {ECO:0000269|PubMed:10607701}.
FT                                /FTId=VAR_009886.
FT   VARIANT     202    202       F -> C (in GT; associated with abrogation
FT                                of alpha-IIb/beta-3 complex formation).
FT                                {ECO:0000269|PubMed:15219201}.
FT                                /FTId=VAR_030449.
FT   VARIANT     207    207       T -> I (in GT).
FT                                {ECO:0000269|PubMed:9215749}.
FT                                /FTId=VAR_030450.
FT   VARIANT     214    214       L -> P (in GT; disrupts the structural
FT                                conformation and the ligand binding
FT                                properties of the heterodimeric complex;
FT                                in addition the mutation appears to
FT                                confer susceptibility to proteolysis;
FT                                dbSNP:rs137852911).
FT                                {ECO:0000269|PubMed:9473221}.
FT                                /FTId=VAR_030451.
FT   VARIANT     222    222       F -> L (in GT).
FT                                {ECO:0000269|PubMed:11798398}.
FT                                /FTId=VAR_030452.
FT   VARIANT     267    267       G -> E (in GT).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030453.
FT   VARIANT     273    273       G -> D (in GT; alters the heterodimer
FT                                conformation thus impairing their
FT                                intracellular transport;
FT                                dbSNP:rs137852907).
FT                                {ECO:0000269|PubMed:8282784}.
FT                                /FTId=VAR_003979.
FT   VARIANT     313    313       G -> A (in dbSNP:rs1126554).
FT                                {ECO:0000269|PubMed:2345548,
FT                                ECO:0000269|PubMed:2439501}.
FT                                /FTId=VAR_054820.
FT   VARIANT     320    320       F -> S (in GT; type I; impairs surface
FT                                expression of alpha-IIb/beta-3).
FT                                {ECO:0000269|PubMed:9722314}.
FT                                /FTId=VAR_009887.
FT   VARIANT     329    329       V -> F (in GT; expression of mutant
FT                                subunit alpha-IIb/bet-3 is 28% of
FT                                control; mutant pro-alpha-IIb subunit is
FT                                retained in the endoplasmic reticulum).
FT                                {ECO:0000269|PubMed:12424194}.
FT                                /FTId=VAR_030454.
FT   VARIANT     355    355       E -> K (in GT; type I; impairs surface
FT                                expression of alpha-IIb/beta-3;
FT                                dbSNP:rs137852910).
FT                                {ECO:0000269|PubMed:9722314,
FT                                ECO:0000269|PubMed:9734640}.
FT                                /FTId=VAR_009888.
FT   VARIANT     358    358       R -> H (in GT; type II;
FT                                dbSNP:rs137852908).
FT                                {ECO:0000269|PubMed:7706461}.
FT                                /FTId=VAR_003980.
FT   VARIANT     380    380       G -> D (in GT; dbSNP:rs766006685).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030455.
FT   VARIANT     405    405       I -> T (in GT; expression of mutant
FT                                subunit alpha-IIb/bet-3 is 11% of
FT                                control; mutant pro-alpha-IIb subunit is
FT                                retained in the endoplasmic reticulum;
FT                                dbSNP:rs75622274).
FT                                {ECO:0000269|PubMed:12083483,
FT                                ECO:0000269|PubMed:12424194,
FT                                ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_030456.
FT   VARIANT     412    412       G -> R (in GT; dbSNP:rs780786843).
FT                                {ECO:0000269|PubMed:11798398}.
FT                                /FTId=VAR_030457.
FT   VARIANT     449    449       G -> D (in GT; type I).
FT                                {ECO:0000269|PubMed:7508443}.
FT                                /FTId=VAR_003981.
FT   VARIANT     456    457       Missing (in GT; alteres the conformation
FT                                of heterodimers such that they were
FT                                neither recognized by the heterodimer-
FT                                specific antibody A2A9 nor able to
FT                                undergo further intracellular processing
FT                                or transport to the cell surface).
FT                                /FTId=VAR_030458.
FT   VARIANT     581    581       A -> D (in GT).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030459.
FT   VARIANT     596    596       I -> T (in GT; type I; dbSNP:rs76811038).
FT                                {ECO:0000269|PubMed:20020534,
FT                                ECO:0000269|PubMed:9215749,
FT                                ECO:0000269|PubMed:9734640}.
FT                                /FTId=VAR_030460.
FT   VARIANT     649    649       V -> L (in dbSNP:rs7207402).
FT                                /FTId=VAR_054821.
FT   VARIANT     705    705       C -> R (in GT; type II; the rate of
FT                                subunit maturation and the surface
FT                                exposure of ghlycoprotein IIb/beta-3 are
FT                                strongly reduced; dbSNP:rs77961246).
FT                                {ECO:0000269|PubMed:12083483,
FT                                ECO:0000269|PubMed:20020534,
FT                                ECO:0000269|PubMed:9920835}.
FT                                /FTId=VAR_030461.
FT   VARIANT     752    752       L -> V (in GT; dbSNP:rs761174160).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030462.
FT   VARIANT     755    755       R -> P (in GT; dbSNP:rs763762304).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030463.
FT   VARIANT     778    778       Q -> P (in GT; type II;
FT                                dbSNP:rs74475415).
FT                                {ECO:0000269|PubMed:20020534,
FT                                ECO:0000269|PubMed:9722314,
FT                                ECO:0000269|PubMed:9763559}.
FT                                /FTId=VAR_003982.
FT   VARIANT     847    847       L -> P (in GT).
FT                                {ECO:0000269|PubMed:11798398}.
FT                                /FTId=VAR_030464.
FT   VARIANT     874    874       I -> S (alloantigen HPA-3B;
FT                                dbSNP:rs5911).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_003983.
FT   VARIANT     934    934       V -> F (in GT; severe type 1 phenotype;
FT                                the mutation prevented normal ITGA2B/
FT                                ITGB3 complex expression on the cell
FT                                surface; dbSNP:rs77458039).
FT                                {ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_069917.
FT   VARIANT     943    943       P -> L (in GT; marked reduction in the
FT                                rate of surface expression).
FT                                {ECO:0000269|PubMed:17018384}.
FT                                /FTId=VAR_030465.
FT   VARIANT     957    957       S -> L (in GT; severe type 1 phenotype;
FT                                the mutation prevented normal ITGA2B/
FT                                ITGB3 complex expression on the cell
FT                                surface; the mutation may interfere with
FT                                correct folding of the protein;
FT                                dbSNP:rs80002943).
FT                                {ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_069918.
FT   VARIANT     968    968       Y -> N (in dbSNP:rs5914).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014177.
FT   VARIANT     982    982       V -> M (in GT; much reduced surface
FT                                expression of alpha-IIb/beta-3 and a
FT                                block in the maturation of pro-alpha-IIb;
FT                                dbSNP:rs78657866).
FT                                {ECO:0000269|PubMed:15099289,
FT                                ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_030466.
FT   VARIANT     989    989       A -> T (in dbSNP:rs78165611).
FT                                {ECO:0000269|PubMed:15099289,
FT                                ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_030467.
FT   VARIANT    1026   1026       R -> Q (in GT and BDPLT16; results in low
FT                                surface expression of the mutant protein;
FT                                dbSNP:rs879255514).
FT                                {ECO:0000269|PubMed:9215749,
FT                                ECO:0000269|PubMed:9834222}.
FT                                /FTId=VAR_030468.
FT   VARIANT    1026   1026       R -> W (in BDPLT16; results in abnormal
FT                                membrane ruffling and cytoplasmic
FT                                protrusions as well as defective
FT                                proplatelet formation;
FT                                dbSNP:rs766503255).
FT                                {ECO:0000269|PubMed:21454453}.
FT                                /FTId=VAR_069919.
FT   MUTAGEN    1029   1030       PP->AA: Imparts constitutive activity
FT                                (ligand-binding) to alpha-IIb/beta-3.
FT                                {ECO:0000269|PubMed:10212286}.
FT   CONFLICT     23     23       P -> A (in Ref. 2; AAA35926).
FT                                {ECO:0000305}.
FT   CONFLICT    120    120       A -> S (in Ref. 4; BAG37735).
FT                                {ECO:0000305}.
FT   CONFLICT    287    288       GA -> VP (in Ref. 3; AAA53150).
FT                                {ECO:0000305}.
FT   CONFLICT    346    346       E -> D (in Ref. 2; AAA35926).
FT                                {ECO:0000305}.
FT   CONFLICT    565    565       N -> D (in Ref. 2; AAA35926).
FT                                {ECO:0000305}.
FT   CONFLICT    566    566       L -> V (in Ref. 11; CAA29987).
FT                                {ECO:0000305}.
FT   CONFLICT    633    633       C -> S (in Ref. 1; AAA60114).
FT                                {ECO:0000305}.
FT   CONFLICT    729    729       Q -> E (in Ref. 11; CAA29987).
FT                                {ECO:0000305}.
FT   CONFLICT    971    971       P -> A (in Ref. 3; AAA53150).
FT                                {ECO:0000305}.
FT   CONFLICT   1029   1029       P -> H (in Ref. 2; AAA35926 and 7;
FT                                AAA52588). {ECO:0000305}.
FT   CONFLICT   1030   1030       P -> T (in Ref. 7; AAA52588).
FT                                {ECO:0000305}.
FT   STRAND       36     38       {ECO:0000244|PDB:3T3P}.
FT   STRAND       40     43       {ECO:0000244|PDB:3T3P}.
FT   STRAND       52     58       {ECO:0000244|PDB:3T3P}.
FT   STRAND       60     62       {ECO:0000244|PDB:1TYE}.
FT   STRAND       64     70       {ECO:0000244|PDB:3T3P}.
FT   STRAND       78     80       {ECO:0000244|PDB:3T3P}.
FT   STRAND       82     88       {ECO:0000244|PDB:3T3P}.
FT   STRAND       93     95       {ECO:0000244|PDB:3FCS}.
FT   STRAND      107    110       {ECO:0000244|PDB:3T3P}.
FT   STRAND      113    118       {ECO:0000244|PDB:3T3P}.
FT   STRAND      126    131       {ECO:0000244|PDB:3T3P}.
FT   STRAND      134    139       {ECO:0000244|PDB:3T3P}.
FT   STRAND      143    148       {ECO:0000244|PDB:3T3P}.
FT   STRAND      151    153       {ECO:0000244|PDB:2VDL}.
FT   STRAND      160    164       {ECO:0000244|PDB:3T3P}.
FT   TURN        166    168       {ECO:0000244|PDB:3T3P}.
FT   STRAND      171    174       {ECO:0000244|PDB:3T3P}.
FT   HELIX       183    188       {ECO:0000244|PDB:3T3P}.
FT   TURN        189    193       {ECO:0000244|PDB:3T3P}.
FT   STRAND      202    206       {ECO:0000244|PDB:3T3P}.
FT   STRAND      211    216       {ECO:0000244|PDB:3T3P}.
FT   HELIX       219    222       {ECO:0000244|PDB:3T3P}.
FT   STRAND      225    230       {ECO:0000244|PDB:3T3P}.
FT   HELIX       231    237       {ECO:0000244|PDB:3T3P}.
FT   HELIX       259    261       {ECO:0000244|PDB:3T3P}.
FT   STRAND      268    273       {ECO:0000244|PDB:3T3P}.
FT   STRAND      279    281       {ECO:0000244|PDB:3FCS}.
FT   STRAND      283    288       {ECO:0000244|PDB:3T3P}.
FT   HELIX       291    294       {ECO:0000244|PDB:3T3P}.
FT   STRAND      297    301       {ECO:0000244|PDB:3T3P}.
FT   STRAND      307    312       {ECO:0000244|PDB:3T3P}.
FT   STRAND      324    327       {ECO:0000244|PDB:3T3P}.
FT   STRAND      330    333       {ECO:0000244|PDB:3T3P}.
FT   STRAND      336    341       {ECO:0000244|PDB:3T3P}.
FT   STRAND      345    348       {ECO:0000244|PDB:3T3P}.
FT   TURN        349    351       {ECO:0000244|PDB:3T3P}.
FT   STRAND      352    355       {ECO:0000244|PDB:3T3P}.
FT   STRAND      358    362       {ECO:0000244|PDB:3T3P}.
FT   STRAND      366    368       {ECO:0000244|PDB:3T3P}.
FT   STRAND      375    379       {ECO:0000244|PDB:3T3P}.
FT   STRAND      391    395       {ECO:0000244|PDB:3T3P}.
FT   STRAND      400    402       {ECO:0000244|PDB:3T3P}.
FT   STRAND      404    409       {ECO:0000244|PDB:3T3P}.
FT   STRAND      413    417       {ECO:0000244|PDB:1TYE}.
FT   STRAND      419    423       {ECO:0000244|PDB:3T3P}.
FT   STRAND      427    430       {ECO:0000244|PDB:1TYE}.
FT   STRAND      435    439       {ECO:0000244|PDB:3T3P}.
FT   STRAND      450    456       {ECO:0000244|PDB:3T3P}.
FT   STRAND      458    463       {ECO:0000244|PDB:3T3P}.
FT   STRAND      465    470       {ECO:0000244|PDB:3T3P}.
FT   HELIX       471    473       {ECO:0000244|PDB:3T3P}.
FT   STRAND      475    479       {ECO:0000244|PDB:3T3P}.
FT   STRAND      484    493       {ECO:0000244|PDB:3FCS}.
FT   STRAND      507    509       {ECO:0000244|PDB:3FCS}.
FT   STRAND      512    525       {ECO:0000244|PDB:3FCS}.
FT   STRAND      534    541       {ECO:0000244|PDB:3FCS}.
FT   TURN        542    544       {ECO:0000244|PDB:3FCS}.
FT   HELIX       547    549       {ECO:0000244|PDB:3FCS}.
FT   STRAND      551    554       {ECO:0000244|PDB:3FCS}.
FT   TURN        555    557       {ECO:0000244|PDB:3FCS}.
FT   STRAND      559    567       {ECO:0000244|PDB:3FCS}.
FT   STRAND      575    583       {ECO:0000244|PDB:3FCS}.
FT   HELIX       586    588       {ECO:0000244|PDB:3FCS}.
FT   STRAND      596    603       {ECO:0000244|PDB:3FCS}.
FT   STRAND      616    619       {ECO:0000244|PDB:3FCS}.
FT   STRAND      622    627       {ECO:0000244|PDB:3FCS}.
FT   TURN        634    637       {ECO:0000244|PDB:3FCS}.
FT   STRAND      643    651       {ECO:0000244|PDB:3FCS}.
FT   STRAND      653    655       {ECO:0000244|PDB:3FCS}.
FT   STRAND      662    670       {ECO:0000244|PDB:3FCS}.
FT   STRAND      678    683       {ECO:0000244|PDB:3FCS}.
FT   STRAND      688    695       {ECO:0000244|PDB:3FCS}.
FT   STRAND      705    708       {ECO:0000244|PDB:3FCS}.
FT   STRAND      710    713       {ECO:0000244|PDB:3FCS}.
FT   STRAND      715    721       {ECO:0000244|PDB:3FCS}.
FT   STRAND      728    738       {ECO:0000244|PDB:3FCS}.
FT   STRAND      746    755       {ECO:0000244|PDB:3FCS}.
FT   STRAND      759    761       {ECO:0000244|PDB:3FCS}.
FT   STRAND      767    774       {ECO:0000244|PDB:3FCS}.
FT   STRAND      779    792       {ECO:0000244|PDB:3FCS}.
FT   STRAND      810    819       {ECO:0000244|PDB:3FCS}.
FT   STRAND      821    823       {ECO:0000244|PDB:3FCS}.
FT   STRAND      825    836       {ECO:0000244|PDB:3FCS}.
FT   STRAND      842    854       {ECO:0000244|PDB:3FCS}.
FT   STRAND      856    861       {ECO:0000244|PDB:3FCS}.
FT   STRAND      906    909       {ECO:0000244|PDB:3FCS}.
FT   TURN        911    913       {ECO:0000244|PDB:3FCS}.
FT   STRAND      916    926       {ECO:0000244|PDB:3FCS}.
FT   STRAND      931    940       {ECO:0000244|PDB:3FCS}.
FT   HELIX       942    945       {ECO:0000244|PDB:3FCS}.
FT   STRAND      952    965       {ECO:0000244|PDB:3FCS}.
FT   STRAND      967    969       {ECO:0000244|PDB:3FCS}.
FT   STRAND      977    988       {ECO:0000244|PDB:3FCS}.
FT   TURN        991    994       {ECO:0000244|PDB:2KNC}.
FT   HELIX       997   1020       {ECO:0000244|PDB:2K1A}.
FT   STRAND     1022   1024       {ECO:0000244|PDB:1DPK}.
FT   TURN       1025   1027       {ECO:0000244|PDB:1DPK}.
FT   HELIX      1028   1031       {ECO:0000244|PDB:1DPK}.
FT   TURN       1035   1038       {ECO:0000244|PDB:1DPQ}.
SQ   SEQUENCE   1039 AA;  113377 MW;  063EE298E026F116 CRC64;
     MARALCPLQA LWLLEWVLLL LGPCAAPPAW ALNLDPVQLT FYAGPNGSQF GFSLDFHKDS
     HGRVAIVVGA PRTLGPSQEE TGGVFLCPWR AEGGQCPSLL FDLRDETRNV GSQTLQTFKA
     RQGLGASVVS WSDVIVACAP WQHWNVLEKT EEAEKTPVGS CFLAQPESGR RAEYSPCRGN
     TLSRIYVEND FSWDKRYCEA GFSSVVTQAG ELVLGAPGGY YFLGLLAQAP VADIFSSYRP
     GILLWHVSSQ SLSFDSSNPE YFDGYWGYSV AVGEFDGDLN TTEYVVGAPT WSWTLGAVEI
     LDSYYQRLHR LRGEQMASYF GHSVAVTDVN GDGRHDLLVG APLYMESRAD RKLAEVGRVY
     LFLQPRGPHA LGAPSLLLTG TQLYGRFGSA IAPLGDLDRD GYNDIAVAAP YGGPSGRGQV
     LVFLGQSEGL RSRPSQVLDS PFPTGSAFGF SLRGAVDIDD NGYPDLIVGA YGANQVAVYR
     AQPVVKASVQ LLVQDSLNPA VKSCVLPQTK TPVSCFNIQM CVGATGHNIP QKLSLNAELQ
     LDRQKPRQGR RVLLLGSQQA GTTLNLDLGG KHSPICHTTM AFLRDEADFR DKLSPIVLSL
     NVSLPPTEAG MAPAVVLHGD THVQEQTRIV LDCGEDDVCV PQLQLTASVT GSPLLVGADN
     VLELQMDAAN EGEGAYEAEL AVHLPQGAHY MRALSNVEGF ERLICNQKKE NETRVVLCEL
     GNPMKKNAQI GIAMLVSVGN LEEAGESVSF QLQIRSKNSQ NPNSKIVLLD VPVRAEAQVE
     LRGNSFPASL VVAAEEGERE QNSLDSWGPK VEHTYELHNN GPGTVNGLHL SIHLPGQSQP
     SDLLYILDIQ PQGGLQCFPQ PPVNPLKVDW GLPIPSPSPI HPAHHKRDRR QIFLPEPEQP
     SRLQDPVLVS CDSAPCTVVQ CDLQEMARGQ RAMVTVLAFL WLPSLYQRPL DQFVLQSHAW
     FNVSSLPYAV PPLSLPRGEA QVWTQLLRAL EERAIPIWWV LVGVLGGLLL LTILVLAMWK
     VGFFKRNRPP LEEDDEEGE
//
ID   ITA1_DROME              Reviewed;        1146 AA.
AC   Q24247; M9PEG3; M9PHG7; M9PJL8; Q8SY51; Q9VYF6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 2.
DT   22-NOV-2017, entry version 171.
DE   RecName: Full=Integrin alpha-PS1;
DE   AltName: Full=Position-specific antigen subunit alpha-1;
DE   AltName: Full=Protein multiple edematous wings;
DE   Contains:
DE     RecName: Full=Integrin alpha-PS1 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-PS1 light chain;
DE   Flags: Precursor;
GN   Name=mew; ORFNames=CG1771;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), PARTIAL PROTEIN SEQUENCE,
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Oregon-R; TISSUE=Embryo, and Larva;
RX   PubMed=8240969; DOI=10.1016/0925-4773(93)90020-X;
RA   Wehrli M., Diantonio A., Fearnley I.M., Smith R.J., Wilcox M.;
RT   "Cloning and characterization of alpha PS1, a novel Drosophila
RT   melanogaster integrin.";
RL   Mech. Dev. 43:21-36(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5]
RP   FUNCTION.
RX   PubMed=7972082; DOI=10.1073/pnas.91.24.11447;
RA   Gotwals P.J., Fessler L.I., Wehrli M., Hynes R.O.;
RT   "Drosophila PS1 integrin is a laminin receptor and differs in ligand
RT   specificity from PS2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:11447-11451(1994).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-657 AND ASN-1027, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Oregon-R; TISSUE=Head;
RX   PubMed=17893096; DOI=10.1093/glycob/cwm097;
RA   Koles K., Lim J.-M., Aoki K., Porterfield M., Tiemeyer M., Wells L.,
RA   Panin V.;
RT   "Identification of N-glycosylated proteins from the central nervous
RT   system of Drosophila melanogaster.";
RL   Glycobiology 17:1388-1403(2007).
RN   [7]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=19035354; DOI=10.1002/dvdy.21802;
RA   Dinkins M.B., Fratto V.M., Lemosy E.K.;
RT   "Integrin alpha chains exhibit distinct temporal and spatial
RT   localization patterns in epithelial cells of the Drosophila ovary.";
RL   Dev. Dyn. 237:3927-3939(2008).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-711; ASN-718 AND ASN-761,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
CC   -!- FUNCTION: Integrin alpha-PS1/beta-PS is a receptor for laminin.
CC       {ECO:0000269|PubMed:7972082}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-PS1 associates with beta-PS.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Lateral cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Basal cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Note=During mid-oogenesis,
CC       localizes to the apical, to the lateral and to the basal membranes
CC       of follicle cells. Apical membrane localization peaks at oogenesis
CC       stages 9 and 10A in columnar follicle cells overlying the oocyte
CC       while decreases in the most posterior follicle cells. Localization
CC       to lateral and basal membranes persists during dorsal appendage
CC       morphogenesis, although diminished and often absent.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=B;
CC         IsoId=Q24247-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=Q24247-2; Sequence=VSP_009270;
CC         Note=No experimental confirmation available.;
CC       Name=C;
CC         IsoId=Q24247-3; Sequence=VSP_053396;
CC         Note=No experimental confirmation available.;
CC       Name=D;
CC         IsoId=Q24247-4; Sequence=VSP_009270, VSP_053396;
CC         Note=No experimental confirmation available.;
CC       Name=E;
CC         IsoId=Q24247-5; Sequence=VSP_009270, VSP_053397;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in follicle cells (at protein
CC       level). At syncytial blastoderm stage, expressed in the ectoderm
CC       but not in the mesodermal precursors. At embryonic stage 7,
CC       expressed in dorsal and ventrolateral ectoderm and in some yolk
CC       nuclei. At late stage 10, expression is homogeneous in the
CC       ectoderm and is particularly abundant in the anterior and
CC       posterior midgut primordia. At stage 11, strongly expressed in a
CC       metameric pattern in the ectoderm, in the proctodeum and in the
CC       posterior midgut primordium. At stage 12, accumulates at the
CC       segment boundaries that start to become morphologically visible,
CC       similar expression pattern is observed in the central nervous
CC       system. In third larval instar wing imaginal disk, strongly
CC       expressed in the dorsal compartment, in the adepithelial cells and
CC       in patches on the peripodial membrane covering the imaginal disk
CC       to the outside. {ECO:0000269|PubMed:19035354,
CC       ECO:0000269|PubMed:8240969}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during mid- and late-oogenesis (at
CC       protein level). Expressed throughout embryonic and larval
CC       development with peaks of expression during mid-embryogenesis and
CC       at third larval instar. {ECO:0000269|PubMed:19035354,
CC       ECO:0000269|PubMed:8240969}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X73975; CAA52155.1; -; mRNA.
DR   EMBL; AE014298; AAF48242.2; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09652.1; -; Genomic_DNA.
DR   EMBL; AE014298; AGB95345.1; -; Genomic_DNA.
DR   EMBL; AE014298; AGB95346.1; -; Genomic_DNA.
DR   EMBL; AE014298; AGB95347.1; -; Genomic_DNA.
DR   EMBL; AY075338; AAL68203.1; -; mRNA.
DR   PIR; S40311; S40311.
DR   RefSeq; NP_001259503.1; NM_001272574.1. [Q24247-5]
DR   RefSeq; NP_001259504.1; NM_001272575.2. [Q24247-3]
DR   RefSeq; NP_001259505.1; NM_001272576.2. [Q24247-4]
DR   RefSeq; NP_511145.2; NM_078590.3. [Q24247-1]
DR   RefSeq; NP_727679.1; NM_167354.2. [Q24247-2]
DR   UniGene; Dm.152; -.
DR   ProteinModelPortal; Q24247; -.
DR   BioGrid; 58660; 11.
DR   IntAct; Q24247; 15.
DR   STRING; 7227.FBpp0302767; -.
DR   iPTMnet; Q24247; -.
DR   PaxDb; Q24247; -.
DR   PRIDE; Q24247; -.
DR   EnsemblMetazoa; FBtr0073731; FBpp0073562; FBgn0004456. [Q24247-2]
DR   EnsemblMetazoa; FBtr0073732; FBpp0073563; FBgn0004456. [Q24247-1]
DR   EnsemblMetazoa; FBtr0310647; FBpp0302767; FBgn0004456. [Q24247-3]
DR   EnsemblMetazoa; FBtr0310648; FBpp0302768; FBgn0004456. [Q24247-4]
DR   EnsemblMetazoa; FBtr0330398; FBpp0303424; FBgn0004456. [Q24247-5]
DR   GeneID; 32275; -.
DR   KEGG; dme:Dmel_CG1771; -.
DR   CTD; 32275; -.
DR   FlyBase; FBgn0004456; mew.
DR   eggNOG; ENOG410IPBB; Eukaryota.
DR   eggNOG; ENOG410XVGZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   InParanoid; Q24247; -.
DR   OrthoDB; EOG091G02JI; -.
DR   PhylomeDB; Q24247; -.
DR   Reactome; R-DME-3000157; Laminin interactions.
DR   Reactome; R-DME-446107; Type I hemidesmosome assembly.
DR   GenomeRNAi; 32275; -.
DR   PRO; PR:Q24247; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0004456; -.
DR   ExpressionAtlas; Q24247; differential.
DR   Genevisible; Q24247; DM.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:FlyBase.
DR   GO; GO:0005925; C:focal adhesion; IDA:FlyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0008305; C:integrin complex; IDA:FlyBase.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IMP:FlyBase.
DR   GO; GO:0050840; F:extracellular matrix binding; IDA:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:FlyBase.
DR   GO; GO:0004872; F:receptor activity; IMP:FlyBase.
DR   GO; GO:0007015; P:actin filament organization; IMP:FlyBase.
DR   GO; GO:0007475; P:apposition of dorsal and ventral imaginal disc-derived wing surfaces; NAS:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IMP:FlyBase.
DR   GO; GO:0007414; P:axonal defasciculation; IMP:FlyBase.
DR   GO; GO:0007155; P:cell adhesion; IMP:FlyBase.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:FlyBase.
DR   GO; GO:0030154; P:cell differentiation; TAS:FlyBase.
DR   GO; GO:0016477; P:cell migration; TAS:FlyBase.
DR   GO; GO:0098609; P:cell-cell adhesion; TAS:FlyBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISS:FlyBase.
DR   GO; GO:0048567; P:ectodermal digestive tract morphogenesis; TAS:FlyBase.
DR   GO; GO:0007427; P:epithelial cell migration, open tracheal system; TAS:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0007476; P:imaginal disc-derived wing morphogenesis; IMP:FlyBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0035160; P:maintenance of epithelial integrity, open tracheal system; IGI:FlyBase.
DR   GO; GO:0007494; P:midgut development; TAS:FlyBase.
DR   GO; GO:0016203; P:muscle attachment; IGI:FlyBase.
DR   GO; GO:0007424; P:open tracheal system development; NAS:FlyBase.
DR   GO; GO:0007432; P:salivary gland boundary specification; IMP:FlyBase.
DR   GO; GO:0007431; P:salivary gland development; TAS:FlyBase.
DR   GO; GO:0007435; P:salivary gland morphogenesis; IGI:FlyBase.
DR   GO; GO:0007608; P:sensory perception of smell; IGI:FlyBase.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:FlyBase.
DR   GO; GO:0007426; P:tracheal outgrowth, open tracheal system; TAS:FlyBase.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 4.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Integrin;
KW   Membrane; Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   CHAIN        31   1146       Integrin alpha-PS1.
FT                                /FTId=PRO_0000016320.
FT   CHAIN        31   ?960       Integrin alpha-PS1 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016321.
FT   CHAIN      ?961   1146       Integrin alpha-PS1 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016322.
FT   TOPO_DOM     31   1085       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1086   1106       Helical. {ECO:0000255}.
FT   TOPO_DOM   1107   1146       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       38    105       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      121    186       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      193    245       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      254    303       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      304    366       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      367    422       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      432    494       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    147    147       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    470    470       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    511    511       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    657    657       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096}.
FT   CARBOHYD    680    680       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    711    711       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    718    718       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    761    761       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    928    928       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1027   1027       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096}.
FT   VAR_SEQ       1     97       Missing (in isoform A, isoform D and
FT                                isoform E).
FT                                {ECO:0000303|PubMed:12537569}.
FT                                /FTId=VSP_009270.
FT   VAR_SEQ     114    115       RN -> RTNGAYEINKH (in isoform C and
FT                                isoform D). {ECO:0000305}.
FT                                /FTId=VSP_053396.
FT   VAR_SEQ    1146   1146       F -> FXQEGTVGWDLVRRRRRRRRLKLRLPVTAQPRHGWR
FT                                KTTDKSINNNNNNNHNNNSSNSRNDSDVDVLSLTPPPPPLS
FT                                IFSWGNDGYYQASAAWWGHHM (in isoform E).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_053397.
FT   CONFLICT    730    731       ML -> IV (in Ref. 1; CAA52155).
FT                                {ECO:0000305}.
FT   CONFLICT    815    815       D -> E (in Ref. 1; CAA52155).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1146 AA;  127973 MW;  E8AB75BC8DE6854E CRC64;
     MLELPFTTIR PNCRLRQNLG ILIILQCVLT CYNFNLEQRL PIVKYGHPHS HFGYSVATHT
     IGEANGPNKT NCVLVGAPLD QNRQPNTTHS GALWRCPMTQ RFDDCEQVIT DGRRNFDSEI
     LSPPGNDEIK EDQWMGVTVR SNPLQANGSG GKVIVCAHRY MYIVRENRYG QGLCYLLTND
     LQFEEVHEPC KGRPVQRQHE DYGLCQAGTS AALLDDDTMV LGSPGPYTWR GSIWVTQVGG
     EYLQRDKTTY YSDHSDLNSP VDKYSYLGMS VTGGRFFGHM SYAAGAPRSE GHGQVVIFDK
     STDNPIPVHS ILDGEQFGSS FGYELATADI NGDHRPDLIV AAPLYFTKTE GGAVYVYQNI
     QDTLPMKYTL KLTGPLESRF GLALANIGDL NKDNCEDLAV GAPYEGNGVV YIYLGSSQGL
     NSKPAQKIQA SELGGTIPNG QPIRTFGISI SGNTDLDDNS YPDVVIGAFN SSAAVILLAR
     PIISIQTSVQ RKELHNMDPN TPGCLDDPAS NLTCFTFRAC CSIEPYDEKN KELRLAYSVE
     AETFDHLKKF SRVFFFDREN KRTNVLSRVV RVHTNGRTEC QAVTGYIKAN TRDIQTPVRF
     RLKYSLVEPP LADSALVRLN PILDQTQAHV DFEGTFQKDC GDDDLCESNL IIRVEPNITE
     SSGNEYTLIL DETELEVRIN VSNLADSAYE AQLFIAHQAG VSYVATKKPT NATCNSYNTT
     LVACSLGNPM LRDTTTFVTI RFQPKGLEPS EKIMLFHIFA NTTSKLVGPE RPERDLRVNV
     VRRAKLNFRG WAIPEQSFYS GSSVANSVAN TAATDIEGHG PMGMDDVGSQ VHHMFTIFNE
     GPSTAPKVQM VIHWPYSLYS DPQSGRPVQY LLYLEQVPTV EVSQGECHVA KEYVNPLNLA
     SGSRENPAYL SAPAQMRMFP SQSRHSFNKS LIHSQRSYYS SSHRDDHSDD TQSNRNRVRR
     SFLERVTRLE RLMYDPESSN AANGKKQDIV ELDCNKGATN CVRIECDILN MPALSEAQVV
     VKARLWNSTL VSEYPRVERV RIFSTATAQI PESYGVEVMD HNNIEVETRA YPELRNQQRD
     TSIPWLIIIL GIVGGLLLLA LVTYVLWKVG FFKRIRPTDP TLSGNLEKMN EEKPFLAPSK
     NTHHVF
//
ID   ITA8_MOUSE              Reviewed;        1062 AA.
AC   A2ARA8; O70304; Q3UXV8; Q8BRG3; Q8C0H7;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 1.
DT   22-NOV-2017, entry version 96.
DE   RecName: Full=Integrin alpha-8;
DE   Contains:
DE     RecName: Full=Integrin alpha-8 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-8 light chain;
DE   Flags: Precursor;
GN   Name=Itga8;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Embryo, Testis, and Wolffian duct;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 45-1056 (ISOFORM 1), FUNCTION,
RP   DISRUPTION PHENOTYPE, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Fibroblast;
RX   PubMed=9054500; DOI=10.1016/S0092-8674(00)81903-0;
RA   Mueller U., Wang D., Denda S., Meneses J.J., Pedersen R.A.,
RA   Reichardt L.F.;
RT   "Integrin alpha8beta1 is critically important for epithelial-
RT   mesenchymal interactions during kidney morphogenesis.";
RL   Cell 88:603-613(1997).
RN   [4]
RP   FUNCTION.
RX   PubMed=9548928; DOI=10.1021/bi9727489;
RA   Denda S., Mueller U., Crossin K.L., Erickson H.P., Reichardt L.F.;
RT   "Utilization of a soluble integrin-alkaline phosphatase chimera to
RT   characterize integrin alpha 8 beta 1 receptor interactions with
RT   tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C
RT   fragments, but not to native tenascin-C.";
RL   Biochemistry 37:5464-5474(1998).
RN   [5]
RP   FUNCTION.
RX   PubMed=9614184; DOI=10.1091/mbc.9.6.1425;
RA   Denda S., Reichardt L.F., Mueller U.;
RT   "Identification of osteopontin as a novel ligand for the integrin
RT   alpha8 beta1 and potential roles for this integrin-ligand interaction
RT   in kidney morphogenesis.";
RL   Mol. Biol. Cell 9:1425-1435(1998).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=10024342;
RA   Pinkstaff J.K., Detterich J., Lynch G., Gall C.;
RT   "Integrin subunit gene expression is regionally differentiated in
RT   adult brain.";
RL   J. Neurosci. 19:1541-1556(1999).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=10504498; DOI=10.1046/j.1523-1755.1999.00662.x;
RA   Hartner A., Schoecklmann H., Proels F., Mueller U., Sterzel R.B.;
RT   "Alpha8 integrin in glomerular mesangial cells and in experimental
RT   glomerulonephritis.";
RL   Kidney Int. 56:1468-1480(1999).
RN   [8]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND SUBCELLULAR LOCATION.
RX   PubMed=10742111; DOI=10.1038/74286;
RA   Littlewood Evans A., Mueller U.;
RT   "Stereocilia defects in the sensory hair cells of the inner ear in
RT   mice deficient in integrin alpha8beta1.";
RL   Nat. Genet. 24:424-428(2000).
RN   [9]
RP   FUNCTION.
RX   PubMed=11470831; DOI=10.1083/jcb.200103069;
RA   Brandenberger R., Schmidt A., Linton J., Wang D., Backus C., Denda S.,
RA   Mueller U., Reichardt L.F.;
RT   "Identification and characterization of a novel extracellular matrix
RT   protein nephronectin that is associated with integrin alpha8beta1 in
RT   the embryonic kidney.";
RL   J. Cell Biol. 154:447-458(2001).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=11891185; DOI=10.1016/S0002-9440(10)64909-7;
RA   Hartner A., Cordasic N., Klanke B., Mueller U., Sterzel R.B.,
RA   Hilgers K.F.;
RT   "The alpha8 integrin chain affords mechanical stability to the
RT   glomerular capillary tuft in hypertensive glomerular disease.";
RL   Am. J. Pathol. 160:861-867(2002).
RN   [11]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=14500699; DOI=10.1177/002215540305101008;
RA   Wagner T.E., Frevert C.W., Herzog E.L., Schnapp L.M.;
RT   "Expression of the integrin subunit alpha8 in murine lung
RT   development.";
RL   J. Histochem. Cytochem. 51:1307-1315(2003).
RN   [12]
RP   FUNCTION.
RX   PubMed=12787402; DOI=10.1046/j.1523-1755.2003.00057.x;
RA   Bieritz B., Spessotto P., Colombatti A., Jahn A., Prols F.,
RA   Hartner A.;
RT   "Role of alpha8 integrin in mesangial cell adhesion, migration, and
RT   proliferation.";
RL   Kidney Int. 64:119-127(2003).
RN   [13]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17537792; DOI=10.1242/dev.005033;
RA   Linton J.M., Martin G.R., Reichardt L.F.;
RT   "The ECM protein nephronectin promotes kidney development via integrin
RT   alpha8beta1-mediated stimulation of Gdnf expression.";
RL   Development 134:2501-2509(2007).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Integrin alpha-8/beta-1 functions in the genesis of
CC       kidney and probably of other organs by regulating the recruitment
CC       of mesenchymal cells into epithelial structures. It recognizes the
CC       sequence R-G-D in a wide array of ligands including TNC, FN1, SPP1
CC       TGFB1, TGFB3 and VTN. NPNT is probably its functional ligand in
CC       kidney genesis. Neuronal receptor for TNC it mediates cell-cell
CC       interactions and regulates neurite outgrowth of sensory and motor
CC       neurons. {ECO:0000269|PubMed:10742111,
CC       ECO:0000269|PubMed:11470831, ECO:0000269|PubMed:11891185,
CC       ECO:0000269|PubMed:12787402, ECO:0000269|PubMed:17537792,
CC       ECO:0000269|PubMed:9054500, ECO:0000269|PubMed:9548928,
CC       ECO:0000269|PubMed:9614184}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-8 associates with beta-1.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10742111};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:10742111}.
CC       Cell membrane {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A2ARA8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A2ARA8-2; Sequence=VSP_027364, VSP_027365;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: In brain, expressed in deep cortex,
CC       hippocampal CA1, basolateral amygdala and striatum. In kidney,
CC       expressed in glomerular mesengium (at protein level).
CC       {ECO:0000269|PubMed:10024342, ECO:0000269|PubMed:10504498}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in mesenchymal cells of developing
CC       organs such as gut, lung, gonads and nephrogenic cord.
CC       {ECO:0000269|PubMed:14500699, ECO:0000269|PubMed:9054500}.
CC   -!- DISRUPTION PHENOTYPE: Mice display renal agenesis and dysgenesis.
CC       This is associated with a reduced expression of Gdnf that is
CC       similarly found in mice lacking Npnt. Adult mice also display
CC       increased susceptibility to glomerular capillary destruction upon
CC       mechanical stress. Mice lacking Itga8 also have difficulty
CC       balancing associated with structural defects in the inner ear
CC       where utricular hair cells lack stereocilia.
CC       {ECO:0000269|PubMed:10742111, ECO:0000269|PubMed:11891185,
CC       ECO:0000269|PubMed:17537792, ECO:0000269|PubMed:9054500}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK031326; BAC27348.1; -; mRNA.
DR   EMBL; AK044910; BAC32137.1; -; mRNA.
DR   EMBL; AK135193; BAE22455.1; -; mRNA.
DR   EMBL; AL845313; CAM17354.1; -; Genomic_DNA.
DR   EMBL; AF041409; AAC15665.1; -; mRNA.
DR   CCDS; CCDS15689.1; -. [A2ARA8-1]
DR   RefSeq; NP_001001309.1; NM_001001309.3. [A2ARA8-1]
DR   UniGene; Mm.329997; -.
DR   ProteinModelPortal; A2ARA8; -.
DR   SMR; A2ARA8; -.
DR   IntAct; A2ARA8; 1.
DR   MINT; MINT-4105300; -.
DR   STRING; 10090.ENSMUSP00000028106; -.
DR   iPTMnet; A2ARA8; -.
DR   PhosphoSitePlus; A2ARA8; -.
DR   MaxQB; A2ARA8; -.
DR   PaxDb; A2ARA8; -.
DR   PeptideAtlas; A2ARA8; -.
DR   PRIDE; A2ARA8; -.
DR   Ensembl; ENSMUST00000028106; ENSMUSP00000028106; ENSMUSG00000026768. [A2ARA8-1]
DR   GeneID; 241226; -.
DR   KEGG; mmu:241226; -.
DR   UCSC; uc008ijk.1; mouse. [A2ARA8-1]
DR   UCSC; uc008ijl.1; mouse. [A2ARA8-2]
DR   CTD; 8516; -.
DR   MGI; MGI:109442; Itga8.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; A2ARA8; -.
DR   KO; K06584; -.
DR   OMA; CRQIPFD; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   PhylomeDB; A2ARA8; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-MMU-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   Reactome; R-MMU-3000178; ECM proteoglycans.
DR   PRO; PR:A2ARA8; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000026768; -.
DR   CleanEx; MM_ITGA8; -.
DR   ExpressionAtlas; A2ARA8; baseline and differential.
DR   Genevisible; A2ARA8; MM.
DR   GO; GO:0045177; C:apical part of cell; IDA:MGI.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0032591; C:dendritic spine membrane; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005925; C:focal adhesion; ISO:MGI.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0030030; P:cell projection organization; IMP:MGI.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:MGI.
DR   GO; GO:0045184; P:establishment of protein localization; IMP:BHF-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; IMP:MGI.
DR   GO; GO:0042472; P:inner ear morphogenesis; IMP:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0001822; P:kidney development; ISO:MGI.
DR   GO; GO:0007613; P:memory; IMP:MGI.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEA:Ensembl.
DR   GO; GO:0001656; P:metanephros development; IMP:MGI.
DR   GO; GO:2000721; P:positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:MGI.
DR   GO; GO:0048745; P:smooth muscle tissue development; IMP:BHF-UCL.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISO:MGI.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 6.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell membrane;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond; Glycoprotein;
KW   Integrin; Membrane; Metal-binding; Neurogenesis; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     35       {ECO:0000255}.
FT   CHAIN        36   1062       Integrin alpha-8.
FT                                /FTId=PRO_0000297709.
FT   CHAIN        38    905       Integrin alpha-8 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000297710.
FT   CHAIN       906   1062       Integrin alpha-8 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000297711.
FT   TOPO_DOM     36   1010       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1011   1031       Helical. {ECO:0000255}.
FT   TOPO_DOM   1032   1062       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       41    104       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      121    182       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      187    239       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      252    305       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      306    371       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      372    430       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      434    497       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     328    336       {ECO:0000255}.
FT   CA_BIND     394    402       {ECO:0000255}.
FT   CA_BIND     458    466       {ECO:0000255}.
FT   MOTIF       454    456       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD     80     80       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    176    176       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    238    238       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    301    301       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    503    503       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    600    600       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    604    604       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    718    718       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    736    736       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    752    752       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    779    779       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    895    895       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    922    922       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1004   1004       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     95    105       {ECO:0000250}.
FT   DISULFID    149    170       {ECO:0000250}.
FT   DISULFID    186    199       {ECO:0000250}.
FT   DISULFID    506    517       {ECO:0000250}.
FT   DISULFID    523    579       {ECO:0000250}.
FT   DISULFID    640    646       {ECO:0000250}.
FT   DISULFID    712    725       {ECO:0000250}.
FT   DISULFID    866    923       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    928    933       {ECO:0000250}.
FT   VAR_SEQ     282    286       ELVAG -> GQRHP (in isoform 2).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_027364.
FT   VAR_SEQ     287   1062       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_027365.
FT   CONFLICT     66     66       D -> G (in Ref. 1; BAE22455).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1062 AA;  117556 MW;  DB1ACA43FADD3AC0 CRC64;
     MSAGTHCGPP GNRAPPFARL CCVSAALGML WSPACLAFNL DVDKLTVYSG PEGSYFGYSL
     DFYIPDARTA SVLVGAPKAN TSQPDIVEGG AVYYCPWPSE RSAQCKQIPF DTTNNRKIRV
     NGTKEPIEFK SNQWFGATVR AHKGKVVACA PLYHWRTLKP NPAKDPVGTC YVAIQNFSAY
     AEHSPCRNSN ADPEGQGYCQ AGFSLDFYKN GDLIVGGPGS FYWQGQVITV SIADIIANYS
     FKDILRKLAA EKQTDVAPAS YDDSYLGYSV AAGEFTGDSQ QELVAGIPRG AQNFGYVSII
     NSTDMTFIQN FTGEQMASYF GYTVVVSDVN NDGMDDILVG APLFMEREFE SNPREVGQVY
     LYLQASALLF QDPQVLTGTE TFGRFGSSVA HLGDLNQDGY NDIAIGVPFA GKDQRGKVLI
     YNGNPRGLHS KPSQVLQGIW GSQTIPSGFG FSLRGDADID KNDYPDLLVG AFGKGKVAVY
     RARPVVTVDA QLLLHPMIIN LENKTCQIPE FPTPVACFSV RVCASIAGQS ISNTIALLAE
     VQLDFLKQKG AIKRTLFLHN HQSHFTFPFV MKQQKSLHCQ DFMVYLRDET EFRDKLSPIN
     ISLNYSLDDS TFKDSLEVKP ILNHYRDNVV TEQAHILVDC GEDNLCVPDL KLSARPDKHQ
     IIIGDENHLM LIINARNEGE GAYEAELFVI IPEEADYVGI ERNNKGLRPL SCEYKMENVT
     RMVVCDLGNP MVTGTNFSLG LRFAVPRLEK TNMSINFDLQ IRSSNKDNPD SNFERVQINI
     TAIAQVEIRG VSHPPQIVLP IHNWEPEKKP HKEEEVGPLV EHIYELHNIG PSTISDSILD
     VGWPFSARDE FLLYIFHLQT LGPLQCQTNP EINPQDIKPA ASPEDTPELS AFLRNATIPH
     LVRKRDVPVV QLHRQSPARI LNCTNIDCLQ ISCAVGRLGG GESAVLKVRS RLWAHTFLKR
     KNDHYALASL VSFEVKKMPY KEQPAKLPAG STAVKTSVIW ATPNVSFSIP LWVIILAILL
     GLLVLAILTL ALWKCGFFDR ARPPQDEMTD REQLTSDKTP EA
//
ID   ITB5_MOUSE              Reviewed;         798 AA.
AC   O70309; O70308; O88347;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   22-NOV-2017, entry version 149.
DE   RecName: Full=Integrin beta-5;
DE   Flags: Precursor;
GN   Name=Itgb5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS BETA-5A AND BETA-5B).
RC   TISSUE=Liver;
RX   PubMed=9531507; DOI=10.1042/bj3310631;
RA   Zhang H., Tan S.M., Lu J.;
RT   "cDNA cloning reveals two mouse beta5 integrin transcripts distinct in
RT   cytoplasmic domains as a result of alternative splicing.";
RL   Biochem. J. 331:631-637(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-5A).
RC   TISSUE=Brain;
RX   PubMed=9880508; DOI=10.1074/jbc.274.3.1366;
RA   Feng X., Teitelbaum S.L., Quiroz M.E., Towler D.A., Ross F.P.;
RT   "Cloning of the murine beta5 integrin subunit promoter. Identification
RT   of a novel sequence mediating granulocyte-macrophage colony-
RT   stimulating factor-dependent repression of beta5 integrin gene
RT   transcription.";
RL   J. Biol. Chem. 274:1366-1374(1999).
RN   [3]
RP   INTERACTION WITH FBLN5.
RX   PubMed=11805835; DOI=10.1038/415171a;
RA   Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A.,
RA   Minamisawa S., Cheng C.F., Kobuke K., Dalton N., Takada Y.,
RA   Tashiro K., Ross J., Honjo T., Chien K.R.;
RT   "Fibulin-5/DANCE is essential for elastogenesis in vivo.";
RL   Nature 415:171-175(2002).
RN   [4]
RP   INTERACTION WITH DAB2.
RX   PubMed=12606711; DOI=10.1073/pnas.262791999;
RA   Calderwood D.A., Fujioka Y., de Pereda J.M., Garcia-Alvarez B.,
RA   Nakamoto T., Margolis B., McGlade C.J., Liddington R.C.,
RA   Ginsberg M.H.;
RT   "Integrin beta cytoplasmic domain interactions with phosphotyrosine-
RT   binding domains: a structural prototype for diversity in integrin
RT   signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2272-2277(2003).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Lung, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Integrin alpha-V/beta-5 (ITGAV:ITGB5) is a receptor for
CC       fibronectin. It recognizes the sequence R-G-D in its ligand.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-5
CC       (ITGB5) associates with alpha-V (ITGAV) (Probable). Interacts with
CC       MYO10 (By similarity). Interacts with DAB2. Integrin ITGAV:ITGB5
CC       interacts with FBLN5 (via N-terminus) (PubMed:11805835).
CC       ITGAV:ITGB5 interacts with NOV (By similarity).
CC       {ECO:0000250|UniProtKB:P18084, ECO:0000269|PubMed:11805835,
CC       ECO:0000269|PubMed:12606711, ECO:0000305|PubMed:11805835}.
CC   -!- INTERACTION:
CC       P97479:Myo7a; NbExp=3; IntAct=EBI-8401821, EBI-1149557;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta-5A;
CC         IsoId=O70309-1; Sequence=Displayed;
CC       Name=Beta-5B;
CC         IsoId=O70309-2; Sequence=VSP_002752;
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043257; AAC40110.1; -; mRNA.
DR   EMBL; AF043256; AAC40109.1; -; mRNA.
DR   EMBL; AF022110; AAD08782.1; -; mRNA.
DR   CCDS; CCDS28135.1; -. [O70309-2]
DR   RefSeq; NP_001139356.1; NM_001145884.1.
DR   RefSeq; NP_034710.2; NM_010580.2.
DR   UniGene; Mm.6424; -.
DR   ProteinModelPortal; O70309; -.
DR   SMR; O70309; -.
DR   BioGrid; 200832; 2.
DR   IntAct; O70309; 2.
DR   MINT; MINT-4099048; -.
DR   STRING; 10090.ENSMUSP00000069416; -.
DR   iPTMnet; O70309; -.
DR   PhosphoSitePlus; O70309; -.
DR   EPD; O70309; -.
DR   MaxQB; O70309; -.
DR   PaxDb; O70309; -.
DR   PeptideAtlas; O70309; -.
DR   PRIDE; O70309; -.
DR   GeneID; 16419; -.
DR   KEGG; mmu:16419; -.
DR   CTD; 3693; -.
DR   MGI; MGI:96614; Itgb5.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; O70309; -.
DR   KO; K06588; -.
DR   ChiTaRS; Itgb5; mouse.
DR   PRO; PR:O70309; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_ITGB5; -.
DR   GO; GO:0031252; C:cell leading edge; IDA:MGI.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005925; C:focal adhesion; IDA:MGI.
DR   GO; GO:0034684; C:integrin alphav-beta5 complex; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; ISO:MGI.
DR   GO; GO:0005178; F:integrin binding; IPI:MGI.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:MGI.
DR   GO; GO:0090136; P:epithelial cell-cell adhesion; ISO:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043149; P:stress fiber assembly; IMP:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR027067; Integrin_beta-5.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF26; PTHR10082:SF26; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS00243; INTEGRIN_BETA; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    798       Integrin beta-5.
FT                                /FTId=PRO_0000016349.
FT   TOPO_DOM     24    719       Extracellular. {ECO:0000255}.
FT   TRANSMEM    720    742       Helical. {ECO:0000255}.
FT   TOPO_DOM    743    798       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       27     76       PSI.
FT   DOMAIN      136    378       VWFA.
FT   REPEAT      465    512       I.
FT   REPEAT      513    554       II.
FT   REPEAT      555    593       III.
FT   REPEAT      594    630       IV.
FT   REGION      465    630       Cysteine-rich tandem repeats.
FT   MOD_RES     770    770       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18084}.
FT   CARBOHYD    347    347       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    460    460       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    479    479       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    505    505       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    586    586       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    654    654       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    705    705       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     28    463       {ECO:0000250}.
FT   DISULFID     36     46       {ECO:0000250}.
FT   DISULFID     39     75       {ECO:0000250}.
FT   DISULFID     49     64       {ECO:0000250}.
FT   DISULFID    202    211       {ECO:0000250}.
FT   DISULFID    259    300       {ECO:0000250}.
FT   DISULFID    401    413       {ECO:0000250}.
FT   DISULFID    433    682       {ECO:0000250}.
FT   DISULFID    461    465       {ECO:0000250}.
FT   DISULFID    476    487       {ECO:0000250}.
FT   DISULFID    484    522       {ECO:0000250}.
FT   DISULFID    489    498       {ECO:0000250}.
FT   DISULFID    500    513       {ECO:0000250}.
FT   DISULFID    528    533       {ECO:0000250}.
FT   DISULFID    530    563       {ECO:0000250}.
FT   DISULFID    535    548       {ECO:0000250}.
FT   DISULFID    550    555       {ECO:0000250}.
FT   DISULFID    569    574       {ECO:0000250}.
FT   DISULFID    571    602       {ECO:0000250}.
FT   DISULFID    576    585       {ECO:0000250}.
FT   DISULFID    587    594       {ECO:0000250}.
FT   DISULFID    608    613       {ECO:0000250}.
FT   DISULFID    610    657       {ECO:0000250}.
FT   DISULFID    615    625       {ECO:0000250}.
FT   DISULFID    628    631       {ECO:0000250}.
FT   DISULFID    635    644       {ECO:0000250}.
FT   DISULFID    641    714       {ECO:0000250}.
FT   DISULFID    661    690       {ECO:0000250}.
FT   VAR_SEQ     760    798       ERSRARYEMASNPLYRKPISTHTVDFAFNKFNKSYNGSV
FT                                -> LKPPVQKAHLHTHCRFRLQQVQQILQWLSGLRLLDGWR
FT                                GTKDEDSGVPWTSWTICSR (in isoform Beta-5B).
FT                                {ECO:0000303|PubMed:9531507}.
FT                                /FTId=VSP_002752.
FT   CONFLICT     96     96       S -> C (in Ref. 2; AAD08782).
FT                                {ECO:0000305}.
FT   CONFLICT    259    259       C -> Y (in Ref. 2; AAD08782).
FT                                {ECO:0000305}.
FT   CONFLICT    595    595       K -> R (in Ref. 2; AAD08782).
FT                                {ECO:0000305}.
SQ   SEQUENCE   798 AA;  87909 MW;  34B9D8B07E2688B0 CRC64;
     MPRVPATLYA CLLGLCALVP RLAGLNICTS GSATSCEECL LIHPKCAWCS KEYFGNPRSI
     TSRCDLKANL IRNGCEGEIE SPASSTHVLR NLPLSSKGSS ATGSDVIQMT PQEIAVSLRP
     GEQTTFQLQV RQVEDYPVDL YYLMDLSLSM KDDLENIRSL GTKLAEEMRK LTSNFRLGFG
     SFVDKDISPF SYTAPRYQTN PCIGYKLFPN CVPSFGFRHL LPLTDRVDSF NEEVRKQRVS
     RNRDAPEGGF DAVLQAAVCK EKIGWRKDAL HLLVFTTDDV PHIALDGKLG GLVQPHDGQC
     HLNEANEYTA SNQMDYPSLA LLGEKLAENN INLIFAVTKN HYMLYKNFTA LIPGTTVEIL
     HGDSKNIIQL IINAYSSIRA KVELSVWDQP EDLNLFFTAT CQDGISYPGQ RKCEGLKIGD
     TASFEVSVEA RSCPGRQAAQ SFTLRPVGFR DSLQVEVAYN CTCGCSTGLE PNSARCSGNG
     TYTCGLCECD PGYLGTRCEC QEGENQSGYQ NLCREAEGKP LCSGRGECSC NQCSCFESEF
     GRIYGPFCEC DSFSCARNKG VLCSGHGECH CGECKCHAGY IGDNCNCSTD VSTCKAKDGQ
     ICSDRGRCVC GQCQCTEPGA FGETCEKCPT CPDACSSKRD CVECLLLHQG KPDNQTCHHQ
     CKDEVITWVD TIVKDDQEAV LCFYKTAKDC VMMFSYTELP NGRSNLTVLR EPECGSAPNA
     MTILLAVVGS ILLIGMALLA IWKLLVTIHD RREFAKFQSE RSRARYEMAS NPLYRKPIST
     HTVDFAFNKF NKSYNGSV
//
ID   ITA10_HUMAN             Reviewed;        1167 AA.
AC   O75578; B2RAM4; B2RTV5; Q6UXJ6; Q9UHZ8;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 2.
DT   22-NOV-2017, entry version 164.
DE   RecName: Full=Integrin alpha-10;
DE   Flags: Precursor;
GN   Name=ITGA10; ORFNames=UNQ468/PRO827;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Articular chondrocyte;
RX   PubMed=9685391; DOI=10.1074/jbc.273.32.20383;
RA   Camper L., Hellman U., Lundgren-Aakerlund E.;
RT   "Isolation, cloning, and sequence analysis of the integrin subunit
RT   alpha10, a beta1-associated collagen binding integrin expressed on
RT   chondrocytes.";
RL   J. Biol. Chem. 273:20383-20389(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Endothelial cell, and Heart;
RX   PubMed=10702680;
RA   Lehnert K., Ni J., Leung E., Gough S.M., Morris C.M., Liu D.,
RA   Wang S.-X., Langley R., Krissansen G.W.;
RT   "The integrin alpha10 subunit: expression pattern, partial gene
RT   structure, and chromosomal localization.";
RL   Cytogenet. Cell Genet. 87:238-244(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Integrin alpha-10/beta-1 is a receptor for collagen.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-10
CC       associates with beta-1.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O75578-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75578-2; Sequence=VSP_013114, VSP_013115;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O75578-3; Sequence=VSP_054483;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest expression in
CC       muscle and heart. Found in articular cartilage.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF074015; AAC31952.1; -; mRNA.
DR   EMBL; AF112345; AAF21944.1; -; mRNA.
DR   EMBL; AF172723; AAF61638.1; -; Genomic_DNA.
DR   EMBL; AY358325; AAQ88691.1; -; mRNA.
DR   EMBL; AK314255; BAG36921.1; -; mRNA.
DR   EMBL; AL160282; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471244; EAW71425.1; -; Genomic_DNA.
DR   EMBL; BC140831; AAI40832.1; -; mRNA.
DR   EMBL; BC144637; AAI44638.1; -; mRNA.
DR   CCDS; CCDS72869.1; -. [O75578-1]
DR   CCDS; CCDS76204.1; -. [O75578-3]
DR   RefSeq; NP_001289969.1; NM_001303040.1.
DR   RefSeq; NP_001289970.1; NM_001303041.1. [O75578-3]
DR   RefSeq; NP_003628.2; NM_003637.4. [O75578-1]
DR   UniGene; Hs.158237; -.
DR   ProteinModelPortal; O75578; -.
DR   BioGrid; 114087; 1.
DR   CORUM; O75578; -.
DR   IntAct; O75578; 1.
DR   STRING; 9606.ENSP00000358310; -.
DR   ChEMBL; CHEMBL5882; -.
DR   iPTMnet; O75578; -.
DR   PhosphoSitePlus; O75578; -.
DR   BioMuta; ITGA10; -.
DR   PaxDb; O75578; -.
DR   PeptideAtlas; O75578; -.
DR   PRIDE; O75578; -.
DR   DNASU; 8515; -.
DR   Ensembl; ENST00000369304; ENSP00000358310; ENSG00000143127. [O75578-1]
DR   Ensembl; ENST00000539363; ENSP00000439894; ENSG00000143127. [O75578-3]
DR   GeneID; 8515; -.
DR   KEGG; hsa:8515; -.
DR   UCSC; uc001eoa.4; human. [O75578-1]
DR   CTD; 8515; -.
DR   DisGeNET; 8515; -.
DR   EuPathDB; HostDB:ENSG00000143127.12; -.
DR   GeneCards; ITGA10; -.
DR   HGNC; HGNC:6135; ITGA10.
DR   HPA; HPA064008; -.
DR   MIM; 604042; gene.
DR   neXtProt; NX_O75578; -.
DR   OpenTargets; ENSG00000143127; -.
DR   PharmGKB; PA29936; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000059610; -.
DR   HOVERGEN; HBG006185; -.
DR   InParanoid; O75578; -.
DR   KO; K06586; -.
DR   OMA; SSFGLEM; -.
DR   OrthoDB; EOG091G00QA; -.
DR   PhylomeDB; O75578; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-75892; Platelet Adhesion to exposed collagen.
DR   SIGNOR; O75578; -.
DR   ChiTaRS; ITGA10; human.
DR   GeneWiki; ITGA10; -.
DR   GenomeRNAi; 8515; -.
DR   PRO; PR:O75578; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143127; -.
DR   CleanEx; HS_ITGA10; -.
DR   Genevisible; O75578; HS.
DR   GO; GO:0034680; C:integrin alpha10-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005518; F:collagen binding; TAS:ProtInc.
DR   GO; GO:0098639; F:collagen binding involved in cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS50234; VWFA; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Cell adhesion; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Magnesium; Membrane;
KW   Metal-binding; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1167       Integrin alpha-10.
FT                                /FTId=PRO_0000016317.
FT   TOPO_DOM     23   1122       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1123   1145       Helical. {ECO:0000255}.
FT   TOPO_DOM   1146   1167       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       24     85       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       95    154       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      167    350       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      361    412       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      417    470       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      472    534       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      535    593       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      597    657       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     494    502       {ECO:0000255}.
FT   CA_BIND     558    566       {ECO:0000255}.
FT   CA_BIND     620    628       {ECO:0000255}.
FT   COMPBIAS   1134   1140       Poly-Leu.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    234    234       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    364    364       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    733    733       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    763    763       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    839    839       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    921    921       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1011   1011       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1018   1018       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1039   1039       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     76     86       {ECO:0000250}.
FT   DISULFID    666    675       {ECO:0000250}.
FT   DISULFID    681    736       {ECO:0000250}.
FT   DISULFID    789    795       {ECO:0000250}.
FT   VAR_SEQ      19    161       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054483.
FT   VAR_SEQ     123    124       AC -> VS (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013114.
FT   VAR_SEQ     125   1167       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013115.
FT   VARIANT     381    381       R -> Q (in dbSNP:rs6665210).
FT                                /FTId=VAR_027768.
FT   VARIANT     668    668       R -> W (in dbSNP:rs36073645).
FT                                /FTId=VAR_034026.
FT   VARIANT     691    691       R -> H (in dbSNP:rs2274618).
FT                                /FTId=VAR_027769.
FT   VARIANT     702    702       A -> T (in dbSNP:rs35515885).
FT                                /FTId=VAR_034027.
FT   VARIANT     725    725       R -> Q (in dbSNP:rs2274616).
FT                                /FTId=VAR_027770.
FT   CONFLICT    844    844       L -> I (in Ref. 1; AAC31952).
FT                                {ECO:0000305}.
FT   CONFLICT    909    909       V -> G (in Ref. 1; AAC31952).
FT                                {ECO:0000305}.
FT   CONFLICT    926    926       D -> E (in Ref. 1; AAC31952).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1167 AA;  127602 MW;  2F7FF938B4C0CBAC CRC64;
     MELPFVTHLF LPLVFLTGLC SPFNLDEHHP RLFPGPPEAE FGYSVLQHVG GGQRWMLVGA
     PWDGPSGDRR GDVYRCPVGG AHNAPCAKGH LGDYQLGNSS HPAVNMHLGM SLLETDGDGG
     FMACAPLWSR ACGSSVFSSG ICARVDASFQ PQGSLAPTAQ RCPTYMDVVI VLDGSNSIYP
     WSEVQTFLRR LVGKLFIDPE QIQVGLVQYG ESPVHEWSLG DFRTKEEVVR AAKNLSRREG
     RETKTAQAIM VACTEGFSQS HGGRPEAARL LVVVTDGESH DGEELPAALK ACEAGRVTRY
     GIAVLGHYLR RQRDPSSFLR EIRTIASDPD ERFFFNVTDE AALTDIVDAL GDRIFGLEGS
     HAENESSFGL EMSQIGFSTH RLKDGILFGM VGAYDWGGSV LWLEGGHRLF PPRMALEDEF
     PPALQNHAAY LGYSVSSMLL RGGRRLFLSG APRFRHRGKV IAFQLKKDGA VRVAQSLQGE
     QIGSYFGSEL CPLDTDRDGT TDVLLVAAPM FLGPQNKETG RVYVYLVGQQ SLLTLQGTLQ
     PEPPQDARFG FAMGALPDLN QDGFADVAVG APLEDGHQGA LYLYHGTQSG VRPHPAQRIA
     AASMPHALSY FGRSVDGRLD LDGDDLVDVA VGAQGAAILL SSRPIVHLTP SLEVTPQAIS
     VVQRDCRRRG QEAVCLTAAL CFQVTSRTPG RWDHQFYMRF TASLDEWTAG ARAAFDGSGQ
     RLSPRRLRLS VGNVTCEQLH FHVLDTSDYL RPVALTVTFA LDNTTKPGPV LNEGSPTSIQ
     KLVPFSKDCG PDNECVTDLV LQVNMDIRGS RKAPFVVRGG RRKVLVSTTL ENRKENAYNT
     SLSLIFSRNL HLASLTPQRE SPIKVECAAP SAHARLCSVG HPVFQTGAKV TFLLEFEFSC
     SSLLSQVFVK LTASSDSLER NGTLQDNTAQ TSAYIQYEPH LLFSSESTLH RYEVHPYGTL
     PVGPGPEFKT TLRVQNLGCY VVSGLIISAL LPAVAHGGNY FLSLSQVITN NASCIVQNLT
     EPPGPPVHPE ELQHTNRLNG SNTQCQVVRC HLGQLAKGTE VSVGLLRLVH NEFFRRAKFK
     SLTVVSTFEL GTEEGSVLQL TEASRWSESL LEVVQTRPIL ISLWILIGSV LGGLLLLALL
     VFCLWKLGFF AHKKIPEEEK REEKLEQ
//
ID   ITB3_HUMAN              Reviewed;         788 AA.
AC   P05106; A0PJW2; D3DXJ8; O15495; Q12806; Q13413; Q14648; Q16499;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   20-DEC-2017, entry version 243.
DE   RecName: Full=Integrin beta-3;
DE   AltName: Full=Platelet membrane glycoprotein IIIa;
DE            Short=GPIIIa;
DE   AltName: CD_antigen=CD61;
DE   Flags: Precursor;
GN   Name=ITGB3; Synonyms=GP3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-3A).
RX   PubMed=3494014;
RA   Fitzgerald L.A., Steiner B., Rall S.C. Jr., Lo S., Phillips D.R.;
RT   "Protein sequence of endothelial glycoprotein IIIa derived from a cDNA
RT   clone. Identity with platelet glycoprotein IIIa and similarity to
RT   'integrin'.";
RL   J. Biol. Chem. 262:3936-3939(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-3A).
RX   PubMed=2452834; DOI=10.1172/JCI113478;
RA   Zimrin A.B., Eisman R., Vilaire G., Schwartz E., Bennett J.S.,
RA   Poncz M.;
RT   "Structure of platelet glycoprotein IIIa. A common subunit for two
RT   different membrane receptors.";
RL   J. Clin. Invest. 81:1470-1475(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-3A).
RX   PubMed=2345548; DOI=10.1007/BF00422712;
RA   Frachet P., Uzan G., Thevenon D., Denarier E., Prandini M.H.,
RA   Marguerie G.;
RT   "GPIIb and GPIIIa amino acid sequences deduced from human
RT   megakaryocyte cDNAs.";
RL   Mol. Biol. Rep. 14:27-33(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-3C), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Osteoclastoma;
RX   PubMed=9195946; DOI=10.1074/jbc.272.26.16390;
RA   Kumar C.S., James I.E., Wong A., Mwangi V., Feild J.A.,
RA   Nuthulaganti P., Connor J.R., Eichman C., Ali F., Hwang S.M.,
RA   Rieman D.J., Drake F.H., Gowen M.;
RT   "Cloning and characterization of a novel integrin beta3 subunit.";
RL   J. Biol. Chem. 272:16390-16397(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA-3A).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-26.
RC   TISSUE=Blood;
RX   PubMed=8298129;
RA   Villa-Garcia M., Li L., Riely G., Bray P.F.;
RT   "Isolation and characterization of a TATA-less promoter for the human
RT   beta 3 integrin gene.";
RL   Blood 83:668-676(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-788.
RC   TISSUE=Erythroleukemia;
RX   PubMed=3165296;
RA   Rosa J.P., Bray P.F., Gayet O., Johnston G.I., Cook R.G.,
RA   Jackson K.W., Shuman M.A., McEver R.P.;
RT   "Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells
RT   and localization of the gene to chromosome 17.";
RL   Blood 72:593-600(1988).
RN   [9]
RP   PROTEIN SEQUENCE OF 27-37.
RC   TISSUE=Platelet;
RX   PubMed=1953640; DOI=10.1042/bj2790419;
RA   Catimel B., Parmentier S., Leung L.L., McGregor J.L.;
RT   "Separation of important new platelet glycoproteins (GPIa, GPIc,
RT   GPIc*, GPIIa and GMP-140) by F.P.L.C. Characterization by monoclonal
RT   antibodies and gas-phase sequencing.";
RL   Biochem. J. 279:419-425(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 27-34.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-788.
RX   PubMed=2341395;
RA   Zimrin A.B., Gidwitz S., Lord S., Schwartz E., Bennett J.S.,
RA   White G.C. II, Poncz M.;
RT   "The genomic organization of platelet glycoprotein IIIa.";
RL   J. Biol. Chem. 265:8590-8595(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-788.
RX   PubMed=2145280;
RA   Lanza F., Kieffer N., Phillips D.R., Fitzgerald L.A.;
RT   "Characterization of the human platelet glycoprotein IIIa gene.
RT   Comparison with the fibronectin receptor beta-subunit gene.";
RL   J. Biol. Chem. 265:18098-18103(1990).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-120, AND VARIANTS PRO-59 AND
RP   ARG-66.
RC   TISSUE=Blood;
RA   Pascual C., Balas A., Garcia-Sanchez F., Rodriguez de la Rua A.,
RA   Vicario J.L.;
RT   "A new exon II polymorphism in the platelet glycoprotein IIIa.";
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 122-204.
RX   PubMed=1382574; DOI=10.1093/intimm/4.9.1031;
RA   Jiang W.-M., Jenkins D., Yuan Q., Leung E., Choo K.H., Watson J.D.,
RA   Krissansen G.W.;
RT   "The gene organization of the human beta 7 subunit, the common beta
RT   subunit of the leukocyte integrins HML-1 and LPAM-1.";
RL   Int. Immunol. 4:1031-1040(1992).
RN   [15]
RP   PROTEIN SEQUENCE OF 218-234 AND 439-443.
RX   PubMed=3801670;
RA   Hiraiwa A., Matsukage A., Shiku H., Takahashi T., Naito K., Yamada K.;
RT   "Purification and partial amino acid sequence of human platelet
RT   membrane glycoproteins IIb and IIIa.";
RL   Blood 69:560-564(1987).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 707-788 (ISOFORM BETA-3B).
RC   TISSUE=Placenta;
RX   PubMed=2787511; DOI=10.1073/pnas.86.14.5415;
RA   Van Kuppevelt T.H.M.S.M., Languino L.R., Gailit J.O., Suzuki S.,
RA   Ruoslahti E.;
RT   "An alternative cytoplasmic domain of the integrin beta 3 subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:5415-5418(1989).
RN   [17]
RP   PARTIAL PROTEIN SEQUENCE, AND DISULFIDE BONDS.
RX   PubMed=2001252; DOI=10.1042/bj2740063;
RA   Calvete J.J., Henschen A., Gonzalez-Rodriguez J.;
RT   "Assignment of disulphide bonds in human platelet GPIIIa. A disulphide
RT   pattern for the beta-subunits of the integrin family.";
RL   Biochem. J. 274:63-71(1991).
RN   [18]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH COXSACKIEVIRUS A9
RP   CAPSID PROTEINS.
RX   PubMed=7519807; DOI=10.1006/viro.1994.1494;
RA   Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T.,
RA   Heino J., Hyypiae T.;
RT   "Entry of coxsackievirus A9 into host cells: specific interactions
RT   with alpha v beta 3 integrin, the vitronectin receptor.";
RL   Virology 203:357-365(1994).
RN   [19]
RP   PHOSPHORYLATION AT TYR-773 AND TYR-785 (ISOFORM BETA-3A).
RX   PubMed=8631894; DOI=10.1074/jbc.271.18.10811;
RA   Law D.A., Nannizzi-Alaimo L., Phillips D.R.;
RT   "Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIb
RT   IIIa) tyrosine phosphorylation induced by platelet aggregation.";
RL   J. Biol. Chem. 271:10811-10815(1996).
RN   [20]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HANTAAN
RP   GLYCOPROTEIN G.
RX   PubMed=9618541; DOI=10.1073/pnas.95.12.7074;
RA   Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., Mackow E.R.;
RT   "beta3 Integrins mediate the cellular entry of hantaviruses that cause
RT   respiratory failure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:7074-7079(1998).
RN   [21]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HIV-1 TAT.
RX   PubMed=10397733;
RA   Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S.,
RA   Manzari V., Modesti A., Nair B.C., Cafaro A., Stuerzl M., Ensoli B.;
RT   "The Tat protein of human immunodeficiency virus type-1 promotes
RT   vascular cell growth and locomotion by engaging the alpha5beta1 and
RT   alphavbeta3 integrins and by mobilizing sequestered basic fibroblast
RT   growth factor.";
RL   Blood 94:663-672(1999).
RN   [22]
RP   PHOSPHORYLATION AT THR-779.
RX   PubMed=10896934; DOI=10.1074/jbc.M001908200;
RA   Kirk R.I., Sanderson M.R., Lerea K.M.;
RT   "Threonine phosphorylation of the beta 3 integrin cytoplasmic tail, at
RT   a site recognized by PDK1 and Akt/PKB in vitro, regulates Shc
RT   binding.";
RL   J. Biol. Chem. 275:30901-30906(2000).
RN   [23]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN
RP   PARECHOVIRUS 1 CAPSID PROTEINS.
RX   PubMed=11160695; DOI=10.1128/JVI.75.4.1958-1967.2001;
RA   Joki-Korpela P., Marjomaki V., Krogerus C., Heino J., Hyypia T.;
RT   "Entry of human parechovirus 1.";
RL   J. Virol. 75:1958-1967(2001).
RN   [24]
RP   INTERACTION WITH SYK.
RX   PubMed=11940607; DOI=10.1083/jcb.200112113;
RA   Obergfell A., Eto K., Mocsai A., Buensuceso C., Moores S.L.,
RA   Brugge J.S., Lowell C.A., Shattil S.J.;
RT   "Coordinate interactions of Csk, Src, and Syk kinases with
RT   [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton.";
RL   J. Cell Biol. 157:265-275(2002).
RN   [25]
RP   INTERACTION WITH FLNB.
RC   TISSUE=Keratinocyte, and Skeletal muscle;
RX   PubMed=11807098; DOI=10.1083/jcb.200103037;
RA   van Der Flier A., Kuikman I., Kramer D., Geerts D., Kreft M.,
RA   Takafuta T., Shapiro S.S., Sonnenberg A.;
RT   "Different splice variants of filamin-B affect myogenesis, subcellular
RT   distribution, and determine binding to integrin (beta) subunits.";
RL   J. Cell Biol. 156:361-376(2002).
RN   [26]
RP   INTERACTION WITH NOV.
RX   PubMed=12695522; DOI=10.1074/jbc.M302028200;
RA   Lin C.G., Leu S.J., Chen N., Tebeau C.M., Lin S.X., Yeung C.Y.,
RA   Lau L.F.;
RT   "CCN3 (NOV) is a novel angiogenic regulator of the CCN protein
RT   family.";
RL   J. Biol. Chem. 278:24200-24208(2003).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH FBN1.
RX   PubMed=12807887; DOI=10.1074/jbc.M303159200;
RA   Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J.,
RA   Shuttleworth C.A., Humphries M.J., Kielty C.M.;
RT   "Cell adhesion to fibrillin-1 molecules and microfibrils is mediated
RT   by alpha 5 beta 1 and alpha v beta 3 integrins.";
RL   J. Biol. Chem. 278:34605-34616(2003).
RN   [28]
RP   INTERACTION WITH MYO10.
RX   PubMed=15156152; DOI=10.1038/ncb1136;
RA   Zhang H., Berg J.S., Li Z., Wang Y., Lang P., Sousa A.D., Bhaskar A.,
RA   Cheney R.E., Stromblad S.;
RT   "Myosin-X provides a motor-based link between integrins and the
RT   cytoskeleton.";
RL   Nat. Cell Biol. 6:523-531(2004).
RN   [29]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH
RP   CYTOMEGALOVIRUS/HHV-5 GH:GL PROTEINS.
RX   PubMed=15834425; DOI=10.1038/nm1236;
RA   Wang X., Huang D.Y., Huong S.M., Huang E.S.;
RT   "Integrin alphavbeta3 is a coreceptor for human cytomegalovirus.";
RL   Nat. Med. 11:515-521(2005).
RN   [30]
RP   INTERACTION WITH PDIA6.
RX   PubMed=15466936; DOI=10.1182/blood-2004-02-0608;
RA   Jordan P.A., Stevens J.M., Hubbard G.P., Barrett N.E., Sage T.,
RA   Authi K.S., Gibbins J.M.;
RT   "A role for the thiol isomerase protein ERP5 in platelet function.";
RL   Blood 105:1500-1507(2005).
RN   [31]
RP   INTERACTION WITH EMP2.
RX   PubMed=16216233; DOI=10.1016/j.ydbio.2005.09.003;
RA   Wadehra M., Forbes A., Pushkarna N., Goodglick L., Gordon L.K.,
RA   Williams C.J., Braun J.;
RT   "Epithelial membrane protein-2 regulates surface expression of
RT   alphavbeta3 integrin in the endometrium.";
RL   Dev. Biol. 287:336-345(2005).
RN   [32]
RP   INTERACTION WITH COMP.
RX   PubMed=16051604; DOI=10.1074/jbc.M504778200;
RA   Chen F.-H., Thomas A.O., Hecht J.T., Goldring M.B., Lawler J.;
RT   "Cartilage oligomeric matrix protein/thrombospondin 5 supports
RT   chondrocyte attachment through interaction with integrins.";
RL   J. Biol. Chem. 280:32655-32661(2005).
RN   [33]
RP   REVIEW.
RX   PubMed=16322781; DOI=10.1172/JCI26989;
RA   Bennett J.S.;
RT   "Structure and function of the platelet integrin alphaIIbbeta3.";
RL   J. Clin. Invest. 115:3363-3369(2005).
RN   [34]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [35]
RP   INTERACTION WITH ADGRA2.
RX   PubMed=16982628; DOI=10.1074/jbc.M605291200;
RA   Vallon M., Essler M.;
RT   "Proteolytically processed soluble tumor endothelial marker (TEM) 5
RT   mediates endothelial cell survival during angiogenesis by linking
RT   integrin alpha(v)beta3 to glycosaminoglycans.";
RL   J. Biol. Chem. 281:34179-34188(2006).
RN   [36]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [37]
RP   REVIEW.
RX   PubMed=17635696; DOI=10.1111/j.1538-7836.2007.02537.x;
RA   Ma Y.Q., Qin J., Plow E.F.;
RT   "Platelet integrin alpha(IIb)beta(3): activation mechanisms.";
RL   J. Thromb. Haemost. 5:1345-1352(2007).
RN   [38]
RP   FUNCTION, BINDING TO FGF1, AND IDENTIFICATION IN A COMPLEX WITH FGF1
RP   AND FGFR1.
RX   PubMed=18441324; DOI=10.1074/jbc.M801213200;
RA   Mori S., Wu C.Y., Yamaji S., Saegusa J., Shi B., Ma Z., Kuwabara Y.,
RA   Lam K.S., Isseroff R.R., Takada Y.K., Takada Y.;
RT   "Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1
RT   signaling.";
RL   J. Biol. Chem. 283:18066-18075(2008).
RN   [39]
RP   FUNCTION.
RX   PubMed=18635536; DOI=10.1074/jbc.M804835200;
RA   Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S.,
RA   Liu F.T., Takada Y.K., Takada Y.;
RT   "Pro-inflammatory secretory phospholipase A2 type IIA binds to
RT   integrins alphavbeta3 and alpha4beta1 and induces proliferation of
RT   monocytic cells in an integrin-dependent manner.";
RL   J. Biol. Chem. 283:26107-26115(2008).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-773, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [41]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HHV-8
RP   GLYCOPROTEIN B.
RX   PubMed=18045938; DOI=10.1128/JVI.01673-07;
RA   Garrigues H.J., Rubinchikova Y.E., Dipersio C.M., Rose T.M.;
RT   "Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of
RT   Kaposi's sarcoma-associated herpesvirus and functions as an RGD-
RT   dependent entry receptor.";
RL   J. Virol. 82:1570-1580(2008).
RN   [42]
RP   IDENTIFICATION OF ALLOANTIGEN HPA-1A BY MASS SPECTROMETRY, AND
RP   ASSOCIATION TO ALLELE HLA-DRB3*01:01.
RX   PubMed=19494351; DOI=10.1182/blood-2009-04-211839;
RA   Anani Sarab G., Moss M., Barker R.N., Urbaniak S.J.;
RT   "Naturally processed peptides spanning the HPA-1a polymorphism are
RT   efficiently generated and displayed from platelet glycoprotein by HLA-
RT   DRB3*0101-positive antigen-presenting cells.";
RL   Blood 114:1954-1957(2009).
RN   [43]
RP   FUNCTION, BINDING TO IGF1, AND IDENTIFICATION IN A COMPLEX WITH IGF1
RP   AND IGF1R.
RX   PubMed=19578119; DOI=10.1074/jbc.M109.013201;
RA   Saegusa J., Yamaji S., Ieguchi K., Wu C.Y., Lam K.S., Liu F.T.,
RA   Takada Y.K., Takada Y.;
RT   "The direct binding of insulin-like growth factor-1 (IGF-1) to
RT   integrin alphavbeta3 is involved in IGF-1 signaling.";
RL   J. Biol. Chem. 284:24106-24114(2009).
RN   [44]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-680.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [45]
RP   INTERACTION WITH FERMT2, AND SUBCELLULAR LOCATION.
RX   PubMed=20702409; DOI=10.1074/jbc.C110.134247;
RA   Bledzka K., Bialkowska K., Nie H., Qin J., Byzova T., Wu C.,
RA   Plow E.F., Ma Y.Q.;
RT   "Tyrosine phosphorylation of integrin beta3 regulates kindlin-2
RT   binding and integrin activation.";
RL   J. Biol. Chem. 285:30370-30374(2010).
RN   [46]
RP   FUNCTION, BINDING TO NRG1, AND IDENTIFICATION IN A COMPLEX WITH NRG1
RP   AND ERBB3.
RX   PubMed=20682778; DOI=10.1074/jbc.M110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [47]
RP   FUNCTION, BINDING TO CX3CL1, IDENTIFICATION IN A COMPLEX WITH CX3CR1
RP   AND CX3CL1, AND CX3CL1-BINDING REGION.
RX   PubMed=23125415; DOI=10.4049/jimmunol.1200889;
RA   Fujita M., Takada Y.K., Takada Y.;
RT   "Integrins alphavbeta3 and alpha4beta1 act as coreceptors for
RT   fractalkine, and the integrin-binding defective mutant of fractalkine
RT   is an antagonist of CX3CR1.";
RL   J. Immunol. 189:5809-5819(2012).
RN   [48]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH WEST NILE VIRUS
RP   ENVELOPE PROTEIN E.
RX   PubMed=23658209; DOI=10.1099/vir.0.052613-0;
RA   Schmidt K., Keller M., Bader B.L., Korytar T., Finke S., Ziegler U.,
RA   Groschup M.H.;
RT   "Integrins modulate the infection efficiency of West Nile virus into
RT   cells.";
RL   J. Gen. Virol. 94:1723-1733(2013).
RN   [49]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN
RP   METAPNEUMOVIRUS FUSION PROTEIN.
RX   PubMed=24478423; DOI=10.1128/JVI.03491-13;
RA   Wei Y., Zhang Y., Cai H., Mirza A.M., Iorio R.M., Peeples M.E.,
RA   Niewiesk S., Li J.;
RT   "Roles of the putative integrin-binding motif of the human
RT   metapneumovirus fusion (f) protein in cell-cell fusion, viral
RT   infectivity, and pathogenesis.";
RL   J. Virol. 88:4338-4352(2014).
RN   [50]
RP   BINDING TO CX3CL1, AND CX3CL1-BINDING REGION.
RX   PubMed=24789099; DOI=10.1371/journal.pone.0096372;
RA   Fujita M., Takada Y.K., Takada Y.;
RT   "The chemokine fractalkine can activate integrins without CX3CR1
RT   through direct binding to a ligand-binding site distinct from the
RT   classical RGD-binding site.";
RL   PLoS ONE 9:E96372-E96372(2014).
RN   [51]
RP   FUNCTION.
RX   PubMed=25398877; DOI=10.1074/jbc.M114.579946;
RA   Fujita M., Zhu K., Fujita C.K., Zhao M., Lam K.S., Kurth M.J.,
RA   Takada Y.K., Takada Y.;
RT   "Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces
RT   integrin activation through direct binding to a newly identified
RT   binding site (site 2) in integrins alphavbeta3, alpha4beta1, and
RT   alpha5beta1.";
RL   J. Biol. Chem. 290:259-271(2015).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 27-718, AND GLYCOSYLATION AT
RP   ASN-346; ASN-397; ASN-585 AND ASN-680.
RX   PubMed=11546839; DOI=10.1126/science.1064535;
RA   Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L.,
RA   Joachimiak A., Goodman S.L., Arnaout M.A.;
RT   "Crystal structure of the extracellular segment of integrin alpha
RT   Vbeta3.";
RL   Science 294:339-345(2001).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 50-61 (ALLOANTIGEN HPA-1A)
RP   IN COMPLEX WITH HLA-DRA/HLA-DRB3 HETERODIMER.
RX   PubMed=17583734; DOI=10.1016/j.jmb.2007.05.025;
RA   Parry C.S., Gorski J., Stern L.J.;
RT   "Crystallographic structure of the human leukocyte antigen DRA,
RT   DRB3*0101: models of a directional alloimmune response and
RT   autoimmunity.";
RL   J. Mol. Biol. 371:435-446(2007).
RN   [54]
RP   REVIEW ON GT VARIANTS.
RX   PubMed=7878622;
RA   Bray P.F.;
RT   "Inherited diseases of platelet glycoproteins: considerations for
RT   rapid molecular characterization.";
RL   Thromb. Haemost. 72:492-502(1994).
RN   [55]
RP   VARIANT HPA-1B PRO-59, AND DESCRIPTION OF ALLOANTIGEN SYSTEM PL(A).
RX   PubMed=2565345; DOI=10.1172/JCI114082;
RA   Newman P.J., Derbes R.S., Aster R.H.;
RT   "The human platelet alloantigens, PlA1 and PlA2, are associated with a
RT   leucine33/proline33 amino acid polymorphism in membrane glycoprotein
RT   IIIa, and are distinguishable by DNA typing.";
RL   J. Clin. Invest. 83:1778-1781(1989).
RN   [56]
RP   VARIANT HPA-4B GLN-169, AND DESCRIPTION OF ALLOANTIGEN SYSTEM PEN.
RX   PubMed=1430225; DOI=10.1172/JCI116084;
RA   Wang R., Furihata K., McFarland J.G., Friedman K., Aster R.H.,
RA   Newman P.J.;
RT   "An amino acid polymorphism within the RGD binding domain of platelet
RT   membrane glycoprotein IIIa is responsible for the formation of the
RT   Pena/Penb alloantigen system.";
RL   J. Clin. Invest. 90:2038-2043(1992).
RN   [57]
RP   VARIANT MO(+) ALA-433.
RX   PubMed=8093349;
RA   Kuijpers R.W.A.M., Simsek S., Faber N.M., Goldschmeding R.,
RA   van Wermerkerken R.K.V., von Dem Borne A.E.G.K.;
RT   "Single point mutation in human glycoprotein IIIa is associated with a
RT   new platelet-specific alloantigen (Mo) involved in neonatal alloimmune
RT   thrombocytopenia.";
RL   Blood 81:70-76(1993).
RN   [58]
RP   VARIANT CA(+)/TU(+) GLN-515, AND DESCRIPTION OF ALLOANTIGEN SYSTEM
RP   CA/TU.
RX   PubMed=7694683;
RA   Wang R., McFarland J.G., Kekomaki R., Newman P.J.;
RT   "Amino acid 489 is encoded by a mutational 'hot spot' on the beta 3
RT   integrin chain: the CA/TU human platelet alloantigen system.";
RL   Blood 82:3386-3391(1993).
RN   [59]
RP   VARIANT SR(A) CYS-662, AND DESCRIPTION OF ALLOANTIGEN SYSTEM SR(A).
RX   PubMed=8132570;
RA   Santoso S., Kalb R., Kroll H., Walka M., Kiefel V.,
RA   Mueller-Eckhardt C., Newman P.J.;
RT   "A point mutation leads to an unpaired cysteine residue and a
RT   molecular weight polymorphism of a functional platelet beta 3 integrin
RT   subunit. The Sra alloantigen system of GPIIIa.";
RL   J. Biol. Chem. 269:8439-8444(1994).
RN   [60]
RP   VARIANT GT TYR-145.
RX   PubMed=2392682; DOI=10.1126/science.2392682;
RA   Loftus J.C., O'Toole T.E., Plow E.F., Glass A., Frelinger A.L. III,
RA   Ginsberg M.H.;
RT   "A beta 3 integrin mutation abolishes ligand binding and alters
RT   divalent cation-dependent conformation.";
RL   Science 249:915-918(1990).
RN   [61]
RP   VARIANT GT GLN-240.
RX   PubMed=1371279;
RA   Bajt M.L., Ginsberg M.H., Frelinger A.L. III, Berndt M.C.,
RA   Loftus J.C.;
RT   "A spontaneous mutation of integrin alpha IIb beta 3 (platelet
RT   glycoprotein IIb-IIIa) helps define a ligand binding site.";
RL   J. Biol. Chem. 267:3789-3794(1992).
RN   [62]
RP   VARIANT GT TRP-240.
RX   PubMed=1602006; DOI=10.1172/JCI115808;
RA   Lanza F., Stierle A., Fournier D., Morales M., Andre G., Nurden A.T.,
RA   Cazenave J.-P.;
RT   "A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets
RT   with functionally defective glycoprotein IIb-IIIa complexes and a
RT   glycoprotein IIIa 214Arg-->214Trp mutation.";
RL   J. Clin. Invest. 89:1995-2004(1992).
RN   [63]
RP   VARIANT GT PRO-778.
RX   PubMed=1438206; DOI=10.1073/pnas.89.21.10169;
RA   Chen Y.-P., Djaffar I., Pidard D., Steiner B., Cieutat A.-M.,
RA   Caen J.P., Rosa J.-P.;
RT   "Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3
RT   subunit and defective activation of platelet integrin alpha IIb beta 3
RT   (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:10169-10173(1992).
RN   [64]
RP   VARIANT GT TYR-400.
RX   PubMed=8781422;
RA   Grimaldi C.M., Chen F., Scudder L.E., Coller B.S., French D.L.;
RT   "A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta
RT   3) in a Chinese patient with Glanzmann's thrombasthenia.";
RL   Blood 88:1666-1675(1996).
RN   [65]
RP   VARIANT GT TRP-143.
RX   PubMed=9376589;
RA   Basani R.B., Brown D.L., Vilaire G., Bennett J.S., Poncz M.;
RT   "A Leu117-->Trp mutation within the RGD-peptide cross-linking region
RT   of beta3 results in Glanzmann thrombasthenia by preventing alphaIIb
RT   beta3 export to the platelet surface.";
RL   Blood 90:3082-3088(1997).
RN   [66]
RP   VARIANTS GT ASN-145; GLN-242 AND PRO-288.
RX   PubMed=9215749; DOI=10.1006/bcmd.1997.0117;
RA   French D.L., Coller B.S.;
RT   "Hematologically important mutations: Glanzmann thrombasthenia.";
RL   Blood Cells Mol. Dis. 23:39-51(1997).
RN   [67]
RP   VARIANTS GT PRO-306; PHE-586; SER-598 AND SER-605.
RX   PubMed=9790984; DOI=10.1006/bbrc.1998.9526;
RA   Ambo H., Kamata T., Handa M., Taki M., Kuwajima M., Kawai Y., Oda A.,
RA   Murata M., Takada Y., Watanabe K., Ikeda Y.;
RT   "Three novel integrin beta3 subunit missense mutations (H280P, C560F,
RT   and G579S) in thrombasthenia, including one (H280P) prevalent in
RT   Japanese patients.";
RL   Biochem. Biophys. Res. Commun. 251:763-768(1998).
RN   [68]
RP   VARIANT GT LEU-188.
RX   PubMed=9684783;
RA   Jackson D.E., White M.M., Jennings L.K., Newman P.J.;
RT   "A Ser162-->Leu mutation within glycoprotein (GP) IIIa (integrin
RT   beta3) results in an unstable alphaIIbbeta3 complex that retains
RT   partial function in a novel form of type II Glanzmann
RT   thrombasthenia.";
RL   Thromb. Haemost. 80:42-48(1998).
RN   [69]
RP   VARIANT GT ARG-568.
RX   PubMed=10233432; DOI=10.1111/j.1365-2141.1999.01376.x;
RA   Ruan J., Schmugge M., Clemetson K.J., Cazes E., Combrie R., Bourre F.,
RA   Nurden A.T.;
RT   "Homozygous Cys542-->Arg substitution in GPIIIa in a Swiss patient
RT   with type I Glanzmann's thrombasthenia.";
RL   Br. J. Haematol. 105:523-531(1999).
RN   [70]
RP   VARIANTS PRO-59; GLN-169 AND ILE-453.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [71]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [72]
RP   VARIANT GT ARG-586, AND CHARACTERIZATION OF VARIANT GT ARG-586.
RX   PubMed=11588040; DOI=10.1182/blood.V98.8.2432;
RA   Ruiz C., Liu C.-Y., Sun Q.-H., Sigaud-Fiks M., Fressinaud E.,
RA   Muller J.-Y., Nurden P., Nurden A.T., Newman P.J., Valentin N.;
RT   "A point mutation in the cysteine-rich domain of glycoprotein (GP)
RT   IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3)
RT   integrin receptor locked in a high-affinity state and a Glanzmann
RT   thrombasthenia-like phenotype.";
RL   Blood 98:2432-2441(2001).
RN   [73]
RP   VARIANT ILE-166, AND CHARACTERIZATION OF VARIANT ILE-166.
RX   PubMed=12036875; DOI=10.1182/blood.V99.12.4449;
RA   Jallu V., Meunier M., Brement M., Kaplan C.;
RT   "A new platelet polymorphism Duv(a+), localized within the RGD binding
RT   domain of glycoprotein IIIa, is associated with neonatal
RT   thrombocytopenia.";
RL   Blood 99:4449-4456(2002).
RN   [74]
RP   VARIANT GT PRO-222.
RX   PubMed=11897046; DOI=10.1080/09537100220122466;
RA   Nurden A.T., Ruan J., Pasquet J.-M., Gauthier B., Combrie R.,
RA   Kunicki T., Nurden P.;
RT   "A novel 196Leu to Pro substitution in the beta3 subunit of the
RT   alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann
RT   thrombasthenia.";
RL   Platelets 13:101-111(2002).
RN   [75]
RP   VARIANTS GT TRP-119; VAL-243 AND ARG-601.
RX   PubMed=12083483;
RA   D'Andrea G., Colaizzo D., Vecchione G., Grandone E., Di Minno G.,
RA   Margaglione M.;
RT   "Glanzmann's thrombasthenia: identification of 19 new mutations in 30
RT   patients.";
RL   Thromb. Haemost. 87:1034-1042(2002).
RN   [76]
RP   VARIANT GT TYR-532.
RX   PubMed=12353082; DOI=10.1267/THRO88030503;
RA   Nair S., Li J., Mitchell W.B., Mohanty D., Coller B.S., French D.L.;
RT   "Two new beta3 integrin mutations in Indian patients with Glanzmann
RT   thrombasthenia: localization of mutations affecting cysteine residues
RT   in integrin beta3.";
RL   Thromb. Haemost. 88:503-509(2002).
RN   [77]
RP   VARIANT GT VAL-150, AND CHARACTERIZATION OF VARIANT GT VAL-150.
RX   PubMed=15583747; DOI=10.1267/THRO04061377;
RA   Gonzalez-Manchon C., Butta N., Larrucea S., Arias-Salgado E.G.,
RA   Alonso S., Lopez A., Parrilla R.;
RT   "A variant thrombasthenic phenotype associated with compound
RT   heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the
RT   subunit dimerization rendering a decreased number of constitutive
RT   active alphaIIbbeta3 receptors.";
RL   Thromb. Haemost. 92:1377-1386(2004).
RN   [78]
RP   VARIANTS GT PRO-306 AND ASN-330, AND CHARACTERIZATION OF VARIANT GT
RP   ASN-330.
RX   PubMed=15634267; DOI=10.1111/j.1538-7836.2004.00990.x;
RA   Tanaka S., Hayashi T., Yoshimura K., Nakayama M., Fujita T., Amano T.,
RA   Tani Y.;
RT   "Double heterozygosity for a novel missense mutation of Ile304 to Asn
RT   in addition to the missense mutation His280 to Pro in the integrin
RT   beta3 gene as a cause of the absence of platelet alphaIIbbeta3 in
RT   Glanzmann's thrombasthenia.";
RL   J. Thromb. Haemost. 3:68-73(2005).
RN   [79]
RP   VARIANTS GT CYS-141 AND LEU-321.
RX   PubMed=15748237; DOI=10.1111/j.1538-7836.2005.01159.x;
RA   Nair S., Ghosh K., Shetty S., Mohanty D.;
RT   "Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia
RT   in Indian patients.";
RL   J. Thromb. Haemost. 3:482-488(2005).
RN   [80]
RP   VARIANT BDPLT16 HIS-749, AND CHARACTERIZATION OF VARIANT BDPLT16
RP   HIS-749.
RX   PubMed=18065693; DOI=10.1182/blood-2007-09-112615;
RA   Ghevaert C., Salsmann A., Watkins N.A., Schaffner-Reckinger E.,
RA   Rankin A., Garner S.F., Stephens J., Smith G.A., Debili N.,
RA   Vainchenker W., de Groot P.G., Huntington J.A., Laffan M., Kieffer N.,
RA   Ouwehand W.H.;
RT   "A nonsynonymous SNP in the ITGB3 gene disrupts the conserved
RT   membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3
RT   integrin and cosegregates dominantly with abnormal proplatelet
RT   formation and macrothrombocytopenia.";
RL   Blood 111:3407-3414(2008).
RN   [81]
RP   VARIANTS GT TYR-64; ARG-144; PRO-222; ASP-247 AND MET-279,
RP   CHARACTERIZATION OF VARIANTS TYR-64; PRO-222; ASP-247 AND MET-279, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20020534; DOI=10.1002/humu.21179;
RA   Jallu V., Dusseaux M., Panzer S., Torchet M.F., Hezard N.,
RA   Goudemand J., de Brevern A.G., Kaplan C.;
RT   "AlphaIIbbeta3 integrin: new allelic variants in Glanzmann
RT   thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression,
RT   and structure-function.";
RL   Hum. Mutat. 31:237-246(2010).
CC   -!- FUNCTION: Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for
CC       cytotactin, fibronectin, laminin, matrix metalloproteinase-2,
CC       osteopontin, osteomodulin, prothrombin, thrombospondin,
CC       vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3
CC       (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen,
CC       plasminogen, prothrombin, thrombospondin and vitronectin.
CC       Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the
CC       sequence R-G-D in a wide array of ligands. Integrin alpha-
CC       IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in
CC       fibrinogen gamma chain. Following activation integrin alpha-
CC       IIb/beta-3 brings about platelet/platelet interaction through
CC       binding of soluble fibrinogen. This step leads to rapid platelet
CC       aggregation which physically plugs ruptured endothelial surface.
CC       Fibrinogen binding enhances SELP expression in activated platelets
CC       (By similarity). ITGAV:ITGB3 binds to fractalkine (CX3CL1) and
CC       acts as its coreceptor in CX3CR1-dependent fractalkine signaling
CC       (PubMed:23125415, PubMed:24789099). ITGAV:ITGB3 binds to NRG1 (via
CC       EGF domain) and this binding is essential for NRG1-ERBB signaling
CC       (PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is
CC       essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds
CC       to IGF1 and this binding is essential for IGF1 signaling
CC       (PubMed:19578119). ITGAV:ITGB3 binds to PLA2G2A via a site (site
CC       2) which is distinct from the classical ligand-binding site (site
CC       1) and this induces integrin conformational changes and enhanced
CC       ligand binding to site 1 (PubMed:18635536, PubMed:25398877).
CC       ITGAV:ITGB3 acts as a receptor for fibrillin-1 (FBN1) and mediates
CC       R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887).
CC       {ECO:0000250|UniProtKB:O54890, ECO:0000269|PubMed:12807887,
CC       ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:18635536,
CC       ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:24789099,
CC       ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:9195946,
CC       ECO:0000303|PubMed:16322781, ECO:0000303|PubMed:17635696}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a
CC       receptor for herpes virus 8/HHV-8 (PubMed:18045938). Integrin
CC       ITGAV:ITGB3 acts as a receptor for coxsackievirus A9
CC       (PubMed:7519807). Acts as a receptor for Hantaan virus
CC       (PubMed:9618541). Integrin ITGAV:ITGB3 acts as a receptor for
CC       cytomegalovirus/HHV-5 (PubMed:15834425). Integrin ITGA5:ITGB3 acts
CC       as a receptor for human metapneumovirus (PubMed:24478423).
CC       Integrin ITGAV:ITGB3 acts aP05556s a receptor for human
CC       parechovirus 1 (PubMed:11160695). Integrin ITGAV:ITGB3 acts as a
CC       receptor for west nile virus (PubMed:23658209). In case of HIV-1
CC       infection, the interaction with extracellular viral Tat protein
CC       seems to enhance angiogenesis in Kaposi's sarcoma lesions
CC       (PubMed:10397733). {ECO:0000269|PubMed:10397733,
CC       ECO:0000269|PubMed:11160695, ECO:0000269|PubMed:15834425,
CC       ECO:0000269|PubMed:18045938, ECO:0000269|PubMed:23658209,
CC       ECO:0000269|PubMed:24478423, ECO:0000269|PubMed:7519807,
CC       ECO:0000269|PubMed:9618541}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-3
CC       (ITGB3) associates with either alpha-IIb (ITGA2B) or alpha-V
CC       (ITGAV). Isoform Beta-3C interacts with FLNB. Interacts with COMP.
CC       Interacts with PDIA6 following platelet stimulation. Interacts
CC       with SYK; upon activation by ITGB3 promotes platelet adhesion.
CC       Interacts with MYO10. Interacts with DAB2. Interacts with FERMT2.
CC       Interacts with EMP2; regulates the levels of the heterodimer
CC       ITGA5:ITGB3 integrin expression on the plasma membrane
CC       (PubMed:16216233). Integrin ITGAV:ITGB3 interacts with FBLN5 (via
CC       N-terminus) (By similarity). ITGAV:ITGB3 interacts with NOV
CC       (PubMed:12695522). ITGAV:ITGB3 is found in a ternary complex with
CC       CX3CR1 and CX3CL1 (PubMed:23125415). ITGAV:ITGB3 is found in a
CC       ternary complex with NRG1 and ERBB3 (PubMed:20682778). ITGAV:ITGB3
CC       is found in a ternary complex with FGF1 and FGFR1
CC       (PubMed:18441324). ITGAV:ITGB3 is found in a ternary complex with
CC       IGF1 and IGF1R (PubMed:19578119). ITGAV:ITGB3 interacts with FBN1
CC       (PubMed:12807887). {ECO:0000250|UniProtKB:O54890,
CC       ECO:0000269|PubMed:11807098, ECO:0000269|PubMed:11940607,
CC       ECO:0000269|PubMed:12695522, ECO:0000269|PubMed:12807887,
CC       ECO:0000269|PubMed:15156152, ECO:0000269|PubMed:15466936,
CC       ECO:0000269|PubMed:16051604, ECO:0000269|PubMed:16216233,
CC       ECO:0000269|PubMed:17583734, ECO:0000269|PubMed:18441324,
CC       ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:20702409, ECO:0000269|PubMed:23125415}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       herpes virus 8/HHV-8 glycoprotein B.
CC       {ECO:0000269|PubMed:18045938}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       coxsackievirus A9 capsid proteins. {ECO:0000269|PubMed:7519807}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Hantaan virus
CC       glycoprotein G. {ECO:0000269|PubMed:9618541}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       cytomegalovirus/HHV-5 gH:gL proteins.
CC       {ECO:0000269|PubMed:15834425}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA5:ITGB3 interacts with
CC       human metapneumovirus fusion protein.
CC       {ECO:0000269|PubMed:24478423}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       human parechovirus 1 capsid proteins.
CC       {ECO:0000269|PubMed:11160695}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       west nile virus envelope protein E. {ECO:0000269|PubMed:23658209}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat
CC       (PubMed:10397733). ITGAV:ITGB3 interacts with AGRA2
CC       (PubMed:16982628). {ECO:0000269|PubMed:10397733,
CC       ECO:0000269|PubMed:16982628}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-702847, EBI-702847;
CC       P06935:- (xeno); NbExp=4; IntAct=EBI-702847, EBI-981051;
CC       P05094:ACTN1 (xeno); NbExp=2; IntAct=EBI-702847, EBI-5847257;
CC       P78423:CX3CL1; NbExp=2; IntAct=EBI-702847, EBI-15188013;
CC       P21333:FLNA; NbExp=3; IntAct=EBI-702847, EBI-350432;
CC       F5HB81:gB (xeno); NbExp=2; IntAct=EBI-702847, EBI-9027696;
CC       P08514:ITGA2B; NbExp=11; IntAct=EBI-702847, EBI-702693;
CC       P08514-1:ITGA2B; NbExp=4; IntAct=EBI-702847, EBI-15805658;
CC       P06756:ITGAV; NbExp=13; IntAct=EBI-702847, EBI-298282;
CC       Q62101:Prkd1 (xeno); NbExp=2; IntAct=EBI-702847, EBI-6903636;
CC       P18031:PTPN1; NbExp=4; IntAct=EBI-702847, EBI-968788;
CC       P05480:Src (xeno); NbExp=5; IntAct=EBI-702847, EBI-298680;
CC       P54939:TLN1 (xeno); NbExp=2; IntAct=EBI-702847, EBI-1035421;
CC       Q9Y490:TLN1; NbExp=4; IntAct=EBI-702847, EBI-2462036;
CC       P26039:Tln1 (xeno); NbExp=7; IntAct=EBI-702847, EBI-1039593;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20020534,
CC       ECO:0000269|PubMed:20702409, ECO:0000269|PubMed:9195946}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:20020534,
CC       ECO:0000269|PubMed:20702409, ECO:0000269|PubMed:9195946}. Cell
CC       projection, lamellipodium membrane {ECO:0000269|PubMed:20702409}.
CC       Cell junction, focal adhesion {ECO:0000269|PubMed:20702409}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Beta-3A;
CC         IsoId=P05106-1; Sequence=Displayed;
CC       Name=Beta-3B;
CC         IsoId=P05106-2; Sequence=VSP_002745;
CC       Name=Beta-3C;
CC         IsoId=P05106-3; Sequence=VSP_002746;
CC   -!- TISSUE SPECIFICITY: Isoform beta-3A and isoform beta-3C are widely
CC       expressed. Isoform beta-3A is specifically expressed in osteoblast
CC       cells; isoform beta-3C is specifically expressed in prostate and
CC       testis.
CC   -!- PTM: Phosphorylated on tyrosine residues in response to thrombin-
CC       induced platelet aggregation. Probably involved in outside-in
CC       signaling. A peptide (AA 740-762) is capable of binding GRB2 only
CC       when both Tyr-773 and Tyr-785 are phosphorylated. Phosphorylation
CC       of Thr-779 inhibits SHC binding. {ECO:0000269|PubMed:10896934}.
CC   -!- POLYMORPHISM: Position 59 is associated with platelet-specific
CC       alloantigen HPA-1 (ZW or PL(A)). HPA-1A/ZW(A)/PL(A1) has Leu-59
CC       and HPA-1B/ZW(B)/PL(A2) has Pro-59. HPA-1A is involved in fetal-
CC       maternal alloimmune thromobocytopenia (FMAIT) as well as in
CC       neonatal alloimmune thrombocytopenia (NAIT).
CC   -!- POLYMORPHISM: Position 169 is associated with platelet-specific
CC       alloantigen HPA-4 (PEN or YUK). HPA-4A/PEN(A)/YUK(A) has Arg-169
CC       and HPA-4B/PEN(B)/YUK(B) has Gln-169. HPA-4B is involved in
CC       neonatal alloimmune thrombocytopenia (NAIT or NATP).
CC   -!- POLYMORPHISM: Position 433 is associated with platelet-specific
CC       alloantigen MO. MO(-) has Pro-433 and MO(+) has Ala-433. MO(+) is
CC       involved in NAIT.
CC   -!- POLYMORPHISM: Position 515 is associated with platelet-specific
CC       alloantigen CA/TU. CA(-)/TU(-) has Arg-515 and CA(+)/TU(+) has
CC       Gln-515. CA(+) is involved in NAIT.
CC   -!- POLYMORPHISM: Position 662 is associated with platelet-specific
CC       alloantigen SR(A). SR(A)(-) has Arg-662 and SR(A)(+) has Cys-662.
CC   -!- DISEASE: Glanzmann thrombasthenia (GT) [MIM:273800]: A common
CC       inherited disease of platelet aggregation. It is characterized by
CC       mucocutaneous bleeding of mild-to-moderate severity. GT has been
CC       classified clinically into types I and II. In type I, platelets
CC       show absence of the glycoprotein IIb-IIIa complexes at their
CC       surface and lack fibrinogen and clot retraction capability. In
CC       type II, the platelets express the GPIIb-IIIa complex at reduced
CC       levels, have detectable amounts of fibrinogen, and have low or
CC       moderate clot retraction capability. {ECO:0000269|PubMed:10233432,
CC       ECO:0000269|PubMed:11588040, ECO:0000269|PubMed:11897046,
CC       ECO:0000269|PubMed:12083483, ECO:0000269|PubMed:12353082,
CC       ECO:0000269|PubMed:1371279, ECO:0000269|PubMed:1438206,
CC       ECO:0000269|PubMed:15583747, ECO:0000269|PubMed:15634267,
CC       ECO:0000269|PubMed:15748237, ECO:0000269|PubMed:1602006,
CC       ECO:0000269|PubMed:20020534, ECO:0000269|PubMed:2392682,
CC       ECO:0000269|PubMed:8781422, ECO:0000269|PubMed:9215749,
CC       ECO:0000269|PubMed:9376589, ECO:0000269|PubMed:9684783,
CC       ECO:0000269|PubMed:9790984}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Bleeding disorder, platelet-type 16 (BDPLT16)
CC       [MIM:187800]: An autosomal dominant form of congenital
CC       macrothrombocytopenia associated with platelet anisocytosis. It is
CC       a disorder of platelet production. Affected individuals may have
CC       no or only mildly increased bleeding tendency. In vitro studies
CC       show mild platelet functional abnormalities.
CC       {ECO:0000269|PubMed:18065693}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=ITGB3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02703; AAA52589.1; -; mRNA.
DR   EMBL; M20311; AAA60122.1; -; mRNA.
DR   EMBL; M35999; AAA35927.1; -; mRNA.
DR   EMBL; U95204; AAB71380.1; -; mRNA.
DR   EMBL; CH471231; EAW57682.1; -; Genomic_DNA.
DR   EMBL; BC127666; AAI27667.1; -; mRNA.
DR   EMBL; BC127667; AAI27668.1; -; mRNA.
DR   EMBL; L28832; AAA20880.2; -; Genomic_DNA.
DR   EMBL; M32686; AAA67537.1; -; Genomic_DNA.
DR   EMBL; M32667; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32672; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32673; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32674; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32675; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32680; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32681; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32682; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M32685; AAA67537.1; JOINED; Genomic_DNA.
DR   EMBL; M57494; AAA52600.1; -; Genomic_DNA.
DR   EMBL; M57481; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57482; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57483; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57484; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57485; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57486; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57487; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57488; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57489; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57490; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57491; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57492; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; M57493; AAA52600.1; JOINED; Genomic_DNA.
DR   EMBL; U03881; AAA16076.1; -; Genomic_DNA.
DR   EMBL; S49379; AAB23689.2; -; Genomic_DNA.
DR   EMBL; M25108; AAA36121.1; -; mRNA.
DR   CCDS; CCDS11511.1; -. [P05106-1]
DR   PIR; A26547; A26547.
DR   PIR; A60798; A60798.
DR   PIR; B36268; B36268.
DR   PIR; I77349; I77349.
DR   PIR; S14324; S14324.
DR   RefSeq; NP_000203.2; NM_000212.2. [P05106-1]
DR   UniGene; Hs.218040; -.
DR   PDB; 1JV2; X-ray; 3.10 A; B=27-718.
DR   PDB; 1KUP; NMR; -; B=742-766.
DR   PDB; 1KUZ; NMR; -; B=742-766.
DR   PDB; 1L5G; X-ray; 3.20 A; B=27-718.
DR   PDB; 1M1X; X-ray; 3.30 A; B=27-718.
DR   PDB; 1M8O; NMR; -; B=742-788.
DR   PDB; 1MIZ; X-ray; 1.90 A; A=765-769.
DR   PDB; 1MK7; X-ray; 2.20 A; A/C=765-775.
DR   PDB; 1MK9; X-ray; 2.80 A; A/C/E/G=765-776.
DR   PDB; 1RN0; Model; -; B=135-378.
DR   PDB; 1S4X; NMR; -; A=742-788.
DR   PDB; 1TYE; X-ray; 2.90 A; B/D/F=27-466.
DR   PDB; 1U8C; X-ray; 3.10 A; B=27-718.
DR   PDB; 2INI; Model; -; B=81-460, B=558-716.
DR   PDB; 2K9J; NMR; -; B=711-753.
DR   PDB; 2KNC; NMR; -; B=715-788.
DR   PDB; 2KV9; NMR; -; B=739-788.
DR   PDB; 2L1C; NMR; -; B=762-788.
DR   PDB; 2L91; NMR; -; A=711-753.
DR   PDB; 2LJD; NMR; -; A=742-788.
DR   PDB; 2LJE; NMR; -; A=742-788.
DR   PDB; 2LJF; NMR; -; A=742-788.
DR   PDB; 2MTP; NMR; -; C=742-788.
DR   PDB; 2N9Y; NMR; -; B=712-753.
DR   PDB; 2Q6W; X-ray; 2.25 A; C/F=50-61.
DR   PDB; 2RMZ; NMR; -; A=711-753.
DR   PDB; 2RN0; NMR; -; A=711-753.
DR   PDB; 2VC2; X-ray; 3.10 A; B=27-487.
DR   PDB; 2VDK; X-ray; 2.80 A; B=27-487.
DR   PDB; 2VDL; X-ray; 2.75 A; B=27-487.
DR   PDB; 2VDM; X-ray; 2.90 A; B=27-487.
DR   PDB; 2VDN; X-ray; 2.90 A; B=27-487.
DR   PDB; 2VDO; X-ray; 2.51 A; B=27-487.
DR   PDB; 2VDP; X-ray; 2.80 A; B=27-487.
DR   PDB; 2VDQ; X-ray; 2.59 A; B=27-487.
DR   PDB; 2VDR; X-ray; 2.40 A; B=27-487.
DR   PDB; 3FCS; X-ray; 2.55 A; B/D=27-716.
DR   PDB; 3FCU; X-ray; 2.90 A; B/D/F=27-487.
DR   PDB; 3IJE; X-ray; 2.90 A; B=27-721.
DR   PDB; 3NID; X-ray; 2.30 A; B/D=27-497.
DR   PDB; 3NIF; X-ray; 2.40 A; B/D=27-497.
DR   PDB; 3NIG; X-ray; 2.25 A; B/D=27-497.
DR   PDB; 3T3M; X-ray; 2.60 A; B/D=27-498.
DR   PDB; 3T3P; X-ray; 2.20 A; B/D=27-498.
DR   PDB; 3ZDX; X-ray; 2.45 A; B/D=27-498.
DR   PDB; 3ZDY; X-ray; 2.45 A; B/D=27-498.
DR   PDB; 3ZDZ; X-ray; 2.75 A; B/D=27-498.
DR   PDB; 3ZE0; X-ray; 2.95 A; B/D=27-498.
DR   PDB; 3ZE1; X-ray; 3.00 A; B/D=27-498.
DR   PDB; 3ZE2; X-ray; 2.35 A; B/D=27-498.
DR   PDB; 4CAK; EM; 20.50 A; B=27-716.
DR   PDB; 4G1E; X-ray; 3.00 A; B=27-717.
DR   PDB; 4G1M; X-ray; 2.90 A; B=27-718.
DR   PDB; 4MMX; X-ray; 3.32 A; B=27-718.
DR   PDB; 4MMY; X-ray; 3.18 A; B=27-718.
DR   PDB; 4MMZ; X-ray; 3.10 A; B=27-718.
DR   PDB; 4O02; X-ray; 3.60 A; B=27-718.
DR   PDB; 4Z7N; X-ray; 2.60 A; B/D=29-497.
DR   PDB; 4Z7O; X-ray; 2.85 A; B/D=29-497.
DR   PDB; 4Z7Q; X-ray; 2.70 A; B/D=27-497.
DR   PDB; 5HDB; X-ray; 2.70 A; B/D=27-497.
DR   PDB; 6AVQ; EM; 35.00 A; B=27-718.
DR   PDB; 6AVR; EM; 35.00 A; B=27-718.
DR   PDB; 6AVU; EM; 35.00 A; B=27-718.
DR   PDBsum; 1JV2; -.
DR   PDBsum; 1KUP; -.
DR   PDBsum; 1KUZ; -.
DR   PDBsum; 1L5G; -.
DR   PDBsum; 1M1X; -.
DR   PDBsum; 1M8O; -.
DR   PDBsum; 1MIZ; -.
DR   PDBsum; 1MK7; -.
DR   PDBsum; 1MK9; -.
DR   PDBsum; 1RN0; -.
DR   PDBsum; 1S4X; -.
DR   PDBsum; 1TYE; -.
DR   PDBsum; 1U8C; -.
DR   PDBsum; 2INI; -.
DR   PDBsum; 2K9J; -.
DR   PDBsum; 2KNC; -.
DR   PDBsum; 2KV9; -.
DR   PDBsum; 2L1C; -.
DR   PDBsum; 2L91; -.
DR   PDBsum; 2LJD; -.
DR   PDBsum; 2LJE; -.
DR   PDBsum; 2LJF; -.
DR   PDBsum; 2MTP; -.
DR   PDBsum; 2N9Y; -.
DR   PDBsum; 2Q6W; -.
DR   PDBsum; 2RMZ; -.
DR   PDBsum; 2RN0; -.
DR   PDBsum; 2VC2; -.
DR   PDBsum; 2VDK; -.
DR   PDBsum; 2VDL; -.
DR   PDBsum; 2VDM; -.
DR   PDBsum; 2VDN; -.
DR   PDBsum; 2VDO; -.
DR   PDBsum; 2VDP; -.
DR   PDBsum; 2VDQ; -.
DR   PDBsum; 2VDR; -.
DR   PDBsum; 3FCS; -.
DR   PDBsum; 3FCU; -.
DR   PDBsum; 3IJE; -.
DR   PDBsum; 3NID; -.
DR   PDBsum; 3NIF; -.
DR   PDBsum; 3NIG; -.
DR   PDBsum; 3T3M; -.
DR   PDBsum; 3T3P; -.
DR   PDBsum; 3ZDX; -.
DR   PDBsum; 3ZDY; -.
DR   PDBsum; 3ZDZ; -.
DR   PDBsum; 3ZE0; -.
DR   PDBsum; 3ZE1; -.
DR   PDBsum; 3ZE2; -.
DR   PDBsum; 4CAK; -.
DR   PDBsum; 4G1E; -.
DR   PDBsum; 4G1M; -.
DR   PDBsum; 4MMX; -.
DR   PDBsum; 4MMY; -.
DR   PDBsum; 4MMZ; -.
DR   PDBsum; 4O02; -.
DR   PDBsum; 4Z7N; -.
DR   PDBsum; 4Z7O; -.
DR   PDBsum; 4Z7Q; -.
DR   PDBsum; 5HDB; -.
DR   PDBsum; 6AVQ; -.
DR   PDBsum; 6AVR; -.
DR   PDBsum; 6AVU; -.
DR   ProteinModelPortal; P05106; -.
DR   SMR; P05106; -.
DR   BioGrid; 109896; 30.
DR   CORUM; P05106; -.
DR   DIP; DIP-304N; -.
DR   ELM; P05106; -.
DR   IntAct; P05106; 27.
DR   MINT; MINT-209501; -.
DR   STRING; 9606.ENSP00000262017; -.
DR   BindingDB; P05106; -.
DR   ChEMBL; CHEMBL2111461; -.
DR   DrugBank; DB00054; Abciximab.
DR   DrugBank; DB00098; Anti-thymocyte Globulin (Rabbit).
DR   DrugBank; DB00063; Eptifibatide.
DR   DrugBank; DB04863; Lefradafiban.
DR   DrugBank; DB05787; LM-609.
DR   DrugBank; DB00775; Tirofiban.
DR   GuidetoPHARMACOLOGY; 2457; -.
DR   iPTMnet; P05106; -.
DR   PhosphoSitePlus; P05106; -.
DR   BioMuta; ITGB3; -.
DR   DMDM; 125987835; -.
DR   EPD; P05106; -.
DR   MaxQB; P05106; -.
DR   PaxDb; P05106; -.
DR   PeptideAtlas; P05106; -.
DR   PRIDE; P05106; -.
DR   Ensembl; ENST00000559488; ENSP00000452786; ENSG00000259207. [P05106-1]
DR   GeneID; 3690; -.
DR   KEGG; hsa:3690; -.
DR   UCSC; uc002ilj.4; human. [P05106-1]
DR   CTD; 3690; -.
DR   DisGeNET; 3690; -.
DR   EuPathDB; HostDB:ENSG00000259207.7; -.
DR   GeneCards; ITGB3; -.
DR   HGNC; HGNC:6156; ITGB3.
DR   HPA; HPA027852; -.
DR   MalaCards; ITGB3; -.
DR   MIM; 173470; gene+phenotype.
DR   MIM; 187800; phenotype.
DR   MIM; 273800; phenotype.
DR   neXtProt; NX_P05106; -.
DR   OpenTargets; ENSG00000259207; -.
DR   Orphanet; 140957; Autosomal dominant macrothrombocytopenia.
DR   Orphanet; 853; Fetal and neonatal alloimmune thrombocytopenia.
DR   Orphanet; 849; Glanzmann thrombasthenia.
DR   PharmGKB; PA205; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P05106; -.
DR   KO; K06493; -.
DR   OMA; CHSSDFG; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P05106; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-210990; PECAM1 interactions.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-HSA-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-HSA-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   SignaLink; P05106; -.
DR   SIGNOR; P05106; -.
DR   ChiTaRS; ITGB3; human.
DR   EvolutionaryTrace; P05106; -.
DR   GeneWiki; CD61; -.
DR   GenomeRNAi; 3690; -.
DR   PMAP-CutDB; P05106; -.
DR   PRO; PR:P05106; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000259207; -.
DR   CleanEx; HS_ITGB3; -.
DR   ExpressionAtlas; P05106; baseline and differential.
DR   Genevisible; P05106; HS.
DR   GO; GO:0035867; C:alphav-beta3 integrin-IGF-1-IGF1R complex; IDA:UniProtKB.
DR   GO; GO:0071062; C:alphav-beta3 integrin-vitronectin complex; TAS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031527; C:filopodium membrane; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0034683; C:integrin alphav-beta3 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; IDA:BHF-UCL.
DR   GO; GO:0031258; C:lamellipodium membrane; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IDA:UniProtKB.
DR   GO; GO:0031528; C:microvillus membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031092; C:platelet alpha granule membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0050840; F:extracellular matrix binding; IDA:UniProtKB.
DR   GO; GO:0001968; F:fibronectin binding; IMP:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005161; F:platelet-derived growth factor receptor binding; TAS:BHF-UCL.
DR   GO; GO:0002020; F:protease binding; IDA:UniProtKB.
DR   GO; GO:0003756; F:protein disulfide isomerase activity; IDA:UniProtKB.
DR   GO; GO:0043184; F:vascular endothelial growth factor receptor 2 binding; IPI:BHF-UCL.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0032147; P:activation of protein kinase activity; IMP:BHF-UCL.
DR   GO; GO:0060055; P:angiogenesis involved in wound healing; TAS:BHF-UCL.
DR   GO; GO:0038027; P:apolipoprotein A-I-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0007044; P:cell-substrate junction assembly; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0050919; P:negative chemotaxis; IMP:UniProtKB.
DR   GO; GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL.
DR   GO; GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL.
DR   GO; GO:0050748; P:negative regulation of lipoprotein metabolic process; IMP:BHF-UCL.
DR   GO; GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0030168; P:platelet activation; IMP:UniProtKB.
DR   GO; GO:0070527; P:platelet aggregation; IMP:UniProtKB.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; IMP:BHF-UCL.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; TAS:BHF-UCL.
DR   GO; GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0045124; P:regulation of bone resorption; TAS:BHF-UCL.
DR   GO; GO:0014909; P:smooth muscle cell migration; IMP:BHF-UCL.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB.
DR   GO; GO:0035295; P:tube development; TAS:BHF-UCL.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0046718; P:viral entry into host cell; IMP:UniProtKB.
DR   GO; GO:0042060; P:wound healing; IC:BHF-UCL.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR027068; Integrin_beta-3.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF25; PTHR10082:SF25; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Integrin; Membrane; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    788       Integrin beta-3.
FT                                /FTId=PRO_0000016344.
FT   TOPO_DOM     27    718       Extracellular. {ECO:0000255}.
FT   TRANSMEM    719    741       Helical. {ECO:0000255}.
FT   TOPO_DOM    742    788       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      135    377       VWFA.
FT   REPEAT      463    511       I.
FT   REPEAT      512    553       II.
FT   REPEAT      554    592       III.
FT   REPEAT      593    629       IV.
FT   REGION      203    210       Involved in CX3CL1-, NRG1-, FGF1- and
FT                                IGF1-binding.
FT                                {ECO:0000269|PubMed:18441324,
FT                                ECO:0000269|PubMed:19578119,
FT                                ECO:0000269|PubMed:20682778,
FT                                ECO:0000269|PubMed:23125415}.
FT   REGION      293    313       CX3CL1-binding.
FT                                {ECO:0000269|PubMed:24789099}.
FT   REGION      463    629       Cysteine-rich tandem repeats.
FT   MOD_RES     767    767       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O54890}.
FT   MOD_RES     773    773       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18088087}.
FT   MOD_RES     779    779       Phosphothreonine; by PDPK1 and PKB/AKT1;
FT                                in vitro. {ECO:0000269|PubMed:10896934}.
FT   MOD_RES     785    785       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:8631894}.
FT   CARBOHYD    125    125       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16263699,
FT                                ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    346    346       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:11546839}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:11546839}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    585    585       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:11546839}.
FT   CARBOHYD    680    680       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11546839,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID     31    461       {ECO:0000269|PubMed:2001252}.
FT   DISULFID     39     49       {ECO:0000269|PubMed:2001252}.
FT   DISULFID     42     75       {ECO:0000269|PubMed:2001252}.
FT   DISULFID     52     64       {ECO:0000269|PubMed:2001252}.
FT   DISULFID    203    210       {ECO:0000269|PubMed:2001252}.
FT   DISULFID    258    299       {ECO:0000269|PubMed:2001252}.
FT   DISULFID    400    412       {ECO:0000269|PubMed:2001252}.
FT   DISULFID    432    681       {ECO:0000269|PubMed:2001252}.
FT   DISULFID    459    463       {ECO:0000269|PubMed:2001252}.
FT   DISULFID    474    486       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    483    521       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    488    497       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    499    512       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    527    532       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    529    562       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    534    547       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    549    554       {ECO:0000269|PubMed:2001252}.
FT   DISULFID    568    573       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    570    601       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    575    584       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    586    593       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    607    612       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    609    657       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    614    624       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    627    630       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    634    643       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    640    713       {ECO:0000305|PubMed:2001252}.
FT   DISULFID    661    689       {ECO:0000269|PubMed:2001252}.
FT   VAR_SEQ     768    788       ANNPLYKEATSTFTNITYRGT -> VRDGAGRFLKSLV
FT                                (in isoform Beta-3B).
FT                                {ECO:0000303|PubMed:2787511}.
FT                                /FTId=VSP_002745.
FT   VAR_SEQ     768    788       ANNPLYKEATSTFTNITYRGT -> HYAQSLRKWNQPVSID
FT                                G (in isoform Beta-3C).
FT                                {ECO:0000303|PubMed:9195946}.
FT                                /FTId=VSP_002746.
FT   VARIANT      59     59       L -> P (in alloantigen HPA-1B;
FT                                dbSNP:rs5918).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:2565345,
FT                                ECO:0000269|Ref.13}.
FT                                /FTId=VAR_003993.
FT   VARIANT      64     64       C -> Y (in GT; severe type 1 phenotype;
FT                                the mutation prevents normal ITGA2B/ITGB3
FT                                complex expression; dbSNP:rs74554539).
FT                                {ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_069920.
FT   VARIANT      66     66       L -> R (in dbSNP:rs36080296).
FT                                {ECO:0000269|Ref.13}.
FT                                /FTId=VAR_049633.
FT   VARIANT     119    119       R -> W (in GT; dbSNP:rs781062792).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030473.
FT   VARIANT     141    141       Y -> C (in GT).
FT                                {ECO:0000269|PubMed:15748237}.
FT                                /FTId=VAR_030474.
FT   VARIANT     143    143       L -> W (in GT; dbSNP:rs121918452).
FT                                {ECO:0000269|PubMed:9376589}.
FT                                /FTId=VAR_010649.
FT   VARIANT     144    144       M -> R (in GT; severe type 1 phenotype;
FT                                the mutation prevented normal ITGA2B/
FT                                ITGB3 complex expression on the cell
FT                                surface; dbSNP:rs77963874).
FT                                {ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_069921.
FT   VARIANT     145    145       D -> N (in GT).
FT                                {ECO:0000269|PubMed:9215749}.
FT                                /FTId=VAR_030475.
FT   VARIANT     145    145       D -> Y (in GT; type B;
FT                                dbSNP:rs121918445).
FT                                {ECO:0000269|PubMed:2392682}.
FT                                /FTId=VAR_003998.
FT   VARIANT     150    150       M -> V (in GT; may confer constitutive
FT                                activity to the alpha-IIb/(mutated)beta-3
FT                                receptor; dbSNP:rs767548512).
FT                                {ECO:0000269|PubMed:15583747}.
FT                                /FTId=VAR_030476.
FT   VARIANT     166    166       T -> I (associated with neonatal
FT                                thrombocytopenia; alloantigen Duv(a+);
FT                                does not affect significantly the
FT                                integrin function; dbSNP:rs74708909).
FT                                {ECO:0000269|PubMed:12036875}.
FT                                /FTId=VAR_030477.
FT   VARIANT     169    169       R -> Q (in alloantigen HPA-4B;
FT                                dbSNP:rs5917).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:1430225}.
FT                                /FTId=VAR_003994.
FT   VARIANT     188    188       S -> L (in GT; type II;
FT                                dbSNP:rs143146734).
FT                                {ECO:0000269|PubMed:9684783}.
FT                                /FTId=VAR_010651.
FT   VARIANT     222    222       L -> P (in GT; variant form;
FT                                dbSNP:rs79208797).
FT                                {ECO:0000269|PubMed:11897046,
FT                                ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_030478.
FT   VARIANT     240    240       R -> Q (in GT; type B;
FT                                dbSNP:rs121918444).
FT                                {ECO:0000269|PubMed:1371279}.
FT                                /FTId=VAR_003999.
FT   VARIANT     240    240       R -> W (in GT; variant Strasbourg-1;
FT                                dbSNP:rs121918446).
FT                                {ECO:0000269|PubMed:1602006}.
FT                                /FTId=VAR_004000.
FT   VARIANT     242    242       R -> Q (in GT; dbSNP:rs377162158).
FT                                {ECO:0000269|PubMed:9215749}.
FT                                /FTId=VAR_030479.
FT   VARIANT     243    243       D -> V (in GT).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030480.
FT   VARIANT     247    247       G -> D (in GT; severe type 1 phenotype;
FT                                the mutation prevents normal ITGA2B/ITGB3
FT                                complex expression on the cell surface;
FT                                the mutation may interfere with correct
FT                                folding of the protein;
FT                                dbSNP:rs79560904).
FT                                {ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_069922.
FT   VARIANT     279    279       K -> M (in GT; severe type 1 phenotype;
FT                                the mutation prevents normal ITGA2B/ITGB3
FT                                complex expression on the cell surface;
FT                                the mutation interupts the interaction of
FT                                the ITGA2B/ITGB3 complex;
FT                                dbSNP:rs79775494).
FT                                {ECO:0000269|PubMed:20020534}.
FT                                /FTId=VAR_069923.
FT   VARIANT     288    288       L -> P (in GT).
FT                                {ECO:0000269|PubMed:9215749}.
FT                                /FTId=VAR_030481.
FT   VARIANT     306    306       H -> P (in GT; dbSNP:rs13306476).
FT                                {ECO:0000269|PubMed:15634267,
FT                                ECO:0000269|PubMed:9790984}.
FT                                /FTId=VAR_004001.
FT   VARIANT     321    321       M -> L (in GT).
FT                                {ECO:0000269|PubMed:15748237}.
FT                                /FTId=VAR_030482.
FT   VARIANT     330    330       I -> N (in GT; not expressed on the
FT                                surface and absent inside the transfected
FT                                cells). {ECO:0000269|PubMed:15634267}.
FT                                /FTId=VAR_030483.
FT   VARIANT     400    400       C -> Y (in GT; dbSNP:rs121918449).
FT                                {ECO:0000269|PubMed:8781422}.
FT                                /FTId=VAR_004002.
FT   VARIANT     433    433       P -> A (in alloantigen MO(+); in a case
FT                                of neonatal alloimmune thrombocytopenia;
FT                                dbSNP:rs121918448).
FT                                {ECO:0000269|PubMed:8093349}.
FT                                /FTId=VAR_003995.
FT   VARIANT     453    453       V -> I (in dbSNP:rs5921).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014178.
FT   VARIANT     515    515       R -> Q (in alloantigen CA(+)/TU(+);
FT                                dbSNP:rs13306487).
FT                                {ECO:0000269|PubMed:7694683}.
FT                                /FTId=VAR_003996.
FT   VARIANT     532    532       C -> Y (in GT).
FT                                {ECO:0000269|PubMed:12353082}.
FT                                /FTId=VAR_030484.
FT   VARIANT     568    568       C -> R (in GT; type I).
FT                                {ECO:0000269|PubMed:10233432}.
FT                                /FTId=VAR_010671.
FT   VARIANT     586    586       C -> F (in GT).
FT                                {ECO:0000269|PubMed:9790984}.
FT                                /FTId=VAR_004003.
FT   VARIANT     586    586       C -> R (in GT; gain-of-function mutation;
FT                                constitutively binds ligand-induced
FT                                binding sites antibodies and the
FT                                fibrinogen-mimetic antibody PAC-1).
FT                                {ECO:0000269|PubMed:11588040}.
FT                                /FTId=VAR_030485.
FT   VARIANT     598    598       G -> S (in GT).
FT                                {ECO:0000269|PubMed:9790984}.
FT                                /FTId=VAR_004004.
FT   VARIANT     601    601       C -> R (in GT; dbSNP:rs747534508).
FT                                {ECO:0000269|PubMed:12083483}.
FT                                /FTId=VAR_030486.
FT   VARIANT     605    605       G -> S (in GT; type II;
FT                                dbSNP:rs144884023).
FT                                {ECO:0000269|PubMed:9790984}.
FT                                /FTId=VAR_010672.
FT   VARIANT     662    662       R -> C (in alloantigen SR(A);
FT                                dbSNP:rs151219882).
FT                                {ECO:0000269|PubMed:8132570}.
FT                                /FTId=VAR_003997.
FT   VARIANT     749    749       D -> H (in BDPLT16; the mutant protein is
FT                                constitutively active;
FT                                dbSNP:rs398122372).
FT                                {ECO:0000269|PubMed:18065693}.
FT                                /FTId=VAR_069924.
FT   VARIANT     778    778       S -> P (in GT; variant Strasbourg-1;
FT                                dbSNP:rs121918447).
FT                                {ECO:0000269|PubMed:1438206}.
FT                                /FTId=VAR_004005.
FT   CONFLICT     12     12       A -> V (in Ref. 1; AAA52589 and 3;
FT                                AAA35927). {ECO:0000305}.
FT   CONFLICT    151    151       K -> P (in Ref. 11; AAA67537 and 14;
FT                                AAB23689). {ECO:0000305}.
FT   CONFLICT    205    205       D -> EY (in Ref. 11; AAA67537).
FT                                {ECO:0000305}.
FT   CONFLICT    649    653       GALHD -> EPYMT (in Ref. 1; AAA52589, 2;
FT                                AAA60122 and 4; AAB71380). {ECO:0000305}.
FT   CONFLICT    716    716       G -> H (in Ref. 8). {ECO:0000305}.
FT   CONFLICT    737    741       ALLIW -> PCSSG (in Ref. 11; AAA67537).
FT                                {ECO:0000305}.
FT   HELIX        30     33       {ECO:0000244|PDB:3T3P}.
FT   HELIX        35     37       {ECO:0000244|PDB:4MMX}.
FT   HELIX        39     45       {ECO:0000244|PDB:3T3P}.
FT   STRAND       50     52       {ECO:0000244|PDB:3T3P}.
FT   STRAND       54     57       {ECO:0000244|PDB:3IJE}.
FT   STRAND       59     61       {ECO:0000244|PDB:2VDO}.
FT   STRAND       63     65       {ECO:0000244|PDB:3T3P}.
FT   HELIX        67     72       {ECO:0000244|PDB:3T3P}.
FT   HELIX        77     79       {ECO:0000244|PDB:3T3P}.
FT   STRAND       86     91       {ECO:0000244|PDB:3T3P}.
FT   STRAND       99    101       {ECO:0000244|PDB:3T3P}.
FT   HELIX       103    105       {ECO:0000244|PDB:3ZE2}.
FT   STRAND      109    111       {ECO:0000244|PDB:3NID}.
FT   STRAND      113    118       {ECO:0000244|PDB:3T3P}.
FT   STRAND      123    131       {ECO:0000244|PDB:3T3P}.
FT   STRAND      138    145       {ECO:0000244|PDB:3T3P}.
FT   HELIX       148    150       {ECO:0000244|PDB:3T3P}.
FT   HELIX       151    156       {ECO:0000244|PDB:3T3P}.
FT   TURN        157    159       {ECO:0000244|PDB:3T3P}.
FT   HELIX       160    168       {ECO:0000244|PDB:3T3P}.
FT   TURN        169    171       {ECO:0000244|PDB:3T3P}.
FT   STRAND      175    182       {ECO:0000244|PDB:3T3P}.
FT   TURN        188    190       {ECO:0000244|PDB:3T3P}.
FT   HELIX       196    200       {ECO:0000244|PDB:3T3P}.
FT   TURN        202    207       {ECO:0000244|PDB:3T3P}.
FT   STRAND      215    224       {ECO:0000244|PDB:3T3P}.
FT   HELIX       226    235       {ECO:0000244|PDB:3T3P}.
FT   STRAND      242    246       {ECO:0000244|PDB:3T3P}.
FT   HELIX       248    257       {ECO:0000244|PDB:3T3P}.
FT   HELIX       259    262       {ECO:0000244|PDB:3T3P}.
FT   STRAND      266    278       {ECO:0000244|PDB:3T3P}.
FT   HELIX       285    289       {ECO:0000244|PDB:3T3P}.
FT   STRAND      305    307       {ECO:0000244|PDB:5HDB}.
FT   TURN        308    312       {ECO:0000244|PDB:3T3P}.
FT   HELIX       318    327       {ECO:0000244|PDB:3T3P}.
FT   STRAND      331    336       {ECO:0000244|PDB:3T3P}.
FT   HELIX       338    340       {ECO:0000244|PDB:3T3P}.
FT   HELIX       341    349       {ECO:0000244|PDB:3T3P}.
FT   STRAND      355    358       {ECO:0000244|PDB:3T3P}.
FT   TURN        361    363       {ECO:0000244|PDB:3ZE2}.
FT   HELIX       366    377       {ECO:0000244|PDB:3T3P}.
FT   STRAND      381    387       {ECO:0000244|PDB:3T3P}.
FT   STRAND      392    400       {ECO:0000244|PDB:3T3P}.
FT   TURN        401    403       {ECO:0000244|PDB:3T3P}.
FT   STRAND      404    407       {ECO:0000244|PDB:3T3P}.
FT   STRAND      411    415       {ECO:0000244|PDB:2VDR}.
FT   STRAND      420    429       {ECO:0000244|PDB:3T3P}.
FT   STRAND      434    444       {ECO:0000244|PDB:3T3P}.
FT   STRAND      451    457       {ECO:0000244|PDB:3T3P}.
FT   HELIX       462    466       {ECO:0000244|PDB:3T3P}.
FT   STRAND      468    470       {ECO:0000244|PDB:3NID}.
FT   TURN        472    478       {ECO:0000244|PDB:3T3P}.
FT   STRAND      479    482       {ECO:0000244|PDB:3T3P}.
FT   STRAND      485    488       {ECO:0000244|PDB:3T3P}.
FT   STRAND      489    491       {ECO:0000244|PDB:3IJE}.
FT   TURN        494    497       {ECO:0000244|PDB:3FCS}.
FT   STRAND      500    504       {ECO:0000244|PDB:3IJE}.
FT   STRAND      513    518       {ECO:0000244|PDB:3FCS}.
FT   HELIX       520    523       {ECO:0000244|PDB:3FCS}.
FT   STRAND      524    527       {ECO:0000244|PDB:3FCS}.
FT   STRAND      529    534       {ECO:0000244|PDB:3FCS}.
FT   STRAND      538    540       {ECO:0000244|PDB:4G1M}.
FT   STRAND      542    544       {ECO:0000244|PDB:3IJE}.
FT   STRAND      549    552       {ECO:0000244|PDB:3IJE}.
FT   STRAND      556    561       {ECO:0000244|PDB:3FCS}.
FT   HELIX       562    564       {ECO:0000244|PDB:3FCS}.
FT   STRAND      565    569       {ECO:0000244|PDB:3FCS}.
FT   STRAND      572    575       {ECO:0000244|PDB:3FCS}.
FT   STRAND      579    584       {ECO:0000244|PDB:3FCS}.
FT   TURN        591    593       {ECO:0000244|PDB:3FCS}.
FT   STRAND      598    600       {ECO:0000244|PDB:3FCS}.
FT   STRAND      602    604       {ECO:0000244|PDB:3FCS}.
FT   STRAND      606    608       {ECO:0000244|PDB:3FCS}.
FT   STRAND      611    613       {ECO:0000244|PDB:3FCS}.
FT   TURN        616    618       {ECO:0000244|PDB:3IJE}.
FT   STRAND      620    624       {ECO:0000244|PDB:1U8C}.
FT   STRAND      628    630       {ECO:0000244|PDB:4G1E}.
FT   TURN        633    635       {ECO:0000244|PDB:3FCS}.
FT   HELIX       639    641       {ECO:0000244|PDB:3FCS}.
FT   TURN        642    646       {ECO:0000244|PDB:3FCS}.
FT   STRAND      649    655       {ECO:0000244|PDB:3FCS}.
FT   TURN        658    660       {ECO:0000244|PDB:3FCS}.
FT   STRAND      664    666       {ECO:0000244|PDB:3FCS}.
FT   STRAND      669    671       {ECO:0000244|PDB:1M1X}.
FT   STRAND      674    678       {ECO:0000244|PDB:3FCS}.
FT   STRAND      680    684       {ECO:0000244|PDB:3FCS}.
FT   STRAND      688    694       {ECO:0000244|PDB:3FCS}.
FT   STRAND      698    700       {ECO:0000244|PDB:3FCS}.
FT   STRAND      704    706       {ECO:0000244|PDB:3FCS}.
FT   STRAND      707    710       {ECO:0000244|PDB:1U8C}.
FT   STRAND      715    717       {ECO:0000244|PDB:2KNC}.
FT   TURN        743    759       {ECO:0000244|PDB:1KUP}.
FT   TURN        761    765       {ECO:0000244|PDB:1KUP}.
FT   STRAND      767    770       {ECO:0000244|PDB:1S4X}.
FT   HELIX       771    774       {ECO:0000244|PDB:1MK7}.
FT   HELIX       776    779       {ECO:0000244|PDB:2LJD}.
FT   TURN        782    786       {ECO:0000244|PDB:1S4X}.
SQ   SEQUENCE   788 AA;  87058 MW;  F246623608E05F9E CRC64;
     MRARPRPRPL WATVLALGAL AGVGVGGPNI CTTRGVSSCQ QCLAVSPMCA WCSDEALPLG
     SPRCDLKENL LKDNCAPESI EFPVSEARVL EDRPLSDKGS GDSSQVTQVS PQRIALRLRP
     DDSKNFSIQV RQVEDYPVDI YYLMDLSYSM KDDLWSIQNL GTKLATQMRK LTSNLRIGFG
     AFVDKPVSPY MYISPPEALE NPCYDMKTTC LPMFGYKHVL TLTDQVTRFN EEVKKQSVSR
     NRDAPEGGFD AIMQATVCDE KIGWRNDASH LLVFTTDAKT HIALDGRLAG IVQPNDGQCH
     VGSDNHYSAS TTMDYPSLGL MTEKLSQKNI NLIFAVTENV VNLYQNYSEL IPGTTVGVLS
     MDSSNVLQLI VDAYGKIRSK VELEVRDLPE ELSLSFNATC LNNEVIPGLK SCMGLKIGDT
     VSFSIEAKVR GCPQEKEKSF TIKPVGFKDS LIVQVTFDCD CACQAQAEPN SHRCNNGNGT
     FECGVCRCGP GWLGSQCECS EEDYRPSQQD ECSPREGQPV CSQRGECLCG QCVCHSSDFG
     KITGKYCECD DFSCVRYKGE MCSGHGQCSC GDCLCDSDWT GYYCNCTTRT DTCMSSNGLL
     CSGRGKCECG SCVCIQPGSY GDTCEKCPTC PDACTFKKEC VECKKFDRGA LHDENTCNRY
     CRDEIESVKE LKDTGKDAVN CTYKNEDDCV VRFQYYEDSS GKSILYVVEE PECPKGPDIL
     VVLLSVMGAI LLIGLAALLI WKLLITIHDR KEFAKFEEER ARAKWDTANN PLYKEATSTF
     TNITYRGT
//
ID   ITB2_HUMAN              Reviewed;         769 AA.
AC   P05107; B3KTS8; D3DSM1; Q16418; Q53HS5; Q9UD72;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   20-DEC-2017, entry version 225.
DE   RecName: Full=Integrin beta-2;
DE   AltName: Full=Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta;
DE   AltName: Full=Complement receptor C3 subunit beta;
DE   AltName: CD_antigen=CD18;
DE   Flags: Precursor;
GN   Name=ITGB2; Synonyms=CD18, MFI7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT HIS-354.
RX   PubMed=3028646; DOI=10.1016/0092-8674(87)90246-7;
RA   Kishimoto T.K., O'Connor K., Lee A., Roberts T.M., Springer T.A.;
RT   "Cloning of the beta subunit of the leukocyte adhesion proteins:
RT   homology to an extracellular matrix receptor defines a novel supergene
RT   family.";
RL   Cell 48:681-690(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-354.
RX   PubMed=1683838; DOI=10.1016/0014-5793(91)81351-8;
RA   Weitzman J.B., Wells C.E., Wright A.H., Clark P.A., Law S.K.A.;
RT   "The gene organisation of the human beta 2 integrin subunit (CD18).";
RL   FEBS Lett. 294:97-103(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-354.
RC   TISSUE=Synovial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-354.
RC   TISSUE=Adipose tissue;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT HIS-354.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-354.
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-769, PARTIAL PROTEIN SEQUENCE,
RP   PYROGLUTAMATE FORMATION AT GLN-23, AND VARIANT HIS-354.
RC   TISSUE=Spleen;
RX   PubMed=2954816;
RA   Law S.K.A., Gagnon J., Hildreth J.E., Wells C.E., Willis A.C.,
RA   Wong A.J.;
RT   "The primary structure of the beta-subunit of the cell surface
RT   adhesion glycoproteins LFA-1, CR3 and p150,95 and its relationship to
RT   the fibronectin receptor.";
RL   EMBO J. 6:915-919(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 124-199, AND VARIANT LAD1 LEU-178.
RC   TISSUE=Lymphoblast;
RX   PubMed=7509236; DOI=10.1002/humu.1380020606;
RA   Ohashi Y., Yambe T., Tsuchiya S., Kikuchi H., Konno T.;
RT   "Familial genetic defect in a case of leukocyte adhesion deficiency.";
RL   Hum. Mutat. 2:458-467(1993).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 347-355, VARIANTS LAD1 SER-351 AND
RP   TRP-586, AND VARIANT HIS-354.
RX   PubMed=1346613;
RA   Nelson C., Rabb H., Arnaout M.A.;
RT   "Genetic cause of leukocyte adhesion molecule deficiency. Abnormal
RT   splicing and a missense mutation in a conserved region of CD18 impair
RT   cell surface expression of beta 2 integrins.";
RL   J. Biol. Chem. 267:3351-3357(1992).
RN   [11]
RP   INTERACTION WITH COPS5.
RX   PubMed=10766246; DOI=10.1038/35007098;
RA   Bianchi E., Denti S., Granata A., Bossi G., Geginat J., Villa A.,
RA   Rogge L., Pardi R.;
RT   "Integrin LFA-1 interacts with the transcriptional co-activator JAB1
RT   to modulate AP-1 activity.";
RL   Nature 404:617-621(2000).
RN   [12]
RP   PHOSPHORYLATION AT SER-745; SER-756; THR-758 AND THR-760.
RX   PubMed=11700305; DOI=10.1074/jbc.M106856200;
RA   Fagerholm S., Morrice N., Gahmberg C.G., Cohen P.;
RT   "Phosphorylation of the cytoplasmic domain of the integrin CD18 chain
RT   by protein kinase C isoforms in leukocytes.";
RL   J. Biol. Chem. 277:1728-1738(2002).
RN   [13]
RP   FUNCTION.
RX   PubMed=11812992; DOI=10.1038/ni755;
RA   Ostermann G., Weber K.S., Zernecke A., Schroeder A., Weber C.;
RT   "JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in
RT   transendothelial migration of leukocytes.";
RL   Nat. Immunol. 3:151-158(2002).
RN   [14]
RP   INTERACTION WITH RANBP9.
RX   PubMed=14722085; DOI=10.1074/jbc.M313515200;
RA   Denti S., Sirri A., Cheli A., Rogge L., Innamorati G., Putignano S.,
RA   Fabbri M., Pardi R., Bianchi E.;
RT   "RanBPM is a phosphoprotein that associates with the plasma membrane
RT   and interacts with the integrin LFA-1.";
RL   J. Biol. Chem. 279:13027-13034(2004).
RN   [15]
RP   FUNCTION.
RX   PubMed=15356110; DOI=10.4049/jimmunol.173.6.3653;
RA   Barber D.F., Faure M., Long E.O.;
RT   "LFA-1 contributes an early signal for NK cell cytotoxicity.";
RL   J. Immunol. 173:3653-3659(2004).
RN   [16]
RP   PHOSPHORYLATION AT THR-758, AND MUTAGENESIS OF THR-758.
RX   PubMed=16301335; DOI=10.1083/jcb.200504016;
RA   Fagerholm S.C., Hilden T.J., Nurmi S.M., Gahmberg C.G.;
RT   "Specific integrin alpha and beta chain phosphorylations regulate LFA-
RT   1 activation through affinity-dependent and -independent mechanisms.";
RL   J. Cell Biol. 171:705-715(2005).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [18]
RP   FUNCTION DURING LUNG INJURY.
RX   PubMed=18587400; DOI=10.1038/ni.1628;
RA   Xu J., Gao X.-P., Ramchandran R., Zhao Y.-Y., Vogel S.M., Malik A.B.;
RT   "Nonmuscle myosin light-chain kinase mediates neutrophil
RT   transmigration in sepsis-induced lung inflammation by activating beta2
RT   integrins.";
RL   Nat. Immunol. 9:880-886(2008).
RN   [19]
RP   INTERACTION WITH FLNA.
RX   PubMed=19828450; DOI=10.1074/jbc.M109.060954;
RA   Ithychanda S.S., Hsu D., Li H., Yan L., Liu D.D., Liu D., Das M.,
RA   Plow E.F., Qin J.;
RT   "Identification and characterization of multiple similar ligand-
RT   binding repeats in filamin: implication on filamin-mediated receptor
RT   clustering and cross-talk.";
RL   J. Biol. Chem. 284:35113-35121(2009).
RN   [20]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-50 AND ASN-212.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [21]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-50; ASN-116; ASN-212;
RP   ASN-213 AND ASN-215.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [22]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH CD177 AND ITGAM,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=21193407; DOI=10.1074/jbc.M110.171256;
RA   Jerke U., Rolle S., Dittmar G., Bayat B., Santoso S., Sporbert A.,
RA   Luft F., Kettritz R.;
RT   "Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-
RT   ANCA neutrophil activation.";
RL   J. Biol. Chem. 286:7070-7081(2011).
RN   [23]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23775590; DOI=10.1007/s10495-013-0873-z;
RA   Kristof E., Zahuczky G., Katona K., Doro Z., Nagy E., Fesues L.;
RT   "Novel role of ICAM3 and LFA-1 in the clearance of apoptotic
RT   neutrophils by human macrophages.";
RL   Apoptosis 18:1235-1251(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [25]
RP   INTERACTION WITH THBD.
RX   PubMed=27055590; DOI=10.1016/j.bbrc.2016.04.007;
RA   Kawamoto E., Okamoto T., Takagi Y., Honda G., Suzuki K., Imai H.,
RA   Shimaoka M.;
RT   "LFA-1 and Mac-1 integrins bind to the serine/threonine-rich domain of
RT   thrombomodulin.";
RL   Biochem. Biophys. Res. Commun. 473:1005-1012(2016).
RN   [26]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH CD177 AND ITGAM,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=28807980; DOI=10.1182/blood-2017-03-768507;
RA   Bai M., Grieshaber-Bouyer R., Wang J., Schmider A.B., Wilson Z.S.,
RA   Zeng L., Halyabar O., Godin M.D., Nguyen H.N., Levescot A., Cunin P.,
RA   Lefort C.T., Soberman R.J., Nigrovic P.A.;
RT   "CD177 modulates human neutrophil migration through activation-
RT   mediated integrin and chemoreceptor regulation.";
RL   Blood 0:0-0(2017).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 23-699 IN COMPLEX WITH ITGAX,
RP   GLYCOSYLATION AT ASN-116, DISULFIDE BONDS, CALCIUM-BINDING SITES, AND
RP   SUBUNIT.
RX   PubMed=20033057; DOI=10.1038/emboj.2009.367;
RA   Xie C., Zhu J., Chen X., Mi L., Nishida N., Springer T.A.;
RT   "Structure of an integrin with an alphaI domain, complement receptor
RT   type 4.";
RL   EMBO J. 29:666-679(2010).
RN   [28]
RP   VARIANTS LAD1 THR-196 AND CYS-593.
RX   PubMed=1968911; DOI=10.1172/JCI114529;
RA   Arnaout M.A., Dana N., Gupta S.K., Tenen D.G., Fathallah D.M.;
RT   "Point mutations impairing cell surface expression of the common beta
RT   subunit (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM)
RT   deficiency.";
RL   J. Clin. Invest. 85:977-981(1990).
RN   [29]
RP   VARIANTS LAD1 PRO-149 AND ARG-169.
RX   PubMed=1694220; DOI=10.1084/jem.172.1.335;
RA   Wardlaw A.J., Hibbs M.L., Stacker S.A., Springer T.A.;
RT   "Distinct mutations in two patients with leukocyte adhesion deficiency
RT   and their functional correlates.";
RL   J. Exp. Med. 172:335-345(1990).
RN   [30]
RP   VARIANT LAD1 ASN-128.
RX   PubMed=1590804; DOI=10.1016/S0006-291X(05)80047-6;
RA   Matsuura S., Kishi F., Tsukahara M., Nunoi H., Matsuda I.,
RA   Kobayashi K., Kajii T.;
RT   "Leukocyte adhesion deficiency: identification of novel mutations in
RT   two Japanese patients with a severe form.";
RL   Biochem. Biophys. Res. Commun. 184:1460-1467(1992).
RN   [31]
RP   VARIANT LAD1 ARG-169.
RX   PubMed=1352501; DOI=10.1002/eji.1830220730;
RA   Corbi A., Vara A., Ursa A., Rodriguez M.C.G., Fontan G.,
RA   Sanchez-Madrid F.;
RT   "Molecular basis for a severe case of leukocyte adhesion deficiency.";
RL   Eur. J. Immunol. 22:1877-1881(1992).
RN   [32]
RP   VARIANT LAD1 LEU-178.
RX   PubMed=1347532;
RA   Back L.L., Kwok W.W., Hickstein D.D.;
RT   "Identification of two molecular defects in a child with leukocyte
RT   adherence deficiency.";
RL   J. Biol. Chem. 267:5482-5487(1992).
RN   [33]
RP   VARIANT LAD1 SER-284.
RX   PubMed=7686755; DOI=10.1006/bbrc.1993.1712;
RA   Back L.A., Kerkering M., Baker D., Bauer T.R., Embree L.J.,
RA   Hickstein D.D.;
RT   "A point mutation associated with leukocyte adhesion deficiency type 1
RT   of moderate severity.";
RL   Biochem. Biophys. Res. Commun. 193:912-918(1993).
RN   [34]
RP   VARIANTS LAD1 PRO-138 AND ARG-273.
RX   PubMed=9884339; DOI=10.1172/JCI3312;
RA   Hogg N., Stewart M.P., Scarth S.L., Newton R., Shaw J.M., Law S.K.A.,
RA   Klein N.;
RT   "A novel leukocyte adhesion deficiency caused by expressed but
RT   nonfunctional beta2 integrins Mac-1 and LFA-1.";
RL   J. Clin. Invest. 103:97-106(1999).
RN   [35]
RP   VARIANT LAD1 VAL-300.
RX   PubMed=20529581;
RA   Li L., Jin Y.Y., Cao R.M., Chen T.X.;
RT   "A novel point mutation in CD18 causing leukocyte adhesion deficiency
RT   in a Chinese patient.";
RL   Chin. Med. J. 123:1278-1282(2010).
RN   [36]
RP   VARIANTS LAD1 TYR-128; THR-239 AND ALA-716.
RX   PubMed=20549317; DOI=10.1007/s10875-010-9433-2;
RA   Parvaneh N., Mamishi S., Rezaei A., Rezaei N., Tamizifar B.,
RA   Parvaneh L., Sherkat R., Ghalehbaghi B., Kashef S., Chavoshzadeh Z.,
RA   Isaeian A., Ashrafi F., Aghamohammadi A.;
RT   "Characterization of 11 new cases of leukocyte adhesion deficiency
RT   type 1 with seven novel mutations in the ITGB2 gene.";
RL   J. Clin. Immunol. 30:756-760(2010).
CC   -!- FUNCTION: Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2,
CC       ICAM3 and ICAM4. Integrins ITGAM/ITGB2 and ITGAX/ITGB2 are
CC       receptors for the iC3b fragment of the third complement component
CC       and for fibrinogen. Integrin ITGAX/ITGB2 recognizes the sequence
CC       G-P-R in fibrinogen alpha-chain. Integrin ITGAM/ITGB2 recognizes
CC       P1 and P2 peptides of fibrinogen gamma chain. Integrin ITGAM/ITGB2
CC       is also a receptor for factor X. Integrin ITGAD/ITGB2 is a
CC       receptor for ICAM3 and VCAM1. Contributes to natural killer cell
CC       cytotoxicity (PubMed:15356110). Involved in leukocyte adhesion and
CC       transmigration of leukocytes including T-cells and neutrophils
CC       (PubMed:11812992, PubMed:28807980). Triggers neutrophil
CC       transmigration during lung injury through PTK2B/PYK2-mediated
CC       activation (PubMed:18587400). Integrin ITGAL/ITGB2 in association
CC       with ICAM3, contributes to apoptotic neutrophil phagocytosis by
CC       macrophages (PubMed:23775590). In association with alpha subunit
CC       ITGAM/CD11b, required for CD177-PRTN3-mediated activation of TNF
CC       primed neutrophils (PubMed:21193407).
CC       {ECO:0000269|PubMed:11812992, ECO:0000269|PubMed:15356110,
CC       ECO:0000269|PubMed:18587400, ECO:0000269|PubMed:21193407,
CC       ECO:0000269|PubMed:23775590, ECO:0000269|PubMed:28807980}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit
CC       (PubMed:20033057). ITGB2 associates with either ITGAL, ITGAM,
CC       ITGAX or ITGAD. Found in a complex with CD177 and ITGAM/CD11b
CC       (PubMed:21193407, PubMed:28807980). Interacts with FGR (By
CC       similarity). Interacts with COPS5 and RANBP9 (PubMed:10766246,
CC       PubMed:14722085). Interacts with FLNA (via filamin repeats 4, 9,
CC       12, 17, 19, 21, and 23) (PubMed:19828450). Interacts with THBD
CC       (PubMed:27055590). {ECO:0000250|UniProtKB:P11835,
CC       ECO:0000269|PubMed:10766246, ECO:0000269|PubMed:14722085,
CC       ECO:0000269|PubMed:19828450, ECO:0000269|PubMed:20033057,
CC       ECO:0000269|PubMed:21193407, ECO:0000269|PubMed:27055590,
CC       ECO:0000269|PubMed:28807980}.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=4; IntAct=EBI-300173, EBI-375543;
CC       P20702:ITGAX; NbExp=3; IntAct=EBI-300173, EBI-2568308;
CC       Q7Z3S9:NOTCH2NL; NbExp=8; IntAct=EBI-300173, EBI-945833;
CC       P35241:RDX; NbExp=2; IntAct=EBI-300173, EBI-2514878;
CC       Q9Y4G6:TLN2; NbExp=5; IntAct=EBI-300173, EBI-1220811;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21193407,
CC       ECO:0000269|PubMed:28807980}; Single-pass type I membrane protein
CC       {ECO:0000305}. Membrane raft {ECO:0000269|PubMed:21193407};
CC       Single-pass type I membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Leukocytes (PubMed:23775590). Expressed in
CC       neutrophils (at protein level) (PubMed:21193407, PubMed:28807980).
CC       {ECO:0000269|PubMed:21193407, ECO:0000269|PubMed:23775590,
CC       ECO:0000269|PubMed:28807980}.
CC   -!- PTM: Both Ser-745 and Ser-756 become phosphorylated when T-cells
CC       are exposed to phorbol esters (PubMed:11700305). Phosphorylation
CC       on Thr-758 (but not on Ser-756) allows interaction with 14-3-3
CC       proteins (PubMed:11700305, PubMed:16301335).
CC       {ECO:0000269|PubMed:11700305, ECO:0000269|PubMed:16301335}.
CC   -!- DISEASE: Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]: LAD1
CC       patients have recurrent bacterial infections and their leukocytes
CC       are deficient in a wide range of adhesion-dependent functions.
CC       {ECO:0000269|PubMed:1346613, ECO:0000269|PubMed:1347532,
CC       ECO:0000269|PubMed:1352501, ECO:0000269|PubMed:1590804,
CC       ECO:0000269|PubMed:1694220, ECO:0000269|PubMed:1968911,
CC       ECO:0000269|PubMed:20529581, ECO:0000269|PubMed:20549317,
CC       ECO:0000269|PubMed:7509236, ECO:0000269|PubMed:7686755,
CC       ECO:0000269|PubMed:9884339}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD96225.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=ITGB2base; Note=ITGB2 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/ITGB2base/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15395; AAA59490.1; -; mRNA.
DR   EMBL; X64072; CAA45427.1; -; Genomic_DNA.
DR   EMBL; X64073; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64074; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64075; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64076; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64077; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64078; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64079; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64080; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64081; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64082; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X64083; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X63924; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X63925; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; X63926; CAA45427.1; JOINED; Genomic_DNA.
DR   EMBL; AK095992; BAG53190.1; -; mRNA.
DR   EMBL; AK222505; BAD96225.1; ALT_INIT; mRNA.
DR   EMBL; AL163300; CAB90553.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09381.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09382.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09385.1; -; Genomic_DNA.
DR   EMBL; BC005861; AAH05861.1; -; mRNA.
DR   EMBL; Y00057; CAA68266.1; -; mRNA.
DR   EMBL; S81234; AAB21404.1; -; mRNA.
DR   CCDS; CCDS13716.1; -.
DR   PIR; A25967; IJHULM.
DR   RefSeq; NP_000202.3; NM_000211.4.
DR   RefSeq; NP_001120963.2; NM_001127491.2.
DR   RefSeq; NP_001290167.1; NM_001303238.1.
DR   UniGene; Hs.375957; -.
DR   PDB; 1JX3; Model; -; A=126-364.
DR   PDB; 1L3Y; NMR; -; A=535-574.
DR   PDB; 1YUK; X-ray; 1.80 A; A=23-125, B=365-482.
DR   PDB; 2JF1; X-ray; 2.20 A; T=735-769.
DR   PDB; 2P26; X-ray; 1.75 A; A=23-535.
DR   PDB; 2P28; X-ray; 2.20 A; A=23-122, B=362-574.
DR   PDB; 2V7D; X-ray; 2.50 A; P/Q/R/S=755-764.
DR   PDB; 3K6S; X-ray; 3.50 A; B/D/F/H=23-699.
DR   PDB; 3K71; X-ray; 3.95 A; B/D/F/H=23-699.
DR   PDB; 3K72; X-ray; 3.70 A; B/D=23-699.
DR   PDB; 4NEH; X-ray; 2.75 A; B=23-695.
DR   PDB; 4NEN; X-ray; 2.90 A; B=23-696.
DR   PDB; 5E6R; X-ray; 2.90 A; B=23-482.
DR   PDB; 5E6S; X-ray; 2.15 A; B/D/F=23-482.
DR   PDB; 5E6U; X-ray; 2.50 A; B=23-482.
DR   PDB; 5E6V; X-ray; 1.80 A; A=24-482.
DR   PDB; 5E6W; X-ray; 2.20 A; A=23-118, A=362-574.
DR   PDB; 5E6X; X-ray; 1.75 A; A=23-535.
DR   PDB; 5ES4; X-ray; 3.30 A; B/D/F/H=23-696.
DR   PDBsum; 1JX3; -.
DR   PDBsum; 1L3Y; -.
DR   PDBsum; 1YUK; -.
DR   PDBsum; 2JF1; -.
DR   PDBsum; 2P26; -.
DR   PDBsum; 2P28; -.
DR   PDBsum; 2V7D; -.
DR   PDBsum; 3K6S; -.
DR   PDBsum; 3K71; -.
DR   PDBsum; 3K72; -.
DR   PDBsum; 4NEH; -.
DR   PDBsum; 4NEN; -.
DR   PDBsum; 5E6R; -.
DR   PDBsum; 5E6S; -.
DR   PDBsum; 5E6U; -.
DR   PDBsum; 5E6V; -.
DR   PDBsum; 5E6W; -.
DR   PDBsum; 5E6X; -.
DR   PDBsum; 5ES4; -.
DR   ProteinModelPortal; P05107; -.
DR   SMR; P05107; -.
DR   BioGrid; 109895; 36.
DR   CORUM; P05107; -.
DR   DIP; DIP-478N; -.
DR   ELM; P05107; -.
DR   IntAct; P05107; 24.
DR   MINT; MINT-129139; -.
DR   STRING; 9606.ENSP00000303242; -.
DR   BindingDB; P05107; -.
DR   ChEMBL; CHEMBL3631; -.
DR   DrugBank; DB00641; Simvastatin.
DR   GuidetoPHARMACOLOGY; 2456; -.
DR   iPTMnet; P05107; -.
DR   PhosphoSitePlus; P05107; -.
DR   BioMuta; ITGB2; -.
DR   DMDM; 124056465; -.
DR   EPD; P05107; -.
DR   MaxQB; P05107; -.
DR   PaxDb; P05107; -.
DR   PeptideAtlas; P05107; -.
DR   PRIDE; P05107; -.
DR   DNASU; 3689; -.
DR   Ensembl; ENST00000302347; ENSP00000303242; ENSG00000160255.
DR   Ensembl; ENST00000355153; ENSP00000347279; ENSG00000160255.
DR   Ensembl; ENST00000397850; ENSP00000380948; ENSG00000160255.
DR   Ensembl; ENST00000397852; ENSP00000380950; ENSG00000160255.
DR   Ensembl; ENST00000397857; ENSP00000380955; ENSG00000160255.
DR   GeneID; 3689; -.
DR   KEGG; hsa:3689; -.
DR   UCSC; uc002zgd.4; human.
DR   CTD; 3689; -.
DR   DisGeNET; 3689; -.
DR   EuPathDB; HostDB:ENSG00000160255.16; -.
DR   GeneCards; ITGB2; -.
DR   HGNC; HGNC:6155; ITGB2.
DR   HPA; HPA008877; -.
DR   HPA; HPA016894; -.
DR   MalaCards; ITGB2; -.
DR   MIM; 116920; phenotype.
DR   MIM; 600065; gene.
DR   neXtProt; NX_P05107; -.
DR   Orphanet; 99842; Leukocyte adhesion deficiency type I.
DR   PharmGKB; PA29955; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P05107; -.
DR   KO; K06464; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P05107; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-166016; Toll Like Receptor 4 (TLR4) Cascade.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P05107; -.
DR   SIGNOR; P05107; -.
DR   ChiTaRS; ITGB2; human.
DR   EvolutionaryTrace; P05107; -.
DR   GeneWiki; CD18; -.
DR   GenomeRNAi; 3689; -.
DR   PMAP-CutDB; P05107; -.
DR   PRO; PR:P05107; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000160255; -.
DR   CleanEx; HS_ITGB2; -.
DR   ExpressionAtlas; P05107; baseline and differential.
DR   Genevisible; P05107; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; NAS:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:UniProtKB.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0034687; C:integrin alphaL-beta2 complex; IDA:UniProtKB.
DR   GO; GO:0034688; C:integrin alphaM-beta2 complex; NAS:ARUK-UCL.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0044853; C:plasma membrane raft; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0001540; F:amyloid-beta binding; ISS:ARUK-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IMP:UniProtKB.
DR   GO; GO:0001851; F:complement component C3b binding; ISS:ARUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:CAFA.
DR   GO; GO:0030369; F:ICAM-3 receptor activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; NAS:ARUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0097242; P:amyloid-beta clearance; ISS:ARUK-UCL.
DR   GO; GO:0006915; P:apoptotic process; NAS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0098742; P:cell-cell adhesion via plasma-membrane adhesion molecules; NAS:ARUK-UCL.
DR   GO; GO:0007267; P:cell-cell signaling; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0045123; P:cellular extravasation; IEA:Ensembl.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; ISS:UniProtKB.
DR   GO; GO:0035987; P:endodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0043542; P:endothelial cell migration; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; NAS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0002523; P:leukocyte migration involved in inflammatory response; IEA:Ensembl.
DR   GO; GO:0030101; P:natural killer cell activation; IEA:Ensembl.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:1990266; P:neutrophil migration; IMP:UniProtKB.
DR   GO; GO:0006911; P:phagocytosis, engulfment; ISS:ARUK-UCL.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0043315; P:positive regulation of neutrophil degranulation; IGI:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IGI:UniProtKB.
DR   GO; GO:0043113; P:receptor clustering; IMP:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; NAS:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015439; Integrin_bsu-2.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF15; PTHR10082:SF15; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Cell adhesion; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Integrin; Membrane; Metal-binding; Phagocytosis;
KW   Phosphoprotein; Pyrrolidone carboxylic acid; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     22
FT   CHAIN        23    769       Integrin beta-2.
FT                                /FTId=PRO_0000016341.
FT   TOPO_DOM     23    700       Extracellular. {ECO:0000255}.
FT   TRANSMEM    701    723       Helical. {ECO:0000255}.
FT   TOPO_DOM    724    769       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      124    363       VWFA.
FT   REPEAT      449    496       I.
FT   REPEAT      497    540       II.
FT   REPEAT      541    581       III.
FT   REPEAT      582    617       IV.
FT   REGION      449    617       Cysteine-rich tandem repeats.
FT   MOTIF       397    399       Cell attachment site. {ECO:0000255}.
FT   METAL       138    138       Calcium; via carbonyl oxygen.
FT   METAL       141    141       Calcium.
FT   METAL       142    142       Calcium.
FT   METAL       347    347       Calcium.
FT   MOD_RES      23     23       Pyrrolidone carboxylic acid.
FT                                {ECO:0000305|PubMed:2954816}.
FT   MOD_RES     745    745       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:11700305}.
FT   MOD_RES     756    756       Phosphoserine.
FT                                {ECO:0000269|PubMed:11700305}.
FT   MOD_RES     758    758       Phosphothreonine; by PKC; in vitro.
FT                                {ECO:0000269|PubMed:11700305,
FT                                ECO:0000269|PubMed:16301335}.
FT   MOD_RES     759    759       Phosphothreonine. {ECO:0000255}.
FT   MOD_RES     760    760       Phosphothreonine; by PKC/PRKCA; in vitro.
FT                                {ECO:0000269|PubMed:11700305}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:20033057}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    213    213       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    215    215       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    254    254       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    501    501       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    642    642       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     25     43       {ECO:0000269|PubMed:20033057}.
FT   DISULFID     33    447       {ECO:0000269|PubMed:20033057}.
FT   DISULFID     36     62       {ECO:0000269|PubMed:20033057}.
FT   DISULFID     46     73       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    191    198       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    246    286       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    386    400       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    420    445       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    449    467       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    459    470       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    472    481       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    483    514       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    497    512       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    506    517       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    519    534       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    536    559       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    541    557       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    549    562       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    564    573       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    575    598       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    582    596       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    590    601       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    603    612       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    615    618       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    622    662       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    628    647       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    631    643       {ECO:0000269|PubMed:20033057}.
FT   DISULFID    670    695       {ECO:0000269|PubMed:20033057}.
FT   VARIANT     128    128       D -> N (in LAD1; dbSNP:rs137852615).
FT                                {ECO:0000269|PubMed:1590804}.
FT                                /FTId=VAR_003984.
FT   VARIANT     128    128       D -> Y (in LAD1; dbSNP:rs137852615).
FT                                {ECO:0000269|PubMed:20549317}.
FT                                /FTId=VAR_065661.
FT   VARIANT     138    138       S -> P (in LAD1; dbSNP:rs137852617).
FT                                {ECO:0000269|PubMed:9884339}.
FT                                /FTId=VAR_013402.
FT   VARIANT     149    149       L -> P (in LAD1; dbSNP:rs137852611).
FT                                {ECO:0000269|PubMed:1694220}.
FT                                /FTId=VAR_003985.
FT   VARIANT     169    169       G -> R (in LAD1; dbSNP:rs137852612).
FT                                {ECO:0000269|PubMed:1352501,
FT                                ECO:0000269|PubMed:1694220}.
FT                                /FTId=VAR_003986.
FT   VARIANT     178    178       P -> L (in LAD1; dbSNP:rs137852614).
FT                                {ECO:0000269|PubMed:1347532,
FT                                ECO:0000269|PubMed:7509236}.
FT                                /FTId=VAR_003987.
FT   VARIANT     196    196       K -> T (in LAD1; dbSNP:rs137852610).
FT                                {ECO:0000269|PubMed:1968911}.
FT                                /FTId=VAR_003988.
FT   VARIANT     239    239       A -> T (in LAD1; dbSNP:rs179363873).
FT                                {ECO:0000269|PubMed:20549317}.
FT                                /FTId=VAR_065662.
FT   VARIANT     273    273       G -> R (in LAD1; dbSNP:rs137852618).
FT                                {ECO:0000269|PubMed:9884339}.
FT                                /FTId=VAR_013403.
FT   VARIANT     284    284       G -> S (in LAD1; dbSNP:rs137852616).
FT                                {ECO:0000269|PubMed:7686755}.
FT                                /FTId=VAR_003989.
FT   VARIANT     300    300       D -> V (in LAD1; dbSNP:rs179363874).
FT                                {ECO:0000269|PubMed:20529581}.
FT                                /FTId=VAR_065663.
FT   VARIANT     351    351       N -> S (in LAD1; dbSNP:rs137852613).
FT                                {ECO:0000269|PubMed:1346613}.
FT                                /FTId=VAR_003990.
FT   VARIANT     354    354       Q -> H (in dbSNP:rs235330).
FT                                {ECO:0000269|PubMed:1346613,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1683838,
FT                                ECO:0000269|PubMed:2954816,
FT                                ECO:0000269|PubMed:3028646,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.6}.
FT                                /FTId=VAR_030035.
FT   VARIANT     586    586       R -> W (in LAD1; dbSNP:rs5030672).
FT                                {ECO:0000269|PubMed:1346613}.
FT                                /FTId=VAR_003991.
FT   VARIANT     593    593       R -> C (in LAD1; dbSNP:rs137852609).
FT                                {ECO:0000269|PubMed:1968911}.
FT                                /FTId=VAR_003992.
FT   VARIANT     716    716       G -> A (in LAD1; dbSNP:rs179363872).
FT                                {ECO:0000269|PubMed:20549317}.
FT                                /FTId=VAR_065664.
FT   MUTAGEN     758    758       T->A: Abolishes phosphorylation. Reduces
FT                                COS cell adhesion to ICAM1.
FT                                {ECO:0000269|PubMed:16301335}.
FT   CONFLICT    199    199       Q -> P (in Ref. 8; CAA68266).
FT                                {ECO:0000305}.
FT   CONFLICT    279    279       L -> P (in Ref. 4; BAD96225).
FT                                {ECO:0000305}.
FT   CONFLICT    526    526       G -> C (in Ref. 3; BAG53190).
FT                                {ECO:0000305}.
FT   CONFLICT    630    630       E -> K (in Ref. 3; BAG53190).
FT                                {ECO:0000305}.
FT   HELIX        33     37       {ECO:0000244|PDB:2P26}.
FT   STRAND       44     46       {ECO:0000244|PDB:2P26}.
FT   HELIX        49     51       {ECO:0000244|PDB:2P28}.
FT   STRAND       54     56       {ECO:0000244|PDB:5E6R}.
FT   HELIX        58     61       {ECO:0000244|PDB:2P26}.
FT   HELIX        65     70       {ECO:0000244|PDB:2P26}.
FT   HELIX        75     77       {ECO:0000244|PDB:2P26}.
FT   STRAND       84     88       {ECO:0000244|PDB:2P26}.
FT   STRAND       91     94       {ECO:0000244|PDB:2P26}.
FT   STRAND       96     99       {ECO:0000244|PDB:2P26}.
FT   STRAND      101    107       {ECO:0000244|PDB:2P26}.
FT   STRAND      113    119       {ECO:0000244|PDB:2P26}.
FT   STRAND      121    123       {ECO:0000244|PDB:2P26}.
FT   STRAND      127    134       {ECO:0000244|PDB:5E6S}.
FT   HELIX       137    139       {ECO:0000244|PDB:5E6S}.
FT   HELIX       140    146       {ECO:0000244|PDB:5E6S}.
FT   HELIX       150    160       {ECO:0000244|PDB:5E6S}.
FT   STRAND      161    163       {ECO:0000244|PDB:5E6S}.
FT   STRAND      165    171       {ECO:0000244|PDB:5E6S}.
FT   TURN        177    179       {ECO:0000244|PDB:5E6S}.
FT   HELIX       184    188       {ECO:0000244|PDB:5E6S}.
FT   STRAND      196    198       {ECO:0000244|PDB:4NEH}.
FT   STRAND      203    212       {ECO:0000244|PDB:5E6S}.
FT   HELIX       214    222       {ECO:0000244|PDB:5E6S}.
FT   STRAND      230    234       {ECO:0000244|PDB:5E6S}.
FT   HELIX       236    245       {ECO:0000244|PDB:5E6S}.
FT   HELIX       247    250       {ECO:0000244|PDB:5E6S}.
FT   STRAND      254    265       {ECO:0000244|PDB:5E6S}.
FT   HELIX       272    276       {ECO:0000244|PDB:5E6S}.
FT   STRAND      289    292       {ECO:0000244|PDB:4NEH}.
FT   HELIX       294    297       {ECO:0000244|PDB:5E6S}.
FT   HELIX       304    313       {ECO:0000244|PDB:5E6S}.
FT   STRAND      316    322       {ECO:0000244|PDB:5E6S}.
FT   HELIX       324    326       {ECO:0000244|PDB:5E6S}.
FT   HELIX       327    331       {ECO:0000244|PDB:5E6S}.
FT   HELIX       333    336       {ECO:0000244|PDB:5E6S}.
FT   STRAND      337    339       {ECO:0000244|PDB:5E6S}.
FT   STRAND      341    344       {ECO:0000244|PDB:5E6S}.
FT   HELIX       352    364       {ECO:0000244|PDB:5E6S}.
FT   STRAND      365    371       {ECO:0000244|PDB:2P26}.
FT   STRAND      378    385       {ECO:0000244|PDB:2P26}.
FT   STRAND      387    389       {ECO:0000244|PDB:2P26}.
FT   STRAND      391    402       {ECO:0000244|PDB:2P26}.
FT   STRAND      409    419       {ECO:0000244|PDB:2P26}.
FT   STRAND      424    430       {ECO:0000244|PDB:2P26}.
FT   STRAND      437    443       {ECO:0000244|PDB:2P26}.
FT   STRAND      452    454       {ECO:0000244|PDB:3K6S}.
FT   HELIX       458    461       {ECO:0000244|PDB:2P26}.
FT   STRAND      462    466       {ECO:0000244|PDB:2P26}.
FT   STRAND      469    472       {ECO:0000244|PDB:2P26}.
FT   STRAND      476    478       {ECO:0000244|PDB:2P26}.
FT   STRAND      483    487       {ECO:0000244|PDB:4NEH}.
FT   HELIX       490    495       {ECO:0000244|PDB:2P26}.
FT   STRAND      498    500       {ECO:0000244|PDB:2P28}.
FT   HELIX       505    508       {ECO:0000244|PDB:2P26}.
FT   STRAND      509    513       {ECO:0000244|PDB:2P26}.
FT   STRAND      516    519       {ECO:0000244|PDB:2P26}.
FT   STRAND      528    531       {ECO:0000244|PDB:2P26}.
FT   STRAND      536    539       {ECO:0000244|PDB:2P28}.
FT   STRAND      544    550       {ECO:0000244|PDB:1L3Y}.
FT   TURN        552    554       {ECO:0000244|PDB:2P28}.
FT   STRAND      555    558       {ECO:0000244|PDB:2P28}.
FT   STRAND      561    564       {ECO:0000244|PDB:2P28}.
FT   STRAND      568    570       {ECO:0000244|PDB:2P28}.
FT   STRAND      575    577       {ECO:0000244|PDB:4NEH}.
FT   TURN        580    582       {ECO:0000244|PDB:4NEH}.
FT   TURN        590    592       {ECO:0000244|PDB:5ES4}.
FT   STRAND      593    597       {ECO:0000244|PDB:4NEH}.
FT   STRAND      600    603       {ECO:0000244|PDB:4NEH}.
FT   TURN        609    611       {ECO:0000244|PDB:4NEH}.
FT   STRAND      616    618       {ECO:0000244|PDB:4NEN}.
FT   HELIX       622    624       {ECO:0000244|PDB:4NEH}.
FT   HELIX       626    634       {ECO:0000244|PDB:4NEH}.
FT   HELIX       637    639       {ECO:0000244|PDB:4NEH}.
FT   TURN        640    642       {ECO:0000244|PDB:4NEH}.
FT   HELIX       643    646       {ECO:0000244|PDB:4NEH}.
FT   STRAND      650    655       {ECO:0000244|PDB:4NEH}.
FT   STRAND      658    665       {ECO:0000244|PDB:4NEH}.
FT   STRAND      667    669       {ECO:0000244|PDB:5ES4}.
FT   STRAND      671    679       {ECO:0000244|PDB:4NEH}.
FT   TURN        680    683       {ECO:0000244|PDB:4NEH}.
FT   STRAND      684    689       {ECO:0000244|PDB:4NEH}.
FT   STRAND      754    762       {ECO:0000244|PDB:2JF1}.
SQ   SEQUENCE   769 AA;  84782 MW;  EB9F3C3DF338B4E1 CRC64;
     MLGLRPPLLA LVGLLSLGCV LSQECTKFKV SSCRECIESG PGCTWCQKLN FTGPGDPDSI
     RCDTRPQLLM RGCAADDIMD PTSLAETQED HNGGQKQLSP QKVTLYLRPG QAAAFNVTFR
     RAKGYPIDLY YLMDLSYSML DDLRNVKKLG GDLLRALNEI TESGRIGFGS FVDKTVLPFV
     NTHPDKLRNP CPNKEKECQP PFAFRHVLKL TNNSNQFQTE VGKQLISGNL DAPEGGLDAM
     MQVAACPEEI GWRNVTRLLV FATDDGFHFA GDGKLGAILT PNDGRCHLED NLYKRSNEFD
     YPSVGQLAHK LAENNIQPIF AVTSRMVKTY EKLTEIIPKS AVGELSEDSS NVVQLIKNAY
     NKLSSRVFLD HNALPDTLKV TYDSFCSNGV THRNQPRGDC DGVQINVPIT FQVKVTATEC
     IQEQSFVIRA LGFTDIVTVQ VLPQCECRCR DQSRDRSLCH GKGFLECGIC RCDTGYIGKN
     CECQTQGRSS QELEGSCRKD NNSIICSGLG DCVCGQCLCH TSDVPGKLIY GQYCECDTIN
     CERYNGQVCG GPGRGLCFCG KCRCHPGFEG SACQCERTTE GCLNPRRVEC SGRGRCRCNV
     CECHSGYQLP LCQECPGCPS PCGKYISCAE CLKFEKGPFG KNCSAACPGL QLSNNPVKGR
     TCKERDSEGC WVAYTLEQQD GMDRYLIYVD ESRECVAGPN IAAIVGGTVA GIVLIGILLL
     VIWKALIHLS DLREYRRFEK EKLKSQWNND NPLFKSATTT VMNPKFAES
//
ID   ITAM_MOUSE              Reviewed;        1153 AA.
AC   P05555; Q8CA73;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 2.
DT   20-DEC-2017, entry version 163.
DE   RecName: Full=Integrin alpha-M;
DE   AltName: Full=CD11 antigen-like family member B;
DE   AltName: Full=CR-3 alpha chain;
DE   AltName: Full=Cell surface glycoprotein MAC-1 subunit alpha;
DE   AltName: Full=Leukocyte adhesion receptor MO1;
DE   AltName: CD_antigen=CD11b;
DE   Flags: Precursor;
GN   Name=Itgam;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3044779;
RA   Pytela R.;
RT   "Amino acid sequence of the murine Mac-1 alpha chain reveals homology
RT   with the integrin family and an additional domain related to von
RT   Willebrand factor.";
RL   EMBO J. 7:1371-1378(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Spinal cord;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 11-45.
RC   STRAIN=BALB/cJ; TISSUE=Spleen;
RX   PubMed=2942940; DOI=10.1073/pnas.83.15.5644;
RA   Sastre L., Roman J.M., Teplow D.B., Dreyer W.J., Gee C.E.,
RA   Larson R.S., Roberts T.M., Springer T.A.;
RT   "A partial genomic DNA clone for the alpha subunit of the mouse
RT   complement receptor type 3 and cellular adhesion molecule Mac-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:5644-5648(1986).
RN   [4]
RP   PROTEIN SEQUENCE OF 17-28, AND TISSUE SPECIFICITY.
RX   PubMed=3887182; DOI=10.1038/314540a0;
RA   Springer T.A., Teplow D.B., Dreyer W.J.;
RT   "Sequence homology of the LFA-1 and Mac-1 leukocyte adhesion
RT   glycoproteins and unexpected relation to leukocyte interferon.";
RL   Nature 314:540-542(1985).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=8986723;
RA   Coxon A., Rieu P., Barkalow F.J., Askari S., Sharpe A.H.,
RA   von Andrian U.H., Arnaout M.A., Mayadas T.N.;
RT   "A novel role for the beta 2 integrin CD11b/CD18 in neutrophil
RT   apoptosis: a homeostatic mechanism in inflammation.";
RL   Immunity 5:653-666(1996).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=9382884;
RA   Tang T., Rosenkranz A., Assmann K.J., Goodman M.J.,
RA   Gutierrez-Ramos J.C., Carroll M.C., Cotran R.S., Mayadas T.N.;
RT   "A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil
RT   function in vivo: Mac-1 deficiency abrogates sustained Fcgamma
RT   receptor-dependent neutrophil adhesion and complement-dependent
RT   proteinuria in acute glomerulonephritis.";
RL   J. Exp. Med. 186:1853-1863(1997).
RN   [7]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=9207125;
RA   Dong Z.M., Gutierrez-Ramos J.C., Coxon A., Mayadas T.N., Wagner D.D.;
RT   "A new class of obesity genes encodes leukocyte adhesion receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7526-7530(1997).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=9862668;
RA   Rosenkranz A.R., Coxon A., Maurer M., Gurish M.F., Austen K.F.,
RA   Friend D.S., Galli S.J., Mayadas T.N.;
RT   "Impaired mast cell development and innate immunity in Mac-1
RT   (CD11b/CD18, CR3)-deficient mice.";
RL   J. Immunol. 161:6463-6467(1998).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Integrin ITGAM/ITGB2 is implicated in various adhesive
CC       interactions of monocytes, macrophages and granulocytes as well as
CC       in mediating the uptake of complement-coated particles. It is
CC       identical with CR-3, the receptor for the iC3b fragment of the
CC       third complement component. It probably recognizes the R-G-D
CC       peptide in C3b. Integrin ITGAM/ITGB2 is also a receptor for
CC       fibrinogen, factor X and ICAM1. It recognizes P1 and P2 peptides
CC       of fibrinogen gamma chain. Regulates neutrophil migration
CC       (PubMed:8986723, PubMed:9382884, PubMed:9862668). In association
CC       with beta subunit ITGB2/CD18, required for CD177-PRTN3-mediated
CC       activation of TNF primed neutrophils (By similarity). May regulate
CC       phagocytosis-induced apoptosis in extravasated neutrophils
CC       (PubMed:8986723). May play a role in mast cell development
CC       (PubMed:9862668). {ECO:0000250|UniProtKB:P11215,
CC       ECO:0000269|PubMed:8986723, ECO:0000269|PubMed:9382884,
CC       ECO:0000269|PubMed:9862668}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta chain. ITGAM
CC       associates with ITGB2. Found in a complex with CD177 and
CC       ITGB2/CD18. Interacts with JAM3. Interacts with THBD.
CC       {ECO:0000250|UniProtKB:P11215}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8986723,
CC       ECO:0000269|PubMed:9862668}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:P11215}. Membrane raft
CC       {ECO:0000250|UniProtKB:P11215}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P11215}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05555-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05555-2; Sequence=VSP_010473;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in monocytes and
CC       granulocytes (PubMed:3887182, PubMed:8986723). Expressed in a
CC       subset of peritoneal mast cells (PubMed:9862668).
CC       {ECO:0000269|PubMed:3887182, ECO:0000269|PubMed:8986723,
CC       ECO:0000269|PubMed:9862668}.
CC   -!- INDUCTION: Induced by lipopolysaccharide (LPS) in mast cells.
CC       {ECO:0000269|PubMed:9862668}.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- DISRUPTION PHENOTYPE: Mice are born at the expected Mendelian rate
CC       (PubMed:8986723). The numbers of blood leukocytes are normal and
CC       neutrophils rolling on blood vessels is not affected
CC       (PubMed:8986723). Impaired LTB4-induced neutrophil adhesion to
CC       venules (PubMed:8986723). Numbers of mast cells in the peritoneal
CC       cavity, peritoneal wall and in the dorsal skin are reduced
CC       (PubMed:9862668). In an experimental model of thioglycolate-
CC       induced peritonitis, abnormal accumulation of recruited
CC       neutrophils due to impaired apoptosis (PubMed:8986723). In an
CC       experimental model of acute septic peritonitis, 5-fold increase in
CC       mortality rate, reduced neutrophil recruitment in the peritoneum,
CC       reduced histamine production and impaired bacterial clearence
CC       (PubMed:9862668). In experimental model of immune complex-mediated
CC       glomerulonephritis, reduced neutrophil accumulation without
CC       affecting their initial recruitment and reduced proteinuria
CC       (PubMed:9382884). Enhanced susceptibility to high fat diet-induced
CC       obesity characterized by a weight increase and higher levels of
CC       white and brown fat (PubMed:9207125). {ECO:0000269|PubMed:8986723,
CC       ECO:0000269|PubMed:9207125, ECO:0000269|PubMed:9382884,
CC       ECO:0000269|PubMed:9862668}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X07640; CAA30479.1; -; mRNA.
DR   EMBL; AK039444; BAC30350.1; -; mRNA.
DR   EMBL; M14293; AAA39484.1; -; Genomic_DNA.
DR   CCDS; CCDS21889.1; -. [P05555-1]
DR   PIR; S00551; S00551.
DR   UniGene; Mm.262106; -.
DR   ProteinModelPortal; P05555; -.
DR   SMR; P05555; -.
DR   IntAct; P05555; 2.
DR   MINT; MINT-4098963; -.
DR   STRING; 10090.ENSMUSP00000101849; -.
DR   ChEMBL; CHEMBL3603; -.
DR   PhosphoSitePlus; P05555; -.
DR   MaxQB; P05555; -.
DR   PaxDb; P05555; -.
DR   PeptideAtlas; P05555; -.
DR   PRIDE; P05555; -.
DR   MGI; MGI:96607; Itgam.
DR   eggNOG; ENOG410IPBA; Eukaryota.
DR   eggNOG; ENOG410ZFBE; LUCA.
DR   HOGENOM; HOG000113114; -.
DR   HOVERGEN; HBG100530; -.
DR   InParanoid; P05555; -.
DR   PhylomeDB; P05555; -.
DR   ChiTaRS; Itgam; mouse.
DR   PRO; PR:P05555; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_ITGAM; -.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IDA:MGI.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; ISO:MGI.
DR   GO; GO:0001851; F:complement component C3b binding; IGI:ARUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:MGI.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; IDA:MGI.
DR   GO; GO:0008201; F:heparin binding; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001846; F:opsonin binding; IDA:MGI.
DR   GO; GO:0050798; P:activated T cell proliferation; IMP:MGI.
DR   GO; GO:0097242; P:amyloid-beta clearance; IMP:ARUK-UCL.
DR   GO; GO:0007155; P:cell adhesion; IMP:MGI.
DR   GO; GO:0098609; P:cell-cell adhesion; IGI:MGI.
DR   GO; GO:0045123; P:cellular extravasation; IMP:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0061756; P:leukocyte adhesion to vascular endothelial cell; IMP:UniProtKB.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IMP:MGI.
DR   GO; GO:0002523; P:leukocyte migration involved in inflammatory response; IMP:MGI.
DR   GO; GO:0014005; P:microglia development; IDA:MGI.
DR   GO; GO:0001774; P:microglial cell activation; IMP:ARUK-UCL.
DR   GO; GO:0045963; P:negative regulation of dopamine metabolic process; IDA:ARUK-UCL.
DR   GO; GO:0001781; P:neutrophil apoptotic process; IMP:UniProtKB.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IMP:MGI.
DR   GO; GO:0006909; P:phagocytosis; IMP:UniProtKB.
DR   GO; GO:0006911; P:phagocytosis, engulfment; IMP:ARUK-UCL.
DR   GO; GO:0060376; P:positive regulation of mast cell differentiation; IMP:UniProtKB.
DR   GO; GO:1903980; P:positive regulation of microglial cell activation; IMP:ARUK-UCL.
DR   GO; GO:1901216; P:positive regulation of neuron death; IMP:ARUK-UCL.
DR   GO; GO:0043315; P:positive regulation of neutrophil degranulation; ISO:MGI.
DR   GO; GO:2000363; P:positive regulation of prostaglandin-E synthase activity; IMP:ARUK-UCL.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IMP:ARUK-UCL.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IMP:ARUK-UCL.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Integrin; Membrane; Metal-binding; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     16       {ECO:0000269|PubMed:3887182}.
FT   CHAIN        17   1153       Integrin alpha-M.
FT                                /FTId=PRO_0000016290.
FT   TOPO_DOM     17   1105       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1106   1129       Helical. {ECO:0000255}.
FT   TOPO_DOM   1130   1153       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       18     75       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       76    135       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      164    338       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      339    390       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      391    442       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      443    503       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      506    564       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      569    629       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     465    473       {ECO:0000255}.
FT   CA_BIND     529    537       {ECO:0000255}.
FT   CA_BIND     592    600       {ECO:0000255}.
FT   MOTIF      1132   1136       GFFKR motif.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    391    391       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    696    696       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    734    734       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    772    772       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    801    801       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    881    881       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    907    907       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    941    941       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    980    980       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    994    994       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1022   1022       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1045   1045       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1051   1051       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1076   1076       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     66     73       {ECO:0000250}.
FT   DISULFID    105    123       {ECO:0000250}.
FT   DISULFID    654    711       {ECO:0000250}.
FT   DISULFID    770    776       {ECO:0000250}.
FT   DISULFID    999   1023       {ECO:0000250}.
FT   DISULFID   1028   1033       {ECO:0000250}.
FT   VAR_SEQ     453    569       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_010473.
FT   CONFLICT     37     37       N -> S (in Ref. 2; BAC30350).
FT                                {ECO:0000305}.
FT   CONFLICT    683    683       V -> G (in Ref. 2; BAC30350).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1153 AA;  127481 MW;  178DB988AECB0343 CRC64;
     MTLKALLVTA LALCHGFNLD TEHPMTFQEN AKGFGQNVVQ LGGTSVVVAA PQEAKAVNQT
     GALYQCDYST SRCHPIPLQV PPEAVNMSLG LSLAVSTVPQ QLLACGPTVH QNCKENTYVN
     GLCYLFGSNL LRPPQQFPEA LRECPQQESD IVFLIDGSGS INNIDFQKMK EFVSTVMEQF
     KKSKTLFSLM QYSDEFRIHF TFNDFKRNPS PRSHVSPIKQ LNGRTKTASG IRKVVRELFH
     KTNGARENAA KILVVITDGE KFGDPLDYKD VIPEADRAGV IRYVIGVGNA FNKPQSRREL
     DTIASKPAGE HVFQVDNFEA LNTIQNQLQE KIFAIEGTQT GSTSSFEHEM SQEGFSASIT
     SNGPLLGSVG SFDWAGGAFL YTSKDKVTFI NTTRVDSDMN DAYLGYASAV ILRNRVQSLV
     LGAPRYQHIG LVVMFRENFG TWEPHTSIKG SQIGSYFGAS LCSVDMDADG NTNLILIGAP
     HYYEKTRGGQ VSVCPLPRGR ARWQCEALLH GDQGHPWGRF GAALTVLGDV NGDKLTDVAI
     GAPGEQENQG AVYIFYGASI ASLSASHSHR IIGAHFSPGL QYFGQSLSGG KDLTMDGLMD
     LAVGAQGHLL LLRAQPVLRL EATMEFSPKK VARSVFACQE QVLKNKDAGE VRVCLRVRKN
     TKDRLREGDI QSTVTYDLAL DPVRSRIRAF FDETKNNTRR RTQVFGLMQK CETLKLILPD
     CVDDSVSPII LRLNYTLVGE PLRSFGNLRP VLAMDAQRFF TAMFPFEKNC GNDSICQDDL
     SITMSAMGLD TLVVGGPQDF NMSVTLRNDG EDSYGTQVTV YYPSGLSYRK DSASQNPLTK
     KPWFVKPAES SSSSEGHGAL KSTTWNINHP IFPANSEVTF NVTFDVDSHA SFGNKLLLKA
     IVASENNMSR THKTKFQLEL PVKYAIYMIV TSDESSIRYL NFTASEMTSK VIQHQYQFNN
     LGQRSLPVSV VFWIPVQINN VTVWDHPQVI FSQNLSSACH TEQKSPPHSN FRDQLERTPV
     LNCSVAVCKR IQCDLPSFNT QEIFNVTLKG NLSFDWYIKT SHGHLLLVSS TEILFNDSAF
     ALLPGQESYV RSKTETKVEP YEVHNPVPLI VGSSIGGLVL LALITAGLYK LGFFKRQYKD
     MMNEAAPQDA PPQ
//
ID   ITB1_HUMAN              Reviewed;         798 AA.
AC   P05556; A8K6N2; D3DRX9; D3DRY3; D3DRY4; D3DRY5; P78466; P78467;
AC   Q13089; Q13090; Q13091; Q13212; Q14622; Q14647; Q29RW2; Q7Z3V1;
AC   Q8WUM6;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   20-DEC-2017, entry version 223.
DE   RecName: Full=Integrin beta-1;
DE   AltName: Full=Fibronectin receptor subunit beta;
DE   AltName: Full=Glycoprotein IIa;
DE            Short=GPIIA;
DE   AltName: Full=VLA-4 subunit beta;
DE   AltName: CD_antigen=CD29;
DE   Flags: Precursor;
GN   Name=ITGB1; Synonyms=FNRB, MDF2, MSK12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2958481; DOI=10.1083/jcb.105.3.1183;
RA   Argraves W.S., Suzuki S., Arai H., Thompson K., Pierschbacher M.D.,
RA   Ruoslahti E.;
RT   "Amino acid sequence of the human fibronectin receptor.";
RL   J. Cell Biol. 105:1183-1190(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 717-757, CHARACTERIZATION OF
RP   BETA-1B, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=7681433; DOI=10.1083/jcb.121.1.171;
RA   Balzac F., Belkin A.M., Koteliansky V.E., Balabanov Y.V., Altruda F.,
RA   Silengo L., Tarone G.;
RT   "Expression and functional analysis of a cytoplasmic domain variant of
RT   the beta 1 integrin subunit.";
RL   J. Cell Biol. 121:171-178(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 717-757, AND FUNCTION.
RX   PubMed=7523423; DOI=10.1083/jcb.127.2.557;
RA   Balzac F., Retta S.F., Albini A., Melchiorri A., Koteliansky V.E.,
RA   Geuna M., Silengo L., Tarone G.;
RT   "Expression of beta 1B integrin isoform in CHO cells results in a
RT   dominant negative effect on cell adhesion and motility.";
RL   J. Cell Biol. 127:557-565(1994).
RN   [9]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Skeletal muscle;
RX   PubMed=2249781; DOI=10.1016/0378-1119(90)90369-3;
RA   Altruda F., Cervella P., Tarone G., Botta C., Balzac F., Stefanuto G.,
RA   Silengo L.;
RT   "A human integrin beta 1 subunit with a unique cytoplasmic domain
RT   generated by alternative mRNA processing.";
RL   Gene 95:261-266(1990).
RN   [10]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=1551917;
RA   Languino L.R., Ruoslahti E.;
RT   "An alternative form of the integrin beta 1 subunit with a variant
RT   cytoplasmic domain.";
RL   J. Biol. Chem. 267:7116-7120(1992).
RN   [11]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Skeletal muscle;
RX   PubMed=7545396; DOI=10.1006/bbrc.1995.2285;
RA   Zhidkova N.I., Belkin A.M., Mayne R.;
RT   "Novel isoform of beta 1 integrin expressed in skeletal and cardiac
RT   muscle.";
RL   Biochem. Biophys. Res. Commun. 214:279-285(1995).
RN   [12]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=7544298; DOI=10.1016/0014-5793(95)00814-P;
RA   van der Flier A., Kuikman I., Baudoin C., van der Neut R.,
RA   Sonnenberg A.;
RT   "A novel beta 1 integrin isoform produced by alternative splicing:
RT   unique expression in cardiac and skeletal muscle.";
RL   FEBS Lett. 369:340-344(1995).
RN   [13]
RP   PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 4), AND TISSUE SPECIFICITY.
RX   PubMed=9494094; DOI=10.1042/bj3301255;
RA   Svineng G., Faessler R., Johansson S.;
RT   "Identification of beta1C-2, a novel variant of the integrin beta1
RT   subunit generated by utilization of an alternative splice acceptor
RT   site in exon C.";
RL   Biochem. J. 330:1255-1263(1998).
RN   [14]
RP   PROTEIN SEQUENCE OF 775-784 (ISOFORM 5), IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND INTERACTION WITH ACE2.
RX   PubMed=15276642; DOI=10.1016/j.bbadis.2004.05.005;
RA   Lin Q., Keller R.S., Weaver B., Zisman L.S.;
RT   "Interaction of ACE2 and integrin beta1 in failing human heart.";
RL   Biochim. Biophys. Acta 1689:175-178(2004).
RN   [15]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN ECHOVIRUS 1
RP   AND HUMAN ECHOVIRUS 8 CAPSID PROTEINS.
RX   PubMed=8411387;
RA   Bergelson J.M., St John N., Kawaguchi S., Chan M., Stubdal H.,
RA   Modlin J., Finberg R.W.;
RT   "Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of
RT   human VLA-2.";
RL   J. Virol. 67:6847-6852(1993).
RN   [16]
RP   SUBCELLULAR LOCATION.
RX   PubMed=8567725; DOI=10.1083/jcb.132.1.211;
RA   Belkin A.M., Zhidkova N.I., Balzac F., Altruda F., Tomatis D.,
RA   Maier A., Tarone G., Koteliansky V.E., Burridge K.;
RT   "Beta 1D integrin displaces the beta 1A isoform in striated muscles:
RT   localization at junctional structures and signaling potential in
RT   nonmuscle cells.";
RL   J. Cell Biol. 132:211-226(1996).
RN   [17]
RP   INTERACTION WITH LGALS3BP.
RX   PubMed=9501082; DOI=10.1093/emboj/17.6.1606;
RA   Sasaki T., Brakebusch C., Engel J., Timpl R.;
RT   "Mac-2 binding protein is a cell-adhesive protein of the extracellular
RT   matrix which self-assembles into ring-like structures and binds beta1
RT   integrins, collagens and fibronectin.";
RL   EMBO J. 17:1606-1613(1998).
RN   [18]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HIV-1 TAT.
RX   PubMed=10397733;
RA   Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S.,
RA   Manzari V., Modesti A., Nair B.C., Cafaro A., Stuerzl M., Ensoli B.;
RT   "The Tat protein of human immunodeficiency virus type-1 promotes
RT   vascular cell growth and locomotion by engaging the alpha5beta1 and
RT   alphavbeta3 integrins and by mobilizing sequestered basic fibroblast
RT   growth factor.";
RL   Blood 94:663-672(1999).
RN   [19]
RP   FUNCTION, SUBUNIT, INTERACTION WITH FAP, AND SUBCELLULAR LOCATION.
RX   PubMed=10455171; DOI=10.1074/jbc.274.35.24947;
RA   Mueller S.C., Ghersi G., Akiyama S.K., Sang Q.X., Howard L.,
RA   Pineiro-Sanchez M., Nakahara H., Yeh Y., Chen W.T.;
RT   "A novel protease-docking function of integrin at invadopodia.";
RL   J. Biol. Chem. 274:24947-24952(1999).
RN   [20]
RP   INTERACTION WITH NMRK2.
RC   TISSUE=Heart;
RX   PubMed=10613898; DOI=10.1083/jcb.147.7.1391;
RA   Li J., Mayne R., Wu C.;
RT   "A novel muscle-specific beta 1 integrin binding protein (MIBP) that
RT   modulates myogenic differentiation.";
RL   J. Cell Biol. 147:1391-1398(1999).
RN   [21]
RP   INTERACTION WITH ITGB1BP1.
RX   PubMed=11741838; DOI=10.1093/hmg/10.25.2953;
RA   Zhang J., Clatterbuck R.E., Rigamonti D., Chang D.D., Dietz H.C.;
RT   "Interaction between krit1 and icap1alpha infers perturbation of
RT   integrin beta1-mediated angiogenesis in the pathogenesis of cerebral
RT   cavernous malformation.";
RL   Hum. Mol. Genet. 10:2953-2960(2001).
RN   [22]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11919189; DOI=10.1074/jbc.M200200200;
RA   Fournier H.N., Dupe-Manet S., Bouvard D., Lacombe M.L., Marie C.,
RA   Block M.R., Albiges-Rizo C.;
RT   "Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha)
RT   interacts directly with the metastasis suppressor nm23-H2, and both
RT   proteins are targeted to newly formed cell adhesion sites upon
RT   integrin engagement.";
RL   J. Biol. Chem. 277:20895-20902(2002).
RN   [23]
RP   INTERACTION WITH FLNA AND FLNB, AND MUTAGENESIS OF GLY-778 AND
RP   ALA-786.
RX   PubMed=11807098; DOI=10.1083/jcb.200103037;
RA   van Der Flier A., Kuikman I., Kramer D., Geerts D., Kreft M.,
RA   Takafuta T., Shapiro S.S., Sonnenberg A.;
RT   "Different splice variants of filamin-B affect myogenesis, subcellular
RT   distribution, and determine binding to integrin (beta) subunits.";
RL   J. Cell Biol. 156:361-376(2002).
RN   [24]
RP   INTERACTION WITH ITGB1BP1, AND MUTAGENESIS OF 786-ALA--VAL-791.
RX   PubMed=11807099; DOI=10.1083/jcb.200108030;
RA   Degani S., Balzac F., Brancaccio M., Guazzone S., Retta S.F.,
RA   Silengo L., Eva A., Tarone G.;
RT   "The integrin cytoplasmic domain-associated protein ICAP-1 binds and
RT   regulates Rho family GTPases during cell spreading.";
RL   J. Cell Biol. 156:377-387(2002).
RN   [25]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN PARVOVIRUS
RP   B19 CAPSID PROTEIN.
RX   PubMed=12907437; DOI=10.1182/blood-2003-05-1522;
RA   Weigel-Kelley K.A., Yoder M.C., Srivastava A.;
RT   "Alpha5beta1 integrin as a cellular coreceptor for human parvovirus
RT   B19: requirement of functional activation of beta1 integrin for viral
RT   entry.";
RL   Blood 102:3927-3933(2003).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH ITGB1BP1.
RX   PubMed=12473654; DOI=10.1074/jbc.M211258200;
RA   Bouvard D., Vignoud L., Dupe-Manet S., Abed N., Fournier H.N.,
RA   Vincent-Monegat C., Retta S.F., Fassler R., Block M.R.;
RT   "Disruption of focal adhesions by integrin cytoplasmic domain-
RT   associated protein-1 alpha.";
RL   J. Biol. Chem. 278:6567-6574(2003).
RN   [27]
RP   INTERACTION WITH NOV.
RX   PubMed=12695522; DOI=10.1074/jbc.M302028200;
RA   Lin C.G., Leu S.J., Chen N., Tebeau C.M., Lin S.X., Yeung C.Y.,
RA   Lau L.F.;
RT   "CCN3 (NOV) is a novel angiogenic regulator of the CCN protein
RT   family.";
RL   J. Biol. Chem. 278:24200-24208(2003).
RN   [28]
RP   FUNCTION, AND INTERACTION WITH FBN1.
RX   PubMed=12807887; DOI=10.1074/jbc.M303159200;
RA   Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J.,
RA   Shuttleworth C.A., Humphries M.J., Kielty C.M.;
RT   "Cell adhesion to fibrillin-1 molecules and microfibrils is mediated
RT   by alpha 5 beta 1 and alpha v beta 3 integrins.";
RL   J. Biol. Chem. 278:34605-34616(2003).
RN   [29]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN ROTAVIRUS
RP   VP4 PROTEIN.
RX   PubMed=12941907; DOI=10.1128/JVI.77.18.9969-9978.2003;
RA   Graham K.L., Halasz P., Tan Y., Hewish M.J., Takada Y., Mackow E.R.,
RA   Robinson M.K., Coulson B.S.;
RT   "Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain
RT   via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by
RT   using VP7 during cell entry.";
RL   J. Virol. 77:9969-9978(2003).
RN   [30]
RP   INTERACTION WITH RANBP9.
RX   PubMed=14722085; DOI=10.1074/jbc.M313515200;
RA   Denti S., Sirri A., Cheli A., Rogge L., Innamorati G., Putignano S.,
RA   Fabbri M., Pardi R., Bianchi E.;
RT   "RanBPM is a phosphoprotein that associates with the plasma membrane
RT   and interacts with the integrin LFA-1.";
RL   J. Biol. Chem. 279:13027-13034(2004).
RN   [31]
RP   INTERACTION WITH ITGA3; LGALS3 AND CSPG4.
RX   PubMed=15181153; DOI=10.1091/mbc.E04-03-0236;
RA   Fukushi J., Makagiansar I.T., Stallcup W.B.;
RT   "NG2 proteoglycan promotes endothelial cell motility and angiogenesis
RT   via engagement of galectin-3 and alpha3beta1 integrin.";
RL   Mol. Biol. Cell 15:3580-3590(2004).
RN   [32]
RP   INTERACTION WITH MYO10.
RX   PubMed=15156152; DOI=10.1038/ncb1136;
RA   Zhang H., Berg J.S., Li Z., Wang Y., Lang P., Sousa A.D., Bhaskar A.,
RA   Cheney R.E., Stromblad S.;
RT   "Myosin-X provides a motor-based link between integrins and the
RT   cytoskeleton.";
RL   Nat. Cell Biol. 6:523-531(2004).
RN   [33]
RP   FUNCTION, INTERACTION WITH ACAP1, AND SUBCELLULAR LOCATION.
RX   PubMed=16256741; DOI=10.1016/j.devcel.2005.09.012;
RA   Li J., Ballif B.A., Powelka A.M., Dai J., Gygi S.P., Hsu V.W.;
RT   "Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent
RT   recycling of integrin beta1 to control cell migration.";
RL   Dev. Cell 9:663-673(2005).
RN   [34]
RP   INTERACTION WITH FLNB AND FLNC.
RX   PubMed=16076904; DOI=10.1242/jcs.02484;
RA   Gontier Y., Taivainen A., Fontao L., Sonnenberg A., van der Flier A.,
RA   Carpen O., Faulkner G., Borradori L.;
RT   "The Z-disc proteins myotilin and FATZ-1 interact with each other and
RT   are connected to the sarcolemma via muscle-specific filamins.";
RL   J. Cell Sci. 118:3739-3749(2005).
RN   [35]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-406.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [36]
RP   INTERACTION WITH RAB21.
RX   PubMed=16754960; DOI=10.1083/jcb.200509019;
RA   Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M.,
RA   Ivaska J.;
RT   "Small GTPase Rab21 regulates cell adhesion and controls endosomal
RT   traffic of beta1-integrins.";
RL   J. Cell Biol. 173:767-780(2006).
RN   [37]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [38]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH MAMMALIAN
RP   REOVIRUS CAPSID PROTEINS.
RX   PubMed=16501085; DOI=10.1128/JVI.80.6.2760-2770.2006;
RA   Maginnis M.S., Forrest J.C., Kopecky-Bromberg S.A., Dickeson S.K.,
RA   Santoro S.A., Zutter M.M., Nemerow G.R., Bergelson J.M., Dermody T.S.;
RT   "Beta1 integrin mediates internalization of mammalian reovirus.";
RL   J. Virol. 80:2760-2770(2006).
RN   [39]
RP   FUNCTION, INTERACTION WITH KRT1, AND SUBCELLULAR LOCATION.
RX   PubMed=17956333; DOI=10.1042/BST0351292;
RA   Chuang N.N., Huang C.C.;
RT   "Interaction of integrin beta1 with cytokeratin 1 in neuroblastoma
RT   NMB7 cells.";
RL   Biochem. Soc. Trans. 35:1292-1294(2007).
RN   [40]
RP   INTERACTION WITH RAB25.
RX   PubMed=17925226; DOI=10.1016/j.devcel.2007.08.012;
RA   Caswell P.T., Spence H.J., Parsons M., White D.P., Clark K.,
RA   Cheng K.W., Mills G.B., Humphries M.J., Messent A.J., Anderson K.I.,
RA   McCaffrey M.W., Ozanne B.W., Norman J.C.;
RT   "Rab25 associates with alpha5beta1 integrin to promote invasive
RT   migration in 3D microenvironments.";
RL   Dev. Cell 13:496-510(2007).
RN   [41]
RP   FUNCTION, INTERACTION WITH FBN1, AND SUBCELLULAR LOCATION.
RX   PubMed=17158881; DOI=10.1074/jbc.M607008200;
RA   Jovanovic J., Takagi J., Choulier L., Abrescia N.G., Stuart D.I.,
RA   van der Merwe P.A., Mardon H.J., Handford P.A.;
RT   "alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative
RT   studies of molecular determinants underlying integrin-rgd affinity and
RT   specificity.";
RL   J. Biol. Chem. 282:6743-6751(2007).
RN   [42]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18804435; DOI=10.1016/j.devcel.2008.08.001;
RA   Pellinen T., Tuomi S., Arjonen A., Wolf M., Edgren H., Meyer H.,
RA   Grosse R., Kitzing T., Rantala J.K., Kallioniemi O., Faessler R.,
RA   Kallio M., Ivaska J.;
RT   "Integrin trafficking regulated by Rab21 is necessary for
RT   cytokinesis.";
RL   Dev. Cell 15:371-385(2008).
RN   [43]
RP   FUNCTION.
RX   PubMed=18635536; DOI=10.1074/jbc.M804835200;
RA   Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S.,
RA   Liu F.T., Takada Y.K., Takada Y.;
RT   "Pro-inflammatory secretory phospholipase A2 type IIA binds to
RT   integrins alphavbeta3 and alpha4beta1 and induces proliferation of
RT   monocytic cells in an integrin-dependent manner.";
RL   J. Biol. Chem. 283:26107-26115(2008).
RN   [44]
RP   FUNCTION IN LEUKOCYTE TO ENDOTHELIAL CELLS ADHESION, AND INTERACTION
RP   WITH JAML.
RX   PubMed=19064666; DOI=10.1083/jcb.200805061;
RA   Luissint A.C., Lutz P.G., Calderwood D.A., Couraud P.O.,
RA   Bourdoulous S.;
RT   "JAM-L-mediated leukocyte adhesion to endothelial cells is regulated
RT   in cis by alpha4beta1 integrin activation.";
RL   J. Cell Biol. 183:1159-1173(2008).
RN   [45]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH EPSTEIN-BARR
RP   VIRUS/HHV-4 GB PROTEIN.
RX   PubMed=17945327; DOI=10.1016/j.virol.2007.09.012;
RA   Xiao J., Palefsky J.M., Herrera R., Berline J., Tugizov S.M.;
RT   "The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to
RT   oral epithelial cells.";
RL   Virology 370:430-442(2008).
RN   [46]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-212; ASN-481 AND ASN-669.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [47]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-403; ASN-406 AND ASN-411.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [48]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-777, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [49]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-794, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [50]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HHV-5 GB.
RX   PubMed=20660204; DOI=10.1128/JVI.00710-10;
RA   Feire A.L., Roy R.M., Manley K., Compton T.;
RT   "The glycoprotein B disintegrin-like domain binds beta 1 integrin to
RT   mediate cytomegalovirus entry.";
RL   J. Virol. 84:10026-10037(2010).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [52]
RP   INTERACTION WITH ASAP3.
RX   PubMed=22027826; DOI=10.1074/jbc.M111.278770;
RA   Yu X., Wang F., Liu H., Adams G., Aikhionbare F., Liu D., Cao X.,
RA   Fan L., Hu G., Chen Y., Frost A., Partridge E., Ding X., Yao X.;
RT   "ACAP4 protein cooperates with Grb2 protein to orchestrate epidermal
RT   growth factor-stimulated integrin beta1 recycling in cell migration.";
RL   J. Biol. Chem. 286:43735-43747(2011).
RN   [53]
RP   FUNCTION, INTERACTION WITH FERMT2 AND TLN1, AND MUTAGENESIS OF
RP   VAL-787.
RX   PubMed=21768292; DOI=10.1083/jcb.201007108;
RA   Brunner M., Millon-Fremillon A., Chevalier G., Nakchbandi I.A.,
RA   Mosher D., Block M.R., Albiges-Rizo C., Bouvard D.;
RT   "Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent
RT   fibronectin deposition.";
RL   J. Cell Biol. 194:307-322(2011).
RN   [54]
RP   INTERACTION WITH FERMT2.
RX   PubMed=21325030; DOI=10.1242/jcs.076976;
RA   Qu H., Tu Y., Shi X., Larjava H., Saleem M.A., Shattil S.J.,
RA   Fukuda K., Qin J., Kretzler M., Wu C.;
RT   "Kindlin-2 regulates podocyte adhesion and fibronectin matrix
RT   deposition through interactions with phosphoinositides and
RT   integrins.";
RL   J. Cell Sci. 124:879-891(2011).
RN   [55]
RP   FUNCTION, BINDING TO CX3CL1, IDENTIFICATION IN A COMPLEX WITH CX3CR1
RP   AND CX3CL1, AND CX3CL1-BINDING REGION.
RX   PubMed=23125415; DOI=10.4049/jimmunol.1200889;
RA   Fujita M., Takada Y.K., Takada Y.;
RT   "Integrins alphavbeta3 and alpha4beta1 act as coreceptors for
RT   fractalkine, and the integrin-binding defective mutant of fractalkine
RT   is an antagonist of CX3CR1.";
RL   J. Immunol. 189:5809-5819(2012).
RN   [56]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-783, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [57]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-785 AND THR-789, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [58]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-794, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [59]
RP   FUNCTION.
RX   PubMed=25398877; DOI=10.1074/jbc.M114.579946;
RA   Fujita M., Zhu K., Fujita C.K., Zhao M., Lam K.S., Kurth M.J.,
RA   Takada Y.K., Takada Y.;
RT   "Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces
RT   integrin activation through direct binding to a newly identified
RT   binding site (site 2) in integrins alphavbeta3, alpha4beta1, and
RT   alpha5beta1.";
RL   J. Biol. Chem. 290:259-271(2015).
RN   [60]
RP   BINDING TO CX3CL1, AND CX3CL1-BINDING REGION.
RX   PubMed=24789099; DOI=10.1371/journal.pone.0096372;
RA   Fujita M., Takada Y.K., Takada Y.;
RT   "The chemokine fractalkine can activate integrins without CX3CR1
RT   through direct binding to a ligand-binding site distinct from the
RT   classical RGD-binding site.";
RL   PLoS ONE 9:E96372-E96372(2014).
RN   [61]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 758-769 IN COMPLEX WITH
RP   ACAP1, INTERACTION WITH ACAP1 AND ITGA5, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 760-ARG-ARG-761; 762-GLU--PHE-767 AND 768-LYS-GLU-769.
RX   PubMed=22645133; DOI=10.1074/jbc.M112.378810;
RA   Bai M., Pang X., Lou J., Zhou Q., Zhang K., Ma J., Li J., Sun F.,
RA   Hsu V.W.;
RT   "Mechanistic insights into regulated cargo binding by ACAP1 protein.";
RL   J. Biol. Chem. 287:28675-28685(2012).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 21-465 IN COMPLEX WITH
RP   ANTIBODY; ITGA5 AND RGD PEPTIDE, DISULFIDE BONDS, GLYCOSYLATION AT
RP   ASN-269 AND ASN-406, METAL-BINDING SITES, AND SUBUNIT.
RX   PubMed=22451694; DOI=10.1083/jcb.201111077;
RA   Nagae M., Re S., Mihara E., Nogi T., Sugita Y., Takagi J.;
RT   "Crystal structure of alpha5beta1 integrin ectodomain: atomic details
RT   of the fibronectin receptor.";
RL   J. Cell Biol. 197:131-140(2012).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 784-798 IN COMPLEX WITH
RP   ITGB1BP1, INTERACTION WITH ITGB1BP1, AND MUTAGENESIS OF THR-788;
RP   VAL-790; ASN-792 AND TYR-795.
RX   PubMed=23317506; DOI=10.1016/j.molcel.2012.12.005;
RA   Liu W., Draheim K.M., Zhang R., Calderwood D.A., Boggon T.J.;
RT   "Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin
RT   activation.";
RL   Mol. Cell 49:719-729(2013).
CC   -!- FUNCTION: Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-
CC       1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-
CC       1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated
CC       sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-
CC       3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-
CC       10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for
CC       fibronectin. Alpha-4/beta-1 recognizes one or more domains within
CC       the alternatively spliced CS-1 and CS-5 regions of fibronectin.
CC       Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin
CC       alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1
CC       are receptors for lamimin. Integrin alpha-4/beta-1 is a receptor
CC       for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin
CC       alpha-9/beta-1 is a receptor for VCAM1, cytotactin and
CC       osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in
CC       cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin,
CC       thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3
CC       the stimulation by CSPG4 of endothelial cells migration. Integrin
CC       alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins
CC       recognize the sequence R-G-D in a wide array of ligands. Isoform 2
CC       interferes with isoform 1 resulting in a dominant negative effect
CC       on cell adhesion and migration (in vitro). When associated with
CC       alpha-7/beta-1 integrin, regulates cell adhesion and laminin
CC       matrix deposition. Involved in promoting endothelial cell motility
CC       and angiogenesis. Involved in osteoblast compaction through the
CC       fibronectin fibrillogenesis cell-mediated matrix assembly process
CC       and the formation of mineralized bone nodules. May be involved in
CC       up-regulation of the activity of kinases such as PKC via binding
CC       to KRT1. Together with KRT1 and RACK1, serves as a platform for
CC       SRC activation or inactivation. Plays a mechanistic adhesive role
CC       during telophase, required for the successful completion of
CC       cytokinesis. Integrin alpha-3/beta-1 provides a docking site for
CC       FAP (seprase) at invadopodia plasma membranes in a collagen-
CC       dependent manner and hence may participate in the adhesion,
CC       formation of invadopodia and matrix degradation processes,
CC       promoting cell invasion. ITGA4:ITGB1 binds to fractalkine (CX3CL1)
CC       and may act as its coreceptor in CX3CR1-dependent fractalkine
CC       signaling (PubMed:23125415, PubMed:24789099). ITGA4:ITGB1 and
CC       ITGA5:ITGB1 bind to PLA2G2A via a site (site 2) which is distinct
CC       from the classical ligand-binding site (site 1) and this induces
CC       integrin conformational changes and enhanced ligand binding to
CC       site 1 (PubMed:18635536, PubMed:25398877). ITGA5:ITGB1 acts as a
CC       receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell
CC       adhesion to FBN1 (PubMed:12807887, PubMed:17158881).
CC       {ECO:0000269|PubMed:10455171, ECO:0000269|PubMed:12473654,
CC       ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:16256741,
CC       ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18635536,
CC       ECO:0000269|PubMed:18804435, ECO:0000269|PubMed:19064666,
CC       ECO:0000269|PubMed:21768292, ECO:0000269|PubMed:23125415,
CC       ECO:0000269|PubMed:24789099, ECO:0000269|PubMed:25398877,
CC       ECO:0000269|PubMed:7523423}.
CC   -!- FUNCTION: Isoform 5: Isoform 5 displaces isoform 1 in striated
CC       muscles. {ECO:0000250}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGA2:ITGB1 acts as a
CC       receptor for human echoviruses 1 and 8 (PubMed:8411387). Acts as a
CC       receptor for cytomegalovirus/HHV-5 (PubMed:20660204). Acts as a
CC       receptor for Epstein-Barr virus/HHV-4 (PubMed:17945327). Integrin
CC       ITGA5:ITGB1 acts as a receptor for human parvovirus B19
CC       (PubMed:12907437). Integrin ITGA2:ITGB1 acts as a receptor for
CC       human rotavirus (PubMed:12941907). Acts as a receptor for
CC       mammalian reovirus (PubMed:16501085). In case of HIV-1 infection,
CC       integrin ITGA5:ITGB1 binding to extracellular viral Tat protein
CC       seems to enhance angiogenesis in Kaposi's sarcoma lesions
CC       (PubMed:10397733). {ECO:0000269|PubMed:10397733,
CC       ECO:0000269|PubMed:12907437, ECO:0000269|PubMed:12941907,
CC       ECO:0000269|PubMed:16501085, ECO:0000269|PubMed:17945327,
CC       ECO:0000269|PubMed:20660204, ECO:0000269|PubMed:8411387}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-1
CC       associates with either alpha-1, alpha-2, alpha-3, alpha-4, alpha-
CC       5, alpha-6, alpha-7, alpha-8, alpha-9, alpha-10, alpha-11 or
CC       alpha-V. Interacts with seprase FAP (seprase); the interaction
CC       occurs at the cell surface of invadopodia membrane in a collagen-
CC       dependent manner. Binds LGALS3BP and NMRK2, when associated with
CC       alpha-7, but not with alpha-5. Interacts with FGR and HCK.
CC       Interacts (via the cytoplasmic region) with RAB25 (via the
CC       hypervariable C-terminal region). Interacts with RAB21. Interacts
CC       with KRT1 in the presence of RACK1 and SRC. Interacts with JAML;
CC       integrin alpha-4/beta-1 may regulate leukocyte to endothelial
CC       cells adhesion by controlling JAML homodimerization. Interacts
CC       with FLNA, FLNB and RANBP9. Isoform 5 interacts with ACE2. Isoform
CC       1 interacts with the C-terminal region of FLNC. Interacts with
CC       MYO10. Interacts with DAB2. Interacts with FERMT2; the interaction
CC       is inhibited in presence of ITGB1BP1. Interacts with ITGB1BP1 (via
CC       C-terminal region); the interaction is a prerequisite for focal
CC       adhesion disassembly. Interacts with TLN1; the interaction is
CC       prevented by competitive binding of ITGB1BP1. Interacts with
CC       ACAP1; required for ITGB1 recycling. Interacts with ASAP3. Isoform
CC       5 interacts with alpha-7A and alpha-7B in adult skeletal muscle.
CC       Isoform 5 interacts with alpha-7B in cardiomyocytes of adult
CC       heart. Interacts with EMP2; the interaction may be direct or
CC       indirect and ITGB1 has an heterodimer form (By similarity).
CC       ITGA5:ITGB1 interacts with NOV. ITGA4:ITGB1 is found in a ternary
CC       complex with CX3CR1 and CX3CL1 (PubMed:23125415). ITGA5:ITGB1
CC       interacts with FBN1 (PubMed:12807887, PubMed:17158881).
CC       {ECO:0000250|UniProtKB:P09055, ECO:0000269|PubMed:10455171,
CC       ECO:0000269|PubMed:10613898, ECO:0000269|PubMed:11741838,
CC       ECO:0000269|PubMed:11807098, ECO:0000269|PubMed:11807099,
CC       ECO:0000269|PubMed:12473654, ECO:0000269|PubMed:12695522,
CC       ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:14722085,
CC       ECO:0000269|PubMed:15156152, ECO:0000269|PubMed:15181153,
CC       ECO:0000269|PubMed:15276642, ECO:0000269|PubMed:16076904,
CC       ECO:0000269|PubMed:16256741, ECO:0000269|PubMed:16754960,
CC       ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:17925226,
CC       ECO:0000269|PubMed:19064666, ECO:0000269|PubMed:21325030,
CC       ECO:0000269|PubMed:21768292, ECO:0000269|PubMed:22027826,
CC       ECO:0000269|PubMed:22451694, ECO:0000269|PubMed:22645133,
CC       ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:23317506,
CC       ECO:0000269|PubMed:9501082}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA2:ITGB1 interacts with
CC       human echoviruses 1 and 8 capsid proteins.
CC       {ECO:0000269|PubMed:8411387}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human
CC       cytomegalovirus/HHV-5 envelope glycoprotein B/gB.
CC       {ECO:0000269|PubMed:20660204}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-Barr
CC       virus/HHV-4 gB protein. {ECO:0000269|PubMed:17945327}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA5:ITGB1 interacts with
CC       human parvovirus B19 capsid protein.
CC       {ECO:0000269|PubMed:12907437}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA2:ITGB1 interacts with
CC       human rotavirus VP4 protein. {ECO:0000269|PubMed:12941907}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with mammalian reovirus
CC       capsid proteins. {ECO:0000269|PubMed:16501085}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA5:ITGB1 interacts with
CC       HIV-1 Tat. {ECO:0000269|PubMed:10397733}.
CC   -!- INTERACTION:
CC       Q9BY76:ANGPTL4; NbExp=2; IntAct=EBI-703066, EBI-2968146;
CC       P03192:BMRF2 (xeno); NbExp=2; IntAct=EBI-703066, EBI-9348955;
CC       P46109:CRKL; NbExp=2; IntAct=EBI-703066, EBI-910;
CC       P32927:CSF2RB; NbExp=5; IntAct=EBI-703066, EBI-1809771;
CC       P78423:CX3CL1; NbExp=2; IntAct=EBI-703066, EBI-15188013;
CC       P17813:ENG; NbExp=3; IntAct=EBI-703066, EBI-2834630;
CC       P05413:FABP3; NbExp=2; IntAct=EBI-703066, EBI-704216;
CC       P21333:FLNA; NbExp=5; IntAct=EBI-703066, EBI-350432;
CC       P17301:ITGA2; NbExp=3; IntAct=EBI-703066, EBI-702960;
CC       P13612:ITGA4; NbExp=4; IntAct=EBI-703066, EBI-703044;
CC       P08648:ITGA5; NbExp=5; IntAct=EBI-703066, EBI-1382311;
CC       P07948:LYN; NbExp=4; IntAct=EBI-703066, EBI-79452;
CC       P18031:PTPN1; NbExp=2; IntAct=EBI-703066, EBI-968788;
CC       P49023:PXN; NbExp=2; IntAct=EBI-6082935, EBI-702209;
CC       P35282:Rab21 (xeno); NbExp=3; IntAct=EBI-703066, EBI-1993555;
CC       Q9Y490:TLN1; NbExp=2; IntAct=EBI-703066, EBI-2462036;
CC       P26039:Tln1 (xeno); NbExp=2; IntAct=EBI-703066, EBI-1039593;
CC       Q71LX4:Tln2 (xeno); NbExp=3; IntAct=EBI-7208579, EBI-2255655;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000303|PubMed:10455171};
CC       Single-pass type I membrane protein {ECO:0000255}. Cell
CC       projection, invadopodium membrane {ECO:0000269|PubMed:10455171};
CC       Single-pass type I membrane protein {ECO:0000255}. Cell
CC       projection, ruffle membrane {ECO:0000303|PubMed:10455171}; Single-
CC       pass type I membrane protein {ECO:0000255}. Recycling endosome
CC       {ECO:0000269|PubMed:16256741}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cleavage furrow
CC       {ECO:0000269|PubMed:17956333}. Cell projection, lamellipodium
CC       {ECO:0000269|PubMed:11919189}. Cell projection, ruffle
CC       {ECO:0000269|PubMed:11919189}. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:17158881}. Cell surface
CC       {ECO:0000269|PubMed:17158881}. Note=Isoform 2 does not localize to
CC       focal adhesions. Highly enriched in stage I melanosomes. Located
CC       on plasma membrane of neuroblastoma NMB7 cells. In a lung cancer
CC       cell line, in prometaphase and metaphase, localizes diffusely at
CC       the membrane and in a few intracellular vesicles. In early
CC       telophase, detected mainly on the matrix-facing side of the cells.
CC       By mid-telophase, concentrated to the ingressing cleavage furrow,
CC       mainly to the basal side of the furrow. In late telophase,
CC       concentrated to the extending protrusions formed at the opposite
CC       ends of the spreading daughter cells, in vesicles at the base of
CC       the lamellipodia formed by the separating daughter cells.
CC       Colocalizes with ITGB1BP1 and metastatic suppressor protein NME2
CC       at the edge or peripheral ruffles and lamellipodia during the
CC       early stages of cell spreading on fibronectin or collagen.
CC       Translocates from peripheral focal adhesions sites to fibrillar
CC       adhesions in a ITGB1BP1-dependent manner. Enriched preferentially
CC       at invadopodia, cell membrane protrusions that correspond to sites
CC       of cell invasion, in a collagen-dependent manner. Localized at
CC       plasma and ruffle membranes in a collagen-independent manner.
CC       {ECO:0000269|PubMed:10455171, ECO:0000303|PubMed:10455171}.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Cell membrane, sarcolemma
CC       {ECO:0000250}. Cell junction {ECO:0000250}. Note=In cardiac
CC       muscle, isoform 5 is found in costameres and intercalated disks.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Beta-1A;
CC         IsoId=P05556-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta-1B;
CC         IsoId=P05556-2; Sequence=VSP_002741;
CC       Name=3; Synonyms=Beta-1C;
CC         IsoId=P05556-3; Sequence=VSP_002742;
CC       Name=4; Synonyms=Beta-1C-2;
CC         IsoId=P05556-4; Sequence=VSP_002743;
CC       Name=5; Synonyms=Beta-1D;
CC         IsoId=P05556-5; Sequence=VSP_002744;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is widely expressed, other isoforms
CC       are generally coexpressed with a more restricted distribution.
CC       Isoform 2 is expressed in skin, liver, skeletal muscle, cardiac
CC       muscle, placenta, umbilical vein endothelial cells, neuroblastoma
CC       cells, lymphoma cells, hepatoma cells and astrocytoma cells.
CC       Isoform 3 and isoform 4 are expressed in muscle, kidney, liver,
CC       placenta, cervical epithelium, umbilical vein endothelial cells,
CC       fibroblast cells, embryonal kidney cells, platelets and several
CC       blood cell lines. Isoform 4, rather than isoform 3, is selectively
CC       expressed in peripheral T-cells. Isoform 3 is expressed in non-
CC       proliferating and differentiated prostate gland epithelial cells
CC       and in platelets, on the surface of erythroleukemia cells and in
CC       various hematopoietic cell lines. Isoform 5 is expressed
CC       specifically in striated muscle (skeletal and cardiac muscle).
CC       {ECO:0000269|PubMed:1551917, ECO:0000269|PubMed:2249781,
CC       ECO:0000269|PubMed:7544298, ECO:0000269|PubMed:7545396,
CC       ECO:0000269|PubMed:7681433, ECO:0000269|PubMed:9494094}.
CC   -!- PTM: The cysteine residues are involved in intrachain disulfide
CC       bonds. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD97649.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CD29 entry;
CC       URL="https://en.wikipedia.org/wiki/CD29";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X07979; CAA30790.1; -; mRNA.
DR   EMBL; AK291697; BAF84386.1; -; mRNA.
DR   EMBL; BX537407; CAD97649.1; ALT_INIT; mRNA.
DR   EMBL; AL365203; CAI14426.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85948.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85949.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85950.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85951.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85952.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85953.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85954.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85955.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85957.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85958.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW85959.1; -; Genomic_DNA.
DR   EMBL; BC020057; AAH20057.1; -; mRNA.
DR   EMBL; BC113901; AAI13902.1; -; mRNA.
DR   EMBL; U33879; AAA79832.1; -; Genomic_DNA.
DR   EMBL; U33880; AAA79833.1; -; Genomic_DNA.
DR   EMBL; U33879; AAA79833.1; JOINED; Genomic_DNA.
DR   EMBL; U33882; AAA79834.1; -; Genomic_DNA.
DR   EMBL; U33879; AAA79834.1; JOINED; Genomic_DNA.
DR   EMBL; U33881; AAA79834.1; JOINED; Genomic_DNA.
DR   EMBL; U33882; AAA79835.1; -; Genomic_DNA.
DR   EMBL; U33879; AAA79835.1; JOINED; Genomic_DNA.
DR   EMBL; M34189; AAA59182.1; -; mRNA.
DR   EMBL; M84237; AAA74402.1; -; mRNA.
DR   EMBL; M84237; AAA74403.1; -; mRNA.
DR   EMBL; U28252; AAA81366.1; -; mRNA.
DR   CCDS; CCDS7174.1; -. [P05556-1]
DR   PIR; B27079; B27079.
DR   RefSeq; NP_002202.2; NM_002211.3. [P05556-1]
DR   RefSeq; NP_391988.1; NM_033668.2. [P05556-5]
DR   RefSeq; NP_596867.1; NM_133376.2. [P05556-1]
DR   UniGene; Hs.643813; -.
DR   PDB; 1K11; Model; -; B=786-797.
DR   PDB; 1LHA; Model; -; A=86-543.
DR   PDB; 3G9W; X-ray; 2.16 A; C/D=752-785.
DR   PDB; 3T9K; X-ray; 2.30 A; A/B=758-769.
DR   PDB; 3VI3; X-ray; 2.90 A; B/D=21-465.
DR   PDB; 3VI4; X-ray; 2.90 A; B/D=21-465.
DR   PDB; 4DX9; X-ray; 3.00 A; 6/7/8/9/B/D/F/H/J/L/N/P/R/T/V/X/Z/b/d/f/h/j/l/n/p/r/t/v/x/z=784-798.
DR   PDB; 4WJK; X-ray; 1.85 A; B=21-465.
DR   PDB; 4WK0; X-ray; 1.78 A; B=21-465.
DR   PDB; 4WK2; X-ray; 2.50 A; B=21-465.
DR   PDB; 4WK4; X-ray; 2.50 A; B=21-465.
DR   PDBsum; 1K11; -.
DR   PDBsum; 1LHA; -.
DR   PDBsum; 3G9W; -.
DR   PDBsum; 3T9K; -.
DR   PDBsum; 3VI3; -.
DR   PDBsum; 3VI4; -.
DR   PDBsum; 4DX9; -.
DR   PDBsum; 4WJK; -.
DR   PDBsum; 4WK0; -.
DR   PDBsum; 4WK2; -.
DR   PDBsum; 4WK4; -.
DR   ProteinModelPortal; P05556; -.
DR   SMR; P05556; -.
DR   BioGrid; 109894; 96.
DR   CORUM; P05556; -.
DR   DIP; DIP-312N; -.
DR   ELM; P05556; -.
DR   IntAct; P05556; 65.
DR   MINT; MINT-140089; -.
DR   STRING; 9606.ENSP00000303351; -.
DR   BindingDB; P05556; -.
DR   ChEMBL; CHEMBL1905; -.
DR   DrugBank; DB00098; Anti-thymocyte Globulin (Rabbit).
DR   GuidetoPHARMACOLOGY; 2455; -.
DR   TCDB; 9.B.87.1.8; the selenoprotein p receptor (selp-receptor) family.
DR   iPTMnet; P05556; -.
DR   PhosphoSitePlus; P05556; -.
DR   SwissPalm; P05556; -.
DR   UniCarbKB; P05556; -.
DR   BioMuta; ITGB1; -.
DR   DMDM; 218563324; -.
DR   EPD; P05556; -.
DR   MaxQB; P05556; -.
DR   PaxDb; P05556; -.
DR   PeptideAtlas; P05556; -.
DR   PRIDE; P05556; -.
DR   DNASU; 3688; -.
DR   Ensembl; ENST00000302278; ENSP00000303351; ENSG00000150093. [P05556-1]
DR   Ensembl; ENST00000396033; ENSP00000379350; ENSG00000150093. [P05556-1]
DR   Ensembl; ENST00000423113; ENSP00000388694; ENSG00000150093. [P05556-5]
DR   GeneID; 3688; -.
DR   KEGG; hsa:3688; -.
DR   UCSC; uc001iwr.5; human. [P05556-1]
DR   CTD; 3688; -.
DR   DisGeNET; 3688; -.
DR   EuPathDB; HostDB:ENSG00000150093.18; -.
DR   GeneCards; ITGB1; -.
DR   HGNC; HGNC:6153; ITGB1.
DR   HPA; CAB003434; -.
DR   MIM; 135630; gene.
DR   neXtProt; NX_P05556; -.
DR   OpenTargets; ENSG00000150093; -.
DR   PharmGKB; PA29953; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P05556; -.
DR   KO; K05719; -.
DR   OMA; FFDEDDC; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P05556; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-1566977; Fibronectin matrix formation.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-416700; Other semaphorin interactions.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-446343; Localization of the PINCH-ILK-PARVIN complex to focal adhesions.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-75892; Platelet Adhesion to exposed collagen.
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8875513; MET interacts with TNS proteins.
DR   SABIO-RK; P05556; -.
DR   SignaLink; P05556; -.
DR   SIGNOR; P05556; -.
DR   ChiTaRS; ITGB1; human.
DR   EvolutionaryTrace; P05556; -.
DR   GeneWiki; CD29; -.
DR   GenomeRNAi; 3688; -.
DR   PMAP-CutDB; Q8WUM6; -.
DR   PRO; PR:P05556; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000150093; -.
DR   ExpressionAtlas; P05556; baseline and differential.
DR   Genevisible; P05556; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034665; C:integrin alpha1-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0034680; C:integrin alpha10-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0034681; C:integrin alpha11-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0034666; C:integrin alpha2-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0034667; C:integrin alpha3-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0034677; C:integrin alpha7-beta1 complex; IEA:Ensembl.
DR   GO; GO:0034678; C:integrin alpha8-beta1 complex; TAS:BHF-UCL.
DR   GO; GO:0008305; C:integrin complex; NAS:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IEA:Ensembl.
DR   GO; GO:0071438; C:invadopodium membrane; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0035748; C:myelin sheath abaxonal region; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0001726; C:ruffle; TAS:HGNC.
DR   GO; GO:0032587; C:ruffle membrane; NAS:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IDA:MGI.
DR   GO; GO:0097060; C:synaptic membrane; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IDA:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:UniProtKB.
DR   GO; GO:0098639; F:collagen binding involved in cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0001968; F:fibronectin binding; IPI:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0043236; F:laminin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0030183; P:B cell differentiation; IC:BHF-UCL.
DR   GO; GO:0071711; P:basement membrane organization; IEA:Ensembl.
DR   GO; GO:0007161; P:calcium-independent cell-matrix adhesion; IGI:MGI.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:UniProtKB.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; TAS:HGNC.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; IEA:Ensembl.
DR   GO; GO:0033631; P:cell-cell adhesion mediated by integrin; IEP:BHF-UCL.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; ISS:UniProtKB.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0021943; P:formation of radial glial scaffolds; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0008354; P:germ cell migration; IEA:Ensembl.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; TAS:ProtInc.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0050901; P:leukocyte tethering or rolling; IMP:UniProtKB.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IEA:Ensembl.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IDA:UniProtKB.
DR   GO; GO:2000273; P:positive regulation of receptor activity; IDA:BHF-UCL.
DR   GO; GO:0031623; P:receptor internalization; ISS:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0010710; P:regulation of collagen catabolic process; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0045214; P:sarcomere organization; IEA:Ensembl.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR027071; Integrin_beta-1.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF28; PTHR10082:SF28; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Calcium;
KW   Cell adhesion; Cell junction; Cell membrane; Cell projection;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Endosome; Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Integrin; Isopeptide bond; Magnesium;
KW   Membrane; Metal-binding; Phosphoprotein; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     20
FT   CHAIN        21    798       Integrin beta-1.
FT                                /FTId=PRO_0000016334.
FT   TOPO_DOM     21    728       Extracellular. {ECO:0000255}.
FT   TRANSMEM    729    751       Helical. {ECO:0000255}.
FT   TOPO_DOM    752    798       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      140    378       VWFA.
FT   REPEAT      466    515       I.
FT   REPEAT      516    559       II.
FT   REPEAT      560    598       III.
FT   REPEAT      599    635       IV.
FT   REGION      207    213       CX3CL1-binding.
FT                                {ECO:0000269|PubMed:23125415}.
FT   REGION      295    314       CX3CL1-binding.
FT                                {ECO:0000269|PubMed:24789099}.
FT   REGION      466    635       Cysteine-rich tandem repeats.
FT   REGION      762    767       Signal for sorting from recycling
FT                                endosomes; interaction with ACAP1.
FT   REGION      785    792       Interaction with ITGB1BP1.
FT   METAL       152    152       Magnesium.
FT   METAL       154    154       Calcium 1; via carbonyl oxygen.
FT   METAL       156    156       Calcium 1.
FT   METAL       157    157       Calcium 1.
FT   METAL       189    189       Calcium 2.
FT   METAL       244    244       Calcium 2.
FT   METAL       246    246       Calcium 2.
FT   METAL       248    248       Calcium 2; via carbonyl oxygen.
FT   METAL       249    249       Calcium 2.
FT   METAL       249    249       Magnesium.
FT   METAL       362    362       Calcium 1; via carbonyl oxygen.
FT   MOD_RES     777    777       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     783    783       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     785    785       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     789    789       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     794    794       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     94     94       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    212    212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    269    269       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    363    363       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    403    403       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    406    406       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:22451694}.
FT   CARBOHYD    411    411       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    417    417       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    481    481       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    520    520       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    584    584       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    669    669       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID     27     45       {ECO:0000269|PubMed:22451694}.
FT   DISULFID     35    464       {ECO:0000269|PubMed:22451694}.
FT   DISULFID     38     64       {ECO:0000269|PubMed:22451694}.
FT   DISULFID     48     75       {ECO:0000269|PubMed:22451694}.
FT   DISULFID    207    213       {ECO:0000269|PubMed:22451694}.
FT   DISULFID    261    301       {ECO:0000269|PubMed:22451694}.
FT   DISULFID    401    415       {ECO:0000269|PubMed:22451694}.
FT   DISULFID    435    462       {ECO:0000269|PubMed:22451694}.
FT   DISULFID    466    691       {ECO:0000305|PubMed:22451694}.
FT   DISULFID    477    489       {ECO:0000250}.
FT   DISULFID    486    525       {ECO:0000250}.
FT   DISULFID    491    500       {ECO:0000250}.
FT   DISULFID    502    516       {ECO:0000250}.
FT   DISULFID    531    536       {ECO:0000250}.
FT   DISULFID    533    568       {ECO:0000250}.
FT   DISULFID    538    553       {ECO:0000250}.
FT   DISULFID    555    560       {ECO:0000250}.
FT   DISULFID    574    579       {ECO:0000250}.
FT   DISULFID    576    607       {ECO:0000250}.
FT   DISULFID    581    590       {ECO:0000250}.
FT   DISULFID    592    599       {ECO:0000250}.
FT   DISULFID    613    618       {ECO:0000250}.
FT   DISULFID    615    661       {ECO:0000250}.
FT   DISULFID    620    630       {ECO:0000250}.
FT   DISULFID    633    636       {ECO:0000250}.
FT   DISULFID    640    649       {ECO:0000250}.
FT   DISULFID    646    723       {ECO:0000250}.
FT   DISULFID    665    699       {ECO:0000250}.
FT   CROSSLNK    794    794       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   VAR_SEQ     778    798       GENPIYKSAVTTVVNPKYEGK -> VSYKTSKKQSGL (in
FT                                isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002741.
FT   VAR_SEQ     778    798       GENPIYKSAVTTVVNPKYEGK -> SLSVAQPGVQWCDISS
FT                                LQPLTSRFQQFSCLSLPSTWDYRVKILFIRVP (in
FT                                isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_002742.
FT   VAR_SEQ     778    798       GENPIYKSAVTTVVNPKYEGK -> PGVQWCDISSLQPLTS
FT                                RFQQFSCLSLPSTWDYRVKILFIRVP (in isoform
FT                                4). {ECO:0000305}.
FT                                /FTId=VSP_002743.
FT   VAR_SEQ     778    798       GENPIYKSAVTTVVNPKYEGK -> QENPIYKSPINNFKNP
FT                                NYGRKAGL (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_002744.
FT   MUTAGEN     760    761       RR->AA: No effect on interaction with
FT                                ACAP1. {ECO:0000269|PubMed:22645133}.
FT   MUTAGEN     762    767       EFAKFE->AAAAAA: Strongly reduces
FT                                interaction with ACAP1 and ability to
FT                                recycle; does not affect
FT                                heterodimerization with ITGA5.
FT                                {ECO:0000269|PubMed:22645133}.
FT   MUTAGEN     762    763       EF->AA: Slightly reduces interaction with
FT                                ACAP1.
FT   MUTAGEN     765    765       K->A: Reduces interaction with ACAP1.
FT   MUTAGEN     766    767       FE->AA: Slightly reduces interaction with
FT                                ACAP1.
FT   MUTAGEN     768    769       KE->AA: No effect on interaction with
FT                                ACAP1. {ECO:0000269|PubMed:22645133}.
FT   MUTAGEN     778    778       G->Q: Loss of beta-1A interaction with
FT                                FLNA and FLNB.
FT                                {ECO:0000269|PubMed:11807098}.
FT   MUTAGEN     786    791       AVTTVV->PINNFK: Does not interact with
FT                                ITGB1BP1. {ECO:0000269|PubMed:11807099}.
FT   MUTAGEN     786    786       A->P: Loss of beta-1A interaction with
FT                                FLNA and FLNB.
FT                                {ECO:0000269|PubMed:11807098}.
FT   MUTAGEN     787    787       V->T: Reduces interaction with ITGB1BP1,
FT                                but not with FERMT2 or TLN1. Inhibits
FT                                fibronectin deposition and mineralized
FT                                bone nodules formation.
FT                                {ECO:0000269|PubMed:21768292}.
FT   MUTAGEN     788    788       T->D: Strongly reduces ITGB1BP1 binding;
FT                                when associated with D-790.
FT                                {ECO:0000269|PubMed:23317506}.
FT   MUTAGEN     790    790       V->D: Strongly reduces ITGB1BP1 binding;
FT                                when associated with D-788.
FT                                {ECO:0000269|PubMed:23317506}.
FT   MUTAGEN     792    792       N->A: Strongly reduces ITGB1BP1 binding;
FT                                when associated with A-795.
FT                                {ECO:0000269|PubMed:23317506}.
FT   MUTAGEN     795    795       Y->A: Strongly reduces ITGB1BP1 binding;
FT                                when associated with A-792.
FT                                {ECO:0000269|PubMed:23317506}.
FT   CONFLICT    112    112       T -> H (in Ref. 1; CAA30790).
FT                                {ECO:0000305}.
FT   CONFLICT    215    215       S -> T (in Ref. 1; CAA30790).
FT                                {ECO:0000305}.
FT   CONFLICT    261    265       CGSLI -> VWMLL (in Ref. 6; AAI13902).
FT                                {ECO:0000305}.
FT   CONFLICT    385    386       EN -> DG (in Ref. 6; AAI13902).
FT                                {ECO:0000305}.
FT   CONFLICT    463    463       E -> V (in Ref. 2; BAF84386).
FT                                {ECO:0000305}.
FT   TURN         26     31       {ECO:0000244|PDB:4WK0}.
FT   HELIX        35     40       {ECO:0000244|PDB:4WK0}.
FT   STRAND       45     47       {ECO:0000244|PDB:4WK0}.
FT   HELIX        61     63       {ECO:0000244|PDB:4WK0}.
FT   STRAND       64     66       {ECO:0000244|PDB:4WK0}.
FT   HELIX        67     71       {ECO:0000244|PDB:4WK0}.
FT   TURN         72     74       {ECO:0000244|PDB:4WK0}.
FT   TURN         77     79       {ECO:0000244|PDB:4WK0}.
FT   STRAND       86     91       {ECO:0000244|PDB:4WK0}.
FT   HELIX       108    110       {ECO:0000244|PDB:4WK0}.
FT   STRAND      118    124       {ECO:0000244|PDB:4WK0}.
FT   STRAND      129    136       {ECO:0000244|PDB:4WK0}.
FT   STRAND      143    150       {ECO:0000244|PDB:4WK0}.
FT   HELIX       153    155       {ECO:0000244|PDB:4WK0}.
FT   HELIX       156    161       {ECO:0000244|PDB:4WK0}.
FT   HELIX       162    164       {ECO:0000244|PDB:4WK0}.
FT   HELIX       165    173       {ECO:0000244|PDB:4WK0}.
FT   TURN        174    176       {ECO:0000244|PDB:4WK0}.
FT   STRAND      180    187       {ECO:0000244|PDB:4WK0}.
FT   TURN        193    195       {ECO:0000244|PDB:4WK0}.
FT   HELIX       200    204       {ECO:0000244|PDB:4WK0}.
FT   STRAND      209    211       {ECO:0000244|PDB:4WK0}.
FT   STRAND      218    227       {ECO:0000244|PDB:4WK0}.
FT   HELIX       229    236       {ECO:0000244|PDB:4WK0}.
FT   STRAND      245    249       {ECO:0000244|PDB:4WK0}.
FT   HELIX       251    260       {ECO:0000244|PDB:4WK0}.
FT   HELIX       262    264       {ECO:0000244|PDB:4WK0}.
FT   STRAND      269    280       {ECO:0000244|PDB:4WK0}.
FT   HELIX       287    291       {ECO:0000244|PDB:4WK0}.
FT   TURN        311    313       {ECO:0000244|PDB:4WK0}.
FT   HELIX       319    328       {ECO:0000244|PDB:4WK0}.
FT   STRAND      331    337       {ECO:0000244|PDB:4WK0}.
FT   HELIX       339    341       {ECO:0000244|PDB:4WK0}.
FT   HELIX       342    351       {ECO:0000244|PDB:4WK0}.
FT   STRAND      352    359       {ECO:0000244|PDB:4WK0}.
FT   STRAND      362    364       {ECO:0000244|PDB:4WK4}.
FT   HELIX       367    379       {ECO:0000244|PDB:4WK0}.
FT   STRAND      382    386       {ECO:0000244|PDB:4WK0}.
FT   STRAND      393    400       {ECO:0000244|PDB:4WK0}.
FT   HELIX       402    404       {ECO:0000244|PDB:4WK0}.
FT   STRAND      406    408       {ECO:0000244|PDB:4WJK}.
FT   HELIX       409    413       {ECO:0000244|PDB:4WK0}.
FT   STRAND      423    432       {ECO:0000244|PDB:4WK0}.
FT   STRAND      437    439       {ECO:0000244|PDB:4WJK}.
FT   STRAND      441    447       {ECO:0000244|PDB:4WK0}.
FT   STRAND      454    461       {ECO:0000244|PDB:4WK0}.
FT   HELIX       752    769       {ECO:0000244|PDB:3G9W}.
FT   HELIX       770    772       {ECO:0000244|PDB:3G9W}.
SQ   SEQUENCE   798 AA;  88415 MW;  DE35979C1625578C CRC64;
     MNLQPIFWIG LISSVCCVFA QTDENRCLKA NAKSCGECIQ AGPNCGWCTN STFLQEGMPT
     SARCDDLEAL KKKGCPPDDI ENPRGSKDIK KNKNVTNRSK GTAEKLKPED ITQIQPQQLV
     LRLRSGEPQT FTLKFKRAED YPIDLYYLMD LSYSMKDDLE NVKSLGTDLM NEMRRITSDF
     RIGFGSFVEK TVMPYISTTP AKLRNPCTSE QNCTSPFSYK NVLSLTNKGE VFNELVGKQR
     ISGNLDSPEG GFDAIMQVAV CGSLIGWRNV TRLLVFSTDA GFHFAGDGKL GGIVLPNDGQ
     CHLENNMYTM SHYYDYPSIA HLVQKLSENN IQTIFAVTEE FQPVYKELKN LIPKSAVGTL
     SANSSNVIQL IIDAYNSLSS EVILENGKLS EGVTISYKSY CKNGVNGTGE NGRKCSNISI
     GDEVQFEISI TSNKCPKKDS DSFKIRPLGF TEEVEVILQY ICECECQSEG IPESPKCHEG
     NGTFECGACR CNEGRVGRHC ECSTDEVNSE DMDAYCRKEN SSEICSNNGE CVCGQCVCRK
     RDNTNEIYSG KFCECDNFNC DRSNGLICGG NGVCKCRVCE CNPNYTGSAC DCSLDTSTCE
     ASNGQICNGR GICECGVCKC TDPKFQGQTC EMCQTCLGVC AEHKECVQCR AFNKGEKKDT
     CTQECSYFNI TKVESRDKLP QPVQPDPVSH CKEKDVDDCW FYFTYSVNGN NEVMVHVVEN
     PECPTGPDII PIVAGVVAGI VLIGLALLLI WKLLMIIHDR REFAKFEKEK MNAKWDTGEN
     PIYKSAVTTV VNPKYEGK
//
ID   ITAV_HUMAN              Reviewed;        1048 AA.
AC   P06756; A0AV67; B0LPF4; B7Z883; B7ZLX0; D3DPG8; E7EWZ6; Q53SK4;
AC   Q59EB7; Q6LD15;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   20-DEC-2017, entry version 216.
DE   RecName: Full=Integrin alpha-V;
DE   AltName: Full=Vitronectin receptor {ECO:0000312|HGNC:HGNC:6150};
DE   AltName: Full=Vitronectin receptor subunit alpha;
DE   AltName: CD_antigen=CD51;
DE   Contains:
DE     RecName: Full=Integrin alpha-V heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-V light chain;
DE   Flags: Precursor;
GN   Name=ITGAV {ECO:0000312|HGNC:HGNC:6150};
GN   Synonyms=MSK8 {ECO:0000312|HGNC:HGNC:6150},
GN   VNRA {ECO:0000312|HGNC:HGNC:6150}, VTNR {ECO:0000312|HGNC:HGNC:6150};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-783.
RX   PubMed=2443500;
RA   Suzuki S., Argraves W.S., Arai H., Languino L.R., Pierschbacher M.D.,
RA   Ruoslahti E.;
RT   "Amino acid sequence of the vitronectin receptor alpha subunit and
RT   comparative expression of adhesion receptor mRNAs.";
RL   J. Biol. Chem. 262:14080-14085(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10965141;
RA   Sims M.A., Field S., Barnes M.R., Shaikh N., Ellington K.,
RA   Murphy K.E., Spurr N.K., Campbell D.A.;
RT   "Cloning and characterisation of ITGAV, the genomic sequence for human
RT   cell adhesion protein (vitronectin) receptor alpha subunit, CD51.";
RL   Cytogenet. Cell Genet. 89:268-271(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ILE-783.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ILE-783.
RC   TISSUE=Aortic endothelium;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ILE-783.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ILE-783.
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ILE-783.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-62.
RX   PubMed=7522056; DOI=10.1016/0167-4781(94)90278-X;
RA   Donahue J.P., Sugg N., Hawiger J.;
RT   "The integrin alpha v gene: identification and characterization of the
RT   promoter region.";
RL   Biochim. Biophys. Acta 1219:228-232(1994).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 413-1048, AND VARIANT ILE-783.
RX   PubMed=2430295; DOI=10.1073/pnas.83.22.8614;
RA   Suzuki S., Argraves W.S., Pytela R., Arai H., Krusius T.,
RA   Pierschbacher M.D., Ruoslahti E.;
RT   "cDNA and amino acid sequences of the cell adhesion protein receptor
RT   recognizing vitronectin reveal a transmembrane domain and homologies
RT   with other adhesion protein receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:8614-8618(1986).
RN   [11]
RP   PROTEIN SEQUENCE OF 31-41.
RX   PubMed=2467745; DOI=10.1016/0092-8674(89)90172-4;
RA   Cheresh D.A., Smith J.W., Cooper H.M., Quaranta V.;
RT   "A novel vitronectin receptor integrin (alpha v beta x) is responsible
RT   for distinct adhesive properties of carcinoma cells.";
RL   Cell 57:59-69(1989).
RN   [12]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH COXSACKIEVIRUS A9
RP   CAPSID PROTEINS.
RX   PubMed=7519807; DOI=10.1006/viro.1994.1494;
RA   Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T.,
RA   Heino J., Hyypiae T.;
RT   "Entry of coxsackievirus A9 into host cells: specific interactions
RT   with alpha v beta 3 integrin, the vitronectin receptor.";
RL   Virology 203:357-365(1994).
RN   [13]
RP   INTERACTION WITH COXSACKIEVIRUS B1 CAPSID PROTEINS.
RX   PubMed=9426447; DOI=10.1006/viro.1997.8831;
RA   Agrez M.V., Shafren D.R., Gu X., Cox K., Sheppard D., Barry R.D.;
RT   "Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of
RT   human colon cancer cells.";
RL   Virology 239:71-77(1997).
RN   [14]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=10397733;
RA   Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S.,
RA   Manzari V., Modesti A., Nair B.C., Cafaro A., Stuerzl M., Ensoli B.;
RT   "The Tat protein of human immunodeficiency virus type-1 promotes
RT   vascular cell growth and locomotion by engaging the alpha5beta1 and
RT   alphavbeta3 integrins and by mobilizing sequestered basic fibroblast
RT   growth factor.";
RL   Blood 94:663-672(1999).
RN   [15]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN
RP   PARECHOVIRUS 1 CAPSID PROTEINS.
RX   PubMed=11160695; DOI=10.1128/JVI.75.4.1958-1967.2001;
RA   Joki-Korpela P., Marjomaki V., Krogerus C., Heino J., Hyypia T.;
RT   "Entry of human parechovirus 1.";
RL   J. Virol. 75:1958-1967(2001).
RN   [16]
RP   INTERACTION WITH NOV.
RX   PubMed=12695522; DOI=10.1074/jbc.M302028200;
RA   Lin C.G., Leu S.J., Chen N., Tebeau C.M., Lin S.X., Yeung C.Y.,
RA   Lau L.F.;
RT   "CCN3 (NOV) is a novel angiogenic regulator of the CCN protein
RT   family.";
RL   J. Biol. Chem. 278:24200-24208(2003).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH FBN1.
RX   PubMed=12807887; DOI=10.1074/jbc.M303159200;
RA   Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J.,
RA   Shuttleworth C.A., Humphries M.J., Kielty C.M.;
RT   "Cell adhesion to fibrillin-1 molecules and microfibrils is mediated
RT   by alpha 5 beta 1 and alpha v beta 3 integrins.";
RL   J. Biol. Chem. 278:34605-34616(2003).
RN   [18]
RP   GLYCOSYLATION AT ASN-615.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [19]
RP   DISULFIDE BONDS.
RX   PubMed=14596610; DOI=10.1021/bi034726u;
RA   Krokhin O.V., Cheng K., Sousa S.L., Ens W., Standing K.G.,
RA   Wilkins J.A.;
RT   "Mass spectrometric based mapping of the disulfide bonding patterns of
RT   integrin alpha chains.";
RL   Biochemistry 42:12950-12959(2003).
RN   [20]
RP   INTERACTION WITH COXSACKIEVIRUS A9 CAPSID PROTEINS.
RX   PubMed=15194773; DOI=10.1128/JVI.78.13.6967-6973.2004;
RA   Williams C.H., Kajander T., Hyypia T., Jackson T., Sheppard D.,
RA   Stanway G.;
RT   "Integrin alpha v beta 6 is an RGD-dependent receptor for
RT   coxsackievirus A9.";
RL   J. Virol. 78:6967-6973(2004).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [22]
RP   INTERACTION WITH ADGRA2.
RX   PubMed=16982628; DOI=10.1074/jbc.M605291200;
RA   Vallon M., Essler M.;
RT   "Proteolytically processed soluble tumor endothelial marker (TEM) 5
RT   mediates endothelial cell survival during angiogenesis by linking
RT   integrin alpha(v)beta3 to glycosaminoglycans.";
RL   J. Biol. Chem. 281:34179-34188(2006).
RN   [23]
RP   INTERACTION WITH RAB25.
RX   PubMed=17925226; DOI=10.1016/j.devcel.2007.08.012;
RA   Caswell P.T., Spence H.J., Parsons M., White D.P., Clark K.,
RA   Cheng K.W., Mills G.B., Humphries M.J., Messent A.J., Anderson K.I.,
RA   McCaffrey M.W., Ozanne B.W., Norman J.C.;
RT   "Rab25 associates with alpha5beta1 integrin to promote invasive
RT   migration in 3D microenvironments.";
RL   Dev. Cell 13:496-510(2007).
RN   [24]
RP   FUNCTION, INTERACTION WITH FBN1, AND SUBCELLULAR LOCATION.
RX   PubMed=17158881; DOI=10.1074/jbc.M607008200;
RA   Jovanovic J., Takagi J., Choulier L., Abrescia N.G., Stuart D.I.,
RA   van der Merwe P.A., Mardon H.J., Handford P.A.;
RT   "alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative
RT   studies of molecular determinants underlying integrin-rgd affinity and
RT   specificity.";
RL   J. Biol. Chem. 282:6743-6751(2007).
RN   [25]
RP   FUNCTION, BINDING TO FGF1, AND IDENTIFICATION IN A COMPLEX WITH FGF1
RP   AND FGFR1.
RX   PubMed=18441324; DOI=10.1074/jbc.M801213200;
RA   Mori S., Wu C.Y., Yamaji S., Saegusa J., Shi B., Ma Z., Kuwabara Y.,
RA   Lam K.S., Isseroff R.R., Takada Y.K., Takada Y.;
RT   "Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1
RT   signaling.";
RL   J. Biol. Chem. 283:18066-18075(2008).
RN   [26]
RP   FUNCTION.
RX   PubMed=18635536; DOI=10.1074/jbc.M804835200;
RA   Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S.,
RA   Liu F.T., Takada Y.K., Takada Y.;
RT   "Pro-inflammatory secretory phospholipase A2 type IIA binds to
RT   integrins alphavbeta3 and alpha4beta1 and induces proliferation of
RT   monocytic cells in an integrin-dependent manner.";
RL   J. Biol. Chem. 283:26107-26115(2008).
RN   [27]
RP   INTERACTION WITH HHV-8 GLYCOPROTEIN B.
RX   PubMed=18045938; DOI=10.1128/JVI.01673-07;
RA   Garrigues H.J., Rubinchikova Y.E., Dipersio C.M., Rose T.M.;
RT   "Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of
RT   Kaposi's sarcoma-associated herpesvirus and functions as an RGD-
RT   dependent entry receptor.";
RL   J. Virol. 82:1570-1580(2008).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   FUNCTION, BINDING TO IGF1, AND IDENTIFICATION IN A COMPLEX WITH IGF1
RP   AND IGF1R.
RX   PubMed=19578119; DOI=10.1074/jbc.M109.013201;
RA   Saegusa J., Yamaji S., Ieguchi K., Wu C.Y., Lam K.S., Liu F.T.,
RA   Takada Y.K., Takada Y.;
RT   "The direct binding of insulin-like growth factor-1 (IGF-1) to
RT   integrin alphavbeta3 is involved in IGF-1 signaling.";
RL   J. Biol. Chem. 284:24106-24114(2009).
RN   [30]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74; ASN-615; ASN-704 AND
RP   ASN-874.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [31]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74 AND ASN-874.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [32]
RP   FUNCTION, BINDING TO NRG1, AND IDENTIFICATION IN A COMPLEX WITH NRG1
RP   AND ERBB3.
RX   PubMed=20682778; DOI=10.1074/jbc.M110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [33]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH ADENOVIRUS TYPE C
RP   PENTON PROTEIN.
RX   PubMed=20615244; DOI=10.1186/1743-422X-7-148;
RA   Lyle C., McCormick F.;
RT   "Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-
RT   negative cells.";
RL   Virol. J. 7:148-148(2010).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [35]
RP   FUNCTION, BINDING TO CX3CL1, AND IDENTIFICATION IN A COMPLEX WITH
RP   CX3CR1 AND CX3CL1.
RX   PubMed=23125415; DOI=10.4049/jimmunol.1200889;
RA   Fujita M., Takada Y.K., Takada Y.;
RT   "Integrins alphavbeta3 and alpha4beta1 act as coreceptors for
RT   fractalkine, and the integrin-binding defective mutant of fractalkine
RT   is an antagonist of CX3CR1.";
RL   J. Immunol. 189:5809-5819(2012).
RN   [36]
RP   INTERACTION WITH CIB1.
RX   PubMed=24011356; DOI=10.1021/bi400678y;
RA   Freeman T.C. Jr., Black J.L., Bray H.G., Dagliyan O., Wu Y.I.,
RA   Tripathy A., Dokholyan N.V., Leisner T.M., Parise L.V.;
RT   "Identification of novel integrin binding partners for calcium and
RT   integrin binding protein 1 (CIB1): structural and thermodynamic basis
RT   of CIB1 promiscuity.";
RL   Biochemistry 52:7082-7090(2013).
RN   [37]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HERPES SIMPLEX
RP   VIRUS 1 ENVELOPE GLYCOPROTEIN H.
RX   PubMed=24367260; DOI=10.1371/journal.ppat.1003806;
RA   Gianni T., Salvioli S., Chesnokova L.S., Hutt-Fletcher L.M.,
RA   Campadelli-Fiume G.;
RT   "alphavbeta6- and alphavbeta8-integrins serve as interchangeable
RT   receptors for HSV gH/gL to promote endocytosis and activation of
RT   membrane fusion.";
RL   PLoS Pathog. 9:E1003806-E1003806(2013).
RN   [38]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH WEST NILE VIRUS
RP   ENVELOPE PROTEIN E.
RX   PubMed=23658209; DOI=10.1099/vir.0.052613-0;
RA   Schmidt K., Keller M., Bader B.L., Korytar T., Finke S., Ziegler U.,
RA   Groschup M.H.;
RT   "Integrins modulate the infection efficiency of West Nile virus into
RT   cells.";
RL   J. Gen. Virol. 94:1723-1733(2013).
RN   [39]
RP   FUNCTION.
RX   PubMed=25398877; DOI=10.1074/jbc.M114.579946;
RA   Fujita M., Zhu K., Fujita C.K., Zhao M., Lam K.S., Kurth M.J.,
RA   Takada Y.K., Takada Y.;
RT   "Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces
RT   integrin activation through direct binding to a newly identified
RT   binding site (site 2) in integrins alphavbeta3, alpha4beta1, and
RT   alpha5beta1.";
RL   J. Biol. Chem. 290:259-271(2015).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 31-987.
RX   PubMed=11546839; DOI=10.1126/science.1064535;
RA   Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L.,
RA   Joachimiak A., Goodman S.L., Arnaout M.A.;
RT   "Crystal structure of the extracellular segment of integrin alpha
RT   Vbeta3.";
RL   Science 294:339-345(2001).
CC   -!- FUNCTION: The alpha-V (ITGAV) integrins are receptors for
CC       vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix
CC       metalloproteinase-2, osteopontin, osteomodulin, prothrombin,
CC       thrombospondin and vWF. They recognize the sequence R-G-D in a
CC       wide array of ligands. ITGAV:ITGB3 binds to fractalkine (CX3CL1)
CC       and may act as its coreceptor in CX3CR1-dependent fractalkine
CC       signaling (PubMed:23125415). ITGAV:ITGB3 binds to NRG1 (via EGF
CC       domain) and this binding is essential for NRG1-ERBB signaling
CC       (PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is
CC       essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds
CC       to IGF1 and this binding is essential for IGF1 signaling
CC       (PubMed:19578119). ITGAV:ITGB3 binds to PLA2G2A via a site (site
CC       2) which is distinct from the classical ligand-binding site (site
CC       1) and this induces integrin conformational changes and enhanced
CC       ligand binding to site 1 (PubMed:18635536, PubMed:25398877).
CC       ITGAV:ITGB3 and ITGAV:ITGB6 act as a receptor for fibrillin-1
CC       (FBN1) and mediate R-G-D-dependent cell adhesion to FBN1
CC       (PubMed:12807887, PubMed:17158881). {ECO:0000269|PubMed:12807887,
CC       ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18441324,
CC       ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:19578119,
CC       ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:23125415,
CC       ECO:0000269|PubMed:25398877}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 acts as a
CC       receptor for adenovirus type C (PubMed:20615244). Integrin
CC       ITGAV:ITGB5 and ITGAV:ITGB3 act as receptors for coxsackievirus A9
CC       and B1 (PubMed:9426447, PubMed:15194773, PubMed:7519807). Integrin
CC       ITGAV:ITGB3 acts as a receptor for herpes virus 8/HHV-8
CC       (PubMed:18045938). Integrin ITGAV:ITGB6 acts as a receptor for
CC       herpes simplex 1/HHV-1 (PubMed:24367260). Integrin ITGAV:ITGB3
CC       acts as a receptor for Human parechovirus 1 (PubMed:11160695).
CC       Integrin ITGAV:ITGB3 acts as a receptor for West nile virus
CC       (PubMed:23658209). In case of HIV-1 infection, the interaction
CC       with extracellular viral Tat protein seems to enhance angiogenesis
CC       in Kaposi's sarcoma lesions (PubMed:10397733).
CC       {ECO:0000269|PubMed:10397733, ECO:0000269|PubMed:11160695,
CC       ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:18045938,
CC       ECO:0000269|PubMed:20615244, ECO:0000269|PubMed:23658209,
CC       ECO:0000269|PubMed:24367260, ECO:0000269|PubMed:7519807,
CC       ECO:0000269|PubMed:9426447}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-V (ITGAV) associates with either beta-1
CC       (ITGB1), beta-3 (ITGB3), beta-5 (ITGB5), beta-6 (ITGB6) or beta-8
CC       (ITGB8). Interacts with CIB1 (PubMed:24011356). Interacts with
CC       RAB25 (PubMed:17925226). Integrins ITGAV:ITGB3 and ITGAV:ITGB5
CC       interact with FBLN5 (via N-terminus) (By similarity). ITGAV:ITGB3
CC       and ITGAV:ITGB5 interact with NOV (PubMed:12695522). ITGAV:ITGB3
CC       interacts with ADGRA2 (PubMed:16982628). ITGAV:ITGB3 is found in a
CC       ternary complex with CX3CR1 and CX3CL1 (PubMed:23125415).
CC       ITGAV:ITGB3 is found in a ternary complex with NRG1 and ERBB3
CC       (PubMed:20682778). ITGAV:ITGB3 is found in a ternary complex with
CC       FGF1 and FGFR1 (PubMed:18441324). ITGAV:ITGB3 is found in a
CC       ternary complex with IGF1 and IGF1R (PubMed:19578119). ITGAV:ITGB3
CC       and ITGAV:ITGB6 interact with FBN1 (PubMed:12807887,
CC       PubMed:17158881). {ECO:0000250|UniProtKB:P43406,
CC       ECO:0000250|UniProtKB:P80746, ECO:0000269|PubMed:12695522,
CC       ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:16982628,
CC       ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:17925226,
CC       ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:19578119,
CC       ECO:0000269|PubMed:20615244, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:23658209,
CC       ECO:0000269|PubMed:24011356}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       herpes virus 8/HHV-8 envelope glycoprotein B.
CC       {ECO:0000269|PubMed:18045938}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 and
CC       ITGAV:ITGB6 bind to coxsackievirus A9 and coxsackievirus B1 capsid
CC       proteins (PubMed:9426447, PubMed:15194773, PubMed:7519807).
CC       {ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:7519807,
CC       ECO:0000269|PubMed:9426447}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB6 interacts with
CC       herpes simplex 1/HHV-1 envelope glycoprotein H.
CC       {ECO:0000269|PubMed:24367260}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB5 interacts with
CC       adenovirus type C penton protein. {ECO:0000269|PubMed:20615244}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       Human parechovirus 1 capsid proteins.
CC       {ECO:0000269|PubMed:11160695}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       West nile virus envelope protein E. {ECO:0000269|PubMed:23658209}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat.
CC       {ECO:0000269|PubMed:10397733}.
CC   -!- INTERACTION:
CC       P05106:ITGB3; NbExp=13; IntAct=EBI-298282, EBI-702847;
CC       P18084:ITGB5; NbExp=2; IntAct=EBI-298282, EBI-1223434;
CC       P18564:ITGB6; NbExp=7; IntAct=EBI-298282, EBI-2568070;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:17158881}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P06756-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P06756-2; Sequence=VSP_024351;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P06756-3; Sequence=VSP_044914;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD93131.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14648; AAA36808.1; -; mRNA.
DR   EMBL; AF251841; AAG03000.1; -; Genomic_DNA.
DR   EMBL; AF251818; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251819; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251820; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251821; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251822; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251823; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251824; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251825; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251826; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251827; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251828; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251829; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251830; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251831; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251832; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251833; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251834; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251835; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251836; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251837; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251838; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251839; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251840; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AK302990; BAH13869.1; -; mRNA.
DR   EMBL; AB209894; BAD93131.1; ALT_INIT; mRNA.
DR   EMBL; AC017101; AAY24257.1; -; Genomic_DNA.
DR   EMBL; EU332844; ABY87533.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10934.1; -; Genomic_DNA.
DR   EMBL; BC126231; AAI26232.1; -; mRNA.
DR   EMBL; BC136442; AAI36443.1; -; mRNA.
DR   EMBL; BC144100; AAI44101.1; -; mRNA.
DR   EMBL; U07375; AAA61631.1; -; Genomic_DNA.
DR   CCDS; CCDS2292.1; -. [P06756-1]
DR   CCDS; CCDS46470.1; -. [P06756-2]
DR   CCDS; CCDS46471.1; -. [P06756-3]
DR   PIR; A27421; A27421.
DR   RefSeq; NP_001138471.1; NM_001144999.2.
DR   RefSeq; NP_001138472.1; NM_001145000.2.
DR   RefSeq; NP_002201.1; NM_002210.4.
DR   UniGene; Hs.436873; -.
DR   PDB; 1JV2; X-ray; 3.10 A; A=31-987.
DR   PDB; 1L5G; X-ray; 3.20 A; A=31-987.
DR   PDB; 1M1X; X-ray; 3.30 A; A=31-987.
DR   PDB; 1U8C; X-ray; 3.10 A; A=31-987.
DR   PDB; 3IJE; X-ray; 2.90 A; A=31-997.
DR   PDB; 4G1E; X-ray; 3.00 A; A=31-989.
DR   PDB; 4G1M; X-ray; 2.90 A; A=31-989.
DR   PDB; 4MMX; X-ray; 3.32 A; A=31-989.
DR   PDB; 4MMY; X-ray; 3.18 A; A=31-989.
DR   PDB; 4MMZ; X-ray; 3.10 A; A=31-989.
DR   PDB; 4O02; X-ray; 3.60 A; A=31-992.
DR   PDB; 4UM8; X-ray; 2.85 A; A/C=31-625.
DR   PDB; 4UM9; X-ray; 2.50 A; A/C=31-625.
DR   PDB; 5FFG; X-ray; 2.25 A; A=31-625.
DR   PDB; 5FFO; X-ray; 3.49 A; A/E=31-625.
DR   PDB; 5NEM; EM; 3.10 A; A=31-624.
DR   PDB; 5NER; EM; 3.10 A; A=31-624.
DR   PDB; 5NET; EM; 3.10 A; A=31-624.
DR   PDB; 5NEU; EM; 3.10 A; A=31-624.
DR   PDB; 6AVQ; EM; 35.00 A; A=31-987.
DR   PDB; 6AVR; EM; 35.00 A; A=31-987.
DR   PDB; 6AVU; EM; 35.00 A; A=31-987.
DR   PDBsum; 1JV2; -.
DR   PDBsum; 1L5G; -.
DR   PDBsum; 1M1X; -.
DR   PDBsum; 1U8C; -.
DR   PDBsum; 3IJE; -.
DR   PDBsum; 4G1E; -.
DR   PDBsum; 4G1M; -.
DR   PDBsum; 4MMX; -.
DR   PDBsum; 4MMY; -.
DR   PDBsum; 4MMZ; -.
DR   PDBsum; 4O02; -.
DR   PDBsum; 4UM8; -.
DR   PDBsum; 4UM9; -.
DR   PDBsum; 5FFG; -.
DR   PDBsum; 5FFO; -.
DR   PDBsum; 5NEM; -.
DR   PDBsum; 5NER; -.
DR   PDBsum; 5NET; -.
DR   PDBsum; 5NEU; -.
DR   PDBsum; 6AVQ; -.
DR   PDBsum; 6AVR; -.
DR   PDBsum; 6AVU; -.
DR   ProteinModelPortal; P06756; -.
DR   SMR; P06756; -.
DR   BioGrid; 109891; 70.
DR   CORUM; P06756; -.
DR   DIP; DIP-31785N; -.
DR   ELM; P06756; -.
DR   IntAct; P06756; 21.
DR   MINT; MINT-209462; -.
DR   STRING; 9606.ENSP00000261023; -.
DR   BindingDB; P06756; -.
DR   ChEMBL; CHEMBL3660; -.
DR   DrugBank; DB00098; Anti-thymocyte Globulin (Rabbit).
DR   GuidetoPHARMACOLOGY; 2453; -.
DR   TCDB; 8.A.54.1.4; the integrin (integrin) family.
DR   iPTMnet; P06756; -.
DR   PhosphoSitePlus; P06756; -.
DR   DMDM; 143811408; -.
DR   EPD; P06756; -.
DR   MaxQB; P06756; -.
DR   PaxDb; P06756; -.
DR   PeptideAtlas; P06756; -.
DR   PRIDE; P06756; -.
DR   Ensembl; ENST00000261023; ENSP00000261023; ENSG00000138448. [P06756-1]
DR   Ensembl; ENST00000374907; ENSP00000364042; ENSG00000138448. [P06756-2]
DR   Ensembl; ENST00000433736; ENSP00000404291; ENSG00000138448. [P06756-3]
DR   GeneID; 3685; -.
DR   KEGG; hsa:3685; -.
DR   UCSC; uc002upq.5; human. [P06756-1]
DR   CTD; 3685; -.
DR   DisGeNET; 3685; -.
DR   EuPathDB; HostDB:ENSG00000138448.11; -.
DR   GeneCards; ITGAV; -.
DR   HGNC; HGNC:6150; ITGAV.
DR   HPA; CAB002499; -.
DR   HPA; HPA004856; -.
DR   MIM; 193210; gene.
DR   neXtProt; NX_P06756; -.
DR   OpenTargets; ENSG00000138448; -.
DR   PharmGKB; PA37336; -.
DR   eggNOG; ENOG410IPB5; Eukaryota.
DR   eggNOG; ENOG410YR19; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; P06756; -.
DR   KO; K06487; -.
DR   OMA; SCFNVRF; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   PhylomeDB; P06756; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-210990; PECAM1 interactions.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P06756; -.
DR   SIGNOR; P06756; -.
DR   ChiTaRS; ITGAV; human.
DR   EvolutionaryTrace; P06756; -.
DR   GeneWiki; ITGAV; -.
DR   GenomeRNAi; 3685; -.
DR   PMAP-CutDB; B0LPF4; -.
DR   PRO; PR:P06756; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138448; -.
DR   CleanEx; HS_ITGAV; -.
DR   ExpressionAtlas; P06756; baseline and differential.
DR   Genevisible; P06756; HS.
DR   GO; GO:0035867; C:alphav-beta3 integrin-IGF-1-IGF1R complex; IDA:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031527; C:filopodium membrane; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0034683; C:integrin alphav-beta3 complex; IDA:UniProtKB.
DR   GO; GO:0034684; C:integrin alphav-beta5 complex; IDA:UniProtKB.
DR   GO; GO:0034685; C:integrin alphav-beta6 complex; IEA:Ensembl.
DR   GO; GO:0034686; C:integrin alphav-beta8 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; IDA:BHF-UCL.
DR   GO; GO:0031258; C:lamellipodium membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:BHF-UCL.
DR   GO; GO:0031528; C:microvillus membrane; IDA:UniProtKB.
DR   GO; GO:0045335; C:phagocytic vesicle; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0050840; F:extracellular matrix binding; IDA:UniProtKB.
DR   GO; GO:1990430; F:extracellular matrix protein binding; IDA:UniProtKB.
DR   GO; GO:0001968; F:fibronectin binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001846; F:opsonin binding; IEA:Ensembl.
DR   GO; GO:0042277; F:peptide binding; IEA:Ensembl.
DR   GO; GO:0002020; F:protease binding; IDA:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0005102; F:receptor binding; IEA:Ensembl.
DR   GO; GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0038027; P:apolipoprotein A-I-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043277; P:apoptotic cell clearance; IEA:Ensembl.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0035987; P:endodermal cell differentiation; IMP:UniProtKB.
DR   GO; GO:0052066; P:entry of symbiont into host cell by promotion of host phagocytosis; NAS:BHF-UCL.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; ISS:BHF-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISS:BHF-UCL.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0050919; P:negative chemotaxis; IMP:UniProtKB.
DR   GO; GO:2000536; P:negative regulation of entry of bacterium into host cell; IDA:BHF-UCL.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL.
DR   GO; GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL.
DR   GO; GO:0050748; P:negative regulation of lipoprotein metabolic process; IMP:BHF-UCL.
DR   GO; GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl.
DR   GO; GO:2000425; P:regulation of apoptotic cell clearance; ISS:BHF-UCL.
DR   GO; GO:0050764; P:regulation of phagocytosis; IDA:BHF-UCL.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB.
DR   GO; GO:0038044; P:transforming growth factor-beta secretion; IEA:Ensembl.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   GO; GO:0046718; P:viral entry into host cell; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 3.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cell junction; Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Integrin;
KW   Membrane; Metal-binding; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     30       {ECO:0000269|PubMed:2467745}.
FT   CHAIN        31   1048       Integrin alpha-V.
FT                                /FTId=PRO_0000016301.
FT   CHAIN        31    889       Integrin alpha-V heavy chain.
FT                                /FTId=PRO_0000016302.
FT   CHAIN       891   1048       Integrin alpha-V light chain.
FT                                /FTId=PRO_0000016303.
FT   TOPO_DOM     31    992       Extracellular. {ECO:0000255}.
FT   TRANSMEM    993   1016       Helical. {ECO:0000255}.
FT   TOPO_DOM   1017   1048       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       32     98       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      109    170       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      173    225       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      237    291       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      292    357       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      358    415       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      419    482       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     260    268       {ECO:0000255}.
FT   CA_BIND     314    322       {ECO:0000255}.
FT   CA_BIND     379    387       {ECO:0000255}.
FT   CA_BIND     443    451       {ECO:0000255}.
FT   MOTIF      1019   1023       GFFKR motif.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    290    290       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    296    296       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    488    488       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    554    554       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    615    615       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    704    704       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    835    835       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    851    851       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    874    874       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    945    945       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    973    973       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    980    980       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     89     97       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    138    158       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    172    185       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    491    502       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    508    565       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    626    632       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    698    711       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    852    914       Interchain (between heavy and light
FT                                chains). {ECO:0000269|PubMed:14596610}.
FT   DISULFID    904    909       {ECO:0000269|PubMed:14596610}.
FT   VAR_SEQ       1     62       MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEY
FT                                SGPEGSYFGFAVDFFVPSASS -> MLLGTLLLILYILMLC
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044914.
FT   VAR_SEQ     175    211       QDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQG ->
FT                                R (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_024351.
FT   VARIANT     405    405       I -> V (in dbSNP:rs3738918).
FT                                /FTId=VAR_024289.
FT   VARIANT     548    548       S -> A (in dbSNP:rs2230615).
FT                                /FTId=VAR_055970.
FT   VARIANT     783    783       V -> I (in dbSNP:rs2230616).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2430295,
FT                                ECO:0000269|PubMed:2443500,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.6,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_031547.
FT   CONFLICT    425    425       W -> R (in Ref. 2; AAG03000).
FT                                {ECO:0000305}.
FT   CONFLICT    700    700       F -> L (in Ref. 8; AAI44101).
FT                                {ECO:0000305}.
FT   CONFLICT   1039   1039       H -> R (in Ref. 2; AAG03000).
FT                                {ECO:0000305}.
FT   STRAND       39     42       {ECO:0000244|PDB:5FFG}.
FT   TURN         45     50       {ECO:0000244|PDB:5FFG}.
FT   STRAND       51     56       {ECO:0000244|PDB:5FFG}.
FT   STRAND       60     62       {ECO:0000244|PDB:4UM9}.
FT   STRAND       65     70       {ECO:0000244|PDB:5FFG}.
FT   STRAND       85     95       {ECO:0000244|PDB:5FFG}.
FT   STRAND       97    100       {ECO:0000244|PDB:5FFG}.
FT   STRAND      109    111       {ECO:0000244|PDB:5FFG}.
FT   STRAND      114    118       {ECO:0000244|PDB:5FFG}.
FT   STRAND      126    131       {ECO:0000244|PDB:5FFG}.
FT   STRAND      134    139       {ECO:0000244|PDB:5FFG}.
FT   STRAND      147    150       {ECO:0000244|PDB:5FFG}.
FT   STRAND      157    162       {ECO:0000244|PDB:5FFG}.
FT   STRAND      165    169       {ECO:0000244|PDB:5FFG}.
FT   STRAND      174    176       {ECO:0000244|PDB:5FFG}.
FT   TURN        178    184       {ECO:0000244|PDB:5FFG}.
FT   STRAND      189    193       {ECO:0000244|PDB:5FFG}.
FT   STRAND      197    203       {ECO:0000244|PDB:5FFG}.
FT   HELIX       206    209       {ECO:0000244|PDB:5FFG}.
FT   STRAND      211    217       {ECO:0000244|PDB:5FFG}.
FT   HELIX       218    223       {ECO:0000244|PDB:5FFG}.
FT   STRAND      235    239       {ECO:0000244|PDB:4G1E}.
FT   HELIX       245    247       {ECO:0000244|PDB:5FFG}.
FT   STRAND      254    259       {ECO:0000244|PDB:5FFG}.
FT   STRAND      261    266       {ECO:0000244|PDB:5FFG}.
FT   STRAND      268    273       {ECO:0000244|PDB:5FFG}.
FT   HELIX       276    279       {ECO:0000244|PDB:5FFG}.
FT   STRAND      282    286       {ECO:0000244|PDB:5FFG}.
FT   TURN        288    290       {ECO:0000244|PDB:5FFG}.
FT   STRAND      293    298       {ECO:0000244|PDB:5FFG}.
FT   STRAND      308    313       {ECO:0000244|PDB:5FFG}.
FT   STRAND      316    319       {ECO:0000244|PDB:5FFG}.
FT   STRAND      322    327       {ECO:0000244|PDB:5FFG}.
FT   STRAND      331    333       {ECO:0000244|PDB:5FFG}.
FT   STRAND      335    337       {ECO:0000244|PDB:4G1M}.
FT   STRAND      339    341       {ECO:0000244|PDB:5FFG}.
FT   STRAND      344    350       {ECO:0000244|PDB:5FFG}.
FT   STRAND      352    354       {ECO:0000244|PDB:3IJE}.
FT   STRAND      356    362       {ECO:0000244|PDB:5FFG}.
FT   STRAND      364    368       {ECO:0000244|PDB:1JV2}.
FT   HELIX       370    372       {ECO:0000244|PDB:1U8C}.
FT   STRAND      374    378       {ECO:0000244|PDB:5FFG}.
FT   STRAND      383    385       {ECO:0000244|PDB:5FFG}.
FT   STRAND      387    392       {ECO:0000244|PDB:5FFG}.
FT   HELIX       397    399       {ECO:0000244|PDB:5FFG}.
FT   STRAND      402    409       {ECO:0000244|PDB:5FFG}.
FT   STRAND      410    413       {ECO:0000244|PDB:4UM8}.
FT   STRAND      418    422       {ECO:0000244|PDB:5FFG}.
FT   STRAND      428    430       {ECO:0000244|PDB:4UM9}.
FT   STRAND      436    442       {ECO:0000244|PDB:5FFG}.
FT   STRAND      447    449       {ECO:0000244|PDB:5FFG}.
FT   STRAND      451    456       {ECO:0000244|PDB:5FFG}.
FT   HELIX       457    459       {ECO:0000244|PDB:5FFG}.
FT   STRAND      461    465       {ECO:0000244|PDB:5FFG}.
FT   STRAND      470    485       {ECO:0000244|PDB:5FFG}.
FT   STRAND      494    499       {ECO:0000244|PDB:3IJE}.
FT   STRAND      502    512       {ECO:0000244|PDB:5FFG}.
FT   STRAND      514    516       {ECO:0000244|PDB:5FFG}.
FT   STRAND      519    528       {ECO:0000244|PDB:5FFG}.
FT   TURN        529    532       {ECO:0000244|PDB:5FFG}.
FT   STRAND      535    537       {ECO:0000244|PDB:4G1M}.
FT   STRAND      541    543       {ECO:0000244|PDB:5FFG}.
FT   TURN        544    546       {ECO:0000244|PDB:5FFG}.
FT   STRAND      547    558       {ECO:0000244|PDB:5FFG}.
FT   STRAND      559    561       {ECO:0000244|PDB:4MMY}.
FT   STRAND      564    572       {ECO:0000244|PDB:5FFG}.
FT   HELIX       575    577       {ECO:0000244|PDB:5FFG}.
FT   STRAND      585    593       {ECO:0000244|PDB:5FFG}.
FT   TURN        595    597       {ECO:0000244|PDB:4UM9}.
FT   STRAND      601    603       {ECO:0000244|PDB:4G1E}.
FT   STRAND      610    612       {ECO:0000244|PDB:5FFG}.
FT   STRAND      614    623       {ECO:0000244|PDB:5FFG}.
FT   TURN        627    630       {ECO:0000244|PDB:3IJE}.
FT   STRAND      636    641       {ECO:0000244|PDB:3IJE}.
FT   STRAND      646    648       {ECO:0000244|PDB:3IJE}.
FT   STRAND      653    663       {ECO:0000244|PDB:3IJE}.
FT   STRAND      668    670       {ECO:0000244|PDB:3IJE}.
FT   STRAND      672    676       {ECO:0000244|PDB:3IJE}.
FT   STRAND      681    686       {ECO:0000244|PDB:3IJE}.
FT   STRAND      691    693       {ECO:0000244|PDB:4G1E}.
FT   STRAND      697    701       {ECO:0000244|PDB:3IJE}.
FT   STRAND      703    705       {ECO:0000244|PDB:3IJE}.
FT   STRAND      708    712       {ECO:0000244|PDB:3IJE}.
FT   STRAND      715    717       {ECO:0000244|PDB:3IJE}.
FT   STRAND      722    731       {ECO:0000244|PDB:3IJE}.
FT   STRAND      735    737       {ECO:0000244|PDB:4G1E}.
FT   STRAND      739    748       {ECO:0000244|PDB:3IJE}.
FT   STRAND      752    754       {ECO:0000244|PDB:3IJE}.
FT   STRAND      760    767       {ECO:0000244|PDB:3IJE}.
FT   STRAND      772    786       {ECO:0000244|PDB:3IJE}.
FT   TURN        798    802       {ECO:0000244|PDB:3IJE}.
FT   STRAND      805    814       {ECO:0000244|PDB:3IJE}.
FT   STRAND      816    818       {ECO:0000244|PDB:3IJE}.
FT   STRAND      820    833       {ECO:0000244|PDB:3IJE}.
FT   STRAND      839    856       {ECO:0000244|PDB:3IJE}.
FT   STRAND      900    902       {ECO:0000244|PDB:3IJE}.
FT   TURN        904    906       {ECO:0000244|PDB:3IJE}.
FT   STRAND      907    916       {ECO:0000244|PDB:3IJE}.
FT   STRAND      923    933       {ECO:0000244|PDB:3IJE}.
FT   HELIX       935    938       {ECO:0000244|PDB:3IJE}.
FT   STRAND      941    944       {ECO:0000244|PDB:3IJE}.
FT   STRAND      948    960       {ECO:0000244|PDB:3IJE}.
FT   STRAND      964    966       {ECO:0000244|PDB:4G1E}.
FT   STRAND      971    982       {ECO:0000244|PDB:3IJE}.
SQ   SEQUENCE   1048 AA;  116038 MW;  364EE25C5303A2D7 CRC64;
     MAFPPRRRLR LGPRGLPLLL SGLLLPLCRA FNLDVDSPAE YSGPEGSYFG FAVDFFVPSA
     SSRMFLLVGA PKANTTQPGI VEGGQVLKCD WSSTRRCQPI EFDATGNRDY AKDDPLEFKS
     HQWFGASVRS KQDKILACAP LYHWRTEMKQ EREPVGTCFL QDGTKTVEYA PCRSQDIDAD
     GQGFCQGGFS IDFTKADRVL LGGPGSFYWQ GQLISDQVAE IVSKYDPNVY SIKYNNQLAT
     RTAQAIFDDS YLGYSVAVGD FNGDGIDDFV SGVPRAARTL GMVYIYDGKN MSSLYNFTGE
     QMAAYFGFSV AATDINGDDY ADVFIGAPLF MDRGSDGKLQ EVGQVSVSLQ RASGDFQTTK
     LNGFEVFARF GSAIAPLGDL DQDGFNDIAI AAPYGGEDKK GIVYIFNGRS TGLNAVPSQI
     LEGQWAARSM PPSFGYSMKG ATDIDKNGYP DLIVGAFGVD RAILYRARPV ITVNAGLEVY
     PSILNQDNKT CSLPGTALKV SCFNVRFCLK ADGKGVLPRK LNFQVELLLD KLKQKGAIRR
     ALFLYSRSPS HSKNMTISRG GLMQCEELIA YLRDESEFRD KLTPITIFME YRLDYRTAAD
     TTGLQPILNQ FTPANISRQA HILLDCGEDN VCKPKLEVSV DSDQKKIYIG DDNPLTLIVK
     AQNQGEGAYE AELIVSIPLQ ADFIGVVRNN EALARLSCAF KTENQTRQVV CDLGNPMKAG
     TQLLAGLRFS VHQQSEMDTS VKFDLQIQSS NLFDKVSPVV SHKVDLAVLA AVEIRGVSSP
     DHVFLPIPNW EHKENPETEE DVGPVVQHIY ELRNNGPSSF SKAMLHLQWP YKYNNNTLLY
     ILHYDIDGPM NCTSDMEINP LRIKISSLQT TEKNDTVAGQ GERDHLITKR DLALSEGDIH
     TLGCGVAQCL KIVCQVGRLD RGKSAILYVK SLLWTETFMN KENQNHSYSL KSSASFNVIE
     FPYKNLPIED ITNSTLVTTN VTWGIQPAPM PVPVWVIILA VLAGLLLLAV LVFVMYRMGF
     FKRVRPPQEE QEREQLQPHE NGEGNSET
//
ID   ITBX_DROME              Reviewed;         846 AA.
AC   P11584; Q8MYX9; Q9W3L2;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2003, sequence version 3.
DT   22-NOV-2017, entry version 193.
DE   RecName: Full=Integrin beta-PS;
DE   AltName: Full=Position-specific antigen beta subunit;
DE   AltName: Full=Protein myospheroid;
DE   AltName: Full=Protein olfactory C;
DE   Flags: Precursor;
GN   Name=mys; Synonyms=l(1)mys, olfC; ORFNames=CG1560;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3128792; DOI=10.1073/pnas.85.8.2633;
RA   Mackrell A.J., Blumberg B., Haynes S.R., Fessler J.H.;
RT   "The lethal myospheroid gene of Drosophila encodes a membrane protein
RT   homologous to vertebrate integrin beta subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2633-2637(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE, FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   ASP-807; PHE-811; PHE-814; GLU-817; TYR-831 AND TYR-843.
RC   TISSUE=Embryo, and Imaginal disk;
RX   PubMed=8119134;
RA   Grinblat Y., Zusman S., Yee G., Hynes R.O., Kafatos F.C.;
RT   "Functions of the cytoplasmic domain of the beta PS integrin subunit
RT   during Drosophila development.";
RL   Development 120:91-102(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   FUNCTION.
RX   PubMed=7924982;
RA   Fogerty F.J., Fessler L.I., Bunch T.A., Yaron Y., Parker C.G.,
RA   Nelson R.E., Brower D.L., Gullberg D., Fessler J.H.;
RT   "Tiggrin, a novel Drosophila extracellular matrix protein that
RT   functions as a ligand for Drosophila alpha PS2 beta PS integrins.";
RL   Development 120:1747-1758(1994).
RN   [7]
RP   FUNCTION.
RX   PubMed=7972082; DOI=10.1073/pnas.91.24.11447;
RA   Gotwals P.J., Fessler L.I., Wehrli M., Hynes R.O.;
RT   "Drosophila PS1 integrin is a laminin receptor and differs in ligand
RT   specificity from PS2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:11447-11451(1994).
RN   [8]
RP   FUNCTION.
RX   PubMed=9660786; DOI=10.1074/jbc.273.29.18235;
RA   Graner M.W., Bunch T.A., Baumgartner S., Kerschen A., Brower D.L.;
RT   "Splice variants of the Drosophila PS2 integrins differentially
RT   interact with RGD-containing fragments of the extracellular proteins
RT   tiggrin, ten-m, and D-laminin 2.";
RL   J. Biol. Chem. 273:18235-18241(1998).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10821184; DOI=10.1007/s004380051194;
RA   Ayyub C., Rodrigues V., Hasan G., Siddiqi O.;
RT   "Genetic analysis of olfC demonstrates a role for the position-
RT   specific integrins in the olfactory system of Drosophila
RT   melanogaster.";
RL   Mol. Gen. Genet. 263:498-504(2000).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=15469969; DOI=10.1242/dev.01427;
RA   Devenport D., Brown N.H.;
RT   "Morphogenesis in the absence of integrins: mutation of both
RT   Drosophila beta subunits prevents midgut migration.";
RL   Development 131:5405-5415(2004).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-403; ASN-557 AND ASN-718,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Oregon-R; TISSUE=Head;
RX   PubMed=17893096; DOI=10.1093/glycob/cwm097;
RA   Koles K., Lim J.-M., Aoki K., Porterfield M., Tiemeyer M., Wells L.,
RA   Panin V.;
RT   "Identification of N-glycosylated proteins from the central nervous
RT   system of Drosophila melanogaster.";
RL   Glycobiology 17:1388-1403(2007).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19035354; DOI=10.1002/dvdy.21802;
RA   Dinkins M.B., Fratto V.M., Lemosy E.K.;
RT   "Integrin alpha chains exhibit distinct temporal and spatial
RT   localization patterns in epithelial cells of the Drosophila ovary.";
RL   Dev. Dyn. 237:3927-3939(2008).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-266; ASN-403; ASN-557 AND
RP   ASN-718, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [14]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=27191715; DOI=10.1371/journal.pgen.1006043;
RA   Lee J.Y., Chen J.Y., Shaw J.L., Chang K.T.;
RT   "Maintenance of stem cell niche integrity by a novel activator of
RT   integrin signaling.";
RL   PLoS Genet. 12:E1006043-E1006043(2016).
CC   -!- FUNCTION: Integrin alpha-PS1/beta-PS is a receptor for laminin
CC       (PubMed:7972082). Integrin alpha-PS2/beta-PS is a receptor for
CC       Tig, wb and Ten-m (PubMed:7924982, PubMed:7972082,
CC       PubMed:9660786). Contributes to endodermal integrity and adhesion
CC       between the midgut epithelium and the surrounding visceral muscle
CC       (PubMed:15469969). Essential for migration of the primordial
CC       midgut cells and for maintaining, but not establishing, cell
CC       polarity in the midgut epithelium (PubMed:15469969). The two beta
CC       subunits mediate midgut migration by distinct mechanisms: beta-PS
CC       requires rhea/talin and Itgbn does not (PubMed:15469969). Required
CC       for rhea/talin correct cellular localization in the midgut
CC       (PubMed:15469969). Required for many embryonic (dorsal closure and
CC       somatic muscle attachments) and postembryonic developmental
CC       processes (attachment between cell layers of imaginal disks,
CC       organization of ommatidial arrays and flight muscle development)
CC       (PubMed:8119134, PubMed:7924982, PubMed:7972082, PubMed:10821184).
CC       Involved in the function and/or development of the olfactory
CC       system (PubMed:10821184). In the testes, essential for shv-
CC       dependent maintenance of somatic hub cells and their localization
CC       to the apical tip (PubMed:27191715). Plays a role in timely border
CC       cell migration during oogenesis (PubMed:19035354).
CC       {ECO:0000269|PubMed:10821184, ECO:0000269|PubMed:15469969,
CC       ECO:0000269|PubMed:19035354, ECO:0000269|PubMed:27191715,
CC       ECO:0000269|PubMed:7924982, ECO:0000269|PubMed:7972082,
CC       ECO:0000269|PubMed:8119134, ECO:0000269|PubMed:9660786}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-PS
CC       associates with either alpha-PS1, alpha-PS2, alpha-PS3, alpha-PS4
CC       or alpha-PS5.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Lateral cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Basal cell membrane
CC       {ECO:0000269|PubMed:19035354}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:19035354}. Note=In ovary, localizes to the
CC       apical, lateral and basal membranes of follicle cells through
CC       oogenesis stage 10A. Apical membrane expression peaks at oogenesis
CC       stages 9 and 10A in columnar follicle cells overlying the oocyte
CC       but decreases in the most posterior follicle cells. Thereafter, it
CC       is down-regulated. Localization to lateral and basal membranes
CC       persists during dorsal appendage morphogenesis.
CC   -!- TISSUE SPECIFICITY: In ovaries, strongly expressed in follicle
CC       cells (PubMed:19035354). In oocytes, expressed in the forming
CC       dorsal appendages (at protein level) (PubMed:19035354). Expressed
CC       in the embryonic dorsal cuticle, the larval eye and the wing
CC       imaginal disk (PubMed:8119134). In testes, detected at the
CC       interface between somatic hub cells and cyst stem cells
CC       (PubMed:27191715). {ECO:0000269|PubMed:19035354,
CC       ECO:0000269|PubMed:27191715, ECO:0000269|PubMed:8119134}.
CC   -!- DISRUPTION PHENOTYPE: In zygotic mutant embryos, midgut forms
CC       primary constrictions but fails to elongate and the visceral
CC       muscle does not flatten but remains attached to the midgut
CC       epithelium. Embryos lacking maternal and zygotic mys show a delay
CC       in midgut migration. Mutant larvae present an olfactory phenotype,
CC       showing reduced response to isoamyl acetate but normal response to
CC       ethyl acetate. {ECO:0000269|PubMed:10821184,
CC       ECO:0000269|PubMed:15469969}.
CC   -!- MISCELLANEOUS: The absence of the beta-PS subunit results in
CC       detachment and rounding up of the muscles, thus the gene encoding
CC       beta-PS is called myospheroid.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03251; AAA28714.1; -; mRNA.
DR   EMBL; AE014298; AAF46313.2; -; Genomic_DNA.
DR   EMBL; AY113499; AAM29504.1; -; mRNA.
DR   PIR; A30889; A30889.
DR   RefSeq; NP_001284998.1; NM_001298069.1.
DR   RefSeq; NP_001284999.1; NM_001298070.1.
DR   RefSeq; NP_524793.2; NM_080054.3.
DR   UniGene; Dm.1814; -.
DR   ProteinModelPortal; P11584; -.
DR   SMR; P11584; -.
DR   BioGrid; 69357; 44.
DR   IntAct; P11584; 1.
DR   STRING; 7227.FBpp0071061; -.
DR   iPTMnet; P11584; -.
DR   PaxDb; P11584; -.
DR   PRIDE; P11584; -.
DR   EnsemblMetazoa; FBtr0071105; FBpp0071061; FBgn0004657.
DR   EnsemblMetazoa; FBtr0340136; FBpp0309122; FBgn0004657.
DR   EnsemblMetazoa; FBtr0340137; FBpp0309123; FBgn0004657.
DR   GeneID; 44885; -.
DR   KEGG; dme:Dmel_CG1560; -.
DR   CTD; 44885; -.
DR   FlyBase; FBgn0004657; mys.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   InParanoid; P11584; -.
DR   KO; K05719; -.
DR   OMA; FFDEDDC; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P11584; -.
DR   Reactome; R-DME-114608; Platelet degranulation.
DR   Reactome; R-DME-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-DME-1566948; Elastic fibre formation.
DR   Reactome; R-DME-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-DME-216083; Integrin cell surface interactions.
DR   Reactome; R-DME-3000157; Laminin interactions.
DR   Reactome; R-DME-3000170; Syndecan interactions.
DR   Reactome; R-DME-354192; Integrin alphaIIb beta3 signaling.
DR   Reactome; R-DME-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-DME-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-DME-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-DME-445144; Signal transduction by L1.
DR   Reactome; R-DME-445355; Smooth Muscle Contraction.
DR   Reactome; R-DME-446107; Type I hemidesmosome assembly.
DR   ChiTaRS; mys; fly.
DR   GenomeRNAi; 44885; -.
DR   PRO; PR:P11584; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0004657; -.
DR   ExpressionAtlas; P11584; differential.
DR   Genevisible; P11584; DM.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; IDA:FlyBase.
DR   GO; GO:0043034; C:costamere; IDA:FlyBase.
DR   GO; GO:0030425; C:dendrite; IDA:FlyBase.
DR   GO; GO:0005925; C:focal adhesion; IDA:FlyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0008305; C:integrin complex; IDA:FlyBase.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005927; C:muscle tendon junction; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0050839; F:cell adhesion molecule binding; TAS:FlyBase.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:FlyBase.
DR   GO; GO:0004872; F:receptor activity; TAS:FlyBase.
DR   GO; GO:0007015; P:actin filament organization; IMP:FlyBase.
DR   GO; GO:0007475; P:apposition of dorsal and ventral imaginal disc-derived wing surfaces; NAS:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IMP:FlyBase.
DR   GO; GO:0007298; P:border follicle cell migration; IMP:FlyBase.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0016340; P:calcium-dependent cell-matrix adhesion; ISS:FlyBase.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:FlyBase.
DR   GO; GO:0016477; P:cell migration; TAS:FlyBase.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:FlyBase.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:FlyBase.
DR   GO; GO:0007417; P:central nervous system development; IMP:FlyBase.
DR   GO; GO:0021551; P:central nervous system morphogenesis; IMP:FlyBase.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:FlyBase.
DR   GO; GO:0007391; P:dorsal closure; IMP:FlyBase.
DR   GO; GO:0035001; P:dorsal trunk growth, open tracheal system; IMP:FlyBase.
DR   GO; GO:0007427; P:epithelial cell migration, open tracheal system; TAS:FlyBase.
DR   GO; GO:0007629; P:flight behavior; IEA:UniProtKB-KW.
DR   GO; GO:0007377; P:germ-band extension; IMP:FlyBase.
DR   GO; GO:0030718; P:germ-line stem cell population maintenance; IMP:FlyBase.
DR   GO; GO:0035099; P:hemocyte migration; IGI:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:FlyBase.
DR   GO; GO:0048803; P:imaginal disc-derived male genitalia morphogenesis; IMP:FlyBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007508; P:larval heart development; IMP:FlyBase.
DR   GO; GO:0035160; P:maintenance of epithelial integrity, open tracheal system; IMP:FlyBase.
DR   GO; GO:0007494; P:midgut development; TAS:FlyBase.
DR   GO; GO:0016203; P:muscle attachment; IMP:FlyBase.
DR   GO; GO:0007517; P:muscle organ development; IMP:FlyBase.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0003344; P:pericardium morphogenesis; IMP:FlyBase.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:FlyBase.
DR   GO; GO:0051492; P:regulation of stress fiber assembly; IMP:FlyBase.
DR   GO; GO:0007431; P:salivary gland development; IMP:FlyBase.
DR   GO; GO:0045214; P:sarcomere organization; IMP:FlyBase.
DR   GO; GO:0007608; P:sensory perception of smell; IMP:FlyBase.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:FlyBase.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; IGI:FlyBase.
DR   GO; GO:0007426; P:tracheal outgrowth, open tracheal system; TAS:FlyBase.
DR   GO; GO:0007419; P:ventral cord development; IMP:FlyBase.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   Behavior; Cell adhesion; Cell membrane; Complete proteome;
KW   Developmental protein; Disulfide bond; Flight; Glycoprotein; Integrin;
KW   Membrane; Olfaction; Phosphoprotein; Receptor; Reference proteome;
KW   Repeat; Sensory transduction; Signal; Transmembrane;
KW   Transmembrane helix; Vision.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    846       Integrin beta-PS.
FT                                /FTId=PRO_0000016356.
FT   TOPO_DOM     24    776       Extracellular. {ECO:0000255}.
FT   TRANSMEM    777    799       Helical. {ECO:0000255}.
FT   TOPO_DOM    800    846       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      186    419       VWFA.
FT   REPEAT      507    560       I.
FT   REPEAT      561    605       II.
FT   REPEAT      606    646       III.
FT   REPEAT      647    687       IV.
FT   REGION      507    687       Cysteine-rich tandem repeats.
FT   COMPBIAS    115    143       Ser-rich.
FT   MOD_RES     831    831       Phosphotyrosine. {ECO:0000250}.
FT   MOD_RES     843    843       Phosphotyrosine. {ECO:0000250}.
FT   CARBOHYD     72     72       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    277    277       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    403    403       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    557    557       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    603    603       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    644    644       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    718    718       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17893096,
FT                                ECO:0000269|PubMed:19349973}.
FT   DISULFID     46     55       {ECO:0000250}.
FT   DISULFID    249    252       {ECO:0000250}.
FT   DISULFID    300    341       {ECO:0000250}.
FT   DISULFID    441    453       {ECO:0000250}.
FT   DISULFID    473    741       {ECO:0000250}.
FT   DISULFID    503    507       {ECO:0000250}.
FT   DISULFID    522    533       {ECO:0000250}.
FT   DISULFID    530    571       {ECO:0000250}.
FT   DISULFID    535    544       {ECO:0000250}.
FT   DISULFID    546    561       {ECO:0000250}.
FT   DISULFID    584    599       {ECO:0000250}.
FT   DISULFID    601    606       {ECO:0000250}.
FT   DISULFID    622    627       {ECO:0000250}.
FT   DISULFID    624    656       {ECO:0000250}.
FT   DISULFID    629    638       {ECO:0000250}.
FT   DISULFID    640    647       {ECO:0000250}.
FT   DISULFID    662    667       {ECO:0000250}.
FT   DISULFID    664    715       {ECO:0000250}.
FT   DISULFID    669    682       {ECO:0000250}.
FT   DISULFID    685    688       {ECO:0000250}.
FT   DISULFID    692    701       {ECO:0000250}.
FT   DISULFID    698    771       {ECO:0000250}.
FT   DISULFID    719    749       {ECO:0000250}.
FT   MUTAGEN     807    807       D->A: Rescues dorsal closure defect,
FT                                muscle attachment defect, disorganized
FT                                ommatidial array and loss of cell layer
FT                                attachment in mutants; when associated
FT                                with A-817. {ECO:0000269|PubMed:8119134}.
FT   MUTAGEN     811    811       F->A: Rescues muscle attachment defect
FT                                and loss of cell layer attachment in
FT                                mutants; when associated with A-814.
FT                                {ECO:0000269|PubMed:8119134}.
FT   MUTAGEN     814    814       F->A: Rescues muscle attachment defect
FT                                and loss of cell layer attachment in
FT                                mutants; when associated with A-811.
FT                                {ECO:0000269|PubMed:8119134}.
FT   MUTAGEN     817    817       E->A: Rescues dorsal closure defect,
FT                                muscle attachment defects, disorganized
FT                                ommatidial array and loss of cell layer
FT                                attachment in mutants; when associated
FT                                with A-807. {ECO:0000269|PubMed:8119134}.
FT   MUTAGEN     831    831       Y->A: No effect on lethality; when
FT                                associated with A-843.
FT                                {ECO:0000269|PubMed:8119134}.
FT   MUTAGEN     843    843       Y->A: No effect on lethality; when
FT                                associated with A-831.
FT                                {ECO:0000269|PubMed:8119134}.
FT   CONFLICT     18     18       I -> M (in Ref. 1; AAA28714).
FT                                {ECO:0000305}.
FT   CONFLICT     24     24       G -> A (in Ref. 1; AAA28714).
FT                                {ECO:0000305}.
FT   CONFLICT     27     27       D -> N (in Ref. 1; AAA28714).
FT                                {ECO:0000305}.
SQ   SEQUENCE   846 AA;  92656 MW;  3618C74FA1B99AFB CRC64;
     MILERNRRCQ LALLMIAILA AIAGQTDAQK AAKLTAVSTC ASKEKCHTCI QTEGCAWCMQ
     PDFKGQSRCY QNTSSLCPEE FAYSPITVEQ ILVNNKLTNQ YKAELAAGGG GSAMSGSSSS
     SYSSSSSSSS FYSQSSSGSS SASGYEEYSA GEIVQIQPQS MRLALRVNEK HNIKISYSQA
     EGYPVDLYYL MDLSKSMEDD KAKLSTLGDK LSETMKRITN NFHLGFGSFV DKVLMPYVST
     IPKKLEHPCE NCKAPYGYQN HMPLNNNTES FSNEVKNATV SGNLDAPEGG FDAIMQAIAC
     RSQIGWREQA RRLLVFSTDA GFHYAGDGKL GGVIAPNDGE CHLSPKGEYT HSTLQDYPSI
     SQINQKVKDN AINIIFAVTA SQLSVYEKLV EHIQGSSAAK LDNDSSNVVE LVKEEYRKIS
     SSVEMKDNAT GDVKITYFSS CLSNGPEVQT SKCDNLKEGQ QVSFTAQIQL LKCPEDPRDW
     TQTIHISPVG INEVMQIQLT MLCSCPCENP GSIGYQVQAN SCSGHGTSMC GICNCDDSYF
     GNKCECSATD LTSKFANDTS CRADSTSTTD CSGRGHCVCG ACECHKRPNP IEIISGKHCE
     CDNFSCERNR NQLCSGPDHG TCECGRCKCK PGWTGSNCGC QESNDTCMPP GGGEICSGHG
     TCECGVCKCT VNDQGRFSGR HCEKCPTCSG RCQELKDCVQ CQMYKTGELK NGDDCARNCT
     QFVPVGVEKV EIDETKDEQM CKFFDEDDCK FMFKYSEQGE LHVYAQENKE CPAKVFMLGI
     VMGVIAAIVL VGLAILLLWK LLTTIHDRRE FARFEKERMN AKWDTGENPI YKQATSTFKN
     PMYAGK
//
ID   ITA5_MOUSE              Reviewed;        1053 AA.
AC   P11688; E9QN40;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   22-NOV-2017, entry version 171.
DE   RecName: Full=Integrin alpha-5;
DE   AltName: Full=CD49 antigen-like family member E;
DE   AltName: Full=Fibronectin receptor subunit alpha;
DE   AltName: Full=Integrin alpha-F;
DE   AltName: Full=VLA-5;
DE   AltName: CD_antigen=CD49e;
DE   Contains:
DE     RecName: Full=Integrin alpha-5 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-5 light chain;
DE   Flags: Precursor;
GN   Name=Itga5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RA   Morrisey E., Dutt P., Patel V.;
RL   Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 645-1053.
RC   STRAIN=BALB/cJ;
RX   PubMed=2523953; DOI=10.1084/jem.169.5.1589;
RA   Holers V.M., Ruff T.G., Parks D.L., McDonald J.A., Ballard L.L.,
RA   Brown E.J.;
RT   "Molecular cloning of a murine fibronectin receptor and its expression
RT   during inflammation. Expression of VLA-5 is increased in activated
RT   peritoneal macrophages in a manner discordant from major
RT   histocompatibility complex class II.";
RL   J. Exp. Med. 169:1589-1605(1989).
RN   [4]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=7508365;
RA   Yang J.T., Rayburn H., Hynes R.O.;
RT   "Embryonic mesodermal defects in alpha 5 integrin-deficient mice.";
RL   Development 119:1093-1105(1993).
RN   [5]
RP   INTERACTION WITH NISCH.
RC   STRAIN=ICR; TISSUE=Brain;
RX   PubMed=11121431; DOI=10.1083/jcb.151.6.1141;
RA   Alahari S.K., Lee J.W., Juliano R.L.;
RT   "Nischarin, a novel protein that interacts with the integrin alpha5
RT   subunit and inhibits cell migration.";
RL   J. Cell Biol. 151:1141-1154(2000).
RN   [6]
RP   INTERACTION WITH NISCH.
RX   PubMed=14535848; DOI=10.1042/BJ20030411;
RA   Alahari S.K., Nasrallah H.;
RT   "A membrane proximal region of the integrin alpha5 subunit is
RT   important for its interaction with nischarin.";
RL   Biochem. J. 377:449-457(2004).
RN   [7]
RP   INTERACTION WITH NISCH.
RX   PubMed=15229651; DOI=10.1038/sj.emboj.7600291;
RA   Alahari S.K., Reddig P.J., Juliano R.L.;
RT   "The integrin-binding protein Nischarin regulates cell migration by
RT   inhibiting PAK.";
RL   EMBO J. 23:2777-2788(2004).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-300; ASN-310; ASN-596;
RP   ASN-612; ASN-675; ASN-678 AND ASN-685.
RC   TISSUE=Myoblast;
RX   PubMed=19656770; DOI=10.1074/mcp.M900195-MCP200;
RA   Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,
RA   Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,
RA   Wollscheid B.;
RT   "The mouse C2C12 myoblast cell surface N-linked glycoproteome:
RT   identification, glycosite occupancy, and membrane orientation.";
RL   Mol. Cell. Proteomics 8:2555-2569(2009).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-185; ASN-596; ASN-612;
RP   ASN-678; ASN-715; ASN-727 AND ASN-876.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas, and
RC   Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Integrin alpha-5/beta-1 is a receptor for fibronectin
CC       and fibrinogen. It recognizes the sequence R-G-D in its ligands.
CC       ITGA5:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct
CC       from the classical ligand-binding site (site 1) and this induces
CC       integrin conformational changes and enhanced ligand binding to
CC       site 1. ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and
CC       mediates R-G-D-dependent cell adhesion to FBN1.
CC       {ECO:0000250|UniProtKB:P08648}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-5 associates with beta-1. Interacts with
CC       NISCH (PubMed:11121431, PubMed:14535848, PubMed:15229651).
CC       Interacts with HPS5 (By similarity). Interacts with RAB21 and
CC       COMP. Interacts with CIB1 (By similarity). ITGA5:ITGB1 interacts
CC       with NOV (By similarity). ITGA5:ITGB1 interacts with FBN1 (By
CC       similarity). {ECO:0000250|UniProtKB:P08648,
CC       ECO:0000269|PubMed:11121431, ECO:0000269|PubMed:14535848,
CC       ECO:0000269|PubMed:15229651}.
CC   -!- INTERACTION:
CC       P68254:Ywhaq; NbExp=2; IntAct=EBI-6477055, EBI-400675;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:P08648}. Cell surface
CC       {ECO:0000250|UniProtKB:P08648}.
CC   -!- PTM: Proteolytic cleavage by PCSK5 mediates activation of the
CC       precursor. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mice die at day E10-E11. They show both
CC       extraembryonic and embryonic vascular defects, and severe
CC       abnormalities in the development of the posterior trunk.
CC       {ECO:0000269|PubMed:7508365}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X79003; CAA55638.1; -; mRNA.
DR   EMBL; AC131721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X15203; CAA33273.1; -; mRNA.
DR   CCDS; CCDS27903.1; -.
DR   PIR; S44250; S44250.
DR   RefSeq; NP_034707.5; NM_010577.4.
DR   UniGene; Mm.16234; -.
DR   ProteinModelPortal; P11688; -.
DR   SMR; P11688; -.
DR   BioGrid; 200818; 31.
DR   CORUM; P11688; -.
DR   IntAct; P11688; 33.
DR   MINT; MINT-4098865; -.
DR   STRING; 10090.ENSMUSP00000023128; -.
DR   iPTMnet; P11688; -.
DR   PhosphoSitePlus; P11688; -.
DR   MaxQB; P11688; -.
DR   PaxDb; P11688; -.
DR   PeptideAtlas; P11688; -.
DR   PRIDE; P11688; -.
DR   Ensembl; ENSMUST00000023128; ENSMUSP00000023128; ENSMUSG00000000555.
DR   GeneID; 16402; -.
DR   KEGG; mmu:16402; -.
DR   UCSC; uc007xyb.3; mouse.
DR   CTD; 3678; -.
DR   MGI; MGI:96604; Itga5.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; P11688; -.
DR   KO; K06484; -.
DR   OMA; PAMFNPE; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-MMU-1566948; Elastic fibre formation.
DR   Reactome; R-MMU-1566977; Fibronectin matrix formation.
DR   Reactome; R-MMU-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   Reactome; R-MMU-445144; Signal transduction by L1.
DR   ChiTaRS; Itga5; mouse.
DR   PRO; PR:P11688; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   Bgee; ENSMUSG00000000555; -.
DR   CleanEx; MM_ITGA5; -.
DR   ExpressionAtlas; P11688; baseline and differential.
DR   Genevisible; P11688; MM.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:Ensembl.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; IPI:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0033631; P:cell-cell adhesion mediated by integrin; IMP:MGI.
DR   GO; GO:0031589; P:cell-substrate adhesion; ISO:MGI.
DR   GO; GO:0007044; P:cell-substrate junction assembly; IDA:MGI.
DR   GO; GO:0035987; P:endodermal cell differentiation; ISO:MGI.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IMP:MGI.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; ISO:MGI.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IMP:MGI.
DR   GO; GO:0007613; P:memory; IMP:MGI.
DR   GO; GO:2000811; P:negative regulation of anoikis; ISO:MGI.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:MGI.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISO:MGI.
DR   GO; GO:0045765; P:regulation of angiogenesis; IGI:BHF-UCL.
DR   GO; GO:0035313; P:wound healing, spreading of epidermal cells; IEA:Ensembl.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell junction;
KW   Cleavage on pair of basic residues; Complete proteome; Disulfide bond;
KW   Glycoprotein; Integrin; Membrane; Metal-binding; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     44       {ECO:0000250}.
FT   CHAIN        45   1053       Integrin alpha-5.
FT                                /FTId=PRO_0000016252.
FT   CHAIN        45    898       Integrin alpha-5 heavy chain.
FT                                /FTId=PRO_0000016253.
FT   CHAIN       899   1053       Integrin alpha-5 light chain.
FT                                /FTId=PRO_0000016254.
FT   TOPO_DOM     45    999       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1000   1025       Helical. {ECO:0000255}.
FT   TOPO_DOM   1026   1053       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       46    111       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      131    191       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      196    248       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      262    314       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      315    380       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      381    440       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      444    507       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     283    291       {ECO:0000250}.
FT   CA_BIND     337    345       {ECO:0000255}.
FT   CA_BIND     404    412       {ECO:0000255}.
FT   CA_BIND     468    476       {ECO:0000255}.
FT   MOTIF      1024   1028       GFFKR motif.
FT   METAL       283    283       Calcium 1. {ECO:0000250}.
FT   METAL       285    285       Calcium 1. {ECO:0000250}.
FT   METAL       287    287       Calcium 1. {ECO:0000250}.
FT   METAL       289    289       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       291    291       Calcium 1. {ECO:0000250}.
FT   METAL       337    337       Calcium 2. {ECO:0000250}.
FT   METAL       339    339       Calcium 2. {ECO:0000250}.
FT   METAL       341    341       Calcium 2. {ECO:0000250}.
FT   METAL       343    343       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       345    345       Calcium 2. {ECO:0000250}.
FT   METAL       404    404       Calcium 3. {ECO:0000250}.
FT   METAL       406    406       Calcium 3. {ECO:0000250}.
FT   METAL       408    408       Calcium 3. {ECO:0000250}.
FT   METAL       410    410       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       412    412       Calcium 3. {ECO:0000250}.
FT   METAL       468    468       Calcium 4. {ECO:0000250}.
FT   METAL       470    470       Calcium 4. {ECO:0000250}.
FT   METAL       472    472       Calcium 4. {ECO:0000250}.
FT   METAL       474    474       Calcium 4; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       476    476       Calcium 4. {ECO:0000250}.
FT   BINDING     265    265       Arg of R-G-D substrate. {ECO:0000250}.
FT   BINDING     272    272       Arg of R-G-D substrate. {ECO:0000250}.
FT   MOD_RES     130    130       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08648}.
FT   CARBOHYD     87     87       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    185    185       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    319    319       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    527    527       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    533    533       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    596    596       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    612    612       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    675    675       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    678    678       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    685    685       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    715    715       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    727    727       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    776    776       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    872    872       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    876    876       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   DISULFID    102    111       {ECO:0000250}.
FT   DISULFID    159    179       {ECO:0000250}.
FT   DISULFID    195    208       {ECO:0000250}.
FT   DISULFID    516    525       {ECO:0000250}.
FT   DISULFID    531    587       {ECO:0000250}.
FT   DISULFID    648    654       {ECO:0000250}.
FT   DISULFID    721    734       {ECO:0000250}.
FT   DISULFID    873    915       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    920    925       {ECO:0000250}.
FT   CONFLICT     68     68       E -> Q (in Ref. 1; CAA55638).
FT                                {ECO:0000305}.
FT   CONFLICT    377    377       G -> A (in Ref. 1; CAA55638).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1053 AA;  115043 MW;  8624AEF83E4A9C07 CRC64;
     MGSWTPRSPR SPLHAVLLRW GPRRLPPLLP LLLLLWPPPL QVGGFNLDAE APAVLSGPPG
     SLFGFSVEFY RPGRDGVSVL VGAPKANTSQ PGVLQGGAVY VCPWGTSPIQ CTTIQFDSKG
     SRILESSLYS AKGEEPVEYK SLQWFGATVR AHGSSILACA PLYSWRTEKD PQNDPVGTCY
     LSTENFTRIL EYAPCRSDFG SAAGQGYCQG GFSAEFTKTG RVVLGGPGSY FWQGQILSAT
     QEQISESYYP EYLINPVQGQ LQTRQASSVY DDSYLGYSVA VGEFSGDDTE DFVAGVPKGN
     LTYGYVTVLN GSDIHSLYNV SGEQMASYFG YAVAATDTNG DGLDDLLVGA PLLMERTADG
     RPQEVGRVYI YLQRPAGIDP TPTLTLTGQD EFSRFGSSLT PLGDLDQDGY NDVAIGAPFG
     GEAQQGVVFI FPGGPGGLST KPSQVLQPLW AAGRTPDFFG SALRGGRDLD GNGYPDLIVG
     SFGVDKALVY RGRPIISASA SLTIFPSMFN PEERSCSLEG NPVSCINLSF CLNASGKHVP
     NSIGFEVELQ LDWQKQKGGV RRALFLTSKQ ATLTQTLLIQ NGAREDCREM KIYLRNESEF
     RDKLSPIHIA LNFSLDPKAP MDSHGLRPVL HYQSKSRIED KAQILLDCGE DNICVPDLQL
     DVYGEKKHVY LGDKNALNLT FHAQNLGEGG AYEAELRVTA PLEAEYSGLV RHPGNFSSLS
     CDYFAVNQSR QLVCDLGNPM KAGTSLWGGL RFTVPHLQDT KKTIQFDFQI LSKNLNNSQS
     NVVSFPLSVE AQAQVSLNGV SKPEAVIFPV SDWNPQDQPQ KEEDLGPAVH HVYELINQGP
     SSISQGVLEL SCPQALEGQQ LLYVTKVTGL SNCTSNYTPN SQGLELDPET SPHHLQKREA
     PGRSSTASGT QVLKCPEAKC FRLRCEFGPL HRQESRSLQL HFRVWAKTFL QREYQPFSLQ
     CEAVYEALKM PYQILPRQLP QKKLQVATAV QWTKAEGSNG VPLWIIILAI LFGLLLLGLL
     IYVLYKLGFF KRSLPYGTAM EKAQLKPPAT SDA
//
ID   ITB4_HUMAN              Reviewed;        1822 AA.
AC   P16144; A0AVL6; O14690; O14691; O15339; O15340; O15341; Q0VF97;
AC   Q9UIQ4;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 5.
DT   25-OCT-2017, entry version 222.
DE   RecName: Full=Integrin beta-4;
DE   AltName: Full=GP150;
DE   AltName: CD_antigen=CD104;
DE   Flags: Precursor;
GN   Name=ITGB4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-4A), AND VARIANT PRO-1779.
RX   PubMed=2311577;
RA   Suzuki S., Naitoh Y.;
RT   "Amino acid sequence of a novel integrin beta 4 subunit and primary
RT   expression of the mRNA in epithelial cells.";
RL   EMBO J. 9:757-763(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-4B), AND VARIANT PRO-1779.
RX   PubMed=2311578;
RA   Hogervorst F., Kuikman I., von Dem Borne A.E.G.K., Sonnenberg A.;
RT   "Cloning and sequence analysis of beta-4 cDNA: an integrin subunit
RT   that contains a unique 118 kd cytoplasmic domain.";
RL   EMBO J. 9:765-770(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-4C).
RC   TISSUE=Pancreas;
RX   PubMed=1976638; DOI=10.1083/jcb.111.4.1593;
RA   Tamura R.N., Rozzo C., Starr L., Chambers J., Reichardt L.F.,
RA   Cooper H.M., Quaranta V.;
RT   "Epithelial integrin alpha 6 beta 4: complete primary structure of
RT   alpha 6 and variant forms of beta 4.";
RL   J. Cell Biol. 111:1593-1604(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS BETA-4A; BETA-4B
RP   AND BETA-4C), AND VARIANTS SER-1764 AND PRO-1779.
RX   PubMed=9194858;
RA   Pulkkinen L., Kurtz K.S., Xu Y., Bruckner-Tuderman L., Uitto J.;
RT   "Genomic organization of the integrin beta 4 gene (ITGB4): a
RT   homozygous splice-site mutation in a patient with junctional
RT   epidermolysis bullosa associated with pyloric atresia.";
RL   Lab. Invest. 76:823-833(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS BETA-4A; BETA-4B AND
RP   BETA-4C), AND VARIANTS SER-1764 AND PRO-1779.
RC   TISSUE=Lung;
RX   PubMed=9166594; DOI=10.1007/s003359900467;
RA   Iacovacci S., Gagnoux-Palacios L., Zambruno G., Meneguzzi G.,
RA   D'Alessio M.;
RT   "Genomic organization of the human integrin beta 4 gene.";
RL   Mamm. Genome 8:448-450(1997).
RN   [6]
RP   SEQUENCE REVISION.
RA   D'Alessio M.;
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM BETA-4E), AND
RP   VARIANT PRO-1779.
RX   PubMed=9207246; DOI=10.1006/bbrc.1997.6892;
RA   van Leusden M.R., Kuikman I., Sonnenberg A.;
RT   "The unique cytoplasmic domain of the human integrin variant beta4E is
RT   produced by partial retention of intronic sequences.";
RL   Biochem. Biophys. Res. Commun. 235:826-830(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA-4A), AND VARIANT
RP   PRO-1779.
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 28-46.
RX   PubMed=2542022;
RA   Kajiji S., Tamura R.N., Quaranta V.;
RT   "A novel integrin (alpha E beta 4) from human epithelial cells
RT   suggests a fourth family of integrin adhesion receptors.";
RL   EMBO J. 8:673-680(1989).
RN   [12]
RP   ALTERNATIVE SPLICING (ISOFORM BETA-4D).
RX   PubMed=7982032;
RA   Clarke A.S., Lotz M.M., Mercurio A.M.;
RT   "A novel structural variant of the human beta 4 integrin cDNA.";
RL   Cell Adhes. Commun. 2:1-6(1994).
RN   [13]
RP   INTERACTION WITH DSP.
RX   PubMed=10637308; DOI=10.1091/mbc.11.1.277;
RA   Hopkinson S.B., Jones J.C.;
RT   "The N terminus of the transmembrane protein BP180 interacts with the
RT   N-terminal domain of BP230, thereby mediating keratin cytoskeleton
RT   anchorage to the cell surface at the site of the hemidesmosome.";
RL   Mol. Biol. Cell 11:277-286(2000).
RN   [14]
RP   INTERACTION WITH DST.
RX   PubMed=11375975; DOI=10.1074/jbc.M011005200;
RA   Favre B., Fontao L., Koster J., Shafaatian R., Jaunin F.,
RA   Saurat J.-H., Sonnenberg A., Borradori L.;
RT   "The hemidesmosomal protein bullous pemphigoid antigen 1 and the
RT   integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple
RT   alternative splice variants of ERBIN and analysis of their tissue
RT   expression.";
RL   J. Biol. Chem. 276:32427-32436(2001).
RN   [15]
RP   FUNCTION, INTERACTION WITH COL17A1 AND DST, CHARACTERIZATION OF
RP   VARIANT TRP-1281, AND SUBCELLULAR LOCATION.
RX   PubMed=12482924; DOI=10.1242/jcs.00241;
RA   Koster J., Geerts D., Favre B., Borradori L., Sonnenberg A.;
RT   "Analysis of the interactions between BP180, BP230, plectin and the
RT   integrin alpha6beta4 important for hemidesmosome assembly.";
RL   J. Cell Sci. 116:387-399(2003).
RN   [16]
RP   PALMITOYLATION.
RX   PubMed=15611341; DOI=10.1083/jcb.200404100;
RA   Yang X., Kovalenko O.V., Tang W., Claas C., Stipp C.S., Hemler M.E.;
RT   "Palmitoylation supports assembly and function of integrin-tetraspanin
RT   complexes.";
RL   J. Cell Biol. 167:1231-1240(2004).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-695.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1530, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [20]
RP   FUNCTION, INTERACTION WITH RAC1, AND SUBCELLULAR LOCATION.
RX   PubMed=19403692; DOI=10.1091/mbc.E09-01-0051;
RA   Hamill K.J., Hopkinson S.B., DeBiase P., Jones J.C.;
RT   "BPAG1e maintains keratinocyte polarity through beta4 integrin-
RT   mediated modulation of Rac1 and cofilin activities.";
RL   Mol. Biol. Cell 20:2954-2962(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [22]
RP   FUNCTION, BINDING TO NRG1, IDENTIFICATION IN A COMPLEX WITH NRG1 AND
RP   ERBB3, AND NRG1-BINDING REGION.
RX   PubMed=20682778; DOI=10.1074/jbc.M110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   PALMITOYLATION BY DHHC3, AND SUBCELLULAR LOCATION.
RX   PubMed=22314500; DOI=10.1007/s00018-012-0924-6;
RA   Sharma C., Rabinovitz I., Hemler M.E.;
RT   "Palmitoylation by DHHC3 is critical for the function, expression, and
RT   stability of integrin alpha6beta4.";
RL   Cell. Mol. Life Sci. 69:2233-2244(2012).
RN   [25]
RP   FUNCTION, BINDING TO IGF1, IDENTIFICATION IN A COMPLEX WITH IGF1 AND
RP   IGF1R, AND IGF1-BINDING REGION.
RX   PubMed=22351760; DOI=10.1074/jbc.M111.304170;
RA   Fujita M., Ieguchi K., Davari P., Yamaji S., Taniguchi Y.,
RA   Sekiguchi K., Takada Y.K., Takada Y.;
RT   "Cross-talk between integrin alpha6beta4 and insulin-like growth
RT   factor-1 receptor (IGF1R) through direct alpha6beta4 binding to IGF1
RT   and subsequent alpha6beta4-IGF1-IGF1R ternary complex formation in
RT   anchorage-independent conditions.";
RL   J. Biol. Chem. 287:12491-12500(2012).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1069; SER-1454;
RP   SER-1457; SER-1474; THR-1487 AND THR-1530, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 1126-1320.
RX   PubMed=10428948; DOI=10.1093/emboj/18.15.4087;
RA   de Pereda J.M., Wiche G., Liddington R.C.;
RT   "Crystal structure of a tandem pair of fibronectin type III domains
RT   from the cytoplasmic tail of integrin alpha6beta4.";
RL   EMBO J. 18:4087-4095(1999).
RN   [28]
RP   STRUCTURE BY NMR OF 1515-1622.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fibronectin type III domain of human
RT   integrin beta-4.";
RL   Submitted (APR-2008) to the PDB data bank.
RN   [29]
RP   VARIANTS EB-PA TYR-61; CYS-252; ARG-562 AND TRP-1281.
RX   PubMed=9792864; DOI=10.1086/302116;
RA   Pulkkinen L., Rouan F., Bruckner-Tuderman L., Wallerstein R.,
RA   Garzon M., Brown T., Smith L., Carter W.G., Uitto J.;
RT   "Novel ITGB4 mutations in lethal and nonlethal variants of
RT   epidermolysis bullosa with pyloric atresia: missense versus
RT   nonsense.";
RL   Am. J. Hum. Genet. 63:1376-1387(1998).
RN   [30]
RP   VARIANT EB-PA GLY-245.
RX   PubMed=9422533;
RA   Pulkkinen L., Kim D.U., Uitto J.;
RT   "Epidermolysis bullosa with pyloric atresia: novel mutations in the
RT   beta-4 integrin gene (ITGB4).";
RL   Am. J. Pathol. 152:157-166(1998).
RN   [31]
RP   VARIANT EB-PA PRO-156.
RX   PubMed=9546354;
RA   Pulkkinen L., Bruckner-Tuderman L., August C., Uitto J.;
RT   "Compound heterozygosity for missense (L156P) and nonsense (R554X)
RT   mutations in the beta-4 integrin gene (ITGB4) underlies mild,
RT   nonlethal phenotype of epidermolysis bullosa with pyloric atresia.";
RL   Am. J. Pathol. 152:935-941(1998).
RN   [32]
RP   VARIANT EB-PA ARG-38.
RX   PubMed=9892956; DOI=10.1046/j.1365-2133.1998.02515.x;
RA   Mellerio J.E., Pulkkinen L., McMillan J.R., Lake B.D., Horn H.M.,
RA   Tidman M.J., Harper J.I., McGrath J.A., Uitto J., Eady R.A.J.;
RT   "Pyloric atresia-junctional epidermolysis bullosa syndrome: mutations
RT   in the integrin beta4 gene (ITGB4) in two unrelated patients with mild
RT   disease.";
RL   Br. J. Dermatol. 139:862-871(1998).
RN   [33]
RP   VARIANT EB-PA TRP-1281.
RX   PubMed=10873890; DOI=10.1053/ajkd.2000.8293;
RA   Kambham N., Tanji N., Seigle R.L., Markowitz G.S., Pulkkinen L.,
RA   Uitto J., D'Agati V.D.;
RT   "Congenital focal segmental glomerulosclerosis associated with beta4
RT   integrin mutation and epidermolysis bullosa.";
RL   Am. J. Kidney Dis. 36:190-196(2000).
RN   [34]
RP   VARIANT GABEB ASP-931.
RX   PubMed=10792571; DOI=10.1046/j.1523-1747.2000.00960-3.x;
RA   Inoue M., Tamai K., Shimizu H., Owaribe K., Nakama T., Hashimoto T.,
RA   McGrath J.A.;
RT   "A homozygous missense mutation in the cytoplasmic tail of beta4
RT   integrin, G931D, that disrupts hemidesmosome assembly and underlies
RT   non-Herlitz junctional epidermolysis bullosa without pyloric
RT   atresia?";
RL   J. Invest. Dermatol. 114:1061-1064(2000).
RN   [35]
RP   VARIANTS EB-PA.
RX   PubMed=11251584; DOI=10.1046/j.1365-2133.2001.04038.x;
RA   Ashton G.H.S., Sorelli P., Mellerio J.E., Keane F.M., Eady R.A.J.,
RA   McGrath J.A.;
RT   "Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis
RT   bullosa with pyloric atresia.";
RL   Br. J. Dermatol. 144:408-414(2001).
RN   [36]
RP   VARIANTS HIS-98 AND LEU-844.
RX   PubMed=11289717; DOI=10.1007/s100380170122;
RA   Hirano A., Nagai H., Harada H., Terada Y., Haga S., Kajiwara T.,
RA   Emi M.;
RT   "Nine novel single-nucleotide polymorphisms in the integrin beta4
RT   (ITGB4) gene in the Japanese population.";
RL   J. Hum. Genet. 46:35-37(2001).
RN   [37]
RP   VARIANTS EB-PA TYR-131; CYS-252; ASP-273; CYS-283; ASP-325; PRO-336
RP   AND HIS-1225, AND VARIANT GLN-1216.
RX   PubMed=11328943; DOI=10.1203/00006450-200105000-00003;
RA   Nakano A., Pulkkinen L., Murrell D., Rico J., Lucky A.W., Garzon M.,
RA   Stevens C.A., Robertson S., Pfendner E., Uitto J.;
RT   "Epidermolysis bullosa with congenital pyloric atresia: novel
RT   mutations in the beta 4 integrin gene (ITGB4) and genotype/phenotype
RT   correlations.";
RL   Pediatr. Res. 49:618-626(2001).
CC   -!- FUNCTION: Integrin alpha-6/beta-4 is a receptor for laminin. Plays
CC       a critical structural role in the hemidesmosome of epithelial
CC       cells. Is required for the regulation of keratinocyte polarity and
CC       motility. ITGA6:ITGB4 binds to NRG1 (via EGF domain) and this
CC       binding is essential for NRG1-ERBB signaling (PubMed:20682778).
CC       ITGA6:ITGB4 binds to IGF1 and this binding is essential for IGF1
CC       signaling (PubMed:22351760). {ECO:0000269|PubMed:12482924,
CC       ECO:0000269|PubMed:19403692, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:22351760}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-4
CC       associates with alpha-6. Interacts (via cytoplasmic region) with
CC       COL17A1 (via cytoplasmic region). Interacts (via cytoplasmic
CC       region) with DST isoform 3 (via N-terminus). Isoform beta-4a
CC       interacts (via cytoplasmic domain) with DST (via N-terminus).
CC       Interacts with RAC1. ITGA6:ITGB4 is found in a ternary complex
CC       with NRG1 and ERBB3 (PubMed:20682778). ITGA6:ITGB4 is found in a
CC       ternary complex with IGF1 and IGF1R (PubMed:22351760).
CC       {ECO:0000269|PubMed:10637308, ECO:0000269|PubMed:11375975,
CC       ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:19403692,
CC       ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:22351760}.
CC   -!- INTERACTION:
CC       Q96B67:ARRDC3; NbExp=3; IntAct=EBI-948678, EBI-2875665;
CC       Q8R5M8-2:Cadm1 (xeno); NbExp=3; IntAct=EBI-948678, EBI-5651941;
CC       P23229:ITGA6; NbExp=3; IntAct=EBI-948678, EBI-2436548;
CC       Q9BYR5:KRTAP4-2; NbExp=4; IntAct=EBI-11051601, EBI-10172511;
CC       Q15149:PLEC; NbExp=7; IntAct=EBI-948678, EBI-297903;
CC       Q9QXS1-3:Plec (xeno); NbExp=4; IntAct=EBI-948678, EBI-16145475;
CC       Q05397:PTK2; NbExp=7; IntAct=EBI-948678, EBI-702142;
CC       O95136:S1PR2; NbExp=2; IntAct=EBI-948678, EBI-10634606;
CC       Q99500:S1PR3; NbExp=3; IntAct=EBI-948678, EBI-10634734;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Cell membrane; Lipid-anchor. Cell junction,
CC       hemidesmosome. Note=Colocalizes with DST at the leading edge of
CC       migrating keratinocytes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=Beta-4C;
CC         IsoId=P16144-1; Sequence=Displayed;
CC       Name=Beta-4A;
CC         IsoId=P16144-2; Sequence=VSP_002749;
CC       Name=Beta-4B;
CC         IsoId=P16144-3; Sequence=VSP_002749, VSP_002750;
CC       Name=Beta-4D;
CC         IsoId=P16144-4; Sequence=VSP_002749, VSP_002751;
CC       Name=Beta-4E;
CC         IsoId=P16144-5; Sequence=VSP_002747, VSP_002748;
CC   -!- TISSUE SPECIFICITY: Integrin alpha-6/beta-4 is predominantly
CC       expressed by epithelia. Isoform beta-4D is also expressed in colon
CC       and placenta. Isoform beta-4E is also expressed in epidermis,
CC       lung, duodenum, heart, spleen and stomach.
CC   -!- DOMAIN: The fibronectin type-III-like domains bind BPAG1 and
CC       plectin and probably also recruit BP230.
CC   -!- PTM: Palmitoylated by DHHC3 at several cysteines of the membrane-
CC       proximal region, enhancing stability and cell surface expression.
CC       Palmitoylation also promotes secundary association with
CC       tertaspanins. {ECO:0000269|PubMed:15611341,
CC       ECO:0000269|PubMed:22314500}.
CC   -!- DISEASE: Epidermolysis bullosa letalis, with pyloric atresia (EB-
CC       PA) [MIM:226730]: An autosomal recessive, frequently lethal,
CC       epidermolysis bullosa with variable involvement of skin, nails,
CC       mucosa, and with variable effects on the digestive system. It is
CC       characterized by mucocutaneous fragility, aplasia cutis congenita,
CC       and gastrointestinal atresia, which most commonly affects the
CC       pylorus. Pyloric atresia is a primary manifestation rather than a
CC       scarring process secondary to epidermolysis bullosa.
CC       {ECO:0000269|PubMed:10873890, ECO:0000269|PubMed:11251584,
CC       ECO:0000269|PubMed:11328943, ECO:0000269|PubMed:9422533,
CC       ECO:0000269|PubMed:9546354, ECO:0000269|PubMed:9792864,
CC       ECO:0000269|PubMed:9892956}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Generalized atrophic benign epidermolysis bullosa (GABEB)
CC       [MIM:226650]: A non-lethal, adult form of junctional epidermolysis
CC       bullosa characterized by life-long blistering of the skin,
CC       associated with hair and tooth abnormalities.
CC       {ECO:0000269|PubMed:10792571}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA37656.1; Type=Frameshift; Positions=1413, 1429; Evidence={ECO:0000305};
CC       Sequence=CAA37656.1; Type=Frameshift; Positions=1414, 1429; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X51841; CAA36134.1; -; mRNA.
DR   EMBL; X52186; CAA36433.1; -; mRNA.
DR   EMBL; X53587; CAA37656.1; ALT_FRAME; mRNA.
DR   EMBL; U66541; AAC51634.1; -; Genomic_DNA.
DR   EMBL; U66530; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66531; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66532; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66533; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66534; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66535; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66536; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66537; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66538; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66539; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66540; AAC51634.1; JOINED; Genomic_DNA.
DR   EMBL; U66541; AAC51633.1; -; Genomic_DNA.
DR   EMBL; U66530; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66531; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66532; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66533; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66534; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66535; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66536; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66537; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66538; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66539; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66540; AAC51633.1; JOINED; Genomic_DNA.
DR   EMBL; U66541; AAC51632.1; -; Genomic_DNA.
DR   EMBL; U66530; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66531; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66532; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66533; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66534; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66535; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66536; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66537; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66538; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66539; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; U66540; AAC51632.1; JOINED; Genomic_DNA.
DR   EMBL; AC087749; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89305.1; -; Genomic_DNA.
DR   EMBL; BC118916; AAI18917.1; -; mRNA.
DR   EMBL; BC126411; AAI26412.1; -; mRNA.
DR   EMBL; AJ251004; CAB61345.1; -; Genomic_DNA.
DR   EMBL; Y11107; CAB61345.1; JOINED; Genomic_DNA.
DR   EMBL; AF011375; AAB65421.1; -; mRNA.
DR   EMBL; AF011376; AAB65422.1; -; Genomic_DNA.
DR   CCDS; CCDS11727.1; -. [P16144-1]
DR   CCDS; CCDS32736.1; -. [P16144-3]
DR   CCDS; CCDS58599.1; -. [P16144-2]
DR   PIR; JC5545; JC5545.
DR   PIR; S12380; A36429.
DR   RefSeq; NP_000204.3; NM_000213.4. [P16144-1]
DR   RefSeq; NP_001005619.1; NM_001005619.1. [P16144-3]
DR   RefSeq; NP_001005731.1; NM_001005731.2. [P16144-2]
DR   RefSeq; NP_001308052.1; NM_001321123.1. [P16144-2]
DR   UniGene; Hs.632226; -.
DR   PDB; 1QG3; X-ray; 2.15 A; A/B=1126-1320.
DR   PDB; 2YRZ; NMR; -; A=1518-1622.
DR   PDB; 3F7P; X-ray; 2.75 A; C/D/E=1126-1369.
DR   PDB; 3F7Q; X-ray; 1.75 A; A/B=1126-1355.
DR   PDB; 3F7R; X-ray; 2.04 A; A=1126-1369.
DR   PDB; 3FQ4; X-ray; 1.49 A; A/B=989-1107.
DR   PDB; 3FSO; X-ray; 1.41 A; A/B=989-1107.
DR   PDB; 3H6A; X-ray; 1.61 A; A/B=989-1107.
DR   PDB; 4Q58; X-ray; 4.00 A; C/D=1126-1320.
DR   PDB; 4WTW; X-ray; 1.61 A; A/B=1527-1618.
DR   PDB; 4WTX; X-ray; 1.50 A; A=1642-1736.
DR   PDBsum; 1QG3; -.
DR   PDBsum; 2YRZ; -.
DR   PDBsum; 3F7P; -.
DR   PDBsum; 3F7Q; -.
DR   PDBsum; 3F7R; -.
DR   PDBsum; 3FQ4; -.
DR   PDBsum; 3FSO; -.
DR   PDBsum; 3H6A; -.
DR   PDBsum; 4Q58; -.
DR   PDBsum; 4WTW; -.
DR   PDBsum; 4WTX; -.
DR   ProteinModelPortal; P16144; -.
DR   SMR; P16144; -.
DR   BioGrid; 109897; 34.
DR   CORUM; P16144; -.
DR   DIP; DIP-40182N; -.
DR   ELM; P16144; -.
DR   IntAct; P16144; 84.
DR   MINT; MINT-5004072; -.
DR   STRING; 9606.ENSP00000200181; -.
DR   DrugBank; DB05122; R1295.
DR   iPTMnet; P16144; -.
DR   PhosphoSitePlus; P16144; -.
DR   SwissPalm; P16144; -.
DR   BioMuta; ITGB4; -.
DR   DMDM; 317373584; -.
DR   EPD; P16144; -.
DR   MaxQB; P16144; -.
DR   PaxDb; P16144; -.
DR   PeptideAtlas; P16144; -.
DR   PRIDE; P16144; -.
DR   Ensembl; ENST00000200181; ENSP00000200181; ENSG00000132470. [P16144-1]
DR   Ensembl; ENST00000449880; ENSP00000400217; ENSG00000132470. [P16144-3]
DR   Ensembl; ENST00000450894; ENSP00000405536; ENSG00000132470. [P16144-2]
DR   Ensembl; ENST00000579662; ENSP00000463651; ENSG00000132470. [P16144-2]
DR   GeneID; 3691; -.
DR   KEGG; hsa:3691; -.
DR   UCSC; uc002jpg.3; human. [P16144-1]
DR   CTD; 3691; -.
DR   DisGeNET; 3691; -.
DR   EuPathDB; HostDB:ENSG00000132470.13; -.
DR   GeneCards; ITGB4; -.
DR   GeneReviews; ITGB4; -.
DR   H-InvDB; HIX0039036; -.
DR   HGNC; HGNC:6158; ITGB4.
DR   HPA; CAB002422; -.
DR   HPA; CAB005258; -.
DR   HPA; HPA036348; -.
DR   HPA; HPA036349; -.
DR   MalaCards; ITGB4; -.
DR   MIM; 147557; gene.
DR   MIM; 226650; phenotype.
DR   MIM; 226730; phenotype.
DR   neXtProt; NX_P16144; -.
DR   OpenTargets; ENSG00000132470; -.
DR   Orphanet; 158684; Epidermolysis bullosa simplex with pyloric atresia.
DR   Orphanet; 79402; Generalized junctional epidermolysis bullosa, non-Herlitz type.
DR   Orphanet; 79403; Junctional epidermolysis bullosa - pyloric atresia.
DR   Orphanet; 251393; Localized junctional epidermolysis bullosa, non-Herlitz type.
DR   PharmGKB; PA29957; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000231105; -.
DR   HOVERGEN; HBG006189; -.
DR   InParanoid; P16144; -.
DR   KO; K06525; -.
DR   OMA; EDDDCTY; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P16144; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-446107; Type I hemidesmosome assembly.
DR   SignaLink; P16144; -.
DR   SIGNOR; P16144; -.
DR   ChiTaRS; ITGB4; human.
DR   EvolutionaryTrace; P16144; -.
DR   GeneWiki; ITGB4; -.
DR   GenomeRNAi; 3691; -.
DR   PRO; PR:P16144; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000132470; -.
DR   CleanEx; HS_ITGB4; -.
DR   ExpressionAtlas; P16144; baseline and differential.
DR   Genevisible; P16144; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0031252; C:cell leading edge; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030056; C:hemidesmosome; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IPI:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0097186; P:amelogenesis; IMP:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IMP:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; NAS:ProtInc.
DR   GO; GO:0048870; P:cell motility; IMP:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0048565; P:digestive tract development; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0031581; P:hemidesmosome assembly; IDA:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0035878; P:nail development; IMP:UniProtKB.
DR   GO; GO:0072001; P:renal system development; IMP:UniProtKB.
DR   GO; GO:0009611; P:response to wounding; IDA:UniProtKB.
DR   GO; GO:0043588; P:skin development; IMP:UniProtKB.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.30.70.960; -; 1.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR003644; Calx_beta.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR012013; Integrin_bsu-4.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF42; PTHR10082:SF42; 1.
DR   Pfam; PF03160; Calx-beta; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF00041; fn3; 4.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002513; Integrin_B4; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00237; Calx_beta; 1.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS00243; INTEGRIN_BETA; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Epidermolysis bullosa; Glycoprotein;
KW   Integrin; Lipoprotein; Membrane; Palmitate; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     27       {ECO:0000269|PubMed:2542022}.
FT   CHAIN        28   1822       Integrin beta-4.
FT                                /FTId=PRO_0000016346.
FT   TOPO_DOM     28    710       Extracellular. {ECO:0000255}.
FT   TRANSMEM    711    733       Helical. {ECO:0000255}.
FT   TOPO_DOM    734   1822       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       29     73       PSI.
FT   DOMAIN      131    329       VWFA.
FT   REPEAT      456    502       I.
FT   REPEAT      503    542       II.
FT   REPEAT      543    581       III.
FT   REPEAT      582    619       IV.
FT   DOMAIN      979   1084       Calx-beta.
FT   DOMAIN     1129   1218       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1222   1321       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1530   1625       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1643   1739       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   REGION      194    199       Involved in NRG1- and IGF1-binding.
FT                                {ECO:0000269|PubMed:20682778,
FT                                ECO:0000269|PubMed:22351760}.
FT   REGION      456    619       Cysteine-rich tandem repeats.
FT   REGION      732    749       Palmitoylated on several cysteines.
FT   MOD_RES     771    771       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64632}.
FT   MOD_RES    1069   1069       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1119   1119       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64632}.
FT   MOD_RES    1454   1454       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1457   1457       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1474   1474       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1487   1487       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1494   1494       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64632}.
FT   MOD_RES    1530   1530       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1791   1791       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64632}.
FT   CARBOHYD    327    327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    491    491       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    579    579       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    617    617       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    695    695       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   DISULFID     30    455       {ECO:0000250}.
FT   DISULFID     38     48       {ECO:0000250}.
FT   DISULFID     41     72       {ECO:0000250}.
FT   DISULFID     51     61       {ECO:0000250}.
FT   DISULFID    245    288       {ECO:0000250}.
FT   DISULFID    424    671       {ECO:0000250}.
FT   DISULFID    452    457       {ECO:0000250}.
FT   DISULFID    468    479       {ECO:0000250}.
FT   DISULFID    476    512       {ECO:0000250}.
FT   DISULFID    481    490       {ECO:0000250}.
FT   DISULFID    492    503       {ECO:0000250}.
FT   DISULFID    518    523       {ECO:0000250}.
FT   DISULFID    520    551       {ECO:0000250}.
FT   DISULFID    525    536       {ECO:0000250}.
FT   DISULFID    557    562       {ECO:0000250}.
FT   DISULFID    564    573       {ECO:0000250}.
FT   DISULFID    575    582       {ECO:0000250}.
FT   DISULFID    596    601       {ECO:0000250}.
FT   DISULFID    598    648       {ECO:0000250}.
FT   DISULFID    603    614       {ECO:0000250}.
FT   DISULFID    626    635       {ECO:0000250}.
FT   DISULFID    632    706       {ECO:0000250}.
FT   DISULFID    651    680       {ECO:0000250}.
FT   VAR_SEQ     851    964       LNEVYRQISGVHKLQQTKFRQQPNAGKKQDHTIVDTVLMAP
FT                                RSAKPALLKLTEKQVEQRAFHDLKVAPGYYTLTADQDARGM
FT                                VEFQEGVELVDVRVPLFIRPEDDDEKQLLVEA -> VRTQE
FT                                LGLAGDVAERGLQADLRCTQAPADQVPAAAQCREKARPHHC
FT                                GHSADGAPLGQAGPAEAYREAGGTEGLPRPQGGPRLLHPHC
FT                                RPGRPGHGGVPGGRGAGGRTGAPLYPA (in isoform
FT                                Beta-4E). {ECO:0000303|PubMed:9207246}.
FT                                /FTId=VSP_002747.
FT   VAR_SEQ     965   1822       Missing (in isoform Beta-4E).
FT                                {ECO:0000303|PubMed:9207246}.
FT                                /FTId=VSP_002748.
FT   VAR_SEQ    1370   1439       Missing (in isoform Beta-4A, isoform
FT                                Beta-4B and isoform Beta-4D).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2311577,
FT                                ECO:0000303|PubMed:2311578,
FT                                ECO:0000303|PubMed:9194858}.
FT                                /FTId=VSP_002749.
FT   VAR_SEQ    1519   1519       H -> HGLPPIWEHGRSRLPLSWALGSRSRAQMKGFPPSRG
FT                                PRDSIILAGRPAAPSWGP (in isoform Beta-4B).
FT                                {ECO:0000303|PubMed:2311578,
FT                                ECO:0000303|PubMed:9194858}.
FT                                /FTId=VSP_002750.
FT   VAR_SEQ    1678   1685       CEMAQGGG -> W (in isoform Beta-4D).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002751.
FT   VARIANT      38     38       C -> R (in EB-PA; mild form;
FT                                dbSNP:rs121912465).
FT                                {ECO:0000269|PubMed:9892956}.
FT                                /FTId=VAR_010652.
FT   VARIANT      61     61       C -> Y (in EB-PA; lethal form;
FT                                dbSNP:rs80338755).
FT                                {ECO:0000269|PubMed:9792864}.
FT                                /FTId=VAR_004006.
FT   VARIANT      98     98       R -> H (in dbSNP:rs143114124).
FT                                {ECO:0000269|PubMed:11289717}.
FT                                /FTId=VAR_011292.
FT   VARIANT     131    131       D -> Y (in EB-PA; lethal form).
FT                                {ECO:0000269|PubMed:11328943}.
FT                                /FTId=VAR_011293.
FT   VARIANT     156    156       L -> P (in EB-PA; mild form;
FT                                dbSNP:rs121912461).
FT                                {ECO:0000269|PubMed:9546354}.
FT                                /FTId=VAR_004007.
FT   VARIANT     245    245       C -> G (in EB-PA; lethal form).
FT                                {ECO:0000269|PubMed:9422533}.
FT                                /FTId=VAR_004008.
FT   VARIANT     252    252       R -> C (in EB-PA; mild form;
FT                                dbSNP:rs201494421).
FT                                {ECO:0000269|PubMed:11328943,
FT                                ECO:0000269|PubMed:9792864}.
FT                                /FTId=VAR_004009.
FT   VARIANT     273    273       G -> D (in EB-PA; lethal form).
FT                                {ECO:0000269|PubMed:11328943}.
FT                                /FTId=VAR_011294.
FT   VARIANT     283    283       R -> C (in EB-PA).
FT                                {ECO:0000269|PubMed:11328943}.
FT                                /FTId=VAR_011295.
FT   VARIANT     325    325       V -> D (in EB-PA).
FT                                {ECO:0000269|PubMed:11328943}.
FT                                /FTId=VAR_011296.
FT   VARIANT     336    336       L -> P (in EB-PA; mild form).
FT                                {ECO:0000269|PubMed:11328943}.
FT                                /FTId=VAR_011297.
FT   VARIANT     478    478       Q -> H (in dbSNP:rs8079267).
FT                                /FTId=VAR_027803.
FT   VARIANT     562    562       C -> R (in EB-PA; mild form;
FT                                dbSNP:rs121912463).
FT                                {ECO:0000269|PubMed:9792864}.
FT                                /FTId=VAR_004010.
FT   VARIANT     844    844       R -> L (in dbSNP:rs140819116).
FT                                {ECO:0000269|PubMed:11289717}.
FT                                /FTId=VAR_011298.
FT   VARIANT     931    931       G -> D (in GABEB; dbSNP:rs121912466).
FT                                {ECO:0000269|PubMed:10792571}.
FT                                /FTId=VAR_011299.
FT   VARIANT    1216   1216       H -> Q (in dbSNP:rs149284152).
FT                                {ECO:0000269|PubMed:11328943}.
FT                                /FTId=VAR_011300.
FT   VARIANT    1225   1225       R -> H (in EB-PA; mild form;
FT                                dbSNP:rs121912468).
FT                                {ECO:0000269|PubMed:11328943}.
FT                                /FTId=VAR_011301.
FT   VARIANT    1281   1281       R -> W (in EB-PA; mild form; abolishes
FT                                interaction with PLEC and reduces
FT                                interaction with COL17A1;
FT                                dbSNP:rs121912467).
FT                                {ECO:0000269|PubMed:10873890,
FT                                ECO:0000269|PubMed:12482924,
FT                                ECO:0000269|PubMed:9792864}.
FT                                /FTId=VAR_004011.
FT   VARIANT    1764   1764       T -> S (in dbSNP:rs1051486).
FT                                {ECO:0000269|PubMed:9166594,
FT                                ECO:0000269|PubMed:9194858}.
FT                                /FTId=VAR_055971.
FT   VARIANT    1779   1779       L -> P (in dbSNP:rs871443).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2311577,
FT                                ECO:0000269|PubMed:2311578,
FT                                ECO:0000269|PubMed:9166594,
FT                                ECO:0000269|PubMed:9194858,
FT                                ECO:0000269|PubMed:9207246}.
FT                                /FTId=VAR_027804.
FT   CONFLICT     27     27       Missing (in Ref. 5; CAB61345).
FT                                {ECO:0000305}.
FT   CONFLICT     43     43       R -> Y (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     46     46       K -> P (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    621    704       IHPGLCEDLRSCVQCQAWGTGEKKGRTCEECNFKVKMVDEL
FT                                KRAEEVVVRCSFRDEDDDCTYSYTMEGDGAPGPNSTVLVHK
FT                                KK -> STRASARTYAPACSARRGAPARRRGARVRNATSRS
FT                                RWWTSLREARRWWCAAPSGTRMTTAPTATPWKVTAPLGPTA
FT                                LSWCTRRR (in Ref. 5; CAB61345).
FT                                {ECO:0000305}.
FT   CONFLICT    802    804       GFA -> WLC (in Ref. 8; AAB65422).
FT                                {ECO:0000305}.
FT   CONFLICT   1414   1429       HGPPDDGGAGGKGGSL -> TAPRTTAARAGRAAAV (in
FT                                Ref. 3; CAA37656). {ECO:0000305}.
FT   CONFLICT   1755   1755       P -> L (in Ref. 10; AAI18917).
FT                                {ECO:0000305}.
FT   CONFLICT   1777   1777       Missing (in Ref. 5; CAB61345).
FT                                {ECO:0000305}.
FT   STRAND      990    995       {ECO:0000244|PDB:3FSO}.
FT   STRAND      997   1002       {ECO:0000244|PDB:3FSO}.
FT   HELIX      1003   1005       {ECO:0000244|PDB:3FSO}.
FT   STRAND     1006   1016       {ECO:0000244|PDB:3FSO}.
FT   STRAND     1022   1033       {ECO:0000244|PDB:3FSO}.
FT   TURN       1035   1037       {ECO:0000244|PDB:3FSO}.
FT   STRAND     1043   1048       {ECO:0000244|PDB:3FSO}.
FT   STRAND     1054   1061       {ECO:0000244|PDB:3FSO}.
FT   TURN       1070   1073       {ECO:0000244|PDB:3FQ4}.
FT   STRAND     1076   1087       {ECO:0000244|PDB:3FSO}.
FT   STRAND     1096   1103       {ECO:0000244|PDB:3FSO}.
FT   STRAND     1131   1137       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1139   1141       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1143   1148       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1156   1163       {ECO:0000244|PDB:3F7Q}.
FT   HELIX      1168   1170       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1172   1183       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1191   1200       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1203   1207       {ECO:0000244|PDB:3F7P}.
FT   STRAND     1211   1214       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1227   1230       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1232   1234       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1236   1239       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1252   1260       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1262   1264       {ECO:0000244|PDB:3F7R}.
FT   STRAND     1266   1268       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1271   1275       {ECO:0000244|PDB:1QG3}.
FT   STRAND     1282   1286       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1294   1302       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1310   1314       {ECO:0000244|PDB:3F7Q}.
FT   HELIX      1316   1318       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1334   1336       {ECO:0000244|PDB:3F7Q}.
FT   STRAND     1344   1348       {ECO:0000244|PDB:3F7P}.
FT   STRAND     1522   1524       {ECO:0000244|PDB:2YRZ}.
FT   STRAND     1535   1538       {ECO:0000244|PDB:4WTW}.
FT   STRAND     1544   1547       {ECO:0000244|PDB:4WTW}.
FT   STRAND     1557   1566       {ECO:0000244|PDB:4WTW}.
FT   STRAND     1573   1577       {ECO:0000244|PDB:4WTW}.
FT   STRAND     1584   1587       {ECO:0000244|PDB:4WTW}.
FT   STRAND     1595   1604       {ECO:0000244|PDB:4WTW}.
FT   STRAND     1612   1617       {ECO:0000244|PDB:4WTW}.
FT   STRAND     1648   1653       {ECO:0000244|PDB:4WTX}.
FT   STRAND     1656   1662       {ECO:0000244|PDB:4WTX}.
FT   STRAND     1671   1680       {ECO:0000244|PDB:4WTX}.
FT   STRAND     1683   1685       {ECO:0000244|PDB:4WTX}.
FT   STRAND     1688   1694       {ECO:0000244|PDB:4WTX}.
FT   STRAND     1697   1703       {ECO:0000244|PDB:4WTX}.
FT   STRAND     1712   1722       {ECO:0000244|PDB:4WTX}.
FT   STRAND     1724   1732       {ECO:0000244|PDB:4WTX}.
SQ   SEQUENCE   1822 AA;  202167 MW;  09710FFBBD719469 CRC64;
     MAGPRPSPWA RLLLAALISV SLSGTLANRC KKAPVKSCTE CVRVDKDCAY CTDEMFRDRR
     CNTQAELLAA GCQRESIVVM ESSFQITEET QIDTTLRRSQ MSPQGLRVRL RPGEERHFEL
     EVFEPLESPV DLYILMDFSN SMSDDLDNLK KMGQNLARVL SQLTSDYTIG FGKFVDKVSV
     PQTDMRPEKL KEPWPNSDPP FSFKNVISLT EDVDEFRNKL QGERISGNLD APEGGFDAIL
     QTAVCTRDIG WRPDSTHLLV FSTESAFHYE ADGANVLAGI MSRNDERCHL DTTGTYTQYR
     TQDYPSVPTL VRLLAKHNII PIFAVTNYSY SYYEKLHTYF PVSSLGVLQE DSSNIVELLE
     EAFNRIRSNL DIRALDSPRG LRTEVTSKMF QKTRTGSFHI RRGEVGIYQV QLRALEHVDG
     THVCQLPEDQ KGNIHLKPSF SDGLKMDAGI ICDVCTCELQ KEVRSARCSF NGDFVCGQCV
     CSEGWSGQTC NCSTGSLSDI QPCLREGEDK PCSGRGECQC GHCVCYGEGR YEGQFCEYDN
     FQCPRTSGFL CNDRGRCSMG QCVCEPGWTG PSCDCPLSNA TCIDSNGGIC NGRGHCECGR
     CHCHQQSLYT DTICEINYSA IHPGLCEDLR SCVQCQAWGT GEKKGRTCEE CNFKVKMVDE
     LKRAEEVVVR CSFRDEDDDC TYSYTMEGDG APGPNSTVLV HKKKDCPPGS FWWLIPLLLL
     LLPLLALLLL LCWKYCACCK ACLALLPCCN RGHMVGFKED HYMLRENLMA SDHLDTPMLR
     SGNLKGRDVV RWKVTNNMQR PGFATHAASI NPTELVPYGL SLRLARLCTE NLLKPDTREC
     AQLRQEVEEN LNEVYRQISG VHKLQQTKFR QQPNAGKKQD HTIVDTVLMA PRSAKPALLK
     LTEKQVEQRA FHDLKVAPGY YTLTADQDAR GMVEFQEGVE LVDVRVPLFI RPEDDDEKQL
     LVEAIDVPAG TATLGRRLVN ITIIKEQARD VVSFEQPEFS VSRGDQVARI PVIRRVLDGG
     KSQVSYRTQD GTAQGNRDYI PVEGELLFQP GEAWKELQVK LLELQEVDSL LRGRQVRRFH
     VQLSNPKFGA HLGQPHSTTI IIRDPDELDR SFTSQMLSSQ PPPHGDLGAP QNPNAKAAGS
     RKIHFNWLPP SGKPMGYRVK YWIQGDSESE AHLLDSKVPS VELTNLYPYC DYEMKVCAYG
     AQGEGPYSSL VSCRTHQEVP SEPGRLAFNV VSSTVTQLSW AEPAETNGEI TAYEVCYGLV
     NDDNRPIGPM KKVLVDNPKN RMLLIENLRE SQPYRYTVKA RNGAGWGPER EAIINLATQP
     KRPMSIPIIP DIPIVDAQSG EDYDSFLMYS DDVLRSPSGS QRPSVSDDTG CGWKFEPLLG
     EELDLRRVTW RLPPELIPRL SASSGRSSDA EAPHGPPDDG GAGGKGGSLP RSATPGPPGE
     HLVNGRMDFA FPGSTNSLHR MTTTSAAAYG THLSPHVPHR VLSTSSTLTR DYNSLTRSEH
     SHSTTLPRDY STLTSVSSHD SRLTAGVPDT PTRLVFSALG PTSLRVSWQE PRCERPLQGY
     SVEYQLLNGG ELHRLNIPNP AQTSVVVEDL LPNHSYVFRV RAQSQEGWGR EREGVITIES
     QVHPQSPLCP LPGSAFTLST PSAPGPLVFT ALSPDSLQLS WERPRRPNGD IVGYLVTCEM
     AQGGGPATAF RVDGDSPESR LTVPGLSENV PYKFKVQART TEGFGPEREG IITIESQDGG
     PFPQLGSRAG LFQHPLQSEY SSITTTHTSA TEPFLVDGLT LGAQHLEAGG SLTRHVTQEF
     VSRTLTTSGT LSTHMDQQFF QT
//
ID   ITA2_HUMAN              Reviewed;        1181 AA.
AC   P17301; Q14595;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   22-NOV-2017, entry version 202.
DE   RecName: Full=Integrin alpha-2;
DE   AltName: Full=CD49 antigen-like family member B;
DE   AltName: Full=Collagen receptor;
DE   AltName: Full=Platelet membrane glycoprotein Ia;
DE            Short=GPIa;
DE   AltName: Full=VLA-2 subunit alpha;
DE   AltName: CD_antigen=CD49b;
DE   Flags: Precursor;
GN   Name=ITGA2; Synonyms=CD49B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 30-44.
RC   TISSUE=Endothelial cell;
RX   PubMed=2545729; DOI=10.1083/jcb.109.1.397;
RA   Takada Y., Hemler M.E.;
RT   "The primary structure of the VLA-2/collagen receptor alpha 2 subunit
RT   (platelet GPIa): homology to other integrins and the presence of a
RT   possible collagen-binding domain.";
RL   J. Cell Biol. 109:397-407(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-691 AND GLN-1127.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-534.
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21.
RX   PubMed=8276836;
RA   Zutter M.M., Santoro S.A., Painter A.S., Tsung Y.L., Gafford A.;
RT   "The human alpha 2 integrin gene promoter. Identification of positive
RT   and negative regulatory elements important for cell-type and
RT   developmentally restricted gene expression.";
RL   J. Biol. Chem. 269:463-469(1994).
RN   [5]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN ECHOVIRUS 1
RP   AND HUMAN ECHOVIRUS 8 CAPSID PROTEINS.
RX   PubMed=8411387;
RA   Bergelson J.M., St John N., Kawaguchi S., Chan M., Stubdal H.,
RA   Modlin J., Finberg R.W.;
RT   "Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of
RT   human VLA-2.";
RL   J. Virol. 67:6847-6852(1993).
RN   [6]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH ROTAVIRUS A VP4
RP   PROTEIN.
RX   PubMed=12941907; DOI=10.1128/JVI.77.18.9969-9978.2003;
RA   Graham K.L., Halasz P., Tan Y., Hewish M.J., Takada Y., Mackow E.R.,
RA   Robinson M.K., Coulson B.S.;
RT   "Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain
RT   via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by
RT   using VP7 during cell entry.";
RL   J. Virol. 77:9969-9978(2003).
RN   [7]
RP   INTERACTION WITH RAB21, AND MUTAGENESIS OF PHE-1159; LYS-1160;
RP   ARG-1161; LYS-1162; GLU-1164 AND LYS-1165.
RX   PubMed=16754960; DOI=10.1083/jcb.200509019;
RA   Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M.,
RA   Ivaska J.;
RT   "Small GTPase Rab21 regulates cell adhesion and controls endosomal
RT   traffic of beta1-integrins.";
RL   J. Cell Biol. 173:767-780(2006).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-343.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [9]
RP   MUTAGENESIS OF LYS-1160; ARG-1161 AND LYS-1162.
RX   PubMed=18804435; DOI=10.1016/j.devcel.2008.08.001;
RA   Pellinen T., Tuomi S., Arjonen A., Wolf M., Edgren H., Meyer H.,
RA   Grosse R., Kitzing T., Rantala J.K., Kallioniemi O., Faessler R.,
RA   Kallio M., Ivaska J.;
RT   "Integrin trafficking regulated by Rab21 is necessary for
RT   cytokinesis.";
RL   Dev. Cell 15:371-385(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-343.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-343.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 168-368.
RX   PubMed=9353312; DOI=10.1074/jbc.272.45.28512;
RA   Emsley J., King S.L., Bergelson J.M., Liddington R.C.;
RT   "Crystal structure of the I domain from integrin alpha2beta1.";
RL   J. Biol. Chem. 272:28512-28517(1997).
RN   [16]
RP   VARIANT GLU-534, AND POLYMORPHISM.
RX   PubMed=7901236; DOI=10.1172/JCI116849;
RA   Santoso S., Kalb R., Walka M., Kiefel V., Mueller-Eckhardt C.,
RA   Newman P.J.;
RT   "The human platelet alloantigens Br(a) and Brb are associated with a
RT   single amino acid polymorphism on glycoprotein Ia (integrin subunit
RT   alpha 2).";
RL   J. Clin. Invest. 92:2427-2432(1993).
RN   [17]
RP   VARIANT GLU-534.
RX   PubMed=10744142;
RA   Kroll H., Gardemann A., Fechter A., Haberbosch W., Santoso S.;
RT   "The impact of the glycoprotein Ia collagen receptor subunit A1648G
RT   gene polymorphism on coronary artery disease and acute myocardial
RT   infarction.";
RL   Thromb. Haemost. 83:392-396(2000).
RN   [18]
RP   VARIANT LEU-532.
RX   PubMed=23368983; DOI=10.1111/vox.12019;
RA   Bertrand G., Jallu V., Beranger T., Bianchi F., Casale C., Dufour V.,
RA   Chenet C., Quesne J., Martageix C., Kaplan C.;
RT   "HPA-5 typing discrepancy reveals an Ile503Leu substitution in
RT   platelet GPIa (alpha2 integrin).";
RL   Vox Sang. 105:73-76(2013).
CC   -!- FUNCTION: Integrin alpha-2/beta-1 is a receptor for laminin,
CC       collagen, collagen C-propeptides, fibronectin and E-cadherin. It
CC       recognizes the proline-hydroxylated sequence G-F-P-G-E-R in
CC       collagen. It is responsible for adhesion of platelets and other
CC       cells to collagens, modulation of collagen and collagenase gene
CC       expression, force generation and organization of newly synthesized
CC       extracellular matrix.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGA2:ITGB1 acts as a
CC       receptor for human rotavirus A (PubMed:12941907). Integrin
CC       ITGA2:ITGB1 acts as a receptor for human echoviruses 1 and 8
CC       (PubMed:8411387). {ECO:0000269|PubMed:12941907,
CC       ECO:0000269|PubMed:8411387}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-2
CC       associates with beta-1. Interacts with HPS5 and RAB21.
CC       {ECO:0000269|PubMed:16754960}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA2:ITGB1 interacts (via
CC       ITAG2 I-domain) with rotavirus A VP4 protein.
CC       {ECO:0000269|PubMed:12941907}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGA2:ITGB1 interacts with
CC       human echoviruses 1 and 8 capsid proteins.
CC       {ECO:0000269|PubMed:8411387}.
CC   -!- INTERACTION:
CC       P04512:- (xeno); NbExp=3; IntAct=EBI-702960, EBI-15711650;
CC       P84092:Ap2m1 (xeno); NbExp=2; IntAct=EBI-702960, EBI-297693;
CC       P05556:ITGB1; NbExp=3; IntAct=EBI-702960, EBI-703066;
CC       P35968:KDR; NbExp=2; IntAct=EBI-702960, EBI-1005487;
CC       P35282:Rab21 (xeno); NbExp=7; IntAct=EBI-702960, EBI-1993555;
CC       Q9H0F6:SHARPIN; NbExp=5; IntAct=EBI-702960, EBI-3942966;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- POLYMORPHISM: Position 534 is associated with platelet-specific
CC       alloantigen HPA-5 (Br). HPA-5A/Br(a) has Lys-534 and HPA-5B/Br(b)
CC       has Glu-534. HPA-5B is involved in neonatal alloimmune
CC       thrombocytopenia (NAIT or NATP). The Lys-534-Glu polymorphism may
CC       play a role in coronary artery disease (CAD).
CC       {ECO:0000269|PubMed:7901236}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/itga2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X17033; CAA34894.1; -; mRNA.
DR   EMBL; AF512556; AAM34795.1; -; Genomic_DNA.
DR   EMBL; L24121; AAA16619.2; -; Genomic_DNA.
DR   CCDS; CCDS3957.1; -.
DR   PIR; A33998; A33998.
DR   RefSeq; NP_002194.2; NM_002203.3.
DR   UniGene; Hs.482077; -.
DR   PDB; 1AOX; X-ray; 2.10 A; A/B=169-367.
DR   PDB; 1DZI; X-ray; 2.10 A; A=172-355.
DR   PDB; 1PQB; Model; -; A/B=169-366.
DR   PDB; 1V7P; X-ray; 1.90 A; C=167-366.
DR   PDB; 4BJ3; X-ray; 3.04 A; A/B=171-368.
DR   PDB; 5HJ2; X-ray; 2.15 A; A/B/C/D/E/F=170-366.
DR   PDB; 5THP; X-ray; 3.01 A; C/F/I/L/O/R=170-366.
DR   PDBsum; 1AOX; -.
DR   PDBsum; 1DZI; -.
DR   PDBsum; 1PQB; -.
DR   PDBsum; 1V7P; -.
DR   PDBsum; 4BJ3; -.
DR   PDBsum; 5HJ2; -.
DR   PDBsum; 5THP; -.
DR   ProteinModelPortal; P17301; -.
DR   SMR; P17301; -.
DR   BioGrid; 109880; 31.
DR   CORUM; P17301; -.
DR   DIP; DIP-67N; -.
DR   IntAct; P17301; 20.
DR   MINT; MINT-5004079; -.
DR   STRING; 9606.ENSP00000296585; -.
DR   BindingDB; P17301; -.
DR   ChEMBL; CHEMBL4998; -.
DR   GuidetoPHARMACOLOGY; 2441; -.
DR   iPTMnet; P17301; -.
DR   PhosphoSitePlus; P17301; -.
DR   SwissPalm; P17301; -.
DR   BioMuta; ITGA2; -.
DR   DMDM; 124942; -.
DR   EPD; P17301; -.
DR   MaxQB; P17301; -.
DR   PaxDb; P17301; -.
DR   PeptideAtlas; P17301; -.
DR   PRIDE; P17301; -.
DR   DNASU; 3673; -.
DR   Ensembl; ENST00000296585; ENSP00000296585; ENSG00000164171.
DR   GeneID; 3673; -.
DR   KEGG; hsa:3673; -.
DR   UCSC; uc003joy.3; human.
DR   CTD; 3673; -.
DR   DisGeNET; 3673; -.
DR   EuPathDB; HostDB:ENSG00000164171.10; -.
DR   GeneCards; ITGA2; -.
DR   H-InvDB; HIX0032121; -.
DR   HGNC; HGNC:6137; ITGA2.
DR   HPA; CAB017690; -.
DR   HPA; HPA060991; -.
DR   HPA; HPA063556; -.
DR   MalaCards; ITGA2; -.
DR   MIM; 192974; gene+phenotype.
DR   neXtProt; NX_P17301; -.
DR   Orphanet; 853; Fetal and neonatal alloimmune thrombocytopenia.
DR   PharmGKB; PA204; -.
DR   eggNOG; ENOG410IPB9; Eukaryota.
DR   eggNOG; ENOG4110534; LUCA.
DR   HOGENOM; HOG000059610; -.
DR   HOVERGEN; HBG006185; -.
DR   InParanoid; P17301; -.
DR   KO; K06481; -.
DR   OrthoDB; EOG091G00TK; -.
DR   PhylomeDB; P17301; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-75892; Platelet Adhesion to exposed collagen.
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   SignaLink; P17301; -.
DR   SIGNOR; P17301; -.
DR   ChiTaRS; ITGA2; human.
DR   EvolutionaryTrace; P17301; -.
DR   GeneWiki; CD49b; -.
DR   GenomeRNAi; 3673; -.
DR   PRO; PR:P17301; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164171; -.
DR   CleanEx; HS_ITGA2; -.
DR   ExpressionAtlas; P17301; baseline and differential.
DR   Genevisible; P17301; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0045178; C:basal part of cell; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034666; C:integrin alpha2-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0001540; F:amyloid-beta binding; ISS:ARUK-UCL.
DR   GO; GO:0005518; F:collagen binding; IMP:UniProtKB.
DR   GO; GO:0098639; F:collagen binding involved in cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0038064; F:collagen receptor activity; IMP:UniProtKB.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; TAS:ARUK-UCL.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0043236; F:laminin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032403; F:protein complex binding; IPI:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IMP:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0038065; P:collagen-activated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0045184; P:establishment of protein localization; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0048041; P:focal adhesion assembly; IEA:Ensembl.
DR   GO; GO:0070365; P:hepatocyte differentiation; IEA:Ensembl.
DR   GO; GO:0006971; P:hypotonic response; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0030879; P:mammary gland development; IEA:Ensembl.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0010694; P:positive regulation of alkaline phosphatase activity; IEA:Ensembl.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0031346; P:positive regulation of cell projection organization; IEA:Ensembl.
DR   GO; GO:0033343; P:positive regulation of collagen binding; IEA:Ensembl.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl.
DR   GO; GO:0060100; P:positive regulation of phagocytosis, engulfment; IEA:Ensembl.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; IEA:Ensembl.
DR   GO; GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0033591; P:response to L-ascorbic acid; IEA:Ensembl.
DR   GO; GO:0014850; P:response to muscle activity; IEA:Ensembl.
DR   GO; GO:0071107; P:response to parathyroid hormone; IEA:Ensembl.
DR   GO; GO:0043589; P:skin morphogenesis; IEA:Ensembl.
DR   GO; GO:0006929; P:substrate-dependent cell migration; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Integrin;
KW   Magnesium; Membrane; Metal-binding; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000269|PubMed:2545729}.
FT   CHAIN        30   1181       Integrin alpha-2.
FT                                /FTId=PRO_0000016233.
FT   TOPO_DOM     30   1132       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1133   1154       Helical. {ECO:0000255}.
FT   TOPO_DOM   1155   1181       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       34     92       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      101    161       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      188    365       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      366    420       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      423    475       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      477    539       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      540    598       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      602    664       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     499    507       {ECO:0000255}.
FT   CA_BIND     563    571       {ECO:0000255}.
FT   CA_BIND     627    635       {ECO:0000255}.
FT   REGION     1155   1161       Interaction with HPS5.
FT   MOTIF      1157   1161       GFFKR motif.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    112    112       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    343    343       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16263699,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    432    432       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    460    460       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    475    475       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    699    699       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1057   1057       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1074   1074       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1081   1081       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     83     92       {ECO:0000250}.
FT   DISULFID    680    737       {ECO:0000250}.
FT   DISULFID    789    795       {ECO:0000250}.
FT   DISULFID    865    876       {ECO:0000250}.
FT   DISULFID   1019   1050       {ECO:0000250}.
FT   DISULFID   1055   1060       {ECO:0000250}.
FT   VARIANT     532    532       I -> L. {ECO:0000269|PubMed:23368983}.
FT                                /FTId=VAR_076939.
FT   VARIANT     534    534       K -> E (in alloantigen HPA-5B;
FT                                dbSNP:rs1801106).
FT                                {ECO:0000269|PubMed:10744142,
FT                                ECO:0000269|PubMed:15372022,
FT                                ECO:0000269|PubMed:7901236}.
FT                                /FTId=VAR_003977.
FT   VARIANT     691    691       N -> K (in dbSNP:rs3212557).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_029146.
FT   VARIANT     927    927       N -> S (in dbSNP:rs2287870).
FT                                /FTId=VAR_021855.
FT   VARIANT    1127   1127       K -> Q (in dbSNP:rs3212645).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020036.
FT   MUTAGEN    1159   1159       F->A: No significant reduction of RAB21-
FT                                binding by co-immunoprecipitation assay;
FT                                when associated with A-1160 and A-1162.
FT                                {ECO:0000269|PubMed:16754960}.
FT   MUTAGEN    1160   1160       K->A: No effect on RAB21-binding.
FT                                Significant reduction of RAB21-binding;
FT                                when associated with A-1161. Shows
FT                                defective cytokinesis on collagen, but
FT                                not on fibronectin; when associated with
FT                                A-1161. {ECO:0000269|PubMed:16754960,
FT                                ECO:0000269|PubMed:18804435}.
FT   MUTAGEN    1161   1161       R->A: Significant reduction of RAB21-
FT                                binding; when associated with A-1160.
FT                                Shows defective cytokinesis on collagen,
FT                                but not on fibronectin; when associated
FT                                with A-1160.
FT                                {ECO:0000269|PubMed:16754960,
FT                                ECO:0000269|PubMed:18804435}.
FT   MUTAGEN    1162   1162       K->A: No significant reduction of RAB21-
FT                                binding by co-immunoprecipitation assay;
FT                                when associated with A-1159 and A-1160.
FT                                {ECO:0000269|PubMed:16754960,
FT                                ECO:0000269|PubMed:18804435}.
FT   MUTAGEN    1162   1162       K->P: Markedly weakens RAB21-binding.
FT                                Shows defective cytokinesis on collagen,
FT                                but not on fibronectin.
FT                                {ECO:0000269|PubMed:16754960,
FT                                ECO:0000269|PubMed:18804435}.
FT   MUTAGEN    1164   1164       E->A: Significant reduction of RAB21-
FT                                binding; when associated with A-1160; A-
FT                                1161 and A-1165.
FT                                {ECO:0000269|PubMed:16754960}.
FT   MUTAGEN    1165   1165       K->A: Significant reduction of RAB21-
FT                                binding; when associated with A-1160; A-
FT                                1161 and A-1164.
FT                                {ECO:0000269|PubMed:16754960}.
FT   CONFLICT     17     17       L -> V (in Ref. 3; AAA16619).
FT                                {ECO:0000305}.
FT   STRAND      173    180       {ECO:0000244|PDB:1V7P}.
FT   HELIX       188    200       {ECO:0000244|PDB:1V7P}.
FT   STRAND      208    224       {ECO:0000244|PDB:1V7P}.
FT   TURN        226    228       {ECO:0000244|PDB:1V7P}.
FT   HELIX       232    241       {ECO:0000244|PDB:1V7P}.
FT   HELIX       252    262       {ECO:0000244|PDB:1V7P}.
FT   HELIX       266    268       {ECO:0000244|PDB:1V7P}.
FT   STRAND      274    284       {ECO:0000244|PDB:1V7P}.
FT   HELIX       289    291       {ECO:0000244|PDB:1V7P}.
FT   HELIX       292    301       {ECO:0000244|PDB:1V7P}.
FT   STRAND      304    311       {ECO:0000244|PDB:1V7P}.
FT   HELIX       313    317       {ECO:0000244|PDB:1V7P}.
FT   HELIX       323    332       {ECO:0000244|PDB:1V7P}.
FT   HELIX       337    340       {ECO:0000244|PDB:1V7P}.
FT   STRAND      341    347       {ECO:0000244|PDB:1V7P}.
FT   HELIX       348    353       {ECO:0000244|PDB:1V7P}.
FT   HELIX       354    362       {ECO:0000244|PDB:1V7P}.
SQ   SEQUENCE   1181 AA;  129295 MW;  7E1B7ED968A94070 CRC64;
     MGPERTGAAP LPLLLVLALS QGILNCCLAY NVGLPEAKIF SGPSSEQFGY AVQQFINPKG
     NWLLVGSPWS GFPENRMGDV YKCPVDLSTA TCEKLNLQTS TSIPNVTEMK TNMSLGLILT
     RNMGTGGFLT CGPLWAQQCG NQYYTTGVCS DISPDFQLSA SFSPATQPCP SLIDVVVVCD
     ESNSIYPWDA VKNFLEKFVQ GLDIGPTKTQ VGLIQYANNP RVVFNLNTYK TKEEMIVATS
     QTSQYGGDLT NTFGAIQYAR KYAYSAASGG RRSATKVMVV VTDGESHDGS MLKAVIDQCN
     HDNILRFGIA VLGYLNRNAL DTKNLIKEIK AIASIPTERY FFNVSDEAAL LEKAGTLGEQ
     IFSIEGTVQG GDNFQMEMSQ VGFSADYSSQ NDILMLGAVG AFGWSGTIVQ KTSHGHLIFP
     KQAFDQILQD RNHSSYLGYS VAAISTGEST HFVAGAPRAN YTGQIVLYSV NENGNITVIQ
     AHRGDQIGSY FGSVLCSVDV DKDTITDVLL VGAPMYMSDL KKEEGRVYLF TIKKGILGQH
     QFLEGPEGIE NTRFGSAIAA LSDINMDGFN DVIVGSPLEN QNSGAVYIYN GHQGTIRTKY
     SQKILGSDGA FRSHLQYFGR SLDGYGDLNG DSITDVSIGA FGQVVQLWSQ SIADVAIEAS
     FTPEKITLVN KNAQIILKLC FSAKFRPTKQ NNQVAIVYNI TLDADGFSSR VTSRGLFKEN
     NERCLQKNMV VNQAQSCPEH IIYIQEPSDV VNSLDLRVDI SLENPGTSPA LEAYSETAKV
     FSIPFHKDCG EDGLCISDLV LDVRQIPAAQ EQPFIVSNQN KRLTFSVTLK NKRESAYNTG
     IVVDFSENLF FASFSLPVDG TEVTCQVAAS QKSVACDVGY PALKREQQVT FTINFDFNLQ
     NLQNQASLSF QALSESQEEN KADNLVNLKI PLLYDAEIHL TRSTNINFYE ISSDGNVPSI
     VHSFEDVGPK FIFSLKVTTG SVPVSMATVI IHIPQYTKEK NPLMYLTGVQ TDKAGDISCN
     ADINPLKIGQ TSSSVSFKSE NFRHTKELNC RTASCSNVTC WLKDVHMKGE YFVNVTTRIW
     NGTFASSTFQ TVQLTAAAEI NTYNPEIYVI EDNTVTIPLM IMKPDEKAEV PTGVIIGSII
     AGILLLLALV AILWKLGFFK RKYEKMTKNP DEIDETTELS S
//
ID   ITB5_HUMAN              Reviewed;         799 AA.
AC   P18084; B0LPF8; B2RD70;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   22-NOV-2017, entry version 190.
DE   RecName: Full=Integrin beta-5;
DE   Flags: Precursor;
GN   Name=ITGB5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymic epithelium;
RX   PubMed=2328726;
RA   Ramaswamy H., Hemler M.E.;
RT   "Cloning, primary structure and properties of a novel human integrin
RT   beta subunit.";
RL   EMBO J. 9:1561-1568(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2371275; DOI=10.1073/pnas.87.14.5354;
RA   Suzuki S., Huang Z.S., Tanihara H.;
RT   "Cloning of an integrin beta subunit exhibiting high homology with
RT   integrin beta 3 subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:5354-5358(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2211615;
RA   McLean J.W., Vestal D.J., Cheresh D.A., Bodary S.C.;
RT   "cDNA sequence of the human integrin beta 5 subunit.";
RL   J. Biol. Chem. 265:17126-17131(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-431.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH MYO10.
RX   PubMed=15156152; DOI=10.1038/ncb1136;
RA   Zhang H., Berg J.S., Li Z., Wang Y., Lang P., Sousa A.D., Bhaskar A.,
RA   Cheney R.E., Stromblad S.;
RT   "Myosin-X provides a motor-based link between integrins and the
RT   cytoskeleton.";
RL   Nat. Cell Biol. 6:523-531(2004).
RN   [8]
RP   INTERACTION WITH NOV.
RX   PubMed=15611078; DOI=10.1074/jbc.M404903200;
RA   Lin C.G., Chen C.C., Leu S.J., Grzeszkiewicz T.M., Lau L.F.;
RT   "Integrin-dependent functions of the angiogenic inducer NOV (CCN3):
RT   implication in wound healing.";
RL   J. Biol. Chem. 280:8229-8237(2005).
RN   [9]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH ADENOVIRUS TYPE C
RP   PENTON PROTEIN.
RX   PubMed=20615244; DOI=10.1186/1743-422X-7-148;
RA   Lyle C., McCormick F.;
RT   "Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-
RT   negative cells.";
RL   Virol. J. 7:148-148(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-770, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Integrin alpha-V/beta-5 (ITGAV:ITGB5) is a receptor for
CC       fibronectin. It recognizes the sequence R-G-D in its ligand.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 acts as a
CC       receptor for adenovirus type C. {ECO:0000269|PubMed:20615244}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-5
CC       (ITGB5) associates with alpha-V (ITGAV). Interacts with MYO10
CC       (PubMed:15156152). Interacts with DAB2. Integrin ITGAV:ITGB5
CC       interacts with FBLN5 (via N-terminus) (By similarity). ITGAV:ITGB5
CC       interacts with NOV (PubMed:15611078).
CC       {ECO:0000250|UniProtKB:O70309, ECO:0000269|PubMed:15156152,
CC       ECO:0000269|PubMed:15611078}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB5 interacts with
CC       adenovirus type C penton protein. {ECO:0000269|PubMed:20615244}.
CC   -!- INTERACTION:
CC       Q9BY76:ANGPTL4; NbExp=3; IntAct=EBI-1223434, EBI-2968146;
CC       Q7Z6J6:FRMD5; NbExp=3; IntAct=EBI-1223434, EBI-727282;
CC       P06756:ITGAV; NbExp=2; IntAct=EBI-1223434, EBI-298282;
CC       P60410:KRTAP10-8; NbExp=4; IntAct=EBI-1223434, EBI-10171774;
CC       Q9BYR7:KRTAP3-2; NbExp=4; IntAct=EBI-1223434, EBI-751260;
CC       Q9HD67:MYO10; NbExp=2; IntAct=EBI-1223434, EBI-307061;
CC       P97479:Myo7a (xeno); NbExp=8; IntAct=EBI-1223434, EBI-1149557;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X53002; CAA37188.1; -; mRNA.
DR   EMBL; M35011; AAA52707.1; -; mRNA.
DR   EMBL; J05633; AAA59183.1; -; mRNA.
DR   EMBL; AK315429; BAG37817.1; -; mRNA.
DR   EMBL; EU332848; ABY87537.1; -; Genomic_DNA.
DR   EMBL; BC006541; AAH06541.1; -; mRNA.
DR   CCDS; CCDS3030.1; -.
DR   PIR; A38308; A38308.
DR   RefSeq; NP_002204.2; NM_002213.4.
DR   UniGene; Hs.13155; -.
DR   UniGene; Hs.536663; -.
DR   ProteinModelPortal; P18084; -.
DR   SMR; P18084; -.
DR   BioGrid; 109899; 40.
DR   CORUM; P18084; -.
DR   ELM; P18084; -.
DR   IntAct; P18084; 37.
DR   MINT; MINT-258539; -.
DR   STRING; 9606.ENSP00000296181; -.
DR   BindingDB; P18084; -.
DR   ChEMBL; CHEMBL2096675; -.
DR   iPTMnet; P18084; -.
DR   PhosphoSitePlus; P18084; -.
DR   BioMuta; ITGB5; -.
DR   DMDM; 124970; -.
DR   EPD; P18084; -.
DR   MaxQB; P18084; -.
DR   PaxDb; P18084; -.
DR   PeptideAtlas; P18084; -.
DR   PRIDE; P18084; -.
DR   DNASU; 3693; -.
DR   Ensembl; ENST00000296181; ENSP00000296181; ENSG00000082781.
DR   GeneID; 3693; -.
DR   KEGG; hsa:3693; -.
DR   UCSC; uc003eho.4; human.
DR   CTD; 3693; -.
DR   DisGeNET; 3693; -.
DR   EuPathDB; HostDB:ENSG00000082781.11; -.
DR   GeneCards; ITGB5; -.
DR   HGNC; HGNC:6160; ITGB5.
DR   HPA; CAB022050; -.
DR   HPA; HPA001820; -.
DR   MIM; 147561; gene.
DR   neXtProt; NX_P18084; -.
DR   OpenTargets; ENSG00000082781; -.
DR   PharmGKB; PA29959; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P18084; -.
DR   KO; K06588; -.
DR   OMA; PDACSTK; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P18084; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   SignaLink; P18084; -.
DR   SIGNOR; P18084; -.
DR   ChiTaRS; ITGB5; human.
DR   GeneWiki; Integrin,_beta_5; -.
DR   GenomeRNAi; 3693; -.
DR   PRO; PR:P18084; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000082781; -.
DR   CleanEx; HS_ITGB5; -.
DR   ExpressionAtlas; P18084; baseline and differential.
DR   Genevisible; P18084; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034684; C:integrin alphav-beta5 complex; IDA:UniProtKB.
DR   GO; GO:0045335; C:phagocytic vesicle; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0035987; P:endodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0090136; P:epithelial cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006936; P:muscle contraction; TAS:Reactome.
DR   GO; GO:0043149; P:stress fiber assembly; IMP:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR027067; Integrin_beta-5.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF26; PTHR10082:SF26; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS00243; INTEGRIN_BETA; 2.
PE   1: Evidence at protein level;
KW   Cell adhesion; Complete proteome; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Integrin;
KW   Membrane; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    799       Integrin beta-5.
FT                                /FTId=PRO_0000016348.
FT   TOPO_DOM     24    719       Extracellular. {ECO:0000255}.
FT   TRANSMEM    720    742       Helical. {ECO:0000255}.
FT   TOPO_DOM    743    799       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       27     76       PSI.
FT   DOMAIN      136    378       VWFA.
FT   REPEAT      465    512       I.
FT   REPEAT      513    554       II.
FT   REPEAT      555    593       III.
FT   REPEAT      594    630       IV.
FT   REGION      465    630       Cysteine-rich tandem repeats.
FT   MOD_RES     770    770       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    347    347       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    460    460       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    477    477       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    505    505       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    552    552       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    586    586       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    654    654       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    705    705       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     28    463       {ECO:0000250}.
FT   DISULFID     36     46       {ECO:0000250}.
FT   DISULFID     39     75       {ECO:0000250}.
FT   DISULFID     49     64       {ECO:0000250}.
FT   DISULFID    202    211       {ECO:0000250}.
FT   DISULFID    259    300       {ECO:0000250}.
FT   DISULFID    401    413       {ECO:0000250}.
FT   DISULFID    433    682       {ECO:0000250}.
FT   DISULFID    461    465       {ECO:0000250}.
FT   DISULFID    476    487       {ECO:0000250}.
FT   DISULFID    484    522       {ECO:0000250}.
FT   DISULFID    489    498       {ECO:0000250}.
FT   DISULFID    500    513       {ECO:0000250}.
FT   DISULFID    528    533       {ECO:0000250}.
FT   DISULFID    530    563       {ECO:0000250}.
FT   DISULFID    535    548       {ECO:0000250}.
FT   DISULFID    550    555       {ECO:0000250}.
FT   DISULFID    569    574       {ECO:0000250}.
FT   DISULFID    571    602       {ECO:0000250}.
FT   DISULFID    576    585       {ECO:0000250}.
FT   DISULFID    587    594       {ECO:0000250}.
FT   DISULFID    608    613       {ECO:0000250}.
FT   DISULFID    610    657       {ECO:0000250}.
FT   DISULFID    615    625       {ECO:0000250}.
FT   DISULFID    628    631       {ECO:0000250}.
FT   DISULFID    635    644       {ECO:0000250}.
FT   DISULFID    641    714       {ECO:0000250}.
FT   DISULFID    661    690       {ECO:0000250}.
FT   VARIANT     428    428       L -> V (in dbSNP:rs2291090).
FT                                /FTId=VAR_024290.
FT   VARIANT     431    431       R -> Q (in dbSNP:rs2291089).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_049634.
FT   VARIANT     477    477       N -> S (in dbSNP:rs2291087).
FT                                /FTId=VAR_049635.
FT   CONFLICT    193    193       T -> A (in Ref. 2; AAA52707).
FT                                {ECO:0000305}.
FT   CONFLICT    645    645       L -> P (in Ref. 3; AAA59183).
FT                                {ECO:0000305}.
FT   CONFLICT    790    792       Missing (in Ref. 2; AAA52707).
FT                                {ECO:0000305}.
SQ   SEQUENCE   799 AA;  88054 MW;  D7E4727CA310512B CRC64;
     MPRAPAPLYA CLLGLCALLP RLAGLNICTS GSATSCEECL LIHPKCAWCS KEDFGSPRSI
     TSRCDLRANL VKNGCGGEIE SPASSFHVLR SLPLSSKGSG SAGWDVIQMT PQEIAVNLRP
     GDKTTFQLQV RQVEDYPVDL YYLMDLSLSM KDDLDNIRSL GTKLAEEMRK LTSNFRLGFG
     SFVDKDISPF SYTAPRYQTN PCIGYKLFPN CVPSFGFRHL LPLTDRVDSF NEEVRKQRVS
     RNRDAPEGGF DAVLQAAVCK EKIGWRKDAL HLLVFTTDDV PHIALDGKLG GLVQPHDGQC
     HLNEANEYTA SNQMDYPSLA LLGEKLAENN INLIFAVTKN HYMLYKNFTA LIPGTTVEIL
     DGDSKNIIQL IINAYNSIRS KVELSVWDQP EDLNLFFTAT CQDGVSYPGQ RKCEGLKIGD
     TASFEVSLEA RSCPSRHTEH VFALRPVGFR DSLEVGVTYN CTCGCSVGLE PNSARCNGSG
     TYVCGLCECS PGYLGTRCEC QDGENQSVYQ NLCREAEGKP LCSGRGDCSC NQCSCFESEF
     GKIYGPFCEC DNFSCARNKG VLCSGHGECH CGECKCHAGY IGDNCNCSTD ISTCRGRDGQ
     ICSERGHCLC GQCQCTEPGA FGEMCEKCPT CPDACSTKRD CVECLLLHSG KPDNQTCHSL
     CRDEVITWVD TIVKDDQEAV LCFYKTAKDC VMMFTYVELP SGKSNLTVLR EPECGNTPNA
     MTILLAVVGS ILLVGLALLA IWKLLVTIHD RREFAKFQSE RSRARYEMAS NPLYRKPIST
     HTVDFTFNKF NKSYNGTVD
//
ID   ITB6_HUMAN              Reviewed;         788 AA.
AC   P18564; B2R9W5; C9JA97; Q0VA95; Q16500; Q53RG5; Q53RR6;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   22-NOV-2017, entry version 185.
DE   RecName: Full=Integrin beta-6;
DE   Flags: Precursor;
GN   Name=ITGB6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=2365683;
RA   Sheppard D., Rozzo C., Starr L., Quaranta V., Erle D.J., Pytela R.;
RT   "Complete amino acid sequence of a novel integrin beta subunit (beta
RT   6) identified in epithelial cells using the polymerase chain
RT   reaction.";
RL   J. Biol. Chem. 265:11502-11507(1990).
RN   [2]
RP   SEQUENCE REVISION TO 18-24; 158; 642 AND 719.
RA   Askins J.;
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 116-197.
RX   PubMed=1382574; DOI=10.1093/intimm/4.9.1031;
RA   Jiang W.-M., Jenkins D., Yuan Q., Leung E., Choo K.H., Watson J.D.,
RA   Krissansen G.W.;
RT   "The gene organization of the human beta 7 subunit, the common beta
RT   subunit of the leukocyte integrins HML-1 and LPAM-1.";
RL   Int. Immunol. 4:1031-1040(1992).
RN   [8]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH COXSACKIEVIRUS B1
RP   CAPSID PROTEINS.
RX   PubMed=9426447; DOI=10.1006/viro.1997.8831;
RA   Agrez M.V., Shafren D.R., Gu X., Cox K., Sheppard D., Barry R.D.;
RT   "Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of
RT   human colon cancer cells.";
RL   Virology 239:71-77(1997).
RN   [9]
RP   INTERACTION WITH FLNB.
RC   TISSUE=Keratinocyte, and Skeletal muscle;
RX   PubMed=11807098; DOI=10.1083/jcb.200103037;
RA   van Der Flier A., Kuikman I., Kramer D., Geerts D., Kreft M.,
RA   Takafuta T., Shapiro S.S., Sonnenberg A.;
RT   "Different splice variants of filamin-B affect myogenesis, subcellular
RT   distribution, and determine binding to integrin (beta) subunits.";
RL   J. Cell Biol. 156:361-376(2002).
RN   [10]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH COXSACKIEVIRUS A9
RP   CAPSID PROTEINS.
RX   PubMed=15194773; DOI=10.1128/JVI.78.13.6967-6973.2004;
RA   Williams C.H., Kajander T., Hyypia T., Jackson T., Sheppard D.,
RA   Stanway G.;
RT   "Integrin alpha v beta 6 is an RGD-dependent receptor for
RT   coxsackievirus A9.";
RL   J. Virol. 78:6967-6973(2004).
RN   [11]
RP   INTERACTION WITH HAX1, AND FUNCTION.
RX   PubMed=17545607; DOI=10.1158/0008-5472.CAN-07-0318;
RA   Ramsay A.G., Keppler M.D., Jazayeri M., Thomas G.J., Parsons M.,
RA   Violette S., Weinreb P., Hart I.R., Marshall J.F.;
RT   "HS1-associated protein X-1 regulates carcinoma cell migration and
RT   invasion via clathrin-mediated endocytosis of integrin alphavbeta6.";
RL   Cancer Res. 67:5275-5284(2007).
RN   [12]
RP   FUNCTION, INTERACTION WITH FBN1, AND SUBCELLULAR LOCATION.
RX   PubMed=17158881; DOI=10.1074/jbc.M607008200;
RA   Jovanovic J., Takagi J., Choulier L., Abrescia N.G., Stuart D.I.,
RA   van der Merwe P.A., Mardon H.J., Handford P.A.;
RT   "alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative
RT   studies of molecular determinants underlying integrin-rgd affinity and
RT   specificity.";
RL   J. Biol. Chem. 282:6743-6751(2007).
RN   [13]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HERPES
RP   SIMPLES-1/HHV-1 GH:GL PROTEINS.
RX   PubMed=24367260; DOI=10.1371/journal.ppat.1003806;
RA   Gianni T., Salvioli S., Chesnokova L.S., Hutt-Fletcher L.M.,
RA   Campadelli-Fiume G.;
RT   "alphavbeta6- and alphavbeta8-integrins serve as interchangeable
RT   receptors for HSV gH/gL to promote endocytosis and activation of
RT   membrane fusion.";
RL   PLoS Pathog. 9:E1003806-E1003806(2013).
RN   [14]
RP   INVOLVEMENT IN AI1H, AND VARIANT AI1H THR-196.
RX   PubMed=24319098; DOI=10.1093/hmg/ddt616;
RA   Poulter J.A., Brookes S.J., Shore R.C., Smith C.E., Abi Farraj L.,
RA   Kirkham J., Inglehearn C.F., Mighell A.J.;
RT   "A missense mutation in ITGB6 causes pitted hypomineralized
RT   amelogenesis imperfecta.";
RL   Hum. Mol. Genet. 23:2189-2197(2014).
RN   [15]
RP   INVOLVEMENT IN AI1H, AND VARIANTS AI1H THR-143 AND GLN-275.
RX   PubMed=24305999; DOI=10.1093/hmg/ddt611;
RA   Wang S.K., Choi M., Richardson A.S., Reid B.M., Lin B.P., Wang S.J.,
RA   Kim J.W., Simmer J.P., Hu J.C.;
RT   "ITGB6 loss-of-function mutations cause autosomal recessive
RT   amelogenesis imperfecta.";
RL   Hum. Mol. Genet. 23:2157-2163(2014).
CC   -!- FUNCTION: Integrin alpha-V/beta-6 is a receptor for fibronectin
CC       and cytotactin. It recognizes the sequence R-G-D in its ligands.
CC       Internalisation of integrin alpha-V/beta-6 via clathrin-mediated
CC       endocytosis promotes carcinoma cell invasion. ITGAV:ITGB6 acts as
CC       a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent
CC       cell adhesion to FBN1 (PubMed:17158881).
CC       {ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:17545607}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB6 acts as a
CC       receptor for coxsackievirus A9 and coxsackievirus B1
CC       (PubMed:9426447, PubMed:15194773). Integrin ITGAV:ITGB6 acts as a
CC       receptor for herpes simplex virus-1/HHV-1 (PubMed:24367260).
CC       {ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:24367260,
CC       ECO:0000269|PubMed:9426447}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-6
CC       associates with alpha-V. Interacts with FLNB. Interacts with HAX1.
CC       ITGAV:ITGB6 interacts with FBN1 (PubMed:17158881).
CC       {ECO:0000269|PubMed:11807098, ECO:0000269|PubMed:17158881,
CC       ECO:0000269|PubMed:17545607}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB6 interacts with
CC       coxsackievirus A9, coxsackievirus B1 capsid proteins
CC       (PubMed:9426447, PubMed:15194773). {ECO:0000269|PubMed:15194773,
CC       ECO:0000269|PubMed:9426447}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB6 interacts with
CC       herpes simplex virus-1/HHV-1 gH:gL proteins.
CC       {ECO:0000269|PubMed:24367260}.
CC   -!- INTERACTION:
CC       P06756:ITGAV; NbExp=7; IntAct=EBI-2568070, EBI-298282;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:17158881}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P18564-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P18564-2; Sequence=VSP_055189;
CC         Note=No experimental confirmation available. Gene prediction
CC         confirmed by EST data.;
CC   -!- DISEASE: Amelogenesis imperfecta 1H (AI1H) [MIM:616221]: A
CC       disorder characterized by defective enamel formation, resulting in
CC       hypoplastic and hypomineralized tooth enamel that may be rough,
CC       pitted, and/or discolored. {ECO:0000269|PubMed:24305999,
CC       ECO:0000269|PubMed:24319098}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M35198; AAA36122.2; -; mRNA.
DR   EMBL; AC092153; AAX93093.1; -; Genomic_DNA.
DR   EMBL; AK313944; BAG36662.1; -; mRNA.
DR   EMBL; AC080166; AAY24053.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11390.1; -; Genomic_DNA.
DR   EMBL; BC121178; AAI21179.1; -; mRNA.
DR   EMBL; S49380; AAB23690.1; -; Genomic_DNA.
DR   CCDS; CCDS2212.1; -. [P18564-1]
DR   CCDS; CCDS63040.1; -. [P18564-2]
DR   PIR; A37057; A37057.
DR   RefSeq; NP_000879.2; NM_000888.4. [P18564-1]
DR   RefSeq; NP_001269282.1; NM_001282353.1. [P18564-1]
DR   RefSeq; NP_001269284.1; NM_001282355.1. [P18564-2]
DR   RefSeq; NP_001269317.1; NM_001282388.1.
DR   UniGene; Hs.470399; -.
DR   PDB; 1LH9; Model; -; A=76-546.
DR   PDB; 4UM8; X-ray; 2.85 A; B/D=1-788.
DR   PDB; 4UM9; X-ray; 2.50 A; B/D=18-491.
DR   PDB; 5FFG; X-ray; 2.25 A; B=128-378.
DR   PDB; 5FFO; X-ray; 3.49 A; B/F=128-378.
DR   PDB; 5NEM; EM; 3.10 A; B=22-491.
DR   PDB; 5NER; EM; 3.10 A; B=22-491.
DR   PDB; 5NET; EM; 3.10 A; B=22-491.
DR   PDB; 5NEU; EM; 3.10 A; B=22-491.
DR   PDBsum; 1LH9; -.
DR   PDBsum; 4UM8; -.
DR   PDBsum; 4UM9; -.
DR   PDBsum; 5FFG; -.
DR   PDBsum; 5FFO; -.
DR   PDBsum; 5NEM; -.
DR   PDBsum; 5NER; -.
DR   PDBsum; 5NET; -.
DR   PDBsum; 5NEU; -.
DR   ProteinModelPortal; P18564; -.
DR   SMR; P18564; -.
DR   BioGrid; 109900; 5.
DR   CORUM; P18564; -.
DR   DIP; DIP-59187N; -.
DR   ELM; P18564; -.
DR   IntAct; P18564; 1.
DR   STRING; 9606.ENSP00000283249; -.
DR   BindingDB; P18564; -.
DR   ChEMBL; CHEMBL2111416; -.
DR   iPTMnet; P18564; -.
DR   PhosphoSitePlus; P18564; -.
DR   DMDM; 13432176; -.
DR   EPD; P18564; -.
DR   MaxQB; P18564; -.
DR   PaxDb; P18564; -.
DR   PeptideAtlas; P18564; -.
DR   PRIDE; P18564; -.
DR   DNASU; 3694; -.
DR   Ensembl; ENST00000283249; ENSP00000283249; ENSG00000115221. [P18564-1]
DR   Ensembl; ENST00000409872; ENSP00000386367; ENSG00000115221. [P18564-1]
DR   Ensembl; ENST00000409967; ENSP00000386828; ENSG00000115221. [P18564-2]
DR   GeneID; 3694; -.
DR   KEGG; hsa:3694; -.
DR   UCSC; uc010fou.4; human. [P18564-1]
DR   CTD; 3694; -.
DR   DisGeNET; 3694; -.
DR   EuPathDB; HostDB:ENSG00000115221.10; -.
DR   GeneCards; ITGB6; -.
DR   GeneCards; LINC02478; -.
DR   HGNC; HGNC:6161; ITGB6.
DR   HPA; CAB073536; -.
DR   HPA; HPA023626; -.
DR   MalaCards; ITGB6; -.
DR   MIM; 147558; gene.
DR   MIM; 616221; phenotype.
DR   neXtProt; NX_P18564; -.
DR   OpenTargets; ENSG00000115221; -.
DR   Orphanet; 100032; Hypocalcified amelogenesis imperfecta.
DR   Orphanet; 100031; Hypoplastic amelogenesis imperfecta.
DR   PharmGKB; PA29960; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P18564; -.
DR   KO; K06589; -.
DR   OMA; GEYCNCT; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P18564; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   SignaLink; P18564; -.
DR   SIGNOR; P18564; -.
DR   GeneWiki; Integrin,_beta_6; -.
DR   GenomeRNAi; 3694; -.
DR   PRO; PR:P18564; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115221; -.
DR   CleanEx; HS_ITGB6; -.
DR   ExpressionAtlas; P18564; baseline and differential.
DR   Genevisible; P18564; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034685; C:integrin alphav-beta6 complex; IEA:Ensembl.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0038044; P:transforming growth factor-beta secretion; IEA:Ensembl.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015436; Integrin_bsu-6.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF11; PTHR10082:SF11; 1.
DR   Pfam; PF07974; EGF_2; 2.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 2.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amelogenesis imperfecta;
KW   Cell adhesion; Cell junction; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Integrin; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    788       Integrin beta-6.
FT                                /FTId=PRO_0000016350.
FT   TOPO_DOM     22    709       Extracellular. {ECO:0000255}.
FT   TRANSMEM    710    730       Helical. {ECO:0000255}.
FT   TOPO_DOM    731    788       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      131    371       VWFA.
FT   REPEAT      456    501       I.
FT   REPEAT      502    543       II.
FT   REPEAT      544    582       III.
FT   REPEAT      583    619       IV.
FT   REGION      456    619       Cysteine-rich tandem repeats.
FT   REGION      731    758       Interaction with HAX1.
FT                                {ECO:0000269|PubMed:17545607}.
FT   CARBOHYD     48     48       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    260    260       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    387    387       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    396    396       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    463    463       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    471    471       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    541    541       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    575    575       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     23    454       {ECO:0000250}.
FT   DISULFID     31     41       {ECO:0000250}.
FT   DISULFID     34     70       {ECO:0000250}.
FT   DISULFID     44     59       {ECO:0000250}.
FT   DISULFID    197    204       {ECO:0000250}.
FT   DISULFID    252    293       {ECO:0000250}.
FT   DISULFID    394    406       {ECO:0000250}.
FT   DISULFID    426    670       {ECO:0000250}.
FT   DISULFID    452    456       {ECO:0000250}.
FT   DISULFID    467    479       {ECO:0000250}.
FT   DISULFID    476    511       {ECO:0000250}.
FT   DISULFID    481    490       {ECO:0000250}.
FT   DISULFID    492    502       {ECO:0000250}.
FT   DISULFID    517    522       {ECO:0000250}.
FT   DISULFID    519    552       {ECO:0000250}.
FT   DISULFID    524    537       {ECO:0000250}.
FT   DISULFID    539    544       {ECO:0000250}.
FT   DISULFID    558    563       {ECO:0000250}.
FT   DISULFID    560    591       {ECO:0000250}.
FT   DISULFID    565    574       {ECO:0000250}.
FT   DISULFID    576    583       {ECO:0000250}.
FT   DISULFID    597    602       {ECO:0000250}.
FT   DISULFID    599    645       {ECO:0000250}.
FT   DISULFID    604    614       {ECO:0000250}.
FT   DISULFID    617    620       {ECO:0000250}.
FT   DISULFID    624    633       {ECO:0000250}.
FT   DISULFID    630    702       {ECO:0000250}.
FT   DISULFID    649    678       {ECO:0000250}.
FT   VAR_SEQ     554    660       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_055189.
FT   VARIANT     143    143       A -> T (in AI1H; dbSNP:rs140015315).
FT                                {ECO:0000269|PubMed:24305999}.
FT                                /FTId=VAR_073328.
FT   VARIANT     196    196       P -> T (in AI1H; dbSNP:rs730880298).
FT                                {ECO:0000269|PubMed:24319098}.
FT                                /FTId=VAR_073329.
FT   VARIANT     275    275       H -> Q (in AI1H; dbSNP:rs730882118).
FT                                {ECO:0000269|PubMed:24305999}.
FT                                /FTId=VAR_073330.
FT   VARIANT     437    437       P -> T (in dbSNP:rs2305820).
FT                                /FTId=VAR_049636.
FT   TURN         24     26       {ECO:0000244|PDB:4UM9}.
FT   HELIX        31     34       {ECO:0000244|PDB:4UM9}.
FT   STRAND       42     44       {ECO:0000244|PDB:4UM9}.
FT   HELIX        62     68       {ECO:0000244|PDB:4UM9}.
FT   TURN         72     74       {ECO:0000244|PDB:4UM9}.
FT   STRAND       81     86       {ECO:0000244|PDB:4UM9}.
FT   HELIX        98    100       {ECO:0000244|PDB:4UM9}.
FT   STRAND      108    113       {ECO:0000244|PDB:4UM9}.
FT   STRAND      119    126       {ECO:0000244|PDB:4UM9}.
FT   STRAND      133    140       {ECO:0000244|PDB:5FFG}.
FT   HELIX       143    145       {ECO:0000244|PDB:5FFG}.
FT   HELIX       146    151       {ECO:0000244|PDB:5FFG}.
FT   HELIX       152    154       {ECO:0000244|PDB:5FFG}.
FT   HELIX       155    166       {ECO:0000244|PDB:5FFG}.
FT   STRAND      170    177       {ECO:0000244|PDB:5FFG}.
FT   TURN        183    185       {ECO:0000244|PDB:4UM9}.
FT   HELIX       190    194       {ECO:0000244|PDB:5FFG}.
FT   TURN        196    201       {ECO:0000244|PDB:5FFG}.
FT   STRAND      209    218       {ECO:0000244|PDB:5FFG}.
FT   HELIX       220    229       {ECO:0000244|PDB:5FFG}.
FT   STRAND      236    241       {ECO:0000244|PDB:4UM9}.
FT   HELIX       242    251       {ECO:0000244|PDB:5FFG}.
FT   HELIX       253    256       {ECO:0000244|PDB:5FFG}.
FT   STRAND      262    272       {ECO:0000244|PDB:5FFG}.
FT   HELIX       277    283       {ECO:0000244|PDB:5FFG}.
FT   STRAND      297    301       {ECO:0000244|PDB:5FFG}.
FT   TURN        302    306       {ECO:0000244|PDB:5FFG}.
FT   HELIX       312    321       {ECO:0000244|PDB:5FFG}.
FT   STRAND      324    330       {ECO:0000244|PDB:5FFG}.
FT   HELIX       332    344       {ECO:0000244|PDB:5FFG}.
FT   STRAND      349    352       {ECO:0000244|PDB:5FFG}.
FT   HELIX       360    371       {ECO:0000244|PDB:5FFG}.
FT   STRAND      375    382       {ECO:0000244|PDB:4UM9}.
FT   STRAND      387    393       {ECO:0000244|PDB:4UM9}.
FT   TURN        395    397       {ECO:0000244|PDB:4UM8}.
FT   STRAND      399    401       {ECO:0000244|PDB:4UM9}.
FT   STRAND      414    422       {ECO:0000244|PDB:4UM9}.
FT   STRAND      431    437       {ECO:0000244|PDB:4UM9}.
FT   STRAND      444    450       {ECO:0000244|PDB:4UM9}.
FT   HELIX       455    457       {ECO:0000244|PDB:4UM8}.
FT   STRAND      467    475       {ECO:0000244|PDB:4UM9}.
FT   STRAND      478    481       {ECO:0000244|PDB:4UM9}.
SQ   SEQUENCE   788 AA;  85936 MW;  EDB7D533EC4C8C4D CRC64;
     MGIELLCLFF LFLGRNDHVQ GGCALGGAET CEDCLLIGPQ CAWCAQENFT HPSGVGERCD
     TPANLLAKGC QLNFIENPVS QVEILKNKPL SVGRQKNSSD IVQIAPQSLI LKLRPGGAQT
     LQVHVRQTED YPVDLYYLMD LSASMDDDLN TIKELGSRLS KEMSKLTSNF RLGFGSFVEK
     PVSPFVKTTP EEIANPCSSI PYFCLPTFGF KHILPLTNDA ERFNEIVKNQ KISANIDTPE
     GGFDAIMQAA VCKEKIGWRN DSLHLLVFVS DADSHFGMDS KLAGIVIPND GLCHLDSKNE
     YSMSTVLEYP TIGQLIDKLV QNNVLLIFAV TQEQVHLYEN YAKLIPGATV GLLQKDSGNI
     LQLIISAYEE LRSEVELEVL GDTEGLNLSF TAICNNGTLF QHQKKCSHMK VGDTASFSVT
     VNIPHCERRS RHIIIKPVGL GDALELLVSP ECNCDCQKEV EVNSSKCHHG NGSFQCGVCA
     CHPGHMGPRC ECGEDMLSTD SCKEAPDHPS CSGRGDCYCG QCICHLSPYG NIYGPYCQCD
     NFSCVRHKGL LCGGNGDCDC GECVCRSGWT GEYCNCTTST DSCVSEDGVL CSGRGDCVCG
     KCVCTNPGAS GPTCERCPTC GDPCNSKRSC IECHLSAAGQ AREECVDKCK LAGATISEEE
     DFSKDGSVSC SLQGENECLI TFLITTDNEG KTIIHSINEK DCPKPPNIPM IMLGVSLAIL
     LIGVVLLCIW KLLVSFHDRK EVAKFEAERS KAKWQTGTNP LYRGSTSTFK NVTYKHREKQ
     KVDLSTDC
//
ID   ITAL_HUMAN              Reviewed;        1170 AA.
AC   P20701; O43746; Q45H73; Q96HB1; Q9UBC8;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   07-FEB-2006, sequence version 3.
DT   22-NOV-2017, entry version 194.
DE   RecName: Full=Integrin alpha-L;
DE   AltName: Full=CD11 antigen-like family member A;
DE   AltName: Full=Leukocyte adhesion glycoprotein LFA-1 alpha chain;
DE            Short=LFA-1A;
DE   AltName: Full=Leukocyte function-associated molecule 1 alpha chain;
DE   AltName: CD_antigen=CD11a;
DE   Flags: Precursor;
GN   Name=ITGAL; Synonyms=CD11A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE,
RP   DOMAIN, AND VARIANT TRP-214.
RX   PubMed=2537322; DOI=10.1083/jcb.108.2.703;
RA   Larson R.S., Corbi A.L., Berman L., Springer T.;
RT   "Primary structure of the leukocyte function-associated molecule-1
RT   alpha subunit: an integrin with an embedded domain defining a protein
RT   superfamily.";
RL   J. Cell Biol. 108:703-712(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-144; TRP-214;
RP   LYS-746 AND THR-791.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 2), AND VARIANT
RP   TRP-214.
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20.
RX   PubMed=8099450; DOI=10.1073/pnas.90.11.5364;
RA   Shelley C.S., Farokhzad O.C., Arnaout M.A.;
RT   "Identification of cell-specific and developmentally regulated nuclear
RT   factors that direct myeloid and lymphoid expression of the CD11a
RT   gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5364-5368(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20.
RX   PubMed=8103515;
RA   Nueda A., Lopez-Cabrera M., Vara A., Corbi A.L.;
RT   "Characterization of the CD11a (alpha L, LFA-1 alpha) integrin gene
RT   promoter.";
RL   J. Biol. Chem. 268:19305-19311(1993).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20.
RX   PubMed=8097887; DOI=10.1073/pnas.90.9.4221;
RA   Cornwell R.D., Gollahon K.A., Hickstein D.D.;
RT   "Description of the leukocyte function-associated antigen 1 (LFA-1 or
RT   CD11a) promoter.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4221-4225(1993).
RN   [10]
RP   FUNCTION.
RX   PubMed=11812992; DOI=10.1038/ni755;
RA   Ostermann G., Weber K.S., Zernecke A., Schroeder A., Weber C.;
RT   "JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in
RT   transendothelial migration of leukocytes.";
RL   Nat. Immunol. 3:151-158(2002).
RN   [11]
RP   FUNCTION.
RX   PubMed=15356110; DOI=10.4049/jimmunol.173.6.3653;
RA   Barber D.F., Faure M., Long E.O.;
RT   "LFA-1 contributes an early signal for NK cell cytotoxicity.";
RL   J. Immunol. 173:3653-3659(2004).
RN   [12]
RP   DOMAIN, AND FUNCTION.
RX   PubMed=15528364; DOI=10.4049/jimmunol.173.10.6259;
RA   Fraemohs L., Koenen R.R., Ostermann G., Heinemann B., Weber C.;
RT   "The functional interaction of the beta 2 integrin lymphocyte
RT   function-associated antigen-1 with junctional adhesion molecule-A is
RT   mediated by the I domain.";
RL   J. Immunol. 173:6259-6264(2004).
RN   [13]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, PHOSPHORYLATION AT SER-1165,
RP   AND MUTAGENESIS OF SER-1165.
RX   PubMed=16301335; DOI=10.1083/jcb.200504016;
RA   Fagerholm S.C., Hilden T.J., Nurmi S.M., Gahmberg C.G.;
RT   "Specific integrin alpha and beta chain phosphorylations regulate LFA-
RT   1 activation through affinity-dependent and -independent mechanisms.";
RL   J. Cell Biol. 171:705-715(2005).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-188.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [15]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23775590; DOI=10.1007/s10495-013-0873-z;
RA   Kristof E., Zahuczky G., Katona K., Doro Z., Nagy E., Fesues L.;
RT   "Novel role of ICAM3 and LFA-1 in the clearance of apoptotic
RT   neutrophils by human macrophages.";
RL   Apoptosis 18:1235-1251(2013).
RN   [16]
RP   INTERACTION WITH THBD.
RX   PubMed=27055590; DOI=10.1016/j.bbrc.2016.04.007;
RA   Kawamoto E., Okamoto T., Takagi Y., Honda G., Suzuki K., Imai H.,
RA   Shimaoka M.;
RT   "LFA-1 and Mac-1 integrins bind to the serine/threonine-rich domain of
RT   thrombomodulin.";
RL   Biochem. Biophys. Res. Commun. 473:1005-1012(2016).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 153-335, AND SEQUENCE
RP   REVISION TO 214.
RX   PubMed=7479767; DOI=10.1073/pnas.92.22.10277;
RA   Qu A., Leahy D.J.;
RT   "Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L
RT   beta 2) integrin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10277-10281(1995).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 153-335.
RX   PubMed=8805579; DOI=10.1016/S0969-2126(96)00100-1;
RA   Qu A., Leahy D.J.;
RT   "The role of the divalent cation in the structure of the I domain from
RT   the CD11a/CD18 integrin.";
RL   Structure 4:931-942(1996).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 153-334.
RX   PubMed=10493852; DOI=10.1006/jmbi.1999.3047;
RA   Kallen J., Welzenbach K., Ramage P., Geyl D., Kriwacki R., Legge G.,
RA   Cottens S., Weitz-Schmidt G., Hommel U.;
RT   "Structural basis for LFA-1 inhibition upon lovastatin binding to the
RT   CD11a I-domain.";
RL   J. Mol. Biol. 292:1-9(1999).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 155-331 IN COMPLEX WITH
RP   ICAM1.
RX   PubMed=12526797; DOI=10.1016/S0092-8674(02)01257-6;
RA   Shimaoka M., Xiao T., Liu J.H., Yang Y., Dong Y., Jun C.D.,
RA   McCormack A., Zhang R., Joachimiak A., Takagi J., Wang J.H.,
RA   Springer T.A.;
RT   "Structures of the alpha L I domain and its complex with ICAM-1 reveal
RT   a shape-shifting pathway for integrin regulation.";
RL   Cell 112:99-111(2003).
CC   -!- FUNCTION: Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2,
CC       ICAM3 and ICAM4. Integrin alpha-L/beta-2 is also a receptor for
CC       F11R (PubMed:11812992, PubMed:15528364). Involved in a variety of
CC       immune phenomena including leukocyte-endothelial cell interaction,
CC       cytotoxic T-cell mediated killing, and antibody dependent killing
CC       by granulocytes and monocytes. Contributes to natural killer cell
CC       cytotoxicity (PubMed:15356110). Involved in leukocyte adhesion and
CC       transmigration of leukocytes including T-cells and neutrophils
CC       (PubMed:11812992). Required for generation of common lymphoid
CC       progenitor cells in bone marrow, indicating a role in
CC       lymphopoiesis (By similarity). Integrin alpha-L/beta-2 in
CC       association with ICAM3, contributes to apoptotic neutrophil
CC       phagocytosis by macrophages (PubMed:23775590).
CC       {ECO:0000250|UniProtKB:P24063, ECO:0000269|PubMed:11812992,
CC       ECO:0000269|PubMed:15356110, ECO:0000269|PubMed:15528364,
CC       ECO:0000269|PubMed:23775590}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit
CC       (PubMed:12526797). Alpha-L associates with beta-2
CC       (PubMed:12526797). Interacts with THBD (PubMed:27055590).
CC       {ECO:0000269|PubMed:12526797, ECO:0000269|PubMed:27055590}.
CC   -!- INTERACTION:
CC       Q9WMX2:- (xeno); NbExp=2; IntAct=EBI-961214, EBI-6863748;
CC       P05362:ICAM1; NbExp=2; IntAct=EBI-961214, EBI-1035358;
CC       P08575:PTPRC; NbExp=2; IntAct=EBI-961214, EBI-1341;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16301335};
CC       Single-pass type I membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P20701-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P20701-2; Sequence=VSP_002738;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P20701-3; Sequence=VSP_042842, VSP_042843;
CC   -!- TISSUE SPECIFICITY: Leukocytes. {ECO:0000269|PubMed:16301335,
CC       ECO:0000269|PubMed:23775590}.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain
CC       (PubMed:2537322). Integrins with I-domains do not undergo protease
CC       cleavage. The I-domain is necessary and sufficient for interaction
CC       with ICAM1 and F11R (PubMed:15528364).
CC       {ECO:0000269|PubMed:15528364, ECO:0000269|PubMed:2537322}.
CC   -!- PTM: In resting T-cells, up to 40% of surface ITGAL is
CC       constitutively phosphorylated. Phosphorylation causes
CC       conformational changes needed for ligand binding and is necessary
CC       for activation by some physiological agents.
CC       {ECO:0000269|PubMed:16301335}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/itgal/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00796; CAA68747.1; -; mRNA.
DR   EMBL; DQ131904; AAZ38713.1; -; Genomic_DNA.
DR   EMBL; AC002310; AAC31672.1; -; Genomic_DNA.
DR   EMBL; AC116348; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471192; EAW52243.1; -; Genomic_DNA.
DR   EMBL; BC008777; AAH08777.1; -; mRNA.
DR   EMBL; M95609; AAA16474.2; -; Genomic_DNA.
DR   EMBL; Z22804; CAA80461.1; -; Genomic_DNA.
DR   EMBL; M87662; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS32433.1; -. [P20701-1]
DR   CCDS; CCDS45461.1; -. [P20701-3]
DR   PIR; S03308; S03308.
DR   RefSeq; NP_001107852.1; NM_001114380.1. [P20701-3]
DR   RefSeq; NP_002200.2; NM_002209.2. [P20701-1]
DR   UniGene; Hs.174103; -.
DR   PDB; 1CQP; X-ray; 2.60 A; A/B=153-334.
DR   PDB; 1DGQ; NMR; -; A=152-336.
DR   PDB; 1IJ4; Model; -; L=153-333.
DR   PDB; 1LFA; X-ray; 1.80 A; A/B=150-336.
DR   PDB; 1MJN; X-ray; 1.30 A; A=153-331.
DR   PDB; 1MQ8; X-ray; 3.30 A; B/D=155-331.
DR   PDB; 1MQ9; X-ray; 2.00 A; A=153-331.
DR   PDB; 1MQA; X-ray; 2.50 A; A=153-331.
DR   PDB; 1RD4; X-ray; 2.40 A; A/B/C/D=150-336.
DR   PDB; 1T0P; X-ray; 1.66 A; A=153-326.
DR   PDB; 1XDD; X-ray; 2.20 A; A/B=152-336.
DR   PDB; 1XDG; X-ray; 2.10 A; A/B=152-336.
DR   PDB; 1XUO; X-ray; 1.80 A; A/B=152-336.
DR   PDB; 1ZON; X-ray; 2.00 A; A=150-336.
DR   PDB; 1ZOO; X-ray; 3.00 A; A/B=150-336.
DR   PDB; 1ZOP; X-ray; 2.00 A; A/B=150-336.
DR   PDB; 2ICA; X-ray; 1.56 A; A=154-332.
DR   PDB; 2K8O; NMR; -; A=1113-1170.
DR   PDB; 2M3E; NMR; -; A=1082-1128.
DR   PDB; 2O7N; X-ray; 1.75 A; A=154-332.
DR   PDB; 3BN3; X-ray; 2.10 A; A=154-332.
DR   PDB; 3BQM; X-ray; 1.95 A; B/C=153-334.
DR   PDB; 3BQN; X-ray; 1.80 A; B/C=153-334.
DR   PDB; 3E2M; X-ray; 2.00 A; A/B=152-334.
DR   PDB; 3EOA; X-ray; 2.80 A; I/J=153-333.
DR   PDB; 3EOB; X-ray; 3.60 A; I/J=153-333.
DR   PDB; 3F74; X-ray; 1.70 A; A/B/C=153-332.
DR   PDB; 3F78; X-ray; 1.60 A; A/B/C=153-332.
DR   PDB; 3HI6; X-ray; 2.30 A; A/B=153-332.
DR   PDB; 3M6F; X-ray; 1.85 A; A=154-332.
DR   PDB; 3TCX; X-ray; 3.60 A; B/D/F/H/J/L/N/P/R/T/V/X/Z/b=154-332.
DR   PDB; 4IXD; X-ray; 1.80 A; A=152-336.
DR   PDB; 5E6R; X-ray; 2.90 A; A=26-770.
DR   PDB; 5E6S; X-ray; 2.15 A; A/C/E=26-770.
DR   PDB; 5E6U; X-ray; 2.50 A; A=26-770.
DR   PDBsum; 1CQP; -.
DR   PDBsum; 1DGQ; -.
DR   PDBsum; 1IJ4; -.
DR   PDBsum; 1LFA; -.
DR   PDBsum; 1MJN; -.
DR   PDBsum; 1MQ8; -.
DR   PDBsum; 1MQ9; -.
DR   PDBsum; 1MQA; -.
DR   PDBsum; 1RD4; -.
DR   PDBsum; 1T0P; -.
DR   PDBsum; 1XDD; -.
DR   PDBsum; 1XDG; -.
DR   PDBsum; 1XUO; -.
DR   PDBsum; 1ZON; -.
DR   PDBsum; 1ZOO; -.
DR   PDBsum; 1ZOP; -.
DR   PDBsum; 2ICA; -.
DR   PDBsum; 2K8O; -.
DR   PDBsum; 2M3E; -.
DR   PDBsum; 2O7N; -.
DR   PDBsum; 3BN3; -.
DR   PDBsum; 3BQM; -.
DR   PDBsum; 3BQN; -.
DR   PDBsum; 3E2M; -.
DR   PDBsum; 3EOA; -.
DR   PDBsum; 3EOB; -.
DR   PDBsum; 3F74; -.
DR   PDBsum; 3F78; -.
DR   PDBsum; 3HI6; -.
DR   PDBsum; 3M6F; -.
DR   PDBsum; 3TCX; -.
DR   PDBsum; 4IXD; -.
DR   PDBsum; 5E6R; -.
DR   PDBsum; 5E6S; -.
DR   PDBsum; 5E6U; -.
DR   ProteinModelPortal; P20701; -.
DR   SMR; P20701; -.
DR   BioGrid; 109889; 6.
DR   DIP; DIP-623N; -.
DR   IntAct; P20701; 7.
DR   MINT; MINT-1130696; -.
DR   STRING; 9606.ENSP00000349252; -.
DR   BindingDB; P20701; -.
DR   ChEMBL; CHEMBL1803; -.
DR   DrugBank; DB02177; 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine.
DR   DrugBank; DB00098; Anti-thymocyte Globulin (Rabbit).
DR   DrugBank; DB00095; Efalizumab.
DR   DrugBank; DB03932; LFA703.
DR   DrugBank; DB11611; Lifitegrast.
DR   DrugBank; DB00227; Lovastatin.
DR   GuidetoPHARMACOLOGY; 2451; -.
DR   iPTMnet; P20701; -.
DR   PhosphoSitePlus; P20701; -.
DR   BioMuta; ITGAL; -.
DR   DMDM; 88911345; -.
DR   MaxQB; P20701; -.
DR   PaxDb; P20701; -.
DR   PeptideAtlas; P20701; -.
DR   PRIDE; P20701; -.
DR   DNASU; 3683; -.
DR   Ensembl; ENST00000356798; ENSP00000349252; ENSG00000005844. [P20701-1]
DR   Ensembl; ENST00000358164; ENSP00000350886; ENSG00000005844. [P20701-3]
DR   GeneID; 3683; -.
DR   KEGG; hsa:3683; -.
DR   UCSC; uc002dyi.5; human. [P20701-1]
DR   CTD; 3683; -.
DR   DisGeNET; 3683; -.
DR   EuPathDB; HostDB:ENSG00000005844.17; -.
DR   GeneCards; ITGAL; -.
DR   H-InvDB; HIX0012960; -.
DR   H-InvDB; HIX0026987; -.
DR   HGNC; HGNC:6148; ITGAL.
DR   HPA; CAB025011; -.
DR   MIM; 153370; gene.
DR   neXtProt; NX_P20701; -.
DR   OpenTargets; ENSG00000005844; -.
DR   PharmGKB; PA29948; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000113114; -.
DR   HOVERGEN; HBG006188; -.
DR   InParanoid; P20701; -.
DR   KO; K05718; -.
DR   OMA; GEDKKCE; -.
DR   OrthoDB; EOG091G03DW; -.
DR   PhylomeDB; P20701; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8949275; RUNX3 Regulates Immune Response and Cell Migration.
DR   SignaLink; P20701; -.
DR   SIGNOR; P20701; -.
DR   ChiTaRS; ITGAL; human.
DR   EvolutionaryTrace; P20701; -.
DR   GeneWiki; CD11a; -.
DR   GenomeRNAi; 3683; -.
DR   PRO; PR:P20701; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000005844; -.
DR   CleanEx; HS_ITGAL; -.
DR   ExpressionAtlas; P20701; baseline and differential.
DR   Genevisible; P20701; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0034687; C:integrin alphaL-beta2 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IMP:UniProtKB.
DR   GO; GO:0030369; F:ICAM-3 receptor activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IMP:BHF-UCL.
DR   GO; GO:0006954; P:inflammatory response; NAS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; IMP:BHF-UCL.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0006928; P:movement of cell or subcellular component; TAS:ProtInc.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006909; P:phagocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0043113; P:receptor clustering; IMP:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0002291; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; IMP:BHF-UCL.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 1.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 2.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Integrin; Magnesium; Membrane;
KW   Metal-binding; Phagocytosis; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25
FT   CHAIN        26   1170       Integrin alpha-L.
FT                                /FTId=PRO_0000016292.
FT   TOPO_DOM     26   1090       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1091   1111       Helical. {ECO:0000255}.
FT   TOPO_DOM   1112   1170       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       31     82       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       83    141       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      156    327       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      338    389       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      390    445       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      446    506       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      507    563       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      567    627       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     468    476       {ECO:0000255}.
FT   CA_BIND     530    538       {ECO:0000255}.
FT   CA_BIND     590    598       {ECO:0000255}.
FT   MOTIF      1115   1119       GFFKR motif.
FT   MOD_RES    1165   1165       Phosphoserine.
FT                                {ECO:0000269|PubMed:16301335}.
FT   CARBOHYD     65     65       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    188    188       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    649    649       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    670    670       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    726    726       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    730    730       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    862    862       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    885    885       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    897    897       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1060   1060       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1071   1071       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     73     80       {ECO:0000250}.
FT   DISULFID    111    129       {ECO:0000250}.
FT   DISULFID    653    707       {ECO:0000250}.
FT   DISULFID    771    777       {ECO:0000250}.
FT   DISULFID    845    861       {ECO:0000250}.
FT   DISULFID    998   1013       {ECO:0000250}.
FT   DISULFID   1021   1052       {ECO:0000250}.
FT   VAR_SEQ     110    192       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042842.
FT   VAR_SEQ     746    746       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042843.
FT   VAR_SEQ     954    954       Q -> QGVHGLVEMQTSKQILCRPAGDAEHTVGAQEGELPC
FT                                PWGVSEAFRDNIRAGPCR (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002738.
FT   VARIANT     144    144       R -> H (in dbSNP:rs34166708).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_025235.
FT   VARIANT     214    214       R -> W (in dbSNP:rs1064524).
FT                                {ECO:0000269|PubMed:10493829,
FT                                ECO:0000269|PubMed:2537322,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_025236.
FT   VARIANT     746    746       Q -> K (in dbSNP:rs34838942).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_025237.
FT   VARIANT     791    791       R -> T (in dbSNP:rs2230433).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_025238.
FT   MUTAGEN    1165   1165       S->A: Abolishes phosphorylation and MEM-
FT                                83-activated T-cell adhesion to ICAM1.
FT                                Abolishes integrin alpha-L/beta-2
FT                                activation by CXCL12 and TERF2IP/RAP1.
FT                                Does not affect heterodimerization of
FT                                cell surface expression. Does not affect
FT                                TCR- or phorbol ester-activated T-cell
FT                                adhesion to ICAM1.
FT                                {ECO:0000269|PubMed:16301335}.
FT   CONFLICT    660    660       I -> Y (in Ref. 1; CAA68747).
FT                                {ECO:0000305}.
FT   HELIX        30     32       {ECO:0000244|PDB:5E6U}.
FT   STRAND       34     36       {ECO:0000244|PDB:5E6S}.
FT   TURN         43     46       {ECO:0000244|PDB:5E6S}.
FT   STRAND       47     52       {ECO:0000244|PDB:5E6S}.
FT   STRAND       55     60       {ECO:0000244|PDB:5E6S}.
FT   STRAND       69     73       {ECO:0000244|PDB:5E6S}.
FT   TURN         75     77       {ECO:0000244|PDB:5E6S}.
FT   STRAND       80     82       {ECO:0000244|PDB:5E6S}.
FT   TURN         93     96       {ECO:0000244|PDB:5E6S}.
FT   STRAND       97    101       {ECO:0000244|PDB:5E6S}.
FT   TURN        103    105       {ECO:0000244|PDB:5E6S}.
FT   STRAND      108    119       {ECO:0000244|PDB:5E6S}.
FT   STRAND      122    134       {ECO:0000244|PDB:5E6S}.
FT   STRAND      140    143       {ECO:0000244|PDB:5E6S}.
FT   STRAND      155    162       {ECO:0000244|PDB:1MJN}.
FT   HELIX       169    185       {ECO:0000244|PDB:1MJN}.
FT   TURN        186    188       {ECO:0000244|PDB:1MJN}.
FT   STRAND      189    206       {ECO:0000244|PDB:1MJN}.
FT   HELIX       208    214       {ECO:0000244|PDB:1MJN}.
FT   HELIX       217    221       {ECO:0000244|PDB:1MJN}.
FT   HELIX       233    243       {ECO:0000244|PDB:1MJN}.
FT   HELIX       247    249       {ECO:0000244|PDB:1MJN}.
FT   STRAND      255    265       {ECO:0000244|PDB:1MJN}.
FT   HELIX       274    276       {ECO:0000244|PDB:1MJN}.
FT   STRAND      279    287       {ECO:0000244|PDB:1MJN}.
FT   HELIX       288    290       {ECO:0000244|PDB:1MJN}.
FT   HELIX       293    297       {ECO:0000244|PDB:1MJN}.
FT   HELIX       298    302       {ECO:0000244|PDB:1MJN}.
FT   HELIX       307    310       {ECO:0000244|PDB:1MJN}.
FT   STRAND      311    316       {ECO:0000244|PDB:1MJN}.
FT   HELIX       317    319       {ECO:0000244|PDB:1MJN}.
FT   HELIX       323    330       {ECO:0000244|PDB:1MJN}.
FT   STRAND      331    333       {ECO:0000244|PDB:3BQN}.
FT   STRAND      352    359       {ECO:0000244|PDB:5E6S}.
FT   STRAND      362    367       {ECO:0000244|PDB:5E6S}.
FT   HELIX       370    373       {ECO:0000244|PDB:5E6S}.
FT   STRAND      375    380       {ECO:0000244|PDB:5E6S}.
FT   STRAND      387    391       {ECO:0000244|PDB:5E6S}.
FT   TURN        398    401       {ECO:0000244|PDB:5E6S}.
FT   STRAND      406    411       {ECO:0000244|PDB:5E6S}.
FT   STRAND      413    416       {ECO:0000244|PDB:5E6S}.
FT   STRAND      419    424       {ECO:0000244|PDB:5E6S}.
FT   HELIX       427    429       {ECO:0000244|PDB:5E6S}.
FT   STRAND      432    437       {ECO:0000244|PDB:5E6S}.
FT   STRAND      446    452       {ECO:0000244|PDB:5E6S}.
FT   STRAND      462    467       {ECO:0000244|PDB:5E6S}.
FT   STRAND      472    474       {ECO:0000244|PDB:5E6S}.
FT   STRAND      477    482       {ECO:0000244|PDB:5E6S}.
FT   STRAND      493    499       {ECO:0000244|PDB:5E6S}.
FT   STRAND      501    510       {ECO:0000244|PDB:5E6S}.
FT   STRAND      514    516       {ECO:0000244|PDB:5E6S}.
FT   STRAND      523    527       {ECO:0000244|PDB:5E6S}.
FT   STRAND      531    535       {ECO:0000244|PDB:5E6S}.
FT   STRAND      539    543       {ECO:0000244|PDB:5E6S}.
FT   STRAND      549    554       {ECO:0000244|PDB:5E6S}.
FT   STRAND      558    561       {ECO:0000244|PDB:5E6R}.
FT   STRAND      566    570       {ECO:0000244|PDB:5E6S}.
FT   HELIX       571    574       {ECO:0000244|PDB:5E6S}.
FT   STRAND      583    589       {ECO:0000244|PDB:5E6S}.
FT   STRAND      593    595       {ECO:0000244|PDB:5E6S}.
FT   STRAND      598    603       {ECO:0000244|PDB:5E6S}.
FT   STRAND      606    612       {ECO:0000244|PDB:5E6S}.
FT   TURN       1082   1086       {ECO:0000244|PDB:2M3E}.
FT   HELIX      1090   1114       {ECO:0000244|PDB:2M3E}.
FT   HELIX      1118   1123       {ECO:0000244|PDB:2K8O}.
FT   TURN       1124   1127       {ECO:0000244|PDB:2K8O}.
FT   HELIX      1137   1147       {ECO:0000244|PDB:2K8O}.
FT   HELIX      1153   1155       {ECO:0000244|PDB:2K8O}.
FT   HELIX      1156   1165       {ECO:0000244|PDB:2K8O}.
FT   HELIX      1167   1170       {ECO:0000244|PDB:2K8O}.
SQ   SEQUENCE   1170 AA;  128770 MW;  22A7AF92EF286876 CRC64;
     MKDSCITVMA MALLSGFFFF APASSYNLDV RGARSFSPPR AGRHFGYRVL QVGNGVIVGA
     PGEGNSTGSL YQCQSGTGHC LPVTLRGSNY TSKYLGMTLA TDPTDGSILA CDPGLSRTCD
     QNTYLSGLCY LFRQNLQGPM LQGRPGFQEC IKGNVDLVFL FDGSMSLQPD EFQKILDFMK
     DVMKKLSNTS YQFAAVQFST SYKTEFDFSD YVKRKDPDAL LKHVKHMLLL TNTFGAINYV
     ATEVFREELG ARPDATKVLI IITDGEATDS GNIDAAKDII RYIIGIGKHF QTKESQETLH
     KFASKPASEF VKILDTFEKL KDLFTELQKK IYVIEGTSKQ DLTSFNMELS SSGISADLSR
     GHAVVGAVGA KDWAGGFLDL KADLQDDTFI GNEPLTPEVR AGYLGYTVTW LPSRQKTSLL
     ASGAPRYQHM GRVLLFQEPQ GGGHWSQVQT IHGTQIGSYF GGELCGVDVD QDGETELLLI
     GAPLFYGEQR GGRVFIYQRR QLGFEEVSEL QGDPGYPLGR FGEAITALTD INGDGLVDVA
     VGAPLEEQGA VYIFNGRHGG LSPQPSQRIE GTQVLSGIQW FGRSIHGVKD LEGDGLADVA
     VGAESQMIVL SSRPVVDMVT LMSFSPAEIP VHEVECSYST SNKMKEGVNI TICFQIKSLI
     PQFQGRLVAN LTYTLQLDGH RTRRRGLFPG GRHELRRNIA VTTSMSCTDF SFHFPVCVQD
     LISPINVSLN FSLWEEEGTP RDQRAQGKDI PPILRPSLHS ETWEIPFEKN CGEDKKCEAN
     LRVSFSPARS RALRLTAFAS LSVELSLSNL EEDAYWVQLD LHFPPGLSFR KVEMLKPHSQ
     IPVSCEELPE ESRLLSRALS CNVSSPIFKA GHSVALQMMF NTLVNSSWGD SVELHANVTC
     NNEDSDLLED NSATTIIPIL YPINILIQDQ EDSTLYVSFT PKGPKIHQVK HMYQVRIQPS
     IHDHNIPTLE AVVGVPQPPS EGPITHQWSV QMEPPVPCHY EDLERLPDAA EPCLPGALFR
     CPVVFRQEIL VQVIGTLELV GEIEASSMFS LCSSLSISFN SSKHFHLYGS NASLAQVVMK
     VDVVYEKQML YLYVLSGIGG LLLLLLIFIV LYKVGFFKRN LKEKMEAGRG VPNGIPAEDS
     EQLASGQEAG DPGCLKPLHE KDSESGGGKD
//
ID   ITA6_HUMAN              Reviewed;        1130 AA.
AC   P23229; B2RMU9; B4DG69; B4DKB8; C4AM96; G5E9H1; Q08443; Q0MRC7;
AC   Q14646; Q16508; Q53RX7; Q59HB7; Q86VL6; Q9UCT1; Q9UN03;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2013, sequence version 5.
DT   22-NOV-2017, entry version 195.
DE   RecName: Full=Integrin alpha-6;
DE   AltName: Full=CD49 antigen-like family member F;
DE   AltName: Full=VLA-6;
DE   AltName: CD_antigen=CD49f;
DE   Contains:
DE     RecName: Full=Integrin alpha-6 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-6 light chain;
DE   Contains:
DE     RecName: Full=Processed integrin alpha-6;
DE              Short=Alpha6p;
DE   Flags: Precursor;
GN   Name=ITGA6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-6X1A).
RC   TISSUE=Pancreas;
RX   PubMed=1976638; DOI=10.1083/jcb.111.4.1593;
RA   Tamura R.N., Rozzo C., Starr L., Chambers J., Reichardt L.F.,
RA   Cooper H.M., Quaranta V.;
RT   "Epithelial integrin alpha 6 beta 4: complete primary structure of
RT   alpha 6 and variant forms of beta 4.";
RL   J. Cell Biol. 111:1593-1604(1990).
RN   [2]
RP   SEQUENCE REVISION TO 78 AND 362.
RA   Quaranta V.;
RL   Submitted (JUN-1991) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM ALPHA-6X1A).
RA   Pulkkinen L., Uitto J.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 266-1130 (ISOFORM ALPHA-6X1X2A).
RC   TISSUE=Amygdala, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-6X1A), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 412-1130 (ISOFORM 9).
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-6X1A).
RC   TISSUE=Keratinocyte;
RX   PubMed=2070796; DOI=10.1111/j.1432-1033.1991.tb16140.x;
RA   Hogervorst F., Kuikman I., Geurts van Kessel A., Sonnenberg A.;
RT   "Molecular cloning of the human alpha 6 integrin subunit. Alternative
RT   splicing of alpha 6 mRNA and chromosomal localization of the alpha 6
RT   and beta 4 genes.";
RL   Eur. J. Biochem. 199:425-433(1991).
RN   [9]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-6X1A AND
RP   ALPHA-6X1B).
RX   PubMed=1946438; DOI=10.1073/pnas.88.22.10183;
RA   Tamura R.N., Cooper H.M., Collo G., Quaranta V.;
RT   "Cell type-specific integrin variants with alternative alpha chain
RT   cytoplasmic domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10183-10187(1991).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 748-849.
RX   PubMed=1476731;
RA   Starr L., Quaranta V.;
RT   "An efficient and reliable method for cloning PCR-amplification
RT   products: a survey of point mutations in integrin cDNA.";
RL   BioTechniques 13:612-618(1992).
RN   [11]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-6X1A).
RX   PubMed=8496190;
RA   Shaw L.M., Lotz M.M., Mercurio A.M.;
RT   "Inside-out integrin signaling in macrophages. Analysis of the role of
RT   the alpha 6A beta 1 and alpha 6B beta 1 integrin variants in laminin
RT   adhesion by cDNA expression in an alpha 6 integrin-deficient
RT   macrophage cell line.";
RL   J. Biol. Chem. 268:11401-11408(1993).
RN   [12]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Leukocyte;
RX   PubMed=8253814;
RA   Ziober B.L., Vu M.P., Waleh N., Crawford J., Lin C.-S., Kramer R.H.;
RT   "Alternative extracellular and cytoplasmic domains of the integrin
RT   alpha 7 subunit are differentially expressed during development.";
RL   J. Biol. Chem. 268:26773-26783(1993).
RN   [13]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lymphoma;
RX   PubMed=7583007;
RA   Delwel G.O., Kuikman I., Sonnenberg A.;
RT   "An alternatively spliced exon in the extracellular domain of the
RT   human alpha 6 integrin subunit -- functional analysis of the alpha 6
RT   integrin variants.";
RL   Cell Adhes. Commun. 3:143-161(1995).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 565-1130 (ISOFORM
RP   ALPHA-6X1X2B).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   PROTEIN SEQUENCE OF 24-44.
RX   PubMed=2649503;
RA   Hemler M.E., Crouse C., Sonnenberg A.;
RT   "Association of the VLA alpha 6 subunit with a novel protein. A
RT   possible alternative to the common VLA beta 1 subunit on certain cell
RT   lines.";
RL   J. Biol. Chem. 264:6529-6535(1989).
RN   [16]
RP   PROTEIN SEQUENCE OF 24-46.
RX   PubMed=2542022;
RA   Kajiji S., Tamura R.N., Quaranta V.;
RT   "A novel integrin (alpha E beta 4) from human epithelial cells
RT   suggests a fourth family of integrin adhesion receptors.";
RL   EMBO J. 8:673-680(1989).
RN   [17]
RP   PROTEIN SEQUENCE OF 24-36.
RC   TISSUE=Platelet;
RX   PubMed=1953640; DOI=10.1042/bj2790419;
RA   Catimel B., Parmentier S., Leung L.L., McGregor J.L.;
RT   "Separation of important new platelet glycoproteins (GPIa, GPIc,
RT   GPIc*, GPIIa and GMP-140) by F.P.L.C. Characterization by monoclonal
RT   antibodies and gas-phase sequencing.";
RL   Biochem. J. 279:419-425(1991).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1001-1130.
RA   Dydensborg A.B., Herring E., Beaulieu J.-F.;
RT   "Integrin alpha6Abeta4 in human colon cancer.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [19]
RP   PHOSPHORYLATION AT SER-1059 (ISOFORM ALPHA-6X2A), PHOSPHORYLATION AT
RP   SER-1064 (ISOFORM ALPHA-6X1A), AND PHOSPHORYLATION AT SER-1103
RP   (ISOFORM ALPHA-6X1X2A).
RX   PubMed=8360143;
RA   Hogervorst F., Kuikman I., Noteboom E., Sonnenberg A.;
RT   "The role of phosphorylation in activation of the alpha 6A beta 1
RT   laminin receptor.";
RL   J. Biol. Chem. 268:18427-18430(1993).
RN   [20]
RP   CHARACTERIZATION, AND TISSUE SPECIFICITY.
RX   PubMed=7681434; DOI=10.1083/jcb.121.1.179;
RA   Hogervorst F., Admiraal L.G., Niessen C., Kuikman I., Janssen H.,
RA   Daams H., Sonnenberg A.;
RT   "Biochemical characterization and tissue distribution of the A and B
RT   variants of the integrin alpha 6 subunit.";
RL   J. Cell Biol. 121:179-191(1993).
RN   [21]
RP   PALMITOYLATION AT CYS-1078.
RX   PubMed=15611341; DOI=10.1083/jcb.200404100;
RA   Yang X., Kovalenko O.V., Tang W., Claas C., Stipp C.S., Hemler M.E.;
RT   "Palmitoylation supports assembly and function of integrin-tetraspanin
RT   complexes.";
RL   J. Cell Biol. 167:1231-1240(2004).
RN   [22]
RP   INTERACTION WITH RAB21.
RX   PubMed=16754960; DOI=10.1083/jcb.200509019;
RA   Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M.,
RA   Ivaska J.;
RT   "Small GTPase Rab21 regulates cell adhesion and controls endosomal
RT   traffic of beta1-integrins.";
RL   J. Cell Biol. 173:767-780(2006).
RN   [23]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-323.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [24]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-997.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [25]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=17303120; DOI=10.1016/j.yexcr.2007.01.006;
RA   Pawar S.C., Demetriou M.C., Nagle R.B., Bowden G.T., Cress A.E.;
RT   "Integrin alpha6 cleavage: a novel modification to modulate cell
RT   migration.";
RL   Exp. Cell Res. 313:1080-1089(2007).
RN   [26]
RP   FUNCTION, BINDING TO NRG1, AND IDENTIFICATION IN A COMPLEX WITH NRG1
RP   AND ERBB3.
RX   PubMed=20682778; DOI=10.1074/jbc.M110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   PALMITOYLATION AT CYS-1078 BY DHHC3, AND SUBCELLULAR LOCATION.
RX   PubMed=22314500; DOI=10.1007/s00018-012-0924-6;
RA   Sharma C., Rabinovitz I., Hemler M.E.;
RT   "Palmitoylation by DHHC3 is critical for the function, expression, and
RT   stability of integrin alpha6beta4.";
RL   Cell. Mol. Life Sci. 69:2233-2244(2012).
RN   [29]
RP   FUNCTION, BINDING TO IGF1, AND IDENTIFICATION IN A COMPLEX WITH IGF1
RP   AND IGF1R.
RX   PubMed=22351760; DOI=10.1074/jbc.M111.304170;
RA   Fujita M., Ieguchi K., Davari P., Yamaji S., Taniguchi Y.,
RA   Sekiguchi K., Takada Y.K., Takada Y.;
RT   "Cross-talk between integrin alpha6beta4 and insulin-like growth
RT   factor-1 receptor (IGF1R) through direct alpha6beta4 binding to IGF1
RT   and subsequent alpha6beta4-IGF1-IGF1R ternary complex formation in
RT   anchorage-independent conditions.";
RL   J. Biol. Chem. 287:12491-12500(2012).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Integrin alpha-6/beta-1 is a receptor for laminin on
CC       platelets. Integrin alpha-6/beta-4 is a receptor for laminin in
CC       epithelial cells and it plays a critical structural role in the
CC       hemidesmosome (By similarity). ITGA6:ITGB4 binds to NRG1 (via EGF
CC       domain) and this binding is essential for NRG1-ERBB signaling
CC       (PubMed:20682778). ITGA6:ITGB4 binds to IGF1 and this binding is
CC       essential for IGF1 signaling (PubMed:22351760).
CC       {ECO:0000250|UniProtKB:Q61739, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:22351760}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-6 associates with either beta-1 or beta-4.
CC       Interacts with HPS5. Interacts with RAB21. ITGA6:ITGB4 is found in
CC       a ternary complex with NRG1 and ERBB3 (PubMed:20682778).
CC       ITGA6:ITGB4 is found in a ternary complex with IGF1 and IGF1R
CC       (PubMed:22351760). Interacts with ADAM9 (By similarity).
CC       {ECO:0000250|UniProtKB:Q61739, ECO:0000269|PubMed:16754960,
CC       ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:22351760}.
CC   -!- INTERACTION:
CC       P16144:ITGB4; NbExp=3; IntAct=EBI-2436548, EBI-948678;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22314500};
CC       Single-pass type I membrane protein {ECO:0000255}. Cell membrane
CC       {ECO:0000269|PubMed:22314500}; Lipid-anchor
CC       {ECO:0000269|PubMed:22314500}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist. There is a
CC         combination of at least four alternatively spliced domains, two
CC         extracellular (X1 and X2) and two cytoplasmic (A and B). So far
CC         detected are isoform Alpha-6X1A, isoform Alpha-6X1B and isoform
CC         Alpha-6X1X2A (minor). Experimental confirmation may be lacking
CC         for some isoforms.;
CC       Name=Alpha-6X1X2B;
CC         IsoId=P23229-1; Sequence=Displayed;
CC       Name=Alpha-6X1A;
CC         IsoId=P23229-2; Sequence=VSP_002724, VSP_002725;
CC         Note=Contains a phosphoserine at position 1064.
CC         {ECO:0000269|PubMed:8360143};
CC       Name=Alpha-6X1B;
CC         IsoId=P23229-3; Sequence=VSP_002724;
CC       Name=Alpha-6X2A;
CC         IsoId=P23229-4; Sequence=VSP_002723, VSP_002725;
CC         Note=Contains a phosphoserine at position 1059.
CC         {ECO:0000269|PubMed:8360143};
CC       Name=Alpha-6X2B;
CC         IsoId=P23229-5; Sequence=VSP_002723;
CC       Name=Alpha-6X1X2A;
CC         IsoId=P23229-6; Sequence=VSP_002725;
CC         Note=Contains a phosphoserine at position 1103.
CC         {ECO:0000269|PubMed:8360143};
CC       Name=7;
CC         IsoId=P23229-7; Sequence=VSP_036406, VSP_002723, VSP_002725;
CC       Name=9;
CC         IsoId=P23229-9; Sequence=VSP_036407, VSP_002725;
CC   -!- TISSUE SPECIFICITY: Integrin alpha-6/beta-4 is predominantly
CC       expressed by epithelia. Isoforms containing segment X1 are
CC       ubiquitously expressed. Isoforms containing segment X1X2 are
CC       expressed in heart, kidney, placenta, colon, duodenum, myoblasts
CC       and myotubes, and in a limited number of cell lines; they are
CC       always coexpressed with the ubiquitous isoform containing segment
CC       X1. In some tissues (e.g. Salivary gland), isoforms containing
CC       cytoplasmic segment A and isoforms containing segment B are
CC       detected while in others, only isoforms containing one cytoplasmic
CC       segment are found (segment A in epidermis and segment B in
CC       kidney). {ECO:0000269|PubMed:7681434}.
CC   -!- PTM: Isoforms containing segment A, but not segment B, are the
CC       major targets for PMA-induced phosphorylation. Phosphorylation
CC       occurs on 'Ser-1103' of isoform alpha-6X1X2A. Phosphorylation is
CC       not required for the induction of integrin alpha-6A/beta-1 high
CC       affinity but may reduce the affinity for ligand.
CC   -!- PTM: In invasive prostate cancer ITGA6 undergoes PLAU-mediated
CC       cleavage at residues Arg-634-635-Arg in a time-dependent manner
CC       enhancing cell invasion and migration in vitro.
CC       {ECO:0000269|PubMed:17303120}.
CC   -!- PTM: Palmitoylation by DHHC3 enhances stability and cell surface
CC       expression. {ECO:0000269|PubMed:15611341,
CC       ECO:0000269|PubMed:22314500}.
CC   -!- DISEASE: Epidermolysis bullosa letalis, with pyloric atresia (EB-
CC       PA) [MIM:226730]: An autosomal recessive, frequently lethal,
CC       epidermolysis bullosa with variable involvement of skin, nails,
CC       mucosa, and with variable effects on the digestive system. It is
CC       characterized by mucocutaneous fragility, aplasia cutis congenita,
CC       and gastrointestinal atresia, which most commonly affects the
CC       pylorus. Pyloric atresia is a primary manifestation rather than a
CC       scarring process secondary to epidermolysis bullosa. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG57680.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X53586; CAA37655.1; -; mRNA.
DR   EMBL; AF166343; AAD48469.1; -; Genomic_DNA.
DR   EMBL; AF166335; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AF166336; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AF166337; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AF166338; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AF166339; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AF166340; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AF166341; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AF166342; AAD48469.1; JOINED; Genomic_DNA.
DR   EMBL; AK294436; BAG57680.1; ALT_INIT; mRNA.
DR   EMBL; AK296496; BAG59130.1; -; mRNA.
DR   EMBL; AC078883; AAX93133.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11176.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11177.1; -; Genomic_DNA.
DR   EMBL; BC050585; AAH50585.1; -; mRNA.
DR   EMBL; BC136455; AAI36456.1; -; mRNA.
DR   EMBL; BC136456; AAI36457.1; -; mRNA.
DR   EMBL; X59512; CAA42099.1; -; mRNA.
DR   EMBL; S66213; AAB20355.1; -; mRNA.
DR   EMBL; S66196; AAB20354.1; -; mRNA.
DR   EMBL; S52135; AAB24829.1; -; Genomic_DNA.
DR   EMBL; L40385; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB208842; BAD92079.1; -; mRNA.
DR   EMBL; DQ858220; ABH11650.1; -; mRNA.
DR   CCDS; CCDS2249.1; -. [P23229-2]
DR   CCDS; CCDS46451.1; -. [P23229-3]
DR   CCDS; CCDS82534.1; -. [P23229-7]
DR   PIR; A41543; A41543.
DR   PIR; B36429; B36429.
DR   RefSeq; NP_000201.2; NM_000210.3. [P23229-2]
DR   RefSeq; NP_001073286.1; NM_001079818.2. [P23229-3]
DR   RefSeq; NP_001303235.1; NM_001316306.1. [P23229-7]
DR   UniGene; Hs.133397; -.
DR   ProteinModelPortal; P23229; -.
DR   BioGrid; 109864; 45.
DR   CORUM; P23229; -.
DR   IntAct; P23229; 6.
DR   MINT; MINT-5002506; -.
DR   STRING; 9606.ENSP00000386896; -.
DR   ChEMBL; CHEMBL3716; -.
DR   TCDB; 8.A.54.1.2; the integrin (integrin) family.
DR   iPTMnet; P23229; -.
DR   PhosphoSitePlus; P23229; -.
DR   SwissPalm; P23229; -.
DR   BioMuta; ITGA6; -.
DR   DMDM; 519668687; -.
DR   OGP; P23229; -.
DR   EPD; P23229; -.
DR   MaxQB; P23229; -.
DR   PaxDb; P23229; -.
DR   PeptideAtlas; P23229; -.
DR   PRIDE; P23229; -.
DR   Ensembl; ENST00000264107; ENSP00000264107; ENSG00000091409. [P23229-2]
DR   Ensembl; ENST00000409080; ENSP00000386896; ENSG00000091409. [P23229-3]
DR   Ensembl; ENST00000409532; ENSP00000386614; ENSG00000091409. [P23229-7]
DR   Ensembl; ENST00000442250; ENSP00000406694; ENSG00000091409. [P23229-1]
DR   Ensembl; ENST00000458358; ENSP00000394169; ENSG00000091409. [P23229-5]
DR   GeneID; 3655; -.
DR   KEGG; hsa:3655; -.
DR   UCSC; uc002uho.2; human. [P23229-1]
DR   CTD; 3655; -.
DR   DisGeNET; 3655; -.
DR   EuPathDB; HostDB:ENSG00000091409.14; -.
DR   GeneCards; ITGA6; -.
DR   GeneReviews; ITGA6; -.
DR   H-InvDB; HIX0023932; -.
DR   HGNC; HGNC:6142; ITGA6.
DR   HPA; CAB009009; -.
DR   HPA; HPA012696; -.
DR   HPA; HPA027582; -.
DR   MalaCards; ITGA6; -.
DR   MIM; 147556; gene.
DR   MIM; 226730; phenotype.
DR   neXtProt; NX_P23229; -.
DR   OpenTargets; ENSG00000091409; -.
DR   Orphanet; 79403; Junctional epidermolysis bullosa - pyloric atresia.
DR   PharmGKB; PA29942; -.
DR   eggNOG; ENOG410IPBB; Eukaryota.
DR   eggNOG; ENOG410XVGZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOVERGEN; HBG108011; -.
DR   InParanoid; P23229; -.
DR   KO; K06485; -.
DR   OMA; YVYINQQ; -.
DR   OrthoDB; EOG091G012D; -.
DR   PhylomeDB; P23229; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-446107; Type I hemidesmosome assembly.
DR   SignaLink; P23229; -.
DR   SIGNOR; P23229; -.
DR   ChiTaRS; ITGA6; human.
DR   GeneWiki; ITGA6; -.
DR   GenomeRNAi; 3655; -.
DR   PMAP-CutDB; Q53RX7; -.
DR   PRO; PR:P23229; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000091409; -.
DR   CleanEx; HS_ITGA6; -.
DR   ExpressionAtlas; P23229; baseline and differential.
DR   Genevisible; P23229; HS.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:Ensembl.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005913; C:cell-cell adherens junction; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0030175; C:filopodium; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0030056; C:hemidesmosome; IEA:Ensembl.
DR   GO; GO:0034676; C:integrin alpha6-beta4 complex; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0031994; F:insulin-like growth factor I binding; IDA:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0043236; F:laminin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0038132; F:neuregulin binding; IDA:UniProtKB.
DR   GO; GO:0097186; P:amelogenesis; IMP:UniProtKB.
DR   GO; GO:0050873; P:brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IEA:Ensembl.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0007044; P:cell-substrate junction assembly; TAS:ProtInc.
DR   GO; GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0048565; P:digestive tract development; IMP:UniProtKB.
DR   GO; GO:0010668; P:ectodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0046847; P:filopodium assembly; IEA:Ensembl.
DR   GO; GO:0031581; P:hemidesmosome assembly; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0035878; P:nail development; IMP:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0072001; P:renal system development; IMP:UniProtKB.
DR   GO; GO:0043588; P:skin development; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell membrane;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Epidermolysis bullosa;
KW   Glycoprotein; Integrin; Lipoprotein; Membrane; Metal-binding;
KW   Palmitate; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000269|PubMed:1953640,
FT                                ECO:0000269|PubMed:2542022,
FT                                ECO:0000269|PubMed:2649503}.
FT   CHAIN        24   1130       Integrin alpha-6.
FT                                /FTId=PRO_0000016258.
FT   CHAIN        24    938       Integrin alpha-6 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016259.
FT   CHAIN       636   1130       Processed integrin alpha-6.
FT                                /FTId=PRO_0000425742.
FT   CHAIN       942   1130       Integrin alpha-6 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016260.
FT   TOPO_DOM     24   1050       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1051   1076       Helical. {ECO:0000255}.
FT   TOPO_DOM   1077   1130       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       30     95       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      101    166       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      176    229       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      283    339       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      340    402       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      403    458       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      459    518       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     363    371       {ECO:0000255}.
FT   CA_BIND     425    433       {ECO:0000255}.
FT   CA_BIND     480    488       {ECO:0000255}.
FT   REGION     1077   1083       Interaction with HPS5.
FT   MOTIF      1079   1083       GFFKR motif.
FT   SITE        634    635       Cleavage; by PLAU in invasive prostate
FT                                cancer. {ECO:0000269|PubMed:17303120}.
FT   LIPID      1078   1078       S-palmitoyl cysteine; by DHHC3.
FT                                {ECO:0000269|PubMed:15611341,
FT                                ECO:0000269|PubMed:22314500}.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    223    223       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16263699}.
FT   CARBOHYD    409    409       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    770    770       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    787    787       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    930    930       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    966    966       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    997    997       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID     86     94       {ECO:0000250}.
FT   DISULFID    131    154       {ECO:0000250}.
FT   DISULFID    175    188       {ECO:0000250}.
FT   DISULFID    528    535       {ECO:0000250}.
FT   DISULFID    541    601       {ECO:0000250}.
FT   DISULFID    665    671       {ECO:0000250}.
FT   DISULFID    765    776       {ECO:0000250}.
FT   DISULFID    920    967       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    973    978       {ECO:0000250}.
FT   VAR_SEQ       1    114       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036406.
FT   VAR_SEQ     215    258       Missing (in isoform Alpha-6X2A, isoform
FT                                Alpha-6X2B and isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_002723.
FT   VAR_SEQ     259    297       Missing (in isoform Alpha-6X1A and
FT                                isoform Alpha-6X1B).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1976638}.
FT                                /FTId=VSP_002724.
FT   VAR_SEQ     918    932       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036407.
FT   VAR_SEQ    1084   1130       SRYDDSVPRYHAVRIRKEEREIKDEKYIDNLEKKQWITKWN
FT                                ENESYS -> NKKDHYDATYHKAEIHAQPSDKERLTSDA
FT                                (in isoform Alpha-6X1A, isoform Alpha-
FT                                6X2A, isoform Alpha-6X1X2A, isoform 7 and
FT                                isoform 9). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1976638}.
FT                                /FTId=VSP_002725.
FT   CONFLICT     69     69       A -> G (in Ref. 1; CAA37655 and 8;
FT                                CAA42099). {ECO:0000305}.
FT   CONFLICT    419    419       A -> T (in Ref. 4; BAG59130 and 7;
FT                                AAI36456/AAI36457). {ECO:0000305}.
FT   CONFLICT    501    501       F -> L (in Ref. 8; CAA42099).
FT                                {ECO:0000305}.
FT   CONFLICT    805    805       D -> Y (in Ref. 1; CAA37655 and 3;
FT                                AAD48469). {ECO:0000305}.
FT   CONFLICT   1125   1125       E -> R (in Ref. 1; AAB20355).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1130 AA;  126606 MW;  B53712888B7FE3B6 CRC64;
     MAAAGQLCLL YLSAGLLSRL GAAFNLDTRE DNVIRKYGDP GSLFGFSLAM HWQLQPEDKR
     LLLVGAPRAE ALPLQRANRT GGLYSCDITA RGPCTRIEFD NDADPTSESK EDQWMGVTVQ
     SQGPGGKVVT CAHRYEKRQH VNTKQESRDI FGRCYVLSQN LRIEDDMDGG DWSFCDGRLR
     GHEKFGSCQQ GVAATFTKDF HYIVFGAPGT YNWKGIVRVE QKNNTFFDMN IFEDGPYEVG
     GETEHDESLV PVPANSYLGL LFLTSVSYTD PDQFVYKTRP PREQPDTFPD VMMNSYLGFS
     LDSGKGIVSK DEITFVSGAP RANHSGAVVL LKRDMKSAHL LPEHIFDGEG LASSFGYDVA
     VVDLNKDGWQ DIVIGAPQYF DRDGEVGGAV YVYMNQQGRW NNVKPIRLNG TKDSMFGIAV
     KNIGDINQDG YPDIAVGAPY DDLGKVFIYH GSANGINTKP TQVLKGISPY FGYSIAGNMD
     LDRNSYPDVA VGSLSDSVTI FRSRPVINIQ KTITVTPNRI DLRQKTACGA PSGICLQVKS
     CFEYTANPAG YNPSISIVGT LEAEKERRKS GLSSRVQFRN QGSEPKYTQE LTLKRQKQKV
     CMEETLWLQD NIRDKLRPIP ITASVEIQEP SSRRRVNSLP EVLPILNSDE PKTAHIDVHF
     LKEGCGDDNV CNSNLKLEYK FCTREGNQDK FSYLPIQKGV PELVLKDQKD IALEITVTNS
     PSNPRNPTKD GDDAHEAKLI ATFPDTLTYS AYRELRAFPE KQLSCVANQN GSQADCELGN
     PFKRNSNVTF YLVLSTTEVT FDTPDLDINL KLETTSNQDN LAPITAKAKV VIELLLSVSG
     VAKPSQVYFG GTVVGEQAMK SEDEVGSLIE YEFRVINLGK PLTNLGTATL NIQWPKEISN
     GKWLLYLVKV ESKGLEKVTC EPQKEINSLN LTESHNSRKK REITEKQIDD NRKFSLFAER
     KYQTLNCSVN VNCVNIRCPL RGLDSKASLI LRSRLWNSTF LEEYSKLNYL DILMRAFIDV
     TAAAENIRLP NAGTQVRVTV FPSKTVAQYS GVPWWIILVA ILAGILMLAL LVFILWKCGF
     FKRSRYDDSV PRYHAVRIRK EEREIKDEKY IDNLEKKQWI TKWNENESYS
//
ID   ITA3_HUMAN              Reviewed;        1051 AA.
AC   P26006; A7E246; B7ZM80; B9EGQ1; D3DTX4; D3DTX5;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 5.
DT   22-NOV-2017, entry version 189.
DE   RecName: Full=Integrin alpha-3;
DE   AltName: Full=CD49 antigen-like family member C;
DE   AltName: Full=FRP-2;
DE   AltName: Full=Galactoprotein B3;
DE            Short=GAPB3;
DE   AltName: Full=VLA-3 subunit alpha;
DE   AltName: CD_antigen=CD49c;
DE   Contains:
DE     RecName: Full=Integrin alpha-3 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-3 light chain;
DE   Flags: Precursor;
GN   Name=ITGA3; Synonyms=MSK18;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=1655803; DOI=10.1083/jcb.115.1.257;
RA   Takada Y., Murphy E., Pil P., Chen C., Ginsberg M.H., Hemler M.E.;
RT   "Molecular cloning and expression of the cDNA for alpha 3 subunit of
RT   human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin,
RT   laminin, and collagen.";
RL   J. Cell Biol. 115:257-266(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 33-1051 (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=1714443;
RA   Tsuji T., Hakomori S., Osawa T.;
RT   "Identification of human galactoprotein b3, an oncogenic
RT   transformation-induced membrane glycoprotein, as VLA-3 alpha subunit:
RT   the primary structure of human integrin alpha 3.";
RL   J. Biochem. 109:659-665(1991).
RN   [7]
RP   PROTEIN SEQUENCE OF 33-49.
RX   PubMed=8187758;
RA   Ohta H., Tsurudome M., Matsumura H., Koga Y., Morikawa S., Kawano M.,
RA   Kusugawa S., Komada H., Nishio M., Ito Y.;
RT   "Molecular and biological characterization of fusion regulatory
RT   proteins (FRPs): anti-FRP mAbs induced HIV-mediated cell fusion via an
RT   integrin system.";
RL   EMBO J. 13:2044-2055(1994).
RN   [8]
RP   PROTEIN SEQUENCE OF 33-46.
RX   PubMed=3033641; DOI=10.1073/pnas.84.10.3239;
RA   Takada Y., Strominger J.L., Hemler M.E.;
RT   "The very late antigen family of heterodimers is part of a superfamily
RT   of molecules involved in adhesion and embryogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:3239-3243(1987).
RN   [9]
RP   PROTEIN SEQUENCE OF 33-40, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND INTERACTION WITH FAP.
RX   PubMed=10455171; DOI=10.1074/jbc.274.35.24947;
RA   Mueller S.C., Ghersi G., Akiyama S.K., Sang Q.X., Howard L.,
RA   Pineiro-Sanchez M., Nakahara H., Yeh Y., Chen W.T.;
RT   "A novel protease-docking function of integrin at invadopodia.";
RL   J. Biol. Chem. 274:24947-24952(1999).
RN   [10]
RP   ALTERNATIVE SPLICING, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=9111516;
RA   de Melker A.A., Sterk L.M., Delwel G.O., Fles D.L., Daams H.,
RA   Weening J.J., Sonnenberg A.;
RT   "The A and B variants of the alpha 3 integrin subunit: tissue
RT   distribution and functional characterization.";
RL   Lab. Invest. 76:547-563(1997).
RN   [11]
RP   DISULFIDE BONDS.
RX   PubMed=14596610; DOI=10.1021/bi034726u;
RA   Krokhin O.V., Cheng K., Sousa S.L., Ens W., Standing K.G.,
RA   Wilkins J.A.;
RT   "Mass spectrometric based mapping of the disulfide bonding patterns of
RT   integrin alpha chains.";
RL   Biochemistry 42:12950-12959(2003).
RN   [12]
RP   PALMITOYLATION AT CYS-1016, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   CYS-1016.
RX   PubMed=15611341; DOI=10.1083/jcb.200404100;
RA   Yang X., Kovalenko O.V., Tang W., Claas C., Stipp C.S., Hemler M.E.;
RT   "Palmitoylation supports assembly and function of integrin-tetraspanin
RT   complexes.";
RL   J. Cell Biol. 167:1231-1240(2004).
RN   [13]
RP   INTERACTION WITH ITGB1; LGALS3 AND CSPG4, AND FUNCTION.
RX   PubMed=15181153; DOI=10.1091/mbc.E04-03-0236;
RA   Fukushi J., Makagiansar I.T., Stallcup W.B.;
RT   "NG2 proteoglycan promotes endothelial cell motility and angiogenesis
RT   via engagement of galectin-3 and alpha3beta1 integrin.";
RL   Mol. Biol. Cell 15:3580-3590(2004).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   VARIANT ILNEB PRO-628.
RX   PubMed=22512483; DOI=10.1056/NEJMoa1110813;
RA   Has C., Sparta G., Kiritsi D., Weibel L., Moeller A., Vega-Warner V.,
RA   Waters A., He Y., Anikster Y., Esser P., Straub B.K., Hausser I.,
RA   Bockenhauer D., Dekel B., Hildebrandt F., Bruckner-Tuderman L.,
RA   Laube G.F.;
RT   "Integrin alpha3 mutations with kidney, lung, and skin disease.";
RL   N. Engl. J. Med. 366:1508-1514(2012).
RN   [16]
RP   VARIANTS ILNEB ARG-125 AND GLN-274.
RX   PubMed=27717396; DOI=10.1186/s13023-016-0514-z;
RA   Colombo E.A., Spaccini L., Volpi L., Negri G., Cittaro D.,
RA   Lazarevic D., Zirpoli S., Farolfi A., Gervasini C., Cubellis M.V.,
RA   Larizza L.;
RT   "Viable phenotype of ILNEB syndrome without nephrotic impairment in
RT   siblings heterozygous for unreported integrin alpha3 mutations.";
RL   Orphanet J. Rare Dis. 11:136-136(2016).
CC   -!- FUNCTION: Integrin alpha-3/beta-1 is a receptor for fibronectin,
CC       laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin
CC       alpha-3/beta-1 provides a docking site for FAP (seprase) at
CC       invadopodia plasma membranes in a collagen-dependent manner and
CC       hence may participate in the adhesion, formation of invadopodia
CC       and matrix degradation processes, promoting cell invasion. Alpha-
CC       3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of
CC       endothelial cells migration. {ECO:0000269|PubMed:10455171,
CC       ECO:0000269|PubMed:15181153}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-3 associates with beta-1. Interacts with
CC       HPS5. Interacts with FAP (seprase); the interaction occurs at the
CC       cell surface of invadopodia membrane in a collagen-dependent
CC       manner. {ECO:0000269|PubMed:10455171,
CC       ECO:0000269|PubMed:15181153}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15611341};
CC       Single-pass type I membrane protein {ECO:0000255}. Cell membrane
CC       {ECO:0000269|PubMed:15611341}; Lipid-anchor
CC       {ECO:0000269|PubMed:15611341}. Cell projection, invadopodium
CC       membrane {ECO:0000269|PubMed:10455171}; Single-pass type I
CC       membrane protein {ECO:0000255}. Cell projection, filopodium
CC       membrane {ECO:0000269|PubMed:10455171}; Single-pass type I
CC       membrane protein {ECO:0000255}. Note=Enriched preferentially at
CC       invadopodia, cell membrane protrusions that correspond to sites of
CC       cell invasion, in a collagen-dependent manner.
CC       {ECO:0000269|PubMed:10455171}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Alpha-3A;
CC         IsoId=P26006-2; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha-3B;
CC         IsoId=P26006-1; Sequence=VSP_002721;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is widely expressed. Isoform 2 is
CC       expressed in brain and heart. In brain, both isoforms are
CC       exclusively expressed on vascular smooth muscle cells, whereas in
CC       heart isoform 1 is strongly expressed on vascular smooth muscle
CC       cells, isoform 2 is detected only on endothelial vein cells.
CC       {ECO:0000269|PubMed:9111516}.
CC   -!- PTM: Isoform 1, but not isoform 2, is phosphorylated on serine
CC       residues. Phosphorylation increases after phorbol 12-myristate 13-
CC       acetate stimulation. {ECO:0000269|PubMed:9111516}.
CC   -!- DISEASE: Interstitial lung disease, nephrotic syndrome, and
CC       epidermolysis bullosa, congenital (ILNEB) [MIM:614748]: A
CC       multiorgan disorder characterized by congenital nephrotic
CC       syndrome, interstitial lung disease, and epidermolysis bullosa.
CC       The respiratory and renal features predominate, and lung
CC       involvement accounts for the lethal course of the disease.
CC       {ECO:0000269|PubMed:22512483, ECO:0000269|PubMed:27717396}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M59911; AAA36120.1; -; mRNA.
DR   EMBL; AK289961; BAF82650.1; -; mRNA.
DR   EMBL; AC002401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94645.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94646.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94647.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94648.1; -; Genomic_DNA.
DR   EMBL; BC136636; AAI36637.1; -; mRNA.
DR   EMBL; BC144328; AAI44329.1; -; mRNA.
DR   EMBL; BC150190; AAI50191.1; -; mRNA.
DR   EMBL; D01038; BAA00845.1; -; mRNA.
DR   CCDS; CCDS11558.1; -. [P26006-2]
DR   PIR; A40021; A40021.
DR   RefSeq; NP_002195.1; NM_002204.3. [P26006-2]
DR   UniGene; Hs.265829; -.
DR   UniGene; Hs.660689; -.
DR   ProteinModelPortal; P26006; -.
DR   BioGrid; 109882; 16.
DR   CORUM; P26006; -.
DR   DIP; DIP-140N; -.
DR   IntAct; P26006; 5.
DR   MINT; MINT-140288; -.
DR   STRING; 9606.ENSP00000007722; -.
DR   BindingDB; P26006; -.
DR   ChEMBL; CHEMBL3525; -.
DR   GuidetoPHARMACOLOGY; 2442; -.
DR   iPTMnet; P26006; -.
DR   PhosphoSitePlus; P26006; -.
DR   SwissPalm; P26006; -.
DR   UniCarbKB; P26006; -.
DR   BioMuta; ITGA3; -.
DR   DMDM; 347595830; -.
DR   EPD; P26006; -.
DR   PaxDb; P26006; -.
DR   PeptideAtlas; P26006; -.
DR   PRIDE; P26006; -.
DR   Ensembl; ENST00000007722; ENSP00000007722; ENSG00000005884. [P26006-1]
DR   Ensembl; ENST00000320031; ENSP00000315190; ENSG00000005884. [P26006-2]
DR   GeneID; 3675; -.
DR   KEGG; hsa:3675; -.
DR   UCSC; uc010dbl.4; human. [P26006-2]
DR   CTD; 3675; -.
DR   DisGeNET; 3675; -.
DR   EuPathDB; HostDB:ENSG00000005884.17; -.
DR   GeneCards; ITGA3; -.
DR   HGNC; HGNC:6139; ITGA3.
DR   HPA; CAB018594; -.
DR   HPA; HPA008572; -.
DR   MalaCards; ITGA3; -.
DR   MIM; 605025; gene.
DR   MIM; 614748; phenotype.
DR   neXtProt; NX_P26006; -.
DR   OpenTargets; ENSG00000005884; -.
DR   Orphanet; 306504; Congenital nephrotic syndrome-interstitial lung disease-epidermolysis bullosa syndrome.
DR   PharmGKB; PA29939; -.
DR   eggNOG; ENOG410IPB6; Eukaryota.
DR   eggNOG; ENOG410ZZD8; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000015786; -.
DR   HOVERGEN; HBG108011; -.
DR   InParanoid; P26006; -.
DR   KO; K06482; -.
DR   OMA; YNQSAGN; -.
DR   OrthoDB; EOG091G012D; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   SIGNOR; P26006; -.
DR   ChiTaRS; ITGA3; human.
DR   GeneWiki; CD49c; -.
DR   GenomeRNAi; 3675; -.
DR   PMAP-CutDB; P26006; -.
DR   PRO; PR:P26006; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000005884; -.
DR   CleanEx; HS_ITGA3; -.
DR   ExpressionAtlas; P26006; baseline and differential.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0060076; C:excitatory synapse; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031527; C:filopodium membrane; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0034667; C:integrin alpha3-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0071438; C:invadopodium membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0097060; C:synaptic membrane; IEA:Ensembl.
DR   GO; GO:0005518; F:collagen binding; IEA:Ensembl.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0043236; F:laminin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; TAS:ProtInc.
DR   GO; GO:0097062; P:dendritic spine maintenance; IEA:Ensembl.
DR   GO; GO:0035640; P:exploration behavior; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0030324; P:lung development; IMP:UniProtKB.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0031345; P:negative regulation of cell projection organization; IEA:Ensembl.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IEA:Ensembl.
DR   GO; GO:0072006; P:nephron development; IMP:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030510; P:regulation of BMP signaling pathway; IMP:UniProtKB.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0097205; P:renal filtration; IMP:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0034698; P:response to gonadotropin; IEA:Ensembl.
DR   GO; GO:0043588; P:skin development; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell junction;
KW   Cell membrane; Cell projection; Cleavage on pair of basic residues;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Epidermolysis bullosa; Glycoprotein; Integrin;
KW   Lipoprotein; Membrane; Metal-binding; Palmitate; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     32       {ECO:0000269|PubMed:10455171,
FT                                ECO:0000269|PubMed:3033641,
FT                                ECO:0000269|PubMed:8187758}.
FT   CHAIN        33   1051       Integrin alpha-3.
FT                                /FTId=PRO_0000016238.
FT   CHAIN        33    872       Integrin alpha-3 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016239.
FT   CHAIN       876   1051       Integrin alpha-3 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016240.
FT   TOPO_DOM     33    991       Extracellular. {ECO:0000255}.
FT   TRANSMEM    992   1014       Helical. {ECO:0000255}.
FT   TOPO_DOM   1015   1051       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       38    103       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      110    171       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      185    235       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      236    292       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      293    354       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      356    411       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      415    477       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     315    323       {ECO:0000255}.
FT   CA_BIND     378    386       {ECO:0000255}.
FT   CA_BIND     439    447       {ECO:0000255}.
FT   REGION     1015   1021       Interaction with HPS5.
FT   MOTIF      1017   1021       GFFKR motif.
FT   LIPID      1016   1016       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:15611341}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    107    107       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    500    500       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    511    511       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    573    573       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    605    605       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    656    656       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    697    697       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    841    841       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    857    857       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    926    926       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    935    935       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    969    969       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     94    103       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    140    162       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    185    197       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    485    490       {ECO:0000250}.
FT   DISULFID    496    550       {ECO:0000250}.
FT   DISULFID    615    621       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    694    702       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    846    904       Interchain (between heavy and light
FT                                chains). {ECO:0000269|PubMed:14596610}.
FT   DISULFID    911    916       {ECO:0000269|PubMed:14596610}.
FT   VAR_SEQ    1017   1051       GFFKRARTRALYEAKRQKAEMKSQPSETERLTDDY -> DF
FT                                FKRTRYYQIMPKYHAVRIREEERYPPPGSTLPTKKHWVTSW
FT                                QTRDQYY (in isoform 2).
FT                                {ECO:0000303|PubMed:1655803}.
FT                                /FTId=VSP_002721.
FT   VARIANT     125    125       G -> R (in ILNEB).
FT                                {ECO:0000269|PubMed:27717396}.
FT                                /FTId=VAR_077512.
FT   VARIANT     268    268       I -> F (in dbSNP:rs2230390).
FT                                /FTId=VAR_055967.
FT   VARIANT     274    274       R -> Q (in ILNEB; dbSNP:rs745505565).
FT                                {ECO:0000269|PubMed:27717396}.
FT                                /FTId=VAR_077513.
FT   VARIANT     628    628       R -> P (in ILNEB; dbSNP:rs140781106).
FT                                {ECO:0000269|PubMed:22512483}.
FT                                /FTId=VAR_068808.
FT   VARIANT     719    719       A -> T (in dbSNP:rs2230392).
FT                                /FTId=VAR_055968.
FT   VARIANT     840    840       G -> S (in dbSNP:rs2301626).
FT                                /FTId=VAR_055969.
FT   MUTAGEN    1016   1016       C->S: Abolishes palmitoylation.
FT                                {ECO:0000269|PubMed:15611341}.
SQ   SEQUENCE   1051 AA;  116612 MW;  EEAFA7778EF17B21 CRC64;
     MGPGPSRAPR APRLMLCALA LMVAAGGCVV SAFNLDTRFL VVKEAGNPGS LFGYSVALHR
     QTERQQRYLL LAGAPRELAV PDGYTNRTGA VYLCPLTAHK DDCERMNITV KNDPGHHIIE
     DMWLGVTVAS QGPAGRVLVC AHRYTQVLWS GSEDQRRMVG KCYVRGNDLE LDSSDDWQTY
     HNEMCNSNTD YLETGMCQLG TSGGFTQNTV YFGAPGAYNW KGNSYMIQRK EWDLSEYSYK
     DPEDQGNLYI GYTMQVGSFI LHPKNITIVT GAPRHRHMGA VFLLSQEAGG DLRRRQVLEG
     SQVGAYFGSA IALADLNNDG WQDLLVGAPY YFERKEEVGG AIYVFMNQAG TSFPAHPSLL
     LHGPSGSAFG LSVASIGDIN QDGFQDIAVG APFEGLGKVY IYHSSSKGLL RQPQQVIHGE
     KLGLPGLATF GYSLSGQMDV DENFYPDLLV GSLSDHIVLL RARPVINIVH KTLVPRPAVL
     DPALCTATSC VQVELCFAYN QSAGNPNYRR NITLAYTLEA DRDRRPPRLR FAGSESAVFH
     GFFSMPEMRC QKLELLLMDN LRDKLRPIII SMNYSLPLRM PDRPRLGLRS LDAYPILNQA
     QALENHTEVQ FQKECGPDNK CESNLQMRAA FVSEQQQKLS RLQYSRDVRK LLLSINVTNT
     RTSERSGEDA HEALLTLVVP PALLLSSVRP PGACQANETI FCELGNPFKR NQRMELLIAF
     EVIGVTLHTR DLQVQLQLST SSHQDNLWPM ILTLLVDYTL QTSLSMVNHR LQSFFGGTVM
     GESGMKTVED VGSPLKYEFQ VGPMGEGLVG LGTLVLGLEW PYEVSNGKWL LYPTEITVHG
     NGSWPCRPPG DLINPLNLTL SDPGDRPSSP QRRRRQLDPG GGQGPPPVTL AAAKKAKSET
     VLTCATGRAH CVWLECPIPD APVVTNVTVK ARVWNSTFIE DYRDFDRVRV NGWATLFLRT
     SIPTINMENK TTWFSVDIDS ELVEELPAEI ELWLVLVAVG AGLLLLGLII LLLWKCGFFK
     RARTRALYEA KRQKAEMKSQ PSETERLTDD Y
//
ID   ITB7_HUMAN              Reviewed;         798 AA.
AC   P26010; Q9UCP7; Q9UCS7;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   22-NOV-2017, entry version 182.
DE   RecName: Full=Integrin beta-7;
DE   AltName: Full=Gut homing receptor beta subunit;
DE   Flags: Precursor;
GN   Name=ITGB7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RC   TISSUE=T-cell;
RX   PubMed=2083230; DOI=10.1093/intimm/2.11.1097;
RA   Yuan Q., Jiang W.-M., Krissansen G.W., Watson J.D.;
RT   "Cloning and sequence analysis of a novel beta 2-related integrin
RT   transcript from T lymphocytes: homology of integrin cysteine-rich
RT   repeats to domain III of laminin B chains.";
RL   Int. Immunol. 2:1097-1108(1990).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=1777426; DOI=10.1093/intimm/3.12.1373;
RA   Yuan Q., Jiang W.-M., Krissansen G.W., Watson J.D.;
RT   "Cloning and sequence analysis of a novel beta 2-related integrin
RT   transcript from T lymphocytes: homology of integrin cysteine-rich
RT   repeats to domain III of laminin B chains.";
RL   Int. Immunol. 3:1373-1374(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT).
RC   TISSUE=Leukocyte;
RX   PubMed=2040616;
RA   Erle D.J., Rueegg C., Sheppard D., Pytela R.;
RT   "Complete amino acid sequence of an integrin beta subunit (beta 7)
RT   identified in leukocytes.";
RL   J. Biol. Chem. 266:11009-11016(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1382574; DOI=10.1093/intimm/4.9.1031;
RA   Jiang W.-M., Jenkins D., Yuan Q., Leung E., Choo K.H., Watson J.D.,
RA   Krissansen G.W.;
RT   "The gene organization of the human beta 7 subunit, the common beta
RT   subunit of the leukocyte integrins HML-1 and LPAM-1.";
RL   Int. Immunol. 4:1031-1040(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 20-36, INTERACTION WITH INTEGRIN ALPHA-4 AND
RP   INTEGRIN ALPHA-E, AND INDUCTION.
RX   PubMed=1542691; DOI=10.1073/pnas.89.5.1924;
RA   Parker C.M., Cepek K.L., Russell G.J., Shaw S.K., Posnett D.N.,
RA   Schwarting R., Brenner M.B.;
RT   "A family of beta 7 integrins on human mucosal lymphocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1924-1928(1992).
RN   [7]
RP   PROTEIN SEQUENCE OF 20-34.
RC   TISSUE=Leukemia;
RX   PubMed=1750505;
RA   Micklem K.J., Dong Y., Willis A., Pulford K.A., Visser L., Duerkop H.,
RA   Poppema S., Stein H., Mason D.Y.;
RT   "HML-1 antigen on mucosa-associated T cells, activated cells, and
RT   hairy leukemic cells is a new integrin containing the beta 7
RT   subunit.";
RL   Am. J. Pathol. 139:1297-1301(1991).
RN   [8]
RP   MUTAGENESIS OF ASP-159.
RX   PubMed=10837471; DOI=10.1074/jbc.M001228200;
RA   Higgins J.M.G., Cernadas M., Tan K., Irie A., Wang J.-H., Takada Y.,
RA   Brenner M.B.;
RT   "The role of alpha and beta chains in ligand recognition by beta 7
RT   integrins.";
RL   J. Biol. Chem. 275:25652-25664(2000).
RN   [9]
RP   REVIEW.
RX   PubMed=12297042; DOI=10.1016/S0092-8674(02)00971-6;
RA   Hynes R.O.;
RT   "Integrins: bidirectional, allosteric signaling machines.";
RL   Cell 110:673-687(2002).
RN   [10]
RP   INTERACTION WITH HIV-1 GP120.
RX   PubMed=18264102; DOI=10.1038/ni1566;
RA   Arthos J., Cicala C., Martinelli E., Macleod K., Van Ryk D., Wei D.,
RA   Xiao Z., Veenstra T.D., Conrad T.P., Lempicki R.A., McLaughlin S.,
RA   Pascuccio M., Gopaul R., McNally J., Cruz C.C., Censoplano N.,
RA   Chung E., Reitano K.N., Kottilil S., Goode D.J., Fauci A.S.;
RT   "HIV-1 envelope protein binds to and signals through integrin
RT   alpha4beta7, the gut mucosal homing receptor for peripheral T cells.";
RL   Nat. Immunol. 9:301-309(2008).
RN   [11]
RP   INTERACTION WITH FLNA.
RX   PubMed=19828450; DOI=10.1074/jbc.M109.060954;
RA   Ithychanda S.S., Hsu D., Li H., Yan L., Liu D.D., Liu D., Das M.,
RA   Plow E.F., Qin J.;
RT   "Identification and characterization of multiple similar ligand-
RT   binding repeats in filamin: implication on filamin-mediated receptor
RT   clustering and cross-talk.";
RL   J. Biol. Chem. 284:35113-35121(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 768-798.
RX   PubMed=16455489; DOI=10.1016/j.molcel.2006.01.011;
RA   Kiema T., Lad Y., Jiang P., Oxley C.L., Baldassarre M., Wegener K.L.,
RA   Campbell I.D., Ylanne J., Calderwood D.A.;
RT   "The molecular basis of filamin binding to integrins and competition
RT   with talin.";
RL   Mol. Cell 21:337-347(2006).
CC   -!- FUNCTION: Integrin alpha-4/beta-7 (Peyer patches-specific homing
CC       receptor LPAM-1) is an adhesion molecule that mediates lymphocyte
CC       migration and homing to gut-associated lymphoid tissue (GALT).
CC       Integrin alpha-4/beta-7 interacts with the cell surface adhesion
CC       molecules MADCAM1 which is normally expressed by the vascular
CC       endothelium of the gastrointestinal tract. Interacts also with
CC       VCAM1 and fibronectin, an extracellular matrix component. It
CC       recognizes one or more domains within the alternatively spliced
CC       CS-1 region of fibronectin. Interactions involves the tripeptide
CC       L-D-T in MADCAM1, and L-D-V in fibronectin. Binds to HIV-1 gp120,
CC       thereby allowing the virus to enter GALT, which is thought to be
CC       the major trigger of AIDS disease. Interaction would involve a
CC       tripeptide L-D-I in HIV-1 gp120. Integrin alpha-E/beta-7 (HML-1)
CC       is a receptor for E-cadherin.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-7
CC       associates with either alpha-4 or alpha-E. Integrin alpha-4/beta-7
CC       interacts with MADCAM1, VCAM1, fibronectin, and may also interact
CC       with HIV-1 gp120. Interacts with FLNA (via filamin repeats 4, 9,
CC       12, 17, 19, 21, and 23) (PubMed:19828450).
CC       {ECO:0000269|PubMed:1542691, ECO:0000269|PubMed:18264102,
CC       ECO:0000269|PubMed:19828450}.
CC   -!- INTERACTION:
CC       P21333:FLNA; NbExp=6; IntAct=EBI-702932, EBI-350432;
CC       P13612:ITGA4; NbExp=6; IntAct=EBI-702932, EBI-703044;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P26010-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P26010-2; Sequence=VSP_002753;
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of leukocyte lines.
CC   -!- INDUCTION: Integrin alpha-E/beta-7 is induced by TGFB1.
CC       {ECO:0000269|PubMed:1542691}.
CC   -!- DOMAIN: Domain I contains three cation-binding sites: the ligand-
CC       integrin-binding site (LIMBS), the metal ion-dependent adhesion
CC       site (MIDAS), and the adjacent to MIDAS site (ADMIDAS). In the
CC       absence of a ligand or in calcium-dependent binding, only ADMIDAS
CC       is occupied. In magnesium-dependent binding all three sites bind
CC       metal ions. LIMBS positively modify ligand binding whereas ADMIDAS
CC       negatively modify ligand binding.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M68892; AAA59184.1; -; mRNA.
DR   EMBL; S80335; AAB21332.1; -; mRNA.
DR   EMBL; M62880; AAA59185.1; -; mRNA.
DR   EMBL; L23823; AAA36118.1; -; Genomic_DNA.
DR   EMBL; L23810; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23811; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23812; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23813; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23814; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23815; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23816; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23817; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23818; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23819; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23820; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23821; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; L23822; AAA36118.1; JOINED; Genomic_DNA.
DR   EMBL; S49378; AAB23688.1; -; Genomic_DNA.
DR   EMBL; S49364; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49365; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49366; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49367; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49368; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49369; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49370; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49371; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49373; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49374; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49375; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49376; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; S49377; AAB23688.1; JOINED; Genomic_DNA.
DR   EMBL; BC015916; AAH15916.1; -; mRNA.
DR   CCDS; CCDS8849.1; -. [P26010-1]
DR   PIR; A40526; A40526.
DR   RefSeq; NP_000880.1; NM_000889.2. [P26010-1]
DR   RefSeq; XP_005268908.1; XM_005268851.3. [P26010-1]
DR   RefSeq; XP_005268909.1; XM_005268852.4. [P26010-1]
DR   UniGene; Hs.654470; -.
DR   PDB; 2BRQ; X-ray; 2.10 A; C/D=768-798.
DR   PDB; 3V4P; X-ray; 3.15 A; B/D=20-512.
DR   PDB; 3V4V; X-ray; 3.10 A; B/D=20-512.
DR   PDBsum; 2BRQ; -.
DR   PDBsum; 3V4P; -.
DR   PDBsum; 3V4V; -.
DR   ProteinModelPortal; P26010; -.
DR   SMR; P26010; -.
DR   BioGrid; 109901; 4.
DR   CORUM; P26010; -.
DR   DIP; DIP-34970N; -.
DR   ELM; P26010; -.
DR   IntAct; P26010; 3.
DR   MINT; MINT-258650; -.
DR   STRING; 9606.ENSP00000267082; -.
DR   BindingDB; P26010; -.
DR   ChEMBL; CHEMBL2979; -.
DR   DrugBank; DB05802; MLN-02.
DR   DrugBank; DB05122; R1295.
DR   DrugBank; DB09033; Vedolizumab.
DR   GuidetoPHARMACOLOGY; 2461; -.
DR   iPTMnet; P26010; -.
DR   PhosphoSitePlus; P26010; -.
DR   BioMuta; ITGB7; -.
DR   DMDM; 124973; -.
DR   MaxQB; P26010; -.
DR   PaxDb; P26010; -.
DR   PeptideAtlas; P26010; -.
DR   PRIDE; P26010; -.
DR   DNASU; 3695; -.
DR   Ensembl; ENST00000267082; ENSP00000267082; ENSG00000139626. [P26010-1]
DR   Ensembl; ENST00000422257; ENSP00000408741; ENSG00000139626. [P26010-1]
DR   Ensembl; ENST00000550743; ENSP00000455374; ENSG00000139626. [P26010-2]
DR   GeneID; 3695; -.
DR   KEGG; hsa:3695; -.
DR   UCSC; uc001scc.4; human. [P26010-1]
DR   CTD; 3695; -.
DR   DisGeNET; 3695; -.
DR   EuPathDB; HostDB:ENSG00000139626.15; -.
DR   GeneCards; ITGB7; -.
DR   HGNC; HGNC:6162; ITGB7.
DR   HPA; HPA042277; -.
DR   MIM; 147559; gene.
DR   neXtProt; NX_P26010; -.
DR   OpenTargets; ENSG00000139626; -.
DR   PharmGKB; PA29961; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   HOVERGEN; HBG006190; -.
DR   InParanoid; P26010; -.
DR   KO; K06590; -.
DR   OMA; TLCDCNC; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; P26010; -.
DR   TreeFam; TF105392; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   SignaLink; P26010; -.
DR   SIGNOR; P26010; -.
DR   ChiTaRS; ITGB7; human.
DR   EvolutionaryTrace; P26010; -.
DR   GeneWiki; ITGB7; -.
DR   GenomeRNAi; 3695; -.
DR   PRO; PR:P26010; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139626; -.
DR   CleanEx; HS_ITGB7; -.
DR   ExpressionAtlas; P26010; baseline and differential.
DR   Genevisible; P26010; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0034669; C:integrin alpha4-beta7 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0003366; P:cell-matrix adhesion involved in ameboidal cell migration; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0050901; P:leukocyte tethering or rolling; IMP:UniProtKB.
DR   GO; GO:0043113; P:receptor clustering; IMP:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   GO; GO:0072678; P:T cell migration; IEA:Ensembl.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR015437; Integrin_bsu-7.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   PANTHER; PTHR10082:SF36; PTHR10082:SF36; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SMART; SM00423; PSI; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 4.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Integrin; Magnesium; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:1542691,
FT                                ECO:0000269|PubMed:1750505}.
FT   CHAIN        20    798       Integrin beta-7.
FT                                /FTId=PRO_0000016352.
FT   TOPO_DOM     20    723       Extracellular. {ECO:0000255}.
FT   TRANSMEM    724    746       Helical. {ECO:0000255}.
FT   TOPO_DOM    747    798       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      150    389       VWFA.
FT   REPEAT      478    526       I.
FT   REPEAT      527    565       II.
FT   REPEAT      566    604       III.
FT   REPEAT      605    640       IV.
FT   REGION      478    640       Cysteine-rich tandem repeats.
FT   METAL       159    159       Magnesium; MIDAS motif. {ECO:0000250}.
FT   METAL       161    161       Magnesium; MIDAS motif. {ECO:0000250}.
FT   METAL       163    163       Magnesium; MIDAS motif. {ECO:0000250}.
FT   METAL       166    166       Magnesium or calcium; ADMIDAS motif.
FT                                {ECO:0000250}.
FT   METAL       167    167       Magnesium or calcium; ADMIDAS motif.
FT                                {ECO:0000250}.
FT   METAL       198    198       Magnesium; LIMBS motif. {ECO:0000250}.
FT   METAL       254    254       Magnesium; LIMBS motif. {ECO:0000250}.
FT   METAL       256    256       Magnesium; LIMBS motif. {ECO:0000250}.
FT   METAL       259    259       Magnesium; LIMBS motif. {ECO:0000250}.
FT   METAL       289    289       Magnesium; MIDAS motif. {ECO:0000250}.
FT   MOD_RES     778    778       Phosphotyrosine; by Tyr-kinases.
FT                                {ECO:0000250}.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    434    434       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    477    477       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    531    531       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    590    590       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    665    665       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    674    674       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     45    476       {ECO:0000250}.
FT   DISULFID     51     61       {ECO:0000250}.
FT   DISULFID     54     91       {ECO:0000250}.
FT   DISULFID     64     80       {ECO:0000250}.
FT   DISULFID    216    223       {ECO:0000250}.
FT   DISULFID    271    311       {ECO:0000250}.
FT   DISULFID    412    428       {ECO:0000250}.
FT   DISULFID    448    688       {ECO:0000250}.
FT   DISULFID    474    478       {ECO:0000250}.
FT   DISULFID    488    500       {ECO:0000250}.
FT   DISULFID    497    537       {ECO:0000250}.
FT   DISULFID    502    511       {ECO:0000250}.
FT   DISULFID    513    527       {ECO:0000250}.
FT   DISULFID    543    548       {ECO:0000250}.
FT   DISULFID    545    574       {ECO:0000250}.
FT   DISULFID    550    559       {ECO:0000250}.
FT   DISULFID    561    566       {ECO:0000250}.
FT   DISULFID    580    585       {ECO:0000250}.
FT   DISULFID    582    613       {ECO:0000250}.
FT   DISULFID    587    596       {ECO:0000250}.
FT   DISULFID    598    605       {ECO:0000250}.
FT   DISULFID    619    624       {ECO:0000250}.
FT   DISULFID    621    666       {ECO:0000250}.
FT   DISULFID    626    635       {ECO:0000250}.
FT   DISULFID    638    641       {ECO:0000250}.
FT   DISULFID    645    654       {ECO:0000250}.
FT   VAR_SEQ     501    648       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:2040616}.
FT                                /FTId=VSP_002753.
FT   VARIANT     672    672       H -> Y (in dbSNP:rs11539433).
FT                                /FTId=VAR_049637.
FT   MUTAGEN     159    159       D->A: Loss of integrin alpha-E/beta-7
FT                                binding to E-cadherin and of integrin
FT                                alpha-4/beta-7 binding to MADCAM1.
FT                                {ECO:0000269|PubMed:10837471}.
FT   CONFLICT     34     34       W -> A (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND      102    105       {ECO:0000244|PDB:3V4V}.
FT   TURN        114    116       {ECO:0000244|PDB:3V4V}.
FT   STRAND      117    119       {ECO:0000244|PDB:3V4V}.
FT   STRAND      127    131       {ECO:0000244|PDB:3V4V}.
FT   STRAND      138    145       {ECO:0000244|PDB:3V4V}.
FT   STRAND      152    159       {ECO:0000244|PDB:3V4V}.
FT   HELIX       162    164       {ECO:0000244|PDB:3V4V}.
FT   HELIX       165    173       {ECO:0000244|PDB:3V4V}.
FT   HELIX       176    182       {ECO:0000244|PDB:3V4V}.
FT   TURN        183    185       {ECO:0000244|PDB:3V4V}.
FT   STRAND      189    196       {ECO:0000244|PDB:3V4V}.
FT   TURN        202    204       {ECO:0000244|PDB:3V4V}.
FT   HELIX       209    213       {ECO:0000244|PDB:3V4V}.
FT   STRAND      219    221       {ECO:0000244|PDB:3V4V}.
FT   STRAND      228    237       {ECO:0000244|PDB:3V4V}.
FT   HELIX       240    246       {ECO:0000244|PDB:3V4V}.
FT   STRAND      255    259       {ECO:0000244|PDB:3V4V}.
FT   HELIX       261    270       {ECO:0000244|PDB:3V4V}.
FT   HELIX       272    275       {ECO:0000244|PDB:3V4V}.
FT   STRAND      279    290       {ECO:0000244|PDB:3V4V}.
FT   HELIX       297    299       {ECO:0000244|PDB:3V4V}.
FT   TURN        300    302       {ECO:0000244|PDB:3V4V}.
FT   STRAND      317    319       {ECO:0000244|PDB:3V4V}.
FT   HELIX       320    324       {ECO:0000244|PDB:3V4V}.
FT   HELIX       330    339       {ECO:0000244|PDB:3V4V}.
FT   STRAND      342    348       {ECO:0000244|PDB:3V4V}.
FT   STRAND      350    352       {ECO:0000244|PDB:3V4V}.
FT   HELIX       353    360       {ECO:0000244|PDB:3V4V}.
FT   STRAND      367    370       {ECO:0000244|PDB:3V4V}.
FT   HELIX       378    390       {ECO:0000244|PDB:3V4V}.
FT   STRAND      393    396       {ECO:0000244|PDB:3V4V}.
FT   STRAND      404    408       {ECO:0000244|PDB:3V4V}.
FT   STRAND      413    415       {ECO:0000244|PDB:3V4V}.
FT   STRAND      423    428       {ECO:0000244|PDB:3V4V}.
FT   STRAND      436    445       {ECO:0000244|PDB:3V4V}.
FT   STRAND      454    460       {ECO:0000244|PDB:3V4V}.
FT   STRAND      465    469       {ECO:0000244|PDB:3V4V}.
FT   STRAND      777    786       {ECO:0000244|PDB:2BRQ}.
SQ   SEQUENCE   798 AA;  86903 MW;  CBE275E0E9992385 CRC64;
     MVALPMVLVL LLVLSRGESE LDAKIPSTGD ATEWRNPHLS MLGSCQPAPS CQKCILSHPS
     CAWCKQLNFT ASGEAEARRC ARREELLARG CPLEELEEPR GQQEVLQDQP LSQGARGEGA
     TQLAPQRVRV TLRPGEPQQL QVRFLRAEGY PVDLYYLMDL SYSMKDDLER VRQLGHALLV
     RLQEVTHSVR IGFGSFVDKT VLPFVSTVPS KLRHPCPTRL ERCQSPFSFH HVLSLTGDAQ
     AFEREVGRQS VSGNLDSPEG GFDAILQAAL CQEQIGWRNV SRLLVFTSDD TFHTAGDGKL
     GGIFMPSDGH CHLDSNGLYS RSTEFDYPSV GQVAQALSAA NIQPIFAVTS AALPVYQELS
     KLIPKSAVGE LSEDSSNVVQ LIMDAYNSLS STVTLEHSSL PPGVHISYES QCEGPEKREG
     KAEDRGQCNH VRINQTVTFW VSLQATHCLP EPHLLRLRAL GFSEELIVEL HTLCDCNCSD
     TQPQAPHCSD GQGHLQCGVC SCAPGRLGRL CECSVAELSS PDLESGCRAP NGTGPLCSGK
     GHCQCGRCSC SGQSSGHLCE CDDASCERHE GILCGGFGRC QCGVCHCHAN RTGRACECSG
     DMDSCISPEG GLCSGHGRCK CNRCQCLDGY YGALCDQCPG CKTPCERHRD CAECGAFRTG
     PLATNCSTAC AHTNVTLALA PILDDGWCKE RTLDNQLFFF LVEDDARGTV VLRVRPQEKG
     ADHTQAIVLG CVGGIVAVGL GLVLAYRLSV EIYDRREYSR FEKEQQQLNW KQDSNPLYKS
     AITTTINPRF QEADSPTL
//
ID   ITAE_HUMAN              Reviewed;        1179 AA.
AC   P38570; Q17RS6; Q9NZU9;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 3.
DT   22-NOV-2017, entry version 168.
DE   RecName: Full=Integrin alpha-E;
DE   AltName: Full=HML-1 antigen;
DE   AltName: Full=Integrin alpha-IEL;
DE   AltName: Full=Mucosal lymphocyte 1 antigen;
DE   AltName: CD_antigen=CD103;
DE   Contains:
DE     RecName: Full=Integrin alpha-E light chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-E heavy chain;
DE   Flags: Precursor;
GN   Name=ITGAE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 19-38 AND 179-188, AND
RP   VARIANTS VAL-477; GLN-482 AND ALA-1019.
RC   TISSUE=Leukemia, and Lymphocyte;
RX   PubMed=8119947;
RA   Shaw S.K., Cepek K.L., Murphy E.A., Russell G.J., Brenner M.B.,
RA   Parker C.M.;
RT   "Molecular cloning of the human mucosal lymphocyte integrin alpha E
RT   subunit. Unusual structure and restricted RNA distribution.";
RL   J. Biol. Chem. 269:6016-6025(1994).
RN   [2]
RP   SEQUENCE REVISION TO 88-114.
RA   Parker C.M.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-477; GLN-482
RP   AND ALA-1019.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 53-1179, AND VARIANT TRP-950.
RC   TISSUE=Fetal kidney;
RX   PubMed=10673275; DOI=10.1101/gr.10.2.165;
RA   Touchman J.W., Anikster Y., Dietrich N.L., Maduro V.V.B., McDowell G.,
RA   Shotelersuk V., Bouffard G.G., Beckstrom-Sternberg S.M., Gahl W.A.,
RA   Green E.D.;
RT   "The genomic region encompassing the nephropathic cystinosis gene
RT   (CTNS): complete sequencing of a 200-kb segment and discovery of a
RT   novel gene within the common cystinosis-causing deletion.";
RL   Genome Res. 10:165-173(2000).
RN   [6]
RP   INTERACTION WITH INTEGRIN BETA-7, AND INDUCTION.
RX   PubMed=1542691; DOI=10.1073/pnas.89.5.1924;
RA   Parker C.M., Cepek K.L., Russell G.J., Shaw S.K., Posnett D.N.,
RA   Schwarting R., Brenner M.B.;
RT   "A family of beta 7 integrins on human mucosal lymphocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1924-1928(1992).
RN   [7]
RP   MUTAGENESIS OF ASP-208 AND PHE-316.
RX   PubMed=10837471; DOI=10.1074/jbc.M001228200;
RA   Higgins J.M.G., Cernadas M., Tan K., Irie A., Wang J.-H., Takada Y.,
RA   Brenner M.B.;
RT   "The role of alpha and beta chains in ligand recognition by beta 7
RT   integrins.";
RL   J. Biol. Chem. 275:25652-25664(2000).
CC   -!- FUNCTION: Integrin alpha-E/beta-7 is a receptor for E-cadherin. It
CC       mediates adhesion of intra-epithelial T-lymphocytes to epithelial
CC       cell monolayers.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chains linked by a
CC       disulfide bond. Alpha-E associates with beta-7.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Expressed on a subclass of T-lymphocytes known
CC       as intra-epithelial lymphocytes which are located between mucosal
CC       epithelial cells.
CC   -!- INDUCTION: Integrin alpha-E/beta-7 is induced by TGFB1.
CC       {ECO:0000269|PubMed:1542691}.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L25851; AAB59359.2; -; mRNA.
DR   EMBL; AC116914; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC113436; AAI13437.1; -; mRNA.
DR   EMBL; BC117207; AAI17208.1; -; mRNA.
DR   EMBL; AF168787; AAF43107.1; -; Genomic_DNA.
DR   CCDS; CCDS32531.1; -.
DR   PIR; A53213; A53213.
DR   RefSeq; NP_002199.3; NM_002208.4.
DR   UniGene; Hs.513867; -.
DR   ProteinModelPortal; P38570; -.
DR   SMR; P38570; -.
DR   BioGrid; 109888; 2.
DR   CORUM; P38570; -.
DR   IntAct; P38570; 1.
DR   MINT; MINT-1397425; -.
DR   STRING; 9606.ENSP00000263087; -.
DR   iPTMnet; P38570; -.
DR   PhosphoSitePlus; P38570; -.
DR   BioMuta; ITGAE; -.
DR   DMDM; 226694184; -.
DR   EPD; P38570; -.
DR   PaxDb; P38570; -.
DR   PeptideAtlas; P38570; -.
DR   PRIDE; P38570; -.
DR   DNASU; 3682; -.
DR   Ensembl; ENST00000263087; ENSP00000263087; ENSG00000083457.
DR   GeneID; 3682; -.
DR   KEGG; hsa:3682; -.
DR   UCSC; uc002fwo.5; human.
DR   CTD; 3682; -.
DR   DisGeNET; 3682; -.
DR   EuPathDB; HostDB:ENSG00000083457.11; -.
DR   GeneCards; ITGAE; -.
DR   H-InvDB; HIX0202464; -.
DR   HGNC; HGNC:6147; ITGAE.
DR   HPA; CAB026461; -.
DR   HPA; HPA036313; -.
DR   MIM; 604682; gene.
DR   neXtProt; NX_P38570; -.
DR   OpenTargets; ENSG00000083457; -.
DR   PharmGKB; PA29947; -.
DR   eggNOG; ENOG410IPAZ; Eukaryota.
DR   eggNOG; ENOG410XR7I; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000049185; -.
DR   HOVERGEN; HBG006187; -.
DR   InParanoid; P38570; -.
DR   KO; K06524; -.
DR   OMA; KMQGVER; -.
DR   OrthoDB; EOG091G09V5; -.
DR   PhylomeDB; P38570; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   SIGNOR; P38570; -.
DR   ChiTaRS; ITGAE; human.
DR   GeneWiki; ITGAE; -.
DR   GenomeRNAi; 3682; -.
DR   PRO; PR:P38570; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000083457; -.
DR   CleanEx; HS_ITGAE; -.
DR   ExpressionAtlas; P38570; baseline and differential.
DR   Genevisible; P38570; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 4.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 2.
DR   PROSITE; PS51470; FG_GAP; 5.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cleavage on pair of basic residues;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Integrin; Magnesium; Membrane; Metal-binding;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000269|PubMed:8119947}.
FT   CHAIN        19   1179       Integrin alpha-E.
FT                                /FTId=PRO_0000016283.
FT   CHAIN        19    177       Integrin alpha-E light chain.
FT                                /FTId=PRO_0000016284.
FT   CHAIN       179   1177       Integrin alpha-E heavy chain.
FT                                /FTId=PRO_0000016285.
FT   TOPO_DOM     19   1124       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1125   1147       Helical. {ECO:0000255}.
FT   TOPO_DOM   1148   1179       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       22     79       FG-GAP 1.
FT   REPEAT       80    138       FG-GAP 2.
FT   DOMAIN      200    389       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      390    442       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      447    499       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      500    560       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      563    627       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      631    691       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     522    530       {ECO:0000255}.
FT   CA_BIND     586    594       {ECO:0000255}.
FT   CA_BIND     654    662       {ECO:0000255}.
FT   REGION      145    199       X-domain (extra domain).
FT   MOTIF      1150   1154       GFFKR motif.
FT   COMPBIAS    181    198       Glu-rich (acidic).
FT   CARBOHYD     49     49       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    271    271       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    321    321       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    444    444       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    726    726       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    782    782       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    857    857       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    934    934       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    954    954       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1065   1065       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1096   1096       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     70     79       {ECO:0000250}.
FT   DISULFID    126    159       {ECO:0000250}.
FT   DISULFID    706    762       {ECO:0000250}.
FT   DISULFID    823    829       {ECO:0000250}.
FT   DISULFID    893    907       {ECO:0000250}.
FT   DISULFID   1008   1033       {ECO:0000250}.
FT   DISULFID   1041   1057       {ECO:0000250}.
FT   VARIANT     360    360       D -> E.
FT                                /FTId=VAR_008884.
FT   VARIANT     477    477       I -> V (in dbSNP:rs220479).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8119947}.
FT                                /FTId=VAR_054889.
FT   VARIANT     482    482       R -> Q (in dbSNP:rs2272606).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8119947}.
FT                                /FTId=VAR_054890.
FT   VARIANT     892    892       Q -> H (in dbSNP:rs3744679).
FT                                /FTId=VAR_020037.
FT   VARIANT     950    950       R -> W (in dbSNP:rs1716).
FT                                {ECO:0000269|PubMed:10673275}.
FT                                /FTId=VAR_034025.
FT   VARIANT    1019   1019       V -> A (in dbSNP:rs2976230).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8119947}.
FT                                /FTId=VAR_054891.
FT   VARIANT    1041   1041       C -> S.
FT                                /FTId=VAR_008885.
FT   MUTAGEN     208    208       D->A: Loss of E-cadherin binding.
FT                                {ECO:0000269|PubMed:10837471}.
FT   MUTAGEN     316    316       F->A: Loss of E-cadherin binding.
FT                                {ECO:0000269|PubMed:10837471}.
SQ   SEQUENCE   1179 AA;  130159 MW;  6645F8FFF9A0F045 CRC64;
     MWLFHTLLCI ASLALLAAFN VDVARPWLTP KGGAPFVLSS LLHQDPSTNQ TWLLVTSPRT
     KRTPGPLHRC SLVQDEILCH PVEHVPIPKG RHRGVTVVRS HHGVLICIQV LVRRPHSLSS
     ELTGTCSLLG PDLRPQAQAN FFDLENLLDP DARVDTGDCY SNKEGGGEDD VNTARQRRAL
     EKEEEEDKEE EEDEEEEEAG TEIAIILDGS GSIDPPDFQR AKDFISNMMR NFYEKCFECN
     FALVQYGGVI QTEFDLRDSQ DVMASLARVQ NITQVGSVTK TASAMQHVLD SIFTSSHGSR
     RKASKVMVVL TDGGIFEDPL NLTTVINSPK MQGVERFAIG VGEEFKSART ARELNLIASD
     PDETHAFKVT NYMALDGLLS KLRYNIISME GTVGDALHYQ LAQIGFSAQI LDERQVLLGA
     VGAFDWSGGA LLYDTRSRRG RFLNQTAAAA ADAEAAQYSY LGYAVAVLHK TCSLSYIAGA
     PRYKHHGAVF ELQKEGREAS FLPVLEGEQM GSYFGSELCP VDIDMDGSTD FLLVAAPFYH
     VHGEEGRVYV YRLSEQDGSF SLARILSGHP GFTNARFGFA MAAMGDLSQD KLTDVAIGAP
     LEGFGADDGA SFGSVYIYNG HWDGLSASPS QRIRASTVAP GLQYFGMSMA GGFDISGDGL
     ADITVGTLGQ AVVFRSRPVV RLKVSMAFTP SALPIGFNGV VNVRLCFEIS SVTTASESGL
     REALLNFTLD VDVGKQRRRL QCSDVRSCLG CLREWSSGSQ LCEDLLLMPT EGELCEEDCF
     SNASVKVSYQ LQTPEGQTDH PQPILDRYTE PFAIFQLPYE KACKNKLFCV AELQLATTVS
     QQELVVGLTK ELTLNINLTN SGEDSYMTSM ALNYPRNLQL KRMQKPPSPN IQCDDPQPVA
     SVLIMNCRIG HPVLKRSSAH VSVVWQLEEN AFPNRTADIT VTVTNSNERR SLANETHTLQ
     FRHGFVAVLS KPSIMYVNTG QGLSHHKEFL FHVHGENLFG AEYQLQICVP TKLRGLQVVA
     VKKLTRTQAS TVCTWSQERA CAYSSVQHVE EWHSVSCVIA SDKENVTVAA EISWDHSEEL
     LKDVTELQIL GEISFNKSLY EGLNAENHRT KITVVFLKDE KYHSLPIIIK GSVGGLLVLI
     VILVILFKCG FFKRKYQQLN LESIRKAQLK SENLLEEEN
//
ID   ITA8_HUMAN              Reviewed;        1063 AA.
AC   P53708; B0YJ31; Q5VX94;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   22-NOV-2017, entry version 155.
DE   RecName: Full=Integrin alpha-8;
DE   Contains:
DE     RecName: Full=Integrin alpha-8 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-8 light chain;
DE   Flags: Precursor;
GN   Name=ITGA8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-216; PHE-577;
RP   PRO-581; HIS-748; VAL-993 AND ALA-994.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 39-1063, TISSUE SPECIFICITY, AND VARIANT
RP   ALA-994.
RX   PubMed=7768999;
RA   Schnapp L.M., Breuss J.M., Ramos D.M., Sheppard D., Pytela R.;
RT   "Sequence and tissue distribution of the human integrin alpha 8
RT   subunit: a beta 1-associated alpha subunit expressed in smooth muscle
RT   cells.";
RL   J. Cell Sci. 108:537-544(1995).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=10504498; DOI=10.1046/j.1523-1755.1999.00662.x;
RA   Hartner A., Schoecklmann H., Proels F., Mueller U., Sterzel R.B.;
RT   "Alpha8 integrin in glomerular mesangial cells and in experimental
RT   glomerulonephritis.";
RL   Kidney Int. 56:1468-1480(1999).
RN   [7]
RP   FUNCTION.
RX   PubMed=12415008; DOI=10.1242/jcs.00145;
RA   Lu M., Munger J.S., Steadele M., Busald C., Tellier M., Schnapp L.M.;
RT   "Integrin alpha8beta1 mediates adhesion to LAP-TGFbeta1.";
RL   J. Cell Sci. 115:4641-4648(2002).
RN   [8]
RP   FUNCTION.
RX   PubMed=15721307; DOI=10.1016/j.bbrc.2005.01.125;
RA   Farias E., Lu M., Li X., Schnapp L.M.;
RT   "Integrin alpha8beta1-fibronectin interactions promote cell survival
RT   via PI3 kinase pathway.";
RL   Biochem. Biophys. Res. Commun. 329:305-311(2005).
RN   [9]
RP   SUBCELLULAR LOCATION, VARIANTS RHDA1 MET-255 AND ARG-407, AND
RP   CHARACTERIZATION OF VARIANT RHDA1 ARG-407.
RX   PubMed=24439109; DOI=10.1016/j.ajhg.2013.12.017;
RA   Humbert C., Silbermann F., Morar B., Parisot M., Zarhrate M.,
RA   Masson C., Tores F., Blanchet P., Perez M.J., Petrov Y.,
RA   Khau Van Kien P., Roume J., Leroy B., Gribouval O., Kalaydjieva L.,
RA   Heidet L., Salomon R., Antignac C., Benmerah A., Saunier S.,
RA   Jeanpierre C.;
RT   "Integrin alpha 8 recessive mutations are responsible for bilateral
RT   renal agenesis in humans.";
RL   Am. J. Hum. Genet. 94:288-294(2014).
RN   [10]
RP   VARIANTS LEU-567; PHE-577; PRO-581; HIS-748; VAL-993 AND ALA-994.
RX   PubMed=15579315; DOI=10.1016/j.matbio.2004.08.005;
RA   Ekwa-Ekoka C., Diaz G.A., Carlson C., Hasegawa T., Samudrala R.,
RA   Lim K.-C., Yabu J.M., Levy B., Schnapp L.M.;
RT   "Genomic organization and sequence variation of the human integrin
RT   subunit alpha8 gene (ITGA8).";
RL   Matrix Biol. 23:487-496(2004).
CC   -!- FUNCTION: Integrin alpha-8/beta-1 functions in the genesis of
CC       kidney and probably of other organs by regulating the recruitment
CC       of mesenchymal cells into epithelial structures. It recognizes the
CC       sequence R-G-D in a wide array of ligands including TNC, FN1, SPP1
CC       TGFB1, TGFB3 and VTN. NPNT is probably its functional ligand in
CC       kidney genesis. Neuronal receptor for TNC it mediates cell-cell
CC       interactions and regulates neurite outgrowth of sensory and motor
CC       neurons. {ECO:0000269|PubMed:12415008,
CC       ECO:0000269|PubMed:15721307}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-8 associates with beta-1.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:24439109};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:24439109}.
CC       Cell membrane {ECO:0000269|PubMed:24439109}.
CC   -!- TISSUE SPECIFICITY: Expressed in mesenchymal cells, including
CC       alveolar myofibroblasts, kidney mesangial cells and hepatic
CC       stellar cells and vascular and visceral smooth muscle (at protein
CC       level). {ECO:0000269|PubMed:10504498, ECO:0000269|PubMed:7768999}.
CC   -!- DISEASE: Renal hypodysplasia/aplasia 1 (RHDA1) [MIM:191830]: A
CC       perinatally lethal renal disease encompassing a spectrum of kidney
CC       development defects, including renal agenesis, bilateral renal
CC       aplasia, hypoplasia, (cystic) dysplasia, and severe obstructive
CC       uropathy. {ECO:0000269|PubMed:24439109}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/itga8/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY371697; AAQ56848.2; -; Genomic_DNA.
DR   EMBL; EF444991; ACA06009.1; -; Genomic_DNA.
DR   EMBL; AL359645; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590636; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86235.1; -; Genomic_DNA.
DR   EMBL; L36531; AAA93514.1; -; mRNA.
DR   CCDS; CCDS31155.1; -.
DR   RefSeq; NP_003629.2; NM_003638.2.
DR   UniGene; Hs.171311; -.
DR   UniGene; Hs.592472; -.
DR   ProteinModelPortal; P53708; -.
DR   SMR; P53708; -.
DR   BioGrid; 114088; 25.
DR   CORUM; P53708; -.
DR   STRING; 9606.ENSP00000367316; -.
DR   iPTMnet; P53708; -.
DR   PhosphoSitePlus; P53708; -.
DR   BioMuta; ITGA8; -.
DR   DMDM; 311033437; -.
DR   MaxQB; P53708; -.
DR   PaxDb; P53708; -.
DR   PeptideAtlas; P53708; -.
DR   PRIDE; P53708; -.
DR   DNASU; 8516; -.
DR   Ensembl; ENST00000378076; ENSP00000367316; ENSG00000077943.
DR   GeneID; 8516; -.
DR   KEGG; hsa:8516; -.
DR   UCSC; uc001ioc.2; human.
DR   CTD; 8516; -.
DR   DisGeNET; 8516; -.
DR   EuPathDB; HostDB:ENSG00000077943.7; -.
DR   GeneCards; ITGA8; -.
DR   H-InvDB; HIX0035424; -.
DR   HGNC; HGNC:6144; ITGA8.
DR   HPA; HPA003432; -.
DR   MalaCards; ITGA8; -.
DR   MIM; 191830; phenotype.
DR   MIM; 604063; gene.
DR   neXtProt; NX_P53708; -.
DR   OpenTargets; ENSG00000077943; -.
DR   Orphanet; 1848; Bilateral renal agenesis.
DR   PharmGKB; PA29944; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; P53708; -.
DR   KO; K06584; -.
DR   OMA; CRQIPFD; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   PhylomeDB; P53708; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   SignaLink; P53708; -.
DR   SIGNOR; P53708; -.
DR   ChiTaRS; ITGA8; human.
DR   GeneWiki; ITGA8; -.
DR   GenomeRNAi; 8516; -.
DR   PRO; PR:P53708; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000077943; -.
DR   CleanEx; HS_ITGA8; -.
DR   Genevisible; P53708; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0032591; C:dendritic spine membrane; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034678; C:integrin alpha8-beta1 complex; TAS:BHF-UCL.
DR   GO; GO:0008305; C:integrin complex; TAS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0030030; P:cell projection organization; IEA:Ensembl.
DR   GO; GO:0098609; P:cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0045184; P:establishment of protein localization; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0042472; P:inner ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0001822; P:kidney development; IMP:UniProtKB.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEP:UniProtKB.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:2000721; P:positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048745; P:smooth muscle tissue development; IEA:Ensembl.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 6.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Developmental protein; Differentiation; Disease mutation;
KW   Disulfide bond; Glycoprotein; Integrin; Membrane; Metal-binding;
KW   Neurogenesis; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     38       {ECO:0000255}.
FT   CHAIN        39   1063       Integrin alpha-8.
FT                                /FTId=PRO_0000016310.
FT   CHAIN        39    906       Integrin alpha-8 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016311.
FT   CHAIN       907   1063       Integrin alpha-8 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016312.
FT   TOPO_DOM     39   1012       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1013   1033       Helical. {ECO:0000255}.
FT   TOPO_DOM   1034   1063       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       44    105       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      122    183       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      188    240       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      253    306       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      307    372       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      373    431       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      435    498       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     329    337       {ECO:0000255}.
FT   CA_BIND     395    403       {ECO:0000255}.
FT   CA_BIND     459    467       {ECO:0000255}.
FT   MOTIF       455    457       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD     81     81       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    122    122       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    177    177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    239    239       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    302    302       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    311    311       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    504    504       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    601    601       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    605    605       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    719    719       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    737    737       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    753    753       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    780    780       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    896    896       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    923    923       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1005   1005       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     96    106       {ECO:0000250}.
FT   DISULFID    150    171       {ECO:0000250}.
FT   DISULFID    187    200       {ECO:0000250}.
FT   DISULFID    507    518       {ECO:0000250}.
FT   DISULFID    524    580       {ECO:0000250}.
FT   DISULFID    641    647       {ECO:0000250}.
FT   DISULFID    713    726       {ECO:0000250}.
FT   DISULFID    867    924       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    929    934       {ECO:0000250}.
FT   VARIANT     216    216       V -> L (in dbSNP:rs7895372).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_018673.
FT   VARIANT     255    255       T -> M (in RHDA1; unknown pathological
FT                                significance; dbSNP:rs587777281).
FT                                {ECO:0000269|PubMed:24439109}.
FT                                /FTId=VAR_071106.
FT   VARIANT     407    407       G -> R (in RHDA1; the mutant does not
FT                                localize at the cell membrane;
FT                                dbSNP:rs374664941).
FT                                {ECO:0000269|PubMed:24439109}.
FT                                /FTId=VAR_071107.
FT   VARIANT     567    567       V -> L. {ECO:0000269|PubMed:15579315}.
FT                                /FTId=VAR_034682.
FT   VARIANT     577    577       S -> F (in dbSNP:rs2298033).
FT                                {ECO:0000269|PubMed:15579315,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_018674.
FT   VARIANT     581    581       Q -> P (in dbSNP:rs9333269).
FT                                {ECO:0000269|PubMed:15579315,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_018675.
FT   VARIANT     748    748       R -> H (in dbSNP:rs9333174).
FT                                {ECO:0000269|PubMed:15579315,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_018676.
FT   VARIANT     993    993       I -> V (in dbSNP:rs9333241).
FT                                {ECO:0000269|PubMed:15579315,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_018677.
FT   VARIANT     994    994       V -> A (in dbSNP:rs1041135).
FT                                {ECO:0000269|PubMed:15579315,
FT                                ECO:0000269|PubMed:7768999,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_018678.
FT   CONFLICT     47     47       T -> A (in Ref. 5; AAA93514).
FT                                {ECO:0000305}.
FT   CONFLICT    166    166       D -> G (in Ref. 5; AAA93514).
FT                                {ECO:0000305}.
FT   CONFLICT    188    188       R -> G (in Ref. 5; AAA93514).
FT                                {ECO:0000305}.
FT   CONFLICT    304    304       T -> Y (in Ref. 5; AAA93514).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1063 AA;  117474 MW;  8F9614BDBB897D77 CRC64;
     MSPGASRGPR GSQAPLIAPL CCAAAALGML LWSPACQAFN LDVEKLTVYS GPKGSYFGYA
     VDFHIPDART ASVLVGAPKA NTSQPDIVEG GAVYYCPWPA EGSAQCRQIP FDTTNNRKIR
     VNGTKEPIEF KSNQWFGATV KAHKGKVVAC APLYHWRTLK PTPEKDPVGT CYVAIQNFSA
     YAEFSPCRNS NADPEGQGYC QAGFSLDFYK NGDLIVGGPG SFYWQGQVIT ASVADIIANY
     SFKDILRKLA GEKQTEVAPA SYDDSYLGYS VAAGEFTGDS QQELVAGIPR GAQNFGYVSI
     INSTDMTFIQ NFTGEQMASY FGYTVVVSDV NSDGLDDVLV GAPLFMEREF ESNPREVGQI
     YLYLQVSSLL FRDPQILTGT ETFGRFGSAM AHLGDLNQDG YNDIAIGVPF AGKDQRGKVL
     IYNGNKDGLN TKPSQVLQGV WASHAVPSGF GFTLRGDSDI DKNDYPDLIV GAFGTGKVAV
     YRARPVVTVD AQLLLHPMII NLENKTCQVP DSMTSAACFS LRVCASVTGQ SIANTIVLMA
     EVQLDSLKQK GAIKRTLFLD NHQAHRVFPL VIKRQKSHQC QDFIVYLRDE TEFRDKLSPI
     NISLNYSLDE STFKEGLEVK PILNYYRENI VSEQAHILVD CGEDNLCVPD LKLSARPDKH
     QVIIGDENHL MLIINARNEG EGAYEAELFV MIPEEADYVG IERNNKGFRP LSCEYKMENV
     TRMVVCDLGN PMVSGTNYSL GLRFAVPRLE KTNMSINFDL QIRSSNKDNP DSNFVSLQIN
     ITAVAQVEIR GVSHPPQIVL PIHNWEPEEE PHKEEEVGPL VEHIYELHNI GPSTISDTIL
     EVGWPFSARD EFLLYIFHIQ TLGPLQCQPN PNINPQDIKP AASPEDTPEL SAFLRNSTIP
     HLVRKRDVHV VEFHRQSPAK ILNCTNIECL QISCAVGRLE GGESAVLKVR SRLWAHTFLQ
     RKNDPYALAS LVSFEVKKMP YTDQPAKLPE GSIVIKTSVI WATPNVSFSI PLWVIILAIL
     LGLLVLAILT LALWKCGFFD RARPPQEDMT DREQLTNDKT PEA
//
ID   ITA1_HUMAN              Reviewed;        1179 AA.
AC   P56199; B2RNU0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-NOV-2017, entry version 177.
DE   RecName: Full=Integrin alpha-1;
DE   AltName: Full=CD49 antigen-like family member A;
DE   AltName: Full=Laminin and collagen receptor;
DE   AltName: Full=VLA-1;
DE   AltName: CD_antigen=CD49a;
DE   Flags: Precursor;
GN   Name=ITGA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-1179.
RX   PubMed=8428973;
RA   Briesewitz R., Epstein M.R., Marcantonio E.E.;
RT   "Expression of native and truncated forms of the human integrin alpha
RT   1 subunit.";
RL   J. Biol. Chem. 268:2989-2996(1993).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-532.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [5]
RP   FUNCTION IN EGFR SIGNALING, AND INTERACTION WITH PTPN2.
RX   PubMed=15592458; DOI=10.1038/ncb1209;
RA   Mattila E., Pellinen T., Nevo J., Vuoriluoto K., Arjonen A.,
RA   Ivaska J.;
RT   "Negative regulation of EGFR signalling through integrin-alpha1beta1-
RT   mediated activation of protein tyrosine phosphatase TCPTP.";
RL   Nat. Cell Biol. 7:78-85(2005).
RN   [6]
RP   INTERACTION WITH RAB21.
RX   PubMed=16754960; DOI=10.1083/jcb.200509019;
RA   Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M.,
RA   Ivaska J.;
RT   "Small GTPase Rab21 regulates cell adhesion and controls endosomal
RT   traffic of beta1-integrins.";
RL   J. Cell Biol. 173:767-780(2006).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-100; ASN-105; ASN-217;
RP   ASN-341; ASN-418; ASN-460; ASN-532; ASN-780; ASN-840; ASN-966; ASN-974
RP   AND ASN-1008.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 168-359.
RX   PubMed=10455165; DOI=10.1074/jbc.274.35.24906;
RA   Rich R.L., Deivanayagam C.C., Owens R.T., Carson M., Hook A.,
RA   Moore D., Symersky J., Yang V.W., Narayana S.V., Hook M.;
RT   "Trench-shaped binding sites promote multiple classes of interactions
RT   between collagen and the adherence receptors, alpha(1)beta(1) integrin
RT   and Staphylococcus aureus cna MSCRAMM.";
RL   J. Biol. Chem. 274:24906-24913(1999).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.87 ANGSTROMS) OF 166-356.
RX   PubMed=14660600; DOI=10.1074/jbc.M312912200;
RA   Nymalm Y., Puranen J.S., Nyholm T.K., Kapyla J., Kidron H.,
RA   Pentikainen O.T., Airenne T.T., Heino J., Slotte J.P., Johnson M.S.,
RA   Salminen T.A.;
RT   "Jararhagin-derived RKKH peptides induce structural changes in alpha1I
RT   domain of human integrin alpha1beta1.";
RL   J. Biol. Chem. 279:7962-7970(2004).
CC   -!- FUNCTION: Integrin alpha-1/beta-1 is a receptor for laminin and
CC       collagen. It recognizes the proline-hydroxylated sequence G-F-P-G-
CC       E-R in collagen. Involved in anchorage-dependent, negative
CC       regulation of EGF-stimulated cell growth.
CC       {ECO:0000269|PubMed:15592458}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-1
CC       associates with beta-1. Interacts with RAB21. Interacts (via
CC       cytoplasmic domain) with PTPN2; activates PTPN2 phosphatase
CC       activity towards EGFR and negatively regulates EGF signaling.
CC       {ECO:0000269|PubMed:15592458, ECO:0000269|PubMed:16754960}.
CC   -!- INTERACTION:
CC       P04512:- (xeno); NbExp=2; IntAct=EBI-2554465, EBI-15711650;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC027326; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025180; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC137121; AAI37122.1; -; mRNA.
DR   EMBL; BC137122; AAI37123.1; -; mRNA.
DR   EMBL; X68742; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS3955.1; -.
DR   PIR; A45226; A45226.
DR   RefSeq; NP_852478.1; NM_181501.1.
DR   UniGene; Hs.644352; -.
DR   PDB; 1PT6; X-ray; 1.87 A; A/B=166-366.
DR   PDB; 1QC5; X-ray; 2.00 A; A/B=168-359.
DR   PDB; 1QCY; X-ray; 2.30 A; A=169-361.
DR   PDB; 2L8S; NMR; -; A=1135-1179.
DR   PDB; 2M32; NMR; -; A=168-359.
DR   PDB; 4A0Q; X-ray; 1.90 A; A/B=166-366.
DR   PDB; 5HGJ; X-ray; 1.40 A; A/B=170-364.
DR   PDBsum; 1PT6; -.
DR   PDBsum; 1QC5; -.
DR   PDBsum; 1QCY; -.
DR   PDBsum; 2L8S; -.
DR   PDBsum; 2M32; -.
DR   PDBsum; 4A0Q; -.
DR   PDBsum; 5HGJ; -.
DR   ProteinModelPortal; P56199; -.
DR   SMR; P56199; -.
DR   BioGrid; 109879; 18.
DR   CORUM; P56199; -.
DR   DIP; DIP-206N; -.
DR   IntAct; P56199; 15.
DR   MINT; MINT-7004837; -.
DR   STRING; 9606.ENSP00000282588; -.
DR   BindingDB; P56199; -.
DR   ChEMBL; CHEMBL3682; -.
DR   GuidetoPHARMACOLOGY; 2437; -.
DR   TCDB; 8.A.54.1.1; the integrin (integrin) family.
DR   iPTMnet; P56199; -.
DR   PhosphoSitePlus; P56199; -.
DR   BioMuta; ITGA1; -.
DR   DMDM; 124056463; -.
DR   EPD; P56199; -.
DR   MaxQB; P56199; -.
DR   PaxDb; P56199; -.
DR   PeptideAtlas; P56199; -.
DR   PRIDE; P56199; -.
DR   Ensembl; ENST00000282588; ENSP00000282588; ENSG00000213949.
DR   GeneID; 3672; -.
DR   KEGG; hsa:3672; -.
DR   UCSC; uc003jou.4; human.
DR   CTD; 3672; -.
DR   DisGeNET; 3672; -.
DR   EuPathDB; HostDB:ENSG00000213949.8; -.
DR   GeneCards; ITGA1; -.
DR   HGNC; HGNC:6134; ITGA1.
DR   HPA; HPA042555; -.
DR   MIM; 192968; gene.
DR   neXtProt; NX_P56199; -.
DR   OpenTargets; ENSG00000213949; -.
DR   PharmGKB; PA29935; -.
DR   eggNOG; ENOG410IPB7; Eukaryota.
DR   eggNOG; ENOG410YEM8; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000059610; -.
DR   HOVERGEN; HBG006185; -.
DR   InParanoid; P56199; -.
DR   KO; K06480; -.
DR   OMA; QRFSIAI; -.
DR   OrthoDB; EOG091G00TK; -.
DR   PhylomeDB; P56199; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-416700; Other semaphorin interactions.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-75892; Platelet Adhesion to exposed collagen.
DR   SignaLink; P56199; -.
DR   SIGNOR; P56199; -.
DR   ChiTaRS; ITGA1; human.
DR   EvolutionaryTrace; P56199; -.
DR   GeneWiki; CD49a; -.
DR   GenomeRNAi; 3672; -.
DR   PRO; PR:P56199; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000213949; -.
DR   Genevisible; P56199; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0045178; C:basal part of cell; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034665; C:integrin alpha1-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005518; F:collagen binding; TAS:UniProtKB.
DR   GO; GO:0098639; F:collagen binding involved in cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IEA:Ensembl.
DR   GO; GO:0000187; P:activation of MAPK activity; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0045123; P:cellular extravasation; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006936; P:muscle contraction; TAS:Reactome.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042311; P:vasodilation; IEA:Ensembl.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Magnesium; Membrane;
KW   Metal-binding; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29   1179       Integrin alpha-1.
FT                                /FTId=PRO_0000174215.
FT   TOPO_DOM     29   1141       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1142   1164       Helical. {ECO:0000255}.
FT   TOPO_DOM   1165   1179       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       30     91       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      101    160       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      161    360       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      365    417       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      422    475       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      476    538       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      557    615       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      619    679       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     498    506       {ECO:0000255}.
FT   CA_BIND     580    588       {ECO:0000255}.
FT   CA_BIND     642    650       {ECO:0000255}.
FT   MOTIF      1167   1171       GFFKR motif.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    100    100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    112    112       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    217    217       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    317    317       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    402    402       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    418    418       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    460    460       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    532    532       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    699    699       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    748    748       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    780    780       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    840    840       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    883    883       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    908    908       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    915    915       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    939    939       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    966    966       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    974    974       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1008   1008       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1073   1073       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1083   1083       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1102   1102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1113   1113       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     82     92       {ECO:0000250}.
FT   DISULFID    688    697       {ECO:0000250}.
FT   DISULFID    703    756       {ECO:0000250}.
FT   DISULFID    808    814       {ECO:0000250}.
FT   DISULFID    878    886       {ECO:0000250}.
FT   DISULFID   1030   1062       {ECO:0000250}.
FT   DISULFID   1065   1072       {ECO:0000250}.
FT   VARIANT     480    480       T -> M (in dbSNP:rs4145748).
FT                                /FTId=VAR_034022.
FT   VARIANT     670    670       V -> I (in dbSNP:rs2279587).
FT                                /FTId=VAR_049630.
FT   VARIANT     961    961       I -> M (in dbSNP:rs12520591).
FT                                /FTId=VAR_034023.
FT   VARIANT    1108   1108       E -> G (in dbSNP:rs988574).
FT                                /FTId=VAR_034024.
FT   CONFLICT    198    198       E -> K (in Ref. 3). {ECO:0000305}.
FT   CONFLICT    254    254       I -> T (in Ref. 3). {ECO:0000305}.
FT   CONFLICT    705    705       D -> E (in Ref. 3). {ECO:0000305}.
FT   STRAND      171    178       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       187    197       {ECO:0000244|PDB:5HGJ}.
FT   STRAND      206    222       {ECO:0000244|PDB:5HGJ}.
FT   TURN        224    226       {ECO:0000244|PDB:1PT6}.
FT   HELIX       230    238       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       250    259       {ECO:0000244|PDB:5HGJ}.
FT   TURN        260    262       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       264    266       {ECO:0000244|PDB:5HGJ}.
FT   STRAND      272    282       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       287    289       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       290    299       {ECO:0000244|PDB:5HGJ}.
FT   STRAND      302    309       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       311    315       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       321    330       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       335    338       {ECO:0000244|PDB:5HGJ}.
FT   STRAND      339    344       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       345    351       {ECO:0000244|PDB:5HGJ}.
FT   HELIX       352    359       {ECO:0000244|PDB:5HGJ}.
FT   HELIX      1143   1168       {ECO:0000244|PDB:2L8S}.
SQ   SEQUENCE   1179 AA;  130848 MW;  1A86F30FD916C845 CRC64;
     MAPRPRARPG VAVACCWLLT VVLRCCVSFN VDVKNSMTFS GPVEDMFGYT VQQYENEEGK
     WVLIGSPLVG QPKNRTGDVY KCPVGRGESL PCVKLDLPVN TSIPNVTEVK ENMTFGSTLV
     TNPNGGFLAC GPLYAYRCGH LHYTTGICSD VSPTFQVVNS IAPVQECSTQ LDIVIVLDGS
     NSIYPWDSVT AFLNDLLERM DIGPKQTQVG IVQYGENVTH EFNLNKYSST EEVLVAAKKI
     VQRGGRQTMT ALGIDTARKE AFTEARGARR GVKKVMVIVT DGESHDNHRL KKVIQDCEDE
     NIQRFSIAIL GSYNRGNLST EKFVEEIKSI ASEPTEKHFF NVSDELALVT IVKTLGERIF
     ALEATADQSA ASFEMEMSQT GFSAHYSQDW VMLGAVGAYD WNGTVVMQKA SQIIIPRNTT
     FNVESTKKNE PLASYLGYTV NSATASSGDV LYIAGQPRYN HTGQVIIYRM EDGNIKILQT
     LSGEQIGSYF GSILTTTDID KDSNTDILLV GAPMYMGTEK EEQGKVYVYA LNQTRFEYQM
     SLEPIKQTCC SSRQHNSCTT ENKNEPCGAR FGTAIAAVKD LNLDGFNDIV IGAPLEDDHG
     GAVYIYHGSG KTIRKEYAQR IPSGGDGKTL KFFGQSIHGE MDLNGDGLTD VTIGGLGGAA
     LFWSRDVAVV KVTMNFEPNK VNIQKKNCHM EGKETVCINA TVCFDVKLKS KEDTIYEADL
     QYRVTLDSLR QISRSFFSGT QERKVQRNIT VRKSECTKHS FYMLDKHDFQ DSVRITLDFN
     LTDPENGPVL DDSLPNSVHE YIPFAKDCGN KEKCISDLSL HVATTEKDLL IVRSQNDKFN
     VSLTVKNTKD SAYNTRTIVH YSPNLVFSGI EAIQKDSCES NHNITCKVGY PFLRRGEMVT
     FKILFQFNTS YLMENVTIYL SATSDSEEPP ETLSDNVVNI SIPVKYEVGL QFYSSASEYH
     ISIAANETVP EVINSTEDIG NEINIFYLIR KSGSFPMPEL KLSISFPNMT SNGYPVLYPT
     GLSSSENANC RPHIFEDPFS INSGKKMTTS TDHLKRGTIL DCNTCKFATI TCNLTSSDIS
     QVNVSLILWK PTFIKSYFSS LNLTIRGELR SENASLVLSS SNQKRELAIQ ISKDGLPGRV
     PLWVILLSAF AGLLLLMLLI LALWKIGFFK RPLKKKMEK
//
ID   CD47_HUMAN              Reviewed;         323 AA.
AC   Q08722; A8K198; D3DN59; Q53Y71; Q96A60;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   25-OCT-2017, entry version 165.
DE   RecName: Full=Leukocyte surface antigen CD47;
DE   AltName: Full=Antigenic surface determinant protein OA3;
DE   AltName: Full=Integrin-associated protein;
DE            Short=IAP;
DE   AltName: Full=Protein MER6;
DE   AltName: CD_antigen=CD47;
DE   Flags: Precursor;
GN   Name=CD47; Synonyms=MER6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM OA3-323).
RC   TISSUE=Ovary;
RX   PubMed=1394148;
RA   Campbell I.G., Freemont P.S., Foulkes W., Trowsdale J.;
RT   "An ovarian tumor marker with homology to vaccinia virus contains an
RT   IgV-like region and multiple transmembrane domains.";
RL   Cancer Res. 52:5416-5420(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM OA3-305), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TOPOLOGY.
RC   TISSUE=Myelomonocyte;
RX   PubMed=7691831; DOI=10.1083/jcb.123.2.485;
RA   Lindberg F.P., Gresham H.D., Schwarz E., Brown E.J.;
RT   "Molecular cloning of integrin-associated protein: an immunoglobulin
RT   family member with multiple membrane spanning domains implicated in
RT   alpha-v beta-3-dependent ligand binding.";
RL   J. Cell Biol. 123:485-496(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM OA3-305).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM OA3-323).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM OA3-305).
RC   TISSUE=Hippocampus, Leiomyosarcoma, and Ovarian adenocarcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE, AND IDENTIFICATION AS CD47.
RC   TISSUE=Erythrocyte;
RX   PubMed=7998989; DOI=10.1042/bj3040525;
RA   Mawby W.J., Holmes C.H., Anstee D.J., Spring F.A., Tanner M.J.A.;
RT   "Isolation and characterization of CD47 glycoprotein: a multispanning
RT   membrane protein which is the same as integrin-associated protein
RT   (IAP) and the ovarian tumour marker OA3.";
RL   Biochem. J. 304:525-530(1994).
RN   [8]
RP   INTERACTION WITH UBQLN1 AND UBQLN2.
RX   PubMed=10549293; DOI=10.1016/S1097-2765(00)80212-9;
RA   Wu A.-L., Wang J., Zheleznyak A., Brown E.J.;
RT   "Ubiquitin-related proteins regulate interaction of vimentin
RT   intermediate filaments with the plasma membrane.";
RL   Mol. Cell 4:619-625(1999).
RN   [9]
RP   DISULFIDE BOND.
RX   PubMed=11454874; DOI=10.1074/jbc.M106107200;
RA   Rebres R.A., Vaz L.E., Green J.M., Brown E.J.;
RT   "Normal ligand binding and signaling by CD47 (integrin-associated
RT   protein) requires a long range disulfide bond between the
RT   extracellular and membrane-spanning domains.";
RL   J. Biol. Chem. 276:34607-34616(2001).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SIRPA.
RX   PubMed=11509594; DOI=10.4049/jimmunol.167.5.2547;
RA   Latour S., Tanaka H., Demeure C., Mateo V., Rubio M., Brown E.J.,
RA   Maliszewski C., Lindberg F.P., Oldenborg A., Ullrich A.,
RA   Delespesse G., Sarfati M.;
RT   "Bidirectional negative regulation of human T and dendritic cells by
RT   CD47 and its cognate receptor signal-regulator protein-alpha: down-
RT   regulation of IL-12 responsiveness and inhibition of dendritic cell
RT   activation.";
RL   J. Immunol. 167:2547-2554(2001).
RN   [11]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH SIRPG.
RC   TISSUE=T-cell;
RX   PubMed=15383453; DOI=10.1182/blood-2004-07-2823;
RA   Piccio L., Vermi W., Boles K.S., Fuchs A., Strader C.A., Facchetti F.,
RA   Cella M., Colonna M.;
RT   "Adhesion of human T cells to antigen-presenting cells through
RT   SIRPbeta2-CD47 interaction costimulates T-cell proliferation.";
RL   Blood 105:2421-2427(2005).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-73 AND ASN-111.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-50 AND ASN-73.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 19-136 IN COMPLEX WITH
RP   SIRPA, DISULFIDE BOND, GLYCOSYLATION AT ASN-23; ASN-50; ASN-73 AND
RP   ASN-111, AND PYROGLUTAMATE FORMATION AT GLN-19.
RX   PubMed=18657508; DOI=10.1016/j.molcel.2008.05.026;
RA   Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I.,
RA   Barclay A.N.;
RT   "Paired receptor specificity explained by structures of signal
RT   regulatory proteins alone and complexed with CD47.";
RL   Mol. Cell 31:266-277(2008).
CC   -!- FUNCTION: Has a role in both cell adhesion by acting as an
CC       adhesion receptor for THBS1 on platelets, and in the modulation of
CC       integrins. Plays an important role in memory formation and
CC       synaptic plasticity in the hippocampus (By similarity). Receptor
CC       for SIRPA, binding to which prevents maturation of immature
CC       dendritic cells and inhibits cytokine production by mature
CC       dendritic cells. Interaction with SIRPG mediates cell-cell
CC       adhesion, enhances superantigen-dependent T-cell-mediated
CC       proliferation and costimulates T-cell activation. May play a role
CC       in membrane transport and/or integrin dependent signal
CC       transduction. May prevent premature elimination of red blood
CC       cells. May be involved in membrane permeability changes induced
CC       following virus infection. {ECO:0000250,
CC       ECO:0000269|PubMed:11509594, ECO:0000269|PubMed:15383453,
CC       ECO:0000269|PubMed:7691831}.
CC   -!- SUBUNIT: Interacts with THBS1 and fibrinogen (By similarity).
CC       Monomer. Interacts with SIRPA, SIRPG, UBQLN1 and UBQLN2.
CC       {ECO:0000250, ECO:0000269|PubMed:10549293,
CC       ECO:0000269|PubMed:11509594, ECO:0000269|PubMed:15383453,
CC       ECO:0000269|PubMed:18657508}.
CC   -!- INTERACTION:
CC       Q9P1W8:SIRPG; NbExp=2; IntAct=EBI-1268321, EBI-1268284;
CC       Q8N205:SYNE4; NbExp=3; IntAct=EBI-1268321, EBI-7131783;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7691831};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:7691831}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=OA3-323;
CC         IsoId=Q08722-1; Sequence=Displayed;
CC       Name=OA3-293;
CC         IsoId=Q08722-2; Sequence=VSP_002535;
CC       Name=OA3-305;
CC         IsoId=Q08722-3; Sequence=VSP_002536, VSP_002537;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=OA3-312;
CC         IsoId=Q08722-4; Sequence=VSP_002538;
CC   -!- TISSUE SPECIFICITY: Very broadly distributed on normal adult
CC       tissues, as well as ovarian tumors, being especially abundant in
CC       some epithelia and the brain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X69398; CAA49196.1; -; mRNA.
DR   EMBL; Z25521; CAA80977.1; -; mRNA.
DR   EMBL; BT006907; AAP35553.1; -; mRNA.
DR   EMBL; AK289813; BAF82502.1; -; mRNA.
DR   EMBL; CH471052; EAW79733.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79734.1; -; Genomic_DNA.
DR   EMBL; BC010016; AAH10016.1; -; mRNA.
DR   EMBL; BC012884; AAH12884.1; -; mRNA.
DR   EMBL; BC037306; AAH37306.1; -; mRNA.
DR   CCDS; CCDS43125.1; -. [Q08722-3]
DR   CCDS; CCDS43126.1; -. [Q08722-1]
DR   PIR; A48997; A48997.
DR   RefSeq; NP_001768.1; NM_001777.3. [Q08722-1]
DR   RefSeq; NP_942088.1; NM_198793.2. [Q08722-3]
DR   UniGene; Hs.446414; -.
DR   PDB; 2JJS; X-ray; 1.85 A; C/D=20-136.
DR   PDB; 2JJT; X-ray; 2.30 A; C/D=20-136.
DR   PDB; 2VSC; X-ray; 1.90 A; A/B/C/D=20-136.
DR   PDB; 4CMM; X-ray; 1.92 A; B=20-136.
DR   PDB; 4KJY; X-ray; 1.93 A; A/C=19-135.
DR   PDB; 5IWL; X-ray; 2.80 A; C/D=20-132.
DR   PDB; 5TZ2; X-ray; 2.30 A; C=19-141.
DR   PDB; 5TZT; X-ray; 2.89 A; C/D=20-141.
DR   PDB; 5TZU; X-ray; 2.10 A; C=19-141.
DR   PDBsum; 2JJS; -.
DR   PDBsum; 2JJT; -.
DR   PDBsum; 2VSC; -.
DR   PDBsum; 4CMM; -.
DR   PDBsum; 4KJY; -.
DR   PDBsum; 5IWL; -.
DR   PDBsum; 5TZ2; -.
DR   PDBsum; 5TZT; -.
DR   PDBsum; 5TZU; -.
DR   ProteinModelPortal; Q08722; -.
DR   SMR; Q08722; -.
DR   BioGrid; 107399; 26.
DR   CORUM; Q08722; -.
DR   DIP; DIP-39948N; -.
DR   IntAct; Q08722; 5.
DR   STRING; 9606.ENSP00000355361; -.
DR   TCDB; 1.N.1.1.1; the osteoclast fusion complex (ofc) family.
DR   iPTMnet; Q08722; -.
DR   PhosphoSitePlus; Q08722; -.
DR   SwissPalm; Q08722; -.
DR   BioMuta; CD47; -.
DR   DMDM; 1171879; -.
DR   EPD; Q08722; -.
DR   MaxQB; Q08722; -.
DR   PaxDb; Q08722; -.
DR   PeptideAtlas; Q08722; -.
DR   PRIDE; Q08722; -.
DR   DNASU; 961; -.
DR   Ensembl; ENST00000355354; ENSP00000347512; ENSG00000196776. [Q08722-3]
DR   Ensembl; ENST00000361309; ENSP00000355361; ENSG00000196776. [Q08722-1]
DR   GeneID; 961; -.
DR   KEGG; hsa:961; -.
DR   UCSC; uc003dwt.2; human. [Q08722-1]
DR   CTD; 961; -.
DR   DisGeNET; 961; -.
DR   EuPathDB; HostDB:ENSG00000196776.14; -.
DR   GeneCards; CD47; -.
DR   HGNC; HGNC:1682; CD47.
DR   HPA; CAB016055; -.
DR   HPA; HPA044659; -.
DR   MIM; 601028; gene.
DR   neXtProt; NX_Q08722; -.
DR   OpenTargets; ENSG00000196776; -.
DR   PharmGKB; PA26222; -.
DR   eggNOG; ENOG410IJTS; Eukaryota.
DR   eggNOG; ENOG41113GI; LUCA.
DR   GeneTree; ENSGT00390000007697; -.
DR   HOGENOM; HOG000013020; -.
DR   HOVERGEN; HBG003808; -.
DR   InParanoid; Q08722; -.
DR   KO; K06266; -.
DR   OMA; VYMKFVA; -.
DR   OrthoDB; EOG091G0HUR; -.
DR   PhylomeDB; Q08722; -.
DR   TreeFam; TF336026; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-391160; Signal regulatory protein family interactions.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; Q08722; -.
DR   ChiTaRS; CD47; human.
DR   EvolutionaryTrace; Q08722; -.
DR   GeneWiki; CD47; -.
DR   GenomeRNAi; 961; -.
DR   PRO; PR:Q08722; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000196776; -.
DR   CleanEx; HS_CD47; -.
DR   ExpressionAtlas; Q08722; baseline and differential.
DR   Genevisible; Q08722; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0070053; F:thrombospondin receptor activity; IPI:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0008228; P:opsonization; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IDA:UniProtKB.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR006704; CD47.
DR   InterPro; IPR013147; CD47_TM.
DR   InterPro; IPR013270; CD47_Vset.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   PANTHER; PTHR10613; PTHR10613; 1.
DR   Pfam; PF04549; CD47; 1.
DR   Pfam; PF08204; V-set_CD47; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Membrane; Phosphoprotein;
KW   Pyrrolidone carboxylic acid; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    323       Leukocyte surface antigen CD47.
FT                                /FTId=PRO_0000014880.
FT   TOPO_DOM     19    141       Extracellular. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TOPO_DOM    163    176       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    177    197       Helical. {ECO:0000255}.
FT   TOPO_DOM    198    207       Extracellular. {ECO:0000255}.
FT   TRANSMEM    208    228       Helical. {ECO:0000255}.
FT   TOPO_DOM    229    235       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TOPO_DOM    257    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical. {ECO:0000255}.
FT   TOPO_DOM    290    323       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       19    127       Ig-like V-type.
FT   MOD_RES      19     19       Pyrrolidone carboxylic acid.
FT                                {ECO:0000269|PubMed:18657508}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97829}.
FT   CARBOHYD     23     23       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18657508}.
FT   CARBOHYD     34     34       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD     50     50       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18657508,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18657508,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    111    111       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18657508,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     33    263       {ECO:0000269|PubMed:11454874}.
FT   DISULFID     41    114       {ECO:0000269|PubMed:18657508}.
FT   VAR_SEQ     293    323       Missing (in isoform OA3-293).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002535.
FT   VAR_SEQ     304    305       KA -> NN (in isoform OA3-305).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7691831,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_002536.
FT   VAR_SEQ     306    323       Missing (in isoform OA3-305).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7691831,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_002537.
FT   VAR_SEQ     312    323       Missing (in isoform OA3-312).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002538.
FT   STRAND       26     30       {ECO:0000244|PDB:2JJS}.
FT   STRAND       35     39       {ECO:0000244|PDB:2JJS}.
FT   STRAND       42     45       {ECO:0000244|PDB:2JJS}.
FT   HELIX        51     53       {ECO:0000244|PDB:2JJS}.
FT   STRAND       54     60       {ECO:0000244|PDB:2JJS}.
FT   STRAND       63     69       {ECO:0000244|PDB:2JJS}.
FT   HELIX        70     72       {ECO:0000244|PDB:2JJS}.
FT   STRAND       74     76       {ECO:0000244|PDB:2JJS}.
FT   HELIX        79     81       {ECO:0000244|PDB:2JJS}.
FT   HELIX        88     93       {ECO:0000244|PDB:2JJS}.
FT   STRAND       98    101       {ECO:0000244|PDB:2JJS}.
FT   HELIX       102    106       {ECO:0000244|PDB:2JJS}.
FT   STRAND      110    118       {ECO:0000244|PDB:2JJS}.
FT   STRAND      121    131       {ECO:0000244|PDB:2JJS}.
SQ   SEQUENCE   323 AA;  35214 MW;  5D20730A2632D550 CRC64;
     MWPLVAALLL GSACCGSAQL LFNKTKSVEF TFCNDTVVIP CFVTNMEAQN TTEVYVKWKF
     KGRDIYTFDG ALNKSTVPTD FSSAKIEVSQ LLKGDASLKM DKSDAVSHTG NYTCEVTELT
     REGETIIELK YRVVSWFSPN ENILIVIFPI FAILLFWGQF GIKTLKYRSG GMDEKTIALL
     VAGLVITVIV IVGAILFVPG EYSLKNATGL GLIVTSTGIL ILLHYYVFST AIGLTSFVIA
     ILVIQVIAYI LAVVGLSLCI AACIPMHGPL LISGLSILAL AQLLGLVYMK FVASNQKTIQ
     PPRKAVEEPL NAFKESKGMM NDE
//
ID   PAT3_CAEEL              Reviewed;         809 AA.
AC   Q27874;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 153.
DE   RecName: Full=Integrin beta pat-3;
DE   AltName: Full=Paralyzed arrest at two-fold protein 3;
DE   Flags: Precursor;
GN   Name=pat-3; ORFNames=ZK1058.2;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=7744961; DOI=10.1083/jcb.129.4.1127;
RA   Gettner S.N., Kenyon C., Reichardt L.F.;
RT   "Characterization of beta pat-3 heterodimers, a family of essential
RT   integrin receptors in C. elegans.";
RL   J. Cell Biol. 129:1127-1141(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   INTERACTION WITH INA-1, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=9247263; DOI=10.1016/S0896-6273(00)80347-5;
RA   Baum P.D., Garriga G.;
RT   "Neuronal migrations and axon fasciculation are disrupted in ina-1
RT   integrin mutants.";
RL   Neuron 19:51-62(1997).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-400, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=12754521; DOI=10.1038/nbt829;
RA   Kaji H., Saito H., Yamauchi Y., Shinkawa T., Taoka M., Hirabayashi J.,
RA   Kasai K., Takahashi N., Isobe T.;
RT   "Lectin affinity capture, isotope-coded tagging and mass spectrometry
RT   to identify N-linked glycoproteins.";
RL   Nat. Biotechnol. 21:667-672(2003).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-141 AND ASN-269, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15888633; DOI=10.1093/glycob/cwi075;
RA   Fan X., She Y.-M., Bagshaw R.D., Callahan J.W., Schachter H.,
RA   Mahuran D.J.;
RT   "Identification of the hydrophobic glycoproteins of Caenorhabditis
RT   elegans.";
RL   Glycobiology 15:952-964(2005).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=17326220; DOI=10.1002/dvdy.21091;
RA   Ono K., Yu R., Ono S.;
RT   "Structural components of the nonstriated contractile apparatuses in
RT   the Caenorhabditis elegans gonadal myoepithelial sheath and their
RT   essential roles for ovulation.";
RL   Dev. Dyn. 236:1093-1105(2007).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-141; ASN-269; ASN-400;
RP   ASN-530 AND ASN-672, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19023419; DOI=10.1371/journal.pgen.1000269;
RA   Lucanic M., Cheng H.J.;
RT   "A RAC/CDC-42-independent GIT/PIX/PAK signaling pathway mediates cell
RT   migration in C. elegans.";
RL   PLoS Genet. 4:E1000269-E1000269(2008).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20226672; DOI=10.1016/j.cub.2010.01.062;
RA   Hsu T.Y., Wu Y.C.;
RT   "Engulfment of apoptotic cells in C. elegans is mediated by integrin
RT   alpha/SRC signaling.";
RL   Curr. Biol. 20:477-486(2010).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=23283987; DOI=10.1091/mbc.E12-06-0478;
RA   Warner A., Xiong G., Qadota H., Rogalski T., Vogl A.W., Moerman D.G.,
RA   Benian G.M.;
RT   "CPNA-1, a copine domain protein, is located at integrin adhesion
RT   sites and is required for myofilament stability in Caenorhabditis
RT   elegans.";
RL   Mol. Biol. Cell 24:601-616(2013).
RN   [11]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, PHOSPHORYLATION AT TYR-792,
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF TYR-792 AND 796-THR--THR-798.
RX   PubMed=28135265; DOI=10.1371/journal.pgen.1006592;
RA   Walser M., Umbricht C.A., Froehli E., Nanni P., Hajnal A.;
RT   "beta-Integrin de-phosphorylation by the density-enhanced phosphatase
RT   DEP-1 attenuates EGFR signaling in C. elegans.";
RL   PLoS Genet. 13:E1006592-E1006592(2017).
CC   -!- FUNCTION: Integrin alpha ina-1/beta pat-3 is a receptor for
CC       laminin. Integrin alpha pat-2/beta pat-3 recognizes the sequence
CC       R-G-D in its ligands (Probable). Plays a role in cell migration,
CC       morphogenesis and probably in cell-cell interactions
CC       (PubMed:19023419, PubMed:17326220, PubMed:23283987). During gonad
CC       morphogenesis, involved in distal tip cell (DTC)-mediated guidance
CC       of gonad elongation, in maintaining their sharp tapering
CC       morphology and in their migration (PubMed:19023419). Involved in
CC       the assembly of dense bodies and M lines during body wall muscle
CC       embryonic development by recruiting one of their components, cpna-
CC       1, to integrin-mediated attachment sites (PubMed:23283987). May
CC       play a similar role in the assembly of dense bodies in gonadal
CC       myoepithelial sheath cells (PubMed:17326220). Probably by acting
CC       as a receptor for apoptotic cells, plays a role in the clearance
CC       of apoptotic cells during mid-embryogenesis (PubMed:20226672).
CC       Required for ovulation (PubMed:17326220). Dephosphorylated,
CC       probably within the alpha pat-2/beta pat-3 integrin receptor
CC       complex, by the phosphatase dep-1, which leads to down-stream
CC       effects including the negative regulation of let-23 signaling and
CC       vulval induction (PubMed:28135265). When unphosphosphorylated,
CC       recruits the cytoplasmic adapter protein tln-1 to the plasma
CC       membrane of secondary vulval precursor cells (PubMed:28135265).
CC       This promotes the linking of focal adhesion sites to the F-actin
CC       cytoskeleton, and it also acts to restrict the mobility of the
CC       let-23 receptor on the plasma membrane of vulval cells which
CC       thereby attenuates let-23 signaling (PubMed:28135265).
CC       {ECO:0000269|PubMed:17326220, ECO:0000269|PubMed:19023419,
CC       ECO:0000269|PubMed:20226672, ECO:0000269|PubMed:23283987,
CC       ECO:0000269|PubMed:28135265, ECO:0000305}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit (Probable).
CC       Interacts with alpha subunit ina-1 (PubMed:9247263). Interacts
CC       with alpha subunit pat-2 (Probable). {ECO:0000269|PubMed:9247263,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9247263};
CC       Single-pass type I membrane protein {ECO:0000305}. Lateral cell
CC       membrane {ECO:0000269|PubMed:28135265}; Single-pass type I
CC       membrane protein {ECO:0000305}. Basal cell membrane
CC       {ECO:0000269|PubMed:28135265}; Single-pass type I membrane protein
CC       {ECO:0000305}. Cytoplasm, myofibril, sarcomere, M line
CC       {ECO:0000269|PubMed:23283987}. Note=In body wall muscles,
CC       colocalizes with cpna-1 at integrin adhesion structures (M line
CC       and dense bodies) (PubMed:23283987). In myoepithelial sheath
CC       cells, colocalizes in dense bodies-like structures with actin thin
CC       filaments, deb-1/vinculin and unc-52 (PubMed:17326220).
CC       {ECO:0000269|PubMed:17326220, ECO:0000269|PubMed:23283987}.
CC   -!- TISSUE SPECIFICITY: Expressed in body wall muscles (at protein
CC       level) (PubMed:23283987). Expressed in gonadal sheath cells and
CC       spermatheca (PubMed:17326220). Expressed in vulval cells and along
CC       the basal laminae that separate the vulval cells from the uterus
CC       (at the protein level) (PubMed:28135265).
CC       {ECO:0000269|PubMed:17326220, ECO:0000269|PubMed:23283987,
CC       ECO:0000269|PubMed:28135265}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryos (PubMed:9247263,
CC       PubMed:23283987). Highly expressed in mid to late L3 stage larvae
CC       (PubMed:28135265). {ECO:0000269|PubMed:23283987,
CC       ECO:0000269|PubMed:28135265, ECO:0000269|PubMed:9247263}.
CC   -!- PTM: Phosphorylated. Dephosphorylated by dep-1.
CC       {ECO:0000269|PubMed:28135265}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown in distal tip cell
CC       (DTC) causes DTC migration and guidance defects during the second
CC       phase of gonad elongation resulting in a triangular shaped gonad
CC       (PubMed:19023419). Embryos at the comma and 1.5-fold stages have
CC       increased number of cell corpses (PubMed:20226672). RNAi-mediated
CC       knockdown causes an accumulation in the proximal gonad of
CC       endomitotic mature oocytes (PubMed:17326220). RNAi-mediated
CC       knockdown results in increased mobility of let-23 receptor on the
CC       plasma membrane of vulval cells resulting in enhanced activity of
CC       the signaling pathway (PubMed:28135265). RNAi-mediated knockdown
CC       in vulval precursor cells in a let-60 gain of function mutant
CC       background results in increased vulval induction and an adjacent
CC       primary fate (Apf) phenotype whereby secondary vulval precursor
CC       cells transform into primary-like vulval cells (PubMed:28135265).
CC       {ECO:0000269|PubMed:17326220, ECO:0000269|PubMed:19023419,
CC       ECO:0000269|PubMed:20226672, ECO:0000269|PubMed:28135265}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U19744; AAA85704.1; -; Genomic_DNA.
DR   EMBL; Z35604; CAA84677.1; -; Genomic_DNA.
DR   PIR; A57283; A57283.
DR   RefSeq; NP_497787.1; NM_065386.5.
DR   UniGene; Cel.5347; -.
DR   ProteinModelPortal; Q27874; -.
DR   SMR; Q27874; -.
DR   BioGrid; 40742; 11.
DR   DIP; DIP-27060N; -.
DR   IntAct; Q27874; 3.
DR   MINT; MINT-1114713; -.
DR   STRING; 6239.ZK1058.2; -.
DR   iPTMnet; Q27874; -.
DR   EPD; Q27874; -.
DR   PaxDb; Q27874; -.
DR   PeptideAtlas; Q27874; -.
DR   PRIDE; Q27874; -.
DR   EnsemblMetazoa; ZK1058.2; ZK1058.2; WBGene00003930.
DR   GeneID; 175504; -.
DR   KEGG; cel:CELE_ZK1058.2; -.
DR   UCSC; ZK1058.2; c. elegans.
DR   CTD; 175504; -.
DR   WormBase; ZK1058.2; CE01102; WBGene00003930; pat-3.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000252936; -.
DR   InParanoid; Q27874; -.
DR   KO; K05719; -.
DR   OMA; FFDEDDC; -.
DR   OrthoDB; EOG091G029W; -.
DR   PhylomeDB; Q27874; -.
DR   SignaLink; Q27874; -.
DR   PRO; PR:Q27874; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00003930; -.
DR   GO; GO:0005605; C:basal lamina; IDA:UniProtKB.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; IDA:WormBase.
DR   GO; GO:0008305; C:integrin complex; IPI:WormBase.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031430; C:M band; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:WormBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:WormBase.
DR   GO; GO:0055120; C:striated muscle dense body; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0055001; P:muscle cell development; IMP:WormBase.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:1903356; P:positive regulation of distal tip cell migration; IMP:UniProtKB.
DR   GO; GO:0040017; P:positive regulation of locomotion; IMP:WormBase.
DR   GO; GO:1904901; P:positive regulation of myosin II filament organization; IMP:UniProtKB.
DR   GO; GO:0060279; P:positive regulation of ovulation; IMP:UniProtKB.
DR   GO; GO:0060298; P:positive regulation of sarcomere organization; IMP:UniProtKB.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; IMP:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:1903354; P:regulation of distal tip cell migration; IMP:UniProtKB.
DR   GO; GO:0040028; P:regulation of vulval development; IGI:UniProtKB.
DR   GO; GO:0055002; P:striated muscle cell development; IMP:UniProtKB.
DR   GO; GO:0072327; P:vulval cell fate specification; IGI:UniProtKB.
DR   Gene3D; 1.20.5.100; -; 1.
DR   Gene3D; 1.20.5.630; -; 1.
DR   InterPro; IPR021157; Cyt_c1_TM_anchor_C.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR033760; Integrin_beta_N.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR014836; Integrin_bsu_cyt_dom.
DR   InterPro; IPR037076; Integrin_bsu_cyt_dom_sf.
DR   InterPro; IPR012896; Integrin_bsu_tail.
DR   InterPro; IPR036349; Integrin_bsu_tail_dom_sf.
DR   InterPro; IPR002369; Integrin_bsu_VWA.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF08725; Integrin_b_cyt; 1.
DR   Pfam; PF07965; Integrin_B_tail; 1.
DR   Pfam; PF00362; Integrin_beta; 1.
DR   Pfam; PF17205; PSI_integrin; 1.
DR   PIRSF; PIRSF002512; Integrin_B; 1.
DR   PRINTS; PR01186; INTEGRINB.
DR   SMART; SM00187; INB; 1.
DR   SMART; SM01241; Integrin_b_cyt; 1.
DR   SMART; SM01242; Integrin_B_tail; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   SUPFAM; SSF69687; SSF69687; 1.
DR   PROSITE; PS00022; EGF_1; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 2.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Complete proteome; Cytoplasm;
KW   Glycoprotein; Integrin; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    809       Integrin beta pat-3.
FT                                /FTId=PRO_0000016358.
FT   TOPO_DOM     20    737       Extracellular. {ECO:0000255}.
FT   TRANSMEM    738    758       Helical. {ECO:0000255}.
FT   TOPO_DOM    759    809       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      153    352       VWFA.
FT   MOD_RES     792    792       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:28135265}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    269    269       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15888633,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    373    373       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    400    400       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754521,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    530    530       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    672    672       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    693    693       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    721    721       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     792    792       Y->F: In zh105; abolishes phosphorylation
FT                                and enhances recruitment of tln-1 to the
FT                                plasma membrane. Reduces the vulval lumen
FT                                diameter and partially suppresses the Apf
FT                                phenotype caused by hyperactive let-23
FT                                signaling in the double dep-1/lip-1 loss
FT                                of function mutant. Increases vulval
FT                                induction in the dep-1/lin-7 loss of
FT                                function mutant.
FT                                {ECO:0000269|PubMed:28135265}.
FT   MUTAGEN     796    798       TTT->AAA: Abolishes association with the
FT                                phosphatase dep-1.
FT                                {ECO:0000269|PubMed:28135265}.
SQ   SEQUENCE   809 AA;  90138 MW;  70C4AB01C8FE9189 CRC64;
     MPPSTSLLLL AALLPFALPA SDWKTGEVTG KVVEKSEFPC YSLSRDNYTC SACIQYHESC
     AWCGAPMFDE KKPYARCDSR AKLMEHGCPN SYIEDPATKL DITEDSKLSD QGQVESEEEA
     VQIKPQEMYV EIRPKSRVRF NVTYRQAVDY PVDLYYLMDL SYSMKDDKQK LSELGDLLAE
     RMRTVTKNFR LGFGSFIDKK LMPFIDPRIE KQLSPCPTPC AEPYGFKHQM SLTTNTAKFK
     AEVDKAEISG NLDAPEGGFD AVVQALACNK TIGWRERARK MIVFSTDAGF HFAGDGRLAG
     VVEPNDGTCH LDREGYYTET LNQDYPSIAL LHQMIKDRKA NVIFAVTKNN QDLYTQLSNA
     LPDVSSSVGV LANDSRNIVD LIEKEYLKIS EKIIMVDNAN ASEGLKLTYR SMCLDGTTLK
     DTNVCEGIRV GDEVQFEVTL ENTHCIDKRD FVLRIGPSGL DETLIVNVKV LCDCDCERQD
     RIVTNSADCN GGDMVCGVCR CKGGNVGKYC ECNRPGMSTA ALNEKCKRTN ESAICEGRGV
     CNCGRCECNP RANPEEQISG EFCECDNFNC PRHDRKICAE HGECNCGKCI CAPGWTGRAC
     ECPISTDSCL SANGKICNGK GECICGRCRC FDSPDGNRYS GAKCEICPTC PTKCVEYKNC
     VMCQQWQTGP LNETACDQCE FKVIPVEELP NLNETTPCQF VDPADDCTFY YLYYYDEATD
     NATVWVRKHK DCPPPVPVLA IVLGVIAGIV ILGILLLLLW KLLTVLHDRS EYATFNNERL
     MAKWDTNENP IYKQATTTFK NPVYAGKAN
//
ID   ITA5_BOVIN              Reviewed;         385 AA.
AC   Q27977;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   22-NOV-2017, entry version 98.
DE   RecName: Full=Integrin alpha-5;
DE   AltName: Full=Fibronectin receptor subunit alpha;
DE   AltName: Full=Integrin alpha-F;
DE   AltName: Full=VLA-5;
DE   Contains:
DE     RecName: Full=Integrin alpha-5 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-5 light chain;
DE   Flags: Fragment;
GN   Name=ITGA5;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7545439; DOI=10.1095/biolreprod53.1.153;
RA   Maclaren L.A., Wildeman A.G.;
RT   "Fibronectin receptors in preimplantation development: cloning,
RT   expression, and localization of the alpha 5 and beta 1 integrin
RT   subunits in bovine trophoblast.";
RL   Biol. Reprod. 53:153-165(1995).
CC   -!- FUNCTION: Integrin alpha-5/beta-1 is a receptor for fibronectin
CC       and fibrinogen. It recognizes the sequence R-G-D in its ligands.
CC       ITGA5:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct
CC       from the classical ligand-binding site (site 1) and this induces
CC       integrin conformational changes and enhanced ligand binding to
CC       site 1. ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and
CC       mediates R-G-D-dependent cell adhesion to FBN1.
CC       {ECO:0000250|UniProtKB:P08648}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-5 associates with beta-1. Interacts with
CC       HPS5 and NISCH. Interacts with RAB21 and COMP. ITGA5:ITGB1
CC       interacts with NOV. ITGA5:ITGB1 interacts with FBN1.
CC       {ECO:0000250|UniProtKB:P08648, ECO:0000250|UniProtKB:P11688}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:P08648}. Cell surface
CC       {ECO:0000250|UniProtKB:P08648}.
CC   -!- PTM: Proteolytic cleavage by PCSK5 mediates activation of the
CC       precursor. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10866; AAA80572.1; -; mRNA.
DR   PIR; I46060; I46060.
DR   UniGene; Bt.27462; -.
DR   ProteinModelPortal; Q27977; -.
DR   SMR; Q27977; -.
DR   STRING; 9913.ENSBTAP00000018261; -.
DR   PaxDb; Q27977; -.
DR   PRIDE; Q27977; -.
DR   eggNOG; KOG3637; Eukaryota.
DR   eggNOG; ENOG410XPVZ; LUCA.
DR   HOGENOM; HOG000231603; -.
DR   InParanoid; Q27977; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   SUPFAM; SSF69179; SSF69179; 2.
PE   2: Evidence at transcript level;
KW   Cell adhesion; Cell junction; Cleavage on pair of basic residues;
KW   Complete proteome; Disulfide bond; Glycoprotein; Integrin; Membrane;
KW   Metal-binding; Receptor; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN        <1   >385       Integrin alpha-5.
FT                                /FTId=PRO_0000016247.
FT   CHAIN        <1    252       Integrin alpha-5 heavy chain.
FT                                /FTId=PRO_0000409493.
FT   CHAIN       253   >385       Integrin alpha-5 light chain.
FT                                /FTId=PRO_0000016248.
FT   TOPO_DOM     <1    353       Extracellular. {ECO:0000255}.
FT   TRANSMEM    354    379       Helical. {ECO:0000255}.
FT   TOPO_DOM    380   >385       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     31     31       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     80     80       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    225    225       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID      1      7       {ECO:0000250}.
FT   DISULFID     74     87       {ECO:0000250}.
FT   DISULFID    226    269       {ECO:0000250}.
FT   DISULFID    274    279       {ECO:0000250}.
FT   NON_TER       1      1
FT   NON_TER     385    385
SQ   SEQUENCE   385 AA;  42943 MW;  EBE199BCEF51D9C8 CRC64;
     CGEENICVPD LQLEVFGEQN HVYLGDKNSL NLTFHAQNVG EGGAYEAELR VTAPPEAEYS
     GLVRHPGNFS SLSCDYFAVN QSRLLVCDLG NPMKAGASLW GGLRFTVPHL RDIKKTIQFD
     FQILSKNLNN VQSDVVSFRL SVEAQAQVSL NGVSKPEAVL FPMSDWHPQD QPQEEGDVGP
     AVHHVYELIN LGPSSISQGV LELSCPHALD GQQLLYVTRV TGLSNCTTSH PPNPEGLELD
     PEGSQHHRLQ RRMFLGRSPA SSGPQILKCP EAECFKLRCE LGPLHRQESR SLQLHFRVWA
     KAFLQREHQP FSLQCEAVYE ALKMPYKILP RQLPQKALQV ATAVQWIKAE GSHGVPLWII
     ILAILIGLLL LGLLIYILYN LFFFK
//
ID   ITAE_MOUSE              Reviewed;        1167 AA.
AC   Q60677; B1AUD5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   22-NOV-2017, entry version 144.
DE   RecName: Full=Integrin alpha-E;
DE   AltName: Full=Integrin alpha M290;
DE   AltName: CD_antigen=CD103;
DE   Contains:
DE     RecName: Full=Integrin alpha-E light chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-E heavy chain;
DE   Flags: Precursor;
GN   Name=Itgae;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=AKR/J;
RX   PubMed=7882170; DOI=10.1016/1074-7613(94)90070-1;
RA   Smith T.J., Ducharme L.A., Shaw S.K., Parker C.M., Brenner M.B.,
RA   Kilshaw P.J., Weis J.H.;
RT   "Murine M290 integrin expression modulated by mast cell activation.";
RL   Immunity 1:393-403(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
CC   -!- FUNCTION: Integrin alpha-E/beta-7 is a receptor for E-cadherin. It
CC       mediates adhesion of intra-epithelial T-lymphocytes to epithelial
CC       cell monolayers. Mice expressing a null mutation of the alpha-E
CC       subunit gene exhibit a marked reduction in the numbers of
CC       intraepithelial lymphocytes in the gut and in the development of
CC       gut-associated lymphoid aggregates, supporting a specific role for
CC       this integrin in mediating retention of lymphocytes in the
CC       intestinal wall.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chains linked by a
CC       disulfide bond. Alpha-E associates with beta-7.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U12236; AAC52142.1; -; mRNA.
DR   EMBL; AL670399; CAI24788.1; -; Genomic_DNA.
DR   CCDS; CCDS24995.1; -.
DR   RefSeq; NP_032425.2; NM_008399.2.
DR   UniGene; Mm.96; -.
DR   ProteinModelPortal; Q60677; -.
DR   SMR; Q60677; -.
DR   STRING; 10090.ENSMUSP00000006101; -.
DR   iPTMnet; Q60677; -.
DR   PhosphoSitePlus; Q60677; -.
DR   EPD; Q60677; -.
DR   MaxQB; Q60677; -.
DR   PaxDb; Q60677; -.
DR   PRIDE; Q60677; -.
DR   Ensembl; ENSMUST00000006101; ENSMUSP00000006101; ENSMUSG00000005947.
DR   GeneID; 16407; -.
DR   KEGG; mmu:16407; -.
DR   UCSC; uc007jzy.2; mouse.
DR   CTD; 3682; -.
DR   MGI; MGI:1298377; Itgae.
DR   eggNOG; ENOG410IPAZ; Eukaryota.
DR   eggNOG; ENOG410XR7I; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000049185; -.
DR   HOVERGEN; HBG006187; -.
DR   InParanoid; Q60677; -.
DR   KO; K06524; -.
DR   OMA; KMQGVER; -.
DR   OrthoDB; EOG091G09V5; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   ChiTaRS; Itgae; mouse.
DR   PRO; PR:Q60677; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   Bgee; ENSMUSG00000005947; -.
DR   CleanEx; MM_ITGAE; -.
DR   ExpressionAtlas; Q60677; baseline and differential.
DR   Genevisible; Q60677; MM.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0008305; C:integrin complex; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 4.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 2.
DR   PROSITE; PS51470; FG_GAP; 6.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell adhesion; Cleavage on pair of basic residues;
KW   Complete proteome; Disulfide bond; Glycoprotein; Integrin; Magnesium;
KW   Membrane; Metal-binding; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000250}.
FT   CHAIN        20   1167       Integrin alpha-E.
FT                                /FTId=PRO_0000016286.
FT   CHAIN        20    181       Integrin alpha-E light chain.
FT                                /FTId=PRO_0000016287.
FT   CHAIN       183   1167       Integrin alpha-E heavy chain.
FT                                /FTId=PRO_0000016288.
FT   TOPO_DOM     20   1114       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1115   1137       Helical. {ECO:0000255}.
FT   TOPO_DOM   1138   1167       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       27     81       FG-GAP 1.
FT   REPEAT       84    142       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      193    382       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      383    435       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      438    491       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      492    552       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      555    619       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      623    683       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     514    522       {ECO:0000255}.
FT   CA_BIND     578    586       {ECO:0000255}.
FT   CA_BIND     646    654       {ECO:0000255}.
FT   REGION      149    192       X-domain (extra domain).
FT   MOTIF      1140   1144       GFFKR motif.
FT   COMPBIAS    185    191       Glu-rich (acidic).
FT   CARBOHYD     51     51       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    256    256       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    314    314       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    364    364       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    418    418       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    437    437       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    718    718       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    773    773       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    829    829       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    846    846       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    911    911       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    925    925       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    968    968       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1013   1013       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1055   1055       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1086   1086       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     72     83       {ECO:0000250}.
FT   DISULFID    130    164       {ECO:0000250}.
FT   DISULFID    698    754       {ECO:0000250}.
FT   DISULFID    814    820       {ECO:0000250}.
FT   DISULFID    884    898       {ECO:0000250}.
FT   DISULFID    998   1023       {ECO:0000250}.
FT   DISULFID   1031   1047       {ECO:0000250}.
FT   CONFLICT     22     22       L -> M (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
FT   CONFLICT     46     46       Q -> L (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       E -> G (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       A -> R (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
FT   CONFLICT    378    378       H -> R (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
FT   CONFLICT    465    465       V -> I (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
FT   CONFLICT    696    696       K -> N (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
FT   CONFLICT    705    705       G -> V (in Ref. 1; AAC52142).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1167 AA;  128906 MW;  7534783B341175E5 CRC64;
     MKWLFHTLLC MASLKPQGAF NLDVDWAWVT ALQPGAPAVL SSLLHQDPSN NQTCLLVARR
     SSNRNTAALY RCAISISPDE IACQPVEHIC MPKGRYQGVT LVGNHNGVLV CIQVQARKFR
     SLNSELTGAC SLLTPNLDLQ AQAYFSDLEG FLDPGAHVDS GDYCRSKGGS TGEEKKSARR
     RRTVEEEDEE EDGTEIAIVL DGSGSIEPSD FQKAKNFIST MMRNFYEKCF ECNFALVQYG
     AVIQTEFDLQ ESRDINASLA KVQSIVQVKE VTKTASAMQH VLDNIFIPSR GSRKKALKVM
     VVLTDGDIFG DPLNLTTVIN SPKMQGVVRF AIGVGDAFKN NNTYRELKLI ASDPKEAHTF
     KVTNYSALDG LLSKLQQHIV HMEGTVGDAL QYQLAQTGFS AQILDKGQVL LGTVGAFNWS
     GGALLYSTQN GRGCFLNQTA KEDSRTVQYS YLGYSLAVLH KAHGVSYVAG APRHKLRGAV
     FELRKEDREE DAFVRRIEGE QMGSYFGSVL CPVDIDMDGT TDFLLVAAPF YHIRGEEGRV
     YVYQVPEQDA SFSLAHTLSG HPGLTNSRFG FAMAAVGDIN QDKFTDVAIG APLEGFGAGD
     GASYGSVYIY NGHSGGLYDS PSQQIRASSV ASGLHYFGMS VSGGLDFNGD GLADITVGSR
     DSAVVLRSRP VVDLTVSMTF TPDALPMVFI GKMDVKLCFE VDSSGVASEP GLREMFLNFT
     VDVDVTKQRQ RLQCEDSSGC QSCLRKWNGG SFLCEHFWLI STEELCEEDC FSNITIKVTY
     EFQTSGGRRD YPNPTLDHYK EPSAIFQLPY EKDCKNKVFC IAEIQLTTNI SQQELVVGVT
     KEVTMNISLT NSGEDSYMTN MALNYPRNLQ FKKIQKPVSP DVQCDDPKPV ASVLVMNCKI
     GHPILKRSSV NVSVTWQLEE SVFPNRTADI TVTISNSNEK SLARETRSLQ FRHAFIAVLS
     RPSVMYMNTS QSPSDHKEFF FNVHGENLFG AVFQLQICVP IKLQDFQIVR VKNLTKTQDH
     TECTQSQEPA CGSDPVQHVK EWHSVVCAIT SNKENVTVAA EISVGHTKQL LRDVSELPIL
     GEISFNKSLY EGLNAENHRT KITVIFLKEE ETRSLPLIIG SSIGGLLVLV VIIAILFKCG
     FFKRKYQQLN LESTRRAQLK ADSLLQD
//
ID   ITA3_MOUSE              Reviewed;        1053 AA.
AC   Q62470; Q08441; Q08442; Q5SWA8; Q5SWB9; Q6P6I1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-NOV-2017, entry version 159.
DE   RecName: Full=Integrin alpha-3;
DE   AltName: Full=CD49 antigen-like family member C;
DE   AltName: Full=Galactoprotein B3;
DE            Short=GAPB3;
DE   AltName: Full=VLA-3 subunit alpha;
DE   AltName: CD_antigen=CD49c;
DE   Contains:
DE     RecName: Full=Integrin alpha-3 heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-3 light chain;
DE   Flags: Precursor;
GN   Name=Itga3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=BALB/cJ;
RX   PubMed=7759572; DOI=10.1002/jcb.240570221;
RA   Takeuchi K., Hirano K., Tuji T., Osawa T., Irimura T.;
RT   "cDNA cloning of mouse VLA-3 alpha subunit.";
RL   J. Cell. Biochem. 57:371-377(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J, and FVB/N; TISSUE=Embryonic brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 913-1053 (ISOFORM 1), PARTIAL NUCLEOTIDE
RP   SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=1946438; DOI=10.1073/pnas.88.22.10183;
RA   Tamura R.N., Cooper H.M., Collo G., Quaranta V.;
RT   "Cell type-specific integrin variants with alternative alpha chain
RT   cytoplasmic domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10183-10187(1991).
RN   [5]
RP   INTERACTION WITH ITGB1; LGALS3 AND CSPG4.
RX   PubMed=15181153; DOI=10.1091/mbc.E04-03-0236;
RA   Fukushi J., Makagiansar I.T., Stallcup W.B.;
RT   "NG2 proteoglycan promotes endothelial cell motility and angiogenesis
RT   via engagement of galectin-3 and alpha3beta1 integrin.";
RL   Mol. Biol. Cell 15:3580-3590(2004).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-86; ASN-574; ASN-599;
RP   ASN-606; ASN-657; ASN-928 AND ASN-937.
RC   TISSUE=Myoblast;
RX   PubMed=19656770; DOI=10.1074/mcp.M900195-MCP200;
RA   Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,
RA   Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,
RA   Wollscheid B.;
RT   "The mouse C2C12 myoblast cell surface N-linked glycoproteome:
RT   identification, glycosite occupancy, and membrane orientation.";
RL   Mol. Cell. Proteomics 8:2555-2569(2009).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-86; ASN-512; ASN-574;
RP   ASN-657; ASN-937 AND ASN-971.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Liver, Lung, Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Integrin alpha-3/beta-1 is a receptor for fibronectin,
CC       laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin
CC       alpha-3/beta-1 provides a docking site for FAP (seprase) at
CC       invadopodia plasma membranes in a collagen-dependent manner and
CC       hence may participate in the adhesion, formation of invadopodia
CC       and matrix degradation processes, promoting cell invasion. Alpha-
CC       3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of
CC       endothelial cells migration. {ECO:0000250|UniProtKB:P26006}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-3 associates with beta-1. Interacts with
CC       HPS5. Interacts with FAP (seprase); the interaction occurs at the
CC       cell surface of invadopodia membrane in a collagen-dependent
CC       manner. {ECO:0000250|UniProtKB:P26006}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Cell membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}.
CC       Cell projection, invadopodium membrane
CC       {ECO:0000250|UniProtKB:P26006}; Single-pass type I membrane
CC       protein {ECO:0000255}. Cell projection, filopodium membrane
CC       {ECO:0000250|UniProtKB:P26006}; Single-pass type I membrane
CC       protein {ECO:0000255}. Note=Enriched preferentially at
CC       invadopodia, cell membrane protrusions that correspond to sites of
CC       cell invasion, in a collagen-dependent manner.
CC       {ECO:0000250|UniProtKB:P26006}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Alpha-3A;
CC         IsoId=Q62470-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha-3B;
CC         IsoId=Q62470-2; Sequence=VSP_002722;
CC       Name=3;
CC         IsoId=Q62470-3; Sequence=VSP_041797;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in heart
CC       and brain. Only isoform 1 is detected in lung.
CC       {ECO:0000269|PubMed:1946438}.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13867; BAA02980.1; -; mRNA.
DR   EMBL; AL606480; CAI23969.2; -; Genomic_DNA.
DR   EMBL; AL606480; CAI23971.1; -; Genomic_DNA.
DR   EMBL; AL606480; CAI23972.1; -; Genomic_DNA.
DR   EMBL; BC053031; AAH53031.1; -; mRNA.
DR   EMBL; BC062205; AAH62205.1; -; mRNA.
DR   EMBL; S66292; AAB20356.2; -; mRNA.
DR   EMBL; S66294; AAB20357.2; -; mRNA.
DR   CCDS; CCDS25271.1; -. [Q62470-1]
DR   CCDS; CCDS83877.1; -. [Q62470-3]
DR   CCDS; CCDS83878.1; -. [Q62470-2]
DR   PIR; B41543; B41543.
DR   PIR; I55534; I55534.
DR   RefSeq; NP_001293000.1; NM_001306071.1. [Q62470-3]
DR   RefSeq; NP_001293091.1; NM_001306162.1. [Q62470-2]
DR   RefSeq; NP_038593.1; NM_013565.3. [Q62470-1]
DR   RefSeq; XP_006532373.1; XM_006532310.3. [Q62470-2]
DR   RefSeq; XP_006532374.1; XM_006532311.3. [Q62470-1]
DR   UniGene; Mm.57035; -.
DR   ProteinModelPortal; Q62470; -.
DR   BioGrid; 200816; 2.
DR   CORUM; Q62470; -.
DR   IntAct; Q62470; 1.
DR   MINT; MINT-4098816; -.
DR   STRING; 10090.ENSMUSP00000001548; -.
DR   iPTMnet; Q62470; -.
DR   PhosphoSitePlus; Q62470; -.
DR   SwissPalm; Q62470; -.
DR   PaxDb; Q62470; -.
DR   PeptideAtlas; Q62470; -.
DR   PRIDE; Q62470; -.
DR   Ensembl; ENSMUST00000001548; ENSMUSP00000001548; ENSMUSG00000001507. [Q62470-1]
DR   Ensembl; ENSMUST00000107739; ENSMUSP00000103368; ENSMUSG00000001507. [Q62470-3]
DR   Ensembl; ENSMUST00000120375; ENSMUSP00000113556; ENSMUSG00000001507. [Q62470-2]
DR   GeneID; 16400; -.
DR   KEGG; mmu:16400; -.
DR   UCSC; uc007kzv.1; mouse. [Q62470-3]
DR   UCSC; uc007kzw.1; mouse. [Q62470-1]
DR   UCSC; uc007kzx.1; mouse. [Q62470-2]
DR   CTD; 3675; -.
DR   MGI; MGI:96602; Itga3.
DR   eggNOG; ENOG410IPB6; Eukaryota.
DR   eggNOG; ENOG410ZZD8; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000015786; -.
DR   HOVERGEN; HBG108011; -.
DR   InParanoid; Q62470; -.
DR   KO; K06482; -.
DR   OMA; YNQSAGN; -.
DR   OrthoDB; EOG091G012D; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-MMU-210991; Basigin interactions.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   Reactome; R-MMU-3000157; Laminin interactions.
DR   Reactome; R-MMU-8874081; MET activates PTK2 signaling.
DR   PMAP-CutDB; Q62470; -.
DR   PRO; PR:Q62470; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   Bgee; ENSMUSG00000001507; -.
DR   CleanEx; MM_ITGA3; -.
DR   ExpressionAtlas; Q62470; baseline and differential.
DR   Genevisible; Q62470; MM.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:MGI.
DR   GO; GO:0071944; C:cell periphery; ISO:MGI.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0060076; C:excitatory synapse; IDA:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0031527; C:filopodium membrane; ISS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; ISO:MGI.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0034667; C:integrin alpha3-beta1 complex; ISO:MGI.
DR   GO; GO:0071438; C:invadopodium membrane; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0043235; C:receptor complex; ISO:MGI.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0097060; C:synaptic membrane; IDA:MGI.
DR   GO; GO:0005518; F:collagen binding; IEA:Ensembl.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0043236; F:laminin binding; IEA:Ensembl.
DR   GO; GO:0002020; F:protease binding; ISO:MGI.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0097062; P:dendritic spine maintenance; IMP:MGI.
DR   GO; GO:0035640; P:exploration behavior; IGI:MGI.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0030324; P:lung development; ISO:MGI.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IMP:MGI.
DR   GO; GO:0048333; P:mesodermal cell differentiation; IEA:Ensembl.
DR   GO; GO:0031345; P:negative regulation of cell projection organization; IEA:Ensembl.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IGI:MGI.
DR   GO; GO:0072006; P:nephron development; ISO:MGI.
DR   GO; GO:0001764; P:neuron migration; IMP:MGI.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030510; P:regulation of BMP signaling pathway; ISO:MGI.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; ISO:MGI.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; ISO:MGI.
DR   GO; GO:0097205; P:renal filtration; ISO:MGI.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0034698; P:response to gonadotropin; IEA:Ensembl.
DR   GO; GO:0043588; P:skin development; ISO:MGI.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell junction; Cell membrane;
KW   Cell projection; Cleavage on pair of basic residues;
KW   Complete proteome; Disulfide bond; Glycoprotein; Integrin;
KW   Lipoprotein; Membrane; Palmitate; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     32       {ECO:0000250}.
FT   CHAIN        33   1053       Integrin alpha-3.
FT                                /FTId=PRO_0000016241.
FT   CHAIN        33    874       Integrin alpha-3 heavy chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016242.
FT   CHAIN       878   1053       Integrin alpha-3 light chain.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000016243.
FT   TOPO_DOM     33    993       Extracellular. {ECO:0000255}.
FT   TRANSMEM    994   1021       Helical. {ECO:0000255}.
FT   TOPO_DOM   1022   1053       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       38    103       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      110    171       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      185    235       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      236    293       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      294    355       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      357    412       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      416    478       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   LIPID      1018   1018       S-palmitoyl cysteine. {ECO:0000250}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    501    501       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    512    512       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    574    574       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    599    599       N-linked (GlcNAc...) asparagine;
FT                                atypical. {ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    606    606       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    657    657       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    699    699       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    843    843       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    859    859       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    925    925       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    928    928       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    937    937       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973,
FT                                ECO:0000269|PubMed:19656770}.
FT   CARBOHYD    971    971       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   DISULFID     94    103       {ECO:0000250}.
FT   DISULFID    140    162       {ECO:0000250}.
FT   DISULFID    185    197       {ECO:0000250}.
FT   DISULFID    486    491       {ECO:0000250}.
FT   DISULFID    497    551       {ECO:0000250}.
FT   DISULFID    616    622       {ECO:0000250}.
FT   DISULFID    695    704       {ECO:0000250}.
FT   DISULFID    848    906       Interchain (between heavy and light
FT                                chains). {ECO:0000250}.
FT   DISULFID    913    918       {ECO:0000250}.
FT   VAR_SEQ       1     69       MGPGPCRVPRAPGWLLRALALMVAACGRVAFAFNLDTRFLV
FT                                VKEAVNPGSLFGYSVALHRQTERQQRYL -> MSYLQTLVW
FT                                SPCSESVDLQADWREACKARLTHPPSFSS (in isoform
FT                                3). {ECO:0000305}.
FT                                /FTId=VSP_041797.
FT   VAR_SEQ    1019   1053       GFFKRARTRALYEAKRQKAEMKSQPSETERLTDDY -> DF
FT                                FKPTRYYRIMPKYHAVRIREEDRYPPPGSTLPTKKHWVTSW
FT                                QIRDRYY (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002722.
FT   CONFLICT    975    975       W -> C (in Ref. 4; AAB20356/AAB20357).
FT                                {ECO:0000305}.
FT   CONFLICT    979    979       D -> N (in Ref. 4; AAB20356/AAB20357).
FT                                {ECO:0000305}.
FT   CONFLICT   1002   1002       G -> S (in Ref. 4; AAB20356/AAB20357).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1053 AA;  116745 MW;  6A5E8FBDBA86D6E5 CRC64;
     MGPGPCRVPR APGWLLRALA LMVAACGRVA FAFNLDTRFL VVKEAVNPGS LFGYSVALHR
     QTERQQRYLL LAGAPRDLAV GDDYTNRTGA VYLCPLTAHK DDCERMDISE KSDPDHHIIE
     DMWLGVTVAS QGPAGRVLVC AHRYTKVLWS GLEDQRRMVG KCYVRGNDLQ LDPGDDWQTY
     HNEMCNSNTD YLQTGMCQLG TSGGFTQNTV YFGAPGAYNW KGNSYMIQRK DWDLSEYSYR
     GSEEQGNLYI GYTVQVGNAI LHPTDIITVV TGAPRHQHMG AVFLLKQESG GDLQRKQVLK
     GTQVGAYFGS AIALADLNND GWQDLLVGAP YYFERKEEVG GAVYVFMNQA GASFPDQPSL
     LLHGPSRSAF GISIASIGDI NQDGFQDIAV GAPFEGLGKV YIYHSSSGGL LRQPQQIIHG
     EKLGLPGLAT FGYSLSGKMD VDENLYPDLL VGSLSDHIVL LRARPVINIL HRTLVARPAV
     LDPALCTATS CVQVELCFAY NQSAGNPNYR RNITLAYTLE ADRDRRPPRL RFARSQSSVF
     HGFFSMPETH CQTLELLLMD NVRDKLRPIV IAMNYSLPLR MPDRLKLGLR SLDAYPVLNQ
     AQAMENHTEV HFQKECGPDN KCDSNLQMRA AFLSEQLQPL SRLQYSRDTK KLFLSINVTN
     SPSSQRAGED AHEALLTLEV PSALLLSSVR PSGTCQANNE TILCELGNPF KRNQRMELLI
     AFEVIGVTLH TRDLPVLLQL STSSHQDNLQ PVLLTLQVDY TLQASLSLMN HRLQSFFGGT
     VMGEAAMKTA EDVGSPLKYE FQVSPVGDGL AALGTLVLGL EWPYEVTNGK WLLYPTEITI
     HSNGSWPCQP SGNLVNPLNL TLSDPGVTPL SPQRRRRQLD PGGDQSSPPV TLAAAKKAKS
     ETVLTCSNGR ARCVWLECPL PDTSNITNVT VKARVWNSTF IEDYKDFDRV RVDGWATLFL
     RTSIPTINME NKTTWFSVDI DSELVEELPA EIELWLVLVA VGAGLLLLGL IILLLWKCGF
     FKRARTRALY EAKRQKAEMK SQPSETERLT DDY
//
ID   ITBL_CAEEL              Reviewed;         423 AA.
AC   Q9GYK2;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 3.
DT   22-NOV-2017, entry version 111.
DE   RecName: Full=Uncharacterized integrin beta-like protein C05D9.3;
DE   Flags: Precursor;
GN   ORFNames=C05D9.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-65, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=12754521; DOI=10.1038/nbt829;
RA   Kaji H., Saito H., Yamauchi Y., Shinkawa T., Taoka M., Hirabayashi J.,
RA   Kasai K., Takahashi N., Isobe T.;
RT   "Lectin affinity capture, isotope-coded tagging and mass spectrometry
RT   to identify N-linked glycoproteins.";
RL   Nat. Biotechnol. 21:667-672(2003).
RN   [3]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-65 AND ASN-274, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the integrin beta chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FO080359; CCD63144.1; -; Genomic_DNA.
DR   RefSeq; NP_508212.3; NM_075811.5.
DR   UniGene; Cel.20186; -.
DR   ProteinModelPortal; Q9GYK2; -.
DR   SMR; Q9GYK2; -.
DR   IntAct; Q9GYK2; 1.
DR   STRING; 6239.C05D9.3; -.
DR   iPTMnet; Q9GYK2; -.
DR   EPD; Q9GYK2; -.
DR   PaxDb; Q9GYK2; -.
DR   PeptideAtlas; Q9GYK2; -.
DR   PRIDE; Q9GYK2; -.
DR   EnsemblMetazoa; C05D9.3; C05D9.3; WBGene00015472.
DR   GeneID; 182254; -.
DR   KEGG; cel:CELE_C05D9.3; -.
DR   UCSC; C05D9.3; c. elegans.
DR   CTD; 182254; -.
DR   WormBase; C05D9.3; CE35381; WBGene00015472; -.
DR   eggNOG; KOG1226; Eukaryota.
DR   eggNOG; ENOG410XP60; LUCA.
DR   GeneTree; ENSGT00760000119064; -.
DR   HOGENOM; HOG000017230; -.
DR   InParanoid; Q9GYK2; -.
DR   OMA; ICGCECE; -.
DR   OrthoDB; EOG091G0AG1; -.
DR   PhylomeDB; Q9GYK2; -.
DR   Reactome; R-CEL-3000157; Laminin interactions.
DR   Reactome; R-CEL-446107; Type I hemidesmosome assembly.
DR   SignaLink; Q9GYK2; -.
DR   PRO; PR:Q9GYK2; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00015472; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR015812; Integrin_bsu.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   PANTHER; PTHR10082; PTHR10082; 2.
DR   PRINTS; PR01186; INTEGRINB.
DR   SUPFAM; SSF69179; SSF69179; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS00243; INTEGRIN_BETA; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Integrin; Membrane;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   CHAIN        17    423       Uncharacterized integrin beta-like
FT                                protein C05D9.3.
FT                                /FTId=PRO_0000250560.
FT   TOPO_DOM     17    402       Extracellular. {ECO:0000255}.
FT   TRANSMEM    403    421       Helical. {ECO:0000255}.
FT   TOPO_DOM    422    423       Cytoplasmic. {ECO:0000255}.
FT   REGION      215    350       Cysteine-rich tandem repeats.
FT   CARBOHYD     65     65       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754521,
FT                                ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    307    307       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     24    217       {ECO:0000250}.
FT   DISULFID     33     43       {ECO:0000250}.
FT   DISULFID     36     68       {ECO:0000250}.
FT   DISULFID     46     57       {ECO:0000250}.
FT   DISULFID    215    219       {ECO:0000250}.
FT   DISULFID    230    241       {ECO:0000250}.
FT   DISULFID    238    280       {ECO:0000250}.
FT   DISULFID    243    252       {ECO:0000250}.
FT   DISULFID    254    271       {ECO:0000250}.
FT   DISULFID    286    291       {ECO:0000250}.
FT   DISULFID    288    319       {ECO:0000250}.
FT   DISULFID    293    303       {ECO:0000250}.
FT   DISULFID    305    310       {ECO:0000250}.
FT   DISULFID    325    330       {ECO:0000250}.
FT   DISULFID    332    341       {ECO:0000250}.
FT   DISULFID    343    350       {ECO:0000250}.
SQ   SEQUENCE   423 AA;  46223 MW;  0690DA1C7E279C77 CRC64;
     MKSRIFFITL LTIVAAQESA DQLCSSFDAQ QSCGQCIKAH AECAWCIDPH SSLTNRCQLK
     SKFTNETCTP HLVYSPQTAQ VKIQQNLPLE TKQHDGKTIV RQQPQAVSVR LMPSHSATVS
     FKYLHQTDPS RRSTEPETME IQTSDVKDTP LQLKFFIVCD GELKETKSCR VQNNQIVEFK
     IEVLVNSCSS TGDITLSVGI LRQRTIAGLY VTTICGCECE KHPEINSRLC HQNGHLVCGQ
     CVCDQSRGGD KCECPLASHG VSKASELEDK CRFNSSSPVC SASGKCKCGQ CQCNKPTVTG
     KFCQCDNDSC PLAVNGKVCS GNGVCDCGVC KCEMGWERDD CSCSTASNNC VDNGTPAPEE
     KDKPESVPEE PEATEKPDDM PSDSDLEKEL DESSSAKEEQ TSSSGVVSRV CVLLTFFLLV
     LNF
//
ID   ITA11_HUMAN             Reviewed;        1188 AA.
AC   Q9UKX5; J3KQM2; Q8WYI8; Q9UKQ1;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   22-NOV-2017, entry version 166.
DE   RecName: Full=Integrin alpha-11;
DE   Flags: Precursor;
GN   Name=ITGA11; ORFNames=MSTP018;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS ARG-524; LEU-972
RP   AND ILE-1003.
RC   TISSUE=Fetal heart, and Osteoblast;
RX   PubMed=10486209; DOI=10.1006/geno.1999.5909;
RA   Lehnert K., Ni J., Leung E., Gough S.M., Weaver A., Yao W.P., Liu D.,
RA   Wang S.-X., Morris C.M., Krissansen G.W.;
RT   "Cloning, sequence analysis, and chromosomal localization of the novel
RT   human integrin alpha11 subunit (ITGA11).";
RL   Genomics 60:179-187(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANTS ARG-524 AND LEU-972.
RC   TISSUE=Fetal muscle, and Uterus;
RX   PubMed=10464311; DOI=10.1074/jbc.274.36.25735;
RA   Velling T., Kusche-Gullberg M., Sejersen T., Gullberg D.;
RT   "cDNA cloning and chromosomal localization of human alpha(11)
RT   integrin. A collagen-binding, I domain-containing, beta(1)-associated
RT   integrin alpha-chain present in muscle tissues.";
RL   J. Biol. Chem. 274:25735-25742(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 317-1188 (ISOFORM 1), AND
RP   VARIANTS ARG-524 AND LEU-972.
RC   TISSUE=Aorta;
RA   Xu Y.Y., Sun L.Z., Wu Q.Y., Liu Y.Q., Liu B., Zhao B., Wang X.Y.,
RA   Song L., Ye J., Sheng H., Gao Y., Zhang C.L., Zhang J., Wei Y.J.,
RA   Sun Y.H., Jiang Y.X., Zhao X.W., Liu S., Liu L.S., Ding J.F.,
RA   Gao R.L., Qiang B.Q., Yuan J.G., Liew C.C., Zhao M.S., Hui R.T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 954-1188 (ISOFORM 1).
RC   TISSUE=Fibroblast;
RG   The European IMAGE consortium;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH RAB21, AND MUTAGENESIS OF ARG-1170.
RX   PubMed=16754960; DOI=10.1083/jcb.200509019;
RA   Pellinen T., Arjonen A., Vuoriluoto K., Kallio K., Fransen J.A.M.,
RA   Ivaska J.;
RT   "Small GTPase Rab21 regulates cell adhesion and controls endosomal
RT   traffic of beta1-integrins.";
RL   J. Cell Biol. 173:767-780(2006).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-331.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
CC   -!- FUNCTION: Integrin alpha-11/beta-1 is a receptor for collagen.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-11
CC       associates with beta-1. Interacts with RAB21.
CC       {ECO:0000269|PubMed:16754960}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UKX5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKX5-2; Sequence=VSP_053416;
CC   -!- TISSUE SPECIFICITY: According to PubMed:10464311, highest levels
CC       of expression in uterus and heart, intermediate levels in skeletal
CC       muscle and intermediate to low levels in pancreas, kidney and
CC       placenta. According to PubMed:10486209, also found in brain,
CC       colon, lung, small intestine, stomach, testis, salivary glands,
CC       thyroid glands and prostate. Very low levels in peripheral blood
CC       lymphocytes, fetal brain and fetal liver.
CC       {ECO:0000269|PubMed:10464311}.
CC   -!- DEVELOPMENTAL STAGE: Strongly up-regulated in differentiating
CC       fetal muscle cells (in vitro).
CC   -!- DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins
CC       with I-domains do not undergo protease cleavage.
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL39001.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ITGA11ID41001ch15q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF109681; AAF01258.1; -; mRNA.
DR   EMBL; AF137378; AAD51919.2; -; mRNA.
DR   EMBL; AC021553; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC100825; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF111799; AAL39001.1; ALT_INIT; mRNA.
DR   EMBL; AL359064; CAB94392.1; -; mRNA.
DR   CCDS; CCDS45291.1; -. [Q9UKX5-1]
DR   RefSeq; NP_001004439.1; NM_001004439.1. [Q9UKX5-1]
DR   UniGene; Hs.436416; -.
DR   UniGene; Hs.458733; -.
DR   ProteinModelPortal; Q9UKX5; -.
DR   BioGrid; 116481; 1.
DR   CORUM; Q9UKX5; -.
DR   IntAct; Q9UKX5; 3.
DR   STRING; 9606.ENSP00000327290; -.
DR   ChEMBL; CHEMBL5883; -.
DR   iPTMnet; Q9UKX5; -.
DR   PhosphoSitePlus; Q9UKX5; -.
DR   BioMuta; ITGA11; -.
DR   DMDM; 313104119; -.
DR   PaxDb; Q9UKX5; -.
DR   PeptideAtlas; Q9UKX5; -.
DR   PRIDE; Q9UKX5; -.
DR   DNASU; 22801; -.
DR   Ensembl; ENST00000315757; ENSP00000327290; ENSG00000137809. [Q9UKX5-1]
DR   Ensembl; ENST00000423218; ENSP00000403392; ENSG00000137809. [Q9UKX5-2]
DR   GeneID; 22801; -.
DR   KEGG; hsa:22801; -.
DR   UCSC; uc002ari.4; human. [Q9UKX5-1]
DR   CTD; 22801; -.
DR   DisGeNET; 22801; -.
DR   EuPathDB; HostDB:ENSG00000137809.16; -.
DR   GeneCards; ITGA11; -.
DR   H-InvDB; HIX0012380; -.
DR   HGNC; HGNC:6136; ITGA11.
DR   HPA; HPA051813; -.
DR   MIM; 604789; gene.
DR   neXtProt; NX_Q9UKX5; -.
DR   OpenTargets; ENSG00000137809; -.
DR   PharmGKB; PA29937; -.
DR   eggNOG; ENOG410IPB8; Eukaryota.
DR   eggNOG; ENOG410YTFZ; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000059610; -.
DR   HOVERGEN; HBG006185; -.
DR   InParanoid; Q9UKX5; -.
DR   KO; K06587; -.
DR   OMA; FHLKYEA; -.
DR   OrthoDB; EOG091G00QA; -.
DR   PhylomeDB; Q9UKX5; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   SignaLink; Q9UKX5; -.
DR   SIGNOR; Q9UKX5; -.
DR   ChiTaRS; ITGA11; human.
DR   GenomeRNAi; 22801; -.
DR   PRO; PR:Q9UKX5; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000137809; -.
DR   CleanEx; HS_ITGA11; -.
DR   Genevisible; Q9UKX5; HS.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0034681; C:integrin alpha11-beta1 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005518; F:collagen binding; IMP:UniProtKB.
DR   GO; GO:0098639; F:collagen binding involved in cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0038064; F:collagen receptor activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IMP:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0038065; P:collagen-activated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007517; P:muscle organ development; TAS:ProtInc.
DR   GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0006929; P:substrate-dependent cell migration; IMP:UniProtKB.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01839; FG-GAP; 2.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   Pfam; PF00092; VWA; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF69179; SSF69179; 4.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS50234; VWFA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Complete proteome;
KW   Disulfide bond; Glycoprotein; Integrin; Magnesium; Membrane;
KW   Metal-binding; Polymorphism; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23   1188       Integrin alpha-11.
FT                                /FTId=PRO_0000016318.
FT   TOPO_DOM     23   1141       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1142   1164       Helical. {ECO:0000255}.
FT   TOPO_DOM   1165   1188       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       24     85       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT       91    151       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   DOMAIN      164    345       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REPEAT      355    406       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      411    461       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      462    527       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      528    586       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      590    650       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     488    496       {ECO:0000255}.
FT   CA_BIND     551    559       {ECO:0000255}.
FT   CA_BIND     613    621       {ECO:0000255}.
FT   COMPBIAS   1153   1161       Poly-Leu.
FT   COMPBIAS   1173   1176       Poly-Arg.
FT   CARBOHYD     82     82       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     95     95       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    291    291       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    331    331       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    358    358       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    449    449       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    462    462       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    528    528       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    642    642       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    694    694       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    857    857       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    894    894       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    973    973       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1031   1031       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1039   1039       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1059   1059       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     76     83       {ECO:0000250}.
FT   DISULFID    121    139       {ECO:0000255}.
FT   DISULFID    129    159       {ECO:0000255}.
FT   DISULFID    659    668       {ECO:0000250}.
FT   DISULFID    674    729       {ECO:0000250}.
FT   DISULFID    781    787       {ECO:0000250}.
FT   DISULFID    881    893       {ECO:0000250}.
FT   VAR_SEQ    1029   1029       E -> EV (in isoform 2).
FT                                {ECO:0000303|PubMed:10486209}.
FT                                /FTId=VSP_053416.
FT   VARIANT     433    433       V -> M (in dbSNP:rs2306022).
FT                                /FTId=VAR_009889.
FT   VARIANT     471    471       M -> L (in dbSNP:rs2306024).
FT                                /FTId=VAR_020038.
FT   VARIANT     524    524       L -> R (in dbSNP:rs7168069).
FT                                {ECO:0000269|PubMed:10464311,
FT                                ECO:0000269|PubMed:10486209,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_009890.
FT   VARIANT     891    891       Q -> K (in dbSNP:rs2271725).
FT                                /FTId=VAR_020039.
FT   VARIANT     972    972       P -> L (in dbSNP:rs4777035).
FT                                {ECO:0000269|PubMed:10464311,
FT                                ECO:0000269|PubMed:10486209,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_009891.
FT   VARIANT    1003   1003       M -> I. {ECO:0000269|PubMed:10486209}.
FT                                /FTId=VAR_009892.
FT   VARIANT    1093   1093       L -> V.
FT                                /FTId=VAR_009894.
FT   MUTAGEN    1170   1170       R->A: No effect on RAB21-binding.
FT                                {ECO:0000269|PubMed:16754960}.
SQ   SEQUENCE   1188 AA;  133470 MW;  BFD95E57ED5D5849 CRC64;
     MDLPRGLVVA WALSLWPGFT DTFNMDTRKP RVIPGSRTAF FGYTVQQHDI SGNKWLVVGA
     PLETNGYQKT GDVYKCPVIH GNCTKLNLGR VTLSNVSERK DNMRLGLSLA TNPKDNSFLA
     CSPLWSHECG SSYYTTGMCS RVNSNFRFSK TVAPALQRCQ TYMDIVIVLD GSNSIYPWVE
     VQHFLINILK KFYIGPGQIQ VGVVQYGEDV VHEFHLNDYR SVKDVVEAAS HIEQRGGTET
     RTAFGIEFAR SEAFQKGGRK GAKKVMIVIT DGESHDSPDL EKVIQQSERD NVTRYAVAVL
     GYYNRRGINP ETFLNEIKYI ASDPDDKHFF NVTDEAALKD IVDALGDRIF SLEGTNKNET
     SFGLEMSQTG FSSHVVEDGV LLGAVGAYDW NGAVLKETSA GKVIPLRESY LKEFPEELKN
     HGAYLGYTVT SVVSSRQGRV YVAGAPRFNH TGKVILFTMH NNRSLTIHQA MRGQQIGSYF
     GSEITSVDID GDGVTDVLLV GAPMYFNEGR ERGKVYVYEL RQNLFVYNGT LKDSHSYQNA
     RFGSSIASVR DLNQDSYNDV VVGAPLEDNH AGAIYIFHGF RGSILKTPKQ RITASELATG
     LQYFGCSIHG QLDLNEDGLI DLAVGALGNA VILWSRPVVQ INASLHFEPS KINIFHRDCK
     RSGRDATCLA AFLCFTPIFL APHFQTTTVG IRYNATMDER RYTPRAHLDE GGDRFTNRAV
     LLSSGQELCE RINFHVLDTA DYVKPVTFSV EYSLEDPDHG PMLDDGWPTT LRVSVPFWNG
     CNEDEHCVPD LVLDARSDLP TAMEYCQRVL RKPAQDCSAY TLSFDTTVFI IESTRQRVAV
     EATLENRGEN AYSTVLNISQ SANLQFASLI QKEDSDGSIE CVNEERRLQK QVCNVSYPFF
     RAKAKVAFRL DFEFSKSIFL HHLEIELAAG SDSNERDSTK EDNVAPLRFH LKYEADVLFT
     RSSSLSHYEV KPNSSLERYD GIGPPFSCIF RIQNLGLFPI HGMMMKITIP IATRSGNRLL
     KLRDFLTDEA NTSCNIWGNS TEYRPTPVEE DLRRAPQLNH SNSDVVSINC NIRLVPNQEI
     NFHLLGNLWL RSLKALKYKS MKIMVNAALQ RQFHSPFIFR EEDPSRQIVF EISKQEDWQV
     PIWIIVGSTL GGLLLLALLV LALWKLGFFR SARRRREPGL DPTPKVLE
//
